{"meta":{"query_hash":"9135368537ec","filters":{"venue":"Multiple Sclerosis Journal"},"cohort_total":655,"direct_labels_cover":3,"predictions_cover":655,"exported":655,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/9135368537ec","api":"https://metacan.xera.ac/api/v1/cohort?venue=Multiple+Sclerosis+Journal"},"results":[{"id":"W1150265801","doi":"10.1177/1352458514546077","title":"2014 Joint ACTRIMS-ECTRIMS Meeting (MSBoston 2014) MS Journal Online: Poster Session 1","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Jewish General Hospital; Karadeniz Teknik Üniversitesi; Flinders University","keywords":"Session (web analytics); Joint (building); Multiple sclerosis; Medicine; Physical medicine and rehabilitation; Psychology; Computer science; World Wide Web; Engineering; Psychiatry","score_opus":0.6440041051294333,"score_gpt":0.4428276700272841,"score_spread":0.20117643510214916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1150265801","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0072400016,0.0124975275,0.009684701,0.31490773,0.59951365,0.0021485824,0.008131067,0.0009353996,0.044941343],"genre_scores_gemma":[0.034777913,0.01606443,0.024432937,0.08330106,0.36641943,0.0044804923,0.011967063,0.0014654243,0.4570913],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9920054,0.0033425288,0.00067543576,0.00081306876,0.0019838118,0.0011796076],"domain_scores_gemma":[0.97213644,0.0037427293,0.0018617186,0.0008974707,0.011235729,0.01012585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.031696584,0.0021024374,0.0018574727,0.0034993708,0.0028760443,0.0072400095,0.0023882112,0.009309476,0.18348047],"category_scores_gemma":[0.024276119,0.0011116825,0.003226538,0.0013402489,0.0010044441,0.0030191734,0.007015963,0.006546508,0.060234435],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009414226,0.00012304158,0.000491912,0.0004354601,0.00007877425,0.00010894832,0.000030992844,0.00013509506,0.0011507955,0.00043021177,0.97804755,0.018025849],"study_design_scores_gemma":[0.0004089226,0.00038114595,0.005532949,0.00083510036,0.00013578428,0.00020879958,0.00015702462,0.0006934984,0.0013106823,0.0031052341,0.9871587,0.000072052135],"about_ca_topic_score_codex":0.0015745702,"about_ca_topic_score_gemma":0.0072515956,"teacher_disagreement_score":0.18348047,"about_ca_system_score_codex":0.0032127912,"about_ca_system_score_gemma":0.0100078285,"threshold_uncertainty_score":0.6138033},"labels":[],"label_agreement":null},{"id":"W1534773079","doi":"10.1177/1352458515579444","title":"Level of education and multiple sclerosis risk after adjustment for known risk factors: The EnvIMS study","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"Universitetet i Bergen; Helse Vest; Multiple Sclerosis Society of Canada; Multiple Sclerosis Society; Fondazione Italiana Sclerosi Multipla","keywords":"Medicine; Multiple sclerosis; Socioeconomic status; Mononucleosis; Case-control study; Risk factor; Disease; Vitamin D and neurology; Demography; Internal medicine; Environmental health; Immunology; Population","score_opus":0.29767078911086164,"score_gpt":0.3490772758925649,"score_spread":0.05140648678170323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1534773079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998481,0.00061700755,0.0000747605,0.000057786696,0.0000123433265,0.0000069362386,0.0004123615,0.0000028117001,0.00033502537],"genre_scores_gemma":[0.9989619,0.00015350204,0.000082407,0.000020396832,0.000011240151,0.000009835281,0.00053770124,0.0000025839358,0.00022040725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995472,0.00014845446,0.00004961744,0.00008851104,0.000070999726,0.000095225296],"domain_scores_gemma":[0.99903595,0.00016321141,0.00036804524,0.000111116184,0.000091776565,0.00022988814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011512109,0.0003157646,0.00044798065,0.00064260745,0.00036565762,0.000677846,0.00046445424,0.0005213256,0.0013302946],"category_scores_gemma":[0.0020905032,0.00027670397,0.0009149009,0.0010458112,0.00018495502,0.00037658564,0.0005185387,0.00068029884,0.00014015083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037234518,0.00003955996,0.99825674,0.0000128863885,0.00022742421,0.000076957345,0.00006936305,0.000030855317,0.00010431909,0.000013242475,0.00009656196,0.000699684],"study_design_scores_gemma":[0.000022706223,0.00011143486,0.9993104,0.000011460266,0.00011977618,0.00007628206,0.00007656747,0.00007346973,0.000024565801,0.000012130293,0.00015902003,0.0000022566905],"about_ca_topic_score_codex":0.012735183,"about_ca_topic_score_gemma":0.013552131,"teacher_disagreement_score":0.012735183,"about_ca_system_score_codex":0.00027840657,"about_ca_system_score_gemma":0.0004500804,"threshold_uncertainty_score":0.02532214},"labels":[],"label_agreement":null},{"id":"W1576311387","doi":"10.1177/1352458515579441","title":"Corticospinal tract integrity measured using transcranial magnetic stimulation and magnetic resonance imaging in neuromyelitis optica and multiple sclerosis","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society; Vertex Pharmaceuticals","keywords":"Multiple sclerosis; Transcranial magnetic stimulation; Neuromyelitis optica; Magnetic resonance imaging; Corticospinal tract; Medicine; Neuroscience; Functional magnetic resonance imaging; Nuclear magnetic resonance; Stimulation; Psychology; Radiology; Physics; Diffusion MRI; Internal medicine; Immunology","score_opus":0.18740043981590304,"score_gpt":0.31398923760363023,"score_spread":0.1265887977877272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1576311387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995702,0.00011832245,0.00009128874,0.0000076359065,8.679885e-7,0.000007952233,0.00003621453,0.000003141999,0.00016440972],"genre_scores_gemma":[0.99969316,0.000030085579,0.00013716798,0.000006555655,0.0000012011036,0.0000076299875,0.00004798867,0.0000011277783,0.000075053766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997551,0.0000537807,0.000032654378,0.000064980886,0.0000669765,0.000026475964],"domain_scores_gemma":[0.99913496,0.00017485497,0.0003835159,0.000038899947,0.00013167402,0.00013610526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006043222,0.00034166244,0.00025938393,0.00074256095,0.00019478638,0.00025429117,0.00015604752,0.00047195627,0.00087938417],"category_scores_gemma":[0.0025009804,0.00013659682,0.00016061503,0.00026261187,0.00034803874,0.0003024395,0.00031473668,0.00023467623,0.00015823451],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027623437,0.00026103298,0.9236336,0.00012105021,0.00030626508,0.00078340556,0.0008076286,0.00045426984,0.058892146,0.000040117648,0.00009861729,0.011839505],"study_design_scores_gemma":[0.0000074178893,0.00037198747,0.9981116,0.000003543877,0.000016997896,0.0004902655,0.00005378028,0.00012939736,0.0007578954,0.000023239529,0.000031024996,0.0000028089182],"about_ca_topic_score_codex":0.0023849981,"about_ca_topic_score_gemma":0.003529756,"teacher_disagreement_score":0.0023849981,"about_ca_system_score_codex":0.00032728055,"about_ca_system_score_gemma":0.00017319468,"threshold_uncertainty_score":0.0047422647},"labels":[],"label_agreement":null},{"id":"W1829172417","doi":"10.1177/1352458515573094","title":"Multiple sclerosis patient-derived CSF induces transcriptional changes in proliferating oligodendrocyte progenitors","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Neurogenesis and neuroplasticity mechanisms","field":"Neuroscience","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada","keywords":"Oligodendrocyte; Multiple sclerosis; Biology; Cerebrospinal fluid; Progenitor cell; Western blot; Parenchyma; Gene expression; Transcriptome; Microarray analysis techniques; Pathology; Immunology; Myelin; Central nervous system; Cell biology; Gene; Medicine; Stem cell; Neuroscience; Genetics","score_opus":0.20823496788358556,"score_gpt":0.25610863007719503,"score_spread":0.04787366219360947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1829172417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99874085,0.00044266786,0.00022999366,0.000024758267,0.00001025707,0.000011949753,0.00021549562,0.000012261129,0.00031178267],"genre_scores_gemma":[0.9978982,0.0003648541,0.00052124285,0.00004099742,0.0000132501345,0.000040953808,0.0005687598,0.0000052825612,0.00054645084],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998653,0.000020094954,0.000011354223,0.000027069818,0.000037917354,0.00003828215],"domain_scores_gemma":[0.99989796,0.000026895616,0.000021935153,0.000010200366,0.000019045763,0.00002391078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010453113,0.00021748884,0.00023229778,0.00034355535,0.00012947172,0.00021394934,0.00006346177,0.00015542752,0.0011260202],"category_scores_gemma":[0.00021990284,0.00007718658,0.00019752618,0.00016487039,0.00017636972,0.000065750246,0.0001738421,0.0002810468,0.0002051111],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039263093,0.00005198997,0.0019823234,0.000050649858,0.0000080746,0.000114065486,0.000051773655,0.000028344417,0.99474996,0.000015264834,0.000049017985,0.0025058521],"study_design_scores_gemma":[0.000045412507,0.0022793028,0.15596253,0.000033651613,0.00005550648,0.0012190749,0.00038381413,0.00041074603,0.8367374,0.000094155876,0.0027674322,0.000011134939],"about_ca_topic_score_codex":0.000294807,"about_ca_topic_score_gemma":0.0005586876,"teacher_disagreement_score":0.0011260202,"about_ca_system_score_codex":0.00017092933,"about_ca_system_score_gemma":0.00015138886,"threshold_uncertainty_score":0.0037668943},"labels":[],"label_agreement":null},{"id":"W1834460196","doi":"10.1177/1352458515614091","title":"Spin echo transverse relaxation and atrophy in multiple sclerosis deep gray matter: A two-year longitudinal study","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Globus pallidus; Atrophy; Multiple sclerosis; Magnetic resonance imaging; Basal ganglia; Medicine; Central nervous system disease; Subthalamic nucleus; Nuclear medicine; Pathology; Parkinson's disease; Internal medicine; Deep brain stimulation; Disease; Radiology; Central nervous system","score_opus":0.1652316971842355,"score_gpt":0.32428517991665573,"score_spread":0.15905348273242023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1834460196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99958664,0.00014085879,0.000051392017,0.000021775946,0.0000034709385,0.000010752492,0.00009421677,0.0000037938628,0.00008712389],"genre_scores_gemma":[0.9989147,0.00008070892,0.00012006733,0.00002478559,0.0000088006855,0.000024401534,0.00045256148,0.0000021725405,0.00037171933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975294,0.000056286957,0.000021096239,0.000061001625,0.000045763634,0.000062882646],"domain_scores_gemma":[0.998831,0.000076975484,0.0004563507,0.000080003905,0.00021103404,0.0003446875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013953642,0.0004690523,0.00035899697,0.0006618964,0.00058151496,0.0004414229,0.00027872872,0.00071532954,0.0006439906],"category_scores_gemma":[0.0015758675,0.00034334665,0.0004737807,0.00037535004,0.0002989746,0.00053305965,0.0004917495,0.00082705554,0.00029382852],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014006566,0.0006186314,0.991527,0.00001874855,0.00020701291,0.00027176997,0.00040607862,0.000059164548,0.0025402715,0.000013893702,0.00012999981,0.0028067029],"study_design_scores_gemma":[0.00002363485,0.0011161965,0.998083,0.00000427251,0.000050615115,0.00022702149,0.000078627,0.00006751163,0.00017278445,0.000009328434,0.00016126968,0.0000057716775],"about_ca_topic_score_codex":0.003874044,"about_ca_topic_score_gemma":0.004094588,"teacher_disagreement_score":0.003874044,"about_ca_system_score_codex":0.0003979888,"about_ca_system_score_gemma":0.00030344632,"threshold_uncertainty_score":0.0077029467},"labels":[],"label_agreement":null},{"id":"W1856687084","doi":"10.1177/1352458515599073","title":"Adverse health behaviours are associated with depression and anxiety in multiple sclerosis: A prospective multisite study","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; St. Francis Xavier University; University of Manitoba; University of Calgary; Dalhousie University; University of British Columbia","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada","keywords":"Anxiety; Depression (economics); Medicine; Psychiatry; Multiple sclerosis; Incidence (geometry); Mental health; Odds ratio; Prospective cohort study; Internal medicine","score_opus":0.13749075565584384,"score_gpt":0.3196705339360339,"score_spread":0.18217977828019005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1856687084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991055,0.0001868024,0.000032639946,0.000043799082,0.0000036232968,0.00002147782,0.00043111778,0.0000017749069,0.0001732669],"genre_scores_gemma":[0.99926966,0.00014009843,0.000070151196,0.00003452135,0.000006328153,0.000017374754,0.00034279088,0.0000011418557,0.0001179034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993414,0.00018293766,0.00008180191,0.0001248549,0.0001531243,0.00011583256],"domain_scores_gemma":[0.9979219,0.00020772447,0.0008244408,0.00014810427,0.0003545678,0.0005433233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008263375,0.0003454743,0.00034539856,0.00071749894,0.0008993029,0.0008078996,0.0005135302,0.00069811393,0.0012750202],"category_scores_gemma":[0.0020814796,0.000586582,0.00069379684,0.0012430536,0.00035611255,0.0004795527,0.0007834186,0.00095558626,0.00018981168],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004279572,0.000027981103,0.99950147,0.000006466717,0.00004755722,0.00003175256,0.00006213032,0.0000061898813,0.000056082234,0.000002843995,0.000033621738,0.00018113444],"study_design_scores_gemma":[0.000005711743,0.000042944957,0.9997048,0.0000047912836,0.0000181787,0.000074112766,0.000079451136,0.000027680506,0.000006476038,0.0000027588858,0.000031082254,0.0000019314223],"about_ca_topic_score_codex":0.08058625,"about_ca_topic_score_gemma":0.13320918,"teacher_disagreement_score":0.08058625,"about_ca_system_score_codex":0.0007472421,"about_ca_system_score_gemma":0.0008777309,"threshold_uncertainty_score":0.16023439},"labels":[],"label_agreement":null},{"id":"W1893794029","doi":"10.1177/1352458515594041","title":"The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Cégep de Lévis; Hôpital Notre-Dame; Hôpital Charles-Le Moyne","funders":"National Health and Medical Research Council; Canadian Institutes of Health Research; Novartis Pharma; EMD Serono; H. Lundbeck A/S; Eli Lilly and Company; CSL Behring; Biogen; Associazione Italiana Sclerosi Multipla; Sanofi; European Commission; Pfizer; Multiple Sclerosis Australia; Teva Pharmaceutical Industries; National Research Foundation","keywords":"Multiple sclerosis; Persistence (discontinuity); Medicine; Immunology","score_opus":0.22713318913554484,"score_gpt":0.3184297553659268,"score_spread":0.09129656623038199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1893794029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99876887,0.00064524513,0.00004646673,0.000110135,0.0000039969723,0.000003870675,0.00017831587,0.0000026290293,0.00024044135],"genre_scores_gemma":[0.9995616,0.00013051691,0.00004116025,0.000019364948,0.000010471373,0.0000032339954,0.00014929229,0.0000019957843,0.00008229408],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981097,0.0007535114,0.00021064628,0.0002558364,0.0003872474,0.00028310163],"domain_scores_gemma":[0.98296887,0.005278518,0.009307501,0.0006409366,0.00063766114,0.001166429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002302465,0.00021462952,0.0003784369,0.0005455511,0.00033561527,0.0010215008,0.00044632642,0.0006135277,0.001921142],"category_scores_gemma":[0.014332529,0.00016470384,0.0009480859,0.000929489,0.00031367506,0.00070607045,0.00064998586,0.0010644469,0.00020576673],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046555322,0.00008950564,0.99613756,0.000016039197,0.0001335543,0.000024873454,0.000043044216,0.000080058526,0.000070604794,0.000010672536,0.00003316671,0.0028954053],"study_design_scores_gemma":[0.000010850514,0.000274186,0.99888796,0.0000120228815,0.00006872736,0.0001235185,0.00006728765,0.00039970543,0.000053780088,0.000020361895,0.00007816618,0.0000035416042],"about_ca_topic_score_codex":0.0050547123,"about_ca_topic_score_gemma":0.003537792,"teacher_disagreement_score":0.0050547123,"about_ca_system_score_codex":0.00044378373,"about_ca_system_score_gemma":0.00062228536,"threshold_uncertainty_score":0.012176752},"labels":[],"label_agreement":null},{"id":"W1893840820","doi":"10.1177/1352458515586086","title":"Progressive multiple sclerosis exhibits decreasing glutamate and glutamine over two years","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of British Columbia","funders":"Michael Smith Health Research BC","keywords":"Glutamine; Glutamate receptor; Creatine; Multiple sclerosis; Medicine; Internal medicine; Amyotrophic lateral sclerosis; Choline; Biomarker; Confidence interval; Endocrinology; Gastroenterology; Biology; Biochemistry; Disease; Immunology; Amino acid","score_opus":0.1502959326861515,"score_gpt":0.33536690691931803,"score_spread":0.18507097423316654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1893840820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99893755,0.0004934746,0.00012086901,0.000022002689,0.0000028048557,0.0000076229485,0.00006044756,0.000010787659,0.00034437398],"genre_scores_gemma":[0.99942553,0.00011835307,0.00009771427,0.000023231629,0.0000040633363,0.0000053935546,0.00013720478,0.0000021489604,0.00018631824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996251,0.000087609,0.00002871075,0.00008350967,0.000127352,0.000047649497],"domain_scores_gemma":[0.99787176,0.00036829378,0.0010713019,0.00018428628,0.00031968637,0.00018470787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011459783,0.0002748603,0.00035165861,0.00051047635,0.00016308608,0.00034264458,0.00022187838,0.00036156335,0.0009954652],"category_scores_gemma":[0.0028725923,0.00012609406,0.00023754286,0.0003892701,0.00029991844,0.00024441406,0.0003342725,0.000322442,0.00023139434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056865416,0.0004328169,0.9216875,0.00018367475,0.00040380112,0.0005378085,0.00040281645,0.00048095462,0.04402203,0.000085019194,0.00030431943,0.025772654],"study_design_scores_gemma":[0.00002309559,0.0015337802,0.9956239,0.0000044718267,0.000039713654,0.0004356368,0.00004263644,0.000111926136,0.0019074773,0.000047575006,0.00022601683,0.000003859296],"about_ca_topic_score_codex":0.0013446881,"about_ca_topic_score_gemma":0.0012215793,"teacher_disagreement_score":0.0013446881,"about_ca_system_score_codex":0.000225258,"about_ca_system_score_gemma":0.00021665517,"threshold_uncertainty_score":0.0060605407},"labels":[],"label_agreement":null},{"id":"W1940540259","doi":"10.1177/1352458510375568","title":"Meeting Review: The management of multiple sclerosis in children: a European view","year":2010,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Multiple Sclerosis Society; National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Medicine; Disease; Pediatrics; Population; Clinical trial; Intensive care medicine; Cognition; Physical therapy; Psychiatry; Pathology","score_opus":0.07895769089397592,"score_gpt":0.2966382770612843,"score_spread":0.2176805861673084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1940540259","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023328875,0.94774044,0.00011142078,0.036461,0.013648749,0.000023190847,0.000047959384,0.000007731494,0.0017262695],"genre_scores_gemma":[0.0034331842,0.941777,0.0006140977,0.028539127,0.023889126,0.000047917376,0.00008301661,0.0000070385,0.0016094403],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953667,0.0014348595,0.0013441107,0.0003084365,0.0013304362,0.0002154723],"domain_scores_gemma":[0.9842306,0.00429277,0.0034546738,0.00023446234,0.0064370516,0.0013504844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008422263,0.0009786917,0.0025492737,0.0023373365,0.0005576621,0.0027142728,0.0016184134,0.004952345,0.0041512004],"category_scores_gemma":[0.01421637,0.0002894356,0.0009908953,0.004049483,0.0011261913,0.0036281096,0.0012040937,0.0032434529,0.0017542636],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032048317,0.000069600654,0.0006587829,0.038726795,0.00021185492,0.0006569494,0.0001997061,0.00021736199,0.0008610519,0.0020456195,0.53388506,0.42214674],"study_design_scores_gemma":[0.0000673311,0.00013340617,0.0025336945,0.03163671,0.0002938939,0.0019562654,0.00023399603,0.000046292018,0.0001509778,0.00071203,0.9622064,0.000029047233],"about_ca_topic_score_codex":0.0014075756,"about_ca_topic_score_gemma":0.002866165,"teacher_disagreement_score":0.008422263,"about_ca_system_score_codex":0.0027473974,"about_ca_system_score_gemma":0.0040970934,"threshold_uncertainty_score":0.044541776},"labels":[],"label_agreement":null},{"id":"W1959008146","doi":"10.1177/1352458515595132","title":"Contribution of the cerebellum to cognitive performance in children and adolescents with multiple sclerosis","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Montreal Neurological Institute and Hospital; University of Toronto; Hospital for Sick Children; York University; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Cerebellum; Neuropsychology; Cognition; Multiple sclerosis; Brain size; Psychology; Audiology; Medicine; Magnetic resonance imaging; Expanded Disability Status Scale; Frontal lobe; Neuroscience; Psychiatry; Radiology","score_opus":0.06086575164846521,"score_gpt":0.27058420204301353,"score_spread":0.20971845039454834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1959008146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997744,0.00010110682,0.00001019401,0.000012232019,8.7544566e-7,0.0000011614717,0.000037168993,0.0000013602609,0.00006158948],"genre_scores_gemma":[0.9997204,0.00009195706,0.00003875451,0.000006110086,0.0000023851642,0.0000026606042,0.00009868348,0.0000013297282,0.000037789487],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998166,0.000035518693,0.000017135862,0.00004277685,0.000051783296,0.000036201454],"domain_scores_gemma":[0.99907565,0.00015552586,0.0005266641,0.000027742264,0.00009129833,0.00012304928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029600394,0.00046904088,0.00032301707,0.0006783395,0.00025874222,0.00046709488,0.00025013977,0.00035085075,0.0008312279],"category_scores_gemma":[0.0017386118,0.00017409737,0.00019958768,0.00045550364,0.00044908593,0.00032735517,0.00035278522,0.0003478195,0.00013563687],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008621863,0.000026359268,0.9975799,0.000008712008,0.000018283868,0.000214944,0.00011616012,0.00003851797,0.00042142023,0.0000074933077,0.00003419077,0.0014478359],"study_design_scores_gemma":[0.000002238033,0.00006683772,0.99917185,0.0000034486925,0.000009051309,0.00048350275,0.00010676595,0.000043168784,0.0000738065,0.0000071320565,0.000031566633,8.0860303e-7],"about_ca_topic_score_codex":0.0075421887,"about_ca_topic_score_gemma":0.0075025554,"teacher_disagreement_score":0.0075421887,"about_ca_system_score_codex":0.00039419514,"about_ca_system_score_gemma":0.00036004183,"threshold_uncertainty_score":0.014996588},"labels":[],"label_agreement":null},{"id":"W1963729408","doi":"10.1177/1352458512471876","title":"The Multiple Sclerosis Intimacy and Sexuality Questionnaire — re-validation and development of a 15-item version with a large US sample","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Multiple sclerosis; Sample (material); Human sexuality; Psychology; Clinical psychology; Psychometrics; Medicine; Developmental psychology; Psychiatry; Gender studies; Sociology","score_opus":0.08310433867471291,"score_gpt":0.2959736657401284,"score_spread":0.2128693270654155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963729408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904235,0.0007067555,0.0029130683,0.000353636,0.0000784284,0.0010074575,0.0026756749,0.000060537353,0.0017809022],"genre_scores_gemma":[0.9739455,0.0007936918,0.017138634,0.00024694297,0.00004445256,0.0019004337,0.0048556384,0.000028812292,0.0010458778],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99795234,0.0008960677,0.00040156455,0.0001272704,0.00054755516,0.00007515802],"domain_scores_gemma":[0.99502087,0.0013332815,0.0012618134,0.00039309982,0.001691631,0.00029936078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007933655,0.00035504712,0.0004974327,0.0009919703,0.00037620493,0.00045963546,0.00050780474,0.00027430346,0.0015979732],"category_scores_gemma":[0.010276849,0.00019258725,0.000775378,0.00084429357,0.00026341606,0.0006066695,0.0006869655,0.0007943552,0.00034756528],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031539754,0.00045181278,0.9104212,0.0002011925,0.00031264446,0.00012041304,0.00079359545,0.00035173527,0.0017149583,0.0002263678,0.003665524,0.0814252],"study_design_scores_gemma":[0.00010309701,0.0006520261,0.99262106,0.00011438623,0.00008020134,0.0004889879,0.00028191457,0.00078499335,0.0006915341,0.00016487867,0.004001041,0.000015892796],"about_ca_topic_score_codex":0.0015512708,"about_ca_topic_score_gemma":0.002508986,"teacher_disagreement_score":0.007933655,"about_ca_system_score_codex":0.00038155424,"about_ca_system_score_gemma":0.00081880105,"threshold_uncertainty_score":0.041957736},"labels":[],"label_agreement":null},{"id":"W1963889958","doi":"10.1177/1352458515579440","title":"Diffusivity signatures characterize trigeminal neuralgia associated with multiple sclerosis","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Trigeminal Neuralgia and Treatments","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; St. Michael's Hospital; Ontario Brain Institute; University of Toronto; University Health Network","funders":"","keywords":"Trigeminal neuralgia; Fractional anisotropy; Multiple sclerosis; Diffusion MRI; Fluid-attenuated inversion recovery; Neuroimaging; Medicine; Neuropathic pain; Trigeminal nerve; Pathology; Anesthesia; Neuroscience; Psychology; Magnetic resonance imaging; Radiology","score_opus":0.12153299854358864,"score_gpt":0.2603143732909866,"score_spread":0.138781374747398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963889958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998221,0.000443033,0.0007285696,0.00002065384,0.0000024989301,0.000012438701,0.00011155058,0.00001194907,0.00044829914],"genre_scores_gemma":[0.99909604,0.00013665688,0.00054212566,0.000004892093,0.0000041437206,0.000007206412,0.00009589536,0.0000027589338,0.00011033489],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99993193,0.000010363545,0.0000098927185,0.000018855111,0.00001595314,0.000012932743],"domain_scores_gemma":[0.9996383,0.00004391046,0.00021805656,0.000020689204,0.000033532193,0.00004551744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020444237,0.00029879282,0.00015676278,0.00086310314,0.00014198032,0.0002566269,0.00013367113,0.00017846316,0.001300369],"category_scores_gemma":[0.0007234828,0.000072477655,0.000093165654,0.00035889226,0.00022067051,0.00021609526,0.00025377722,0.00013919485,0.000078275305],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029605636,0.00015578275,0.61749077,0.00034794206,0.00026929297,0.0028184948,0.0006500631,0.0009987644,0.320694,0.0005536431,0.00040850442,0.0526522],"study_design_scores_gemma":[0.000030148603,0.00033165156,0.97613984,0.000025829579,0.000081097176,0.008136794,0.00021789646,0.0018188932,0.011981004,0.000724017,0.00049897714,0.000013748371],"about_ca_topic_score_codex":0.0010757083,"about_ca_topic_score_gemma":0.0013113687,"teacher_disagreement_score":0.001300369,"about_ca_system_score_codex":0.0002645875,"about_ca_system_score_gemma":0.00012868093,"threshold_uncertainty_score":0.004350126},"labels":[],"label_agreement":null},{"id":"W1964447312","doi":"10.1191/1352458504ms1036oa","title":"Cervical cord atrophy assessment on magnetic resonance imaging: PRO MiSe trial","year":2004,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Advanced Neuroimaging Techniques and Applications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Medicine; Magnetic resonance imaging; Multiple sclerosis; Atrophy; Spinal cord; Clinical trial; Cord; Nuclear medicine; Radiology; Surgery; Pathology","score_opus":0.26893492290091914,"score_gpt":0.4225708523278115,"score_spread":0.15363592942689236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964447312","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0046300003,0.9933518,0.000072890536,0.00056938274,0.00019046059,0.00005388509,0.0000897795,0.000007146813,0.0010345537],"genre_scores_gemma":[0.029764868,0.96660733,0.00056208635,0.0011378385,0.0003979792,0.00020744011,0.00025354986,0.0000027295587,0.0010662562],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9997719,0.00010494938,0.000021539729,0.000026033587,0.00005669299,0.000018815812],"domain_scores_gemma":[0.9996568,0.00018568615,0.00006106444,0.000008582095,0.00005467781,0.000033237728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009416941,0.00059174193,0.00226492,0.00036371662,0.00013868083,0.00037638735,0.0005533295,0.0008155867,0.0018757293],"category_scores_gemma":[0.0011153442,0.00009762906,0.00059714064,0.00053649314,0.00016063187,0.00032470227,0.00015354205,0.0010023143,0.0003663132],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0126815485,0.00038902523,0.0010658732,0.029813979,0.0016896181,0.00024093915,0.00003602362,0.00031890196,0.0016693515,0.00057081366,0.02857219,0.92295176],"study_design_scores_gemma":[0.11008993,0.034785524,0.07956801,0.05024984,0.020663531,0.009267392,0.0003449536,0.0013895499,0.005290807,0.00461554,0.68357193,0.00016300834],"about_ca_topic_score_codex":0.00058721885,"about_ca_topic_score_gemma":0.002419698,"teacher_disagreement_score":0.00226492,"about_ca_system_score_codex":0.00030931734,"about_ca_system_score_gemma":0.00072347664,"threshold_uncertainty_score":0.0062749386},"labels":[],"label_agreement":null},{"id":"W1965665283","doi":"10.1177/1352458511431729","title":"The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitude","year":2011,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Cégep de Lévis; Hôpital Notre-Dame","funders":"Biogen; Novartis Pharma; Sanofi","keywords":"Multiple sclerosis; Medicine; Expanded Disability Status Scale; Cerebrospinal fluid; Internal medicine; Lumbar puncture; McDonald criteria; Gastroenterology; Immunology","score_opus":0.17817861646960662,"score_gpt":0.285962768091985,"score_spread":0.1077841516223784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965665283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99782515,0.00074483576,0.00018118575,0.000039168997,0.0000070459255,0.0000054267175,0.00036778275,0.000009864073,0.0008195377],"genre_scores_gemma":[0.9993381,0.00022834858,0.00015330291,0.00001652485,0.00001004567,0.0000042651773,0.00018630514,0.0000028347085,0.000060242703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991671,0.00022571957,0.00013475081,0.0001950045,0.00019925875,0.00007819526],"domain_scores_gemma":[0.9917789,0.001437643,0.0052663656,0.00045100416,0.00075423537,0.00031185342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008910444,0.00019135357,0.00031384855,0.0016445075,0.0003315674,0.0008383308,0.00021674276,0.00032724126,0.001800398],"category_scores_gemma":[0.0057954993,0.00018879223,0.00024107116,0.0019205778,0.0004441284,0.00041932482,0.00057542365,0.00023941004,0.00047988378],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006721101,0.000004361015,0.99685043,0.000021678366,0.000026215497,0.00009714773,0.0001255946,0.00002811198,0.00060612586,0.000010470134,0.00006293829,0.0020996933],"study_design_scores_gemma":[0.000001424032,0.000018190674,0.9990152,0.000008250933,0.000012664546,0.0004615563,0.00013726205,0.000029280736,0.00012073255,0.000026590738,0.00016663857,0.0000021760914],"about_ca_topic_score_codex":0.0022245487,"about_ca_topic_score_gemma":0.001784862,"teacher_disagreement_score":0.0022245487,"about_ca_system_score_codex":0.00023560955,"about_ca_system_score_gemma":0.00020072302,"threshold_uncertainty_score":0.0060228705},"labels":[],"label_agreement":null},{"id":"W1965936322","doi":"10.1177/1352458506070704","title":"Long-term follow-up of patients treated with glatiramer acetate: a multicentre, multinational extension of the European/Canadian double-blind, placebo-controlled, MRI-monitored trial","year":2007,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Glatiramer acetate; Medicine; Multiple sclerosis; Magnetic resonance imaging; Placebo; Clinical trial; Randomized controlled trial; Clinically isolated syndrome; Lesion; Surgery; Internal medicine; Pediatrics; Radiology; Pathology","score_opus":0.07372830957651066,"score_gpt":0.3016159711945199,"score_spread":0.22788766161800922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965936322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931392,0.0034511155,0.0001379175,0.0003863927,0.000107279215,0.0010227511,0.000760577,0.000029968713,0.00096478075],"genre_scores_gemma":[0.9948815,0.0011856157,0.00047779107,0.0006314603,0.00020570408,0.00077358127,0.0011649552,0.000005632297,0.00067393546],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990702,0.00037823536,0.000053909458,0.00015847682,0.00012850379,0.00021066991],"domain_scores_gemma":[0.9985135,0.00016241295,0.00032082165,0.00015746195,0.00019010536,0.0006557484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00289374,0.0012656533,0.0019164198,0.0003104154,0.0010923981,0.0010089552,0.00088886044,0.0017744302,0.0014327283],"category_scores_gemma":[0.0017513903,0.00041778886,0.0012316029,0.000683775,0.00096362166,0.0006993598,0.0003745065,0.0017351807,0.00028514335],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94985056,0.006165182,0.012524594,0.00027214203,0.0010456519,0.00008088698,0.00011576143,0.00018827945,0.0026460595,0.00005224862,0.001225648,0.025832837],"study_design_scores_gemma":[0.70108926,0.1605634,0.1307978,0.000080673475,0.0020856413,0.00018592815,0.00009131899,0.0005944862,0.0010529448,0.00009482931,0.0032966093,0.000067077905],"about_ca_topic_score_codex":0.026659673,"about_ca_topic_score_gemma":0.044598147,"teacher_disagreement_score":0.026659673,"about_ca_system_score_codex":0.0021579897,"about_ca_system_score_gemma":0.003806468,"threshold_uncertainty_score":0.053008974},"labels":[],"label_agreement":null},{"id":"W1965997336","doi":"10.1177/1352458512460605","title":"Scoring treatment response in patients with relapsing multiple sclerosis","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":257,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Multiple sclerosis; Medicine; Immunology","score_opus":0.12705088316048876,"score_gpt":0.2940942887571419,"score_spread":0.16704340559665312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965997336","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979684,0.0003194141,0.00067637983,0.00004706629,0.0000067672404,0.000032736923,0.000731,0.000018854986,0.0001994377],"genre_scores_gemma":[0.997509,0.000064236054,0.0006905895,0.000026134507,0.000010608279,0.000031254007,0.001621378,0.0000031114573,0.00004362983],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99776804,0.0011617721,0.00022684208,0.00045750244,0.00028778618,0.00009807244],"domain_scores_gemma":[0.99369603,0.0021242192,0.0028366053,0.0005811445,0.00053005933,0.00023193263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004267205,0.00058730785,0.000893687,0.0011662629,0.00024341614,0.0005670762,0.00055397116,0.00062759407,0.0006106677],"category_scores_gemma":[0.00831305,0.00015783428,0.0006478766,0.0008075155,0.0003051065,0.00035877747,0.0006017768,0.00055843923,0.00020910529],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010149218,0.00008504626,0.98710746,0.000055709097,0.00031220497,0.00003135359,0.00006400494,0.0009721646,0.0006962054,0.000013407237,0.0002515686,0.009395924],"study_design_scores_gemma":[0.00009418906,0.00054480333,0.9932509,0.000019263345,0.00014536362,0.00030778497,0.000049225542,0.004503303,0.0006554145,0.00009825088,0.0003158393,0.000015552338],"about_ca_topic_score_codex":0.00084413786,"about_ca_topic_score_gemma":0.0011448757,"teacher_disagreement_score":0.004267205,"about_ca_system_score_codex":0.0003188009,"about_ca_system_score_gemma":0.00029774237,"threshold_uncertainty_score":0.022567391},"labels":[],"label_agreement":null},{"id":"W1966077481","doi":"10.1177/1352458513517280","title":"Progressive multiple sclerosis does not associate with rs996343 and rs2046748","year":2013,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Multiple sclerosis; Medicine; Clinical neurology; Psychology; Neuroscience; Psychiatry","score_opus":0.0965273471910253,"score_gpt":0.27892999442192556,"score_spread":0.18240264723090027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966077481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93080354,0.003091907,0.00075544417,0.03762404,0.0019112609,0.00002607043,0.001250682,0.00006090036,0.0244761],"genre_scores_gemma":[0.98756486,0.00047739912,0.00042296044,0.0055955993,0.0015902555,0.000014109071,0.00029406263,0.000022745178,0.00401785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886394,0.00036190267,0.00016793449,0.00020182836,0.00024805978,0.00015642935],"domain_scores_gemma":[0.99310946,0.0040390925,0.0011370992,0.00065587764,0.00072801346,0.00033050458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010332952,0.00047778463,0.0006839484,0.00077137334,0.0010946451,0.00080147083,0.0006285384,0.0032659804,0.006608872],"category_scores_gemma":[0.013169788,0.00018689854,0.0005374305,0.0015240054,0.00066442677,0.00065018167,0.000343194,0.0014496868,0.0010695384],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046052844,0.00028396657,0.8250159,0.00023941291,0.00087310263,0.08305137,0.0011048741,0.00020292801,0.0074043134,0.002582982,0.03670693,0.03792898],"study_design_scores_gemma":[0.0006207626,0.00061994087,0.81567925,0.00031897993,0.0009224094,0.13016918,0.0014486829,0.0008175451,0.0020646248,0.008201604,0.03906058,0.00007634397],"about_ca_topic_score_codex":0.002819163,"about_ca_topic_score_gemma":0.0036889182,"teacher_disagreement_score":0.006608872,"about_ca_system_score_codex":0.0002798089,"about_ca_system_score_gemma":0.00038043305,"threshold_uncertainty_score":0.022108912},"labels":[],"label_agreement":null},{"id":"W1966562413","doi":"10.1177/1352458514521308","title":"Birth outcomes of pregnancies fathered by men with multiple sclerosis","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia","funders":"Canadian Institutes of Health Research; University of British Columbia","keywords":"Multiple sclerosis; Expanded Disability Status Scale; Medicine; Cohort; Population; Birth weight; Multivariate analysis; Pregnancy; Cohort study; Demography; Pediatrics; Gerontology; Internal medicine; Psychiatry; Environmental health","score_opus":0.07369110276768734,"score_gpt":0.27428767417602495,"score_spread":0.20059657140833762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966562413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950387,0.00050537626,0.00009928943,0.000039826315,0.000004142385,0.000013160456,0.0038154258,0.000004427404,0.0004795324],"genre_scores_gemma":[0.9962554,0.0004416452,0.00018420462,0.000024933639,0.0000038133699,0.000016353875,0.0027500864,0.0000025295617,0.00032105023],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99926466,0.00016811021,0.0000885849,0.00016208683,0.00018041478,0.00013603909],"domain_scores_gemma":[0.99713624,0.0006603328,0.0012061028,0.00026283038,0.00044420676,0.00029025026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007732331,0.00019060823,0.00036007562,0.0010397508,0.0008896129,0.00051593577,0.00047590124,0.00028362824,0.0009450277],"category_scores_gemma":[0.004301973,0.00028525293,0.00024753125,0.0020190985,0.00030488524,0.00026434494,0.0005300991,0.0005652994,0.00012487822],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041998224,0.0000060524553,0.9986835,0.000009288812,0.000026923835,0.000073445975,0.00017231362,0.00004205967,0.00004836705,0.000029725728,0.00010541108,0.0007609953],"study_design_scores_gemma":[0.0000034904335,0.000022131824,0.9991264,0.000015334155,0.000014062196,0.00014100826,0.0002299357,0.00013604737,0.000049874263,0.000019908946,0.00023781884,0.000003969088],"about_ca_topic_score_codex":0.53174585,"about_ca_topic_score_gemma":0.5487267,"teacher_disagreement_score":0.53174585,"about_ca_system_score_codex":0.0025489645,"about_ca_system_score_gemma":0.0019356322,"threshold_uncertainty_score":0.9420236},"labels":[],"label_agreement":null},{"id":"W1966824567","doi":"10.1177/1352458509345920","title":"‘Time is brain’ also in multiple sclerosis","year":2009,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Multiple sclerosis; Medicine; Neuroscience; Psychology; Psychiatry","score_opus":0.14102039203987857,"score_gpt":0.3043496335505447,"score_spread":0.1633292415106661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966824567","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00057187775,0.0017734582,0.000042942032,0.98075074,0.01568835,0.000003775248,0.00001405913,0.000004281769,0.0011505274],"genre_scores_gemma":[0.0055623865,0.0010195374,0.00010361925,0.948995,0.042501207,0.000016345504,0.000010825397,0.000009596214,0.0017814155],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99135864,0.0041874764,0.0017162111,0.0009105336,0.00093701674,0.00089009875],"domain_scores_gemma":[0.9649715,0.026673649,0.0025298842,0.00096949626,0.0022096892,0.0026457745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008599276,0.0007640357,0.0023891234,0.00091300637,0.005774374,0.0038476794,0.0027597526,0.07201049,0.0050604832],"category_scores_gemma":[0.059661776,0.00085372553,0.0011122067,0.0016699042,0.0074654785,0.008864863,0.0036153297,0.049382538,0.0026054606],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013625794,0.00004786247,0.001930385,0.00030606973,0.000054514065,0.006420299,0.0019280761,0.000042021562,0.00018996165,0.009550825,0.969913,0.009480649],"study_design_scores_gemma":[0.0006156616,0.0001800454,0.008023016,0.0020357282,0.00017476814,0.017589582,0.006100258,0.00039191163,0.00031757666,0.03736199,0.92702615,0.0001833218],"about_ca_topic_score_codex":0.009046608,"about_ca_topic_score_gemma":0.020030338,"teacher_disagreement_score":0.07201049,"about_ca_system_score_codex":0.005086881,"about_ca_system_score_gemma":0.004712544,"threshold_uncertainty_score":0.045477867},"labels":[],"label_agreement":null},{"id":"W1970393648","doi":"10.1177/1352458509106230","title":"Serial combination therapy: is immune modulation in multiple sclerosis enhanced by initial immune suppression?","year":2009,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of British Columbia; University of Ottawa; Montreal Neurological Institute and Hospital","funders":"","keywords":"Mitoxantrone; Immune system; Multiple sclerosis; Medicine; Immune modulation; Antibody; Immunology; Glatiramer acetate; Combination therapy; Immunotherapy; Oncology; Internal medicine; Chemotherapy","score_opus":0.0952274905675262,"score_gpt":0.3188835299187216,"score_spread":0.22365603935119538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970393648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95765364,0.032937605,0.0037181494,0.0005420091,0.000096568096,0.00018084515,0.00005961416,0.00012371689,0.0046879714],"genre_scores_gemma":[0.995144,0.0027569826,0.0011377153,0.0001714367,0.00021535486,0.000048371574,0.000054042735,0.000007398691,0.00046483544],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99959844,0.0001491182,0.00003473117,0.000056835586,0.00010991042,0.000051032774],"domain_scores_gemma":[0.99933356,0.00022021038,0.00022208465,0.000104662235,0.00004834622,0.00007114816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009679202,0.00039198776,0.0011441469,0.0003819451,0.00019200513,0.0003352312,0.00029645272,0.00054557895,0.0023268259],"category_scores_gemma":[0.0010120465,0.00012198379,0.00034840012,0.0002869974,0.00034938595,0.0004744871,0.00019800948,0.00052144413,0.00041355533],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01664985,0.0027847234,0.06931289,0.0018292861,0.00072256033,0.0024953235,0.0001987531,0.0012883494,0.25996763,0.00073855807,0.0014509413,0.64256114],"study_design_scores_gemma":[0.006392755,0.18138771,0.5196206,0.00065650867,0.0028133274,0.048744958,0.00021961216,0.006662659,0.19785017,0.0028532627,0.032715008,0.00008340671],"about_ca_topic_score_codex":0.00008963821,"about_ca_topic_score_gemma":0.00022355147,"teacher_disagreement_score":0.0023268259,"about_ca_system_score_codex":0.0003263695,"about_ca_system_score_gemma":0.00019550369,"threshold_uncertainty_score":0.0077839494},"labels":[],"label_agreement":null},{"id":"W1970927198","doi":"10.1177/1352458511428464","title":"Quantitative high-field imaging of sub-cortical gray matter in multiple sclerosis","year":2011,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Multiple sclerosis; Gray (unit); Neuroscience; Neuroimaging; Medicine; Psychology; Nuclear medicine","score_opus":0.16996852822369524,"score_gpt":0.31126497211693593,"score_spread":0.1412964438932407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970927198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98876256,0.0015424474,0.009034478,0.000036342426,0.0000029619746,0.000018638259,0.00010284091,0.000055128727,0.00044464992],"genre_scores_gemma":[0.9964232,0.0001644087,0.003247519,0.0000066363073,0.0000037469076,0.000008798329,0.000044924083,0.0000058670075,0.000094866686],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998828,0.000055297813,0.00000767476,0.000018603774,0.000027360305,0.000008237224],"domain_scores_gemma":[0.99949896,0.00016295476,0.00017639014,0.000035547324,0.00008975535,0.000036414604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007051925,0.00020495725,0.00011413195,0.000806152,0.00008773787,0.00021575658,0.00017404211,0.00020667948,0.0008606689],"category_scores_gemma":[0.0013554746,0.0001096001,0.00007502816,0.000232409,0.0003191969,0.00029545755,0.00014226463,0.00012213475,0.00010860593],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002600365,0.00019654809,0.17767556,0.00098372,0.00047759482,0.00080587744,0.0007030078,0.0068122908,0.68650436,0.0005871424,0.0005134393,0.1221401],"study_design_scores_gemma":[0.00012240458,0.0010932455,0.90464556,0.00006682419,0.00022894134,0.00752557,0.0002604061,0.013796814,0.06915971,0.0019988767,0.0010425178,0.00005917304],"about_ca_topic_score_codex":0.00049208687,"about_ca_topic_score_gemma":0.000678365,"teacher_disagreement_score":0.0008606689,"about_ca_system_score_codex":0.00021181992,"about_ca_system_score_gemma":0.00008896904,"threshold_uncertainty_score":0.0037294626},"labels":[],"label_agreement":null},{"id":"W1970963099","doi":"10.1177/135245850000600207","title":"Cost and health related quality of life consequences of multiple sclerosis","year":2000,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; McMaster University; Nexus Clinical Research (Canada)","funders":"Teva Pharmaceutical Industries","keywords":"Multiple sclerosis; Medicine; Quality of life (healthcare); Health care; Physical therapy; Quality-adjusted life year; Expanded Disability Status Scale; Cost effectiveness; Psychiatry; Nursing","score_opus":0.3555741367552577,"score_gpt":0.38168002761249914,"score_spread":0.026105890857241465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970963099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867899,0.0057975505,0.00033567697,0.001654406,0.000025321644,0.000026855552,0.0011183141,0.000004885706,0.0042471522],"genre_scores_gemma":[0.9989409,0.00050223357,0.00015515131,0.00004536724,0.000013151499,0.0000052858672,0.00022331093,0.000001069729,0.00011360793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984602,0.0008569239,0.00007881583,0.00005426307,0.00039943235,0.00015038258],"domain_scores_gemma":[0.9975343,0.0009843529,0.00074777106,0.00005810945,0.0004514144,0.00022415254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011255683,0.00020483653,0.00019164571,0.00084901985,0.0002444203,0.0005463314,0.00020695734,0.00031498913,0.0014934756],"category_scores_gemma":[0.010319466,0.000082824445,0.00044750478,0.000923709,0.00038101376,0.00043602567,0.00036677692,0.00041845388,0.000063798834],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083641405,0.00022470467,0.9236967,0.00020955228,0.0008364667,0.0004273949,0.00015667807,0.009746327,0.00037510024,0.0021962093,0.0016962512,0.05959815],"study_design_scores_gemma":[0.000028599196,0.00022732734,0.99283665,0.00007393687,0.00017896469,0.0004642057,0.00023050283,0.003763792,0.00012868861,0.0009596333,0.001092615,0.000015019524],"about_ca_topic_score_codex":0.03612743,"about_ca_topic_score_gemma":0.06228504,"teacher_disagreement_score":0.03612743,"about_ca_system_score_codex":0.0027845295,"about_ca_system_score_gemma":0.0010277893,"threshold_uncertainty_score":0.071834266},"labels":[],"label_agreement":null},{"id":"W1972876345","doi":"10.1191/1352458504ms1007oa","title":"Elevated aminotransferases during treatment with interferon-beta for multiple sclerosis: actions and outcomes","year":2004,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver Hospital and Health Sciences Centre; University of British Columbia","funders":"","keywords":"Medicine; Multiple sclerosis; Toxicity; Internal medicine; Gastroenterology; Liver toxicity; Surgery; Immunology","score_opus":0.1509522817518502,"score_gpt":0.31558199734574205,"score_spread":0.16462971559389186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972876345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99881387,0.00028281196,0.000040352024,0.000034451183,0.0000024382982,0.000011945499,0.0003609711,0.000002477159,0.000450697],"genre_scores_gemma":[0.99933606,0.00013238494,0.000046607962,0.00001846686,0.0000033594267,0.000005075685,0.0003539382,0.0000013726932,0.000102844984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988205,0.00023006488,0.00021385872,0.0001221581,0.0003918321,0.00022156585],"domain_scores_gemma":[0.9932319,0.0011365629,0.0036474508,0.00019062801,0.0012355718,0.00055789633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071617437,0.00018889632,0.00028054323,0.0013692784,0.00066500256,0.0007609309,0.00024100128,0.00028629808,0.0005053012],"category_scores_gemma":[0.004365017,0.00015412513,0.000309088,0.0022927336,0.00033503442,0.00034666716,0.0003720263,0.00050291093,0.000102816615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056711382,0.00001309578,0.9982476,0.00000807003,0.000011245748,0.00030824344,0.00015354875,0.000013680144,0.000071895374,0.0000037549678,0.000045631452,0.0010666739],"study_design_scores_gemma":[0.0000025463723,0.000069688205,0.99869007,0.0000066272237,0.000015660355,0.00065534574,0.00024889328,0.000032467888,0.000106604915,0.0000038355506,0.00016432433,0.0000039573865],"about_ca_topic_score_codex":0.0648774,"about_ca_topic_score_gemma":0.08461548,"teacher_disagreement_score":0.0648774,"about_ca_system_score_codex":0.00137723,"about_ca_system_score_gemma":0.0012589697,"threshold_uncertainty_score":0.12899953},"labels":[],"label_agreement":null},{"id":"W1973067526","doi":"10.1177/1352458508095131","title":"Defining the natural history of MS: the need for complete data and rigorous definitions","year":2008,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Natural history; Multiple sclerosis; Natural (archaeology); Computer science; Epistemology; Data science; Medicine; History; Philosophy; Psychiatry; Archaeology","score_opus":0.2733681012331404,"score_gpt":0.31147826660162947,"score_spread":0.038110165368489046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973067526","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019280391,0.072951876,0.028398046,0.88044196,0.013519937,0.00042616617,0.0006647467,0.00010765271,0.0015615629],"genre_scores_gemma":[0.047808327,0.05123445,0.173234,0.6347908,0.08721046,0.0032987765,0.001540924,0.00022134322,0.00066090137],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.48904538,0.34522706,0.1065326,0.00905592,0.047474023,0.002665024],"domain_scores_gemma":[0.058510795,0.84049565,0.03039149,0.028728075,0.03800513,0.0038689293],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.47346845,0.0023094227,0.014658893,0.009233444,0.0052870433,0.021272141,0.017369568,0.02630903,0.0019547802],"category_scores_gemma":[0.77296954,0.0026542319,0.004256383,0.0062937452,0.02861652,0.06488869,0.018499337,0.07085719,0.0011356556],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017835081,0.0010429535,0.031212712,0.019268682,0.0022850325,0.0022332345,0.007274735,0.0032455807,0.00095869484,0.28567535,0.31733608,0.32768345],"study_design_scores_gemma":[0.0010869931,0.0009891726,0.012631462,0.027475756,0.0007235796,0.0032742613,0.0053750924,0.005501274,0.0006743915,0.7506712,0.1908607,0.00073608337],"about_ca_topic_score_codex":0.0050150743,"about_ca_topic_score_gemma":0.005681129,"teacher_disagreement_score":0.47346845,"about_ca_system_score_codex":0.011150821,"about_ca_system_score_gemma":0.023018103,"threshold_uncertainty_score":0.64930713},"labels":[],"label_agreement":null},{"id":"W1974775914","doi":"10.1177/135245850000600210","title":"Biopsychosocial correlates of lifetime major depression in a multiple sclerosis population","year":2000,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"University of Calgary","keywords":"Biopsychosocial model; CIDI; Depression (economics); Medicine; Population; Psychiatry; Clinical psychology; National Comorbidity Survey; Comorbidity; Environmental health","score_opus":0.07727314593194598,"score_gpt":0.29848621100913264,"score_spread":0.22121306507718666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974775914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99969614,0.000111445246,0.000019926949,0.00002603067,0.0000011257067,0.000002749181,0.0000310295,7.247532e-7,0.000110849964],"genre_scores_gemma":[0.99980015,0.000078106954,0.000023166162,0.000010400771,0.000004111912,0.00000233566,0.00005104102,3.1118583e-7,0.000030262961],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996705,0.00013435418,0.000029905998,0.00004322659,0.000077409444,0.000044521574],"domain_scores_gemma":[0.9990729,0.0001846227,0.0004197061,0.000043213193,0.00009090087,0.0001886744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040894694,0.00015153472,0.0002586897,0.000766238,0.00043735947,0.00040194936,0.00015173657,0.00031716604,0.0009785588],"category_scores_gemma":[0.0029783256,0.00018623626,0.00012993068,0.00054262544,0.00032700328,0.0002764967,0.00036092228,0.00037331256,0.00011368185],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000582603,0.000048242677,0.9982256,0.000005788677,0.000034522298,0.00007570316,0.00012075511,0.000015098369,0.0002716542,0.000011547762,0.000030490237,0.0011022664],"study_design_scores_gemma":[0.0000025016245,0.00006454636,0.99951077,0.0000018561547,0.000007114018,0.00020294005,0.00012320493,0.00003790868,0.000012392121,0.000011787883,0.00002380516,0.0000011696009],"about_ca_topic_score_codex":0.003062556,"about_ca_topic_score_gemma":0.0058983117,"teacher_disagreement_score":0.003062556,"about_ca_system_score_codex":0.00013904349,"about_ca_system_score_gemma":0.0001493396,"threshold_uncertainty_score":0.006089449},"labels":[],"label_agreement":null},{"id":"W1978426087","doi":"10.1177/1352458512465136","title":"Observational studies of treatment effectiveness: useful, useless or somewhere in between?","year":2013,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Observational study; Multiple sclerosis; Medicine; Internal medicine; Psychiatry","score_opus":0.5150001251313869,"score_gpt":0.40978027275724865,"score_spread":0.10521985237413828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978426087","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008559413,0.03983763,0.0008050151,0.93760115,0.019535406,0.000030422269,0.00027289893,0.000026117012,0.0010353563],"genre_scores_gemma":[0.01596685,0.020967048,0.0036464469,0.85951334,0.09876624,0.00018413788,0.00021700346,0.000041297862,0.000697628],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.7767164,0.16520725,0.032283448,0.006146664,0.017807776,0.0018383979],"domain_scores_gemma":[0.18810694,0.749612,0.021574512,0.013478101,0.022285612,0.004942859],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.215874,0.0014921842,0.009015912,0.0037745722,0.0032277082,0.006722792,0.008825472,0.040905856,0.0058496445],"category_scores_gemma":[0.5742312,0.0019799655,0.0035941643,0.0055044405,0.011288452,0.016139004,0.0045632645,0.034718897,0.0028072312],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024538706,0.00029404883,0.028667638,0.008673283,0.00493476,0.0025373749,0.0011205148,0.00031540488,0.00030222556,0.03057273,0.803875,0.116253056],"study_design_scores_gemma":[0.00837094,0.0011003445,0.025291258,0.030404296,0.0057059894,0.0048497785,0.0044150157,0.0021438831,0.000700707,0.21479918,0.70134664,0.0008719534],"about_ca_topic_score_codex":0.005954077,"about_ca_topic_score_gemma":0.010823905,"teacher_disagreement_score":0.784126,"about_ca_system_score_codex":0.005267864,"about_ca_system_score_gemma":0.008544367,"threshold_uncertainty_score":0.966967},"labels":[],"label_agreement":null},{"id":"W1978928514","doi":"10.1177/1352458513507822","title":"Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":194,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Neuromyelitis optica; Hiccups; Population; Vertigo; Vomiting; Pediatrics; Brainstem; Trigeminal neuralgia; Ataxia; Optic neuritis; Multiple sclerosis; Anesthesia; Internal medicine; Surgery; Immunology","score_opus":0.0800234183058476,"score_gpt":0.293007724955086,"score_spread":0.2129843066492384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978928514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997141,0.000055464232,0.000022786215,0.000009681628,0.0000017550494,0.000009699743,0.00008854314,0.0000012129171,0.00009682871],"genre_scores_gemma":[0.99954337,0.000060025202,0.00006564767,0.000019848841,0.0000095137375,0.000018142306,0.00022414073,0.0000015819678,0.000057644473],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99948514,0.00011441821,0.00006243449,0.00017803087,0.00007553997,0.00008436686],"domain_scores_gemma":[0.9991155,0.000111786605,0.00037221392,0.0000671878,0.00009379753,0.00023945209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006329957,0.00048162357,0.00058275694,0.00082878885,0.00077315647,0.00054597977,0.00033019995,0.00045194544,0.0013246881],"category_scores_gemma":[0.0013837881,0.00047136057,0.00032390305,0.0006456391,0.00034385733,0.00064833893,0.00061406306,0.00035578493,0.00038316686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019118749,0.0000900614,0.9974559,0.000009275076,0.00003187242,0.0005040271,0.00021533416,0.000018940238,0.0007260449,0.000007719057,0.000057549274,0.0006920645],"study_design_scores_gemma":[0.000040667113,0.000488521,0.99648094,0.00000937157,0.00003315091,0.0021327622,0.00038992093,0.00009015616,0.000099913945,0.000009280461,0.00021813286,0.000007163305],"about_ca_topic_score_codex":0.0024761164,"about_ca_topic_score_gemma":0.0022336917,"teacher_disagreement_score":0.0024761164,"about_ca_system_score_codex":0.0003800229,"about_ca_system_score_gemma":0.00027412307,"threshold_uncertainty_score":0.0049233437},"labels":[],"label_agreement":null},{"id":"W1980181887","doi":"10.1177/1352458506070659","title":"Identifying reliable change in tactile temporal thresholds in multiple sclerosis: test-retest reliability","year":2006,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Reliability (semiconductor); Multiple sclerosis; Audiology; Sensory threshold; Psychology; Medicine; Physical medicine and rehabilitation; Cognitive psychology","score_opus":0.1808226291541926,"score_gpt":0.32257374267434236,"score_spread":0.14175111352014977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980181887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903785,0.00096151733,0.0058346572,0.000069959875,0.000084055195,0.00029212845,0.00023569053,0.00005620823,0.0020873747],"genre_scores_gemma":[0.99625236,0.000119413286,0.0028912476,0.000032215234,0.000027897222,0.00017549755,0.0002086348,0.000017080542,0.00027568702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9910858,0.004242635,0.000953686,0.0011875868,0.0023215627,0.00020862285],"domain_scores_gemma":[0.9388828,0.03981163,0.00684264,0.005038645,0.008744875,0.0006792927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020409735,0.0005358367,0.00065799785,0.00096613227,0.0004849413,0.00081145525,0.00050758093,0.0008096012,0.00096647104],"category_scores_gemma":[0.05262208,0.0003514046,0.0007361128,0.00056465185,0.0008987542,0.000861457,0.0009282871,0.0007951061,0.00044240718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016961155,0.00037636282,0.94661397,0.00026983058,0.0013167314,0.000104513325,0.0021144748,0.0011809077,0.00775993,0.00021017915,0.00061077566,0.037746105],"study_design_scores_gemma":[0.00007153003,0.0015667706,0.9898086,0.00004155595,0.00029806962,0.00037291195,0.00023354401,0.0020947112,0.004281281,0.00032583706,0.0008722971,0.000032969125],"about_ca_topic_score_codex":0.0010467068,"about_ca_topic_score_gemma":0.0017787693,"teacher_disagreement_score":0.020409735,"about_ca_system_score_codex":0.00032417738,"about_ca_system_score_gemma":0.00037960688,"threshold_uncertainty_score":0.10793829},"labels":[],"label_agreement":null},{"id":"W1981166534","doi":"10.1191/1352458503ms960oa","title":"Depressive symptoms in a treated multiple sclerosis cohort","year":2003,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Multiple sclerosis; Cohort; Medicine; Cohort study; Depression (economics); Depressive symptoms; Psychiatry; Internal medicine; Cognition","score_opus":0.08829095200082727,"score_gpt":0.29308264660378563,"score_spread":0.20479169460295837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981166534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994454,0.00006646366,0.00002183215,0.000023156572,0.0000046955292,0.000011255752,0.00022443295,0.000001760773,0.00020105939],"genre_scores_gemma":[0.99900264,0.00007816651,0.0000321673,0.00004660743,0.000010104309,0.000018241222,0.0005693702,0.0000015308492,0.00024118577],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99961567,0.00010025025,0.000024627618,0.000088612716,0.000105075385,0.000065723274],"domain_scores_gemma":[0.9994259,0.000064435655,0.00016229428,0.00006154289,0.00008165177,0.00020426157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046074204,0.00023949589,0.000461099,0.0006205811,0.00076724414,0.00076993176,0.0003551671,0.0005191576,0.0013402503],"category_scores_gemma":[0.0013808142,0.0003855961,0.00041198652,0.00081558316,0.00027687606,0.0003843901,0.0002659596,0.00077522924,0.00030242017],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040517966,0.00021216396,0.99711144,0.000006483177,0.00008599981,0.00040685298,0.00021545739,0.000035222936,0.00046507802,0.000015431833,0.00018233024,0.00085823546],"study_design_scores_gemma":[0.00007009931,0.00031046322,0.9984125,0.0000044820044,0.000048089543,0.0005433357,0.0001950822,0.00015676043,0.00006949704,0.000016316813,0.00016732798,0.000005972465],"about_ca_topic_score_codex":0.016433904,"about_ca_topic_score_gemma":0.014912176,"teacher_disagreement_score":0.016433904,"about_ca_system_score_codex":0.0005264166,"about_ca_system_score_gemma":0.0004362171,"threshold_uncertainty_score":0.03267646},"labels":[],"label_agreement":null},{"id":"W1985235854","doi":"10.1177/135245850000600509","title":"Multiple sclerosis, disease modifying treatments and depression: a critical methodological review","year":2000,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Depression (economics); Mood; Psychiatry; Disease; Psychology; Clinical psychology; Mood disorders; Multiple sclerosis; Major depressive disorder; Placebo; Medicine; Anxiety; Alternative medicine; Internal medicine","score_opus":0.5577539936427163,"score_gpt":0.46577594370169356,"score_spread":0.09197804994102271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985235854","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000093360555,0.9972893,0.00027861708,0.0012171492,0.0005425433,0.00041068284,0.000058748774,0.0000043217633,0.00010539722],"genre_scores_gemma":[0.003072106,0.9888087,0.0026907532,0.002347006,0.0005781462,0.0023066925,0.000092476206,0.000007878204,0.00009623316],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9142082,0.04485758,0.028403152,0.0022583588,0.009570389,0.0007023719],"domain_scores_gemma":[0.6559005,0.2778032,0.038017265,0.005043232,0.021934364,0.0013015158],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.09981266,0.0020284487,0.009447256,0.020139711,0.0019934087,0.007428597,0.0037021646,0.0059355097,0.004205014],"category_scores_gemma":[0.26650742,0.0019273004,0.00901687,0.016460909,0.0032164033,0.005246461,0.0038838105,0.003992128,0.0006078488],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042705302,0.00005281323,0.00074556336,0.844797,0.0077750334,0.00009413467,0.00041106687,0.00022072432,0.0001409156,0.002367524,0.008438999,0.13452913],"study_design_scores_gemma":[0.00033800068,0.0002743956,0.0016522792,0.93016803,0.0205412,0.00024147135,0.00036054762,0.00013003453,0.00010109064,0.0026556177,0.04348656,0.0000506631],"about_ca_topic_score_codex":0.006507555,"about_ca_topic_score_gemma":0.014407136,"teacher_disagreement_score":0.9001874,"about_ca_system_score_codex":0.012125715,"about_ca_system_score_gemma":0.031193653,"threshold_uncertainty_score":0.5278661},"labels":[{"model":"gemma","categories":["metaresearch"],"domain":"methods","study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":["metaresearch","metaepi_broad"],"domain":"methods","study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W1985863851","doi":"10.1177/1352458514521310","title":"Administrative databases for observational studies in multiple sclerosis: power or peril?","year":2014,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Multiple sclerosis; Observational study; Medicine; MEDLINE; Database; Computer science; Psychiatry; Political science; Internal medicine","score_opus":0.9193335190700312,"score_gpt":0.5021998921628826,"score_spread":0.4171336269071486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985863851","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00077569543,0.0037846654,0.0010377567,0.9845047,0.0069625587,0.00005544872,0.00087771786,0.00006620621,0.0019353515],"genre_scores_gemma":[0.013747408,0.0031863304,0.0058134184,0.9301599,0.044321053,0.00048135762,0.00085048744,0.000086422464,0.0013536758],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.6892897,0.19590995,0.059110776,0.007649586,0.04336277,0.0046772],"domain_scores_gemma":[0.09332161,0.8102816,0.03284272,0.021860143,0.032949712,0.008744194],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.2585961,0.0009205083,0.0050175185,0.006477072,0.0039144964,0.012775698,0.0076217474,0.039898474,0.005459135],"category_scores_gemma":[0.6755926,0.0029295972,0.0028391732,0.011535025,0.010276742,0.017104778,0.009246448,0.031878546,0.004741312],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046134205,0.00007875205,0.013803316,0.0011488406,0.00049020845,0.00044938846,0.00064185995,0.00023333883,0.00012749579,0.024165925,0.90441185,0.05398772],"study_design_scores_gemma":[0.0019532656,0.00019828322,0.028917555,0.009709057,0.0006994182,0.0014553041,0.0014827908,0.004522272,0.00043963458,0.111592464,0.83851993,0.0005100376],"about_ca_topic_score_codex":0.013880014,"about_ca_topic_score_gemma":0.020810597,"teacher_disagreement_score":0.74140394,"about_ca_system_score_codex":0.007495284,"about_ca_system_score_gemma":0.01757083,"threshold_uncertainty_score":0.91428304},"labels":[],"label_agreement":null},{"id":"W1987304611","doi":"10.1191/1352458505ms1222oa","title":"Upregulation of TRAIL expression on human T lymphocytes by interferon b and glatiramer acetate","year":2005,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"Multiple Sclerosis Society of Canada; McGill University","keywords":"Glatiramer acetate; Downregulation and upregulation; In vivo; In vitro; Interferon; Multiple sclerosis; Tumor necrosis factor alpha; Apoptosis; Immunology; CD3; Receptor; Chemistry; Biology; Cancer research; Medicine; Molecular biology; Internal medicine; Antigen; CD8; Biochemistry","score_opus":0.03710836405683279,"score_gpt":0.25474287810179275,"score_spread":0.21763451404495995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987304611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99733704,0.0014627551,0.00024432715,0.000027942888,0.000011403611,0.000015786904,0.00017313597,0.000017303568,0.0007102129],"genre_scores_gemma":[0.99702376,0.0009311268,0.0006687699,0.00005079416,0.000019538345,0.00004089677,0.00038239834,0.000006224721,0.00087655947],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99980754,0.00006849291,0.000016681708,0.000022998878,0.00003617521,0.00004808212],"domain_scores_gemma":[0.9999057,0.000025785785,0.000023637873,0.000015402667,0.00001370365,0.000015732543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013125151,0.00021835092,0.00021322255,0.00029603275,0.00014576384,0.0003196668,0.0000605221,0.00020500473,0.0008957727],"category_scores_gemma":[0.0002113021,0.00009935016,0.00020505382,0.00026067832,0.00012666926,0.000117174815,0.00009723661,0.0002497073,0.00046916807],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001286697,0.000044194876,0.0018129708,0.000042613083,0.000011560732,0.00013263326,0.000044140415,0.00008739544,0.9917985,0.000019997604,0.000045973637,0.004673293],"study_design_scores_gemma":[0.0002812701,0.0036980915,0.042040557,0.000020231932,0.00009242315,0.0010341558,0.00009789323,0.0006586333,0.9489207,0.00009392078,0.0030501445,0.000012109564],"about_ca_topic_score_codex":0.000427436,"about_ca_topic_score_gemma":0.0005272725,"teacher_disagreement_score":0.0008957727,"about_ca_system_score_codex":0.00022548664,"about_ca_system_score_gemma":0.0001236517,"threshold_uncertainty_score":0.0029966235},"labels":[],"label_agreement":null},{"id":"W1988098374","doi":"10.1191/1352458505ms1190oa","title":"The mechanism of action of methylprednisolone in the treatment of multiple sclerosis","year":2005,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":206,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. John’s Health Sciences Centre; Memorial University of Newfoundland","funders":"","keywords":"Multiple sclerosis; Methylprednisolone; Immune system; Nitric oxide; Medicine; Mechanism (biology); Tumor necrosis factor alpha; Disease; Immunology; Apoptosis; Mechanism of action; Extravasation; Inflammation; Cytokine; Microglia; Neuroscience; Pharmacology; Biology; Internal medicine","score_opus":0.3692665200133362,"score_gpt":0.4033581294156865,"score_spread":0.03409160940235029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988098374","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001131451,0.99914134,0.00007112953,0.00009748593,0.00009788745,0.000003950926,0.00000582967,0.00000383398,0.00046539723],"genre_scores_gemma":[0.0008313417,0.9983583,0.00021440226,0.00008896601,0.00009987466,0.000006095055,0.000008773448,6.811347e-7,0.0003916381],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996774,0.00008098258,0.0000523482,0.00004338747,0.00012801708,0.000017879758],"domain_scores_gemma":[0.99973494,0.0001183283,0.00005351077,0.000008508684,0.0000618314,0.000022791362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007920925,0.0009014403,0.001873942,0.0031115145,0.0003011944,0.0008724017,0.0011468235,0.0013800418,0.0035518073],"category_scores_gemma":[0.0006303278,0.00022812745,0.00045389368,0.0029162227,0.0006483492,0.0011740436,0.00039717712,0.0011045745,0.002536356],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014862813,0.00010849606,0.0002164974,0.02146841,0.0001054255,0.0006747048,0.000079182195,0.00031062376,0.0049840217,0.0019662322,0.010234399,0.9597034],"study_design_scores_gemma":[0.00009288575,0.0004899366,0.0031551141,0.0074518593,0.00029220176,0.008322423,0.00015457951,0.00010626324,0.0028186105,0.002208295,0.9748708,0.000037181646],"about_ca_topic_score_codex":0.0012576412,"about_ca_topic_score_gemma":0.0020600783,"teacher_disagreement_score":0.0035518073,"about_ca_system_score_codex":0.0007718009,"about_ca_system_score_gemma":0.00092117593,"threshold_uncertainty_score":0.011882007},"labels":[],"label_agreement":null},{"id":"W1988510033","doi":"10.1177/1352458514556303","title":"Development and validation of an administrative data algorithm to estimate the disease burden and epidemiology of multiple sclerosis in Ontario, Canada","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Western Hospital; St. Michael's Hospital; The Scarborough Hospital; Health Sciences Centre; Women's College Hospital; University Health Network; University of Toronto; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences","funders":"Canadian Institutes of Health Research; Health Canada","keywords":"Epidemiology; Medicine; Multiple sclerosis; Incidence (geometry); Algorithm; Disease burden; Population; Demography; Computer science; Internal medicine; Environmental health; Mathematics","score_opus":0.23554736585337574,"score_gpt":0.372692536325335,"score_spread":0.13714517047195926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988510033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81458336,0.00242251,0.120296724,0.0031087005,0.00021216007,0.0059456816,0.034160994,0.0020495735,0.017220305],"genre_scores_gemma":[0.8105663,0.0007604865,0.17288978,0.0003083825,0.000032026594,0.0010607415,0.012561145,0.00010890708,0.0017121965],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99477226,0.0012338626,0.00076330436,0.0005666886,0.002309901,0.00035387604],"domain_scores_gemma":[0.96907145,0.0049773837,0.002019663,0.00092895684,0.022499423,0.00050310075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010213237,0.00067295,0.0007365843,0.0031683757,0.0017096284,0.0022202355,0.0018181276,0.00053813995,0.0012248976],"category_scores_gemma":[0.04401249,0.00045813297,0.00082614075,0.0034850617,0.0004967324,0.0006226244,0.0010049882,0.000609044,0.0003924499],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004512216,0.00021706805,0.8316037,0.00037292318,0.00035280798,0.00013830476,0.00059242087,0.027525434,0.00089915766,0.0011466851,0.013406287,0.123293884],"study_design_scores_gemma":[0.00035924886,0.0001331297,0.6893216,0.0003225522,0.0003238674,0.00017426324,0.000583988,0.2950973,0.0019013663,0.0006751341,0.011027702,0.00007980392],"about_ca_topic_score_codex":0.9655398,"about_ca_topic_score_gemma":0.95650977,"teacher_disagreement_score":0.034460187,"about_ca_system_score_codex":0.02543453,"about_ca_system_score_gemma":0.051431403,"threshold_uncertainty_score":0.18454129},"labels":[],"label_agreement":null},{"id":"W1989531971","doi":"10.1177/135245850000600606","title":"Neuropsychological counseling improves social behavior in cognitively-impaired multiple sclerosis patients","year":2000,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Multiple Sclerosis Society; University of Victoria; National Multiple Sclerosis Society","keywords":"Neuropsychology; Psychology; Clinical psychology; Neuropsychological assessment; Neuropsychological test; Intervention (counseling); Cognition; Psychiatry","score_opus":0.12287503230053289,"score_gpt":0.3162649411889916,"score_spread":0.19338990888845875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989531971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998719,0.00055774674,0.00004647464,0.00006553507,0.0000098719765,0.000036727146,0.000011117478,0.000014483339,0.0005390513],"genre_scores_gemma":[0.9991272,0.0002899801,0.00023475937,0.00009293183,0.000030391087,0.000033725762,0.000035002417,9.2152004e-7,0.0001550539],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999851,0.000069931164,0.000015307172,0.000015628444,0.000022468415,0.000025685493],"domain_scores_gemma":[0.99962294,0.00010310395,0.00007357475,0.000015207977,0.000026113972,0.0001590825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027133513,0.0003026166,0.00031764837,0.00023018476,0.00038055205,0.00015085841,0.00017318295,0.00025407426,0.0012975192],"category_scores_gemma":[0.0014311301,0.00008550274,0.0001929808,0.00010801753,0.00018284211,0.00010382223,0.00015247204,0.00021946152,0.0001345974],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04981123,0.06472413,0.16461903,0.0011904206,0.0010708269,0.0014583515,0.001641432,0.001531666,0.029222049,0.0001091947,0.002024178,0.6825976],"study_design_scores_gemma":[0.013540374,0.18539725,0.78823805,0.00017594751,0.0006952232,0.001513385,0.00064224616,0.0015207644,0.0050686295,0.00022641262,0.0029453905,0.000036304456],"about_ca_topic_score_codex":0.0012635016,"about_ca_topic_score_gemma":0.003300359,"teacher_disagreement_score":0.0012975192,"about_ca_system_score_codex":0.00019100012,"about_ca_system_score_gemma":0.00028885363,"threshold_uncertainty_score":0.0043407083},"labels":[],"label_agreement":null},{"id":"W1990367147","doi":"10.1177/1352458512436595","title":"Characteristics of multiple sclerosis in aboriginals living in British Columbia, Canada","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"Multiple Sclerosis Society; Serono Symposia International Foundation; European Committee for Treatment and Research in Multiple Sclerosis; Canadian Institutes of Health Research; Teva Pharmaceutical Industries; Sanofi; National Multiple Sclerosis Society","keywords":"Medicine; Multiple sclerosis; Expanded Disability Status Scale; Cohort; Disease; Demographics; Family history; Medical record; Young adult; Demography; Internal medicine; Pediatrics; Immunology","score_opus":0.07137228223706386,"score_gpt":0.2760600211986346,"score_spread":0.20468773896157072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990367147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976802,0.00021746657,0.000029419394,0.000058530277,0.0000035036876,0.000019355079,0.0010786685,0.0000031744626,0.000909727],"genre_scores_gemma":[0.9982508,0.00024662845,0.00007428358,0.000052474235,0.000003101058,0.0000148806075,0.00078583584,0.0000025354936,0.0005694691],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996326,0.000030277462,0.00003095642,0.00005612212,0.0001365257,0.00011349897],"domain_scores_gemma":[0.9990895,0.000059602728,0.00021185908,0.000025404679,0.00040435963,0.00020932156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023588739,0.0002150597,0.00028855968,0.0011541975,0.0018706351,0.0006341052,0.0005083779,0.000277886,0.001507831],"category_scores_gemma":[0.0010523801,0.00018477031,0.00015071953,0.0019997396,0.0004327175,0.00021263133,0.0003883809,0.0003003133,0.00025447988],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037465314,0.000021330303,0.99613637,0.000027045875,0.000012974451,0.00022260075,0.0010000688,0.000033643028,0.00033708062,0.000015638778,0.00029992967,0.0018558255],"study_design_scores_gemma":[0.0000018024135,0.000021419803,0.9976247,0.000012282107,0.000006087446,0.00018635378,0.0017268183,0.000039967457,0.000024654371,0.0000049191835,0.00034767008,0.0000034020416],"about_ca_topic_score_codex":0.947463,"about_ca_topic_score_gemma":0.96095264,"teacher_disagreement_score":0.052537024,"about_ca_system_score_codex":0.0042272797,"about_ca_system_score_gemma":0.0049854033,"threshold_uncertainty_score":0.105692804},"labels":[],"label_agreement":null},{"id":"W1990704394","doi":"10.1191/1352458505ms1126oa","title":"Randomized study of once-weekly interferon β-1a therapy in relapsing multiple sclerosis: three-year data from the OWIMS study","year":2005,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital de l'Enfant-Jésus; Queen Elizabeth II Health Sciences Centre; Hôpital Notre-Dame; St. Michael's Hospital; University Hospital; Ottawa Hospital","funders":"University of British Columbia","keywords":"Medicine; Multiple sclerosis; Placebo; Magnetic resonance imaging; Internal medicine; Dosing; Gastroenterology; Lesion; Randomized controlled trial; Surgery; Pathology; Immunology; Radiology","score_opus":0.2978339590507148,"score_gpt":0.3571284223480456,"score_spread":0.05929446329733079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990704394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852166,0.0076819123,0.00093999476,0.0005470818,0.00039761496,0.0021347152,0.0018527546,0.00009201356,0.0011373763],"genre_scores_gemma":[0.9887472,0.002115684,0.0011585874,0.0009355829,0.0004021287,0.0024658167,0.0027293034,0.000027759,0.0014179425],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9957287,0.0029759328,0.00033647785,0.00030726308,0.00036841712,0.00028316665],"domain_scores_gemma":[0.99372226,0.0019083814,0.0018467389,0.000807967,0.0005318217,0.0011829402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0076986477,0.0010652128,0.0040010307,0.0005150413,0.00055568886,0.001250456,0.000961304,0.0017270336,0.0037061682],"category_scores_gemma":[0.006317602,0.0006118022,0.003178523,0.00061180687,0.0009966623,0.00088744296,0.0005877026,0.0022150034,0.00070170645],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98236084,0.0024778205,0.003379568,0.00025913343,0.002396011,0.000040442268,0.00003080461,0.00020647176,0.0009816305,0.000044701857,0.00048896123,0.0073337164],"study_design_scores_gemma":[0.9293674,0.049251437,0.017358616,0.000041460153,0.002326174,0.00006271978,0.000020210035,0.0003361268,0.00029598785,0.00010334534,0.0008121499,0.000024365334],"about_ca_topic_score_codex":0.0011765676,"about_ca_topic_score_gemma":0.0015181198,"teacher_disagreement_score":0.0076986477,"about_ca_system_score_codex":0.00064207544,"about_ca_system_score_gemma":0.0013018487,"threshold_uncertainty_score":0.0407148},"labels":[],"label_agreement":null},{"id":"W1990917514","doi":"10.1177/1352458510384008","title":"Pathological basis of diffusely abnormal white matter: insights from magnetic resonance imaging and histology","year":2010,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Myelin; Luxol fast blue stain; Multiple sclerosis; White matter; Magnetization transfer; Pathology; Myelin basic protein; Expanded Disability Status Scale; Glial fibrillary acidic protein; Magnetic resonance imaging; Chemistry; Biology; Medicine; Internal medicine; Central nervous system; Immunology; Immunohistochemistry; Radiology","score_opus":0.03626906730659938,"score_gpt":0.25802916105199886,"score_spread":0.22176009374539948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990917514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99419326,0.0039924607,0.0011887902,0.00004002494,0.0000053201998,0.000009214177,0.000049063772,0.000014993088,0.0005068233],"genre_scores_gemma":[0.99720097,0.0014066212,0.0011121868,0.000024197385,0.000016592503,0.0000036611273,0.000062334766,0.000003187894,0.00017026473],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999107,0.000015559417,0.000012298188,0.000022468472,0.000024902987,0.000014027115],"domain_scores_gemma":[0.9997286,0.0000343168,0.00009943153,0.000030863877,0.000059676982,0.00004709457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035814717,0.00025363592,0.0001749217,0.0008009173,0.00011318354,0.0002977378,0.00017148159,0.00023804279,0.00080057286],"category_scores_gemma":[0.00035059464,0.0001606475,0.000088208486,0.00019889598,0.00053700985,0.00029242033,0.00020917266,0.0001538762,0.00023810474],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010218768,0.00010910752,0.37206072,0.00038423025,0.00011572178,0.0042809388,0.00037043594,0.00025620128,0.5886129,0.00030518096,0.0001429085,0.032339763],"study_design_scores_gemma":[0.000025122423,0.0005637706,0.9494597,0.000040980987,0.00008544194,0.024087634,0.00040088248,0.00053878466,0.02330675,0.00030460715,0.0011751894,0.0000112311245],"about_ca_topic_score_codex":0.00059049483,"about_ca_topic_score_gemma":0.00089033827,"teacher_disagreement_score":0.0008009173,"about_ca_system_score_codex":0.00014410478,"about_ca_system_score_gemma":0.00013134454,"threshold_uncertainty_score":0.0026782155},"labels":[],"label_agreement":null},{"id":"W1991460270","doi":"10.1177/1352458507080733","title":"Validation of the Multiple Sclerosis International Quality of Life questionnaire","year":2007,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":197,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Merck KGaA","keywords":"Quality of life (healthcare); Checklist; Construct validity; Discriminant validity; Reliability (semiconductor); Scale (ratio); External validity; Multiple sclerosis; Medicine; Clinical psychology; Psychometrics; Psychology; Physical therapy; Internal consistency; Psychiatry; Social psychology","score_opus":0.17518544664910574,"score_gpt":0.3521559668013095,"score_spread":0.17697052015220377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991460270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97873086,0.0016243672,0.006450675,0.0006841718,0.00021736028,0.0016873697,0.0030574312,0.000059083835,0.007488761],"genre_scores_gemma":[0.98065853,0.000624605,0.009828648,0.00040837505,0.00007332278,0.0025440175,0.0045122975,0.000029381365,0.0013209225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99439865,0.0025455689,0.000843896,0.00032211567,0.0016739334,0.00021578911],"domain_scores_gemma":[0.9891083,0.0043035084,0.0017674452,0.0006427034,0.0036462515,0.00053163664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014439829,0.0003005768,0.00051347783,0.0013122938,0.00039382066,0.0006116066,0.0005431931,0.00035278418,0.0015092432],"category_scores_gemma":[0.026413137,0.00016046836,0.0008252976,0.00078660384,0.00037972955,0.00069559494,0.0009055604,0.0006105763,0.00052129483],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059219,0.0006807507,0.86006147,0.00021006924,0.00033331616,0.00008337637,0.0012648836,0.000576511,0.0009822476,0.0005452395,0.002999717,0.13167016],"study_design_scores_gemma":[0.00017387977,0.0013161391,0.9842891,0.0001685198,0.000090138674,0.00031531265,0.0005607347,0.0009935639,0.00047553275,0.00034213744,0.011250091,0.000024797075],"about_ca_topic_score_codex":0.0011966138,"about_ca_topic_score_gemma":0.0017928759,"teacher_disagreement_score":0.014439829,"about_ca_system_score_codex":0.0004656121,"about_ca_system_score_gemma":0.0009877726,"threshold_uncertainty_score":0.07636607},"labels":[],"label_agreement":null},{"id":"W1991643405","doi":"10.1177/1352458507084266","title":"Through the eyes of a child: research insights gained through the study of childhood multiple sclerosis","year":2007,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; SickKids Foundation","funders":"","keywords":"Multiple sclerosis; Medicine; Psychology; Clinical neurology; Developmental psychology; Neuroscience; Psychiatry","score_opus":0.23184495182908016,"score_gpt":0.3683210655924814,"score_spread":0.13647611376340124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991643405","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18791279,0.18841825,0.00051672134,0.606113,0.0032128799,0.00005264845,0.00018306865,0.00000986742,0.013580636],"genre_scores_gemma":[0.5696205,0.24354401,0.0017543896,0.17404948,0.008136963,0.00016964418,0.000056273286,0.000031806994,0.0026369982],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.99133027,0.0070822206,0.0003456942,0.00029354132,0.0005829566,0.00036531044],"domain_scores_gemma":[0.94143736,0.052213874,0.0021613813,0.00086891564,0.0021190045,0.0011994638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010916852,0.00042141197,0.0012489151,0.0010353773,0.0041074064,0.004030839,0.0010344491,0.008056842,0.0019627344],"category_scores_gemma":[0.04539549,0.0003287817,0.0004913665,0.002187858,0.0057121627,0.005583996,0.0025532977,0.0069523663,0.00029128423],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013764545,0.0011241024,0.11630094,0.008920048,0.0007141755,0.048281893,0.3992921,0.000330048,0.0036994042,0.03429031,0.18372318,0.2019474],"study_design_scores_gemma":[0.00033396605,0.001134729,0.11492357,0.01255403,0.0006178588,0.05740115,0.460455,0.00015851938,0.0014227532,0.026861634,0.32395563,0.0001811722],"about_ca_topic_score_codex":0.012862184,"about_ca_topic_score_gemma":0.033031814,"teacher_disagreement_score":0.012862184,"about_ca_system_score_codex":0.0021768215,"about_ca_system_score_gemma":0.0045674774,"threshold_uncertainty_score":0.05773455},"labels":[],"label_agreement":null},{"id":"W1992531794","doi":"10.1191/135248506ms1267oa","title":"The relation between menarche and the age of first symptoms in a multiple sclerosis cohort","year":2006,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Menarche; Medicine; Multiple sclerosis; Cohort; Population; Pediatrics; Age of onset; Cohort study; Demography; Internal medicine; Disease; Immunology","score_opus":0.08959393901813134,"score_gpt":0.28123874248510305,"score_spread":0.1916448034669717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992531794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99922514,0.00029889896,0.00002627544,0.00007995652,0.000004264809,0.0000025054023,0.00018221611,0.000002633747,0.00017805077],"genre_scores_gemma":[0.99956626,0.000095739226,0.000023983133,0.000011791809,0.0000054327816,0.000002144777,0.00016750488,0.0000015820297,0.00012551507],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956006,0.000101595346,0.000029330811,0.00010625839,0.00008758417,0.000115190036],"domain_scores_gemma":[0.99610186,0.0011704792,0.0012589438,0.000248666,0.0003587199,0.00086137286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014572623,0.0001749232,0.00031697104,0.00093392003,0.0004921221,0.00068448734,0.0003149711,0.00036509318,0.0015111442],"category_scores_gemma":[0.0056660622,0.0002662115,0.0003447038,0.0006493466,0.00032405162,0.0003955914,0.00028295978,0.0007903023,0.00015402197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010802483,0.000012106672,0.99914753,0.0000027196443,0.00003200332,0.000039600134,0.000051690837,0.000023400315,0.000099337354,0.000007652678,0.000050963365,0.0004248434],"study_design_scores_gemma":[0.0000030680476,0.000034113615,0.99965906,0.0000017378583,0.000010727264,0.00010875623,0.000051592273,0.000044726745,0.000019909496,0.0000049315986,0.00005997127,0.0000014084642],"about_ca_topic_score_codex":0.037321072,"about_ca_topic_score_gemma":0.031890236,"teacher_disagreement_score":0.037321072,"about_ca_system_score_codex":0.0006647469,"about_ca_system_score_gemma":0.0009194691,"threshold_uncertainty_score":0.07420766},"labels":[],"label_agreement":null},{"id":"W1996771233","doi":"10.1177/1352458507076989","title":"Binding antibodies: Vancouver's perspective","year":2007,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Multiple sclerosis; Antibody; Medicine; Interferon beta; Immunology; Perspective (graphical); Interferon","score_opus":0.09803620989031762,"score_gpt":0.3399826878967504,"score_spread":0.24194647800643276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996771233","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006718748,0.635699,0.0004476831,0.25419283,0.047278754,0.000031615356,0.00030697513,0.0000417648,0.061329603],"genre_scores_gemma":[0.011061268,0.7788745,0.0008059805,0.11100955,0.0247466,0.000051204588,0.0001853854,0.00004013831,0.07322534],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988813,0.00019919682,0.000102050355,0.00017825552,0.0004728599,0.00016636631],"domain_scores_gemma":[0.9967565,0.00048416032,0.00014599635,0.000098875804,0.0014321848,0.001082283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016690508,0.00089099765,0.00085529615,0.0025564656,0.0013628762,0.0035876571,0.0013147308,0.0066251643,0.02708251],"category_scores_gemma":[0.0040765638,0.00033953573,0.0005285859,0.0020902338,0.0016010809,0.002795969,0.0016299908,0.0053220736,0.0069822264],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005362489,0.000043202952,0.00072503014,0.00081074476,0.000023867333,0.00058328995,0.00010790139,0.00007953396,0.00024318085,0.013909796,0.7852076,0.19821213],"study_design_scores_gemma":[0.000007999037,0.000019194073,0.0005036447,0.0006451462,0.000007699718,0.00057031226,0.00007959546,0.000013671076,0.000029592728,0.0016039727,0.99651235,0.0000067890956],"about_ca_topic_score_codex":0.048139676,"about_ca_topic_score_gemma":0.098323956,"teacher_disagreement_score":0.048139676,"about_ca_system_score_codex":0.004850954,"about_ca_system_score_gemma":0.00958342,"threshold_uncertainty_score":0.09571898},"labels":[],"label_agreement":null},{"id":"W1996975196","doi":"10.1191/1352458505ms1200cr","title":"Neuromyelitis optica with hypothalamic involvement","year":2005,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":144,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Montreal Neurological Institute and Hospital","funders":"","keywords":"Neuromyelitis optica; Multiple sclerosis; Medicine; Pathology; Neuroscience; Immunology; Psychology","score_opus":0.23918158387338267,"score_gpt":0.3555429929514433,"score_spread":0.11636140907806064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996975196","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0059806174,0.9890472,0.00032282353,0.00025454143,0.00015273671,0.00001426761,0.000020902702,0.000013813247,0.0041930303],"genre_scores_gemma":[0.07132634,0.92430615,0.0010569288,0.0010330193,0.00037859046,0.000025410101,0.000055419736,0.0000033302267,0.0018147767],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9998723,0.000024321165,0.000028737579,0.000024808449,0.00003394032,0.00001584206],"domain_scores_gemma":[0.9998678,0.00004499211,0.00005209564,0.000007401533,0.000015763726,0.000011960019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015098392,0.00055893685,0.0006304705,0.0012351478,0.00025870252,0.00041223245,0.00032103658,0.0005881677,0.0011419881],"category_scores_gemma":[0.00055461837,0.00014000565,0.00019679997,0.0012458325,0.00038138553,0.00047453004,0.00034443772,0.00035629695,0.00072252343],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015602713,0.00006900676,0.0073676105,0.018413298,0.0002449014,0.14254898,0.00053926086,0.00021413056,0.006607834,0.0018355435,0.007905555,0.8140979],"study_design_scores_gemma":[0.00005745817,0.00017509829,0.01798801,0.0036428594,0.0003647556,0.7079039,0.00047303797,0.00007794587,0.0025570327,0.0014156996,0.26530874,0.000035449764],"about_ca_topic_score_codex":0.001245734,"about_ca_topic_score_gemma":0.0026784102,"teacher_disagreement_score":0.001245734,"about_ca_system_score_codex":0.00028332716,"about_ca_system_score_gemma":0.0006216638,"threshold_uncertainty_score":0.0038203597},"labels":[],"label_agreement":null},{"id":"W1997079576","doi":"10.1177/135245850000600603","title":"Increase in serum levels of uric acid, an endogenous antioxidant, under treatment with glatiramer acetate for multiple sclerosis","year":2000,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Glatiramer acetate; Multiple sclerosis; Peroxynitrite; Medicine; Placebo; Uric acid; Antioxidant; Internal medicine; Endocrinology; Immunology; Chemistry; Biochemistry; Pathology","score_opus":0.20876449591271362,"score_gpt":0.31356243200209366,"score_spread":0.10479793608938004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997079576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975376,0.0017577182,0.0000896104,0.000046373963,0.000009948957,0.00001588472,0.000037707658,0.000017811191,0.00048725048],"genre_scores_gemma":[0.9990088,0.00028777716,0.00012457228,0.00006936329,0.000022262808,0.000013021,0.0001015244,0.000002064828,0.00037044982],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99982363,0.000060554918,0.000017052613,0.0000309621,0.000032592026,0.000035321336],"domain_scores_gemma":[0.99967337,0.00006418528,0.00013827007,0.000015831265,0.000022536695,0.00008588112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022334182,0.0003482336,0.000506132,0.00032776923,0.0002238443,0.0002399164,0.00013066485,0.0003610365,0.00096102705],"category_scores_gemma":[0.00069732603,0.00010070708,0.00019993226,0.0002730164,0.00020769963,0.00016316168,0.00011491923,0.0003999433,0.00024636622],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02080652,0.001965535,0.6486434,0.0003307615,0.00048436038,0.0064362036,0.0009220878,0.00020314447,0.18269636,0.00008863974,0.0009281095,0.13649477],"study_design_scores_gemma":[0.00033382664,0.016239805,0.9657887,0.000020637399,0.0001480899,0.00656667,0.00015692344,0.000271719,0.008690282,0.000039622802,0.0017316387,0.000012010854],"about_ca_topic_score_codex":0.0004112735,"about_ca_topic_score_gemma":0.00056338124,"teacher_disagreement_score":0.00096102705,"about_ca_system_score_codex":0.0002846023,"about_ca_system_score_gemma":0.00011368727,"threshold_uncertainty_score":0.0032149553},"labels":[],"label_agreement":null},{"id":"W1997203784","doi":"10.1177/1352458513504251","title":"Patterns and predictors of naturally occurring change in depressive symptoms over a 30-month period in multiple sclerosis","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Depressive symptoms; Hospital Anxiety and Depression Scale; Depression (economics); Multiple sclerosis; Anxiety; Medicine; Latent class model; Psychology; Psychiatry; Clinical psychology","score_opus":0.07584306808951044,"score_gpt":0.2860943064292159,"score_spread":0.21025123833970547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997203784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999627,0.00007769851,0.00006733101,0.000042210282,0.0000020674975,0.000004367065,0.00012297567,0.0000027756344,0.000053643453],"genre_scores_gemma":[0.9996551,0.000030288946,0.000053988057,0.000006026017,0.0000020521231,0.0000047885515,0.00021832222,6.930544e-7,0.000028662014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99940145,0.000233639,0.00007050292,0.00011741644,0.0000892925,0.00008767941],"domain_scores_gemma":[0.99707615,0.0007045531,0.0013821982,0.0001462405,0.00021381858,0.00047703573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013007004,0.00019297014,0.00023707427,0.0004972533,0.00032435698,0.00045980315,0.0003527736,0.0004831868,0.0007858808],"category_scores_gemma":[0.00434891,0.0002128364,0.00045014502,0.00044534935,0.00026044107,0.00030690216,0.00046510994,0.000727662,0.00015367226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010440944,0.000042492862,0.9985373,0.0000053307976,0.000034522473,0.000020614232,0.0000621116,0.000094463525,0.000072464456,0.000007278051,0.00005188619,0.00096711045],"study_design_scores_gemma":[0.0000030040774,0.00005085035,0.99928683,0.000002788133,0.00000498453,0.00004636888,0.00006332787,0.0004841469,0.000015474516,0.00001598877,0.000024282434,0.000001871964],"about_ca_topic_score_codex":0.006416905,"about_ca_topic_score_gemma":0.009776686,"teacher_disagreement_score":0.006416905,"about_ca_system_score_codex":0.0005177855,"about_ca_system_score_gemma":0.00034920964,"threshold_uncertainty_score":0.012759149},"labels":[],"label_agreement":null},{"id":"W1998973561","doi":"10.1177/1352458514547407","title":"Ten-year follow-up of the ‘minimal MRI lesion’ subgroup from the original CHAMPS Multiple Sclerosis Prevention Trial","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Marshall Space Flight Center; National Institutes of Health; IC Design Education Center; Biogen","keywords":"Medicine; Multiple sclerosis; Lesion; Magnetic resonance imaging; Clinically isolated syndrome; Quartile; Clinical trial; Radiology; Expanded Disability Status Scale; Internal medicine; Surgery; Confidence interval","score_opus":0.13388370044376247,"score_gpt":0.31131728259390395,"score_spread":0.1774335821501415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998973561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929276,0.0021240811,0.00010638891,0.00056472584,0.00014190376,0.00028501355,0.0013615546,0.000020818288,0.0024678162],"genre_scores_gemma":[0.9937441,0.00064677565,0.00021081603,0.00066769443,0.00028611431,0.00041640268,0.0027999457,0.0000056819767,0.0012225503],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9991708,0.0003641817,0.00006419817,0.000158366,0.00008498001,0.00015757402],"domain_scores_gemma":[0.9984711,0.0002492874,0.00046778357,0.00019196316,0.0001698759,0.0004500798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026616848,0.00061968365,0.0016586849,0.00029301504,0.0005695652,0.00092668406,0.00044338664,0.0011759279,0.003374524],"category_scores_gemma":[0.0032277727,0.00025285676,0.0012217864,0.0003730267,0.00031360926,0.00063195947,0.00047584294,0.0012520255,0.0003416522],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.84313416,0.0030822314,0.09249548,0.0005791933,0.0047815223,0.00022773411,0.00019854403,0.00088348944,0.0021237591,0.00033798433,0.007956639,0.044199336],"study_design_scores_gemma":[0.37686196,0.10629185,0.49379033,0.0004238887,0.0086788675,0.000559265,0.0002975302,0.0023191206,0.0011694012,0.0018783766,0.0076190317,0.000110269735],"about_ca_topic_score_codex":0.0017584086,"about_ca_topic_score_gemma":0.003818147,"teacher_disagreement_score":0.003374524,"about_ca_system_score_codex":0.00044206652,"about_ca_system_score_gemma":0.0008590623,"threshold_uncertainty_score":0.014076531},"labels":[],"label_agreement":null},{"id":"W2000414235","doi":"10.1191/1352458503ms964oa","title":"Co-occurrence of multiple sclerosis and myasthenia gravis in British C olumbia","year":2003,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Hospital and Health Sciences Centre; University of British Columbia","funders":"","keywords":"Myasthenia gravis; Multiple sclerosis; Medicine; Pathogenesis; Pediatrics; Immunology","score_opus":0.05868104228575564,"score_gpt":0.254147240616558,"score_spread":0.1954661983308024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000414235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99857545,0.0002727685,0.000034881647,0.000055173652,0.0000068693835,0.000005484893,0.000023994002,0.0000039197907,0.0010213179],"genre_scores_gemma":[0.9995505,0.0001131091,0.000043793356,0.000053725973,0.0000108135755,0.0000033286708,0.000029923858,0.0000020933207,0.00019251647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995433,0.00007616933,0.000045244113,0.00007627786,0.00009274462,0.00016630518],"domain_scores_gemma":[0.9989642,0.00018918718,0.00038795738,0.00006626568,0.00009657483,0.0002957513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016458123,0.0003934178,0.00044647345,0.0012641678,0.0018017576,0.00055692194,0.00033317172,0.000724417,0.002904819],"category_scores_gemma":[0.002144711,0.00059343124,0.00018542915,0.0010191135,0.00082800025,0.00036677692,0.0009202405,0.0006112383,0.00036794436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015927292,0.00006878294,0.96471167,0.00002926728,0.000024558052,0.028519634,0.0009680067,0.000038282993,0.0010780336,0.000058752757,0.00030575774,0.0040380047],"study_design_scores_gemma":[0.000051682873,0.00023266002,0.8397069,0.00003453239,0.00004294852,0.15683031,0.0011778128,0.0001503281,0.00018077002,0.00007712611,0.0014893082,0.000025734445],"about_ca_topic_score_codex":0.043300636,"about_ca_topic_score_gemma":0.04776474,"teacher_disagreement_score":0.9566994,"about_ca_system_score_codex":0.00061644113,"about_ca_system_score_gemma":0.00069381663,"threshold_uncertainty_score":0.08609718},"labels":[],"label_agreement":null},{"id":"W2001110565","doi":"10.1177/1352458514538110","title":"Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":305,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of Neurological Disorders and Stroke; European Committee for Treatment and Research in Multiple Sclerosis","keywords":"Kappa; Optical coherence tomography; Clinically isolated syndrome; Medicine; Medical physics; Test (biology); Retinal; Cohen's kappa; Computer science; Artificial intelligence; Optometry; Multiple sclerosis; Ophthalmology; Mathematics; Machine learning","score_opus":0.17671126256298503,"score_gpt":0.3528978875698814,"score_spread":0.17618662500689636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001110565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7352678,0.011936741,0.18052752,0.004972153,0.0019102655,0.026449373,0.0040784716,0.001182048,0.03367563],"genre_scores_gemma":[0.88661325,0.00097198243,0.09943498,0.00052548153,0.00017438004,0.007846369,0.0027079952,0.00021850246,0.001507115],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.84029305,0.07124005,0.040512335,0.0045959298,0.040938355,0.0024202005],"domain_scores_gemma":[0.62531984,0.10994039,0.059199683,0.026547452,0.17317614,0.0058165328],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.24389192,0.0007343524,0.0013520805,0.00583313,0.0023971584,0.0029627543,0.0025789985,0.0014414734,0.0011757682],"category_scores_gemma":[0.22393928,0.0003992662,0.0021912844,0.002985817,0.0023840328,0.0015492212,0.0033331588,0.0012804728,0.00055432745],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060635665,0.0011265235,0.61848944,0.004243757,0.0010469108,0.00040042136,0.009795518,0.0032639161,0.013976791,0.004837585,0.01709405,0.31966156],"study_design_scores_gemma":[0.00069035287,0.0055484534,0.8935003,0.0034822358,0.00088873046,0.0014905473,0.0039700116,0.018096209,0.021075698,0.0031641265,0.04772833,0.00036504917],"about_ca_topic_score_codex":0.004391223,"about_ca_topic_score_gemma":0.0045382334,"teacher_disagreement_score":0.24389192,"about_ca_system_score_codex":0.0030559015,"about_ca_system_score_gemma":0.0076342407,"threshold_uncertainty_score":0.93241584},"labels":[],"label_agreement":null},{"id":"W2007895122","doi":"10.1177/135245850501100123","title":"Pathologic Classification Systems in MS: What is their Significance?","year":2005,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Queen's University","funders":"","keywords":"Multiple sclerosis; Medicine; Clinical significance; Pathology; Psychiatry","score_opus":0.33702484826797857,"score_gpt":0.38580667135155006,"score_spread":0.048781823083571485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007895122","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009575885,0.999019,0.00008737646,0.0003802079,0.0002180273,0.0000045264105,0.000021564292,0.0000029200742,0.00017057548],"genre_scores_gemma":[0.0009073137,0.9981139,0.00047043173,0.00019968241,0.00018563929,0.0000067103897,0.000034665765,0.0000012316892,0.0000804584],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982639,0.00052996585,0.0005155293,0.00021385861,0.00041371197,0.00006304748],"domain_scores_gemma":[0.9943672,0.0034565032,0.00085771637,0.00010825523,0.0011036717,0.00010661491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005169104,0.0012763081,0.004762081,0.007847271,0.0004839185,0.0030481277,0.0022037495,0.0014415613,0.001722568],"category_scores_gemma":[0.008906756,0.00051736174,0.0012784189,0.010988279,0.0017621574,0.003305448,0.00088172214,0.0016517816,0.00080732745],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001312844,0.000048790604,0.0027856685,0.055856466,0.000609398,0.00020941086,0.00020652672,0.00027664125,0.00030075925,0.0040532337,0.029128334,0.90639347],"study_design_scores_gemma":[0.00015801104,0.0002379551,0.020786598,0.11096662,0.0046939827,0.004585662,0.0013646024,0.00055181107,0.0005490295,0.009511767,0.8464332,0.0001607722],"about_ca_topic_score_codex":0.0058778524,"about_ca_topic_score_gemma":0.01010387,"teacher_disagreement_score":0.007847271,"about_ca_system_score_codex":0.001840143,"about_ca_system_score_gemma":0.004448589,"threshold_uncertainty_score":0.027337193},"labels":[],"label_agreement":null},{"id":"W2009156994","doi":"10.1191/1352458502ms810oa","title":"Cytokine production in T lymphocytemicroglia interaction is attenuated by glatiramer acetate: a mechanism for therapeutic efficacy in multiple sclerosis","year":2002,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Neuroinflammation and Neurodegeneration Mechanisms","field":"Neuroscience","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Teva Pharmaceutical Industries","keywords":"Glatiramer acetate; Microglia; Multiple sclerosis; Cytokine; Medicine; Immunology; Pharmacology; Inflammation","score_opus":0.17003342961674386,"score_gpt":0.27452928030763246,"score_spread":0.1044958506908886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009156994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99317694,0.004289305,0.0009556563,0.00023229793,0.000048725822,0.00003726193,0.000085593834,0.00009868726,0.001075374],"genre_scores_gemma":[0.996403,0.0015256727,0.00093103753,0.0000705583,0.000046075984,0.000045799985,0.00009820454,0.00000744917,0.0008721521],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998473,0.00005338695,0.000015235737,0.000010750855,0.000026476993,0.000046822755],"domain_scores_gemma":[0.9999031,0.000019541883,0.000026907966,0.000014411562,0.000012692011,0.00002338942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002107928,0.0004126437,0.0004305856,0.00024216909,0.00015961868,0.000292468,0.00018780494,0.00042922894,0.0018207133],"category_scores_gemma":[0.00019675306,0.00010315965,0.00024538772,0.00015074668,0.00026731123,0.0001907184,0.00011348765,0.00063409493,0.00041275955],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010230097,0.000135346,0.00027683118,0.00008484013,0.000009003738,0.00017141218,0.000022882325,0.000040939394,0.9929778,0.00007100633,0.00005574941,0.0051312326],"study_design_scores_gemma":[0.00026113956,0.004040154,0.010097347,0.000018963288,0.00005307128,0.00071354146,0.00003798502,0.0004127744,0.98183584,0.00014181563,0.002382858,0.0000045982238],"about_ca_topic_score_codex":0.00014636038,"about_ca_topic_score_gemma":0.00021465716,"teacher_disagreement_score":0.0018207133,"about_ca_system_score_codex":0.0001658815,"about_ca_system_score_gemma":0.00015403637,"threshold_uncertainty_score":0.0060908794},"labels":[],"label_agreement":null},{"id":"W2009611974","doi":"10.1177/1352458512444751","title":"Increase in the prevalence of multiple sclerosis over a 17-year period in Osona, Catalonia, Spain","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria General Hospital","funders":"Departament de Salut, Generalitat de Catalunya","keywords":"Multiple sclerosis; Medicine; Prevalence; Cross-sectional study; Demography; Epidemiology; Pediatrics; Internal medicine; Pathology; Immunology","score_opus":0.09526381451252357,"score_gpt":0.3031978890711598,"score_spread":0.20793407455863622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009611974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986512,0.00080066366,0.0000225799,0.000028796032,0.000008307228,0.0000030972883,0.00022957969,0.0000023162843,0.0002534678],"genre_scores_gemma":[0.9987639,0.0005845316,0.00005951998,0.000024970355,0.000007748449,0.000004529149,0.00034317546,0.000001141539,0.00021046719],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999597,0.00011857494,0.000061153914,0.00009625514,0.00005272697,0.000074418735],"domain_scores_gemma":[0.99904317,0.00014944242,0.0004623014,0.00004404242,0.0001587566,0.00014223198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008655397,0.00023830189,0.00036388967,0.0011637416,0.00019973979,0.0008185741,0.0003616928,0.00035035273,0.00066263933],"category_scores_gemma":[0.0011147955,0.00020960232,0.0003503222,0.00095776515,0.00025077065,0.00025929714,0.00044510278,0.0002324522,0.000120493045],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014623634,0.000023673667,0.99626166,0.00003457063,0.00006802678,0.00030962695,0.0002765343,0.00006827982,0.00028265239,0.000010461156,0.00012260677,0.0023957477],"study_design_scores_gemma":[0.0000036203057,0.000025352905,0.9993266,0.000010365453,0.000015436117,0.00012763722,0.00028767192,0.000031126783,0.0000178381,0.0000026947378,0.00014986837,0.0000017604966],"about_ca_topic_score_codex":0.042552635,"about_ca_topic_score_gemma":0.03393603,"teacher_disagreement_score":0.042552635,"about_ca_system_score_codex":0.00087459607,"about_ca_system_score_gemma":0.00051273784,"threshold_uncertainty_score":0.084609926},"labels":[],"label_agreement":null},{"id":"W2012272935","doi":"10.1177/1352458513518259","title":"Disability weight for each level of the Expanded Disability Status Scale in multiple sclerosis","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of British Columbia; Inje University; World Bank Group","keywords":"Expanded Disability Status Scale; Multiple sclerosis; Ordinal Scale; Medicine; Scale (ratio); Statistics; Mathematics; Geography; Cartography; Psychiatry","score_opus":0.2492007932855591,"score_gpt":0.33424011987217234,"score_spread":0.08503932658661323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012272935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8115302,0.0015802043,0.12978023,0.0021886167,0.00037264096,0.0063679754,0.0044068317,0.0002993529,0.043473992],"genre_scores_gemma":[0.8571711,0.00047483086,0.13533278,0.000100392404,0.000043160246,0.0034396537,0.0016771914,0.00004495503,0.0017160693],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99114275,0.0051748194,0.0010543702,0.0003271081,0.002094166,0.00020683008],"domain_scores_gemma":[0.9866194,0.006222832,0.0021892393,0.0011760473,0.003468754,0.00032364964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016018448,0.0004014665,0.00031823094,0.0023320697,0.00037957684,0.0005943363,0.00059804803,0.00029995988,0.0040881764],"category_scores_gemma":[0.037663486,0.00010631638,0.0007616095,0.0015062877,0.00062034605,0.00067051663,0.0014687077,0.0009185016,0.0005374956],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012732912,0.00037348326,0.28544718,0.0014157472,0.00046462484,0.00014780913,0.0061754496,0.007249341,0.0042268964,0.011439449,0.012582236,0.6692044],"study_design_scores_gemma":[0.0003708502,0.0032404037,0.86971563,0.0010262965,0.0003642848,0.0010809327,0.0060318485,0.017923046,0.0062600975,0.020604484,0.07321148,0.00017052774],"about_ca_topic_score_codex":0.0011761318,"about_ca_topic_score_gemma":0.0015581575,"teacher_disagreement_score":0.016018448,"about_ca_system_score_codex":0.0012303981,"about_ca_system_score_gemma":0.0011106641,"threshold_uncertainty_score":0.08471465},"labels":[],"label_agreement":null},{"id":"W2015050903","doi":"10.1177/1352458515581436","title":"Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Balance, Gait, and Falls Prevention","field":"Health Professions","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"European Commission; Biogen","keywords":"Berg Balance Scale; Medicine; Placebo; Balance (ability); Physical therapy; Preferred walking speed; Randomized controlled trial; Posturography; Physical medicine and rehabilitation; Internal medicine","score_opus":0.06912946438971042,"score_gpt":0.33114270893381376,"score_spread":0.26201324454410335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015050903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9567464,0.031112084,0.00063644664,0.001186558,0.0009131064,0.005314294,0.0017811403,0.00015667662,0.0021533403],"genre_scores_gemma":[0.9736517,0.011115528,0.0015279106,0.0011402337,0.001007098,0.0071495725,0.0010848802,0.000015805543,0.003307195],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994344,0.00030553213,0.00005739739,0.000082082035,0.000042769225,0.00007771445],"domain_scores_gemma":[0.99922514,0.00024517963,0.0002406921,0.000042333213,0.000058325146,0.00018826635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013777149,0.0012187539,0.0032332558,0.00047245208,0.00032190696,0.0007997733,0.0007485521,0.002198213,0.0076257517],"category_scores_gemma":[0.0018154728,0.000544679,0.0018154875,0.0004804909,0.0008595732,0.00076063804,0.0003734553,0.0016050135,0.00067197555],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9865758,0.001200316,0.00025502653,0.001351108,0.00070688355,0.00003369509,0.000023062159,0.00014456925,0.0010407047,0.00005112257,0.0003626155,0.008255129],"study_design_scores_gemma":[0.97966605,0.018714804,0.00075741165,0.000061181345,0.00027007915,0.00002325863,0.000007983041,0.00010492283,0.00008832432,0.000032071173,0.00026888287,0.0000051074608],"about_ca_topic_score_codex":0.001435418,"about_ca_topic_score_gemma":0.0027985561,"teacher_disagreement_score":0.0076257517,"about_ca_system_score_codex":0.0006629748,"about_ca_system_score_gemma":0.0008618959,"threshold_uncertainty_score":0.025510728},"labels":[],"label_agreement":null},{"id":"W2016306773","doi":"10.1191/1352458505ms1219sr","title":"Tactile temporal thresholds detect relapse-related changes in multiple sclerosis: a preliminary study","year":2005,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Tactile and Sensory Interactions","field":"Neuroscience","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Multiple Sclerosis Society","keywords":"Multiple sclerosis; Audiology; Medicine; Sensory threshold; Physical medicine and rehabilitation; Psychology; Cognitive psychology; Immunology","score_opus":0.13352812620196916,"score_gpt":0.28248660439908413,"score_spread":0.14895847819711497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016306773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988257,0.00025987116,0.00033726054,0.000022060904,0.000004435684,0.000062858366,0.00005382733,0.000009277562,0.00042462675],"genre_scores_gemma":[0.9990828,0.00007802055,0.0003958792,0.00003303456,0.000010361461,0.000046408517,0.00006211401,0.0000034346526,0.00028793793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99957424,0.00014009957,0.000031184958,0.00006673538,0.00012424427,0.00006337321],"domain_scores_gemma":[0.9986339,0.00048254058,0.00023292517,0.00012919263,0.0003141266,0.00020719737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016048782,0.00036784683,0.00042456374,0.0004980139,0.00032270682,0.00035429074,0.0003008414,0.0007372037,0.001846748],"category_scores_gemma":[0.0037476632,0.00020763787,0.0003061307,0.00022214254,0.0004342671,0.0004605844,0.00039066325,0.0006335718,0.0004239997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027781071,0.0077065206,0.5441247,0.0004898238,0.00031269804,0.002793647,0.0036922044,0.0003177153,0.31862143,0.00014001495,0.00070930825,0.093310714],"study_design_scores_gemma":[0.00028569452,0.028297666,0.95158577,0.000020777672,0.00019958886,0.004103752,0.0007044918,0.0006536327,0.013260997,0.00013629923,0.00072634197,0.000025041107],"about_ca_topic_score_codex":0.00081857917,"about_ca_topic_score_gemma":0.00085067225,"teacher_disagreement_score":0.001846748,"about_ca_system_score_codex":0.0001831679,"about_ca_system_score_gemma":0.00016955426,"threshold_uncertainty_score":0.008487523},"labels":[],"label_agreement":null},{"id":"W2017412635","doi":"10.1177/1352458512438454","title":"A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Multiple Sclerosis Society","keywords":"Medicine; Transplantation; Clinical trial; Randomized controlled trial; Multiple sclerosis; Hematopoietic stem cell transplantation; Stem cell; Disease; Internal medicine; Surgery; Intensive care medicine; Physical therapy; Immunology","score_opus":0.05443925455572737,"score_gpt":0.289801992512282,"score_spread":0.23536273795655463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017412635","genre_codex":"empirical","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84146816,0.036481474,0.0052999104,0.01992811,0.023193939,0.061955024,0.004258094,0.0003291814,0.0070860395],"genre_scores_gemma":[0.8908916,0.0106973825,0.010647079,0.015994929,0.011173414,0.049582105,0.002480796,0.000053160282,0.008479404],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99355114,0.0045796866,0.0006431803,0.0006207171,0.0003173486,0.00028803575],"domain_scores_gemma":[0.99109954,0.0046442393,0.0015757339,0.0006625031,0.00064137275,0.0013765664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012735891,0.0015607427,0.003035609,0.00046906862,0.000921474,0.0019152645,0.0012652773,0.004813447,0.011476508],"category_scores_gemma":[0.013357341,0.0007054301,0.0033686773,0.0005567385,0.0013794242,0.0016061723,0.0006766862,0.003064547,0.0014144166],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9849525,0.002389114,0.0006065237,0.0009998741,0.0021932784,0.000046322104,0.000046298872,0.00010061831,0.0006688429,0.00031061412,0.0009930789,0.006692925],"study_design_scores_gemma":[0.979622,0.017682854,0.0004012544,0.00005976116,0.0009734993,0.000012553516,0.000011928205,0.00010602951,0.00010712762,0.00017244164,0.00084293506,0.0000076832275],"about_ca_topic_score_codex":0.0004692553,"about_ca_topic_score_gemma":0.0008227551,"teacher_disagreement_score":0.012735891,"about_ca_system_score_codex":0.0006463471,"about_ca_system_score_gemma":0.0024146182,"threshold_uncertainty_score":0.06735462},"labels":[],"label_agreement":null},{"id":"W2018427555","doi":"10.1177/1352458512474706","title":"Retinal nerve fiber layer thickness in benign multiple sclerosis","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia","funders":"","keywords":"Nerve fiber layer; Optic neuritis; Medicine; Multiple sclerosis; Retinal; Ophthalmology; Expanded Disability Status Scale; Atrophy; Optical coherence tomography; Pathology","score_opus":0.1321560716710385,"score_gpt":0.3010018885308205,"score_spread":0.168845816859782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018427555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990326,0.00048783302,0.000040644107,0.000011666419,0.0000026632963,0.000005182771,0.00013763722,0.00000528838,0.0002765927],"genre_scores_gemma":[0.99969673,0.00006398258,0.000067051835,0.000006409205,0.0000035102942,0.0000035511166,0.000107328524,8.945962e-7,0.000050613766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996569,0.00006197735,0.00005577666,0.00009013386,0.00009688765,0.000038325416],"domain_scores_gemma":[0.9987305,0.0002462446,0.000701178,0.000045376462,0.00012946747,0.00014731589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043967547,0.00032684935,0.000328202,0.0010508447,0.00032790896,0.00031535,0.00021585842,0.0002762901,0.001875249],"category_scores_gemma":[0.001939785,0.00014537977,0.00017516488,0.0005376716,0.00027066516,0.00020858397,0.00030741582,0.00017745877,0.00021912865],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057629583,0.00002156981,0.99459696,0.000042983218,0.00004929296,0.0002593021,0.000064914915,0.00006622789,0.0013956445,0.000010478096,0.000065524895,0.0028507933],"study_design_scores_gemma":[0.000006618198,0.00007199929,0.99871755,0.0000052734586,0.000018735373,0.00083165313,0.00003083978,0.000083716244,0.00016876926,0.000011944757,0.000051294035,0.0000015377962],"about_ca_topic_score_codex":0.0062506767,"about_ca_topic_score_gemma":0.006336099,"teacher_disagreement_score":0.0062506767,"about_ca_system_score_codex":0.0004937584,"about_ca_system_score_gemma":0.00022561137,"threshold_uncertainty_score":0.012428582},"labels":[],"label_agreement":null},{"id":"W2020085437","doi":"10.1177/1352458507087468","title":"Expression of the inhibitor of apoptosis protein family in multiple sclerosis reveals a potential immunomodulatory role during autoimmune mediated demyelination","year":2008,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; Aegera Therapeutics (Canada); Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"National Institute of Neurological Disorders and Stroke; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; Dalhousie Medical Research Foundation; National Multiple Sclerosis Society","keywords":"XIAP; Inhibitor of apoptosis; Survivin; Multiple sclerosis; Apoptosis; Immunology; Pathogenesis; Biology; Immune system; Demyelinating disease; Cancer research; Programmed cell death; Caspase; Genetics","score_opus":0.023705179765680862,"score_gpt":0.1955905409909953,"score_spread":0.17188536122531442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020085437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99409276,0.0044987565,0.0007104984,0.00005889466,0.0000065096483,0.0000058846013,0.00008717666,0.000028066745,0.00051141984],"genre_scores_gemma":[0.99696094,0.0016292159,0.0005238627,0.000024609435,0.0000142662575,0.000010314735,0.00013406569,0.0000029142561,0.0006997821],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999243,0.000011950365,0.0000060327466,0.00002000405,0.000022132079,0.000015459364],"domain_scores_gemma":[0.99988747,0.000016458642,0.00004618723,0.0000071095556,0.000020850104,0.000021945973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011200146,0.00015385979,0.00016765068,0.00048148996,0.00017629525,0.00024366063,0.0000863779,0.00017690953,0.0004885612],"category_scores_gemma":[0.0002576647,0.000094836905,0.00010001716,0.00023294431,0.00017160148,0.00016798782,0.0001327301,0.0002277202,0.00017789146],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006682484,0.000039815674,0.02365595,0.00008793518,0.00002342572,0.00064526807,0.00011981272,0.00012549562,0.9609797,0.00011761744,0.00013087718,0.013406028],"study_design_scores_gemma":[0.00006036993,0.0011810448,0.75205296,0.000054511496,0.00014347179,0.011266306,0.00031863453,0.0029006596,0.22141474,0.00077924074,0.009807033,0.000020969688],"about_ca_topic_score_codex":0.0002925698,"about_ca_topic_score_gemma":0.00021851044,"teacher_disagreement_score":0.0004885612,"about_ca_system_score_codex":0.00019118525,"about_ca_system_score_gemma":0.00010341011,"threshold_uncertainty_score":0.0016343594},"labels":[],"label_agreement":null},{"id":"W2020947088","doi":"10.1177/1352458513501230","title":"Application and a proposed modification of the 2010 McDonald criteria for the diagnosis of multiple sclerosis in a Canadian cohort of patients with clinically isolated syndromes","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of British Columbia","funders":"Multiple Sclerosis Society","keywords":"Medicine; Multiple sclerosis; Asymptomatic; McDonald criteria; Clinically isolated syndrome; Cohort; Magnetic resonance imaging; Pediatrics; Internal medicine; Radiology","score_opus":0.09125668181315834,"score_gpt":0.3081421807616698,"score_spread":0.2168854989485115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020947088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920276,0.0020137583,0.0005279008,0.0013386458,0.00009719365,0.0005131862,0.0009604323,0.000013387695,0.0025079153],"genre_scores_gemma":[0.9948939,0.00058540277,0.002822236,0.00027709382,0.00005256038,0.00022338575,0.000750084,0.0000034391574,0.00039186468],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969285,0.00078675384,0.00030894342,0.00045742973,0.0011477842,0.00037050768],"domain_scores_gemma":[0.99527234,0.0007200163,0.0013612303,0.0002229105,0.0017815407,0.0006419556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067166206,0.0004321882,0.000595434,0.0006054675,0.001271852,0.00084225746,0.0010767017,0.0007720775,0.0010184539],"category_scores_gemma":[0.014396165,0.0001920227,0.0008268046,0.0009901036,0.0005981563,0.00047013376,0.00059894414,0.00070984627,0.00010749841],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00852034,0.0003843576,0.9532674,0.00024473885,0.00030620088,0.00012578833,0.00034090344,0.0006007292,0.0011993148,0.00031295503,0.0020141418,0.032683104],"study_design_scores_gemma":[0.0012485051,0.0025522802,0.9894728,0.00009920833,0.0006036058,0.00047816636,0.0003166409,0.0018237124,0.0004272942,0.00010325847,0.0028299824,0.000044696062],"about_ca_topic_score_codex":0.6709035,"about_ca_topic_score_gemma":0.77220684,"teacher_disagreement_score":0.3290965,"about_ca_system_score_codex":0.008860235,"about_ca_system_score_gemma":0.018722622,"threshold_uncertainty_score":0.6620692},"labels":[],"label_agreement":null},{"id":"W2021159412","doi":"10.1177/135245850000600205","title":"Diagnostic brain MRI findings in primary progressive multiple sclerosis","year":2000,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Multiple sclerosis; Medicine; Magnetic resonance imaging; Radiology; Central nervous system disease; Lesion; Mri scan; Nuclear medicine; Pathology; Internal medicine","score_opus":0.07052779601430365,"score_gpt":0.2895847382709688,"score_spread":0.21905694225666517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021159412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99724764,0.001196151,0.0001865091,0.000040429273,0.000007492785,0.00002750873,0.00008361935,0.000016156564,0.0011945675],"genre_scores_gemma":[0.9989272,0.00033735496,0.00041246982,0.000036433015,0.000018317416,0.000014394037,0.00012852863,0.000002756356,0.00012248823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99948347,0.00014033676,0.000081227045,0.00007305085,0.00014874499,0.00007322006],"domain_scores_gemma":[0.9984261,0.00052149146,0.00047414732,0.000100624515,0.00023903756,0.00023864966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009465357,0.00041835158,0.00032218697,0.0020103115,0.00040288793,0.00033688135,0.00036206847,0.0004675388,0.0017935802],"category_scores_gemma":[0.0058029667,0.00028196792,0.00013855472,0.00038304672,0.0006706342,0.00035961784,0.0004778561,0.00021402586,0.00046959805],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011039674,0.00014003296,0.9579594,0.00017213575,0.000049455062,0.011278668,0.0003559043,0.00011655478,0.014544776,0.000088306566,0.00039279435,0.013797968],"study_design_scores_gemma":[0.0000743965,0.00070460275,0.92339206,0.000052846714,0.000061418956,0.07064014,0.00030477325,0.00029278747,0.003693617,0.00015873507,0.000609122,0.000015413543],"about_ca_topic_score_codex":0.00087132165,"about_ca_topic_score_gemma":0.0012677568,"teacher_disagreement_score":0.0020103115,"about_ca_system_score_codex":0.0002393564,"about_ca_system_score_gemma":0.00025654203,"threshold_uncertainty_score":0.006000161},"labels":[],"label_agreement":null},{"id":"W2021696430","doi":"10.1177/1352458514540357","title":"Bibliometric profile of the global scientific research on multiple sclerosis (2003–2012)","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Multiple sclerosis; Medicine; Geography; Data science; Computer science; Psychiatry","score_opus":0.2747564037285854,"score_gpt":0.38053301495158426,"score_spread":0.10577661122299886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021696430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80977714,0.074003786,0.001147886,0.0031513583,0.00021270462,0.00023561888,0.08647543,0.00035195122,0.024644086],"genre_scores_gemma":[0.9429746,0.022537425,0.001180674,0.00017106517,0.00045492087,0.00022604564,0.030992508,0.000055053068,0.0014077163],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99121726,0.0012645974,0.0022654363,0.0006714219,0.0041923267,0.0003890983],"domain_scores_gemma":[0.9529694,0.015681658,0.020028505,0.001194575,0.009021521,0.0011044177],"candidate_categories":["metaresearch","bibliometrics"],"consensus_categories":[],"category_scores_codex":[0.00481834,0.00042593983,0.0013605626,0.08289067,0.00069024146,0.0033132115,0.0006193249,0.0006232888,0.0033899427],"category_scores_gemma":[0.034071106,0.00014714483,0.0013037552,0.14146158,0.00054933544,0.0021142492,0.0016061708,0.00034694752,0.0010180058],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002867022,0.00005742642,0.9066519,0.0059089414,0.0011539086,0.00033423826,0.0011941417,0.0005374621,0.0009445825,0.0011273483,0.008164245,0.07363904],"study_design_scores_gemma":[0.000011530009,0.000053295716,0.98359597,0.0005966379,0.0002913103,0.0006265309,0.00092467933,0.00034840783,0.00025445517,0.00030078887,0.012977659,0.000018816236],"about_ca_topic_score_codex":0.004584828,"about_ca_topic_score_gemma":0.0049192626,"teacher_disagreement_score":0.9951817,"about_ca_system_score_codex":0.0020326376,"about_ca_system_score_gemma":0.0024771024,"threshold_uncertainty_score":0.025482118},"labels":[],"label_agreement":null},{"id":"W2022418012","doi":"10.1177/1352458508096567","title":"Setting the agenda for multiple sclerosis rehabilitation research","year":2008,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"","keywords":"Multiple sclerosis; Rehabilitation; Physical medicine and rehabilitation; Medicine; Physical therapy; Psychiatry","score_opus":0.3389668451321856,"score_gpt":0.38240071621346744,"score_spread":0.04343387108128183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022418012","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000075510725,0.00095122505,0.00004615531,0.98997504,0.008583982,0.000007000761,0.000008134737,0.000005451112,0.00034751734],"genre_scores_gemma":[0.001040956,0.00062339957,0.00033159548,0.97668797,0.020064374,0.000050665254,0.000009285051,0.000007966853,0.0011838572],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9198223,0.04401892,0.010307155,0.0045227865,0.016094206,0.005234725],"domain_scores_gemma":[0.7047189,0.20826282,0.010128965,0.007039564,0.030630495,0.039219245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0738205,0.0012207173,0.004365693,0.0025384726,0.0144132925,0.013963975,0.0069272723,0.16373903,0.014365912],"category_scores_gemma":[0.19386494,0.002112007,0.002877672,0.0020420407,0.021857971,0.026660234,0.0152476905,0.1371284,0.007628643],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001281966,0.00009667074,0.0005452131,0.0002964538,0.000045869245,0.00069303776,0.00042516307,0.0000476997,0.00013895264,0.008137447,0.9791677,0.01027761],"study_design_scores_gemma":[0.0007237185,0.00019341269,0.0014727336,0.0026556524,0.000111452835,0.0012991958,0.003821691,0.00040972614,0.00021490965,0.056063194,0.9328225,0.0002118651],"about_ca_topic_score_codex":0.008932643,"about_ca_topic_score_gemma":0.020826839,"teacher_disagreement_score":0.16373903,"about_ca_system_score_codex":0.011341106,"about_ca_system_score_gemma":0.03790939,"threshold_uncertainty_score":0.39040482},"labels":[],"label_agreement":null},{"id":"W2023797462","doi":"10.1191/1352458505ms1144oa","title":"The relationship between depression and interferon beta-1a therapy in patients with multiple sclerosis","year":2005,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Depression (economics); Discontinuation; Medicine; Multiple sclerosis; Internal medicine; Clinical trial; Psychiatry; Rating scale; Clinical psychology; Psychology","score_opus":0.1391694580439447,"score_gpt":0.305925328844874,"score_spread":0.1667558708009293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023797462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9644772,0.03349349,0.0003040921,0.00041700128,0.000034933706,0.000039011604,0.00033049236,0.0000075212215,0.00089617644],"genre_scores_gemma":[0.99771535,0.0017862596,0.00014131008,0.0000969498,0.000050730356,0.000015116002,0.00014690575,0.0000011074759,0.00004624438],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959686,0.0021464543,0.00085448154,0.00029703966,0.0006243108,0.00010919499],"domain_scores_gemma":[0.98317724,0.0077724545,0.00713981,0.0006599149,0.0007414685,0.0005090749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041818013,0.0002101935,0.0011547139,0.0010697601,0.0002976246,0.0006783194,0.00023345927,0.0006346584,0.0006497381],"category_scores_gemma":[0.013949019,0.00027360008,0.00095047144,0.0017871021,0.0003041568,0.00035101935,0.00036821142,0.00074128085,0.00007340301],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022053411,0.000052499523,0.98450893,0.00022073612,0.0030030617,0.00019775168,0.000062704996,0.00008514113,0.00038878445,0.000023728198,0.00011809396,0.009133291],"study_design_scores_gemma":[0.00014564402,0.000722084,0.9968016,0.000038801736,0.00094595354,0.00074788416,0.00003790785,0.00015285025,0.000077786455,0.00005922322,0.00026368175,0.0000065643685],"about_ca_topic_score_codex":0.00078251434,"about_ca_topic_score_gemma":0.0016744543,"teacher_disagreement_score":0.0041818013,"about_ca_system_score_codex":0.00031050362,"about_ca_system_score_gemma":0.00023259966,"threshold_uncertainty_score":0.022115767},"labels":[],"label_agreement":null},{"id":"W2024251669","doi":"10.1177/1352458511427514","title":"Relapses do not matter in relation to long-term disability: Yes","year":2011,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Multiple sclerosis; Term (time); Medicine; Relation (database); Physical medicine and rehabilitation; Psychology; Physical therapy; Psychiatry; Physics; Computer science","score_opus":0.16180337888770607,"score_gpt":0.32424741119623124,"score_spread":0.16244403230852517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024251669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77676857,0.084651954,0.0012396381,0.11156645,0.0041705607,0.00013879468,0.002450927,0.00011165897,0.01890144],"genre_scores_gemma":[0.9717086,0.0068621347,0.0007103261,0.012937918,0.0041129417,0.00006361398,0.0009601409,0.00007642244,0.0025679045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9898509,0.0038173576,0.0012683556,0.0027940718,0.0012293747,0.0010399652],"domain_scores_gemma":[0.8947793,0.056501612,0.02351416,0.0100140385,0.0064373403,0.00875358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017266273,0.0010616088,0.0037441358,0.0015271346,0.0022182981,0.0039199125,0.004274079,0.01078903,0.02283067],"category_scores_gemma":[0.068972155,0.0010879558,0.006508942,0.0031924387,0.0040723416,0.008544686,0.0022148052,0.0064659184,0.0020661405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076955566,0.0005575448,0.90543324,0.0030324971,0.015900139,0.0011669357,0.0023209236,0.00027317784,0.00056260324,0.0030020475,0.015802769,0.044252574],"study_design_scores_gemma":[0.0011536649,0.0010111156,0.9712782,0.0016876124,0.0072727017,0.00083488633,0.0027832706,0.00043921554,0.00014770305,0.007948631,0.005314904,0.00012818913],"about_ca_topic_score_codex":0.010940748,"about_ca_topic_score_gemma":0.02039162,"teacher_disagreement_score":0.02283067,"about_ca_system_score_codex":0.0009275891,"about_ca_system_score_gemma":0.0020575596,"threshold_uncertainty_score":0.0913139},"labels":[],"label_agreement":null},{"id":"W2025358672","doi":"10.1177/1352458513484547","title":"International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Multiple sclerosis; Medicine; Acute disseminated encephalomyelitis; Neuromyelitis optica; Demyelinating Disorder; Pediatrics; Clinically isolated syndrome; Encephalomyelitis; Immunology","score_opus":0.12281433637285197,"score_gpt":0.3067056860104898,"score_spread":0.18389134963763784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025358672","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20946468,0.20276165,0.17726873,0.17373115,0.05005585,0.024688443,0.051348012,0.0021003124,0.1085812],"genre_scores_gemma":[0.26895687,0.06861757,0.48169175,0.02370444,0.005762371,0.038034614,0.09792334,0.000769227,0.014539872],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9804984,0.006366933,0.006872155,0.0008756717,0.004342035,0.0010449135],"domain_scores_gemma":[0.95894456,0.008852342,0.0075646276,0.0018571132,0.020966262,0.0018151887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024156796,0.0012883455,0.001910077,0.004915872,0.0010054782,0.0017551698,0.0037047456,0.0021152915,0.0018270304],"category_scores_gemma":[0.038989916,0.00053731096,0.0022350238,0.004749388,0.0015622221,0.00199283,0.0025481163,0.0068387655,0.0009496042],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006311074,0.00032557032,0.19395694,0.0027141976,0.00032218324,0.0024586567,0.005102872,0.0018676854,0.0021742175,0.033475544,0.5464675,0.21050356],"study_design_scores_gemma":[0.0004609723,0.0004811995,0.26293406,0.0069733877,0.000622798,0.016144726,0.0037215133,0.0026917462,0.0025403593,0.013715944,0.68943286,0.00028045537],"about_ca_topic_score_codex":0.009486161,"about_ca_topic_score_gemma":0.012793794,"teacher_disagreement_score":0.024156796,"about_ca_system_score_codex":0.0037870868,"about_ca_system_score_gemma":0.015881458,"threshold_uncertainty_score":0.12775487},"labels":[],"label_agreement":null},{"id":"W2025694051","doi":"10.1177/1352458507084264","title":"Natural history of secondary-progressive multiple sclerosis","year":2008,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":217,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; University of British Columbia","funders":"","keywords":"Medicine; Multiple sclerosis; Age of onset; Expanded Disability Status Scale; Natural history; Population; Pediatrics; Internal medicine; Disease; Immunology","score_opus":0.14037438966095195,"score_gpt":0.28525029468680385,"score_spread":0.1448759050258519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025694051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983165,0.0004483547,0.000029463605,0.00009490419,0.000004943893,0.0000068154254,0.0003637831,0.000005701696,0.0007294737],"genre_scores_gemma":[0.9994204,0.000101327365,0.000022508098,0.00001977938,0.0000094863135,0.0000032953592,0.00030187244,8.2193355e-7,0.00012049228],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997677,0.00004776987,0.000019357843,0.00006242879,0.000059251834,0.00004352148],"domain_scores_gemma":[0.99876,0.00010272749,0.00064643857,0.000053279633,0.00014754717,0.00029011164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029785905,0.0001464218,0.00025281194,0.0005720797,0.00034623826,0.0002824528,0.00024027193,0.0002856666,0.0021962016],"category_scores_gemma":[0.0016835739,0.00012056522,0.00017759064,0.00039716557,0.0002432484,0.0002962829,0.00023901318,0.0003448818,0.000319074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011321307,0.000021478401,0.9977976,0.000007856798,0.000017492654,0.0003353067,0.000025926583,0.000024311748,0.00014810376,0.000012316354,0.00012356325,0.0013727896],"study_design_scores_gemma":[0.0000038083977,0.000055937584,0.99798894,0.000006129622,0.0000058870805,0.0016984701,0.000031162563,0.00005657591,0.000021773718,0.000020539192,0.00010921321,0.0000015174744],"about_ca_topic_score_codex":0.00536454,"about_ca_topic_score_gemma":0.005046587,"teacher_disagreement_score":0.00536454,"about_ca_system_score_codex":0.00034592103,"about_ca_system_score_gemma":0.00034988575,"threshold_uncertainty_score":0.010666609},"labels":[],"label_agreement":null},{"id":"W2025697993","doi":"10.1177/1352458512456613","title":"‘Clinically definite benign multiple sclerosis’, an unwarranted conceptual hodgepodge: evidence from a 30-year observational study","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Observational study; Multiple sclerosis; Medicine; Expanded Disability Status Scale; Pediatrics; Internal medicine; Psychiatry","score_opus":0.5437792632147593,"score_gpt":0.399133312620413,"score_spread":0.14464595059434632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025697993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8659883,0.12767842,0.000781033,0.0017099333,0.00039693853,0.00010291448,0.0016824843,0.0000096329795,0.0016504504],"genre_scores_gemma":[0.98503995,0.012691835,0.00034047308,0.0006088854,0.00028346168,0.000038353814,0.00090340746,0.000005782789,0.00008783445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9855031,0.007819306,0.0025942463,0.002018283,0.0016515113,0.00041357515],"domain_scores_gemma":[0.84634393,0.08744995,0.048127484,0.0085354,0.0070507964,0.0024924024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023416309,0.00052279036,0.0013267038,0.0013007623,0.00064872956,0.0020676197,0.0013944309,0.001859138,0.002480163],"category_scores_gemma":[0.06897507,0.0004894702,0.0020976008,0.0025085302,0.0018601808,0.0018461524,0.0012360393,0.0010936471,0.00035934162],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042929947,0.00012518324,0.9733489,0.0024117623,0.005757056,0.00018181131,0.0006368947,0.000072814706,0.00009979117,0.00028678268,0.0008054994,0.011980595],"study_design_scores_gemma":[0.0005021805,0.00095264666,0.9835097,0.002457706,0.006101063,0.00079641404,0.0010187186,0.00034616597,0.00007410508,0.0004121771,0.0037805883,0.000048420447],"about_ca_topic_score_codex":0.0051916386,"about_ca_topic_score_gemma":0.0053586075,"teacher_disagreement_score":0.023416309,"about_ca_system_score_codex":0.0005943077,"about_ca_system_score_gemma":0.0010024494,"threshold_uncertainty_score":0.12383878},"labels":[],"label_agreement":null},{"id":"W2026497829","doi":"10.1177/1352458512470310","title":"Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Neuromyelitis optica; Myelin oligodendrocyte glycoprotein; Medicine; Antibody; Multiple sclerosis; Aquaporin 4; Immunology; Immunoglobulin G; Pathology; Experimental autoimmune encephalomyelitis","score_opus":0.09708425003817218,"score_gpt":0.3268405672589309,"score_spread":0.22975631722075873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026497829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99925095,0.00032892468,0.00009645821,0.000017456658,0.0000041518515,0.000009201609,0.000059009853,0.0000042810398,0.0002295347],"genre_scores_gemma":[0.9991999,0.00028050845,0.00025291945,0.000029734121,0.000015934118,0.000012772666,0.00014702813,0.0000024404019,0.000058715614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997243,0.000036759702,0.00004080944,0.00006899777,0.000058398986,0.00007078182],"domain_scores_gemma":[0.99896014,0.00024052226,0.0004974907,0.00003333827,0.00010454145,0.00016389841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003345075,0.00034288966,0.00030574654,0.0007286553,0.00039071578,0.00042439965,0.0002573701,0.00042046158,0.0009317319],"category_scores_gemma":[0.001596606,0.00021779368,0.00015508468,0.00057823665,0.00047495362,0.00048677804,0.00030207468,0.00035556857,0.00019069748],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026384476,0.000067920606,0.97860366,0.0000525554,0.000014243777,0.012072345,0.00028374002,0.00006238638,0.0033982904,0.000035286852,0.0001503907,0.0049953465],"study_design_scores_gemma":[0.000024346007,0.0005342493,0.93048304,0.00002133406,0.000036357906,0.06630323,0.000386756,0.00016237322,0.0012475152,0.000055520777,0.0007381178,0.0000071693],"about_ca_topic_score_codex":0.0014907462,"about_ca_topic_score_gemma":0.0014815821,"teacher_disagreement_score":0.0014907462,"about_ca_system_score_codex":0.00033058264,"about_ca_system_score_gemma":0.00034232103,"threshold_uncertainty_score":0.0031169653},"labels":[],"label_agreement":null},{"id":"W2027200886","doi":"10.1177/1352458508099143","title":"Social anxiety in a multiple sclerosis clinic population","year":2008,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Capital District Health Authority; Dalhousie University","funders":"Dalhousie University","keywords":"Anxiety; Hospital Anxiety and Depression Scale; Expanded Disability Status Scale; Social anxiety; Psychiatry; Multiple sclerosis; Depression (economics); Medicine; Population; Clinical psychology; Psychology; Quality of life (healthcare); Physical therapy","score_opus":0.2634675235834458,"score_gpt":0.3476363671300395,"score_spread":0.08416884354659371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027200886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992932,0.0002117859,0.000011558635,0.00009242733,0.0000025258746,0.000008142006,0.00008847092,0.000002004942,0.00028982782],"genre_scores_gemma":[0.999637,0.00014120119,0.000017068562,0.000064213054,0.000013929002,0.00000938776,0.00007690268,3.1704843e-7,0.0000399771],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995788,0.00014466814,0.000035041827,0.00007134768,0.000098648234,0.00007150666],"domain_scores_gemma":[0.9990977,0.00020948604,0.0003688748,0.00002106079,0.00007883533,0.00022404913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042953817,0.00019734433,0.0002661407,0.00082189945,0.0005802377,0.0005728899,0.00023599312,0.00049141,0.0016518114],"category_scores_gemma":[0.0016901289,0.00016984243,0.00017077163,0.000584843,0.00036439375,0.00033511428,0.0003171228,0.00038196548,0.00021039463],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006409131,0.000078031895,0.9963097,0.000021146401,0.000028735554,0.00025349428,0.00033846218,0.000019010004,0.00016417626,0.000013757956,0.0002695819,0.002439774],"study_design_scores_gemma":[0.000013027274,0.00014986402,0.9985764,0.0000107204705,0.00001544057,0.0006256727,0.00039005137,0.000057141093,0.000015261876,0.000012471927,0.00013110123,0.0000028668803],"about_ca_topic_score_codex":0.007811608,"about_ca_topic_score_gemma":0.008532047,"teacher_disagreement_score":0.007811608,"about_ca_system_score_codex":0.00051973964,"about_ca_system_score_gemma":0.00039449043,"threshold_uncertainty_score":0.015532255},"labels":[],"label_agreement":null},{"id":"W2029459149","doi":"10.1177/1352458509345903","title":"Treatment with the phosphodiesterase type-4 inhibitor rolipram fails to inhibit blood—brain barrier disruption in multiple sclerosis","year":2009,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health","keywords":"Rolipram; Multiple sclerosis; Experimental autoimmune encephalomyelitis; Medicine; Neuroprotection; Pharmacology; Autoimmunity; In vivo; Encephalomyelitis; Clinical trial; Phosphodiesterase; Immunology; Internal medicine; Disease; Chemistry; Biology; Enzyme","score_opus":0.0809961044682882,"score_gpt":0.2973789276538074,"score_spread":0.2163828231855192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029459149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968425,0.0020047533,0.0003145539,0.0001634518,0.000033995773,0.000026745343,0.000042643504,0.00002535997,0.0005459899],"genre_scores_gemma":[0.99842083,0.00068397715,0.00033510203,0.00006255397,0.000036665795,0.00002528846,0.00012411995,0.000004366927,0.00030720368],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998547,0.000047503792,0.000018568438,0.000015979906,0.000031097294,0.00003212882],"domain_scores_gemma":[0.9998068,0.000043277076,0.000044455388,0.000031913587,0.000012950822,0.00006061798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039484617,0.0002658075,0.0010146367,0.00016577999,0.00016942303,0.00019389286,0.000200143,0.00028145307,0.00090442697],"category_scores_gemma":[0.00048717816,0.00011880066,0.0002645063,0.000112732436,0.00026293832,0.00023344794,0.00009224038,0.0007418399,0.0003219297],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015906423,0.0030415375,0.003374079,0.00022176455,0.00014486809,0.0010774757,0.000115046096,0.00027961016,0.89239085,0.0001603467,0.00086368714,0.0824242],"study_design_scores_gemma":[0.010303632,0.20601352,0.13042186,0.00007920784,0.00069996034,0.011884945,0.00016687196,0.00406208,0.62416077,0.0006020907,0.011560607,0.000044475917],"about_ca_topic_score_codex":0.00026410236,"about_ca_topic_score_gemma":0.00060802203,"teacher_disagreement_score":0.0010146367,"about_ca_system_score_codex":0.00016439539,"about_ca_system_score_gemma":0.00020524707,"threshold_uncertainty_score":0.003025651},"labels":[],"label_agreement":null},{"id":"W2030810833","doi":"10.1177/1352458511414041","title":"Substantial adverse association of visual and vascular comorbidities on visual disability in multiple sclerosis","year":2011,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Dental and Craniofacial Research; National Institute of Neurological Disorders and Stroke; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research","keywords":"Medicine; Comorbidity; Interquartile range; Visual impairment; Hazard ratio; Multiple sclerosis; Expanded Disability Status Scale; Internal medicine; Confidence interval; Psychiatry","score_opus":0.13711316487777922,"score_gpt":0.3094305174417259,"score_spread":0.17231735256394667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030810833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948027,0.0030859984,0.00014283018,0.00034828426,0.000015743513,0.000008463105,0.00041580878,0.0000085938555,0.0011714927],"genre_scores_gemma":[0.9992711,0.0004292815,0.000057071942,0.00002991849,0.000019266603,0.0000021800847,0.00011669075,0.000001165665,0.00007321225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888617,0.00037854025,0.00011559467,0.00013416186,0.0003057573,0.00017975815],"domain_scores_gemma":[0.9901329,0.0028674644,0.0046680057,0.00038891035,0.0008737179,0.0010690619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011223867,0.00019163493,0.00029923808,0.00050914293,0.00037063437,0.0005284431,0.00022247023,0.00029433434,0.0025882095],"category_scores_gemma":[0.006746971,0.00012499176,0.0006541475,0.000687924,0.0002615801,0.000284214,0.0005939671,0.0007997623,0.00014603723],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017465427,0.000018834187,0.995265,0.00003289524,0.00012206258,0.000081802216,0.000019742916,0.00006187795,0.000081013284,0.000016024707,0.00011937825,0.0040067905],"study_design_scores_gemma":[0.0000033737256,0.00004191954,0.9993291,0.00001696954,0.000035676065,0.0002642553,0.00002999056,0.00011439359,0.000027424914,0.000033371263,0.00010039417,0.0000030677897],"about_ca_topic_score_codex":0.005275303,"about_ca_topic_score_gemma":0.00866331,"teacher_disagreement_score":0.005275303,"about_ca_system_score_codex":0.00039358195,"about_ca_system_score_gemma":0.0005757004,"threshold_uncertainty_score":0.010489225},"labels":[],"label_agreement":null},{"id":"W2031952471","doi":"10.1177/135245850000600108","title":"Macrophages: their myelinotrophic or neurotoxic actions depend upon tissue oxidative stress","year":2000,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Cameco (Canada)","funders":"Medical Research Council","keywords":"Oxidative stress; Menadione; Macrophage; Myelin; Lesion; Inflammation; Biology; Chemistry; Cell biology; Immunology; Biochemistry; Pathology; Endocrinology; In vitro; Central nervous system; Medicine","score_opus":0.1432409063247949,"score_gpt":0.33777756261580627,"score_spread":0.19453665629101138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031952471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98796207,0.009282584,0.0014824581,0.00020821535,0.00001917847,0.000016986209,0.000079141864,0.000020424743,0.00092898315],"genre_scores_gemma":[0.9938076,0.003806312,0.0009109415,0.000054760185,0.00002084449,0.000014055372,0.000032687327,0.0000028612194,0.0013498242],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99989176,0.00003154738,0.000009193893,0.000017022188,0.000020862824,0.000029603932],"domain_scores_gemma":[0.9998877,0.000028843922,0.00003131408,0.000012013689,0.00001843061,0.000021576745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037539835,0.00025207736,0.00022547848,0.00013759243,0.00011396785,0.00026558532,0.0001021661,0.0002512953,0.0008615888],"category_scores_gemma":[0.0001714471,0.00007694846,0.00009829811,0.000105948195,0.00029329536,0.00036430638,0.00021899455,0.00020275445,0.0002579223],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027539424,0.000013880397,0.0015939076,0.0001571989,0.0000066961884,0.00020381674,0.00013388341,0.000028796692,0.9941567,0.0002477642,0.00002198286,0.003159914],"study_design_scores_gemma":[0.00003424505,0.0010835452,0.04072699,0.00006837716,0.00005923896,0.0016778884,0.0004927662,0.00031231137,0.951355,0.0007874525,0.003390834,0.00001132039],"about_ca_topic_score_codex":0.00015264034,"about_ca_topic_score_gemma":0.00032351728,"teacher_disagreement_score":0.0008615888,"about_ca_system_score_codex":0.000096958465,"about_ca_system_score_gemma":0.000116386414,"threshold_uncertainty_score":0.0028823018},"labels":[],"label_agreement":null},{"id":"W2032071249","doi":"10.1177/1352458507085801","title":"Argentine Patagonia: prevalence and clinical features of multiple sclerosis","year":2008,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Multiple sclerosis; Demography; Population; Incidence (geometry); Prevalence; Geography; Medicine","score_opus":0.18022371036141147,"score_gpt":0.3418067466174209,"score_spread":0.16158303625600942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032071249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99591607,0.0013580075,0.000050639497,0.00011923725,0.0000066504936,0.0000125090655,0.00052137044,0.0000044248172,0.0020111992],"genre_scores_gemma":[0.9982779,0.00066100695,0.0001267226,0.00004003568,0.000017638687,0.000014858691,0.00037317805,0.000001860404,0.00048687583],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998417,0.00007031303,0.000011315688,0.000028272701,0.000025932666,0.00002234977],"domain_scores_gemma":[0.99977475,0.00003659282,0.00011126626,0.000008877516,0.000034373643,0.000034128043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022617026,0.00020259657,0.00017313393,0.0006861757,0.00026488584,0.0004061203,0.00013170183,0.0002493454,0.0021000428],"category_scores_gemma":[0.00065755117,0.00012669667,0.00007615337,0.00078080484,0.00015990202,0.00017987307,0.00019299572,0.0001854051,0.00018240226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030426504,0.00004931468,0.99069667,0.000068133224,0.000045196586,0.00047325637,0.00042747016,0.000036240363,0.000798915,0.000026285916,0.0006791359,0.006394935],"study_design_scores_gemma":[0.000006385486,0.000041156163,0.9987135,0.00000877436,0.0000069417656,0.0003484037,0.0001526181,0.000019430343,0.000027003924,0.000005115857,0.0006696146,0.000001119433],"about_ca_topic_score_codex":0.024387265,"about_ca_topic_score_gemma":0.024301358,"teacher_disagreement_score":0.024387265,"about_ca_system_score_codex":0.0002747424,"about_ca_system_score_gemma":0.00012456544,"threshold_uncertainty_score":0.048490644},"labels":[],"label_agreement":null},{"id":"W2033735368","doi":"10.1177/1352458510377770","title":"Challenges in screening for depression in multiple sclerosis","year":2010,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hotchkiss Brain Institute; Ontario Brain Institute; University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Depression (economics); Multiple sclerosis; Rating scale; Center for Epidemiologic Studies Depression Scale; Medicine; Psychological intervention; Population; Psychiatry; Depressive symptoms; Clinical psychology; Psychology; Environmental health; Cognition","score_opus":0.33873310580961435,"score_gpt":0.3517637553763881,"score_spread":0.013030649566773744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033735368","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7264294,0.041340556,0.01659043,0.19625098,0.0011136797,0.0008916259,0.0015889487,0.0001250494,0.015669385],"genre_scores_gemma":[0.97266924,0.0060475515,0.0140758725,0.0054330057,0.00068993156,0.00032418405,0.00032314105,0.000014841796,0.00042215554],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.959322,0.029094106,0.003980881,0.001503805,0.0051856064,0.00091353763],"domain_scores_gemma":[0.89997226,0.07597141,0.008274462,0.0020809069,0.010456709,0.0032442345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.056913678,0.00033544734,0.00082410907,0.0017437255,0.0010134615,0.0017820192,0.0014992895,0.0011304832,0.00096897606],"category_scores_gemma":[0.13008364,0.000300727,0.0004588711,0.0021609038,0.0013208387,0.0016894403,0.002200756,0.0015905882,0.00029883522],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022792262,0.00013400732,0.74738985,0.0010927183,0.00018867178,0.0005498929,0.0033794052,0.0009498882,0.00026389357,0.0011262697,0.008845319,0.23585208],"study_design_scores_gemma":[0.00006209788,0.00081633404,0.9541461,0.0028126966,0.0001521203,0.0032888884,0.0093112765,0.005280938,0.0003960084,0.0067343167,0.016909495,0.000089761255],"about_ca_topic_score_codex":0.019656653,"about_ca_topic_score_gemma":0.028631024,"teacher_disagreement_score":0.056913678,"about_ca_system_score_codex":0.0013543572,"about_ca_system_score_gemma":0.0034973545,"threshold_uncertainty_score":0.3009919},"labels":[],"label_agreement":null},{"id":"W2037409902","doi":"10.1177/1352458510381259","title":"Interferon-β is a key regulator of proinflammatory events in experimental autoimmune encephalomyelitis","year":2010,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Experimental autoimmune encephalomyelitis; Myelin oligodendrocyte glycoprotein; Immunology; Multiple sclerosis; Immune system; Proinflammatory cytokine; Autoimmune disease; T cell; Context (archaeology); Interferon; Medicine; Bone marrow; Biology; Inflammation; Antibody","score_opus":0.05365358914862301,"score_gpt":0.303671895765425,"score_spread":0.250018306616802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037409902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56796306,0.38914225,0.019776111,0.0020876643,0.0019137783,0.0003308341,0.0027030245,0.0005566826,0.0155266],"genre_scores_gemma":[0.89476174,0.09021501,0.0057681273,0.0008562896,0.000747822,0.00027859313,0.0017301963,0.00004785862,0.0055942787],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981314,0.000041424006,0.000025415615,0.000034902274,0.0000569786,0.00002825669],"domain_scores_gemma":[0.9998567,0.00001605975,0.000059574195,0.0000073237165,0.000035357927,0.000024831474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032482488,0.0006449048,0.00038897555,0.00030507715,0.00015730422,0.00031851477,0.00012881757,0.00037294065,0.0010590254],"category_scores_gemma":[0.0001220088,0.00010874915,0.00020430266,0.00019013303,0.00021136636,0.00015473887,0.000193789,0.00064898684,0.000496901],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009196277,0.00008664413,0.0038220596,0.0007550713,0.000038610142,0.00045855597,0.000039020993,0.00019545417,0.9691162,0.0005770673,0.00087967503,0.023111971],"study_design_scores_gemma":[0.00028548815,0.002602964,0.110768445,0.0009316333,0.0004390592,0.0048416946,0.00027630813,0.0020240492,0.74010044,0.0028161746,0.13486172,0.00005199425],"about_ca_topic_score_codex":0.00012604549,"about_ca_topic_score_gemma":0.00012120578,"teacher_disagreement_score":0.0010590254,"about_ca_system_score_codex":0.0002498111,"about_ca_system_score_gemma":0.0001844853,"threshold_uncertainty_score":0.0035427809},"labels":[],"label_agreement":null},{"id":"W2037425477","doi":"10.1177/1352458510382554","title":"Severe acute disseminated encephalomyelitis: a paediatric intensive care population-based study","year":2010,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Intensive Care Society; University of Leeds; Hospital for Sick Children; Multiple Sclerosis Society; Action Medical Research; NHS Health Scotland","keywords":"Medicine; Acute disseminated encephalomyelitis; Pediatrics; Stridor; Epidemiology; Intensive care; Population; Incidence (geometry); Intensive care unit; Emergency medicine; Intensive care medicine; Airway; Surgery; Disease; Internal medicine","score_opus":0.04167366819705982,"score_gpt":0.3126446622878463,"score_spread":0.2709709940907865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037425477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99741673,0.0006640356,0.0000940831,0.00008965049,0.00000855586,0.00005708829,0.00086256873,0.0000044623885,0.00080284354],"genre_scores_gemma":[0.997396,0.0012692382,0.00019189679,0.000095932155,0.000028736642,0.000067628716,0.00086656486,0.0000033466529,0.00008066718],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984719,0.00040253226,0.00018786697,0.0003232618,0.0004330373,0.00018143482],"domain_scores_gemma":[0.9981635,0.00030574892,0.0007218999,0.00012034982,0.00037820576,0.0003103201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000942132,0.00038480034,0.00075875357,0.0022401796,0.000680641,0.00093354593,0.000519811,0.0006161345,0.0012607042],"category_scores_gemma":[0.0035654386,0.0005062073,0.00042531372,0.0040783645,0.00055973866,0.0010914989,0.00084790215,0.00072484685,0.00029596078],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021542945,0.000024993544,0.9984395,0.000023478255,0.000030168128,0.0002476899,0.00021727043,0.000017829694,0.000055571778,0.000016152966,0.00012959834,0.0007762657],"study_design_scores_gemma":[0.0000070566507,0.0000891095,0.99824476,0.000019741365,0.000015969521,0.0008952381,0.00043589287,0.000046689565,0.000010806342,0.000010017737,0.00022063185,0.0000041460016],"about_ca_topic_score_codex":0.03567116,"about_ca_topic_score_gemma":0.03707826,"teacher_disagreement_score":0.03567116,"about_ca_system_score_codex":0.0012568808,"about_ca_system_score_gemma":0.0013641132,"threshold_uncertainty_score":0.07092708},"labels":[],"label_agreement":null},{"id":"W2039942440","doi":"10.1191/1352458502ms776oa","title":"Paclitaxel (Taxol) attenuates clinical disease in a spontaneously demyelinating transgenic mouse and induces remyelination","year":2002,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Queen's University; University of Toronto; Hospital for Sick Children","funders":"Multiple Sclerosis Society of Canada","keywords":"Remyelination; Astrogliosis; Myelin basic protein; Myelin; Oligodendrocyte; Genetically modified mouse; Multiple sclerosis; Medicine; Immunology; Pathology; Endocrinology; Internal medicine; Biology; Transgene; Central nervous system; Biochemistry","score_opus":0.13218723502597188,"score_gpt":0.3026428177222813,"score_spread":0.17045558269630942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039942440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976598,0.00034098537,0.00072594365,0.00007676016,0.00002086455,0.000037216552,0.00024801062,0.00014475081,0.0007456503],"genre_scores_gemma":[0.9906696,0.00074352446,0.0017974086,0.0000904004,0.000020023113,0.000096808144,0.0007109275,0.00004148613,0.0058297995],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989176,0.00001834369,0.0000129709215,0.000020193307,0.000023015582,0.000033659635],"domain_scores_gemma":[0.99987745,0.000013696966,0.00004798264,0.000010099933,0.000010513372,0.000040217405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010606091,0.00037745901,0.00024711882,0.0004813156,0.00012649267,0.00021276335,0.00016211101,0.0003419888,0.00087790476],"category_scores_gemma":[0.00009618475,0.00016739142,0.00018786512,0.00015873382,0.00019840732,0.00014498441,0.00008112267,0.0005792215,0.00028955287],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017578217,0.00009419842,0.0001410363,0.000015676844,0.0000030107003,0.00007358335,0.00001003274,0.00003942162,0.99848783,0.00004041525,0.00003342863,0.00088553363],"study_design_scores_gemma":[0.000156609,0.0026991258,0.0050765593,0.00001292691,0.00003128105,0.000516178,0.000026682079,0.0012876557,0.9876841,0.000058805213,0.0024439222,0.0000061085702],"about_ca_topic_score_codex":0.00077765237,"about_ca_topic_score_gemma":0.0014551114,"teacher_disagreement_score":0.00087790476,"about_ca_system_score_codex":0.0003228093,"about_ca_system_score_gemma":0.00022042784,"threshold_uncertainty_score":0.0029368997},"labels":[],"label_agreement":null},{"id":"W2040220974","doi":"10.1177/1352458508101037","title":"Reflections on 2008","year":2008,"lang":"en","type":"editorial","venue":"Multiple Sclerosis Journal","topic":"Academic Writing and Publishing","field":"Arts and Humanities","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Impact factor; Audience measurement; Publishing; Quality (philosophy); Psychology; Medicine; Political science; Law; Philosophy; Epistemology","score_opus":0.17127745348299725,"score_gpt":0.3055030837246057,"score_spread":0.13422563024160847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040220974","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036345786,0.0076816273,0.00018787842,0.7049711,0.26505867,0.000034176137,0.0005277839,0.000147507,0.021027857],"genre_scores_gemma":[0.0035920935,0.006106276,0.00046490572,0.80005926,0.052202586,0.000109871304,0.00042528866,0.00020089981,0.13683888],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9932279,0.0012297126,0.0004060944,0.0010167877,0.0027500829,0.0013693934],"domain_scores_gemma":[0.9873459,0.0026648128,0.00067932537,0.00057694,0.0045715524,0.0041614794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006543501,0.0018234514,0.0011315978,0.0011044587,0.003451237,0.009699692,0.0024702367,0.02117042,0.05880675],"category_scores_gemma":[0.03619053,0.00063509564,0.0018361195,0.0010120021,0.0037216432,0.0076556886,0.00480873,0.032670368,0.038970158],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024243827,0.000013877068,0.000056609075,0.000051081883,0.000003653888,0.00007870049,0.00006822916,0.000009963691,0.000045358054,0.001354217,0.9940103,0.0042836936],"study_design_scores_gemma":[0.000010998443,0.000021417269,0.00026033292,0.00017112317,0.0000034305167,0.00009224319,0.00017641013,0.000009466506,0.00005744478,0.0007944106,0.9983918,0.000010919641],"about_ca_topic_score_codex":0.0063362005,"about_ca_topic_score_gemma":0.011442014,"teacher_disagreement_score":0.05880675,"about_ca_system_score_codex":0.0061046695,"about_ca_system_score_gemma":0.009772269,"threshold_uncertainty_score":0.19672817},"labels":[],"label_agreement":null},{"id":"W2040728132","doi":"10.1177/1352458506071174","title":"Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica","year":2007,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":284,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Neuromyelitis optica; Optic neuritis; Medicine; Myelitis; Multiple sclerosis; Methylprednisolone; Central nervous system; Autoantibody; Transverse myelitis; Immunology; Internal medicine; Gastroenterology; Spinal cord; Antibody","score_opus":0.059103471578565506,"score_gpt":0.28712473643766345,"score_spread":0.22802126485909796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040728132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99275935,0.005118226,0.00022239178,0.00024359731,0.00004132473,0.000044906315,0.000025279856,0.0000478475,0.001497123],"genre_scores_gemma":[0.9988919,0.0005572508,0.00015540075,0.00012099599,0.00006650196,0.000023131635,0.000052595944,0.0000024458814,0.00012979019],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9996462,0.00019470358,0.000028347675,0.00003585369,0.00005001985,0.0000447887],"domain_scores_gemma":[0.99942124,0.00027521967,0.00011069474,0.000031569907,0.000027943606,0.00013331581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062196754,0.00038368296,0.0008756045,0.0003121667,0.0003997192,0.00031564716,0.00024194084,0.0006510346,0.00068349583],"category_scores_gemma":[0.0027157178,0.00012798268,0.00026634603,0.00017594779,0.00029405582,0.0002641406,0.00015915818,0.00062018255,0.00016249157],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.124682,0.013528205,0.18707106,0.0010302899,0.0018197373,0.008888768,0.0012779942,0.0036889364,0.07300507,0.00048824787,0.0029251575,0.5815945],"study_design_scores_gemma":[0.01457158,0.21586594,0.71002215,0.00029216087,0.0015065897,0.017102232,0.00047214807,0.0054864497,0.024866497,0.0008866815,0.0088260835,0.000101528225],"about_ca_topic_score_codex":0.00037656358,"about_ca_topic_score_gemma":0.00039534466,"teacher_disagreement_score":0.0008756045,"about_ca_system_score_codex":0.0003121209,"about_ca_system_score_gemma":0.00018338792,"threshold_uncertainty_score":0.003289342},"labels":[],"label_agreement":null},{"id":"W2041554374","doi":"10.1191/1352458505ms1168oa","title":"Severity of chronic pain and its relationship to quality of life in multiple sclerosis","year":2005,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":196,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada","keywords":"Medicine; Chronic pain; Depression (economics); Quality of life (healthcare); Multiple sclerosis; McGill Pain Questionnaire; Physical therapy; Anxiety; Osteoarthritis; Rheumatoid arthritis; Internal medicine; Pain catastrophizing; Visual analogue scale; Psychiatry; Alternative medicine; Pathology","score_opus":0.2403712403511937,"score_gpt":0.34946043243010116,"score_spread":0.10908919207890747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041554374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942557,0.004516816,0.00012459239,0.00019544817,0.000013827026,0.000029182955,0.000259848,0.0000028490283,0.0006016457],"genre_scores_gemma":[0.99890506,0.00063730153,0.00018020956,0.000032765154,0.000020881193,0.000021070911,0.00014263963,6.4775895e-7,0.000059581896],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985555,0.00069173216,0.00023715427,0.00008124377,0.00036479702,0.000069597474],"domain_scores_gemma":[0.9922408,0.0025834772,0.003975829,0.00012872696,0.00061237154,0.00045888132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022368236,0.00019900051,0.00032038378,0.0009701129,0.0002123319,0.0005397764,0.00018453489,0.00027537413,0.0021064638],"category_scores_gemma":[0.009858817,0.000110380424,0.00027931848,0.00096487475,0.00029362857,0.00027452872,0.00054907525,0.00038096748,0.00012455012],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017363293,0.000082307524,0.9912026,0.00016706287,0.00020606093,0.000027899578,0.000153766,0.000053993008,0.00014986376,0.000019063764,0.00011312354,0.007650691],"study_design_scores_gemma":[0.000014125215,0.00023758755,0.9991365,0.00004420746,0.000038505736,0.00014066826,0.00008812252,0.00006649756,0.0000409521,0.000025377423,0.00016441583,0.000003048471],"about_ca_topic_score_codex":0.0010432459,"about_ca_topic_score_gemma":0.0012464343,"teacher_disagreement_score":0.0022368236,"about_ca_system_score_codex":0.0002373554,"about_ca_system_score_gemma":0.00025617465,"threshold_uncertainty_score":0.011829615},"labels":[],"label_agreement":null},{"id":"W2043373435","doi":"10.1177/1352458507076961","title":"Multiple sclerosis susceptibility and the X chromosome","year":2007,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health; University of British Columbia Hospital","funders":"Multiple Sclerosis Society; Multiple Sclerosis Society of Canada","keywords":"Genetics; Locus (genetics); Biology; Microsatellite; Genetic linkage; Multiple sclerosis; Allele; Trait; Immunology; Gene","score_opus":0.1099400964624682,"score_gpt":0.30539147028123925,"score_spread":0.19545137381877103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043373435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959921,0.001343376,0.0006550545,0.0001622335,0.0000059318045,0.0000043299865,0.00069590553,0.0000098189375,0.0011313289],"genre_scores_gemma":[0.99609345,0.00049247005,0.0009900264,0.000042455493,0.000015628219,0.000016019365,0.0015911993,0.0000060827015,0.0007525611],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892247,0.00050788955,0.00007977298,0.00021955017,0.00021049478,0.000059850317],"domain_scores_gemma":[0.99510163,0.003131926,0.0010453087,0.00034955473,0.00014770741,0.00022385213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011894867,0.00019710757,0.00038172762,0.00072830095,0.0005040317,0.00062036794,0.00030150355,0.00023143957,0.002615369],"category_scores_gemma":[0.005948751,0.00010970821,0.00024678893,0.0010991519,0.00031804078,0.00028720763,0.0006315467,0.00029999792,0.00022285747],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014869878,0.00006517542,0.941253,0.00015935798,0.0005222016,0.00060514547,0.00038738138,0.0012111096,0.0057186596,0.0011712852,0.0008272048,0.046592534],"study_design_scores_gemma":[0.000036993348,0.00013508061,0.99161506,0.000035326986,0.00013406955,0.00084566366,0.00010463956,0.00094584917,0.0011531382,0.0014086963,0.0035789951,0.000006539124],"about_ca_topic_score_codex":0.0012918432,"about_ca_topic_score_gemma":0.0022796395,"teacher_disagreement_score":0.002615369,"about_ca_system_score_codex":0.0001327501,"about_ca_system_score_gemma":0.0002715005,"threshold_uncertainty_score":0.008749247},"labels":[],"label_agreement":null},{"id":"W2043472471","doi":"10.1191/1352458503ms958oa","title":"Disability in multiple sclerosis is related to normal appearing brain tissue MTR histogram abnormalities","year":2003,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Multiple sclerosis; Expanded Disability Status Scale; Medicine; Magnetization transfer; Magnetic resonance imaging; Nuclear medicine; Lesion; Central nervous system disease; Pathology; Internal medicine; Radiology","score_opus":0.10770040285057866,"score_gpt":0.3200785667297669,"score_spread":0.21237816387918826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043472471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99911124,0.0003315688,0.00015224863,0.000031050266,0.000004551794,0.00000793237,0.000047348207,0.000016607395,0.00029736233],"genre_scores_gemma":[0.9995901,0.00008797759,0.0001553213,0.000011724327,0.000013802426,0.0000055089704,0.00007092954,0.0000043245145,0.000060273585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99952555,0.00012850619,0.00006148332,0.000096425756,0.0001455519,0.000042406158],"domain_scores_gemma":[0.99511576,0.0013702571,0.002498019,0.00026340454,0.00025760135,0.00049488543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006372459,0.00037079977,0.00039914288,0.0009270007,0.0002609984,0.00034676035,0.00026273885,0.00037814173,0.0014312718],"category_scores_gemma":[0.00534112,0.0001805439,0.00024721283,0.00038687908,0.00064894755,0.00034420873,0.0005569389,0.00044036694,0.00030612602],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032845389,0.00057844556,0.9358754,0.0001661761,0.00038524606,0.00075668155,0.00021364739,0.00054143,0.025125984,0.00004959141,0.00037374865,0.032649137],"study_design_scores_gemma":[0.000015159481,0.00043930075,0.99722433,0.0000051566667,0.00003294969,0.0013302905,0.000022997505,0.00025140936,0.00054794,0.000058023626,0.0000677737,0.0000047126896],"about_ca_topic_score_codex":0.0005333048,"about_ca_topic_score_gemma":0.00049373624,"teacher_disagreement_score":0.0014312718,"about_ca_system_score_codex":0.00018777074,"about_ca_system_score_gemma":0.00011617385,"threshold_uncertainty_score":0.0047881007},"labels":[],"label_agreement":null},{"id":"W2045091008","doi":"10.1177/1352458512439119","title":"Natural, innate improvements in multiple sclerosis disability","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Natural history; Multiple sclerosis; Expanded Disability Status Scale; Medicine; Observational study; Natural history study; Logistic regression; Clinical trial; Clinical endpoint; Confidence interval; Physical therapy; Internal medicine; Pediatrics; Demography; Psychiatry","score_opus":0.1464856655963924,"score_gpt":0.3227992360109472,"score_spread":0.17631357041455478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045091008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98378444,0.0072032087,0.00054166326,0.00054275116,0.000015977983,0.000052464587,0.0020816068,0.000042471398,0.005735499],"genre_scores_gemma":[0.9976326,0.0009021384,0.00031938,0.000089875546,0.000022430326,0.000017676019,0.00046911428,0.0000037870384,0.00054285594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992205,0.00021317409,0.00006187672,0.00014542147,0.00024250841,0.000116579286],"domain_scores_gemma":[0.996912,0.0005720382,0.0016254246,0.00020928108,0.00038641013,0.00029495213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001267676,0.00024383911,0.00026242316,0.000777891,0.00023955342,0.0006327107,0.00031136983,0.00023833619,0.0029270728],"category_scores_gemma":[0.0031382127,0.00008892654,0.00022012732,0.0007699369,0.0006542478,0.00037870216,0.00055603083,0.00055597734,0.00029910746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005372823,0.0001389499,0.9596184,0.0002534783,0.00013885478,0.00018206846,0.00019905057,0.0005508934,0.0014449722,0.00031489105,0.0007831735,0.03583798],"study_design_scores_gemma":[0.0000067932615,0.00009046606,0.9982856,0.00002545022,0.000018281698,0.00020825608,0.00004131837,0.00013766081,0.00014656769,0.00019231135,0.0008432188,0.0000040679665],"about_ca_topic_score_codex":0.012956212,"about_ca_topic_score_gemma":0.018108498,"teacher_disagreement_score":0.012956212,"about_ca_system_score_codex":0.0012982293,"about_ca_system_score_gemma":0.001071279,"threshold_uncertainty_score":0.025761604},"labels":[],"label_agreement":null},{"id":"W2047413783","doi":"10.1177/1352458514528762","title":"Risk of relapse phenotype recurrence in multiple sclerosis","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne; Université Laval; Cégep de Lévis; Hôpital Notre-Dame","funders":"Fleni; Monash University","keywords":"Multiple sclerosis; Medicine; Phenotype; Oncology; Psychiatry; Biology; Genetics; Gene","score_opus":0.11270801621476442,"score_gpt":0.29564239464373676,"score_spread":0.18293437842897234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047413783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99936074,0.00026813356,0.000085646134,0.000053025447,0.0000024081955,0.000003408651,0.000088052904,0.000008058445,0.00013062215],"genre_scores_gemma":[0.9997054,0.000053302912,0.000048559985,0.00000767653,0.0000064793094,0.0000027557608,0.000121733916,0.0000025873167,0.00005147823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990387,0.0004099385,0.00008037412,0.00019522393,0.00015724817,0.000118527925],"domain_scores_gemma":[0.9960568,0.00074787147,0.002311586,0.00025198152,0.00025953536,0.00037213968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010998637,0.00025350056,0.0003833276,0.0006661205,0.000339801,0.0003894694,0.00037722522,0.0004942691,0.0017833352],"category_scores_gemma":[0.005610151,0.00016998808,0.00048233866,0.00063155725,0.0002520538,0.00045035165,0.00059333764,0.00073281507,0.00026801508],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023020411,0.00002461048,0.9966838,0.000009311236,0.000050525075,0.00014052488,0.000043312855,0.00005333418,0.00016226676,0.000014132447,0.00008585692,0.0025021387],"study_design_scores_gemma":[0.0000040643554,0.0001317353,0.99845374,0.0000052368737,0.000021147613,0.00092619145,0.000067036264,0.0002518348,0.000056212848,0.000032776188,0.000046789926,0.0000033363199],"about_ca_topic_score_codex":0.0012308329,"about_ca_topic_score_gemma":0.0009978005,"teacher_disagreement_score":0.0017833352,"about_ca_system_score_codex":0.00012295577,"about_ca_system_score_gemma":0.00019395,"threshold_uncertainty_score":0.0059658885},"labels":[],"label_agreement":null},{"id":"W2049683216","doi":"10.1177/135245850000600502","title":"Kinetic profiles of cerebrospinal fluid anti-MBP in response to intravenous MBP synthetic peptide DENP85VVHFFKNIVTP96RT in multiple sclerosis patients","year":2000,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Multiple sclerosis; Cerebrospinal fluid; Medicine; Peptide; Immunology; Internal medicine; Chemistry","score_opus":0.029234455766703065,"score_gpt":0.22615880334552763,"score_spread":0.19692434757882457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049683216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99919134,0.00027467633,0.00010945517,0.000010201911,0.000004898895,0.0000110126475,0.0001158008,0.000017113049,0.0002655537],"genre_scores_gemma":[0.9992611,0.00008936361,0.000085552776,0.000030909225,0.000007691002,0.000014267843,0.0003031817,0.000004091487,0.0002038214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981457,0.00003727243,0.000017336894,0.00004491829,0.00004926891,0.000036701258],"domain_scores_gemma":[0.99932814,0.00014974488,0.00021280399,0.00003739176,0.00008214135,0.00018982403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018797084,0.0003069446,0.0004422252,0.00042676117,0.00017276865,0.00040293112,0.00015445628,0.00035179156,0.0005914769],"category_scores_gemma":[0.0012491083,0.00016438377,0.00018160138,0.0002368147,0.00016901255,0.00021791479,0.00012070304,0.00039440373,0.0003190889],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029821178,0.0015034801,0.5758932,0.00016610265,0.00027221715,0.0032007615,0.00077839126,0.0011665152,0.34205383,0.00011675752,0.0006392664,0.044388235],"study_design_scores_gemma":[0.00023182081,0.013587716,0.94825953,0.00002188637,0.0001373087,0.0038138449,0.00024700814,0.0016102078,0.030862583,0.00006851284,0.001124125,0.000035547924],"about_ca_topic_score_codex":0.0006586221,"about_ca_topic_score_gemma":0.00051761104,"teacher_disagreement_score":0.0006586221,"about_ca_system_score_codex":0.0002350995,"about_ca_system_score_gemma":0.000108847074,"threshold_uncertainty_score":0.0019786954},"labels":[],"label_agreement":null},{"id":"W2049733663","doi":"10.1177/1352458511422097","title":"Temporal trends of disability progression in multiple sclerosis: findings from British Columbia, Canada (1975–2009)","year":2011,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Natural history; Medicine; Multiple sclerosis; Expanded Disability Status Scale; Demography; Age of onset; Pediatrics; Survival analysis; Disease; Internal medicine; Immunology","score_opus":0.1265162919507938,"score_gpt":0.2859786609938437,"score_spread":0.15946236904304992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049733663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9557454,0.009231837,0.0002076086,0.0012090425,0.000054497763,0.00007520067,0.027919851,0.000038241422,0.0055183093],"genre_scores_gemma":[0.9902997,0.002795359,0.00020928343,0.00023883898,0.000013593685,0.000029472194,0.004643774,0.000013535085,0.0017564782],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909675,0.000060268892,0.000098208286,0.00017613293,0.00028139495,0.000287173],"domain_scores_gemma":[0.99610305,0.0001736951,0.00062315,0.000103981816,0.002352117,0.0006440711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008144862,0.00038922075,0.00056816847,0.002614011,0.0021626975,0.0014135607,0.0013413203,0.00053319783,0.002624772],"category_scores_gemma":[0.0025579736,0.00031036453,0.0007187606,0.008962452,0.0006160693,0.0004018848,0.0009949451,0.0008450888,0.00032651922],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021611067,0.000028162376,0.98232275,0.00020764318,0.00015996819,0.00020185304,0.00087766256,0.00025834737,0.00022384878,0.00013210668,0.003883987,0.011487462],"study_design_scores_gemma":[0.0000070681344,0.000012275662,0.9972676,0.00009556161,0.00006229543,0.00006847951,0.0008973246,0.00015570673,0.00003852663,0.000014176386,0.0013690684,0.000011834934],"about_ca_topic_score_codex":0.99787307,"about_ca_topic_score_gemma":0.99852943,"teacher_disagreement_score":0.025352016,"about_ca_system_score_codex":0.025352016,"about_ca_system_score_gemma":0.041220047,"threshold_uncertainty_score":0.18394262},"labels":[],"label_agreement":null},{"id":"W2049871497","doi":"10.1177/1352458511411061","title":"Oral fingolimod (FTY720) in relapsing multiple sclerosis: impact on health-related quality of life in a phase II study","year":2011,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Fingolimod; Placebo; Medicine; Multiple sclerosis; Depression (economics); Quality of life (healthcare); Beck Depression Inventory; Internal medicine; Physical therapy; Clinical trial; Psychiatry; Anxiety; Alternative medicine","score_opus":0.17284795054402027,"score_gpt":0.33392886294287094,"score_spread":0.16108091239885067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049871497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915142,0.0038014292,0.0004887277,0.000292912,0.000079892096,0.0022070752,0.00084788067,0.00007359591,0.0006942646],"genre_scores_gemma":[0.9784539,0.006159994,0.002118306,0.0011091526,0.00047588962,0.006389566,0.003161133,0.000036428562,0.0020956274],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99919873,0.0004318452,0.000035977013,0.0000923556,0.00010629619,0.00013485906],"domain_scores_gemma":[0.9988589,0.00020658971,0.00031176928,0.00010825957,0.00007326061,0.00044123188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003937722,0.0020337743,0.00285884,0.00045347112,0.00040473085,0.00093045266,0.00096228224,0.001616372,0.0023554685],"category_scores_gemma":[0.001255357,0.00057826255,0.0020097184,0.00046820578,0.00090330094,0.0005496219,0.00036073927,0.0020318155,0.00054033543],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7565482,0.09745497,0.008054611,0.0015948252,0.003056569,0.00058019254,0.0003322014,0.0013968744,0.041731633,0.00015551379,0.0026105924,0.086483955],"study_design_scores_gemma":[0.64223975,0.33437136,0.019397255,0.00004343961,0.0007519029,0.00022649628,0.000034620036,0.0004516665,0.0014171457,0.00007174971,0.00097388274,0.000020681973],"about_ca_topic_score_codex":0.0008545206,"about_ca_topic_score_gemma":0.0011126121,"teacher_disagreement_score":0.003937722,"about_ca_system_score_codex":0.0005927741,"about_ca_system_score_gemma":0.0012567898,"threshold_uncertainty_score":0.02082491},"labels":[],"label_agreement":null},{"id":"W2050175727","doi":"10.1177/1352458507088106","title":"Atrophy in white matter fiber tracts in multiple sclerosis is not dependent on tract length or local white matter lesions","year":2008,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"National Institute on Aging","keywords":"Atrophy; White matter; Multiple sclerosis; Pathology; Lesion; Fiber tract; Corticospinal tract; Medicine; Expanded Disability Status Scale; Pathogenesis; Magnetic resonance imaging; Diffusion MRI; Anatomy; Radiology","score_opus":0.15435305877938077,"score_gpt":0.30165010955625376,"score_spread":0.147297050776873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050175727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99928623,0.00023471053,0.00027999407,0.0000066297002,5.271178e-7,0.000002250837,0.000036979898,0.0000086125565,0.0001441301],"genre_scores_gemma":[0.9990758,0.00017779849,0.00043611493,0.000004187909,0.000002528029,0.0000036196284,0.00009885318,0.000004662433,0.00019635206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99989295,0.00002307867,0.000010412098,0.000027780216,0.000033200846,0.000012501382],"domain_scores_gemma":[0.9991105,0.0001720949,0.00046945026,0.0001107018,0.00006182178,0.00007531216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036665404,0.00015890312,0.0001723236,0.00050221797,0.00014350378,0.00019126764,0.00009228419,0.00013571774,0.0007919955],"category_scores_gemma":[0.0012620192,0.00012629501,0.00012272502,0.00028805967,0.00041673717,0.0003864773,0.00019629957,0.00016154272,0.00016797197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015121258,0.000104502265,0.53277874,0.0001670845,0.00025087327,0.0003841992,0.00043343502,0.0015127489,0.42527846,0.000121887504,0.00011971776,0.03733627],"study_design_scores_gemma":[0.0000036489068,0.00024961345,0.9922019,0.0000045635575,0.000020213374,0.0005566045,0.000026161322,0.00042021222,0.0063603367,0.00007499659,0.00007832862,0.000003462381],"about_ca_topic_score_codex":0.0007986329,"about_ca_topic_score_gemma":0.0020231544,"teacher_disagreement_score":0.0007986329,"about_ca_system_score_codex":0.00012619136,"about_ca_system_score_gemma":0.00010250433,"threshold_uncertainty_score":0.002649486},"labels":[],"label_agreement":null},{"id":"W2050322688","doi":"10.1177/1352458514531348","title":"Adherence in multiple sclerosis (ADAMS): Classification, relevance, and research needs. A meeting report","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Institutes of Health; University of Missouri; Princeton University; Teva Pharmaceutical Industries; Multiple Sclerosis Society; Biogen","keywords":"Psychological intervention; Medicine; Focus group; Multiple sclerosis; Alternative medicine; Session (web analytics); Relevance (law); MEDLINE; Health care; Family medicine; Psychology; Psychiatry","score_opus":0.28142241811258845,"score_gpt":0.36563490045210456,"score_spread":0.08421248233951611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050322688","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.52807015,0.1820185,0.006285054,0.19194676,0.012020638,0.014406763,0.01239658,0.0004998935,0.052355517],"genre_scores_gemma":[0.84081924,0.082810774,0.026644316,0.006885891,0.010245271,0.008680898,0.012769527,0.00007215856,0.0110719595],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.993071,0.0019934627,0.002784573,0.00023077326,0.0015266767,0.00039341682],"domain_scores_gemma":[0.9811353,0.0054432494,0.004646005,0.00049908133,0.0058008446,0.0024754507],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0142316,0.00047406415,0.0006542313,0.0046335845,0.0014150633,0.0019006542,0.0008496977,0.001456873,0.0035377734],"category_scores_gemma":[0.030486094,0.00031632168,0.000994685,0.0040940186,0.00041875217,0.0021172704,0.0027335915,0.0014797907,0.00077631994],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008985461,0.0010445139,0.2505308,0.00721048,0.00014597253,0.0009551923,0.0048451987,0.00025634767,0.0011475263,0.00092027866,0.06701534,0.6650298],"study_design_scores_gemma":[0.00030696712,0.0023646825,0.8749432,0.007448561,0.00032909313,0.0043148817,0.0148665225,0.0011102881,0.00068134815,0.0012394914,0.09223998,0.00015500418],"about_ca_topic_score_codex":0.005756348,"about_ca_topic_score_gemma":0.0051137125,"teacher_disagreement_score":0.9857684,"about_ca_system_score_codex":0.0016123948,"about_ca_system_score_gemma":0.0042124484,"threshold_uncertainty_score":0.07526481},"labels":[],"label_agreement":null},{"id":"W2051588049","doi":"10.1177/1352458514551594","title":"Quantitative Measurement of tissue damage and recovery within new T2w lesions in pediatric- and adult-onset multiple sclerosis","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; McGill University; Hospital for Sick Children; Montreal Neurological Institute and Hospital","funders":"Canadian Institutes of Health Research; Hospital for Sick Children; Multiple Sclerosis Society; Multiple Sclerosis Scientific Research Foundation","keywords":"Lesion; Multiple sclerosis; Medicine; Intensity (physics); Nuclear medicine; Pathology; Radiology","score_opus":0.1578637544711017,"score_gpt":0.3144957273046325,"score_spread":0.15663197283353078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051588049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99838674,0.00020669203,0.0011454016,0.0000047567123,0.0000011903252,0.000007657797,0.000089413916,0.000014244881,0.00014390127],"genre_scores_gemma":[0.9974475,0.00014901758,0.0019518432,0.0000044994217,0.0000027332255,0.000020094596,0.00022084598,0.000008512824,0.00019502752],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99988866,0.000028798351,0.0000076117535,0.000031985463,0.000030583444,0.000012231865],"domain_scores_gemma":[0.9995714,0.00008234591,0.0001859196,0.00003252497,0.00007351478,0.000054367254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053232035,0.00020894864,0.00015996698,0.0003531067,0.00008052919,0.0001974006,0.00015450991,0.00029472887,0.0009019588],"category_scores_gemma":[0.0009405575,0.00014512078,0.00009737116,0.000189576,0.00019703279,0.00026728577,0.0001259119,0.00014840272,0.00018699211],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045709554,0.00022391853,0.5631967,0.00025664258,0.00018656034,0.00075264595,0.00081443397,0.0030134935,0.3859257,0.00012119203,0.00035039344,0.040587336],"study_design_scores_gemma":[0.000027619073,0.0008942885,0.97144735,0.0000075683615,0.000043785258,0.0021786357,0.00013805559,0.0023769313,0.022459477,0.000028226112,0.00038861795,0.00000947498],"about_ca_topic_score_codex":0.0011286519,"about_ca_topic_score_gemma":0.0010155516,"teacher_disagreement_score":0.0011286519,"about_ca_system_score_codex":0.0001716843,"about_ca_system_score_gemma":0.000092414,"threshold_uncertainty_score":0.003017366},"labels":[],"label_agreement":null},{"id":"W2052610851","doi":"10.1177/135245850000600612","title":"The Immunological Rationale for Bone Marrow Transplantation in Multiple Sclerosis","year":2000,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Multiple sclerosis; Medicine; Bone marrow transplantation; Transplantation; Bone marrow; Immunology; Pathology; Internal medicine","score_opus":0.14053426378639552,"score_gpt":0.2989657048133035,"score_spread":0.15843144102690795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052610851","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18531868,0.2943671,0.01168596,0.44033158,0.019304547,0.0002902691,0.00023293133,0.00006028987,0.048408587],"genre_scores_gemma":[0.86493254,0.024904447,0.00602469,0.07492103,0.025088867,0.00029486456,0.00005922349,0.000037030237,0.0037373526],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.993985,0.0046111564,0.0004315117,0.00020738562,0.00056578784,0.00019914297],"domain_scores_gemma":[0.9818388,0.0147927115,0.0011494505,0.00075345644,0.00080221356,0.0006633029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02334267,0.00023204542,0.0005855218,0.00096077746,0.00087002944,0.0013723929,0.0008525781,0.003249537,0.0029074927],"category_scores_gemma":[0.019257074,0.00020642346,0.0004768676,0.00059877295,0.0059903273,0.0013027695,0.0015531894,0.0053348034,0.0004129034],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009832829,0.0011608318,0.032829687,0.003101056,0.00053359545,0.0031239383,0.0013211457,0.0012074424,0.013085222,0.6616754,0.027794803,0.24433407],"study_design_scores_gemma":[0.0070187123,0.0048092213,0.079236865,0.0069006057,0.0015726238,0.016094428,0.0019209203,0.002825341,0.017107788,0.45741296,0.4048901,0.00021048677],"about_ca_topic_score_codex":0.00030053325,"about_ca_topic_score_gemma":0.00059047935,"teacher_disagreement_score":0.02334267,"about_ca_system_score_codex":0.0007365788,"about_ca_system_score_gemma":0.0016320538,"threshold_uncertainty_score":0.123449326},"labels":[],"label_agreement":null},{"id":"W2052712688","doi":"10.1177/1352458508097921","title":"Neuromyelitis optica and multiple sclerosis in sisters","year":2008,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neuromyelitis optica; Multiple sclerosis; Medicine; Human leukocyte antigen; Population; Immunology; Antigen; Environmental health","score_opus":0.17748016409803954,"score_gpt":0.2872376722819923,"score_spread":0.10975750818395277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052712688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934143,0.00079203275,0.00020327218,0.00022830891,0.00009956809,0.0000333948,0.00012056383,0.000026282567,0.0050821486],"genre_scores_gemma":[0.99785256,0.00040014845,0.00030479147,0.00020003799,0.00007348208,0.000013663193,0.00008178839,0.0000064010196,0.0010670865],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9994068,0.00010697413,0.00010442623,0.00016625362,0.00013374853,0.00008172336],"domain_scores_gemma":[0.9989343,0.00023946095,0.00025447638,0.00014053521,0.00014480752,0.0002864128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062333065,0.0009270258,0.0006430666,0.0015742201,0.0024933573,0.000592919,0.0004914342,0.0012323504,0.0057775313],"category_scores_gemma":[0.004006423,0.00062089076,0.0003834698,0.0008994815,0.00069713296,0.00065260596,0.001159798,0.0008540599,0.0008923332],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005139987,0.00047548892,0.5250297,0.0002742717,0.000092578935,0.43245348,0.010398722,0.00011188066,0.010990911,0.0008492212,0.0013636076,0.01744598],"study_design_scores_gemma":[0.000053538566,0.00045584422,0.12370218,0.00009950165,0.00006701639,0.868018,0.0020861523,0.00014086337,0.001315489,0.00042655552,0.0036119584,0.000022895181],"about_ca_topic_score_codex":0.005142323,"about_ca_topic_score_gemma":0.004795358,"teacher_disagreement_score":0.0057775313,"about_ca_system_score_codex":0.00055223727,"about_ca_system_score_gemma":0.0006677054,"threshold_uncertainty_score":0.01932776},"labels":[],"label_agreement":null},{"id":"W2052748265","doi":"10.1191/1352458505ms1124oa","title":"The Paced Auditory Serial Addition Test: to what extent is it performed as instructed, and is it associated with disease course?","year":2005,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Streptococcal Infections and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Queen's University","funders":"Marshall Space Flight Center; Multiple Sclerosis Society","keywords":"Test (biology); Multiple sclerosis; Audiology; Disease; Medicine; Psychology; Psychiatry; Pathology","score_opus":0.04353811264214161,"score_gpt":0.28434516575288843,"score_spread":0.24080705311074682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052748265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99366105,0.0010884729,0.0011906369,0.00028931125,0.00004174929,0.00005784834,0.00066268916,0.00003448078,0.002973837],"genre_scores_gemma":[0.9963497,0.00052158994,0.0012557886,0.00015681026,0.000048982463,0.00007001115,0.00069082377,0.000015394377,0.0008909331],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979551,0.0005607843,0.00039199454,0.00042650182,0.00051597523,0.00014967138],"domain_scores_gemma":[0.9906771,0.0022206814,0.004683301,0.0005154602,0.0014191103,0.00048441152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024033263,0.00054776116,0.00063516037,0.0010786353,0.00034510973,0.00080711127,0.00056923606,0.00073561596,0.001899803],"category_scores_gemma":[0.014237081,0.00014996904,0.00050948636,0.0011179183,0.0005580237,0.0011902546,0.00041783246,0.00079374574,0.00066035555],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011061935,0.00035708668,0.9516857,0.00017244092,0.00042090163,0.00019203979,0.00042233046,0.00040462991,0.0017721264,0.00012198343,0.0007892632,0.04255527],"study_design_scores_gemma":[0.000030770385,0.00053292076,0.9965862,0.000057176912,0.000086169064,0.00043065552,0.00017321578,0.000717713,0.00052434497,0.00017373261,0.00066717644,0.000019854051],"about_ca_topic_score_codex":0.0038529723,"about_ca_topic_score_gemma":0.007452026,"teacher_disagreement_score":0.0038529723,"about_ca_system_score_codex":0.00039503895,"about_ca_system_score_gemma":0.0005611949,"threshold_uncertainty_score":0.012710214},"labels":[],"label_agreement":null},{"id":"W2053615666","doi":"10.1177/1352458512447597","title":"Evaluation of pattern-reversal visual evoked potential in patients with neuromyelitis optica","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cytodiagnostics (Canada)","funders":"","keywords":"Neuromyelitis optica; Multiple sclerosis; Optic neuritis; Visual evoked potentials; Medicine; Evoked potential; Transverse myelitis; Audiology; Spinal cord; Ophthalmology; Immunology","score_opus":0.07933465481186845,"score_gpt":0.31242650510137016,"score_spread":0.2330918502895017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053615666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990201,0.00025421273,0.000080891215,0.000025319667,0.000003607947,0.000014374359,0.00003441731,0.00000337193,0.00056377513],"genre_scores_gemma":[0.99968886,0.000094408104,0.000070453556,0.00002354537,0.000008014691,0.000007754412,0.000046016186,9.16626e-7,0.0000601216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997701,0.00006018948,0.0000343124,0.000043019994,0.000045397024,0.000046943616],"domain_scores_gemma":[0.9993937,0.00021236301,0.0001974215,0.000024585077,0.0000834882,0.00008836134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003296357,0.00037533607,0.00036034948,0.0008222148,0.00033269115,0.0003130629,0.00018922638,0.00040508632,0.0013313878],"category_scores_gemma":[0.0020350863,0.00010607425,0.0001309596,0.00034461363,0.00027106493,0.00039034642,0.0002100845,0.00023456797,0.00023562102],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006892602,0.00010545494,0.9714318,0.000069928494,0.000026477548,0.013093127,0.00027171665,0.00006933324,0.005961905,0.000040387844,0.00017890414,0.0080618],"study_design_scores_gemma":[0.000054224372,0.0010641762,0.923047,0.000024989773,0.0000375127,0.073245935,0.0004789391,0.00027039216,0.0011887082,0.000084952706,0.00049180473,0.0000113214],"about_ca_topic_score_codex":0.0004895873,"about_ca_topic_score_gemma":0.00057594466,"teacher_disagreement_score":0.0013313878,"about_ca_system_score_codex":0.00018017688,"about_ca_system_score_gemma":0.00017602732,"threshold_uncertainty_score":0.004453957},"labels":[],"label_agreement":null},{"id":"W2054962526","doi":"10.1177/1352458513507816","title":"Predictors and dynamics of postpartum relapses in women with multiple sclerosis","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":185,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Cégep de Lévis; Hôpital Notre-Dame","funders":"Medical Research Council; Novartis Pharma; Sanofi","keywords":"Medicine; Pregnancy; Multiple sclerosis; Postpartum period; Observational study; Obstetrics; Logistic regression; Expanded Disability Status Scale; Internal medicine","score_opus":0.04471579156247234,"score_gpt":0.25050048256732693,"score_spread":0.20578469100485458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054962526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99903715,0.0004930515,0.000057233414,0.00010353654,0.000005250042,0.0000044862118,0.00009067337,0.0000035986136,0.00020505417],"genre_scores_gemma":[0.99959356,0.00018875851,0.000054687753,0.0000123455375,0.000006001004,0.000005378039,0.00007792536,0.0000015220726,0.000059810045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99952054,0.00018267422,0.000049387538,0.00008339638,0.000080383135,0.00008369651],"domain_scores_gemma":[0.9976654,0.0008271602,0.0010467514,0.00014233903,0.00012503909,0.00019344248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010246587,0.00014550654,0.00028143937,0.00042404197,0.00027583766,0.00044233276,0.00033493826,0.00032499465,0.001026768],"category_scores_gemma":[0.006879271,0.00023895373,0.00029355526,0.0005578654,0.00022525198,0.00030445302,0.00029802183,0.00067762454,0.00015183049],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001518419,0.000020349033,0.99763167,0.0000054839393,0.00001819454,0.000116194846,0.000079593054,0.000020005255,0.00006120982,0.000012104282,0.000056946694,0.0018264776],"study_design_scores_gemma":[0.00000411859,0.000080035155,0.9989267,0.000010404308,0.000021238619,0.000448759,0.00017870669,0.00019118331,0.000037631326,0.000028687846,0.00007000511,0.0000024307628],"about_ca_topic_score_codex":0.0031774216,"about_ca_topic_score_gemma":0.002311368,"teacher_disagreement_score":0.0031774216,"about_ca_system_score_codex":0.00022288617,"about_ca_system_score_gemma":0.00028808412,"threshold_uncertainty_score":0.006317854},"labels":[],"label_agreement":null},{"id":"W2055670101","doi":"10.1177/1352458510378021","title":"Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks","year":2010,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Natalizumab; Multiple sclerosis; Neuropsychology; Cohort; Medicine; Cognition; Neuropsychological test; Psychology; Physical therapy; Audiology; Internal medicine; Psychiatry","score_opus":0.08293361720354528,"score_gpt":0.32292379078953776,"score_spread":0.23999017358599248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055670101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994831,0.0001479884,0.000064763895,0.000014447788,0.0000026430357,0.000023557615,0.00008752089,0.0000052327073,0.00017069232],"genre_scores_gemma":[0.9993868,0.00007677755,0.00016653417,0.00002063897,0.0000058554538,0.00003241048,0.00017494726,0.0000016958959,0.0001343354],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9992188,0.00029856374,0.00010510872,0.00012468727,0.00018644305,0.0000664152],"domain_scores_gemma":[0.9976005,0.00041330382,0.0012023269,0.00011332216,0.00034570126,0.00032488297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002105616,0.0005581093,0.0009815809,0.00059846026,0.00034138712,0.00039327051,0.00037637033,0.0004673942,0.00074222276],"category_scores_gemma":[0.004031668,0.00027591657,0.000576022,0.0005585635,0.00025139307,0.0005464676,0.0002793896,0.00060471485,0.00028313356],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054561924,0.00062353996,0.9741546,0.00006169591,0.00030271243,0.0002295035,0.00037599483,0.00038843072,0.0036511305,0.000006217745,0.00017977964,0.014570196],"study_design_scores_gemma":[0.00018478681,0.0032164296,0.99518895,0.0000055619503,0.000075946155,0.00030128058,0.000052087176,0.00034630118,0.0004832731,0.0000085641,0.00012908629,0.000007741809],"about_ca_topic_score_codex":0.0018048115,"about_ca_topic_score_gemma":0.0023219439,"teacher_disagreement_score":0.002105616,"about_ca_system_score_codex":0.00044583148,"about_ca_system_score_gemma":0.0002526153,"threshold_uncertainty_score":0.011135638},"labels":[],"label_agreement":null},{"id":"W2059349666","doi":"10.1177/1352458511418629","title":"Neutralizing antibodies to interferon beta-1b multiple sclerosis: a clinico-radiographic paradox in the BEYOND trial","year":2011,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Michael's Hospital","funders":"","keywords":"Medicine; Titer; Glatiramer acetate; Multiple sclerosis; Internal medicine; Antibody; Gastroenterology; Neutralizing antibody; Interferon beta; Randomized controlled trial; Immunology","score_opus":0.3023020924661958,"score_gpt":0.34502276223390443,"score_spread":0.04272066976770861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059349666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98570806,0.010354034,0.00024018087,0.001041867,0.00014063627,0.00013710436,0.00029271617,0.000023686063,0.0020617263],"genre_scores_gemma":[0.99573815,0.0017498176,0.00042294612,0.00080324855,0.000197005,0.00011498665,0.00029719534,0.0000070521814,0.00066965027],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99802643,0.0015745813,0.00009616854,0.0001053363,0.000107762215,0.0000896976],"domain_scores_gemma":[0.9973573,0.0013143072,0.000687808,0.00023988479,0.00011789366,0.00028274636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004989148,0.00036007428,0.0017349875,0.00018310311,0.00019395037,0.00060653745,0.00032094723,0.0006128749,0.0020420125],"category_scores_gemma":[0.0032353848,0.00012406909,0.0012858743,0.00027889753,0.0005609612,0.0005395586,0.00025700498,0.0009788255,0.00012908378],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8073189,0.002540276,0.02556312,0.0025714103,0.0060002133,0.00020626759,0.00019764784,0.001447006,0.011536104,0.0021657709,0.0027170281,0.13773626],"study_design_scores_gemma":[0.514576,0.2955783,0.13642485,0.0016653833,0.016106127,0.0010111986,0.00030673403,0.0034340692,0.0049795993,0.0066623436,0.019129073,0.00012635945],"about_ca_topic_score_codex":0.00030040662,"about_ca_topic_score_gemma":0.001083465,"teacher_disagreement_score":0.004989148,"about_ca_system_score_codex":0.0002749468,"about_ca_system_score_gemma":0.000560873,"threshold_uncertainty_score":0.026385427},"labels":[],"label_agreement":null},{"id":"W2059898472","doi":"10.1177/1352458514564590","title":"Analysis of genes, pathways and networks involved in disease severity and age at onset in primary-progressive multiple sclerosis","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Multiple Sclerosis Trust; Ministère de la Santé et des Services sociaux; Wellcome Trust","keywords":"Genome-wide association study; Multiple sclerosis; Context (archaeology); Disease; Medicine; Single-nucleotide polymorphism; Genetics; Gene; Biology; Internal medicine; Immunology; Genotype","score_opus":0.13765125678233298,"score_gpt":0.2897771080637355,"score_spread":0.15212585128140255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059898472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925068,0.0027160833,0.0019134916,0.00018241034,0.000008370933,0.000016949289,0.002041846,0.000042761658,0.0005711737],"genre_scores_gemma":[0.99607986,0.0006785011,0.0017597729,0.000040296447,0.000011417273,0.000020306297,0.0011202211,0.000005494878,0.00028413392],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99978155,0.000051056042,0.000012599867,0.00009396627,0.000030184347,0.000030646406],"domain_scores_gemma":[0.9993506,0.00025362908,0.00024056397,0.00004035246,0.000044914104,0.000069976195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041560567,0.00035823355,0.00029563083,0.00091375574,0.00022191158,0.0003893818,0.00022580657,0.0002833674,0.0016131802],"category_scores_gemma":[0.0009124898,0.000118963886,0.0006356033,0.0009355004,0.00022975454,0.0002473305,0.00031128552,0.00022701501,0.00021610636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014232562,0.000098609526,0.91767764,0.0005535164,0.00090910133,0.00057830213,0.00015712694,0.00315552,0.049842745,0.0004882806,0.0005659066,0.02455005],"study_design_scores_gemma":[0.000028995262,0.00018497289,0.99123764,0.000026150306,0.0004120804,0.0005769224,0.000066965666,0.002827141,0.0024732926,0.001233582,0.00092397764,0.000008286961],"about_ca_topic_score_codex":0.0012666303,"about_ca_topic_score_gemma":0.0013990646,"teacher_disagreement_score":0.0016131802,"about_ca_system_score_codex":0.00029897573,"about_ca_system_score_gemma":0.00039551107,"threshold_uncertainty_score":0.0053966045},"labels":[],"label_agreement":null},{"id":"W2065198908","doi":"10.1177/1352458507076988","title":"Neutralizing antibodies and interferon treatment of multiple sclerosis: addressing the open questions","year":2007,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Multiple sclerosis; Antibody; Medicine; Interferon; Interferon beta; Virology; Immunology","score_opus":0.3478707443885182,"score_gpt":0.3952532679387781,"score_spread":0.04738252355025985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065198908","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016400177,0.8879117,0.00027463792,0.09226634,0.0014963358,0.000017864324,0.00005357435,0.00000437967,0.0015749539],"genre_scores_gemma":[0.2966751,0.5933941,0.0015956596,0.057425346,0.049770847,0.000117982236,0.00010591029,0.000019570782,0.000895539],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9712554,0.0228143,0.002594119,0.0010199195,0.0017856904,0.00053048896],"domain_scores_gemma":[0.62663823,0.34235233,0.020039601,0.0032817258,0.005363513,0.0023245725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06473208,0.0007436185,0.004273452,0.0018106299,0.0012417312,0.0051647364,0.0033671854,0.011449319,0.006287673],"category_scores_gemma":[0.12004412,0.0006409596,0.0016026244,0.0034450265,0.0074927127,0.009986426,0.0026850342,0.0065396554,0.00059880945],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016160937,0.0022515142,0.109065,0.037997697,0.01614119,0.0009341559,0.0026895134,0.00071514666,0.00073189574,0.042305082,0.039180733,0.73182714],"study_design_scores_gemma":[0.0140823675,0.00924831,0.30720288,0.090077214,0.023616228,0.0057176696,0.024537409,0.005025383,0.00091966457,0.2525683,0.2664522,0.00055238],"about_ca_topic_score_codex":0.0021463865,"about_ca_topic_score_gemma":0.0050310916,"teacher_disagreement_score":0.06473208,"about_ca_system_score_codex":0.0014866719,"about_ca_system_score_gemma":0.0045179925,"threshold_uncertainty_score":0.34234005},"labels":[],"label_agreement":null},{"id":"W2066703886","doi":"10.1177/1352458509355461","title":"Diffusion tensor imaging abnormalities in depressed multiple sclerosis patients","year":2009,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Multiple Sclerosis Society","keywords":"Fractional anisotropy; White matter; Diffusion MRI; Grey matter; Magnetic resonance imaging; Multiple sclerosis; Hyperintensity; Depression (economics); Psychology; Medicine; Nuclear medicine; Radiology; Psychiatry","score_opus":0.07328913343466291,"score_gpt":0.27926450485650717,"score_spread":0.20597537142184424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066703886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99930894,0.00029361068,0.00003371646,0.000037836417,0.0000028413951,0.000005824668,0.000053926557,0.00000270112,0.00026054322],"genre_scores_gemma":[0.99953294,0.00018739488,0.00008096153,0.00001946597,0.0000074399804,0.0000061728742,0.00009659775,6.569558e-7,0.00006854839],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984145,0.000039055147,0.000030318408,0.000029513227,0.000038035054,0.000021623868],"domain_scores_gemma":[0.99929154,0.0001049622,0.00038229965,0.000033267057,0.000088128545,0.00009975013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002479023,0.00027356044,0.00034178328,0.0007809362,0.00030361765,0.00035906062,0.00012998508,0.0002776048,0.0008486131],"category_scores_gemma":[0.0023127387,0.000192405,0.0001647076,0.00043601528,0.00022728292,0.00017681762,0.00018369223,0.0002288058,0.00020240176],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041508625,0.00005919699,0.98815584,0.000032951197,0.0000760538,0.0015184861,0.00031660992,0.000047067493,0.0034137894,0.000035886816,0.00019594723,0.0057331114],"study_design_scores_gemma":[0.000024314124,0.0001321232,0.9960382,0.0000089214,0.0000286909,0.0031986004,0.00013541388,0.00009893146,0.00019345472,0.000036698177,0.00010132055,0.000003352619],"about_ca_topic_score_codex":0.001846176,"about_ca_topic_score_gemma":0.002048086,"teacher_disagreement_score":0.001846176,"about_ca_system_score_codex":0.00019590376,"about_ca_system_score_gemma":0.00012323019,"threshold_uncertainty_score":0.0036708713},"labels":[],"label_agreement":null},{"id":"W2067663958","doi":"10.1177/1352458510391837","title":"Magnetic resonance active lesions as individual-level surrogate for relapses in multiple sclerosis","year":2010,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Multiple sclerosis; Medicine; Magnetic resonance imaging; Surrogate endpoint; Clinical trial; Placebo; Lesion; Internal medicine; Surgery; Radiology; Pathology; Immunology","score_opus":0.3715157068469907,"score_gpt":0.37935466283444463,"score_spread":0.007838955987453933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067663958","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9532233,0.018961223,0.022657868,0.00042938834,0.00007498398,0.0006987227,0.0016316405,0.00011761397,0.0022052824],"genre_scores_gemma":[0.9939745,0.00048504086,0.0043473416,0.00009843279,0.000055381435,0.00038182226,0.00051002135,0.000015516509,0.00013192506],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9634331,0.029072639,0.0024319242,0.0019692408,0.0028547193,0.00023832233],"domain_scores_gemma":[0.8939486,0.061259408,0.03210302,0.009180447,0.0024855323,0.0010230298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.058360852,0.00070432044,0.0019046465,0.0013751102,0.0002928475,0.0009909426,0.0008560148,0.0009585356,0.0008961406],"category_scores_gemma":[0.05767045,0.00027554695,0.0021523025,0.001139528,0.0009693931,0.0009953855,0.00093191833,0.0011341517,0.00014912829],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.069601424,0.00072178495,0.7673897,0.0034986655,0.020265443,0.00022392292,0.0006141602,0.01415287,0.011502613,0.0014442123,0.0010095659,0.10957555],"study_design_scores_gemma":[0.0019980385,0.0256487,0.929376,0.00031547513,0.008091732,0.0013970057,0.00013526117,0.013444767,0.01202341,0.0041150055,0.003274907,0.00017964502],"about_ca_topic_score_codex":0.0001645635,"about_ca_topic_score_gemma":0.00026549163,"teacher_disagreement_score":0.058360852,"about_ca_system_score_codex":0.0005047861,"about_ca_system_score_gemma":0.00053780846,"threshold_uncertainty_score":0.30864543},"labels":[],"label_agreement":null},{"id":"W2067777541","doi":"10.1177/1352458514533846","title":"Further investigation of safety monitoring guidelines based on magnetic resonance imaging lesion activity in multiple sclerosis clinical trials","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Multiple sclerosis; Medicine; Guideline; Clinical trial; Magnetic resonance imaging; Odds ratio; Lesion; Cohort; Medical physics; Radiology; Internal medicine; Pathology; Psychiatry","score_opus":0.4590526859922196,"score_gpt":0.43068479568666235,"score_spread":0.028367890305557253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067777541","genre_codex":"empirical","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5012323,0.11944518,0.13673387,0.14131117,0.007292003,0.047484536,0.01019807,0.001620163,0.034682736],"genre_scores_gemma":[0.72203124,0.0072932187,0.18909594,0.0456819,0.0025104235,0.0277792,0.0038060162,0.000297311,0.0015048155],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.36980584,0.54099506,0.053017348,0.0060566496,0.028223647,0.0019013289],"domain_scores_gemma":[0.12193497,0.6514245,0.12487022,0.029075082,0.06902805,0.003667248],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.45667967,0.0012227766,0.0035567114,0.0029128152,0.00089918374,0.0071115973,0.004073543,0.0061823605,0.0032322141],"category_scores_gemma":[0.699574,0.00076955254,0.0059397123,0.005647799,0.0014069504,0.0077096242,0.0023412881,0.0041074418,0.00061846257],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049856782,0.003813471,0.3017114,0.027832394,0.03888526,0.00033583082,0.0032283373,0.014025518,0.0034408218,0.012885737,0.039287586,0.5046968],"study_design_scores_gemma":[0.04383071,0.06406981,0.5800151,0.0318173,0.039937492,0.0008365142,0.0019232717,0.057457183,0.007211949,0.024745466,0.14722005,0.00093514647],"about_ca_topic_score_codex":0.0021514292,"about_ca_topic_score_gemma":0.004706067,"teacher_disagreement_score":0.5433203,"about_ca_system_score_codex":0.0033616421,"about_ca_system_score_gemma":0.009635363,"threshold_uncertainty_score":0.6700107},"labels":[],"label_agreement":null},{"id":"W2068169278","doi":"10.1177/1352458507076994","title":"Clinical significance of glatiramer acetate antibodies","year":2007,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Teva Pharmaceuticals (Canada)","funders":"","keywords":"Glatiramer acetate; Multiple sclerosis; Antibody; Immunology; Antigen; Remyelination; Medicine; In vitro; Pharmacology; Chemistry; Internal medicine; Biochemistry; Myelin; Central nervous system","score_opus":0.0781630640935224,"score_gpt":0.3150464879561985,"score_spread":0.23688342386267608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068169278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7916471,0.065074205,0.0009052319,0.0071328687,0.00063599006,0.000203169,0.0005289114,0.00016741402,0.13370517],"genre_scores_gemma":[0.9939825,0.0026320308,0.00017140308,0.00092239253,0.0004050778,0.000014298766,0.00013240408,0.000006506245,0.0017333218],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99948835,0.00014849698,0.00004820118,0.00007287753,0.00013229871,0.00010974425],"domain_scores_gemma":[0.9982406,0.00067036046,0.00037981817,0.000079039346,0.0003265886,0.00030368014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006173951,0.00037025404,0.0005161168,0.0006546436,0.0004562711,0.0008450989,0.0002580694,0.0009149937,0.0044405838],"category_scores_gemma":[0.0041781906,0.00011497009,0.00019296996,0.0006130855,0.00047882457,0.000512962,0.00018594401,0.0009210737,0.00092906354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071394187,0.0008015402,0.61367357,0.00075929135,0.00016067,0.067954615,0.00037778725,0.00046524324,0.021101778,0.0019711165,0.0128048975,0.27279022],"study_design_scores_gemma":[0.00043379542,0.003584298,0.80224365,0.00038779757,0.00026057567,0.14796196,0.00039571064,0.00082895637,0.0046973187,0.0018337171,0.037316695,0.00005535894],"about_ca_topic_score_codex":0.0007691394,"about_ca_topic_score_gemma":0.00059158687,"teacher_disagreement_score":0.0044405838,"about_ca_system_score_codex":0.000556694,"about_ca_system_score_gemma":0.00038013107,"threshold_uncertainty_score":0.014855206},"labels":[],"label_agreement":null},{"id":"W2068621861","doi":"10.1191/1352458503ms890cr","title":"Clinical presentation of primary progressive multiple sclerosis 10 years after the incidental finding of typical magnetic resonance imaging brain lesions","year":2003,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Hospital and Health Sciences Centre; University of British Columbia Hospital","funders":"","keywords":"Magnetic resonance imaging; Medicine; Subclinical infection; Multiple sclerosis; Weakness; Neurological examination; Radiology; White matter; Pathology; Surgery","score_opus":0.11315162277365372,"score_gpt":0.3495906413341083,"score_spread":0.23643901856045457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068621861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791566,0.0027407657,0.0007324439,0.0016757934,0.0002466663,0.00014777055,0.00037356454,0.0001494799,0.014776941],"genre_scores_gemma":[0.9963003,0.00066155224,0.00021709684,0.0008178145,0.0003181381,0.000024677964,0.00024443492,0.0000086042155,0.0014074604],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.999718,0.000026269656,0.000026903806,0.00007920246,0.000045546345,0.00010399366],"domain_scores_gemma":[0.999062,0.00014305851,0.0002159398,0.000040640927,0.00010626786,0.00043216947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034667886,0.0011951643,0.0008222665,0.00084515364,0.0010280737,0.00070986693,0.00059902866,0.0035295112,0.0034518484],"category_scores_gemma":[0.001679235,0.0004309704,0.0004383898,0.00078106753,0.00092975027,0.0009834189,0.0007872623,0.0017891608,0.001302625],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004667727,0.00022053177,0.09033972,0.00009138744,0.0000371281,0.8989224,0.0005654577,0.00012331041,0.0035053224,0.0002495611,0.0016887027,0.003789619],"study_design_scores_gemma":[0.000077143595,0.0009988104,0.11173845,0.00006145082,0.000031707834,0.8844727,0.0001815952,0.00015261545,0.00042086953,0.00015491978,0.001682974,0.000026894668],"about_ca_topic_score_codex":0.0019372782,"about_ca_topic_score_gemma":0.0018849658,"teacher_disagreement_score":0.0035295112,"about_ca_system_score_codex":0.00072977174,"about_ca_system_score_gemma":0.00060021423,"threshold_uncertainty_score":0.011547625},"labels":[],"label_agreement":null},{"id":"W2069614919","doi":"10.1177/1352458508101877","title":"What does a structured review of the effectiveness of exercise interventions for persons with multiple sclerosis tell us about the challenges of designing trials?","year":2009,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"CINAHL; Medicine; Psychological intervention; Psychosocial; Physical therapy; MEDLINE; Randomized controlled trial; Medical prescription; Quality of life (healthcare); Exercise prescription; Meta-analysis; PsycINFO; Physical medicine and rehabilitation; Evidence-based medicine; Alternative medicine; Psychiatry; Internal medicine; Nursing","score_opus":0.30852877835541037,"score_gpt":0.40388154075467614,"score_spread":0.09535276239926577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069614919","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015674852,0.9591364,0.00500863,0.023827665,0.005206447,0.0035530564,0.0004901721,0.00007424279,0.0011359634],"genre_scores_gemma":[0.040449977,0.8678582,0.04790936,0.02488361,0.003931441,0.013778832,0.0005384125,0.0000901222,0.00056003605],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.68806267,0.18680848,0.09007002,0.006336157,0.027401477,0.0013212305],"domain_scores_gemma":[0.37860194,0.4953914,0.07080838,0.014357368,0.038709614,0.00213131],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.25690678,0.0020879414,0.021260684,0.011009043,0.001715863,0.010576829,0.0039498243,0.008070347,0.005214129],"category_scores_gemma":[0.6286772,0.0034425538,0.012225394,0.012419029,0.004013725,0.016528688,0.0030396872,0.004624842,0.0011922193],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069204776,0.00007973439,0.0011866529,0.85907966,0.0108419275,0.00010662011,0.0010500698,0.000326752,0.00055234955,0.003250003,0.008048642,0.11478547],"study_design_scores_gemma":[0.001773339,0.0006237526,0.0024971457,0.9286628,0.025336891,0.00024519887,0.00080329395,0.0003859624,0.00034356603,0.0073245554,0.031884495,0.00011912011],"about_ca_topic_score_codex":0.0040383693,"about_ca_topic_score_gemma":0.010531744,"teacher_disagreement_score":0.74309325,"about_ca_system_score_codex":0.008260476,"about_ca_system_score_gemma":0.032547407,"threshold_uncertainty_score":0.9163662},"labels":[],"label_agreement":null},{"id":"W2070532347","doi":"10.1177/1352458509106212","title":"Assessing disability progression with the Multiple Sclerosis Functional Composite","year":2009,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Marshall Space Flight Center; U.S. Food and Drug Administration; IC Design Education Center; Biogen","keywords":"Medicine; Multiple sclerosis; Natalizumab; Expanded Disability Status Scale; Tumor progression; Internal medicine; Immunology; Cancer","score_opus":0.15916972394199919,"score_gpt":0.3407200830062368,"score_spread":0.1815503590642376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070532347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9610629,0.005785477,0.008422641,0.00047206375,0.000095021394,0.0011194117,0.009016659,0.0003018668,0.013723998],"genre_scores_gemma":[0.9869091,0.0007003877,0.0066540637,0.00010409848,0.00006533616,0.0007291323,0.0037714795,0.000019038585,0.0010474384],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980782,0.0006621598,0.0002451085,0.0002056258,0.0006662377,0.00014255826],"domain_scores_gemma":[0.9946544,0.0011795366,0.0025157363,0.00018216946,0.001013589,0.00045461892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043815463,0.00068654097,0.0006070038,0.002692357,0.00035882674,0.00070181856,0.0005088535,0.00042149873,0.0021163689],"category_scores_gemma":[0.006489142,0.00010493951,0.0010267749,0.001244921,0.00031923098,0.0006225612,0.0009365638,0.00084871094,0.00037474488],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002849591,0.00042231503,0.9028496,0.0004275255,0.001169437,0.00009781206,0.00024491234,0.0026902424,0.000858303,0.00035805214,0.0042733294,0.083758734],"study_design_scores_gemma":[0.00020968051,0.001788882,0.9881926,0.00009893041,0.0003604243,0.0007581418,0.000092414804,0.0032452454,0.001072123,0.0005209596,0.0036159456,0.00004464283],"about_ca_topic_score_codex":0.0025936288,"about_ca_topic_score_gemma":0.0036132773,"teacher_disagreement_score":0.0043815463,"about_ca_system_score_codex":0.00077317376,"about_ca_system_score_gemma":0.00083174056,"threshold_uncertainty_score":0.02317214},"labels":[],"label_agreement":null},{"id":"W2071187169","doi":"10.1177/1352458509350307","title":"Disease progression among multiple sclerosis patients before and during a disease-modifying drug program: a longitudinal population-based evaluation","year":2009,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Dalhousie University","funders":"Research Nova Scotia; Canadian Institutes of Health Research; Dalhousie University; Health Research Board","keywords":"Medicine; Multiple sclerosis; Population; Disease; Expanded Disability Status Scale; Clinical trial; Randomized controlled trial; Physical therapy; Family medicine; Internal medicine; Psychiatry; Environmental health","score_opus":0.07698403910704203,"score_gpt":0.34697230562340625,"score_spread":0.2699882665163642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071187169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969658,0.0012912625,0.00014491066,0.00008530362,0.00001403409,0.0005542489,0.00058952416,0.000009465326,0.00034533703],"genre_scores_gemma":[0.99659556,0.00075376016,0.00054480805,0.000098008684,0.00004802781,0.0006806,0.0009941269,0.0000016647053,0.00028341828],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99578744,0.002685014,0.00035180125,0.00035188228,0.00051660393,0.00030716724],"domain_scores_gemma":[0.9917892,0.0019881716,0.0032003482,0.0006932029,0.0008653236,0.0014637228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007963196,0.0005837826,0.0012527412,0.0008052668,0.0010009335,0.00059109647,0.0006831562,0.0009970688,0.0010743702],"category_scores_gemma":[0.009507507,0.00040911892,0.0017072888,0.0010412312,0.00063672714,0.0005917724,0.0005569402,0.0008722151,0.00016593037],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.38554063,0.018762572,0.534055,0.0009848817,0.006556936,0.0001806568,0.0006871957,0.00086194027,0.0012669998,0.00014135623,0.0006872225,0.050274707],"study_design_scores_gemma":[0.050150234,0.1843705,0.75676894,0.00018438908,0.0054519707,0.00013227656,0.00023982085,0.00083149556,0.00068526436,0.00010032511,0.001035991,0.000048798636],"about_ca_topic_score_codex":0.022932522,"about_ca_topic_score_gemma":0.02823005,"teacher_disagreement_score":0.022932522,"about_ca_system_score_codex":0.0016703106,"about_ca_system_score_gemma":0.0031401494,"threshold_uncertainty_score":0.04559809},"labels":[],"label_agreement":null},{"id":"W2072924355","doi":"10.1177/1352458514546790","title":"Pregnancy and fetal outcomes following natalizumab exposure in pregnancy. A prospective, controlled observational study","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Natalizumab; Pregnancy; Medicine; Obstetrics; Miscarriage; Fetus; Premature birth; Prospective cohort study; Multiple sclerosis; Gynecology; Gestation; Internal medicine; Immunology; Biology","score_opus":0.09738529578808428,"score_gpt":0.3143172657045213,"score_spread":0.216931969916437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072924355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996218,0.0025137325,0.0002053383,0.00002669575,0.00001051493,0.00005688178,0.00070213206,0.0000033697208,0.000263238],"genre_scores_gemma":[0.99787164,0.0009686522,0.0001788069,0.000035674253,0.000015157406,0.000077210265,0.0007642005,0.000002159715,0.000086622604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997999,0.0008273231,0.00029410716,0.00043178437,0.00032635703,0.000121391306],"domain_scores_gemma":[0.9944676,0.0014597364,0.003126868,0.00044106905,0.0001974785,0.00030719634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021398703,0.00035688333,0.0006034284,0.0008630221,0.00038113017,0.00057037687,0.00044444943,0.00063430314,0.00085746427],"category_scores_gemma":[0.0056143585,0.00041363185,0.00095543603,0.0013791905,0.0003688869,0.00039511896,0.0003574622,0.0006398963,0.00010332948],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019927635,0.00011298152,0.99508375,0.00016652106,0.00063201104,0.000141141,0.00007098315,0.00003961103,0.00020760199,0.0000209619,0.000059612987,0.0014719774],"study_design_scores_gemma":[0.00018390718,0.0010552821,0.997253,0.000044685436,0.0005363393,0.00041630105,0.000082564846,0.0001324736,0.00007910126,0.000020992455,0.00018830379,0.000007020569],"about_ca_topic_score_codex":0.0036973683,"about_ca_topic_score_gemma":0.0027803206,"teacher_disagreement_score":0.0036973683,"about_ca_system_score_codex":0.0003354921,"about_ca_system_score_gemma":0.00042706233,"threshold_uncertainty_score":0.011316836},"labels":[],"label_agreement":null},{"id":"W2073107052","doi":"10.1177/1352458514523692","title":"Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in relapsing-remitting multiple sclerosis patients on high-dose interferon β","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Thrombotic thrombocytopenic purpura; Hemolytic anemia; Multiple sclerosis; Internal medicine; Pediatrics; Microangiopathic hemolytic anemia; Interferon beta-1a; Complication; Gastroenterology; Plasmapheresis; Immunology; Platelet; Interferon beta; Antibody","score_opus":0.05475181792089281,"score_gpt":0.23515836579819868,"score_spread":0.18040654787730587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073107052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987155,0.00024173604,0.000089792746,0.00008144874,0.000010347118,0.000016524953,0.000021480822,0.000005524745,0.00081756606],"genre_scores_gemma":[0.9995665,0.0001064456,0.00005143158,0.00006991873,0.000026194808,0.0000045479137,0.000024944513,0.0000016059,0.00014832319],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981743,0.000031424363,0.000029027327,0.00003520483,0.000027014059,0.0000598187],"domain_scores_gemma":[0.99958915,0.00009190238,0.00015037367,0.000027110984,0.00002840673,0.00011308888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016593798,0.00043936397,0.00036214202,0.0006645879,0.0013691331,0.00054076046,0.00020996034,0.00067289773,0.0012493083],"category_scores_gemma":[0.0010907125,0.00028093028,0.00032480477,0.00048054243,0.00047013193,0.00026983008,0.00038315755,0.00058399333,0.00017226955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046890386,0.00026261926,0.70018494,0.000041196457,0.0000513042,0.28839114,0.00095916993,0.000071348215,0.0032045303,0.00012274066,0.0002660995,0.005976013],"study_design_scores_gemma":[0.000065016364,0.0006818347,0.5310573,0.000023680595,0.00007014328,0.4655289,0.00075340905,0.00023341973,0.0007958857,0.0001240791,0.00064565585,0.00002062671],"about_ca_topic_score_codex":0.002062764,"about_ca_topic_score_gemma":0.0023684178,"teacher_disagreement_score":0.002062764,"about_ca_system_score_codex":0.0003297372,"about_ca_system_score_gemma":0.00035135302,"threshold_uncertainty_score":0.0041793585},"labels":[],"label_agreement":null},{"id":"W2074128816","doi":"10.1191/1352458503ms903oa","title":"Patient and community preferences for treatments and health states in multiple sclerosis","year":2003,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Respondent; Medicine; Quality of life (healthcare); Multiple sclerosis; Family medicine; Gerontology; Disease; Health economics; Community health; Demography; Public health; Psychiatry; Nursing; Internal medicine","score_opus":0.2846911395605672,"score_gpt":0.35104593332551415,"score_spread":0.06635479376494696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074128816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99908257,0.00016580058,0.00007148807,0.00016850955,0.0000021570836,0.000009349112,0.00004048648,0.0000011986918,0.000458372],"genre_scores_gemma":[0.9997334,0.000043215252,0.000088237415,0.000042205033,0.000002890157,0.000006900369,0.000032082,3.1513548e-7,0.000050727973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99723536,0.0020236417,0.00016670328,0.00008017809,0.0003220008,0.0001720946],"domain_scores_gemma":[0.9928237,0.0033811044,0.002579503,0.00012046275,0.0003742816,0.00072099693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029552728,0.0001846949,0.00022900592,0.0005862145,0.0004343617,0.00071623345,0.00012724247,0.00042178112,0.0030089968],"category_scores_gemma":[0.014646729,0.00009111465,0.00032659515,0.00043797775,0.0004862976,0.0007282725,0.0006445315,0.00048540675,0.00015894615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010233707,0.00036355018,0.9683534,0.0000904765,0.00025893378,0.00016190873,0.002897929,0.00054924993,0.0003279482,0.00021756615,0.00062394113,0.025131816],"study_design_scores_gemma":[0.00018545441,0.0025478129,0.9773695,0.00010785084,0.000118427815,0.0016043797,0.011196925,0.0034998772,0.00032793722,0.0010036869,0.001984094,0.000054107288],"about_ca_topic_score_codex":0.0011603909,"about_ca_topic_score_gemma":0.0020515497,"teacher_disagreement_score":0.0030089968,"about_ca_system_score_codex":0.00041694578,"about_ca_system_score_gemma":0.0002606321,"threshold_uncertainty_score":0.015629172},"labels":[],"label_agreement":null},{"id":"W2074733161","doi":"10.1177/135245850000600309","title":"Confabulation and multiple sclerosis: a rare association","year":2000,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Memory and Neural Mechanisms","field":"Neuroscience","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baycrest Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"Medical Research Council","keywords":"Confabulation (neural networks); Psychology; Amnesia; Multiple sclerosis; Neuroscience; Frontal lobe; Context (archaeology); Neuropsychology; Cognition; Episodic memory; Neuropsychological assessment; Cognitive psychology; Psychiatry","score_opus":0.17802218245320597,"score_gpt":0.26947723633001963,"score_spread":0.09145505387681366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074733161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824636,0.008539568,0.0011641427,0.0014773756,0.000116785515,0.00004895096,0.00010780231,0.00011653397,0.00596533],"genre_scores_gemma":[0.99740905,0.0013357541,0.00033255998,0.00017439501,0.0003892357,0.000016032755,0.00006625502,0.000010733744,0.0002659265],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99866664,0.00026146616,0.0002311049,0.00031056773,0.00022737554,0.00030289963],"domain_scores_gemma":[0.99232167,0.0026725603,0.0032563028,0.00050818315,0.00033767064,0.00090361334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061800564,0.0015873028,0.0011875243,0.0027188202,0.0021643343,0.0014721524,0.0012344022,0.004631331,0.0054104296],"category_scores_gemma":[0.0062299008,0.0007959805,0.0005577905,0.003006096,0.0024918162,0.0015340844,0.0017317291,0.0020604343,0.0010854417],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024429406,0.00014184398,0.1455972,0.00023398658,0.000095051255,0.8395873,0.0009657144,0.00020180253,0.0021301366,0.0009655413,0.0010892159,0.008747994],"study_design_scores_gemma":[0.0000109526745,0.00006241523,0.0152671095,0.00003033975,0.000027466305,0.98339635,0.00018248992,0.00011854852,0.00013923262,0.00033605951,0.00041696,0.000012097219],"about_ca_topic_score_codex":0.0010469496,"about_ca_topic_score_gemma":0.000918825,"teacher_disagreement_score":0.0054104296,"about_ca_system_score_codex":0.00047749825,"about_ca_system_score_gemma":0.0006753584,"threshold_uncertainty_score":0.018099725},"labels":[],"label_agreement":null},{"id":"W2075877026","doi":"10.1177/1352458513489853","title":"CRYAB modulates the activation of CD4 <sup>+</sup> T cells from relapsing–remitting multiple sclerosis patients","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Brain Institute; University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Multiple sclerosis; Cytokine; Medicine; Immunology; Encephalomyelitis; T cell; CD8; Immune system","score_opus":0.040508655124709185,"score_gpt":0.23478996158266616,"score_spread":0.19428130645795696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075877026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991345,0.00036650003,0.000073880925,0.000033155513,0.0000069924213,0.000011019912,0.0001037003,0.000009386136,0.00026087638],"genre_scores_gemma":[0.9986829,0.0002324342,0.00015554362,0.00008067689,0.000014882563,0.000029876112,0.00035048285,0.0000054497395,0.0004477666],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998561,0.00003271881,0.00001454007,0.000024795037,0.0000338813,0.000037933893],"domain_scores_gemma":[0.99984753,0.000018793437,0.000050667863,0.000009074273,0.000033005414,0.000040923678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014343072,0.00029163074,0.00035204773,0.00030972192,0.00022269202,0.00023246041,0.00012225256,0.00024389422,0.002341336],"category_scores_gemma":[0.00037378742,0.00013706744,0.00017739685,0.0001609391,0.00013290322,0.00011645402,0.00021721487,0.0004263566,0.0003934137],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028741146,0.00018486254,0.026135374,0.00019873562,0.000065616914,0.00063581206,0.00022922897,0.000092602924,0.96120805,0.000022873184,0.0003098287,0.008042828],"study_design_scores_gemma":[0.00038893672,0.0072570774,0.80651814,0.00006114905,0.00024594957,0.0054644677,0.0008115032,0.00087402173,0.173266,0.00016637289,0.0049153245,0.000031121093],"about_ca_topic_score_codex":0.0004074554,"about_ca_topic_score_gemma":0.00036241952,"teacher_disagreement_score":0.002341336,"about_ca_system_score_codex":0.00015948876,"about_ca_system_score_gemma":0.00011537282,"threshold_uncertainty_score":0.007832527},"labels":[],"label_agreement":null},{"id":"W2076224442","doi":"10.1177/1352458506070943","title":"Multiple sclerosis conference synopsis and discussion: cellular therapy for treatment of autoimmune diseases (October 2005)","year":2006,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; McGill University; Ottawa Hospital","funders":"","keywords":"Multiple sclerosis; Immunosuppression; Medicine; Clinical trial; Magnetic resonance imaging; Intensive care medicine; Medical physics; Pathology; Immunology; Radiology","score_opus":0.10857163179573183,"score_gpt":0.29567875969736734,"score_spread":0.18710712790163553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076224442","genre_codex":"editorial","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035178405,0.029468708,0.0004332906,0.38965812,0.5712414,0.00031624912,0.00030062321,0.00006590214,0.008163931],"genre_scores_gemma":[0.0029722613,0.020902093,0.00096662506,0.53195655,0.39208606,0.0005253996,0.00041396366,0.000095183226,0.050081797],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99670404,0.00076485524,0.00046662096,0.00038030234,0.0012702921,0.00041392242],"domain_scores_gemma":[0.989888,0.0029931832,0.0009196764,0.00021487217,0.0031799856,0.002804206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008162049,0.0027330313,0.0019217116,0.0019743736,0.0041808262,0.006655895,0.0033092569,0.026934572,0.013099739],"category_scores_gemma":[0.009912654,0.00078420807,0.002359949,0.0015559427,0.001600219,0.0034222,0.0029101644,0.024195302,0.0065126684],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060698734,0.000029508772,0.000067004374,0.0001949244,0.000007750891,0.00014842224,0.000032349017,0.000031981104,0.00015463866,0.0003538504,0.9937743,0.0051444876],"study_design_scores_gemma":[0.000047011385,0.00005842036,0.00060935126,0.0005312799,0.000018553623,0.00018098776,0.00011616336,0.000053154363,0.00013122312,0.0005196332,0.99771535,0.00001878275],"about_ca_topic_score_codex":0.00406272,"about_ca_topic_score_gemma":0.009095053,"teacher_disagreement_score":0.026934572,"about_ca_system_score_codex":0.0035208832,"about_ca_system_score_gemma":0.004693797,"threshold_uncertainty_score":0.043822944},"labels":[],"label_agreement":null},{"id":"W2079172650","doi":"10.1191/1352458504ms1083oa","title":"Multiple sclerosis gender issues: clinical practices of women neurologists","year":2004,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Teva Pharmaceutical Industries","keywords":"Medicine; Discontinuation; Breastfeeding; Multiple sclerosis; Glatiramer acetate; Pregnancy; Family medicine; Reproductive health; Disease; Obstetrics and gynaecology; Natalizumab; Pediatrics; Obstetrics; Psychiatry; Internal medicine; Population","score_opus":0.3547212749573583,"score_gpt":0.4156737202397511,"score_spread":0.0609524452823928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079172650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9646989,0.0072186897,0.00020275358,0.014354783,0.00013552906,0.00003902641,0.00017138313,0.00002519564,0.013153735],"genre_scores_gemma":[0.9860692,0.0072530364,0.00038579752,0.003314163,0.00009567257,0.00003867679,0.000068105655,0.000010817189,0.0027646315],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9981865,0.0009993641,0.00016019573,0.00013754322,0.0002668408,0.00024957],"domain_scores_gemma":[0.99481684,0.0017715963,0.0017781731,0.00009790124,0.00055826857,0.0009773356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016314386,0.00013155698,0.00027359303,0.00078789226,0.0015154248,0.0010674862,0.00030424353,0.0007930396,0.0028347273],"category_scores_gemma":[0.009179979,0.0002716429,0.00014073418,0.0008956651,0.0006514849,0.0008282859,0.0010549614,0.0004273672,0.00050623575],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020002048,0.00009969604,0.7789672,0.0004214246,0.0000374461,0.004500682,0.10897479,0.000047751313,0.001710143,0.00032985475,0.010396251,0.0943147],"study_design_scores_gemma":[0.000041356245,0.0005067056,0.5925942,0.0011961354,0.000045895955,0.014099802,0.330734,0.00016577305,0.0004686207,0.0003546878,0.059730954,0.000061761944],"about_ca_topic_score_codex":0.013250456,"about_ca_topic_score_gemma":0.02627843,"teacher_disagreement_score":0.013250456,"about_ca_system_score_codex":0.0008963447,"about_ca_system_score_gemma":0.0015813757,"threshold_uncertainty_score":0.026346684},"labels":[],"label_agreement":null},{"id":"W2080270161","doi":"10.1177/135245850100700606","title":"Baló's concentric sclerosis: surviving normal myelin in a patient with a relapsing-remitting clinical course","year":2001,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; Vancouver Hospital and Health Sciences Centre; University of British Columbia","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Multiple sclerosis; Myelin; Remyelination; Concentric; Lesion; Pathology; Pathogenesis; Medicine; Central nervous system; Immunology; Internal medicine","score_opus":0.11706648513721615,"score_gpt":0.3312075394348427,"score_spread":0.21414105429762656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080270161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99405956,0.0008861002,0.00041174414,0.0005821238,0.00006401289,0.000066151086,0.000036589776,0.000051136325,0.003842688],"genre_scores_gemma":[0.9985903,0.0002727408,0.00016083008,0.00029652414,0.000072513656,0.000009165234,0.000019023268,0.000007688757,0.0005711659],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99963915,0.000036778943,0.000031950683,0.00009038964,0.000067884714,0.00013378305],"domain_scores_gemma":[0.99912125,0.00014732295,0.00014369765,0.00006520349,0.00007749415,0.00044509614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036750108,0.0015716754,0.0010108987,0.0016875402,0.0029666177,0.000621365,0.00052057655,0.0021394417,0.0012725724],"category_scores_gemma":[0.0022362256,0.0008172577,0.00050253427,0.0012228104,0.0014274741,0.0010634875,0.0009121964,0.0014786756,0.0004198922],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003449116,0.00030229663,0.05201123,0.00007630089,0.000035284447,0.9356966,0.0020453741,0.00010998859,0.0051122624,0.0002958244,0.00035336663,0.0036165286],"study_design_scores_gemma":[0.00004866311,0.00063145085,0.06401906,0.000029634322,0.00005101056,0.93252254,0.0006587303,0.00027240693,0.0006816047,0.0002830807,0.0007650443,0.000036832604],"about_ca_topic_score_codex":0.0038339563,"about_ca_topic_score_gemma":0.0037635448,"teacher_disagreement_score":0.0038339563,"about_ca_system_score_codex":0.00061795965,"about_ca_system_score_gemma":0.000722887,"threshold_uncertainty_score":0.0076232553},"labels":[],"label_agreement":null},{"id":"W2080859771","doi":"10.1177/1352458513516528","title":"Metabolomic profiling in multiple sclerosis: insights into biomarkers and pathogenesis","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Metabolomics; Pathogenesis; Multiple sclerosis; Metabolite; Choline; Cerebrospinal fluid; Metabolome; Chemistry; Medicine; Internal medicine; Pathology; Biochemistry; Immunology; Chromatography","score_opus":0.09206724863939346,"score_gpt":0.28314625544626326,"score_spread":0.1910790068068698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080859771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97299135,0.01681081,0.008167233,0.00045420602,0.00001540988,0.00003688802,0.0006049762,0.000066188986,0.00085294334],"genre_scores_gemma":[0.98511434,0.0057013705,0.008543689,0.00008192227,0.000020906113,0.000019857716,0.0002283584,0.0000059094164,0.00028373086],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99986327,0.00005431901,0.000009918053,0.000030137051,0.000028811135,0.000013566381],"domain_scores_gemma":[0.99985015,0.00003951111,0.000049651182,0.000010900086,0.000027534394,0.000022226717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042680147,0.00036358472,0.00033557863,0.0013301634,0.00018544258,0.00044778382,0.0001188878,0.00032237472,0.00033498392],"category_scores_gemma":[0.00047601128,0.00010337029,0.00013482476,0.0009423816,0.00030322422,0.0003097187,0.0002474687,0.00026235086,0.000120665754],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012941848,0.00013887178,0.07514299,0.00046459658,0.00019159794,0.00042551017,0.00022837576,0.00090761983,0.8297842,0.0006190032,0.00028779267,0.09051523],"study_design_scores_gemma":[0.00004199258,0.0014895266,0.75661373,0.000120669436,0.00023960914,0.0029327625,0.0005724571,0.006543588,0.22102052,0.005491525,0.0048681777,0.000065426386],"about_ca_topic_score_codex":0.0006818261,"about_ca_topic_score_gemma":0.0010717016,"teacher_disagreement_score":0.0013301634,"about_ca_system_score_codex":0.00019399698,"about_ca_system_score_gemma":0.00027642158,"threshold_uncertainty_score":0.0022571683},"labels":[],"label_agreement":null},{"id":"W2084404808","doi":"10.1177/1352458509106779","title":"Glatiramer acetate in combination with minocycline in patients with relapsing—remitting multiple sclerosis: results of a Canadian, multicenter, double-blind, placebo-controlled trial","year":2009,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; University of British Columbia; Hôpital Notre-Dame; University of Alberta; University of Calgary","funders":"Teva Pharmaceutical Industries","keywords":"Glatiramer acetate; Minocycline; Medicine; Multiple sclerosis; Placebo; Natalizumab; Magnetic resonance imaging; Clinical endpoint; Internal medicine; Randomized controlled trial; Gastroenterology; Surgery; Pathology; Antibiotics; Radiology; Immunology; Chemistry","score_opus":0.09012657667490344,"score_gpt":0.289785313866564,"score_spread":0.19965873719166055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084404808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98381686,0.012049027,0.00021552031,0.0005438061,0.00030633452,0.0014274716,0.000390397,0.00006343656,0.0011872681],"genre_scores_gemma":[0.98965305,0.0059188926,0.0007634856,0.00061663246,0.0005054698,0.0009019709,0.00045111708,0.000011177564,0.0011782075],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991454,0.00039864038,0.00007538031,0.00012275312,0.00012705644,0.00013075577],"domain_scores_gemma":[0.9990109,0.0001823966,0.00024013844,0.00006276106,0.00013523242,0.00036856075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019844198,0.0012047052,0.0034560468,0.00037099476,0.00064264965,0.00085178186,0.00090648537,0.0016361495,0.0022589292],"category_scores_gemma":[0.0015900537,0.0005490007,0.0016015216,0.00057867274,0.0008894641,0.00059241516,0.00027538833,0.0019918925,0.00038921612],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95572233,0.006822895,0.0012385839,0.001060959,0.0015463162,0.00007692373,0.000095608855,0.00012455543,0.0056908424,0.000034616798,0.0004866737,0.02709981],"study_design_scores_gemma":[0.8888627,0.09652148,0.0116660865,0.000067055335,0.0012716526,0.00005885689,0.00003668842,0.00020848279,0.0005404678,0.000034086403,0.0007125913,0.000019743808],"about_ca_topic_score_codex":0.009860121,"about_ca_topic_score_gemma":0.020918405,"teacher_disagreement_score":0.9901399,"about_ca_system_score_codex":0.0013165678,"about_ca_system_score_gemma":0.0023108171,"threshold_uncertainty_score":0.019605458},"labels":[],"label_agreement":null},{"id":"W2086164539","doi":"10.1177/1352458514564492","title":"Twin studies in multiple sclerosis: A meta-estimation of heritability and environmentality","year":2015,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Heritability; Confidence interval; Meta-analysis; Twin study; Demography; Population; Medicine; Polychoric correlation; Environmental health; Biology; Genetics; Internal medicine; Mathematics","score_opus":0.6045651878235708,"score_gpt":0.42972281535086937,"score_spread":0.17484237247270146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086164539","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09482176,0.8681024,0.031906832,0.0014732657,0.0006843525,0.0003767153,0.0013248553,0.00020771752,0.0011020689],"genre_scores_gemma":[0.85731065,0.1189987,0.020819101,0.0005455577,0.0003461272,0.0005397278,0.0011151381,0.00011622386,0.00020878001],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9454369,0.042289376,0.0049879826,0.0042012795,0.002640173,0.00044431887],"domain_scores_gemma":[0.8883081,0.0881096,0.009335606,0.010208344,0.0032688437,0.0007695348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.060879596,0.0023739755,0.010040386,0.010134214,0.001009159,0.0045762984,0.0020853232,0.00214251,0.0015499591],"category_scores_gemma":[0.11182277,0.001989899,0.030082677,0.010754722,0.0011965169,0.0020970202,0.0023196938,0.0024227295,0.00017502715],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018638854,0.000033457563,0.12161212,0.013045859,0.83917546,0.00036263716,0.00024645712,0.0042737555,0.0005007842,0.0009614267,0.0007699699,0.017154101],"study_design_scores_gemma":[0.0005131595,0.00024863833,0.04804357,0.0047104987,0.93545777,0.00062138744,0.00014900859,0.004523336,0.0004053271,0.0037167552,0.0015612511,0.000049278322],"about_ca_topic_score_codex":0.0037890591,"about_ca_topic_score_gemma":0.0044009653,"teacher_disagreement_score":0.060879596,"about_ca_system_score_codex":0.0015820534,"about_ca_system_score_gemma":0.0016710717,"threshold_uncertainty_score":0.32196593},"labels":[],"label_agreement":null},{"id":"W2086900658","doi":"10.1177/1352458515569098","title":"Sample-size calculations for short-term proof-of-concept studies of tissue protection and repair in multiple sclerosis lesions via conventional clinical imaging","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health; Myelin Repair Foundation","keywords":"Sample size determination; Lesion; Multiple sclerosis; Medicine; Magnetic resonance imaging; Clinical trial; Nuclear medicine; Percentile; Radiology; Statistics; Mathematics; Pathology","score_opus":0.41396155585310357,"score_gpt":0.42495341242445117,"score_spread":0.010991856571347602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086900658","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09073644,0.007795641,0.8072326,0.0019865134,0.0026444593,0.072440155,0.006194144,0.0014978497,0.009472255],"genre_scores_gemma":[0.37335303,0.0009450637,0.48282492,0.0017177552,0.00030152535,0.13582277,0.0021732673,0.00036691796,0.0024947957],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.8749858,0.09796385,0.007894974,0.00423446,0.01410487,0.00081607694],"domain_scores_gemma":[0.7458684,0.21949008,0.009882563,0.013872668,0.00997125,0.0009150774],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.18654601,0.0015609241,0.0022519748,0.0020590199,0.0008169268,0.0013222805,0.002063144,0.003360361,0.005863248],"category_scores_gemma":[0.30141506,0.0008002002,0.0033524765,0.001180223,0.0014418439,0.001802171,0.001959714,0.0025067683,0.0012602288],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09756062,0.004216988,0.07150135,0.014132755,0.013322614,0.001475685,0.0026143913,0.050582916,0.051903367,0.038274936,0.049100056,0.6053143],"study_design_scores_gemma":[0.0351129,0.1235501,0.11992159,0.005591817,0.016597819,0.0027829434,0.0012123733,0.24954367,0.1282304,0.068653904,0.24801308,0.0007894783],"about_ca_topic_score_codex":0.00037205557,"about_ca_topic_score_gemma":0.0004479258,"teacher_disagreement_score":0.813454,"about_ca_system_score_codex":0.00084225944,"about_ca_system_score_gemma":0.0012583038,"threshold_uncertainty_score":0.9865614},"labels":[],"label_agreement":null},{"id":"W2087661946","doi":"10.1191/1352458503ms924oa","title":"The amount of sonic hedgehog in multiple sclerosis white matter is decreased and cleavage to the signaling peptide is deficient","year":2003,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Sonic hedgehog; Myelin basic protein; Myelin; White matter; Oligodendrocyte; Cleavage (geology); Western blot; Myelin-associated glycoprotein; Hedgehog signaling pathway; Biology; Molecular biology; Chemistry; Cell biology; Signal transduction; Biochemistry; Central nervous system; Endocrinology; Medicine; Gene; Magnetic resonance imaging","score_opus":0.05075290348435549,"score_gpt":0.2361219612946219,"score_spread":0.1853690578102664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087661946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99744886,0.0012016832,0.00072858465,0.000039759852,0.000009896048,0.0000053629497,0.00013770556,0.000033652675,0.00039445685],"genre_scores_gemma":[0.99410546,0.0012314895,0.0015051431,0.00003387444,0.0000125249535,0.000015854572,0.0007647656,0.000024006056,0.0023068273],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99984384,0.000017637352,0.000024674808,0.000031400927,0.00005578661,0.000026590898],"domain_scores_gemma":[0.99985015,0.000013630072,0.00004788917,0.000014380624,0.000025245376,0.000048643178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014559938,0.00043061582,0.0002681099,0.0006602187,0.00020786704,0.00031684444,0.00012992634,0.00027493393,0.0010254019],"category_scores_gemma":[0.00013106954,0.00024636928,0.00019525237,0.00021792704,0.0003081494,0.00020539608,0.00018842123,0.00033704308,0.00047994277],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008974954,0.0000099821145,0.0003191072,0.000021502883,0.00000865091,0.00008077309,0.000020190671,0.000008633356,0.99880254,0.000043438966,0.000014020004,0.00058141904],"study_design_scores_gemma":[0.000019612447,0.0003715191,0.019960957,0.000010655986,0.000059970494,0.0020175155,0.0000792155,0.0002968742,0.97419095,0.00019913464,0.002787451,0.0000061668475],"about_ca_topic_score_codex":0.0004649021,"about_ca_topic_score_gemma":0.00051145436,"teacher_disagreement_score":0.0010254019,"about_ca_system_score_codex":0.00018514751,"about_ca_system_score_gemma":0.00015305921,"threshold_uncertainty_score":0.003430307},"labels":[],"label_agreement":null},{"id":"W2089500985","doi":"10.1177/1352458513477228","title":"Cerebral white matter blood flow and energy metabolism in multiple sclerosis","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Phosphocreatine; White matter; Cerebral blood flow; Creatine; Medicine; Multiple sclerosis; In vivo magnetic resonance spectroscopy; Pathology; Magnetic resonance imaging; Energy metabolism; Internal medicine; Radiology","score_opus":0.06410469857743946,"score_gpt":0.2504889488079194,"score_spread":0.18638425023047994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089500985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989459,0.0006509765,0.0000863637,0.00002554002,0.0000018140151,0.0000064709916,0.000058688653,0.000008081307,0.00021623308],"genre_scores_gemma":[0.9995034,0.00017753632,0.00014433835,0.000010874816,0.00000717225,0.000006236073,0.000067219786,0.0000016748651,0.00008150522],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999571,0.000010097685,0.0000040091495,0.000011527695,0.000010299584,0.0000069528355],"domain_scores_gemma":[0.9997422,0.000062006526,0.00011706027,0.0000073710407,0.000031737953,0.00003967721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021767555,0.0002903136,0.00019431688,0.0007302886,0.00016185833,0.00019908269,0.00012525257,0.00026323658,0.0014022145],"category_scores_gemma":[0.0006457951,0.00011841002,0.000080077465,0.0003241335,0.0002754033,0.00016684836,0.00011319562,0.0001800007,0.00014772826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00428898,0.00033230873,0.91034853,0.00021547296,0.00028016805,0.0016016142,0.00037061766,0.00051605445,0.05564539,0.00008296946,0.0003402424,0.025977697],"study_design_scores_gemma":[0.000020320309,0.00019159574,0.99770963,0.0000049794303,0.000024761923,0.00062709046,0.000030131188,0.0001596963,0.0010908897,0.00006162234,0.000076854754,0.0000024340657],"about_ca_topic_score_codex":0.0029959339,"about_ca_topic_score_gemma":0.0022082028,"teacher_disagreement_score":0.0029959339,"about_ca_system_score_codex":0.0002702402,"about_ca_system_score_gemma":0.00016796043,"threshold_uncertainty_score":0.0059570074},"labels":[],"label_agreement":null},{"id":"W2090193300","doi":"10.1177/1352458512437814","title":"Rising prevalence of vascular comorbidities in multiple sclerosis: validation of administrative definitions for diabetes, hypertension, and hyperlipidemia","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of British Columbia; University of Calgary; McGill University; University of Manitoba; Alberta Health; University of Alberta","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society","keywords":"Hyperlipidemia; Medicine; Diabetes mellitus; Comorbidity; Internal medicine; Population; Cohort; Pediatrics; Endocrinology; Environmental health","score_opus":0.33710085680590995,"score_gpt":0.33253995338960335,"score_spread":0.004560903416306605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090193300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922083,0.0009533263,0.003402712,0.00030180012,0.00002911897,0.00013208306,0.001152737,0.000047169382,0.0017727496],"genre_scores_gemma":[0.9957846,0.00018104263,0.0029838341,0.00007929861,0.000020605217,0.000037262726,0.0008521868,0.000004672418,0.00005646355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98608774,0.0058614174,0.0020452414,0.0011783295,0.0044001103,0.00042708058],"domain_scores_gemma":[0.9375071,0.0156186875,0.02444776,0.0064926143,0.014775467,0.001158386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022429151,0.00030924185,0.00043876586,0.001989935,0.0005752235,0.0012654653,0.0012810011,0.00040285278,0.00037998197],"category_scores_gemma":[0.06318944,0.0002756526,0.00063559395,0.002207291,0.000638385,0.0005623748,0.0014821098,0.0009619614,0.00014059174],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004433786,0.000015508667,0.99624735,0.000036539426,0.000044466084,0.0000137090565,0.0001457093,0.000090389214,0.00021043558,0.000028212711,0.000098847166,0.0030244624],"study_design_scores_gemma":[0.0000048180273,0.000024600675,0.9990307,0.00002368682,0.000021266529,0.00008609676,0.0000696464,0.00037600484,0.0002056594,0.000030064095,0.0001244825,0.0000030246235],"about_ca_topic_score_codex":0.037284974,"about_ca_topic_score_gemma":0.040185124,"teacher_disagreement_score":0.037284974,"about_ca_system_score_codex":0.0015229167,"about_ca_system_score_gemma":0.0020569174,"threshold_uncertainty_score":0.11861813},"labels":[],"label_agreement":null},{"id":"W2090719688","doi":"10.1177/1352458511402113","title":"The impact of intensity variations in T1-hypointense lesions on clinical correlations in multiple sclerosis","year":2011,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Multiple sclerosis; Expanded Disability Status Scale; Correlation; Intensity (physics); Voxel; White matter; Lesion; Medicine; Nuclear medicine; Magnetic resonance imaging; Mathematics; Physics; Pathology; Radiology; Geometry; Optics","score_opus":0.39528812407272684,"score_gpt":0.38758149495390276,"score_spread":0.007706629118824082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090719688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979656,0.00038415726,0.001173988,0.000033104345,0.000004458589,0.000011663898,0.000032936565,0.000015220644,0.00037908126],"genre_scores_gemma":[0.99872476,0.000045832952,0.0011290399,0.000008828759,0.000011497545,0.0000062211807,0.00003716284,0.000006944704,0.000029599965],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99759966,0.0013930388,0.00016395327,0.0002746059,0.00048500538,0.000083697785],"domain_scores_gemma":[0.97725666,0.016472036,0.0037207974,0.0009783022,0.0011740981,0.00039812957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045236964,0.00043184945,0.00032277114,0.0010907619,0.00027860864,0.0006917686,0.00031659383,0.00034536445,0.0009933709],"category_scores_gemma":[0.025326239,0.00019466032,0.00025280472,0.00064415566,0.0009225295,0.0005779174,0.00059431477,0.00035596898,0.0002344517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001336188,0.000092313814,0.947302,0.00008592112,0.0003329693,0.0002064806,0.0002938218,0.0028174967,0.008081769,0.00010572411,0.0002208731,0.039124444],"study_design_scores_gemma":[0.00002512709,0.00041360778,0.9919836,0.000009420036,0.00009202133,0.0007385196,0.00006448535,0.0030220235,0.003239727,0.0002458324,0.00015031506,0.000015420823],"about_ca_topic_score_codex":0.0004997563,"about_ca_topic_score_gemma":0.00079334574,"teacher_disagreement_score":0.0045236964,"about_ca_system_score_codex":0.00020937622,"about_ca_system_score_gemma":0.00020793026,"threshold_uncertainty_score":0.023923874},"labels":[],"label_agreement":null},{"id":"W2093444580","doi":"10.1177/1352458509348418","title":"Paediatric and adult multiple sclerosis: age-related differences and time course of the neuroimmunological response in cerebrospinal fluid","year":2009,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"","keywords":"Cerebrospinal fluid; Multiple sclerosis; Medicine; Intrathecal; Pathophysiology; Antibody; Rubella; Internal medicine; Measles; Albumin; Immunology; Anesthesia","score_opus":0.059234836418149736,"score_gpt":0.2686212757729252,"score_spread":0.20938643935477547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093444580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99835926,0.00097204535,0.00013509007,0.00001853469,0.0000056261447,0.000006575805,0.00020828913,0.000007117372,0.0002875407],"genre_scores_gemma":[0.9986608,0.00046323906,0.0002254557,0.00002779278,0.000018697076,0.000017713213,0.00045904116,0.000003339858,0.00012387494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99961543,0.000099426536,0.00004590512,0.00009963117,0.000074213574,0.00006531754],"domain_scores_gemma":[0.99777824,0.00046621595,0.0012302604,0.00008057091,0.00022323275,0.00022149301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005444818,0.00025272614,0.00035778678,0.000886466,0.00016560446,0.00030226915,0.00013336087,0.0003629629,0.00090912957],"category_scores_gemma":[0.0033739016,0.00010621677,0.00018493387,0.00083464594,0.00025974054,0.00038774457,0.00029291728,0.000288944,0.0002877026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009807122,0.00006851585,0.98255897,0.000061546496,0.000050078248,0.0005646271,0.0003242087,0.00012833376,0.0026826975,0.00003899577,0.00014504047,0.012396258],"study_design_scores_gemma":[0.000004905615,0.00033301488,0.99779946,0.000005528243,0.00001250711,0.0011623511,0.000088695,0.00006651734,0.0002413361,0.0000220821,0.00026095126,0.0000025679144],"about_ca_topic_score_codex":0.0008256146,"about_ca_topic_score_gemma":0.00052580505,"teacher_disagreement_score":0.00090912957,"about_ca_system_score_codex":0.0001854944,"about_ca_system_score_gemma":0.00015518392,"threshold_uncertainty_score":0.003041327},"labels":[],"label_agreement":null},{"id":"W2095210906","doi":"10.1177/1352458513500551","title":"Temporal profile of lymphocyte counts and relationship with infections with fingolimod therapy","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":134,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Acorda Therapeutics; Novartis Pharmaceuticals Corporation; Novartis","keywords":"Fingolimod; Lymphocyte; Medicine; Discontinuation; Multiple sclerosis; Placebo; Internal medicine; Immunology; Peripheral blood lymphocyte; Pathology","score_opus":0.03061297707406864,"score_gpt":0.21565698090269395,"score_spread":0.1850440038286253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095210906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99262756,0.0025092738,0.0010111246,0.00007010016,0.000011331182,0.000078613426,0.000616715,0.00004167259,0.003033536],"genre_scores_gemma":[0.9981981,0.00033570002,0.00029899296,0.000039411872,0.00002138901,0.0000481666,0.00051658734,0.0000072839653,0.0005343633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99931145,0.00017938865,0.000057642425,0.00013003183,0.00021498572,0.00010643884],"domain_scores_gemma":[0.99682295,0.00097107684,0.001324975,0.0001401184,0.0005264369,0.00021451928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010821961,0.00017230849,0.00035852636,0.00056857127,0.00018810118,0.00053352525,0.00019644752,0.00033869973,0.0017388833],"category_scores_gemma":[0.00428923,0.00013602167,0.00019077514,0.00057833147,0.00019138386,0.00035937192,0.00025269747,0.00076026947,0.00042745273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016852977,0.0005449476,0.81304634,0.00022153642,0.00025788654,0.0007654331,0.000659436,0.0014349599,0.06486746,0.00039009715,0.0010093288,0.0999495],"study_design_scores_gemma":[0.00006433295,0.0029451568,0.977207,0.000026626374,0.000108632754,0.0014578408,0.0001741096,0.0011361524,0.014288756,0.00022725853,0.002340392,0.000023608116],"about_ca_topic_score_codex":0.000517196,"about_ca_topic_score_gemma":0.00052460685,"teacher_disagreement_score":0.0017388833,"about_ca_system_score_codex":0.00032762054,"about_ca_system_score_gemma":0.00022770002,"threshold_uncertainty_score":0.0058171153},"labels":[],"label_agreement":null},{"id":"W2095979340","doi":"10.1191/1352458505ms1223oa","title":"Suppression of acute experimental allergic encephalomyelitis with a small molecule inhibitor of α4 integrin","year":2005,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Encephalomyelitis; Multiple sclerosis; Inflammation; Pathology; Immunology","score_opus":0.06559445643393817,"score_gpt":0.2965430409808947,"score_spread":0.2309485845469565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095979340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967452,0.0017388748,0.00046130622,0.000077822784,0.000027890932,0.00005183794,0.00006675347,0.00003605849,0.00079418614],"genre_scores_gemma":[0.9941788,0.0026072331,0.0010235732,0.000071779745,0.000045004846,0.000072225535,0.0002607319,0.0000069537714,0.0017336981],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999398,0.00001331112,0.000005840631,0.0000071182053,0.000013262133,0.00002071347],"domain_scores_gemma":[0.9999149,0.000015744905,0.00002395382,0.000008085667,0.000010783333,0.000026634896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016035564,0.0003750174,0.00035157835,0.00016390624,0.00010763206,0.00014117033,0.00018559399,0.00023780277,0.0011600765],"category_scores_gemma":[0.000115102055,0.00007740291,0.00015185078,0.00009686966,0.00021378929,0.0001339332,0.00005637356,0.00047477664,0.000292101],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013828967,0.0006994458,0.00028043744,0.000112359834,0.0000127294325,0.00011256275,0.000012879679,0.00009347536,0.9916971,0.0000472678,0.00010060216,0.0054481905],"study_design_scores_gemma":[0.0012899372,0.03308938,0.010173602,0.000044832246,0.0000992581,0.00094705384,0.000037616075,0.0010819378,0.9504049,0.00006364179,0.0027602308,0.0000075922335],"about_ca_topic_score_codex":0.0002452413,"about_ca_topic_score_gemma":0.00046565675,"teacher_disagreement_score":0.0011600765,"about_ca_system_score_codex":0.00012390653,"about_ca_system_score_gemma":0.00018269868,"threshold_uncertainty_score":0.0038808584},"labels":[],"label_agreement":null},{"id":"W2096555658","doi":"10.1177/1352458508089226","title":"Contribution of incidence to increasing prevalence of multiple sclerosis in Alberta, Canada","year":2008,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health; University of Calgary; University of Alberta","funders":"","keywords":"Incidence (geometry); Demography; Multiple sclerosis; Medicine; Population; Prevalence; Epidemiology; McDonald criteria; Environmental health; Internal medicine; Immunology","score_opus":0.07548102177299536,"score_gpt":0.2823439619819707,"score_spread":0.20686294020897533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096555658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96288323,0.009226186,0.00047713806,0.0027439417,0.000117748736,0.00006996197,0.008330734,0.00009747592,0.016053578],"genre_scores_gemma":[0.99332535,0.0026805575,0.00036277887,0.00017918466,0.000041135507,0.00001049416,0.0019043244,0.000010140973,0.0014860122],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986104,0.00011166638,0.00007133465,0.00010988547,0.0007239965,0.000372656],"domain_scores_gemma":[0.99642986,0.00022407484,0.000627501,0.00008109434,0.0020896224,0.00054784876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000745105,0.00025695254,0.00035627215,0.0034893502,0.00097001996,0.0010418623,0.0011786715,0.00034168537,0.0018372684],"category_scores_gemma":[0.004750283,0.00028539848,0.00045174794,0.0046109813,0.0004552699,0.0002984469,0.0006159463,0.0007707999,0.00014176521],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007022034,0.00001621618,0.9833825,0.000050669736,0.000053837186,0.00017588727,0.000191903,0.000303407,0.0001415467,0.00011895693,0.002336766,0.013158069],"study_design_scores_gemma":[0.000003689546,0.0000076284564,0.9983646,0.000029183468,0.000031094925,0.00011398212,0.00022658239,0.0003064183,0.000032527587,0.000028547862,0.00085076725,0.000004979716],"about_ca_topic_score_codex":0.9921617,"about_ca_topic_score_gemma":0.99269295,"teacher_disagreement_score":0.021204636,"about_ca_system_score_codex":0.021204636,"about_ca_system_score_gemma":0.021941623,"threshold_uncertainty_score":0.15385109},"labels":[],"label_agreement":null},{"id":"W2099462160","doi":"10.1177/1352458507085759","title":"Glatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosis","year":2008,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NeuroRx Research (Canada); University of Ottawa; Montreal Neurological Institute and Hospital","funders":"","keywords":"Glatiramer acetate; Mitoxantrone; Medicine; Multiple sclerosis; Expanded Disability Status Scale; Adverse effect; Magnetic resonance imaging; Internal medicine; Confidence interval; Gastroenterology; Surgery; Nuclear medicine; Chemotherapy; Radiology; Immunology","score_opus":0.14905469875367341,"score_gpt":0.2854956197840501,"score_spread":0.13644092103037667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099462160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970477,0.0022618643,0.00013034046,0.00007213175,0.0000356501,0.00016091709,0.000058441372,0.000026092941,0.00020687557],"genre_scores_gemma":[0.996842,0.0016916422,0.00040855413,0.00015374986,0.0000929476,0.00024694222,0.00021537553,0.000004007297,0.00034489148],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99952686,0.0002560851,0.00003844195,0.000052814205,0.000050042217,0.00007569233],"domain_scores_gemma":[0.999551,0.00013940489,0.00013464878,0.000043470773,0.000009766229,0.000121661964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009011097,0.00043869935,0.0019290459,0.00030407126,0.00015848865,0.00027762543,0.00046631633,0.00067301956,0.0010582766],"category_scores_gemma":[0.0011648856,0.0002191136,0.00063387956,0.00034686827,0.0005425603,0.0003196799,0.00027312862,0.000958232,0.00027934593],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7025988,0.014413541,0.012565753,0.0006216027,0.0009904766,0.00039250866,0.00014416856,0.0016916109,0.028965993,0.00013303892,0.0007438667,0.23673859],"study_design_scores_gemma":[0.1972545,0.7221579,0.06938185,0.000096068434,0.00072723156,0.0005544159,0.000058947542,0.0013605283,0.0064564594,0.00021696377,0.0017065165,0.000028582861],"about_ca_topic_score_codex":0.00036800312,"about_ca_topic_score_gemma":0.00071267993,"teacher_disagreement_score":0.0019290459,"about_ca_system_score_codex":0.00031380545,"about_ca_system_score_gemma":0.00028902694,"threshold_uncertainty_score":0.00476557},"labels":[],"label_agreement":null},{"id":"W2100170145","doi":"10.1177/1352458508096680","title":"High frequency of adverse health behaviors in multiple sclerosis","year":2008,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","keywords":"Medicine; Overweight; Population; Obesity; Logistic regression; Behavioral Risk Factor Surveillance System; Environmental health; Socioeconomic status; Public health; Gerontology; Demography; Internal medicine; Pathology","score_opus":0.17167442542039996,"score_gpt":0.31765505104145536,"score_spread":0.1459806256210554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100170145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980692,0.0005419836,0.000062650615,0.00014256813,0.0000065054096,0.000008445363,0.00040092395,0.000007175653,0.0007604605],"genre_scores_gemma":[0.9993704,0.0002030821,0.00008566574,0.00003536689,0.00001597509,0.0000064599517,0.00019643451,0.0000011599631,0.00008553986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994097,0.00017143115,0.00008934307,0.00009446819,0.00016454486,0.00007052939],"domain_scores_gemma":[0.99670166,0.0004971133,0.0022174886,0.00008455702,0.00020614374,0.00029308852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052921864,0.00017427043,0.00029514503,0.00074954145,0.00038396963,0.00041065828,0.00016656508,0.00030310775,0.0022822602],"category_scores_gemma":[0.002582616,0.00014468555,0.00026692008,0.0010822002,0.00021211963,0.00026415498,0.0004479734,0.00054772536,0.00021138614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024450974,0.000016580054,0.9982628,0.000015202775,0.000021813741,0.000030868745,0.000024068362,0.000018801466,0.00005806334,0.0000033145436,0.0000565424,0.0014675042],"study_design_scores_gemma":[0.0000012270015,0.000025670168,0.99958616,0.000006587617,0.000010601717,0.00020003648,0.000036136964,0.000040132672,0.000020480727,0.000011355242,0.000060484097,0.0000011402007],"about_ca_topic_score_codex":0.002254124,"about_ca_topic_score_gemma":0.00355842,"teacher_disagreement_score":0.0022822602,"about_ca_system_score_codex":0.00023427472,"about_ca_system_score_gemma":0.00025259872,"threshold_uncertainty_score":0.0076349378},"labels":[],"label_agreement":null},{"id":"W2102179492","doi":"10.1177/1352458506070319","title":"The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study","year":2007,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Multiple sclerosis; Minocycline; Immune system; Medicine; Neuroscience; Immunology; Psychology; Biology; Antibiotics; Microbiology","score_opus":0.2900977318572744,"score_gpt":0.3943405373314306,"score_spread":0.10424280547415621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102179492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99862266,0.00058952055,0.000090071015,0.00003792578,0.00002649265,0.00021510138,0.000050218536,0.000008343424,0.00035964415],"genre_scores_gemma":[0.9987332,0.0003328605,0.00012823289,0.000047813053,0.000090162204,0.00014865732,0.00009250214,0.0000038011435,0.00042277586],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995596,0.00016919628,0.000048325575,0.00006177276,0.00006659962,0.000094501],"domain_scores_gemma":[0.9992003,0.00017231764,0.00016881687,0.00009684026,0.00007587325,0.0002858728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009865782,0.0005663993,0.0013251164,0.00027741428,0.00034160918,0.00040765395,0.00035210882,0.0006728781,0.002011322],"category_scores_gemma":[0.0008916775,0.00017422608,0.0006819382,0.0002091669,0.00059822615,0.00040570644,0.00024628005,0.0010778912,0.00037214442],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42648658,0.12562275,0.029293217,0.0008659642,0.0007402155,0.0022065437,0.0006865711,0.00048535396,0.30550483,0.000090951944,0.00063086156,0.10738614],"study_design_scores_gemma":[0.013632424,0.89298487,0.07715146,0.000018937968,0.00028594318,0.00078762457,0.00012392993,0.00034966864,0.013311208,0.00005288146,0.0012801538,0.000020764961],"about_ca_topic_score_codex":0.00033638085,"about_ca_topic_score_gemma":0.00040417525,"teacher_disagreement_score":0.002011322,"about_ca_system_score_codex":0.00022899131,"about_ca_system_score_gemma":0.00040751172,"threshold_uncertainty_score":0.0067285895},"labels":[],"label_agreement":null},{"id":"W2102473502","doi":"10.1177/1352458512444661","title":"Evaluation of the 2010 McDonald multiple sclerosis criteria in children with a clinically isolated syndrome","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Multiple sclerosis; Clinically isolated syndrome; McDonald criteria; Medicine; Physical medicine and rehabilitation; Pediatrics; Psychology; Physical therapy; Psychiatry","score_opus":0.1794129889964637,"score_gpt":0.349014254819803,"score_spread":0.16960126582333931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102473502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977822,0.0009079343,0.00012672262,0.00007887665,0.00000982155,0.000027302487,0.00023710761,0.00000500255,0.00082494586],"genre_scores_gemma":[0.9988715,0.00032264017,0.00041935165,0.000027819144,0.0000118412345,0.000027155878,0.00024722467,0.000003515916,0.000068989226],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988789,0.00029771763,0.00022481717,0.00013990108,0.00031877848,0.00013990908],"domain_scores_gemma":[0.9941116,0.0015687182,0.002824622,0.00011460411,0.00085122656,0.0005291842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017419262,0.00043325013,0.00044375137,0.0019122788,0.0004527345,0.00044127333,0.00036450734,0.00056283834,0.001595792],"category_scores_gemma":[0.007573197,0.00020007603,0.00025255463,0.0008560426,0.0006572539,0.0006163806,0.00040288598,0.0004552482,0.00022139888],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000095820964,0.000009747572,0.99611557,0.000045066558,0.000019972718,0.0011811797,0.00019885568,0.000047801932,0.0003098731,0.000027711712,0.00023652855,0.0017118016],"study_design_scores_gemma":[0.00002209107,0.00020215022,0.9789883,0.0001070428,0.000050063893,0.018646596,0.00052269467,0.00018807966,0.0004791583,0.000030187452,0.0007530142,0.000010601767],"about_ca_topic_score_codex":0.005698635,"about_ca_topic_score_gemma":0.006950552,"teacher_disagreement_score":0.005698635,"about_ca_system_score_codex":0.00069478864,"about_ca_system_score_gemma":0.0009441224,"threshold_uncertainty_score":0.011330903},"labels":[],"label_agreement":null},{"id":"W2102575453","doi":"10.1177/1352458513486519","title":"2010 McDonald criteria in a pediatric cohort: is positivity at onset associated with a more aggressive multiple sclerosis course?","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Multiple sclerosis; Medicine; McDonald criteria; Cohort; Expanded Disability Status Scale; Clinically isolated syndrome; Pediatrics; Magnetic resonance imaging; Internal medicine; Psychiatry; Radiology","score_opus":0.0705414655702983,"score_gpt":0.29780099153340955,"score_spread":0.22725952596311125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102575453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99950314,0.00014453997,0.00003060736,0.00003156497,0.000003287464,0.0000032936903,0.00009522582,0.0000017953037,0.00018646105],"genre_scores_gemma":[0.99934727,0.00020857759,0.00008964063,0.000028917051,0.000016416585,0.0000065191284,0.00022983283,0.0000043114946,0.00006844761],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99953306,0.00009829626,0.00004612104,0.00012095271,0.000110306864,0.00009127622],"domain_scores_gemma":[0.996765,0.00036802425,0.001976757,0.00010379294,0.00025447697,0.0005318409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065902836,0.00033406133,0.00048876036,0.00079143315,0.00051259174,0.0007937427,0.00033725813,0.0005164522,0.0016053452],"category_scores_gemma":[0.0033660044,0.0002847345,0.0003878002,0.0009765141,0.0004264332,0.0008132477,0.00039523293,0.0006225636,0.00030598682],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054393324,0.000013625813,0.99888307,0.000003977541,0.000010694289,0.00026968884,0.000053671356,0.000009980387,0.00015059972,0.000011108451,0.00005229768,0.00048694244],"study_design_scores_gemma":[0.0000070764495,0.00016162965,0.9955114,0.000008780041,0.000025281079,0.003620419,0.0003372251,0.00007806856,0.00007151018,0.000023487288,0.00015121851,0.000003942512],"about_ca_topic_score_codex":0.0033668221,"about_ca_topic_score_gemma":0.0031215483,"teacher_disagreement_score":0.0033668221,"about_ca_system_score_codex":0.00028293036,"about_ca_system_score_gemma":0.0005281931,"threshold_uncertainty_score":0.006694436},"labels":[],"label_agreement":null},{"id":"W2102772856","doi":"10.1177/1352458508091367","title":"Tracking retinal nerve fiber layer loss after optic neuritis: a prospective study using optical coherence tomography","year":2008,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":224,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Calgary","funders":"National Eye Institute; Baker Foundation; Ottawa Hospital Research Institute; Biogen; Research to Prevent Blindness","keywords":"Nerve fiber layer; Optic neuritis; Retinal; Optic nerve; Medicine; Ophthalmology; Optical coherence tomography; Nerve fiber; Retina; Anatomy; Multiple sclerosis; Neuroscience; Biology","score_opus":0.12239503844088438,"score_gpt":0.32396498182406247,"score_spread":0.20156994338317807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102772856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996444,0.00012520805,0.0000489247,0.000007782085,0.0000017590205,0.000020980315,0.000041924093,0.000001181115,0.000107833206],"genre_scores_gemma":[0.99943846,0.00010106495,0.00014099864,0.000017312135,0.0000093138915,0.00003572011,0.00015968998,0.000002095157,0.00009535724],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988961,0.0003750895,0.00013469202,0.00023513187,0.00019815503,0.00016082963],"domain_scores_gemma":[0.99584705,0.0010314257,0.0016463527,0.00041649467,0.0005075814,0.0005510585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021146557,0.00067860424,0.0005303958,0.0009105231,0.0010586788,0.0007714623,0.00040812016,0.00076996774,0.0014027341],"category_scores_gemma":[0.0064074025,0.0007184192,0.000573074,0.00087395083,0.0006398722,0.0013427634,0.0006473859,0.0008059595,0.0005204086],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003610376,0.00017956492,0.9983102,0.000007824178,0.00003635108,0.00014917251,0.0001041822,0.000019725045,0.00015251589,0.0000032817375,0.000017080227,0.0006589657],"study_design_scores_gemma":[0.00008888483,0.003990993,0.9926778,0.00001923518,0.000087868815,0.0020346495,0.0004532158,0.00016248727,0.00026138013,0.000015315498,0.00019332864,0.000014814082],"about_ca_topic_score_codex":0.003012637,"about_ca_topic_score_gemma":0.003471413,"teacher_disagreement_score":0.003012637,"about_ca_system_score_codex":0.00042369205,"about_ca_system_score_gemma":0.0005458697,"threshold_uncertainty_score":0.0111835},"labels":[],"label_agreement":null},{"id":"W2104742284","doi":"10.1177/1352458510367661","title":"Disease onset in familial and sporadic primary progressive multiple sclerosis","year":2010,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Disease; Age of onset; Multiple sclerosis; Family aggregation; Degenerative disease; Population; Central nervous system disease; Internal medicine; Pediatrics; Immunology","score_opus":0.07232019047034279,"score_gpt":0.2882992623615152,"score_spread":0.21597907189117244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104742284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99868137,0.0008047854,0.000060939034,0.000014944892,0.000003808871,0.000003892378,0.00025177668,0.000002546049,0.00017587074],"genre_scores_gemma":[0.9988524,0.0002988849,0.00009087231,0.0000133651565,0.000010530706,0.00000794222,0.0006298913,0.0000023111083,0.000093935996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988918,0.00034073635,0.00016363575,0.00033775953,0.00013394005,0.00013214271],"domain_scores_gemma":[0.9978993,0.0006001681,0.0009008679,0.00015059608,0.00018040158,0.0002685608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011742208,0.0002961863,0.0006809443,0.001708405,0.00043661255,0.0005476113,0.00028236743,0.00060699694,0.0010611295],"category_scores_gemma":[0.004380947,0.00036473904,0.0005903848,0.0019937,0.00023692107,0.00064368715,0.00055055047,0.0003901472,0.0002135513],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002674597,0.000012320098,0.9970298,0.000016003976,0.000058115857,0.00033729026,0.00010250456,0.000029826542,0.00024602324,0.000010822184,0.000038021717,0.0018518838],"study_design_scores_gemma":[0.0000051950997,0.000037550333,0.99877685,0.0000053019007,0.000024247878,0.0008982966,0.000084246145,0.00004186526,0.00002424538,0.000025040883,0.00007460557,0.0000023831947],"about_ca_topic_score_codex":0.0044132066,"about_ca_topic_score_gemma":0.0058200452,"teacher_disagreement_score":0.0044132066,"about_ca_system_score_codex":0.00042292452,"about_ca_system_score_gemma":0.00030693522,"threshold_uncertainty_score":0.008775055},"labels":[],"label_agreement":null},{"id":"W2105242813","doi":"10.1177/1352458512445201","title":"The effects of clinical interventions on health-related quality of life in multiple sclerosis: a meta-analysis","year":2012,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University","funders":"Multiple Sclerosis Society","keywords":"Funnel plot; Medicine; Psychological intervention; Meta-analysis; MEDLINE; Publication bias; Quality of life (healthcare); Randomized controlled trial; Physical therapy; Mood; Clinical psychology; Psychiatry; Nursing; Internal medicine","score_opus":0.7480843048039773,"score_gpt":0.5176749175928677,"score_spread":0.2304093872111096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105242813","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0066704415,0.99045545,0.0013145938,0.00019898407,0.000322721,0.0005519771,0.0002051412,0.000042703243,0.00023797386],"genre_scores_gemma":[0.26763088,0.71666867,0.007968279,0.0012979927,0.0007536657,0.0042714076,0.000686423,0.000072192786,0.0006505052],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9737752,0.015701115,0.0061850906,0.0015524455,0.00235266,0.00043341567],"domain_scores_gemma":[0.9568081,0.034247033,0.00486911,0.0015335514,0.0021100766,0.000432169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03778103,0.0041397004,0.028776335,0.010163588,0.0007512018,0.0048546568,0.0027649135,0.0033687153,0.003192093],"category_scores_gemma":[0.064634256,0.0020204824,0.066794574,0.007774479,0.0009974422,0.002814751,0.002441602,0.0030721023,0.00034582854],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003952937,0.000053971016,0.0012095589,0.12143331,0.86477804,0.000050862738,0.00004452811,0.0003631133,0.00014958033,0.00007926753,0.00013903117,0.007745716],"study_design_scores_gemma":[0.0013040301,0.00040154965,0.0013400763,0.008145476,0.9878735,0.000041250496,0.00002477683,0.00015084774,0.00010136695,0.00012698415,0.00047631367,0.000013861108],"about_ca_topic_score_codex":0.0036802343,"about_ca_topic_score_gemma":0.0067398776,"teacher_disagreement_score":0.03778103,"about_ca_system_score_codex":0.0034700576,"about_ca_system_score_gemma":0.003192935,"threshold_uncertainty_score":0.19980758},"labels":[],"label_agreement":null},{"id":"W2105823731","doi":"10.1177/135245850100700406","title":"Interferon β-1a and depression in relapsing - remitting multiple sclerosis: an analysis of depression data from the PRISMS clinical trial","year":2001,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Depression (economics); Placebo; Medicine; Multiple sclerosis; Rating scale; Internal medicine; Beck Depression Inventory; Randomization; Center for Epidemiologic Studies Depression Scale; Beck Hopelessness Scale; Epidemiology; Clinical trial; Physical therapy; Psychiatry; Psychology; Anxiety; Depressive symptoms","score_opus":0.3852893289964776,"score_gpt":0.41701055514739305,"score_spread":0.03172122615091544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105823731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9603579,0.027908478,0.0013348864,0.0008760186,0.00030685347,0.0019839536,0.004771758,0.00007063629,0.0023895213],"genre_scores_gemma":[0.9857226,0.005281312,0.0011123976,0.00063395174,0.00019047287,0.0015737333,0.0041211606,0.000019641258,0.0013447234],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99376124,0.004591132,0.00047762846,0.00030970227,0.0006690755,0.00019112656],"domain_scores_gemma":[0.99557185,0.0022190567,0.0012156072,0.00033179583,0.00025316162,0.00040843472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008247592,0.00085003255,0.0030934792,0.00042521668,0.00023418135,0.0008558032,0.0005590882,0.0008512528,0.0028151695],"category_scores_gemma":[0.0077368305,0.00040710033,0.003488909,0.00091772265,0.00047202376,0.0005147576,0.0006792403,0.0020306576,0.00024721283],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93683803,0.0008862552,0.0135528585,0.0034076984,0.017066171,0.00019916786,0.00006205314,0.0011890366,0.0015663047,0.00019254368,0.001958329,0.023081629],"study_design_scores_gemma":[0.7472141,0.07604553,0.14469412,0.00060559006,0.019933745,0.00049492455,0.00009880754,0.0042558303,0.00068378996,0.0006968793,0.00518838,0.00008832269],"about_ca_topic_score_codex":0.0005897827,"about_ca_topic_score_gemma":0.0009898465,"teacher_disagreement_score":0.008247592,"about_ca_system_score_codex":0.00043028916,"about_ca_system_score_gemma":0.0010255524,"threshold_uncertainty_score":0.043618023},"labels":[],"label_agreement":null},{"id":"W2105913548","doi":"10.1177/1352458514564487","title":"The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review","year":2015,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":510,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"EMD Serono; National Institutes of Health; Multiple Sclerosis Society of Canada; Genentech; Multiple Sclerosis Society; Cleveland Clinic; National Institute of Neurological Disorders and Stroke; Teva Pharmaceutical Industries; National Heart, Lung, and Blood Institute; Pfizer; U.S. Department of Defense; Sanofi; MedDay Pharmaceuticals; GlaxoSmithKline; National Multiple Sclerosis Society; Biogen; Gilead Sciences","keywords":"Multiple sclerosis; Psychiatry; Incidence (geometry); Medicine; Systematic review; MEDLINE","score_opus":0.16130572927536932,"score_gpt":0.36064317461077444,"score_spread":0.19933744533540512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105913548","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019522302,0.99717784,0.00010312096,0.00013113978,0.000051693485,0.00017033842,0.00029942227,0.000006770539,0.00010740876],"genre_scores_gemma":[0.03068866,0.9674412,0.0007168212,0.00029058693,0.00007812029,0.00045091944,0.00026063825,0.0000054556076,0.000067572095],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99079984,0.002495222,0.004116506,0.00074436085,0.001637284,0.00020680249],"domain_scores_gemma":[0.9679469,0.021730948,0.00754508,0.00047065635,0.0020356614,0.00027071917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008601443,0.0014187827,0.009825217,0.01238344,0.0006179614,0.0027413436,0.0017872781,0.0016334123,0.0023617675],"category_scores_gemma":[0.035540435,0.0012480833,0.009692371,0.013850858,0.0009161985,0.0018911364,0.0014842305,0.000882383,0.00017696385],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017038197,0.000010147465,0.0030240198,0.951464,0.025714999,0.000116295734,0.00012788616,0.00007785168,0.00013736403,0.000070456656,0.0005446899,0.018541984],"study_design_scores_gemma":[0.00024294083,0.00024360101,0.019458199,0.6693585,0.3005079,0.0009882164,0.00028936914,0.00012412429,0.00020421861,0.00023176537,0.008298836,0.00005231455],"about_ca_topic_score_codex":0.006379894,"about_ca_topic_score_gemma":0.018787863,"teacher_disagreement_score":0.01238344,"about_ca_system_score_codex":0.002882938,"about_ca_system_score_gemma":0.00702136,"threshold_uncertainty_score":0.04548931},"labels":[],"label_agreement":null},{"id":"W2106505062","doi":"10.1177/1352458507078393","title":"Deterioration in the health-related quality of life of persons with multiple sclerosis: the possible warning signs","year":2007,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network; Toronto Western Hospital; Cameco (Canada); Provincial Laboratory of Public Health; University of Saskatchewan; University of Alberta","funders":"","keywords":"Mental health; Medicine; Quality of life (healthcare); Psychological intervention; Depression (economics); Population; Beck Depression Inventory; Intrusiveness; Psychiatry; Expanded Disability Status Scale; Multiple sclerosis; Clinical psychology; Gerontology; Psychology; Anxiety; Environmental health","score_opus":0.20442908356771025,"score_gpt":0.3482621397014887,"score_spread":0.14383305613377848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106505062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971992,0.0009473353,0.00010729015,0.00066179276,0.000010686335,0.00001174475,0.00062397495,0.000007927457,0.0004299176],"genre_scores_gemma":[0.999042,0.00022732785,0.00019022918,0.00008256425,0.000012844444,0.0000072841954,0.00033226208,8.4250024e-7,0.000104727435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999699,0.000103716055,0.000039626484,0.000025982381,0.000093140596,0.000038479386],"domain_scores_gemma":[0.99859506,0.00036568192,0.00062574405,0.00004908443,0.0001595543,0.00020479248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084390107,0.00019370292,0.00041021768,0.00060100737,0.00020225706,0.00047070548,0.00017946858,0.00047005445,0.0009420616],"category_scores_gemma":[0.003687294,0.00015391863,0.00021889497,0.000672457,0.00018288483,0.00059605605,0.00045278046,0.0009577815,0.0001320848],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012308665,0.00003248809,0.9942457,0.000032741304,0.000022868342,0.000067135894,0.00006118934,0.000030068271,0.00015328216,0.000014262263,0.00024810393,0.0049691447],"study_design_scores_gemma":[0.0000050204562,0.00008099438,0.9994017,0.000009206685,0.00000963067,0.00013776137,0.00006971526,0.00012231033,0.00004078615,0.000020978941,0.000099681616,0.0000022488312],"about_ca_topic_score_codex":0.0036501014,"about_ca_topic_score_gemma":0.008515638,"teacher_disagreement_score":0.0036501014,"about_ca_system_score_codex":0.0003088591,"about_ca_system_score_gemma":0.0002848067,"threshold_uncertainty_score":0.0072577},"labels":[],"label_agreement":null},{"id":"W2106988882","doi":"10.1177/1352458513477230","title":"Expression of cathepsins S and D signals a distinctive biochemical trait in CD34 <sup>+</sup> hematopoietic stem cells of relapsing–remitting multiple sclerosis patients","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Multiple sclerosis; Haematopoiesis; Cathepsin; Stem cell; CD34; Biology; Cytokine; Pathogenesis; Immunology; Cathepsin D; Proteases; Bone marrow; Enzyme; Cell biology; Biochemistry","score_opus":0.05127720962451044,"score_gpt":0.24970314296172663,"score_spread":0.1984259333372162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106988882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995022,0.00013671491,0.000084759515,0.0000073592983,0.0000010506294,0.0000055056184,0.00011783954,0.0000059516706,0.00013873601],"genre_scores_gemma":[0.9993444,0.00006576894,0.00014548167,0.000011393919,0.0000035840314,0.000009530459,0.0002989318,0.0000017718301,0.00011909887],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991727,0.00001079481,0.000013662808,0.00002224352,0.000020349255,0.000015560634],"domain_scores_gemma":[0.999871,0.00002104351,0.00004349062,0.000010251426,0.000018163004,0.00003605114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008749391,0.0001279379,0.00013429254,0.00046296176,0.00011586817,0.00022063454,0.0000711955,0.00019374615,0.0009410367],"category_scores_gemma":[0.00022114802,0.00007573738,0.00007555315,0.000278167,0.00014418602,0.00006968386,0.00014044033,0.00015999947,0.00019337646],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020988137,0.0000728245,0.10601784,0.00005740244,0.00003098018,0.00094406534,0.0003184243,0.00011880131,0.88165003,0.000102745544,0.00013294308,0.008455086],"study_design_scores_gemma":[0.00011867263,0.001484548,0.868559,0.000011217182,0.00007045418,0.008782312,0.00035281104,0.00071154506,0.11804686,0.00015596056,0.0016940607,0.000012658715],"about_ca_topic_score_codex":0.00025025356,"about_ca_topic_score_gemma":0.00025026881,"teacher_disagreement_score":0.0009410367,"about_ca_system_score_codex":0.000097257565,"about_ca_system_score_gemma":0.000060140195,"threshold_uncertainty_score":0.003148079},"labels":[],"label_agreement":null},{"id":"W2107189247","doi":"10.1177/1352458515601513","title":"Over-the-counter anti-oxidant therapies for use in multiple sclerosis: A systematic review","year":2015,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Biochemical Acid Research Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; Montreal Neurological Institute and Hospital; Women and Children’s Health Research Institute; University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Multiple sclerosis; Medicine; MEDLINE; Intensive care medicine; Immunology; Chemistry","score_opus":0.19818088000202835,"score_gpt":0.33979687441035755,"score_spread":0.1416159944083292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107189247","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00078184746,0.9981932,0.00008667242,0.00016975818,0.00006998287,0.0002346444,0.00026123482,0.000007091258,0.00019555005],"genre_scores_gemma":[0.011014771,0.9873842,0.0004392575,0.000390863,0.00005614726,0.00040874752,0.00018202628,0.0000035493065,0.00012033566],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9958799,0.0014241497,0.0014672201,0.00028616868,0.0007935875,0.0001489576],"domain_scores_gemma":[0.9838164,0.010543197,0.003658695,0.00020161989,0.0015212821,0.000258911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052787843,0.0012898085,0.007943528,0.008530358,0.00063459494,0.0021739989,0.001534031,0.0018164122,0.0049705207],"category_scores_gemma":[0.019430066,0.00082617265,0.006167074,0.009250328,0.00072719686,0.0017954594,0.001187415,0.00089576456,0.00032055945],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021821939,0.0000115734565,0.000337123,0.96784985,0.0063357013,0.000068165085,0.00008025974,0.000053478798,0.00012768661,0.000105846826,0.00093536975,0.023876673],"study_design_scores_gemma":[0.00045559776,0.00029114334,0.003364508,0.8887463,0.088230334,0.00038055363,0.00019885688,0.000084209496,0.00022417394,0.00026216084,0.017726794,0.0000353905],"about_ca_topic_score_codex":0.007753534,"about_ca_topic_score_gemma":0.02483126,"teacher_disagreement_score":0.008530358,"about_ca_system_score_codex":0.003072412,"about_ca_system_score_gemma":0.009934842,"threshold_uncertainty_score":0.027917206},"labels":[],"label_agreement":null},{"id":"W2107328537","doi":"10.1177/1352458512446169","title":"Sex ratio of multiple sclerosis in the National Swedish MS Register (SMSreg)","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Demographic Trends and Gender Preferences","field":"Social Sciences","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sex ratio; Multiple sclerosis; Demography; Male to female; Medicine; Digit ratio; Female to male; Rate ratio; Population; Confidence interval; Epidemiology; Internal medicine; Immunology","score_opus":0.24276253987182958,"score_gpt":0.3200699499479974,"score_spread":0.07730741007616784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107328537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9717604,0.004871538,0.00016610285,0.00012478695,0.00006179647,0.000025747559,0.020698063,0.000064697146,0.0022270049],"genre_scores_gemma":[0.9775972,0.0020722735,0.00027829767,0.0000664125,0.0000441568,0.0000713865,0.01894989,0.000028241193,0.00089214667],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987674,0.0002949509,0.00028715143,0.00025639567,0.00030180498,0.000092297254],"domain_scores_gemma":[0.99848795,0.0003252979,0.0007113505,0.00014172112,0.00025506396,0.00007855119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097129383,0.00022037068,0.00063674175,0.0028043678,0.0001942352,0.0005781942,0.0003644839,0.0004191613,0.002069751],"category_scores_gemma":[0.0038393491,0.00020846148,0.0005176362,0.0028617694,0.0001427752,0.00033395528,0.00027682932,0.00023448546,0.0007590855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041458686,0.00001750414,0.9895432,0.00018134816,0.00023349763,0.00027860404,0.00016041126,0.00010636911,0.00030493154,0.000083356084,0.0023200568,0.0063560735],"study_design_scores_gemma":[0.000019089266,0.00006696085,0.99694747,0.000052896998,0.00010749963,0.0008186326,0.000139875,0.000096521435,0.00010427343,0.00005565658,0.0015839246,0.0000071484333],"about_ca_topic_score_codex":0.009979018,"about_ca_topic_score_gemma":0.007261018,"teacher_disagreement_score":0.009979018,"about_ca_system_score_codex":0.00036309942,"about_ca_system_score_gemma":0.00047727893,"threshold_uncertainty_score":0.01984185},"labels":[],"label_agreement":null},{"id":"W2107480122","doi":"10.1177/1352458508099477","title":"The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated","year":2009,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":222,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Neurological Disorders and Stroke; National Institute of Allergy and Infectious Diseases","keywords":"Multiple sclerosis; Comorbidity; Medicine; MEDLINE; Psychiatry","score_opus":0.144334292568887,"score_gpt":0.31325398692794226,"score_spread":0.16891969435905527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107480122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855166,0.011592957,0.00008905165,0.0016996658,0.000032361408,0.000009638817,0.00046261045,0.000003639426,0.00059350615],"genre_scores_gemma":[0.995952,0.0035121941,0.00010660179,0.0001455893,0.00007138405,0.000005786877,0.00017065063,7.614563e-7,0.0000350047],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976739,0.0013242061,0.00029868094,0.00019315249,0.0003555231,0.0001546153],"domain_scores_gemma":[0.9941619,0.0016389774,0.0031493525,0.00018690624,0.0003839828,0.00047883968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014648429,0.00016430541,0.0003680419,0.0011984856,0.00042588194,0.0009928232,0.00026928398,0.00045113967,0.00082839484],"category_scores_gemma":[0.008187193,0.00015710216,0.00025662789,0.0018621341,0.0004476968,0.0005378418,0.0008098789,0.0005758533,0.000070194605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006111199,0.000016537455,0.9900602,0.00010741538,0.00012409741,0.00017136845,0.00018481133,0.000039926348,0.000085320025,0.000039717703,0.0003134726,0.00879599],"study_design_scores_gemma":[0.000004562835,0.00002495469,0.9984763,0.00009755678,0.000042662305,0.00059435586,0.00034376784,0.000098501376,0.000020207344,0.00006085068,0.00023294706,0.0000032880134],"about_ca_topic_score_codex":0.0068720356,"about_ca_topic_score_gemma":0.010025002,"teacher_disagreement_score":0.0068720356,"about_ca_system_score_codex":0.00046712472,"about_ca_system_score_gemma":0.00072358176,"threshold_uncertainty_score":0.013664067},"labels":[],"label_agreement":null},{"id":"W2107569441","doi":"10.1177/1352458508101939","title":"Proof of concept studies for tissue-protective agents in multiple sclerosis","year":2009,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Multiple sclerosis; Placebo; Medicine; Clinical trial; Clinical study design; Proof of concept; Clinical endpoint; Sample size determination; Randomized controlled trial; Treatment effect; Physical medicine and rehabilitation; Intensive care medicine; Computer science; Pathology; Alternative medicine; Statistics; Psychiatry","score_opus":0.4719566677639761,"score_gpt":0.43587226485570935,"score_spread":0.036084402908266755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107569441","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0049920073,0.97496265,0.008593391,0.0020053545,0.0015686753,0.004036021,0.00042247353,0.00006579798,0.0033536945],"genre_scores_gemma":[0.02881589,0.92502373,0.032761447,0.0031878515,0.00068769197,0.006892878,0.00042530676,0.000019900874,0.0021852772],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951149,0.0029709546,0.0005226908,0.00025914307,0.00096716074,0.00016507428],"domain_scores_gemma":[0.98343974,0.012816725,0.0020909503,0.0004367486,0.0009551537,0.00026068138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020060444,0.0016266666,0.0034551832,0.0019486757,0.00037676914,0.0017583895,0.0025504588,0.004455064,0.0103466315],"category_scores_gemma":[0.016106524,0.00061854534,0.0035856327,0.0011689462,0.0013648486,0.002524513,0.0009688026,0.0027601256,0.0013367058],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055767368,0.0016779632,0.0003550192,0.38311934,0.0021116901,0.0013056562,0.00029511837,0.00094928546,0.024254031,0.014891055,0.011097388,0.55436677],"study_design_scores_gemma":[0.02973172,0.03317962,0.003860622,0.14895746,0.012875569,0.004171004,0.00042564145,0.0007938043,0.041582823,0.015594919,0.70863175,0.00019501435],"about_ca_topic_score_codex":0.00033413107,"about_ca_topic_score_gemma":0.0005485106,"teacher_disagreement_score":0.020060444,"about_ca_system_score_codex":0.00087340386,"about_ca_system_score_gemma":0.0035413257,"threshold_uncertainty_score":0.10609108},"labels":[],"label_agreement":null},{"id":"W2108926058","doi":"10.1177/1352458512470730","title":"Piet Mondrian’s trees and the evolution in understanding multiple sclerosis, Charcot Prize Lecture 2011","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Toronto","funders":"Agencja Badań Medycznych","keywords":"Multiple sclerosis; Mondrian; Medicine; Neuroscience; Psychology; Immunology; Art; Visual arts","score_opus":0.117860913057767,"score_gpt":0.2698007645620776,"score_spread":0.15193985150431058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108926058","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009610676,0.120022245,0.0009383167,0.84452623,0.019037979,0.000008464932,0.00004453252,0.00002407597,0.0144370925],"genre_scores_gemma":[0.16702054,0.20343325,0.005914338,0.5029252,0.055391137,0.0001650189,0.00008878972,0.0002894362,0.0647722],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965718,0.0018485767,0.00013475334,0.0004578977,0.00067540846,0.00031169175],"domain_scores_gemma":[0.9946226,0.0037771775,0.00028259752,0.00013638222,0.0005129916,0.00066831213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0070184884,0.0009507644,0.00081136747,0.0016229238,0.0057703652,0.008059365,0.0011508617,0.005907159,0.003909329],"category_scores_gemma":[0.016229907,0.0005307356,0.00049541245,0.001432815,0.018249834,0.012249234,0.0027338904,0.017828964,0.00089953555],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006070481,0.000016210804,0.00022794554,0.00014493716,0.00001138879,0.00019467006,0.005357717,0.00012074181,0.000062576735,0.2636848,0.7135307,0.016587654],"study_design_scores_gemma":[0.000015605767,0.00001691991,0.00034155164,0.0004128046,0.000007835764,0.00041456078,0.002101329,0.00013731654,0.00007098958,0.120405555,0.87604284,0.000032683165],"about_ca_topic_score_codex":0.016009161,"about_ca_topic_score_gemma":0.022250118,"teacher_disagreement_score":0.016009161,"about_ca_system_score_codex":0.0071051964,"about_ca_system_score_gemma":0.0048264707,"threshold_uncertainty_score":0.051552057},"labels":[],"label_agreement":null},{"id":"W2109265148","doi":"10.1177/135245850501100122","title":"MRI Correlates of MS Pathologic Subtypes","year":2005,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Multiple sclerosis; Neural correlates of consciousness; Medicine; Pathology; Magnetic resonance imaging; Radiology; Cognition; Psychiatry","score_opus":0.20176283075805304,"score_gpt":0.3704165779671115,"score_spread":0.16865374720905849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109265148","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026964492,0.99940336,0.000031036394,0.000066829816,0.000030769446,0.0000026429132,0.000024476765,0.0000015635956,0.00016965113],"genre_scores_gemma":[0.0022560451,0.99732375,0.00015406494,0.00007338859,0.0000798298,0.0000041508088,0.00003766177,7.029753e-7,0.000070348164],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996082,0.00009109689,0.000101915924,0.00007870054,0.000099072764,0.000021047532],"domain_scores_gemma":[0.9983424,0.000840484,0.00047533042,0.000034608718,0.0002747564,0.00003237911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010862128,0.0010232286,0.003043801,0.0046985885,0.00018291133,0.0010780297,0.0012041362,0.0006841655,0.0014179042],"category_scores_gemma":[0.003549789,0.00041998105,0.00060685223,0.0060263486,0.00065746123,0.0011173919,0.0005396807,0.0007141587,0.0004285917],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026485883,0.000042459287,0.00643014,0.05233093,0.0011539645,0.0003512194,0.000090270136,0.00026233643,0.0007642501,0.0005442325,0.011662906,0.9261024],"study_design_scores_gemma":[0.00032279192,0.00060916215,0.11697489,0.126736,0.018755233,0.015415088,0.0009870597,0.00071355875,0.0026250973,0.004631593,0.7120073,0.0002222201],"about_ca_topic_score_codex":0.0041963,"about_ca_topic_score_gemma":0.007859655,"teacher_disagreement_score":0.0046985885,"about_ca_system_score_codex":0.00058030157,"about_ca_system_score_gemma":0.0013514818,"threshold_uncertainty_score":0.008343697},"labels":[],"label_agreement":null},{"id":"W2109752119","doi":"10.1177/1352458513475723","title":"Magnetic resonance imaging outcomes from a phase III trial of teriflunomide","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; University of Toronto; St. Michael's Hospital","funders":"Universität Innsbruck; Warszawski Uniwersytet Medyczny; Universidade de Coimbra; Centre Hospitalier Universitaire de Nantes; Universidad de Chile; Academy of Military Medical Sciences; Universität Rostock; Medizinische Universität Innsbruck","keywords":"Teriflunomide; Magnetic resonance imaging; Multiple sclerosis; Medicine; Nuclear magnetic resonance; Phase (matter); Radiology; Physics; Psychiatry; Fingolimod","score_opus":0.08717246974494447,"score_gpt":0.3241591583027233,"score_spread":0.23698668855777882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109752119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99233115,0.003761137,0.00026478618,0.0003777318,0.000100699894,0.0007825866,0.00086115825,0.000042671807,0.0014780853],"genre_scores_gemma":[0.9931751,0.0015263906,0.00064329355,0.000592018,0.00016194119,0.00092259963,0.0014581325,0.000012000644,0.001508542],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99964535,0.00018934958,0.000026690106,0.00004721557,0.00003677296,0.000054588505],"domain_scores_gemma":[0.9991999,0.00020071845,0.00027469962,0.000057220197,0.00005869501,0.0002087508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013299994,0.00064049335,0.0017127702,0.00015277023,0.0002869282,0.00051719457,0.00036881038,0.00076412485,0.0035586366],"category_scores_gemma":[0.0011198977,0.00018269189,0.000874799,0.00017511295,0.00032038838,0.00038005805,0.00019356592,0.0017387294,0.0005918062],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.89946747,0.010398128,0.0046417285,0.0007321567,0.0019136359,0.0001301893,0.00007664683,0.0007009001,0.015197493,0.00006773082,0.0017990742,0.06487484],"study_design_scores_gemma":[0.63642913,0.32360232,0.030596284,0.00008646895,0.0019991733,0.00034443074,0.00004467753,0.00061818794,0.0034101964,0.00023034154,0.0026138143,0.000024900253],"about_ca_topic_score_codex":0.00029183435,"about_ca_topic_score_gemma":0.00063166866,"teacher_disagreement_score":0.0035586366,"about_ca_system_score_codex":0.00028792678,"about_ca_system_score_gemma":0.0005214817,"threshold_uncertainty_score":0.011904836},"labels":[],"label_agreement":null},{"id":"W2110767197","doi":"10.1177/1352458514546785","title":"Body size and the risk of multiple sclerosis in Norway and Italy: The EnvIMS study","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"Università degli Studi di Sassari; Universitetet i Bergen; McGill University Health Centre; Multiple Sclerosis Society of Canada; McGill University; Multiple Sclerosis Society; Helse Vest; Fondazione Italiana Sclerosi Multipla","keywords":"Odds ratio; Medicine; Risk factor; Multiple sclerosis; Demography; Logistic regression; Obesity; Body mass index; Case-control study; Population; Overweight; Epidemiology; Internal medicine; Environmental health","score_opus":0.05554544088432382,"score_gpt":0.2742067437311857,"score_spread":0.2186613028468619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110767197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99746764,0.0013729947,0.000040464616,0.00008367952,0.000019901632,0.000007727507,0.00043593478,0.000001823524,0.000569888],"genre_scores_gemma":[0.9985513,0.0005462638,0.000090826295,0.00004261931,0.000024572648,0.000016646041,0.00047211218,0.0000021829192,0.0002535379],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99958795,0.00017957437,0.000040966857,0.00007996938,0.000051976956,0.000059534046],"domain_scores_gemma":[0.99905306,0.00017566996,0.000492679,0.00006426288,0.000061749815,0.00015263606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010370467,0.00030091687,0.00034530408,0.0005634425,0.00026671833,0.00052973215,0.00028580445,0.0003714267,0.0012858749],"category_scores_gemma":[0.0016162589,0.00023888129,0.00050286873,0.00077305664,0.00027986363,0.0002301683,0.00051523943,0.00031481832,0.00014502506],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040995202,0.000041679617,0.997701,0.000030600633,0.000119385804,0.000097400094,0.00013441687,0.000031786836,0.00016250364,0.000025929068,0.0002001545,0.0010451985],"study_design_scores_gemma":[0.000023748746,0.00008789161,0.9993278,0.000020765923,0.00005913016,0.00007464423,0.00009806542,0.000038143015,0.000014258021,0.000012239585,0.00024154283,0.000001795177],"about_ca_topic_score_codex":0.020471342,"about_ca_topic_score_gemma":0.022344511,"teacher_disagreement_score":0.020471342,"about_ca_system_score_codex":0.000393678,"about_ca_system_score_gemma":0.00044519358,"threshold_uncertainty_score":0.04070437},"labels":[],"label_agreement":null},{"id":"W2110897431","doi":"10.1177/1352458512474090","title":"Labor induction and augmentation in women with multiple sclerosis","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Vancouver Coastal Health Research Institute; University of British Columbia","keywords":"Medicine; Confidence interval; Odds ratio; Cohort; Multiple sclerosis; Population; Cohort study; Expanded Disability Status Scale; Obstetrics; Labor induction; Proportional hazards model; Gynecology; Internal medicine; Immunology","score_opus":0.07998561984373619,"score_gpt":0.2810743202194326,"score_spread":0.20108870037569643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110897431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99460596,0.0034522181,0.000120684046,0.0005078188,0.000017263328,0.000020240856,0.00021702403,0.000008982117,0.0010498101],"genre_scores_gemma":[0.9984053,0.001120965,0.00011278411,0.000058393503,0.000021536292,0.000011457631,0.00012344599,0.0000019321924,0.00014430289],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99934083,0.00024328123,0.000060609837,0.000066173496,0.0001570508,0.0001320008],"domain_scores_gemma":[0.9969669,0.0008121303,0.0018182512,0.00009767553,0.00008305711,0.00022197748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009112114,0.00015075589,0.00026066764,0.00047771036,0.00036267046,0.00042762083,0.00036186093,0.00032452217,0.00264622],"category_scores_gemma":[0.0054733115,0.00014915729,0.0004193182,0.0005846805,0.00029789683,0.00023528068,0.00044267776,0.0006369095,0.00021131802],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036908506,0.000032506814,0.99002504,0.000058722628,0.000034913824,0.00043799664,0.000110564964,0.00008243255,0.00014292201,0.0000508266,0.0003002726,0.008354746],"study_design_scores_gemma":[0.000030777024,0.00037022104,0.99180776,0.00024032999,0.00006383573,0.004847011,0.0005196497,0.00082097464,0.00018681108,0.00022423595,0.00087889016,0.0000095002415],"about_ca_topic_score_codex":0.0040314915,"about_ca_topic_score_gemma":0.0034764544,"teacher_disagreement_score":0.0040314915,"about_ca_system_score_codex":0.000544988,"about_ca_system_score_gemma":0.00075988343,"threshold_uncertainty_score":0.008852422},"labels":[],"label_agreement":null},{"id":"W2111613885","doi":"10.1177/1352458511414039","title":"Can the functional assessment of multiple sclerosis adapt to changing needs? A psychometric validation in patients with clinically isolated syndrome and early relapsing–remitting multiple sclerosis","year":2011,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Ottawa Hospital","funders":"","keywords":"Multiple sclerosis; Relapsing remitting; Clinically isolated syndrome; Construct validity; Item response theory; Clinical trial; Medicine; Expanded Disability Status Scale; Psychology; Psychometrics; Physical therapy; Clinical psychology; Internal medicine; Psychiatry","score_opus":0.1493264308341575,"score_gpt":0.29319344675073045,"score_spread":0.14386701591657294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111613885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995886,0.0009843764,0.0007586827,0.00036882778,0.000048190326,0.00031036383,0.00016026688,0.000006546653,0.0014766568],"genre_scores_gemma":[0.9979043,0.00025992378,0.0011121124,0.00012164562,0.00001999075,0.00027410258,0.00018715272,0.000002640185,0.00011808009],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99450547,0.0036647266,0.0005657597,0.00024857974,0.00085478346,0.00016072734],"domain_scores_gemma":[0.9836842,0.009914119,0.0028380908,0.0007183579,0.0023870706,0.00045815125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022718932,0.0003892508,0.00073392456,0.00084826583,0.00037516633,0.0009054362,0.00050931715,0.00082906446,0.0013716174],"category_scores_gemma":[0.040492274,0.00020221676,0.0012017648,0.00090311025,0.0008443065,0.0013516512,0.000934947,0.00080781337,0.0003109874],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022579485,0.0006561001,0.9093934,0.00031510968,0.0005221795,0.0000628012,0.0014808391,0.0007180544,0.00053883804,0.0001941338,0.00054624194,0.08331436],"study_design_scores_gemma":[0.0003425481,0.004302018,0.98941994,0.000285189,0.00016362181,0.00019844531,0.0010539257,0.0023683778,0.00022967038,0.00038789804,0.001218969,0.000029312756],"about_ca_topic_score_codex":0.00091342314,"about_ca_topic_score_gemma":0.0015223077,"teacher_disagreement_score":0.022718932,"about_ca_system_score_codex":0.00046168483,"about_ca_system_score_gemma":0.0007359785,"threshold_uncertainty_score":0.120150626},"labels":[],"label_agreement":null},{"id":"W2111959241","doi":"10.1191/1352458504ms992oa","title":"Multiple sclerosis and alcohol: a study of problem drinking","year":2004,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Alcohol Consumption and Health Effects","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Multiple sclerosis; Medicine; Alcohol; Environmental health; Psychology; Psychiatry; Biology","score_opus":0.2204880410900095,"score_gpt":0.3418251555076328,"score_spread":0.12133711441762332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111959241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99910396,0.00032969433,0.0000311352,0.0000970802,0.000006484533,0.000014452187,0.000103104285,0.0000012928622,0.0003128251],"genre_scores_gemma":[0.99903333,0.00031615447,0.00007355149,0.000113015114,0.000016377127,0.000015452615,0.00010853983,0.0000017745485,0.0003218233],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995877,0.00016626278,0.000044204946,0.000046362016,0.00008724246,0.00006825513],"domain_scores_gemma":[0.9990177,0.00015626867,0.0003105842,0.000065826054,0.00011853358,0.00033105467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065689883,0.00022396365,0.00047073557,0.0007405621,0.000970711,0.0006398753,0.00023303005,0.00071108027,0.0013979013],"category_scores_gemma":[0.001739496,0.00054678647,0.00036218364,0.0013315388,0.0003142971,0.0008586863,0.00056143996,0.0009325289,0.00029348335],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015742471,0.00023650195,0.99686927,0.000020988138,0.00007837778,0.0001865164,0.0007266791,0.0000074481013,0.00018480919,0.000017664821,0.00011377796,0.0014006011],"study_design_scores_gemma":[0.00001449235,0.00027901577,0.99800974,0.000007815718,0.00003227326,0.00044136302,0.00077544927,0.000047636237,0.000021972044,0.000020537993,0.0003453013,0.0000044172493],"about_ca_topic_score_codex":0.009878978,"about_ca_topic_score_gemma":0.013091138,"teacher_disagreement_score":0.009878978,"about_ca_system_score_codex":0.00030609596,"about_ca_system_score_gemma":0.00042291306,"threshold_uncertainty_score":0.019643009},"labels":[],"label_agreement":null},{"id":"W2112063945","doi":"10.1177/1352458514564485","title":"A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis","year":2014,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":158,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Institute of Neurological Disorders and Stroke; Canadian Institutes of Health Research; EMD Serono; National Institutes of Health; Multiple Sclerosis Society of Canada; Cleveland Clinic Foundation; Ironwood Pharmaceuticals, Incorporated; National Multiple Sclerosis Society; Genentech; Novartis Pharmaceuticals Corporation; National Heart, Lung, and Blood Institute; Multiple Sclerosis Society; European Committee for Treatment and Research in Multiple Sclerosis; Cleveland Clinic; Teva Pharmaceutical Industries; Bayer HealthCare; Eli Lilly and Company; U.S. Department of Defense; Sanofi; Biogen; Pfizer; MedDay Pharmaceuticals; GlaxoSmithKline; Gilead Sciences","keywords":"Multiple sclerosis; Medicine; Peripheral; Incidence (geometry); Disease; Vascular disease; Cardiology; Stroke (engine); Internal medicine; Immunology","score_opus":0.08095027036917916,"score_gpt":0.30970297849247946,"score_spread":0.22875270812330029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112063945","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007984125,0.9983491,0.00009978748,0.00014355221,0.00007367382,0.00015711894,0.00022040421,0.0000052868386,0.00015266327],"genre_scores_gemma":[0.008283037,0.9904635,0.00052530295,0.00020023523,0.00005129961,0.00026935295,0.00013489301,0.0000028725976,0.0000694946],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9921638,0.002318876,0.0034016802,0.0005368004,0.0013846114,0.00019419266],"domain_scores_gemma":[0.9791037,0.014268361,0.0039342763,0.000336456,0.0021256988,0.00023156125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007763184,0.0016485795,0.009353323,0.013998913,0.000740215,0.002532984,0.0019759038,0.0016778422,0.0038338073],"category_scores_gemma":[0.033361156,0.0011684853,0.006901828,0.015161761,0.00075062254,0.0022672196,0.001379624,0.0009757571,0.0002778799],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009755504,0.000009868865,0.0008164768,0.95885015,0.009232196,0.0001049107,0.00015102532,0.00006491406,0.00014373672,0.00011920773,0.0010233733,0.029386587],"study_design_scores_gemma":[0.00016073462,0.0001995632,0.0075071305,0.8338486,0.13591968,0.00076177006,0.00030316846,0.000079100544,0.0002146717,0.00027689832,0.020690994,0.000037674283],"about_ca_topic_score_codex":0.007950723,"about_ca_topic_score_gemma":0.025080774,"teacher_disagreement_score":0.013998913,"about_ca_system_score_codex":0.0031264827,"about_ca_system_score_gemma":0.010448897,"threshold_uncertainty_score":0.041056097},"labels":[],"label_agreement":null},{"id":"W2114080475","doi":"10.1177/1352458511417835","title":"Multiple sclerosis and depression","year":2011,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":335,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Multiple sclerosis; Psychosocial; Depression (economics); Medicine; Quality of life (healthcare); Mood; Randomized controlled trial; Psychiatry; Clinical psychology; Mindfulness; Mood disorders; Affect (linguistics); Psychology; Anxiety; Internal medicine","score_opus":0.2937370974242926,"score_gpt":0.35762058994847534,"score_spread":0.06388349252418274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114080475","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005698851,0.9992235,0.000018759134,0.00015872408,0.00006771749,0.0000030882295,0.000006572822,0.000002213941,0.0004624532],"genre_scores_gemma":[0.0008238545,0.99851364,0.00007008302,0.00016089628,0.00008853192,0.0000056697695,0.000013277907,4.5220997e-7,0.00032353253],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999534,0.00012982533,0.00008649749,0.0000540739,0.00016788075,0.000027669257],"domain_scores_gemma":[0.9993974,0.0003297588,0.00011739603,0.000014485881,0.00010308894,0.00003796878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006981076,0.0006805313,0.0016676346,0.0019258041,0.00029529675,0.001037259,0.00046918445,0.0010337337,0.0045202193],"category_scores_gemma":[0.0014047233,0.00020733714,0.00042784162,0.0031047713,0.00046164857,0.0008603291,0.0006357884,0.0009542843,0.0018861074],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004973731,0.000043681637,0.00038007225,0.03183479,0.00019809464,0.00018982403,0.00011773871,0.000085471496,0.0005076966,0.0015261702,0.03208625,0.9329804],"study_design_scores_gemma":[0.00006416548,0.00017172146,0.007387981,0.02663483,0.00047255465,0.005286179,0.0003377313,0.00005320576,0.00034531052,0.0034675112,0.9557504,0.000028390154],"about_ca_topic_score_codex":0.0022939448,"about_ca_topic_score_gemma":0.00426106,"teacher_disagreement_score":0.0045202193,"about_ca_system_score_codex":0.00057420187,"about_ca_system_score_gemma":0.0015221867,"threshold_uncertainty_score":0.015121579},"labels":[],"label_agreement":null},{"id":"W2114728329","doi":"10.1177/1352458509347150","title":"Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients","year":2009,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":432,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Multiple Sclerosis Society","keywords":"Anxiety; Hospital Anxiety and Depression Scale; Depression (economics); Multiple sclerosis; Receiver operating characteristic; Confounding; Rating scale; Population; Psychiatry; Psychology; Expanded Disability Status Scale; Medicine; Internal medicine","score_opus":0.05894340111054678,"score_gpt":0.2692807458743455,"score_spread":0.2103373447637987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114728329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97511715,0.0014928598,0.0056591528,0.00060864224,0.00029107337,0.0048330543,0.0033343718,0.00016196241,0.0085017355],"genre_scores_gemma":[0.9766158,0.0005920068,0.012803466,0.0003058615,0.00011864454,0.0048671174,0.0034970916,0.000027500875,0.0011726101],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941875,0.002616687,0.0011582071,0.00034733853,0.0015021154,0.0001881185],"domain_scores_gemma":[0.99154925,0.0027506896,0.0018865932,0.0006198556,0.0026908694,0.00050266803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009581475,0.00061344996,0.0010400618,0.0021099406,0.0007218307,0.00071710214,0.00081242545,0.0006376396,0.001440781],"category_scores_gemma":[0.018643487,0.00042405835,0.0012910812,0.0011264114,0.0004671519,0.0006569633,0.0007797973,0.0012890581,0.0007108271],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011204737,0.0010161398,0.9545315,0.00024031174,0.00035070215,0.00026677366,0.00066031085,0.0004954521,0.002088242,0.00024796606,0.0023421666,0.036639944],"study_design_scores_gemma":[0.00024789944,0.0014720095,0.99350196,0.000070803704,0.00005874095,0.00044484786,0.00022661852,0.0012310777,0.0006490021,0.00013003769,0.0019470147,0.000020026373],"about_ca_topic_score_codex":0.0016239533,"about_ca_topic_score_gemma":0.003215714,"teacher_disagreement_score":0.009581475,"about_ca_system_score_codex":0.0004971109,"about_ca_system_score_gemma":0.000920183,"threshold_uncertainty_score":0.050672293},"labels":[],"label_agreement":null},{"id":"W2114998283","doi":"10.1177/1352458514542363","title":"Late-onset multiple sclerosis presenting with cognitive dysfunction and severe cortical/infratentorial atrophy","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Multiple sclerosis; Atrophy; Medicine; Neuroscience; Cognition; Physical medicine and rehabilitation; Pathology; Psychology; Psychiatry","score_opus":0.07064335417150497,"score_gpt":0.2698732605159684,"score_spread":0.19922990634446341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114998283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992022,0.00020097193,0.00010643492,0.000016376584,0.000004454596,0.000012696814,0.00003729254,0.00000742072,0.00041209772],"genre_scores_gemma":[0.99954396,0.00007949079,0.00008955231,0.00003441648,0.000021646027,0.0000056733898,0.00007299635,0.0000014691093,0.0001507731],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99981683,0.000026282876,0.000027567925,0.000047326554,0.000026139047,0.000055992226],"domain_scores_gemma":[0.99929595,0.00011085717,0.00028807134,0.00004565568,0.000069338246,0.00019011757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021041307,0.0009423483,0.00053996575,0.0009952111,0.0009791445,0.00046169804,0.00033649697,0.00072398665,0.0020467453],"category_scores_gemma":[0.0013430434,0.00034562976,0.00024655517,0.0006328108,0.0005191487,0.0004279789,0.0004618532,0.0004079352,0.0004915377],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036610343,0.00010781009,0.945959,0.000053395215,0.000028372377,0.045891117,0.00043317224,0.000048523332,0.0029897094,0.000027542046,0.00015284475,0.0039425646],"study_design_scores_gemma":[0.00006326275,0.0013656043,0.6754636,0.000031131574,0.00006714264,0.32001594,0.0007727282,0.00018067531,0.0011849152,0.00008536558,0.0007515665,0.00001801919],"about_ca_topic_score_codex":0.0016582744,"about_ca_topic_score_gemma":0.002118884,"teacher_disagreement_score":0.0020467453,"about_ca_system_score_codex":0.00023202974,"about_ca_system_score_gemma":0.00030753747,"threshold_uncertainty_score":0.006847024},"labels":[],"label_agreement":null},{"id":"W2115103546","doi":"10.1177/1352458506072167","title":"Synergy between paclitaxel plus an exogenous methyl donor in the suppression of murine demyelinating diseases","year":2007,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Hospital for Sick Children","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada","keywords":"Remyelination; Multiple sclerosis; Astrocytosis; Myelin basic protein; Myelin; Medicine; Immunology; Experimental autoimmune encephalomyelitis; In vivo; Demyelinating disease; Cancer research; Combination therapy; Pharmacology; Biology; Central nervous system; Internal medicine; Immunohistochemistry","score_opus":0.13202293009807345,"score_gpt":0.35370644913832344,"score_spread":0.22168351904025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115103546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99362975,0.0028716987,0.0012099363,0.00010741279,0.000052381576,0.00007053129,0.0001090291,0.00007697023,0.0018723917],"genre_scores_gemma":[0.9948419,0.0016772735,0.0018630135,0.00003927955,0.00003663785,0.000040822768,0.00013071859,0.000017714136,0.0013526505],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986887,0.000044302644,0.000011372588,0.000016277823,0.00003274345,0.000026380123],"domain_scores_gemma":[0.99989533,0.00002213226,0.00002559232,0.000013173308,0.00000786663,0.000035855952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012573265,0.00028641464,0.00044761613,0.00040855748,0.000139072,0.0002595002,0.00018906334,0.00022233665,0.00078231335],"category_scores_gemma":[0.00010959906,0.00010347483,0.00014785257,0.00021899122,0.000223315,0.00015856407,0.0001657969,0.00039555973,0.00018940619],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054807193,0.0006578133,0.0011428116,0.00020599418,0.00009071401,0.00020850926,0.000058075628,0.0009827686,0.9530996,0.00041416072,0.00030537482,0.037353512],"study_design_scores_gemma":[0.0006048179,0.010368279,0.0023885893,0.000020470883,0.00017261844,0.0006030451,0.000024613695,0.0011891276,0.97665423,0.00011081451,0.007850002,0.000013366353],"about_ca_topic_score_codex":0.0004096983,"about_ca_topic_score_gemma":0.0013805282,"teacher_disagreement_score":0.00078231335,"about_ca_system_score_codex":0.00019299664,"about_ca_system_score_gemma":0.00027111996,"threshold_uncertainty_score":0.0026170611},"labels":[],"label_agreement":null},{"id":"W2115474937","doi":"10.1177/1352458508101944","title":"Anti-α-glucose–based glycan IgM antibodies predict relapse activity in multiple sclerosis after the first neurological event","year":2009,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Cohort; Multiple sclerosis; Medicine; Internal medicine; Biomarker; Antibody; Gastroenterology; Immunology; Biology","score_opus":0.08375616481045695,"score_gpt":0.2883952567213804,"score_spread":0.20463909191092344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115474937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997893,0.00009026185,0.000023556722,0.000005954578,0.0000014650664,0.0000026522753,0.00003057533,0.000001652368,0.00005467494],"genre_scores_gemma":[0.9997993,0.000031393243,0.00004504643,0.0000055857404,0.0000038898625,0.0000028171153,0.00008190076,6.107191e-7,0.00002946097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997173,0.00006898749,0.000033279073,0.00006730088,0.000055253866,0.000057834633],"domain_scores_gemma":[0.998254,0.00039322005,0.0008194237,0.00008002834,0.0001812491,0.000272105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007092678,0.00046654802,0.0003248859,0.0008304378,0.00030166312,0.00041142665,0.00034033606,0.0005791691,0.0009170229],"category_scores_gemma":[0.0026542207,0.00023493123,0.00029689397,0.00038032388,0.00030066707,0.0003093014,0.00035102823,0.0004924165,0.00025397545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024990443,0.000024148165,0.9983961,0.000003959687,0.00001693671,0.000055868688,0.000017376295,0.000030318208,0.00035614555,0.0000014709825,0.000025182615,0.0008225157],"study_design_scores_gemma":[0.000010405621,0.0002301785,0.9985507,0.0000060191187,0.000022591887,0.00056625286,0.00004288393,0.0002291515,0.00029132803,0.000006747628,0.000041745716,0.0000018897057],"about_ca_topic_score_codex":0.0014050297,"about_ca_topic_score_gemma":0.001470429,"teacher_disagreement_score":0.0014050297,"about_ca_system_score_codex":0.00019824998,"about_ca_system_score_gemma":0.000167008,"threshold_uncertainty_score":0.00375098},"labels":[],"label_agreement":null},{"id":"W2115977309","doi":"10.1177/1352458507076411","title":"Deep grey matter `black T2` on 3 tesla magnetic resonance imaging correlates with disability in multiple sclerosis","year":2007,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Multiple Sclerosis Society; Multiple Sclerosis Society of Canada","keywords":"Multiple sclerosis; Grey matter; Magnetic resonance imaging; Expanded Disability Status Scale; Globus pallidus; Nuclear medicine; Medicine; Caudate nucleus; Psychology; White matter; Radiology; Basal ganglia; Internal medicine; Psychiatry; Central nervous system","score_opus":0.061461826365315886,"score_gpt":0.27957573182267487,"score_spread":0.21811390545735898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115977309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99952435,0.00017043047,0.000044545133,0.000018442053,0.0000013845714,0.0000016295159,0.000015891284,0.000002479129,0.00022084029],"genre_scores_gemma":[0.999673,0.000068069574,0.00007033429,0.000012841214,0.000006091359,0.0000018547112,0.000047535766,0.0000015870481,0.00011864685],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999892,0.00003103168,0.000012542116,0.000019478553,0.000020333417,0.000024627405],"domain_scores_gemma":[0.9988393,0.00025267628,0.0005313212,0.000043786786,0.00011142218,0.0002214946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037122206,0.00031915613,0.00019962365,0.0006559642,0.00021377357,0.00024616596,0.00012589077,0.00036548512,0.0012504369],"category_scores_gemma":[0.001616833,0.00016214287,0.00010253033,0.0002747699,0.0003904207,0.0002720179,0.00027534788,0.00023699764,0.00021551704],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017742397,0.00011144658,0.9551443,0.000059231064,0.00016463968,0.0011310304,0.00052656874,0.00020955785,0.028785128,0.000054314725,0.00036779916,0.011671819],"study_design_scores_gemma":[0.000014648381,0.00024335584,0.99716216,0.000005119845,0.000023851318,0.0014515768,0.00006570166,0.0001128947,0.00075096474,0.0000592234,0.00010621204,0.000004214021],"about_ca_topic_score_codex":0.0012593139,"about_ca_topic_score_gemma":0.0019028055,"teacher_disagreement_score":0.0012593139,"about_ca_system_score_codex":0.0001260646,"about_ca_system_score_gemma":0.000072690076,"threshold_uncertainty_score":0.004183173},"labels":[],"label_agreement":null},{"id":"W2116526010","doi":"10.1177/1352458511422244","title":"Perinatal outcomes in women with multiple sclerosis exposed to disease-modifying drugs","year":2011,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Vancouver Coastal Health Research Institute","keywords":"Medicine; Pregnancy; Incidence (geometry); Odds ratio; Obstetrics; Population; Gestation; Vaginal delivery; Gestational age; Pediatrics; Internal medicine","score_opus":0.14244962692372048,"score_gpt":0.2945252923043973,"score_spread":0.1520756653806768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116526010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970906,0.00142036,0.000052181083,0.00008068156,0.0000056555045,0.000010434146,0.0005617158,0.0000027155702,0.00077557005],"genre_scores_gemma":[0.9986971,0.00088911795,0.00005936923,0.000021807793,0.0000053601852,0.0000074183413,0.00025084574,0.0000011351187,0.00006787218],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99933845,0.00021641854,0.00007521506,0.00009171406,0.00017426457,0.000103911465],"domain_scores_gemma":[0.99773043,0.0005641159,0.0012336362,0.00009869229,0.00018335393,0.00018974318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008102128,0.00014490259,0.00027831315,0.00085452833,0.00028311953,0.00048497942,0.0003173248,0.00022544988,0.0008484882],"category_scores_gemma":[0.0043366337,0.00015547125,0.0003269288,0.0012699855,0.0002392202,0.00023385494,0.0003356257,0.00046368144,0.00008736859],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060009046,0.000009185955,0.9984913,0.000012521023,0.000031619922,0.00018576812,0.00004411416,0.000020025167,0.000043392556,0.000012913051,0.000031349296,0.0010578547],"study_design_scores_gemma":[0.0000031032785,0.000092115486,0.9985293,0.000026812377,0.000040168467,0.00087464653,0.0001753901,0.00006048264,0.00006839569,0.000017238324,0.000110091365,0.0000022312888],"about_ca_topic_score_codex":0.013219102,"about_ca_topic_score_gemma":0.008997384,"teacher_disagreement_score":0.013219102,"about_ca_system_score_codex":0.00043652015,"about_ca_system_score_gemma":0.00034843266,"threshold_uncertainty_score":0.026284277},"labels":[],"label_agreement":null},{"id":"W2118096703","doi":"10.1177/1352458514540844","title":"How useful are MS registries?","year":2014,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Multiple sclerosis; Medicine; Clinical neurology; MEDLINE; Neuroscience; Psychology; Chemistry; Psychiatry","score_opus":0.10887535660433517,"score_gpt":0.24223977521564166,"score_spread":0.1333644186113065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118096703","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017436266,0.00029009924,0.000043667227,0.99600273,0.002492732,0.000003397638,0.000013591577,0.0000055109153,0.00097388774],"genre_scores_gemma":[0.0037780148,0.0008528116,0.00025041716,0.97726643,0.015816292,0.000023539136,0.000026224867,0.00001112503,0.0019752744],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98514766,0.006941248,0.0020943598,0.0009164453,0.0030703265,0.0018299152],"domain_scores_gemma":[0.9149738,0.04762644,0.0062256814,0.0020530568,0.012392539,0.016728356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014244023,0.0005614713,0.0013182536,0.0015184877,0.0056299632,0.008147257,0.0024098128,0.07311743,0.008549179],"category_scores_gemma":[0.134399,0.0011680946,0.0010953111,0.0013559827,0.004698292,0.010721134,0.003962065,0.051296864,0.0044095395],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004213306,0.000049513714,0.0036423781,0.00008780337,0.00003620073,0.0017078314,0.00031861034,0.000106982574,0.00010027097,0.006131236,0.9658143,0.021962786],"study_design_scores_gemma":[0.00023505258,0.00010332392,0.00479379,0.001964394,0.00013107261,0.004501724,0.0025445076,0.00087259244,0.0002981218,0.038068213,0.94632715,0.00016020406],"about_ca_topic_score_codex":0.010551634,"about_ca_topic_score_gemma":0.017908402,"teacher_disagreement_score":0.07311743,"about_ca_system_score_codex":0.007975803,"about_ca_system_score_gemma":0.016202735,"threshold_uncertainty_score":0.075330496},"labels":[],"label_agreement":null},{"id":"W2118372228","doi":"10.1191/1352458502ms769oa","title":"International consensus statement on the use of disease-modifying agents in multiple sclerosis","year":2002,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Statement (logic); Multiple sclerosis; Voting; Consensus conference; Medicine; Family medicine; Disease; Steering committee; Alternative medicine; MEDLINE; Political science; Psychiatry; Pathology; Internal medicine; Law; Engineering","score_opus":0.5148747468519949,"score_gpt":0.3560688506872489,"score_spread":0.15880589616474594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118372228","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0041327504,0.14539726,0.11118103,0.49504742,0.16839644,0.015339089,0.0066760113,0.0009515683,0.0528785],"genre_scores_gemma":[0.04944519,0.17391631,0.539549,0.10606104,0.033070028,0.033497807,0.023240658,0.0007694091,0.040450502],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.88496155,0.05072485,0.030826464,0.0024660886,0.027829437,0.0031916648],"domain_scores_gemma":[0.8122901,0.049385384,0.014966079,0.0046613202,0.10682035,0.011876831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.12297571,0.0029615331,0.005395489,0.0075083952,0.0032807307,0.0058339396,0.011640304,0.016891688,0.005685856],"category_scores_gemma":[0.121394046,0.0017960184,0.006989527,0.0060175406,0.0035134247,0.0038507513,0.0056455075,0.023212738,0.006802997],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005997651,0.00033862016,0.0016829238,0.017013626,0.0006128742,0.0012596044,0.0019002696,0.0017045877,0.0019285965,0.013094961,0.70040494,0.25945926],"study_design_scores_gemma":[0.0004945323,0.0003135642,0.0036531775,0.026746789,0.0009058834,0.001390066,0.0010856804,0.0010501368,0.0012798427,0.015749658,0.9471625,0.00016812446],"about_ca_topic_score_codex":0.007327095,"about_ca_topic_score_gemma":0.004804784,"teacher_disagreement_score":0.12297571,"about_ca_system_score_codex":0.0070945877,"about_ca_system_score_gemma":0.0528681,"threshold_uncertainty_score":0.6503655},"labels":[],"label_agreement":null},{"id":"W2118598578","doi":"10.1177/1352458509355462","title":"A randomized trial of memantine as treatment for spasticity in multiple sclerosis","year":2009,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministère de la Santé et des Services sociaux; National Multiple Sclerosis Society","keywords":"Spasticity; Memantine; Modified Ashworth scale; Multiple sclerosis; Randomized controlled trial; Medicine; Placebo; Physical therapy; Physical medicine and rehabilitation; Psychology; Internal medicine; Psychiatry","score_opus":0.1948002845081289,"score_gpt":0.35093360852870165,"score_spread":0.15613332402057276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118598578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9739646,0.0076848464,0.001332235,0.0015416471,0.0019372246,0.010296625,0.00100909,0.00027749554,0.0019562577],"genre_scores_gemma":[0.96953446,0.0038374308,0.0042213127,0.0021237805,0.0014404177,0.014675232,0.0009380041,0.000046703546,0.0031826282],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9977756,0.0015354254,0.00017388059,0.0002266546,0.00012721083,0.00016113902],"domain_scores_gemma":[0.9973035,0.0012197292,0.00050866173,0.00022065536,0.00016868372,0.0005787412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037143007,0.0021589592,0.0046354635,0.00090604584,0.0009882395,0.0010054422,0.001364666,0.0035817456,0.0063967286],"category_scores_gemma":[0.00552684,0.0010402972,0.0018706055,0.00064450176,0.0019648345,0.0014210098,0.0006459019,0.0030269886,0.0010446785],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9868902,0.004358104,0.00011740829,0.0004219099,0.00033799678,0.000027751505,0.000031805303,0.0001048311,0.0014316039,0.000059798793,0.00026054456,0.005957978],"study_design_scores_gemma":[0.9776073,0.021767793,0.00016586116,0.000009835851,0.000110552915,0.000008376511,0.000005063531,0.00007540549,0.00010727385,0.00003875402,0.000099087934,0.000004640074],"about_ca_topic_score_codex":0.0010629983,"about_ca_topic_score_gemma":0.0021906996,"teacher_disagreement_score":0.0063967286,"about_ca_system_score_codex":0.00058996235,"about_ca_system_score_gemma":0.0014821063,"threshold_uncertainty_score":0.0213992},"labels":[],"label_agreement":null},{"id":"W2118948764","doi":"10.1177/1352458514538334","title":"Identifying individuals with multiple sclerosis in an electronic medical record","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network; St. Michael's Hospital; Institute for Clinical Evaluative Sciences; Women's College Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medical record; Medicine; Medical prescription; Electronic medical record; Diagnosis code; MEDLINE; Family medicine; Chart; Medical emergency; Internal medicine; Population; Nursing","score_opus":0.10881662590877705,"score_gpt":0.32381123168379233,"score_spread":0.21499460577501528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118948764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98448807,0.00064260804,0.0023555309,0.0005732369,0.000020738062,0.00053431117,0.00742426,0.00007464567,0.0038865795],"genre_scores_gemma":[0.9875048,0.00044131454,0.0069956314,0.00024055902,0.00003757077,0.00016753415,0.004020574,0.0000045952074,0.00058746175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962335,0.0011302143,0.0008282345,0.0003692814,0.0012319668,0.00020669226],"domain_scores_gemma":[0.982515,0.005283409,0.008105079,0.0009502851,0.0027759937,0.00037023466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036838322,0.00018647505,0.00031180945,0.0025836085,0.00036606728,0.00089145073,0.0005518563,0.00029690503,0.0014083915],"category_scores_gemma":[0.020325007,0.00013668335,0.00022989087,0.0033449507,0.00023771188,0.0005680221,0.0006886681,0.00022229487,0.00033988437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060423343,0.00002783767,0.98730785,0.00009389391,0.000028294473,0.00008021536,0.0002728848,0.00010132978,0.00033205084,0.000052448817,0.0005906302,0.011052104],"study_design_scores_gemma":[0.00001899191,0.0000867413,0.9948726,0.00011080456,0.000042133903,0.00023983938,0.00035477243,0.0011898454,0.0005655375,0.00007629246,0.0024361338,0.0000063390066],"about_ca_topic_score_codex":0.061306775,"about_ca_topic_score_gemma":0.08088093,"teacher_disagreement_score":0.061306775,"about_ca_system_score_codex":0.0011138879,"about_ca_system_score_gemma":0.0018042669,"threshold_uncertainty_score":0.12189984},"labels":[],"label_agreement":null},{"id":"W2118969721","doi":"10.1177/1352458509359727","title":"The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group","year":2010,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":219,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Ottawa Hospital; Montreal Neurological Institute and Hospital; University of Ottawa","funders":"Multiple Sclerosis Society","keywords":"Mesenchymal stem cell; Multiple sclerosis; Remyelination; Stem cell; Medicine; Transplantation; Stem-cell therapy; Regenerative medicine; Regeneration (biology); Cell therapy; Immunology; Pathology; Central nervous system; Biology; Surgery; Internal medicine; Myelin","score_opus":0.10512478994437145,"score_gpt":0.31161315185422545,"score_spread":0.20648836190985398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118969721","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023542568,0.65019,0.0075868424,0.28353557,0.016215144,0.0007508371,0.00089986756,0.00007029706,0.017208962],"genre_scores_gemma":[0.19222577,0.6170788,0.031265616,0.115768075,0.024097629,0.0026670564,0.003195105,0.00021808376,0.013483915],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9918833,0.0022219901,0.0022153624,0.00054982275,0.0026036357,0.00052581466],"domain_scores_gemma":[0.97612154,0.00996436,0.0029331828,0.00046767265,0.008616821,0.0018964674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0319812,0.0007938516,0.0018581597,0.0014694863,0.00074911123,0.0019462717,0.0020442642,0.00590495,0.0009571074],"category_scores_gemma":[0.011821746,0.0003075533,0.0016687885,0.0014721972,0.0011971764,0.001430175,0.001312587,0.004780796,0.0005710756],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025957793,0.00056193507,0.0062178927,0.008004669,0.0004519734,0.0009212004,0.00072321435,0.001200994,0.010559374,0.0062003974,0.13947572,0.82308686],"study_design_scores_gemma":[0.0015945655,0.0031986053,0.017748753,0.015123507,0.0023684257,0.0027270773,0.001418727,0.0013766466,0.029155986,0.0077829137,0.91730386,0.00020094347],"about_ca_topic_score_codex":0.0015622445,"about_ca_topic_score_gemma":0.0018014524,"teacher_disagreement_score":0.0319812,"about_ca_system_score_codex":0.0018208693,"about_ca_system_score_gemma":0.008603976,"threshold_uncertainty_score":0.1691348},"labels":[],"label_agreement":null},{"id":"W2119516839","doi":"10.1191/1352458502ms767xx","title":"The role of MRI as a surrogate outcome measure in multiple sclerosis","year":2002,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"Multiple Sclerosis Society","keywords":"Multiple sclerosis; Medicine; Magnetic resonance imaging; Clinical trial; Surrogate endpoint; Disease; Pathology; Radiology; Psychiatry","score_opus":0.26632659133914205,"score_gpt":0.35765787954063966,"score_spread":0.0913312882014976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119516839","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04365183,0.55829537,0.17143868,0.19512828,0.010738347,0.0016765182,0.0007939778,0.00020921073,0.018067742],"genre_scores_gemma":[0.6612667,0.12045196,0.14111817,0.052098405,0.017593822,0.0040371926,0.0003917811,0.00018277233,0.0028592786],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.68916994,0.27986956,0.011700913,0.003503244,0.015059274,0.0006971582],"domain_scores_gemma":[0.44708887,0.48983136,0.02999976,0.01296273,0.018479874,0.0016374671],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.34621364,0.0010045078,0.003731054,0.002419904,0.0009325227,0.0058893347,0.0017960516,0.003978432,0.0007045356],"category_scores_gemma":[0.3204161,0.00038395077,0.0015194287,0.0030308908,0.0072793504,0.005036974,0.0031993475,0.008513162,0.0002767636],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074987346,0.00050555234,0.03738647,0.01239619,0.0021174392,0.0005092896,0.0036124084,0.0061197197,0.0039355247,0.1512663,0.021086521,0.7535659],"study_design_scores_gemma":[0.0022400385,0.028064404,0.100049086,0.043413214,0.004387121,0.005110318,0.0036189007,0.03957204,0.016358662,0.45080537,0.30472136,0.0016594904],"about_ca_topic_score_codex":0.0011110181,"about_ca_topic_score_gemma":0.00087598176,"teacher_disagreement_score":0.34621364,"about_ca_system_score_codex":0.0028124175,"about_ca_system_score_gemma":0.0039194003,"threshold_uncertainty_score":0.80623496},"labels":[],"label_agreement":null},{"id":"W2120619359","doi":"10.1177/1352458511432327","title":"Predictive nature of IgM anti-α-glucose serum biomarker for relapse activity and EDSS progression in CIS patients: a BENEFIT study analysis","year":2011,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Genentech; Sanofi; Bayer HealthCare; Teva Pharmaceutical Industries; Eisai; UCB Pharma; Bayer Vital; Abbott Laboratories; Celgene; Biogen; GlaxoSmithKline; Bristol-Myers Squibb; AstraZeneca; Universitätsspital Basel","keywords":"Multiple sclerosis; Medicine; Clinically isolated syndrome; Biomarker; Internal medicine; Cohort; Population; Antibody; Cohort study; Predictive value; Gastroenterology; Immunology","score_opus":0.078011698650318,"score_gpt":0.32901778758942357,"score_spread":0.2510060889391056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120619359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994949,0.00016704196,0.00005773328,0.000017693654,0.0000042280985,0.000017748172,0.000077926445,0.0000017670814,0.00016098714],"genre_scores_gemma":[0.99959964,0.000033479322,0.00007421623,0.000014566454,0.000015157525,0.000012635608,0.00018684275,0.000001112961,0.00006236088],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99944,0.00022975948,0.00004172639,0.0001413652,0.00009167649,0.0000555658],"domain_scores_gemma":[0.9978891,0.0007811852,0.0004825275,0.0001987179,0.00018106832,0.0004674445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018166958,0.00062724337,0.0008280299,0.0005095731,0.00028779285,0.00056996004,0.00034087116,0.00046906323,0.0021061923],"category_scores_gemma":[0.003030924,0.0002488659,0.00084602577,0.00034375506,0.00032274588,0.00041441564,0.00045323413,0.0005827933,0.00028121943],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033336353,0.00039038833,0.95701784,0.00009153951,0.0009882331,0.00017080187,0.00009157121,0.00021675887,0.0019263237,0.00004114716,0.0001498981,0.0055790576],"study_design_scores_gemma":[0.001328365,0.010220315,0.9842445,0.000021349491,0.0011968473,0.00065345294,0.00008916745,0.0013272025,0.00045749897,0.00009807129,0.00034618648,0.000017010556],"about_ca_topic_score_codex":0.0003556676,"about_ca_topic_score_gemma":0.00052841316,"teacher_disagreement_score":0.0021061923,"about_ca_system_score_codex":0.00022752793,"about_ca_system_score_gemma":0.000321504,"threshold_uncertainty_score":0.009607673},"labels":[],"label_agreement":null},{"id":"W2121106726","doi":"10.1177/1352458512459684","title":"Oligoclonal bands and cerebrospinal fluid markers in multiple sclerosis: associations with disease course and progression","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Multiple sclerosis; Cerebrospinal fluid; Medicine; Disease; Pathology; Clinically isolated syndrome; Immunology","score_opus":0.08223809029154454,"score_gpt":0.31004725929179217,"score_spread":0.2278091690002476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121106726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998618,0.00087226514,0.000066692846,0.000038752256,0.0000036725446,0.000004700075,0.00010497091,0.0000060626703,0.0002848647],"genre_scores_gemma":[0.9994367,0.00018248688,0.000111407826,0.000012802158,0.000013429988,0.0000048641728,0.00014390334,0.0000024899387,0.00009189204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995485,0.0001068009,0.000057157897,0.000080275524,0.00015429968,0.000052932584],"domain_scores_gemma":[0.9944127,0.0010697837,0.0032644593,0.00015836039,0.00051251205,0.0005822567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096161815,0.0003067325,0.0003012033,0.0010921733,0.00024925082,0.0004870802,0.00028666132,0.0003788549,0.0010335112],"category_scores_gemma":[0.004985992,0.00014262974,0.00020641953,0.000804243,0.00032940196,0.00039548808,0.00035313616,0.00054326124,0.00021514708],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002167364,0.00002079377,0.9966402,0.000011645864,0.000035305846,0.000074727934,0.00003306694,0.00006277523,0.00042569215,0.000008299588,0.000044175384,0.0024266858],"study_design_scores_gemma":[0.0000061678525,0.00007559508,0.9987503,0.000008682982,0.000020298174,0.0007310577,0.000028233007,0.00016782078,0.00009252392,0.000032433636,0.000084392756,0.0000024547082],"about_ca_topic_score_codex":0.0015199505,"about_ca_topic_score_gemma":0.0016154512,"teacher_disagreement_score":0.0015199505,"about_ca_system_score_codex":0.00023258991,"about_ca_system_score_gemma":0.0002797412,"threshold_uncertainty_score":0.0050855875},"labels":[],"label_agreement":null},{"id":"W2121218425","doi":"10.1177/1352458515599072","title":"Effect of intramuscular interferon beta-1a on gray matter atrophy in relapsing−remitting multiple sclerosis: A retrospective analysis","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mitacs; Cleveland Clinic; Biogen; National Institute of Neurological Disorders and Stroke; American Academy of Neurology","keywords":"Atrophy; Multiple sclerosis; Interferon beta-1a; Placebo; Medicine; White matter; Internal medicine; Relapsing remitting; Brain size; Gastroenterology; Pathology; Magnetic resonance imaging; Immunology; Interferon beta; Radiology","score_opus":0.06954738527371836,"score_gpt":0.30236952765164443,"score_spread":0.2328221423779261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121218425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977871,0.0016390489,0.00011071692,0.00001379549,0.000003393619,0.000030398614,0.00021084689,0.0000027479166,0.0002019437],"genre_scores_gemma":[0.99920183,0.00029035573,0.0001173067,0.00001916929,0.000008773169,0.000023127694,0.0002816501,0.0000016010607,0.00005626945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984635,0.00074230524,0.00022591153,0.00026132574,0.00022590096,0.00008104941],"domain_scores_gemma":[0.99550086,0.001629238,0.0020258839,0.00038465476,0.00023643511,0.0002229838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027428768,0.00021538784,0.00055676163,0.00039039075,0.00016150252,0.00034043586,0.00020303536,0.00037837648,0.00078146846],"category_scores_gemma":[0.005486477,0.00020700332,0.0007110738,0.00046385408,0.00034705567,0.00023574212,0.00017790147,0.00031200482,0.0001744184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0227683,0.00029407546,0.9557821,0.0002499252,0.0013541483,0.00024359542,0.000101358266,0.0003024034,0.0018465228,0.000043064403,0.00015830994,0.016856201],"study_design_scores_gemma":[0.0005608608,0.0074290754,0.9889281,0.00003422118,0.0008333959,0.0006325099,0.00004634552,0.0002701144,0.000716194,0.00002956759,0.00050793553,0.000011672543],"about_ca_topic_score_codex":0.00047182292,"about_ca_topic_score_gemma":0.00044739558,"teacher_disagreement_score":0.0027428768,"about_ca_system_score_codex":0.0002923863,"about_ca_system_score_gemma":0.0002251706,"threshold_uncertainty_score":0.014505863},"labels":[],"label_agreement":null},{"id":"W2121397527","doi":"10.1177/1352458509345914","title":"Thalamic stimulation in multiple sclerosis: evidence for a ‘demyelinative thalamotomy’","year":2009,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; International Collaboration On Repair Discoveries; University of British Columbia","funders":"Multiple Sclerosis Society","keywords":"Deep brain stimulation; Thalamus; White matter; Multiple sclerosis; Thalamic stimulator; Thalamotomy; Essential tremor; Neuroscience; Medicine; Stimulation; Cortex (anatomy); Pathology; Magnetic resonance imaging; Parkinson's disease; Psychology; Radiology; Disease","score_opus":0.24866860668062965,"score_gpt":0.338975561023911,"score_spread":0.09030695434328137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121397527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97290504,0.011973465,0.0022991956,0.0009900889,0.000074662246,0.000054122585,0.00006431447,0.00005233618,0.011586722],"genre_scores_gemma":[0.99743915,0.0015964747,0.00041392323,0.00014395415,0.00013081013,0.000009196303,0.00003083231,0.0000033268263,0.00023239681],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99987686,0.000034975405,0.000017509888,0.000015470561,0.000028109855,0.000026983425],"domain_scores_gemma":[0.99960595,0.00017314783,0.00010704871,0.000041086852,0.0000390835,0.00003377605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034483068,0.00030241587,0.00025017103,0.00057609944,0.00027793742,0.00033053977,0.0004401835,0.0008931567,0.0027615645],"category_scores_gemma":[0.0013596973,0.00021451106,0.00024168979,0.00031611274,0.00089032087,0.00043482074,0.00027273854,0.00033454353,0.00050761574],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028782391,0.00030574042,0.113583885,0.0019982036,0.00036615186,0.47098958,0.0016218747,0.00037832963,0.3137028,0.0046022343,0.0017688201,0.08780412],"study_design_scores_gemma":[0.00049795123,0.0022052831,0.17498623,0.00020619722,0.000408489,0.78492904,0.00049319275,0.00091143645,0.028057817,0.0018076535,0.0054636826,0.000033002627],"about_ca_topic_score_codex":0.0006407916,"about_ca_topic_score_gemma":0.0005823416,"teacher_disagreement_score":0.0027615645,"about_ca_system_score_codex":0.00021126363,"about_ca_system_score_gemma":0.0001826252,"threshold_uncertainty_score":0.009238362},"labels":[],"label_agreement":null},{"id":"W2121776596","doi":"10.1177/1352458509106714","title":"The development and validation of the Unidimensional Fatigue Impact Scale (U-FIS)","year":2009,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Rasch model; Cronbach's alpha; Psychology; Construct validity; Scale (ratio); Reliability (semiconductor); Clinical psychology; Psychometrics; Content validity; Developmental psychology","score_opus":0.11340163379341925,"score_gpt":0.33185436665460094,"score_spread":0.2184527328611817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121776596","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9161886,0.00447915,0.057887513,0.0011397235,0.00032586476,0.005994934,0.0016319505,0.00023046532,0.012121846],"genre_scores_gemma":[0.89549583,0.0013862957,0.09374544,0.0002447863,0.000089495436,0.0065594297,0.0013036862,0.000028389926,0.0011467647],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99479204,0.002684129,0.00079916354,0.00021093753,0.0013494717,0.00016426767],"domain_scores_gemma":[0.9855745,0.006094721,0.0016322823,0.0009760448,0.0052288203,0.00049360085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016880462,0.00038663062,0.0005971475,0.0023499483,0.0005038293,0.0006592253,0.00069666206,0.0007192759,0.0015019288],"category_scores_gemma":[0.034684718,0.00022888697,0.0007944999,0.0009826125,0.00071094435,0.0011149314,0.0012666254,0.00090389966,0.00032572544],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005182172,0.00056128367,0.39260978,0.0006704432,0.00019808815,0.0001267608,0.003511133,0.001441385,0.004167045,0.003345586,0.004345091,0.58850515],"study_design_scores_gemma":[0.00016006992,0.0029215205,0.96687436,0.0012740691,0.00013647132,0.00080245064,0.0016097759,0.006013452,0.0024849626,0.0025725444,0.015042557,0.00010788009],"about_ca_topic_score_codex":0.0023520554,"about_ca_topic_score_gemma":0.004130124,"teacher_disagreement_score":0.016880462,"about_ca_system_score_codex":0.00075330725,"about_ca_system_score_gemma":0.00251287,"threshold_uncertainty_score":0.08927351},"labels":[],"label_agreement":null},{"id":"W2122283731","doi":"10.1177/1352458512464686","title":"Mesenchymal stem cells as treatment for MS – progress to date","year":2012,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Mesenchymal stem cell; Multiple sclerosis; Experimental autoimmune encephalomyelitis; Medicine; Neuroprotection; Clinical trial; Stem cell; Magnetic resonance imaging; Encephalomyelitis; Neuroscience; Stem-cell therapy; Progenitor cell; Central nervous system; Cell therapy; Regeneration (biology); Pathology; Immunology; Pharmacology; Internal medicine; Biology; Radiology; Cell biology","score_opus":0.43056284665087285,"score_gpt":0.4246007062888203,"score_spread":0.005962140362052559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122283731","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010199335,0.9990662,0.000059354028,0.00018474896,0.00013954272,0.0000033381816,0.0000069684975,0.0000046058167,0.0004332876],"genre_scores_gemma":[0.0005580881,0.9984433,0.00015426907,0.00017023137,0.00017700081,0.0000051665015,0.000015456866,0.0000016498209,0.00047493662],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997118,0.000054733406,0.000044233842,0.00005213562,0.000112702,0.00002433097],"domain_scores_gemma":[0.9995435,0.00023651303,0.000051634346,0.00001757509,0.00010786202,0.00004291928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012111731,0.0009981666,0.0018030796,0.0022484623,0.00037957213,0.0014165957,0.001182032,0.0017088368,0.003944386],"category_scores_gemma":[0.0009999936,0.00038253015,0.00056896434,0.002209857,0.00080915925,0.0020364386,0.00087485655,0.00245626,0.003173111],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015477493,0.00016050364,0.000115218994,0.014750641,0.00008547548,0.00019759235,0.00009315799,0.0004058363,0.0023606145,0.004351479,0.022522489,0.95480216],"study_design_scores_gemma":[0.00003815625,0.00014888018,0.0004978904,0.0035142342,0.0001135817,0.00097222807,0.00008119168,0.000109183275,0.0008100626,0.0027002678,0.9909949,0.000019480929],"about_ca_topic_score_codex":0.000970951,"about_ca_topic_score_gemma":0.0016832758,"teacher_disagreement_score":0.003944386,"about_ca_system_score_codex":0.0006056715,"about_ca_system_score_gemma":0.0010524177,"threshold_uncertainty_score":0.013195336},"labels":[],"label_agreement":null},{"id":"W2122999365","doi":"10.1177/1352458512450354","title":"Pre-specified subgroup analyses of a placebo-controlled phase III trial (TEMSO) of oral teriflunomide in relapsing multiple sclerosis","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Toronto","funders":"","keywords":"Teriflunomide; Multiple sclerosis; Placebo; Medicine; Subgroup analysis; Internal medicine; Clinical trial; Oncology; Immunology; Alternative medicine; Pathology; Fingolimod; Confidence interval","score_opus":0.25083960982849857,"score_gpt":0.38691556742966565,"score_spread":0.13607595760116709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122999365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95484215,0.02339825,0.005325958,0.00075116527,0.00074458506,0.00980864,0.0027027023,0.00027159444,0.0021550502],"genre_scores_gemma":[0.9846543,0.002225069,0.0033594673,0.00049340626,0.00027009554,0.0066756336,0.0013430719,0.00003871621,0.0009401681],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9939323,0.004119563,0.00090862974,0.00042099482,0.00037721667,0.00024123718],"domain_scores_gemma":[0.99526227,0.0024294,0.00090461934,0.00077908055,0.00039655124,0.00022805731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011590356,0.0013086998,0.004039242,0.00059978076,0.00032363203,0.00078747835,0.00064760586,0.0013182064,0.003074541],"category_scores_gemma":[0.009756519,0.0004045912,0.0068234284,0.00041106812,0.0004087636,0.000569168,0.00044104687,0.0015140545,0.0002931869],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9123561,0.0013471214,0.008356511,0.0026395326,0.02536855,0.00011702954,0.00014152774,0.0010368753,0.0074365637,0.00015620967,0.00084007933,0.04020389],"study_design_scores_gemma":[0.67664266,0.15577847,0.06587028,0.00041126582,0.081654765,0.0002811429,0.00017106383,0.0034943444,0.009022516,0.0013204457,0.0052397223,0.00011318831],"about_ca_topic_score_codex":0.00029786897,"about_ca_topic_score_gemma":0.0011282262,"teacher_disagreement_score":0.011590356,"about_ca_system_score_codex":0.00042913054,"about_ca_system_score_gemma":0.0010419259,"threshold_uncertainty_score":0.061296403},"labels":[],"label_agreement":null},{"id":"W2123678451","doi":"10.1177/1352458513494491","title":"Interferon beta-1b reduces black holes in a randomised trial of clinically isolated syndrome","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Vrije Universiteit Amsterdam","keywords":"Multiple sclerosis; Medicine; Interferon beta; Clinically isolated syndrome; Interferon beta-1b; Interferon beta-1a; Internal medicine; BETA (programming language); Clinical trial; Oncology; Immunology","score_opus":0.10911489260672029,"score_gpt":0.33090474113412066,"score_spread":0.22178984852740036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123678451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98781115,0.00865746,0.00020636065,0.0006175017,0.0005353614,0.0010236355,0.00022630072,0.000039070335,0.0008831783],"genre_scores_gemma":[0.99269015,0.0030281541,0.00049638096,0.0007380581,0.0003386997,0.0014508044,0.00027000252,0.0000064013434,0.0009814332],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99902093,0.0007037665,0.00005379494,0.000076558725,0.00005066548,0.00009433333],"domain_scores_gemma":[0.99874395,0.0004635426,0.00035123073,0.00006820369,0.000056755165,0.00031636024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017359225,0.00093993807,0.0020814757,0.00034796342,0.00033079705,0.0005904017,0.00064711145,0.0014116552,0.0046482305],"category_scores_gemma":[0.002357235,0.00037934116,0.0014658922,0.00032243034,0.00073275436,0.00045077407,0.00035739763,0.0015992046,0.00035901458],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9760692,0.0021061508,0.0007221011,0.0008218858,0.0008434869,0.000065197426,0.00004893933,0.00016929387,0.0015264378,0.000089543326,0.00045170652,0.017085971],"study_design_scores_gemma":[0.9528505,0.04253846,0.0031986528,0.000102537975,0.00031882647,0.000052284686,0.000023577952,0.0002580084,0.00014910736,0.00014654335,0.0003518268,0.000009582748],"about_ca_topic_score_codex":0.0009205763,"about_ca_topic_score_gemma":0.0016536335,"teacher_disagreement_score":0.0046482305,"about_ca_system_score_codex":0.00057722593,"about_ca_system_score_gemma":0.0008601975,"threshold_uncertainty_score":0.015549898},"labels":[],"label_agreement":null},{"id":"W2126266265","doi":"10.1191/1352458504ms1028oa","title":"Primary progressive multiple sclerosis: cerebrospinal fluid considerations","year":2004,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Multiple sclerosis; Cerebrospinal fluid; Medicine; Pathological; Disease; Central nervous system; Demyelinating disease; Central nervous system disease; Pathology; Neuroscience; Psychology; Internal medicine; Immunology","score_opus":0.23279537779163348,"score_gpt":0.3595521033709321,"score_spread":0.1267567255792986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126266265","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012254417,0.9982917,0.00010968438,0.0005582874,0.00018276868,0.0000035726707,0.0000060430684,0.000005893743,0.0007194907],"genre_scores_gemma":[0.0023117678,0.9960686,0.00032457535,0.0003848279,0.0003921596,0.0000063081525,0.000014341052,0.0000013279879,0.0004960509],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99942976,0.00014975967,0.000106916195,0.00007100059,0.00020618486,0.00003637349],"domain_scores_gemma":[0.99914455,0.00036592502,0.00016102912,0.00002595584,0.00025145282,0.00005107059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085638807,0.00093733164,0.0026480553,0.0031535416,0.00038240617,0.0015024128,0.0010796285,0.0017442503,0.0019981747],"category_scores_gemma":[0.001755994,0.00030128143,0.00054674293,0.0027499238,0.0008324891,0.0018280203,0.000557555,0.0013448943,0.001829683],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007269064,0.000057098587,0.00075219886,0.025337469,0.0001204602,0.0059184125,0.00020793025,0.00022516587,0.0018464269,0.0029009033,0.04366791,0.9188933],"study_design_scores_gemma":[0.00003695691,0.00011703288,0.0041778223,0.014580271,0.00022006371,0.05275185,0.0006393884,0.00014495276,0.0012205013,0.0052215755,0.92084724,0.00004225138],"about_ca_topic_score_codex":0.0022276414,"about_ca_topic_score_gemma":0.0037303183,"teacher_disagreement_score":0.0031535416,"about_ca_system_score_codex":0.0007071772,"about_ca_system_score_gemma":0.0014982326,"threshold_uncertainty_score":0.0066846013},"labels":[],"label_agreement":null},{"id":"W2126517980","doi":"10.1177/1352458514559298","title":"Impact of parental multiple sclerosis on early childhood development: A retrospective cohort study","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Family Support in Illness","field":"Social Sciences","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Vancouver Coastal Health; Vancouver Coastal Health Research Institute; University of British Columbia","funders":"Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; Manitoba Health Research Council; Lawson Foundation; Canadian Institutes of Health Research; Multiple Sclerosis Scientific Research Foundation; Social Sciences and Humanities Research Council of Canada; Child and Family Research Institute; Sanofi","keywords":"Medicine; Early childhood; Retrospective cohort study; Odds ratio; Pediatrics; Cohort; Cohort study; Mental health; Logistic regression; Child development; Population; Vulnerability (computing); Confidence interval; Psychiatry; Psychology; Developmental psychology; Environmental health; Internal medicine","score_opus":0.0919503146672521,"score_gpt":0.29833378701627006,"score_spread":0.20638347234901794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126517980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972983,0.0004184698,0.000120361605,0.000036541955,0.0000058045725,0.00003870843,0.0017783102,0.0000039419683,0.00029963444],"genre_scores_gemma":[0.99782205,0.0004845882,0.000196357,0.00004489282,0.0000061505475,0.000040985535,0.0012498952,0.0000030432932,0.00015198332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908507,0.0001883504,0.00009412371,0.00022613366,0.00021527713,0.00019105193],"domain_scores_gemma":[0.9977544,0.00024372317,0.0008352644,0.00031282502,0.00048892054,0.00036483386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011146283,0.00047794994,0.000435245,0.0012009655,0.0013482107,0.0008408157,0.0007435788,0.000464753,0.0010635909],"category_scores_gemma":[0.0024045121,0.000619319,0.0006156939,0.0028809234,0.00044953695,0.00044120688,0.0008033824,0.00078473176,0.0001859683],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024252975,0.000010056342,0.999388,0.0000061030287,0.000040478233,0.00006444427,0.00009126636,0.000011510602,0.00003511401,0.000006930427,0.00006075471,0.00026116063],"study_design_scores_gemma":[0.000005299309,0.000046995443,0.9991897,0.000016665152,0.000038778213,0.00018967,0.00027388486,0.000050194983,0.000023749133,0.000005923014,0.00015550194,0.0000037362752],"about_ca_topic_score_codex":0.3594431,"about_ca_topic_score_gemma":0.36346102,"teacher_disagreement_score":0.3594431,"about_ca_system_score_codex":0.0019959812,"about_ca_system_score_gemma":0.0027323503,"threshold_uncertainty_score":0.7147018},"labels":[],"label_agreement":null},{"id":"W2127478877","doi":"10.1191/1352458505ms1149oa","title":"Discrepancies in the interpretation of clinical symptoms and signs in the diagnosis of multiple sclerosis. A proposal for standardization","year":2005,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Multiple sclerosis; Standardization; Medicine; Interpretation (philosophy); Clinical trial; Magnetic resonance imaging; Disease; Medical physics; Physical therapy; Psychology; Pathology; Radiology; Psychiatry; Computer science","score_opus":0.14715431458710163,"score_gpt":0.380521040263865,"score_spread":0.2333667256767634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127478877","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29073593,0.15798172,0.3738615,0.11932264,0.024316715,0.0072498433,0.001119791,0.00066791044,0.024743868],"genre_scores_gemma":[0.6808239,0.019000024,0.2546802,0.034330107,0.0054473486,0.0029671965,0.00075820426,0.00029589602,0.0016970497],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.31246454,0.4778666,0.12269217,0.014577108,0.07063593,0.0017636291],"domain_scores_gemma":[0.27595276,0.5326767,0.065713346,0.056511782,0.0670946,0.0020508827],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.5447341,0.0008079831,0.002555978,0.007221925,0.0025533827,0.007219993,0.0052537555,0.0033787522,0.00039267278],"category_scores_gemma":[0.52465177,0.001474685,0.0018571836,0.005578621,0.011985061,0.004838225,0.0076388223,0.005176593,0.00038319276],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020334213,0.000377537,0.11954516,0.014491619,0.001689203,0.0026512495,0.16636321,0.0016080501,0.011269186,0.07208878,0.025211133,0.58267146],"study_design_scores_gemma":[0.0011094138,0.0022623548,0.2843944,0.039959315,0.002994039,0.019678222,0.09059544,0.007399309,0.021813298,0.25479147,0.27339056,0.0016122204],"about_ca_topic_score_codex":0.0024117588,"about_ca_topic_score_gemma":0.0039424435,"teacher_disagreement_score":0.5447341,"about_ca_system_score_codex":0.0046688993,"about_ca_system_score_gemma":0.007146838,"threshold_uncertainty_score":0.5614239},"labels":[],"label_agreement":null},{"id":"W2127555980","doi":"10.1177/1352458515578770","title":"Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"Universitetet i Bergen; Helse Vest; Multiple Sclerosis Society of Canada; Multiple Sclerosis Society; Harvard T.H. Chan School of Public Health; Biogen; Sanofi","keywords":"Medicine; Multiple sclerosis; Vitamin D and neurology; Cod liver oil; Vitamin; Internal medicine; Risk factor; Physiology; Gastroenterology; Immunology","score_opus":0.242726996760548,"score_gpt":0.2997247063648875,"score_spread":0.0569977096043395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127555980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998645,0.0005690899,0.00005416753,0.000022303782,0.0000050643303,0.0000065425456,0.00052492705,0.0000014800042,0.00017144528],"genre_scores_gemma":[0.99858356,0.00030434388,0.00011797446,0.000014615875,0.000008360645,0.0000139374715,0.0006815052,0.000002884593,0.0002728256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996313,0.00011471106,0.000045760422,0.0000965613,0.00005882931,0.00005284501],"domain_scores_gemma":[0.9991585,0.00011365826,0.0003991921,0.00009651849,0.000078641584,0.00015353768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000915217,0.00037958968,0.00041154277,0.0005010093,0.00030500678,0.000468475,0.00051226816,0.00049116206,0.00086793967],"category_scores_gemma":[0.0010669561,0.00037993182,0.0007698775,0.00092758425,0.00018733369,0.00025392024,0.0004384619,0.00039991032,0.00012260664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007799993,0.000031706655,0.9978567,0.000019981924,0.00019386373,0.000078671204,0.00008628517,0.000021680846,0.00033352984,0.000010948407,0.000060951857,0.0005257673],"study_design_scores_gemma":[0.000029769248,0.00017908028,0.999057,0.0000136051485,0.0001393712,0.00013815334,0.00012295548,0.000059947033,0.00006330963,0.000009129658,0.0001848837,0.000002887761],"about_ca_topic_score_codex":0.016143782,"about_ca_topic_score_gemma":0.01710283,"teacher_disagreement_score":0.016143782,"about_ca_system_score_codex":0.00029541922,"about_ca_system_score_gemma":0.00040264832,"threshold_uncertainty_score":0.032099605},"labels":[],"label_agreement":null},{"id":"W2128220462","doi":"10.1177/1352458510391343","title":"<i>Staphylococcus aureus</i> harbouring Enterotoxin A as a possible risk factor for multiple sclerosis exacerbations","year":2011,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba; Public Health Agency of Canada","funders":"","keywords":"Enterotoxin; Multiple sclerosis; Staphylococcus aureus; Medicine; Microbiology; Dermatology; Immunology; Bacteria; Escherichia coli; Biology; Gene","score_opus":0.17029343295552904,"score_gpt":0.3024080888005764,"score_spread":0.13211465584504736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128220462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99858737,0.0006586246,0.000065037144,0.00011213111,0.0000070988694,0.000009901827,0.000047944734,0.0000027721026,0.00050918304],"genre_scores_gemma":[0.99951553,0.00015160492,0.00011800734,0.0000567479,0.000021021027,0.0000046547057,0.000047945286,8.420512e-7,0.00008359805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99963105,0.00017128183,0.00005340758,0.000043721724,0.000058597936,0.000041872467],"domain_scores_gemma":[0.99830556,0.0006353881,0.00072644086,0.000051522224,0.00011843055,0.0001627096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006873659,0.00021153332,0.00022209616,0.000506091,0.00024320224,0.0003850295,0.00015368867,0.0003695579,0.0017492789],"category_scores_gemma":[0.002237013,0.000075914104,0.00019815133,0.0004908572,0.00018372307,0.00022682526,0.00021229385,0.0003328704,0.0001496976],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042094258,0.000049474038,0.99550605,0.000033402528,0.00003200294,0.000402756,0.000040532203,0.000017030447,0.000945373,0.000018210327,0.000100484576,0.0024336167],"study_design_scores_gemma":[0.000014732964,0.0004801067,0.9957503,0.000040351213,0.00005356384,0.0025476718,0.00015757376,0.00015662122,0.0004545598,0.000051844458,0.00028959208,0.0000030285291],"about_ca_topic_score_codex":0.00091180584,"about_ca_topic_score_gemma":0.0010148135,"teacher_disagreement_score":0.0017492789,"about_ca_system_score_codex":0.00010951548,"about_ca_system_score_gemma":0.00020376939,"threshold_uncertainty_score":0.0058519244},"labels":[],"label_agreement":null},{"id":"W2129345488","doi":"10.1177/1352458513519179","title":"Multiple sclerosis in the Iranian immigrant population of BC, Canada: prevalence and risk factors","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Fraser Health; SickKids Foundation; University of Toronto; University of British Columbia; Hospital for Sick Children; University of Ottawa","funders":"","keywords":"Multiple sclerosis; Medicine; Immigration; Demography; Population; Odds ratio; Risk factor; Family history; Environmental health; Internal medicine; Immunology; Geography","score_opus":0.07087259934569513,"score_gpt":0.26478388184723733,"score_spread":0.19391128250154221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129345488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967051,0.0009074145,0.000072285286,0.00023876963,0.000008933259,0.000024402836,0.0009163867,0.0000058482246,0.0011208842],"genre_scores_gemma":[0.99786747,0.0008741885,0.00020227452,0.00008485735,0.0000063529,0.000010689846,0.00051620457,0.000002497402,0.0004354548],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997099,0.000021337484,0.000016342457,0.000048957543,0.00011690845,0.00008656298],"domain_scores_gemma":[0.99949956,0.000020350572,0.000093586656,0.000011987217,0.00023490399,0.00013960285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025170055,0.0002887402,0.00025263845,0.001120507,0.002226694,0.00073512783,0.00057232834,0.00038498142,0.0013432583],"category_scores_gemma":[0.0006553262,0.00017255444,0.0002140977,0.0027672602,0.0005432128,0.00019379787,0.00042207693,0.00045043172,0.00015834984],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003016874,0.000022341215,0.9955302,0.000026146241,0.000028868424,0.0001086132,0.00033433182,0.000029889521,0.00027462386,0.000031990654,0.00039914844,0.0031837323],"study_design_scores_gemma":[0.0000036734727,0.000019195195,0.9979563,0.00002823834,0.000021055876,0.00022536542,0.0010594125,0.00010415441,0.0000424381,0.000020022608,0.00051520043,0.000004872672],"about_ca_topic_score_codex":0.9739764,"about_ca_topic_score_gemma":0.97480077,"teacher_disagreement_score":0.026023626,"about_ca_system_score_codex":0.0058602137,"about_ca_system_score_gemma":0.010095222,"threshold_uncertainty_score":0.05235374},"labels":[],"label_agreement":null},{"id":"W2129757393","doi":"10.1191/1352458505ms1192oa","title":"Regional variation of multiple sclerosis prevalence in Canada","year":2005,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Demography; Logistic regression; Confounding; Odds ratio; Medicine; Odds; Multiple sclerosis; Epidemiology; Prevalence; Internal medicine","score_opus":0.1174418285751787,"score_gpt":0.2834842559907382,"score_spread":0.16604242741555947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129757393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98245656,0.0044362885,0.00050399406,0.00052216963,0.000018258357,0.00005788875,0.008531855,0.00005214518,0.0034207888],"genre_scores_gemma":[0.9972806,0.00073615083,0.0003095788,0.000047929956,0.0000035740252,0.000011015241,0.0011785857,0.000006104453,0.00042639754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990338,0.000099307574,0.00005386376,0.00019117117,0.00036937094,0.00025252023],"domain_scores_gemma":[0.99816567,0.00014609112,0.00029549628,0.00004390929,0.0011481371,0.00020077072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007133295,0.0002620339,0.000371301,0.002220822,0.0011492781,0.0008942752,0.00072055304,0.00022307812,0.0014611002],"category_scores_gemma":[0.002575962,0.00017328306,0.0004921122,0.0049649845,0.000513082,0.00023076577,0.0005913329,0.0002587388,0.0001177236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000101193196,0.00000977313,0.9841404,0.00012813469,0.0002009048,0.00013081753,0.00094852253,0.0007124018,0.00048484362,0.00021103169,0.0018515199,0.011080382],"study_design_scores_gemma":[0.0000036449958,0.000007638581,0.9981483,0.000031503456,0.000030769723,0.00006831569,0.00040332234,0.00030553236,0.00004999036,0.000020678746,0.0009212747,0.000009027243],"about_ca_topic_score_codex":0.99339324,"about_ca_topic_score_gemma":0.9939997,"teacher_disagreement_score":0.015814219,"about_ca_system_score_codex":0.015814219,"about_ca_system_score_gemma":0.0153470645,"threshold_uncertainty_score":0.11474067},"labels":[],"label_agreement":null},{"id":"W2129967156","doi":"10.1177/1352458513507821","title":"Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":351,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; Ottawa Hospital; University of Ottawa","funders":"IC Design Education Center; National Institutes of Health; Serono Symposia International Foundation; Bayer HealthCare; Acorda Therapeutics; Multiple Sclerosis Society; Biogen; Sanofi; National Multiple Sclerosis Society","keywords":"Teriflunomide; Medicine; Multiple sclerosis; Internal medicine; Discontinuation; Clinical endpoint; Dimethyl fumarate; Physical therapy; Expanded Disability Status Scale; Randomized controlled trial; Immunology; Fingolimod","score_opus":0.08007616229311648,"score_gpt":0.28900248005295964,"score_spread":0.20892631775984316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129967156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96317863,0.015965454,0.0012870788,0.0018502746,0.0013312534,0.011743403,0.0017500581,0.00028712722,0.0026067],"genre_scores_gemma":[0.9571027,0.008580066,0.0034711328,0.0029580458,0.001159312,0.020975396,0.0013872738,0.000054871693,0.004311258],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99874145,0.00078415766,0.00009124412,0.00015638422,0.000088396526,0.00013843463],"domain_scores_gemma":[0.9984999,0.0005134398,0.00042583357,0.000119235534,0.000092526134,0.0003490538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031665703,0.0017244607,0.0040671234,0.00049769384,0.0006090971,0.0012290055,0.0009999454,0.0026490516,0.0088927215],"category_scores_gemma":[0.0029561596,0.0007026711,0.0029115318,0.00058583386,0.0012383738,0.0010932757,0.00045056848,0.002978643,0.0012730047],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9828189,0.003015766,0.00023111366,0.00091631844,0.00065248285,0.000049596565,0.000052251195,0.0001319997,0.0016393932,0.000056792556,0.00049103436,0.009944295],"study_design_scores_gemma":[0.9779669,0.020894403,0.00044654327,0.00003635322,0.00016149752,0.000021147976,0.000008441054,0.000101915844,0.00007613863,0.00006310747,0.00021723953,0.000006303984],"about_ca_topic_score_codex":0.00094358326,"about_ca_topic_score_gemma":0.0019310797,"teacher_disagreement_score":0.0088927215,"about_ca_system_score_codex":0.0007405159,"about_ca_system_score_gemma":0.0015402451,"threshold_uncertainty_score":0.029749095},"labels":[],"label_agreement":null},{"id":"W2130049682","doi":"10.1191/1352458505ms1196oa","title":"MRI results from the European Study on Intravenous Immunoglobulin in Secondary Progressive Multiple Sclerosis (ESIMS)","year":2005,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Multiple sclerosis; Magnetic resonance imaging; Placebo; Nuclear medicine; Clinical trial; Lesion; Gastroenterology; Internal medicine; Radiology; Surgery; Pathology; Immunology","score_opus":0.10089763253783987,"score_gpt":0.2975885841402293,"score_spread":0.19669095160238945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130049682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954542,0.0005232431,0.00007436327,0.000076769335,0.000006347008,0.000034763667,0.0017494045,0.000007677062,0.0020732316],"genre_scores_gemma":[0.99642867,0.00013927829,0.00013230275,0.00007959251,0.000017717535,0.000022250888,0.0027164505,0.0000052665237,0.00045853588],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994461,0.00015295118,0.00005632278,0.00009871295,0.00016271492,0.00008311688],"domain_scores_gemma":[0.9988078,0.0001588258,0.00040050648,0.00006040968,0.00032784074,0.0002446935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012413445,0.00043959077,0.000392901,0.00055826706,0.00035197544,0.00030955867,0.0002967932,0.00044587313,0.0019452791],"category_scores_gemma":[0.0022392853,0.000110470035,0.00024318394,0.0007411558,0.00016297103,0.00018595163,0.00023079502,0.0002699868,0.0003853923],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036508068,0.00012072235,0.98751044,0.000044896096,0.0002557389,0.00021644686,0.000092733324,0.00008784204,0.0009986111,0.000028370132,0.0011288051,0.00586446],"study_design_scores_gemma":[0.00010357551,0.00019592371,0.9984748,0.000005794469,0.00006035592,0.00036950168,0.000026313364,0.000039132574,0.00008800152,0.000009857842,0.00062444643,0.0000022542058],"about_ca_topic_score_codex":0.018627102,"about_ca_topic_score_gemma":0.01691929,"teacher_disagreement_score":0.018627102,"about_ca_system_score_codex":0.0005540438,"about_ca_system_score_gemma":0.00045559573,"threshold_uncertainty_score":0.037037373},"labels":[],"label_agreement":null},{"id":"W2130686328","doi":"10.1177/1352458513485653","title":"Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing– remitting multiple sclerosis","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; McGill University; University of Ottawa; Montreal Neurological Institute and Hospital","funders":"National Institute of Neurological Disorders and Stroke; National Institute of Allergy and Infectious Diseases; National Heart, Lung, and Blood Institute","keywords":"Multiple sclerosis; Acute disseminated encephalomyelitis; Relapsing remitting; Autoantibody; Medicine; Encephalomyelitis; Immunology; Myelin; Experimental autoimmune encephalomyelitis; Myelin basic protein; Neuromyelitis optica; Myelin oligodendrocyte glycoprotein; Central nervous system; Antibody; Internal medicine","score_opus":0.07375390770311861,"score_gpt":0.29273967519761257,"score_spread":0.21898576749449394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130686328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882009,0.00080002175,0.009575171,0.000067446206,0.000018946674,0.0000315231,0.0003342949,0.00030113925,0.0006705313],"genre_scores_gemma":[0.9850113,0.00021374245,0.013937699,0.000061252365,0.000017329401,0.000028952065,0.00053847063,0.000016365826,0.00017481491],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99956805,0.00008001448,0.00005143558,0.00014283125,0.0001143965,0.00004317857],"domain_scores_gemma":[0.99892944,0.00054937595,0.00027085224,0.000048206944,0.00013096123,0.00007102185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007964821,0.0006103828,0.0003332972,0.0008706324,0.00016915571,0.0004889849,0.00015315894,0.0004100005,0.0007242509],"category_scores_gemma":[0.0020534454,0.0001730405,0.00021711341,0.00036526917,0.00020930058,0.00027602838,0.00023109824,0.00043707772,0.00032541782],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011182559,0.00029821266,0.45372516,0.0002192737,0.00024829875,0.0002659611,0.00014835889,0.0056711705,0.4568214,0.00016644636,0.0010167937,0.0803006],"study_design_scores_gemma":[0.00008249426,0.001236472,0.71181554,0.00006617156,0.00023090042,0.0025079844,0.00014394269,0.06414681,0.21598603,0.0010755069,0.0026734706,0.000034717654],"about_ca_topic_score_codex":0.0003914325,"about_ca_topic_score_gemma":0.00060409243,"teacher_disagreement_score":0.0008706324,"about_ca_system_score_codex":0.00028397783,"about_ca_system_score_gemma":0.00019752675,"threshold_uncertainty_score":0.0042122602},"labels":[],"label_agreement":null},{"id":"W2131040457","doi":"10.1177/1352458514564494","title":"Towards a better understanding of <i>pseudoatrophy</i> in the brain of multiple sclerosis patients","year":2015,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Multiple sclerosis; Medicine; Psychology; Clinical neurology; Neuroscience; Psychiatry","score_opus":0.2006148878248142,"score_gpt":0.2677472813446265,"score_spread":0.06713239351981229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131040457","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35702848,0.06445857,0.0064042034,0.49411365,0.008012384,0.00017485958,0.00047367407,0.0003452378,0.06898892],"genre_scores_gemma":[0.81411695,0.02669927,0.004165468,0.09710285,0.053357564,0.00009787083,0.000298612,0.00007618394,0.0040852632],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994241,0.00014639141,0.00011313384,0.000090666974,0.0000869153,0.00013868442],"domain_scores_gemma":[0.9976928,0.0012210429,0.00039363027,0.0001244038,0.00037487355,0.00019320275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081303145,0.0005190896,0.0011966992,0.0008943289,0.0012473988,0.0022861236,0.0011460787,0.006926279,0.002129818],"category_scores_gemma":[0.0064423745,0.00030111172,0.00061599974,0.00061916147,0.0016278395,0.0029386352,0.0007352466,0.006045109,0.0011652219],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053042726,0.00028666353,0.13293715,0.0010655988,0.00011461091,0.6784473,0.0022597648,0.0007260343,0.008232979,0.014191115,0.07275907,0.08844933],"study_design_scores_gemma":[0.00009458487,0.00020764754,0.04353618,0.0011192341,0.00014227227,0.87708616,0.0021855999,0.0019911334,0.0015845689,0.033846103,0.03810803,0.00009846063],"about_ca_topic_score_codex":0.0024494892,"about_ca_topic_score_gemma":0.0015570468,"teacher_disagreement_score":0.006926279,"about_ca_system_score_codex":0.001527738,"about_ca_system_score_gemma":0.0009652173,"threshold_uncertainty_score":0.011084616},"labels":[],"label_agreement":null},{"id":"W2131078277","doi":"10.1177/1352458512436594","title":"Long-term follow-up of a phase 2 study of oral teriflunomide in relapsing multiple sclerosis: safety and efficacy results up to 8.5 years","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Ottawa; Research Canada; McGill University; University of British Columbia","funders":"Daiichi Sankyo Europe; Daiichi-Sankyo; Sanofi","keywords":"Teriflunomide; Medicine; Adverse effect; Discontinuation; Internal medicine; Placebo; Multiple sclerosis; Asymptomatic; Population; Interim analysis; Gastroenterology; Surgery; Randomized controlled trial; Fingolimod; Immunology; Pathology","score_opus":0.1454125951690546,"score_gpt":0.35551265568532137,"score_spread":0.21010006051626676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131078277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955798,0.0024297733,0.0003202114,0.0001391469,0.000046735713,0.00031245057,0.0005373262,0.000035932546,0.0005986309],"genre_scores_gemma":[0.9949039,0.0006655848,0.0004928991,0.00035877642,0.00011517368,0.00042790073,0.0019955267,0.000013154809,0.0010270538],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9990746,0.0003462669,0.0000888119,0.00014662604,0.00016379778,0.00017985243],"domain_scores_gemma":[0.9968286,0.00056593644,0.0010112143,0.00034499937,0.00036776494,0.00088136864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051145614,0.00081774074,0.0026048645,0.00037971543,0.0007731192,0.0007391055,0.00049873174,0.0011346607,0.0017240759],"category_scores_gemma":[0.002822436,0.0004300036,0.0013229437,0.0003406542,0.0005074866,0.00095170777,0.0004195601,0.0021619762,0.0006505588],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.60741496,0.032026455,0.14012466,0.00075818464,0.003593567,0.001140968,0.00067328085,0.0016528239,0.041222632,0.00009484506,0.0030981703,0.16819948],"study_design_scores_gemma":[0.08303943,0.49874082,0.39862037,0.0001132196,0.004040251,0.0010997648,0.00015462509,0.001395725,0.00830929,0.00018469967,0.0042197513,0.00008199727],"about_ca_topic_score_codex":0.00042657348,"about_ca_topic_score_gemma":0.0007001644,"teacher_disagreement_score":0.0051145614,"about_ca_system_score_codex":0.000456528,"about_ca_system_score_gemma":0.00063157297,"threshold_uncertainty_score":0.027048707},"labels":[],"label_agreement":null},{"id":"W2132728908","doi":"10.1177/1352458506074177","title":"The relation of focal white matter signal abnormality and focal volume loss in multiple sclerosis","year":2007,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"Multiple Sclerosis Society of Canada","keywords":"Multiple sclerosis; White matter; Lesion; Atrophy; Abnormality; Magnetic resonance imaging; Pathology; Medicine; Central nervous system disease; Brain size; Intensity (physics); Radiology; Internal medicine; Physics; Optics","score_opus":0.07853500148478784,"score_gpt":0.28707746888217395,"score_spread":0.2085424673973861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132728908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99775416,0.0011818975,0.00038812397,0.000044756907,0.0000048096276,0.000005439632,0.00002600802,0.00001522674,0.0005795732],"genre_scores_gemma":[0.9996094,0.00013258618,0.00012065272,0.0000072504113,0.00001236442,0.000001955093,0.000019743557,0.0000023690993,0.0000936406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977106,0.000064004555,0.000027602227,0.000040924882,0.00006027058,0.000036117595],"domain_scores_gemma":[0.99812466,0.0006146783,0.0007941143,0.00014439378,0.00016487676,0.00015728151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039382346,0.00018183338,0.00026549594,0.0014649113,0.00018200563,0.00032960266,0.00024045365,0.00034880338,0.0013012028],"category_scores_gemma":[0.0037047565,0.00012115275,0.00013099682,0.0006016458,0.0005956965,0.000657711,0.00040315956,0.00028288935,0.00013085087],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001833842,0.00013842105,0.91884047,0.00017200479,0.00024580272,0.0033886132,0.0004154574,0.0014179946,0.025028722,0.000498581,0.0002152758,0.047804978],"study_design_scores_gemma":[0.000011096983,0.0004994974,0.98955417,0.0000075330595,0.000036603935,0.006324026,0.00012580893,0.0007850242,0.001878896,0.00058724824,0.00018159402,0.000008504482],"about_ca_topic_score_codex":0.00086505566,"about_ca_topic_score_gemma":0.00081011094,"teacher_disagreement_score":0.0014649113,"about_ca_system_score_codex":0.00021781216,"about_ca_system_score_gemma":0.0001466048,"threshold_uncertainty_score":0.004352927},"labels":[],"label_agreement":null},{"id":"W2132906244","doi":"10.1177/1352458514536086","title":"Depression in multiple sclerosis: A long-term longitudinal study","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Depression (economics); Medicine; Multiple sclerosis; Observational study; Comorbidity; Antidepressant; Epidemiology; Population; Expanded Disability Status Scale; Logistic regression; Psychiatry; Internal medicine; Psychology; Anxiety","score_opus":0.19287784208498948,"score_gpt":0.3392148490697939,"score_spread":0.1463370069848044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132906244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976833,0.0009103564,0.00013947215,0.0001733519,0.000011220434,0.000022199538,0.0008294536,0.000004362153,0.00022638025],"genre_scores_gemma":[0.9979771,0.00042751685,0.00018898328,0.000093395276,0.000019405945,0.000042743126,0.0011033337,0.0000024350918,0.0001451069],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990606,0.00036872303,0.00010468605,0.00016760403,0.00017215755,0.00012623478],"domain_scores_gemma":[0.9970688,0.00044706571,0.0010374989,0.0003132544,0.000500049,0.00063325913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027750349,0.00025910168,0.0005425624,0.0007323338,0.0009460769,0.0008039967,0.0004447054,0.00077299366,0.00069991726],"category_scores_gemma":[0.003687581,0.0003612474,0.0006848759,0.0014894834,0.0003110479,0.00074512593,0.00071539433,0.0012780208,0.00022751339],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021901706,0.00009559683,0.9980129,0.000014382865,0.00018541601,0.000083240564,0.00011441312,0.0000220098,0.000117443225,0.000013904356,0.00011778925,0.0010037657],"study_design_scores_gemma":[0.000021178854,0.00019530283,0.99909556,0.000015796546,0.00009475099,0.0001675108,0.000110341985,0.0000857042,0.000019142259,0.000023216497,0.00016749467,0.000004121211],"about_ca_topic_score_codex":0.01125691,"about_ca_topic_score_gemma":0.014463974,"teacher_disagreement_score":0.01125691,"about_ca_system_score_codex":0.00061397784,"about_ca_system_score_gemma":0.0007002699,"threshold_uncertainty_score":0.022382736},"labels":[],"label_agreement":null},{"id":"W2132936146","doi":"10.1177/1352458514533229","title":"Characterizing cognitive function during relapse in multiple sclerosis","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"IC Design Education Center; Teva Pharmaceutical Industries; Multiple Sclerosis Society; Biogen; EMD Serono; National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Cognition; Medicine; Psychology; Neuroscience; Psychiatry","score_opus":0.11142035007989425,"score_gpt":0.28269579529364647,"score_spread":0.1712754452137522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132936146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99956185,0.00018192672,0.000034191,0.000009128628,0.0000012823014,0.0000057875764,0.00004004953,0.0000040298014,0.00016169882],"genre_scores_gemma":[0.99967456,0.000060097696,0.00004736181,0.0000127834255,0.0000042422566,0.000006295467,0.0001176722,0.0000013051088,0.00007567442],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997162,0.000069795286,0.00003372814,0.000040761424,0.000081477185,0.00005798518],"domain_scores_gemma":[0.9991186,0.00014817106,0.0003944741,0.00004864083,0.00014507725,0.00014496026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007487886,0.00040762906,0.00051882124,0.00081382325,0.000339208,0.00043967713,0.00023448857,0.00033396995,0.00059513585],"category_scores_gemma":[0.002793561,0.00009283398,0.0002618391,0.00040551135,0.00025845302,0.0003551211,0.00040697833,0.00032186462,0.00023140009],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013386209,0.00019589342,0.9806651,0.000038644248,0.0000824174,0.0004542491,0.00042058917,0.00010636746,0.002392694,0.000008111979,0.00012743915,0.014169858],"study_design_scores_gemma":[0.0000090292115,0.00075520464,0.99761593,0.0000046977634,0.00002400943,0.00088978105,0.00016377732,0.00010799603,0.00031388213,0.000012867068,0.00009870309,0.000004168693],"about_ca_topic_score_codex":0.0017100151,"about_ca_topic_score_gemma":0.0021019191,"teacher_disagreement_score":0.0017100151,"about_ca_system_score_codex":0.00026744304,"about_ca_system_score_gemma":0.0001648127,"threshold_uncertainty_score":0.0039600134},"labels":[],"label_agreement":null},{"id":"W2133141213","doi":"10.1177/1352458507080468","title":"Reduced effectiveness of long-term interferon-β treatment on relapses in neutralizing antibody-positive multiple sclerosis patients: a Canadian multiple sclerosis clinic-based study","year":2007,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Multiple sclerosis; Internal medicine; Antibody; Gastroenterology; Cohort; Interferon beta-1a; Immunology; Interferon beta","score_opus":0.12448759202791758,"score_gpt":0.3536020782661566,"score_spread":0.229114486238239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133141213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949005,0.0024652192,0.000025157227,0.00026364534,0.000017296396,0.00005662849,0.0006054412,0.0000060664943,0.0016600201],"genre_scores_gemma":[0.9978861,0.0008874484,0.00007578705,0.00014590917,0.000024504063,0.000016862821,0.0005101558,0.000002829559,0.0004503533],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992212,0.00018047629,0.000032687465,0.00008934726,0.00030225274,0.00017414911],"domain_scores_gemma":[0.99825877,0.00016485865,0.0003117695,0.00004932585,0.0005621782,0.0006531283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087288144,0.00042426639,0.00079993345,0.00050051,0.0011320545,0.0006787372,0.0008404363,0.0007007104,0.0013429993],"category_scores_gemma":[0.0022214942,0.00019027866,0.000811049,0.0010278338,0.00039667598,0.0002024556,0.00027751797,0.00073029246,0.00015527377],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026616683,0.0028211507,0.8871218,0.0004880966,0.0014435505,0.00055071,0.00092993357,0.0007039585,0.004421302,0.00019414639,0.0028494569,0.07185927],"study_design_scores_gemma":[0.00061612064,0.001288933,0.9960939,0.00003266108,0.0002743484,0.00011930017,0.0001410495,0.0003391436,0.00012522885,0.00001273765,0.00093530497,0.000021165506],"about_ca_topic_score_codex":0.83880645,"about_ca_topic_score_gemma":0.88781923,"teacher_disagreement_score":0.83880645,"about_ca_system_score_codex":0.008830787,"about_ca_system_score_gemma":0.007946906,"threshold_uncertainty_score":0.3242857},"labels":[],"label_agreement":null},{"id":"W2134454343","doi":"10.1177/1352458513513059","title":"Five-year results from a phase 2 study of oral fingolimod in relapsing multiple sclerosis","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Javna Agencija za Raziskovalno Dejavnost RS","keywords":"Fingolimod; Multiple sclerosis; Medicine; Placebo; Internal medicine; Randomized controlled trial; Physical therapy; Pathology; Immunology; Alternative medicine","score_opus":0.15307827210247577,"score_gpt":0.33146574560855674,"score_spread":0.17838747350608097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134454343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861346,0.007565925,0.00092268747,0.00030217695,0.00013615807,0.0011122276,0.0019493711,0.00009909943,0.001777806],"genre_scores_gemma":[0.98731136,0.0021994635,0.001196977,0.0010598693,0.000260166,0.00063123135,0.0055505335,0.00002584447,0.0017646356],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9985197,0.000722267,0.00017205958,0.00013857479,0.00023092331,0.00021647233],"domain_scores_gemma":[0.99672675,0.000893261,0.00082429533,0.00032039845,0.00033807274,0.0008972695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0063229543,0.0011682009,0.0022122557,0.00058789534,0.00065689225,0.00069914624,0.00049107266,0.0013361038,0.001539981],"category_scores_gemma":[0.0036948747,0.0003343519,0.0018174483,0.00038714457,0.00050084904,0.0008082357,0.0005276748,0.0019866545,0.00045674632],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6695262,0.06905717,0.04444692,0.0014191512,0.0058023334,0.0011836161,0.00063868775,0.0022158595,0.046376903,0.00016559809,0.00485361,0.15431395],"study_design_scores_gemma":[0.119189404,0.69380414,0.17041531,0.00007074307,0.004563169,0.0006250355,0.000112882924,0.0005355693,0.0065772864,0.00019141659,0.0038403952,0.00007470582],"about_ca_topic_score_codex":0.0007848645,"about_ca_topic_score_gemma":0.0010916372,"teacher_disagreement_score":0.0063229543,"about_ca_system_score_codex":0.00031841002,"about_ca_system_score_gemma":0.00063870486,"threshold_uncertainty_score":0.03343934},"labels":[],"label_agreement":null},{"id":"W2134747655","doi":"10.1177/1352458515572405","title":"A randomized, controlled, single-blind, 6-month pilot study to evaluate the efficacy of MS-Line!: a cognitive rehabilitation programme for patients with multiple sclerosis","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"IC Design Education Center; “la Caixa” Foundation; Biogen","keywords":"Paced Auditory Serial Addition Test; Montreal Cognitive Assessment; Cognition; Rehabilitation; Cognitive rehabilitation therapy; Randomized controlled trial; Medicine; Recall; Trail Making Test; Multiple sclerosis; Physical therapy; Visual memory; Audiology; Physical medicine and rehabilitation; Cognitive impairment; Psychology; Internal medicine; Psychiatry","score_opus":0.20235064827951993,"score_gpt":0.351425998276342,"score_spread":0.1490753499968221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134747655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98535955,0.0007743839,0.0006485157,0.0002178471,0.0003701081,0.011537957,0.00056626403,0.00010147549,0.00042393402],"genre_scores_gemma":[0.9559646,0.0012037175,0.005120912,0.0009251799,0.00095753785,0.03256831,0.0011236103,0.000023788847,0.002112342],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99812835,0.0009035039,0.00018761562,0.0003131814,0.0001919877,0.0002752461],"domain_scores_gemma":[0.99656725,0.0008424532,0.0005405081,0.0004050302,0.0004563726,0.0011882721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038026802,0.0015819089,0.005102185,0.00094939664,0.0010919309,0.0007079793,0.0013608465,0.0022128979,0.0062911273],"category_scores_gemma":[0.0030042229,0.0009097098,0.0015889889,0.00061130506,0.0018971467,0.0010878884,0.0007065069,0.0021635755,0.0011197781],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9144293,0.07008683,0.0008460693,0.00042564646,0.0003365935,0.00004440442,0.000085866785,0.00012250798,0.0028003633,0.00003023386,0.00029263544,0.010499521],"study_design_scores_gemma":[0.6372422,0.35975164,0.002260934,0.0000117286745,0.000115464034,0.000017198046,0.00001788082,0.00011738483,0.00025910168,0.000018826531,0.00017795734,0.000009631502],"about_ca_topic_score_codex":0.0008957436,"about_ca_topic_score_gemma":0.0013916828,"teacher_disagreement_score":0.0062911273,"about_ca_system_score_codex":0.0004966527,"about_ca_system_score_gemma":0.0021830052,"threshold_uncertainty_score":0.021045923},"labels":[],"label_agreement":null},{"id":"W2135074145","doi":"10.1191/135248506ms1270oa","title":"Change in clinician-assessed measures of multiple sclerosis and subject-reported quality of life: results from the IMPACT study","year":2006,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Multiple sclerosis; Medicine; Quality of life (healthcare); Expanded Disability Status Scale; Quartile; Placebo; Physical therapy; Interferon beta-1a; Clinical trial; Randomized controlled trial; Internal medicine; Interferon beta; Confidence interval; Pathology; Psychiatry; Alternative medicine","score_opus":0.4079972269186082,"score_gpt":0.4078974773737938,"score_spread":0.00009974954481439813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135074145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805967,0.010945638,0.0005116814,0.00025971045,0.000048373353,0.00041708452,0.0028233693,0.00003583647,0.004361475],"genre_scores_gemma":[0.9950504,0.001326497,0.00042129,0.00013616608,0.00005919573,0.00021984299,0.002257938,0.000012140645,0.0005166035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971124,0.001393134,0.00024858495,0.00020644475,0.0008935099,0.00014599723],"domain_scores_gemma":[0.990475,0.0035002688,0.003447192,0.00046569743,0.0011421466,0.00096976646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008902548,0.0005960822,0.0010087678,0.0007687679,0.0002580657,0.00079749787,0.0004917425,0.0006164761,0.0015642748],"category_scores_gemma":[0.013557794,0.0002446514,0.0012301502,0.0010357966,0.0005164817,0.0005805508,0.00056389323,0.0009004827,0.00030257736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048053022,0.0029994512,0.87282366,0.0009398649,0.008712297,0.00012752056,0.0007250187,0.0006273697,0.0007291917,0.0001357558,0.0017439914,0.06238291],"study_design_scores_gemma":[0.0029837082,0.0068006394,0.98606306,0.00009685966,0.0017453231,0.00020190464,0.00008866559,0.00027019036,0.00023230573,0.00007503188,0.0014159799,0.00002639645],"about_ca_topic_score_codex":0.00199256,"about_ca_topic_score_gemma":0.0018914145,"teacher_disagreement_score":0.008902548,"about_ca_system_score_codex":0.0004991788,"about_ca_system_score_gemma":0.00043447703,"threshold_uncertainty_score":0.04708177},"labels":[],"label_agreement":null},{"id":"W2135440918","doi":"10.1177/1352458508096878","title":"Differential diagnosis of suspected multiple sclerosis: a consensus approach","year":2008,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":643,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Multiple Sclerosis Society","keywords":"Multiple sclerosis; Differential diagnosis; Medical diagnosis; Medicine; Demyelinating Disorder; McDonald criteria; Neurology; Intensive care medicine; Pathology; Pediatrics; Immunology; Psychiatry","score_opus":0.1716670000508236,"score_gpt":0.29068156935442263,"score_spread":0.11901456930359902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135440918","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028171292,0.06908727,0.47914362,0.33958733,0.020379195,0.014180121,0.001610213,0.0014344337,0.046406474],"genre_scores_gemma":[0.17607316,0.031393588,0.7437091,0.026851846,0.007951911,0.0067477305,0.0023719913,0.00021756809,0.004683107],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9177727,0.039778464,0.023143176,0.0042466703,0.013215906,0.0018429506],"domain_scores_gemma":[0.8426205,0.044198137,0.0066812877,0.004282868,0.09166087,0.0105562955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.085933,0.0016824235,0.0036898367,0.01950986,0.005515085,0.0066291853,0.010641843,0.010334613,0.0052104504],"category_scores_gemma":[0.15438794,0.0014836349,0.0030307425,0.00673047,0.0039988193,0.007520412,0.013579582,0.008838211,0.002708825],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031466203,0.00048727603,0.0154556725,0.010576545,0.0009833545,0.011421781,0.011965547,0.0051182937,0.0027217788,0.03439522,0.19209479,0.7144652],"study_design_scores_gemma":[0.0011312113,0.00057589286,0.01578955,0.045250308,0.0017003873,0.028185973,0.026604913,0.025686746,0.0031863113,0.32236403,0.528677,0.0008476786],"about_ca_topic_score_codex":0.0041550263,"about_ca_topic_score_gemma":0.005751288,"teacher_disagreement_score":0.085933,"about_ca_system_score_codex":0.007818663,"about_ca_system_score_gemma":0.026819013,"threshold_uncertainty_score":0.4544626},"labels":[],"label_agreement":null},{"id":"W2135686765","doi":"10.1177/1352458512444326","title":"MRI-based clinical trials in relapsing–remitting MS: new sample size calculations based on a longitudinal model","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Actua; Simon Fraser University","funders":"Chongqing University of Arts and Sciences","keywords":"Sample size determination; Clinical trial; Multiple sclerosis; Medicine; Magnetic resonance imaging; Negative binomial distribution; Lesion; Statistics; Radiology; Mathematics; Pathology; Poisson distribution","score_opus":0.4930818613757792,"score_gpt":0.4618427091295853,"score_spread":0.03123915224619389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135686765","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04698927,0.0013317307,0.94508964,0.0012101668,0.00017744678,0.0032584374,0.00028104888,0.00020183877,0.0014603754],"genre_scores_gemma":[0.4366948,0.0015296713,0.5451773,0.0013408378,0.00020338365,0.012866724,0.0005283766,0.000065918895,0.0015929905],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.8708594,0.11847269,0.0024440708,0.002719435,0.0049868743,0.00051758153],"domain_scores_gemma":[0.7226107,0.25124574,0.011901558,0.00880338,0.004487921,0.00095071184],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.16879487,0.0009886755,0.0024397876,0.0013979471,0.000413744,0.0013757272,0.0028201337,0.0019898952,0.0028736456],"category_scores_gemma":[0.27473757,0.0008669994,0.0024889861,0.00094729953,0.0018905038,0.0028091993,0.001627511,0.002767009,0.00035431946],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011308104,0.0009022384,0.03270329,0.0025285846,0.004336462,0.00066746294,0.0016867329,0.65930414,0.004421894,0.11338567,0.004903519,0.16385193],"study_design_scores_gemma":[0.0035066903,0.005665473,0.007301468,0.0005409018,0.001333502,0.00036442847,0.00009591504,0.89838046,0.0018564267,0.073635034,0.0072059813,0.00011365334],"about_ca_topic_score_codex":0.0014260875,"about_ca_topic_score_gemma":0.0011825772,"teacher_disagreement_score":0.8312051,"about_ca_system_score_codex":0.0018640114,"about_ca_system_score_gemma":0.002649281,"threshold_uncertainty_score":0.89268327},"labels":[],"label_agreement":null},{"id":"W2135746117","doi":"10.1177/1352458509357065","title":"Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results","year":2009,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":158,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; St. Michael's Hospital","funders":"","keywords":"Fingolimod; Medicine; Adverse effect; Multiple sclerosis; Placebo; Internal medicine; Clinical trial; Surgery; Pathology; Immunology","score_opus":0.07880616782050656,"score_gpt":0.2823788777459828,"score_spread":0.20357270992547624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135746117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98183066,0.005532009,0.0015520022,0.00072611676,0.00033027618,0.0057633687,0.001734416,0.00035493798,0.0021762056],"genre_scores_gemma":[0.9734041,0.0046255914,0.0035781981,0.0018084879,0.0006951634,0.006352081,0.004278128,0.00008398127,0.005174324],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995103,0.00020690431,0.000022529688,0.00008759242,0.000057948582,0.00011476774],"domain_scores_gemma":[0.9992785,0.00010298707,0.0001379996,0.000057360747,0.000046395213,0.00037688747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027511795,0.0027101042,0.0032321035,0.0005423064,0.0005369671,0.001148646,0.001011924,0.0020503893,0.0030343828],"category_scores_gemma":[0.0009556664,0.0007509682,0.0014893877,0.00044206675,0.0011173562,0.0008449386,0.00037502704,0.0034953507,0.0011656292],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.84177965,0.057720494,0.0028357345,0.0006050648,0.00084341917,0.0003142659,0.00021218594,0.0011324243,0.033786982,0.00023539989,0.0031557763,0.05737857],"study_design_scores_gemma":[0.76685953,0.22057073,0.0072410344,0.000020917158,0.00026064194,0.00015284614,0.000020501515,0.00062774523,0.0026158483,0.00014187157,0.0014669544,0.0000213577],"about_ca_topic_score_codex":0.00083699945,"about_ca_topic_score_gemma":0.0010495526,"teacher_disagreement_score":0.0032321035,"about_ca_system_score_codex":0.000592645,"about_ca_system_score_gemma":0.0014018146,"threshold_uncertainty_score":0.014549851},"labels":[],"label_agreement":null},{"id":"W2136139191","doi":"10.1177/1352458508097299","title":"Safety and immunogenicity of a new formulation of interferon β-1a (Rebif® New Formulation) in a Phase IIIb study in patients with relapsing multiple sclerosis: 96-week results","year":2008,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institutes of Health","keywords":"Medicine; Tolerability; Immunogenicity; Interferon beta-1a; Multiple sclerosis; Confidence interval; Adverse effect; Internal medicine; Clinical endpoint; Clinical trial; Antibody; Gastroenterology; Immunology; Interferon beta","score_opus":0.12092357691772825,"score_gpt":0.3048185937232836,"score_spread":0.18389501680555537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136139191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99651057,0.001851345,0.0004847948,0.00011767186,0.000034737655,0.00042413065,0.00022365744,0.000029171915,0.00032392042],"genre_scores_gemma":[0.99397427,0.0013363239,0.001453008,0.0002521874,0.00012910097,0.00086556136,0.00079695,0.000020244095,0.0011723934],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9989735,0.0005658042,0.0000653686,0.00015450844,0.00014050052,0.000100319405],"domain_scores_gemma":[0.9978411,0.00058213953,0.000729013,0.00024022626,0.0001568989,0.00045049557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038756798,0.0012766151,0.0017726556,0.00039615785,0.0003156204,0.0007614698,0.00085536623,0.001509504,0.0017993631],"category_scores_gemma":[0.0024081706,0.00063904555,0.0013754345,0.00033899868,0.0008956199,0.00086569344,0.00041260634,0.002669401,0.000589261],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.738843,0.067282535,0.022551032,0.00094394287,0.0020142393,0.0004741136,0.00055490795,0.0022904892,0.06958639,0.00012648244,0.001319433,0.094013326],"study_design_scores_gemma":[0.26824996,0.68860996,0.030535359,0.000040463066,0.0006252414,0.00079707545,0.00005399149,0.0008282431,0.008519841,0.00008037025,0.001617991,0.00004147147],"about_ca_topic_score_codex":0.00035581985,"about_ca_topic_score_gemma":0.00033104848,"teacher_disagreement_score":0.0038756798,"about_ca_system_score_codex":0.0006041287,"about_ca_system_score_gemma":0.00051070366,"threshold_uncertainty_score":0.020496786},"labels":[],"label_agreement":null},{"id":"W2136756445","doi":"10.1177/1352458511399611","title":"Sustained improvement in Expanded Disability Status Scale as a new efficacy measure of neurological change in multiple sclerosis: treatment effects with natalizumab in patients with relapsing multiple sclerosis","year":2011,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Teva Pharmaceutical Industries; Sanofi","keywords":"Expanded Disability Status Scale; Multiple sclerosis; Natalizumab; Medicine; Physical therapy; Quality of life (healthcare); Proportional hazards model; Central nervous system disease; Clinical trial; Internal medicine; Immunology","score_opus":0.11368700742756044,"score_gpt":0.279010791005736,"score_spread":0.16532378357817556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136756445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832796,0.014699468,0.0007370897,0.0002457986,0.000034561213,0.000104860774,0.0004645784,0.00002162006,0.00041232066],"genre_scores_gemma":[0.99768746,0.0009817728,0.00077497086,0.000060397422,0.00004453465,0.000057585476,0.0002693257,0.0000023909158,0.00012158927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99742883,0.0016161589,0.00018548216,0.00021098978,0.00049208244,0.00006636797],"domain_scores_gemma":[0.99363035,0.0025882674,0.0029696838,0.00024723823,0.0002588409,0.00030562328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008548165,0.0005070147,0.0015156759,0.0006251408,0.00014003168,0.0005550269,0.0003327118,0.00038051902,0.00071394874],"category_scores_gemma":[0.0061026267,0.00016401787,0.0012054105,0.000488568,0.0003010087,0.00042000492,0.00037927117,0.00064913806,0.0000821718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10315852,0.0014824118,0.766304,0.0014936936,0.010276111,0.00015893683,0.00020890895,0.002819244,0.0057145827,0.00014135246,0.0008928384,0.10734939],"study_design_scores_gemma":[0.0020651196,0.012242567,0.97797465,0.000088925335,0.001975785,0.00029423085,0.000038264152,0.0034780067,0.0010451195,0.00013827697,0.0006278313,0.000031218617],"about_ca_topic_score_codex":0.0005228297,"about_ca_topic_score_gemma":0.0011834617,"teacher_disagreement_score":0.008548165,"about_ca_system_score_codex":0.00037398844,"about_ca_system_score_gemma":0.0003229983,"threshold_uncertainty_score":0.04520756},"labels":[],"label_agreement":null},{"id":"W2136964907","doi":"10.1177/1352458510388823","title":"High-dose frequency beta-interferons increase the risk of liver test abnormalities in multiple sclerosis: a longitudinal study","year":2010,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Multiple sclerosis; Medicine; BETA (programming language); Interferon beta; Internal medicine; Oncology; Immunology","score_opus":0.1151051219175144,"score_gpt":0.29566413686628784,"score_spread":0.18055901494877344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136964907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99867946,0.00067286927,0.00015836951,0.00007118925,0.000010526845,0.000010525349,0.00020196725,0.000005103044,0.00019000664],"genre_scores_gemma":[0.9990577,0.00024264147,0.00019063028,0.00004557607,0.000020504753,0.000016396983,0.00024559838,0.0000027442356,0.0001781777],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998696,0.00068315153,0.000096556374,0.00024170135,0.00015359223,0.0001290289],"domain_scores_gemma":[0.9947583,0.0009940284,0.0023052925,0.0006785566,0.00054990454,0.000713895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003234787,0.0004007696,0.00037058635,0.00064141606,0.00061437034,0.00080070674,0.000416223,0.0008090344,0.0010655726],"category_scores_gemma":[0.004882048,0.00048118643,0.00092634244,0.00087981496,0.00027315726,0.00063030625,0.00045074892,0.0011270248,0.00023855854],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044668408,0.00012497403,0.99801207,0.000008444937,0.00025945774,0.000052312804,0.0000639387,0.00002236366,0.0001287459,0.000010395228,0.00006501338,0.00080577075],"study_design_scores_gemma":[0.000045171862,0.0008987898,0.99765503,0.000015651063,0.00023206833,0.00036746537,0.00011997826,0.00030888565,0.000076902536,0.000033350232,0.00023909203,0.0000075194516],"about_ca_topic_score_codex":0.0033800786,"about_ca_topic_score_gemma":0.0029185587,"teacher_disagreement_score":0.0033800786,"about_ca_system_score_codex":0.0003007852,"about_ca_system_score_gemma":0.000528105,"threshold_uncertainty_score":0.017107427},"labels":[],"label_agreement":null},{"id":"W2137537898","doi":"10.1177/1352458512455958","title":"Impact of sleep disorder treatment on fatigue in multiple sclerosis","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; McGill University Health Centre","funders":"American Academy of Sleep Medicine","keywords":"Epworth Sleepiness Scale; Polysomnography; Medicine; Pittsburgh Sleep Quality Index; Sleep disorder; Physical therapy; Sleep (system call); Internal medicine; Insomnia; Psychiatry; Sleep quality","score_opus":0.22384573214762477,"score_gpt":0.36054927660546776,"score_spread":0.136703544457843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137537898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932933,0.0056380676,0.0000667857,0.0001033352,0.000047147616,0.00019057326,0.00011091219,0.000010113352,0.0005398806],"genre_scores_gemma":[0.9974343,0.0016515696,0.00020385101,0.00010911723,0.00006643635,0.00018414087,0.00012919406,0.0000013173942,0.00022004543],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99963605,0.00016741532,0.00005424973,0.00003662363,0.000059645063,0.000045917317],"domain_scores_gemma":[0.999263,0.00026940397,0.00023417297,0.000030150888,0.000045488898,0.00015779775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006682685,0.00022656459,0.0006689031,0.0002926825,0.0002743087,0.00018482156,0.00020771727,0.00033092257,0.0015982806],"category_scores_gemma":[0.0011008977,0.000082455634,0.0005979933,0.00018028103,0.00028135593,0.00012700124,0.00017753882,0.00045378398,0.00009552115],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34715474,0.030702814,0.073674805,0.0036383432,0.003728761,0.00027907852,0.00032492046,0.0010889001,0.016759556,0.000121543664,0.0012581882,0.52126837],"study_design_scores_gemma":[0.06301745,0.4258597,0.50077736,0.00037997507,0.0017243663,0.00055509474,0.0001705167,0.001166749,0.0036766334,0.0001669509,0.002480244,0.000025016749],"about_ca_topic_score_codex":0.0010167961,"about_ca_topic_score_gemma":0.0019204655,"teacher_disagreement_score":0.0015982806,"about_ca_system_score_codex":0.00026844753,"about_ca_system_score_gemma":0.00039424287,"threshold_uncertainty_score":0.0053467155},"labels":[],"label_agreement":null},{"id":"W2138229533","doi":"10.1177/1352458512459986","title":"Chronic cerebrospinal venous insufficiency is not more prevalent in patients with mild multiple sclerosis: a sonographer-blinded, case-control ultrasound study","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Cerebral Venous Sinus Thrombosis","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of British Columbia","keywords":"Medicine; Multiple sclerosis; Sonographer; Ultrasound; Supine position; Internal jugular vein; Surgery; Radiology","score_opus":0.06387821660600027,"score_gpt":0.26906598875237214,"score_spread":0.20518777214637188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138229533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994293,0.00013204083,0.0001799046,0.000009373411,0.000008590573,0.00004249636,0.000043870266,0.0000045179086,0.00014987391],"genre_scores_gemma":[0.9993975,0.000041640622,0.00021615719,0.000026957196,0.000030809875,0.00004974252,0.00010473594,0.0000021456526,0.00013037905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857855,0.00047557164,0.00014885316,0.00046589982,0.00022761495,0.00010354243],"domain_scores_gemma":[0.99823546,0.00048159194,0.00048574118,0.00031274758,0.00023543776,0.00024907367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018017911,0.0006201619,0.0006918365,0.00091579003,0.00088441843,0.0006319275,0.00040866729,0.00071022485,0.002722704],"category_scores_gemma":[0.0038305854,0.00044464652,0.00026842783,0.00040530803,0.00071058166,0.00038073873,0.00038981115,0.0003048742,0.00033221356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008306214,0.0015278652,0.9755304,0.0000956098,0.00028362448,0.00086714455,0.0007746703,0.000049645725,0.0072564073,0.00007769094,0.00018414059,0.005046797],"study_design_scores_gemma":[0.0013769568,0.0083669955,0.9834781,0.000016649012,0.00029563133,0.003557274,0.0004388156,0.0004888693,0.0011605399,0.00005288492,0.0007445344,0.000022712315],"about_ca_topic_score_codex":0.0012081929,"about_ca_topic_score_gemma":0.0010079013,"teacher_disagreement_score":0.002722704,"about_ca_system_score_codex":0.00022177746,"about_ca_system_score_gemma":0.00025570468,"threshold_uncertainty_score":0.009528875},"labels":[],"label_agreement":null},{"id":"W2139255064","doi":"10.1177/1352458507086667","title":"Modeling the cost-effectiveness of a new treatment for MS (natalizumab) compared with current standard practice in Sweden","year":2008,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Natalizumab; Medicine; Cost effectiveness; Observational study; Cohort; Quality-adjusted life year; Clinical trial; Population; Cohort study; Physical therapy; Randomized controlled trial; Expanded Disability Status Scale; Multiple sclerosis; Internal medicine; Psychiatry; Environmental health","score_opus":0.2982927285160438,"score_gpt":0.40713462731703237,"score_spread":0.10884189880098855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139255064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96906215,0.0018524969,0.017983241,0.0015138584,0.00006995418,0.00020641327,0.0022125859,0.00012128555,0.0069779446],"genre_scores_gemma":[0.9929368,0.00071525056,0.0036906658,0.000084640895,0.000019271214,0.00019059937,0.00060115475,0.000017748058,0.0017439523],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99801993,0.0013676326,0.00007231027,0.0001492256,0.000107570944,0.00028331467],"domain_scores_gemma":[0.9904793,0.007845661,0.0008699495,0.0001613223,0.00036648585,0.0002772426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034809175,0.0015313138,0.0015533254,0.0023339277,0.00047233547,0.0023671305,0.0013683243,0.002221994,0.0032639632],"category_scores_gemma":[0.012502315,0.0010514291,0.00313033,0.0015278289,0.00092671416,0.0011711713,0.001145892,0.0011078797,0.00036027117],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039562833,0.000059298458,0.005902744,0.00006682401,0.00021911878,0.00008233812,0.000029877398,0.98965234,0.000057805388,0.0017318159,0.0002197338,0.0015824673],"study_design_scores_gemma":[0.0003244887,0.00040546624,0.0047742557,0.000098946286,0.00035175832,0.00011712884,0.00012125141,0.9884539,0.00013636213,0.00456051,0.0006214994,0.000034453882],"about_ca_topic_score_codex":0.057260334,"about_ca_topic_score_gemma":0.020293873,"teacher_disagreement_score":0.057260334,"about_ca_system_score_codex":0.005767411,"about_ca_system_score_gemma":0.0035133774,"threshold_uncertainty_score":0.11385411},"labels":[],"label_agreement":null},{"id":"W2139655506","doi":"10.1177/1352458507077175","title":"Fatigue in multiple sclerosis: association with disease-related, behavioural and psychosocial factors","year":2007,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McGill University; Jewish General Hospital; McGill University Health Centre; Montreal Neurological Institute and Hospital","funders":"Multiple Sclerosis Society","keywords":"Psychosocial; Biopsychosocial model; Medicine; Physical therapy; Depression (economics); Psychology; Clinical psychology; Psychiatry","score_opus":0.14300408430002154,"score_gpt":0.3120863215242343,"score_spread":0.16908223722421278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139655506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99910057,0.0006445137,0.000061235965,0.000028396365,0.0000018020751,0.00000734989,0.0000512447,0.0000022466063,0.000102785845],"genre_scores_gemma":[0.9996376,0.00013552362,0.00007060114,0.000012369133,0.000009878861,0.000009170542,0.000081535596,5.720983e-7,0.000042675238],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995628,0.00020045499,0.000053112395,0.000052706913,0.00008049424,0.000050272043],"domain_scores_gemma":[0.9975138,0.0008616109,0.0010505407,0.000092289774,0.00016893196,0.00031278716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008137701,0.00044519233,0.0004483064,0.0007270724,0.00031873162,0.0003409612,0.00024117208,0.00059167086,0.001044799],"category_scores_gemma":[0.0040898505,0.0002137432,0.0003251285,0.00055954134,0.00034243672,0.00025267675,0.000371154,0.00038959738,0.000123834],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012909128,0.000045893164,0.9973786,0.000019368335,0.000046631307,0.00007359167,0.000042165175,0.00006857471,0.00021703023,0.000007295316,0.000026448623,0.0019454455],"study_design_scores_gemma":[0.0000053081067,0.00013372702,0.9994168,0.0000034758104,0.000012759829,0.00022706443,0.000022853399,0.00012234345,0.000018093291,0.000012161808,0.000023753058,0.0000015759734],"about_ca_topic_score_codex":0.0018077552,"about_ca_topic_score_gemma":0.0024058016,"teacher_disagreement_score":0.0018077552,"about_ca_system_score_codex":0.0002026719,"about_ca_system_score_gemma":0.00019934081,"threshold_uncertainty_score":0.004303694},"labels":[],"label_agreement":null},{"id":"W2140051179","doi":"10.1191/1352458505ms1205oa","title":"Relapse rates and enhancing lesions in a phase II trial of natalizumab in multiple sclerosis","year":2005,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Multiple Sclerosis Society","keywords":"Natalizumab; Multiple sclerosis; Medicine; Internal medicine; Placebo; Lesion; Gastroenterology; Clinical trial; Phases of clinical research; Surgery; Pathology; Immunology","score_opus":0.14144824002174747,"score_gpt":0.348538242617605,"score_spread":0.20709000259585755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140051179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99861014,0.000529026,0.00011665751,0.00007423347,0.000023057788,0.0003113853,0.000097994154,0.000008949532,0.00022857427],"genre_scores_gemma":[0.9979526,0.00018923581,0.00029883845,0.00019182505,0.000054737488,0.00065255206,0.00037363463,0.000005795643,0.00028073008],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9968906,0.002136514,0.00021949469,0.0002697013,0.00026504888,0.00021874513],"domain_scores_gemma":[0.99614346,0.0014113678,0.00115885,0.00035059595,0.00017326372,0.0007623625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006099504,0.0008453006,0.0014476583,0.00031096485,0.00042184786,0.0007568038,0.00051199377,0.0010330845,0.001217437],"category_scores_gemma":[0.005423228,0.00048131583,0.001119815,0.00025410068,0.00056974386,0.0005350803,0.00039779593,0.00196552,0.00027274608],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8409691,0.023412839,0.07874254,0.00032754018,0.0020064316,0.00022060373,0.00040823137,0.0010480934,0.015302802,0.00012021235,0.0010543121,0.036387287],"study_design_scores_gemma":[0.26004076,0.46698382,0.26013285,0.000066303444,0.0017283707,0.0006935595,0.00013045163,0.0033692354,0.0048301117,0.00026777276,0.0016865418,0.00007005805],"about_ca_topic_score_codex":0.00026596594,"about_ca_topic_score_gemma":0.00035137293,"teacher_disagreement_score":0.006099504,"about_ca_system_score_codex":0.00047997542,"about_ca_system_score_gemma":0.00085453084,"threshold_uncertainty_score":0.032257676},"labels":[],"label_agreement":null},{"id":"W2140360882","doi":"10.1177/1352458514559865","title":"Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing–remitting multiple sclerosis","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne; Jewish General Hospital; Cégep de Lévis; Université de Montréal; Hôpital Notre-Dame","funders":"NIH Clinical Center; Novartis Pharma; Multiple Sclerosis Society; York University; Teva Pharmaceutical Industries; Biogen; NYU Langone Medical Center; Sanofi","keywords":"Glatiramer acetate; Medicine; Multiple sclerosis; Propensity score matching; Interferon beta-1a; Internal medicine; Natalizumab; Hazard ratio; Magnetic resonance imaging; Interferon beta; Immunology; Confidence interval","score_opus":0.1326666379516044,"score_gpt":0.32838512792949787,"score_spread":0.19571848997789346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140360882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847534,0.014070066,0.00022036157,0.000119703436,0.00004246651,0.00016412373,0.00012235924,0.000009066336,0.00049842574],"genre_scores_gemma":[0.99697876,0.0023157245,0.00025096495,0.00008446815,0.000055132732,0.00007837518,0.0001215058,0.0000022043314,0.000112882866],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.994214,0.0046911836,0.00032547323,0.00023305842,0.00038852947,0.00014783906],"domain_scores_gemma":[0.99555826,0.0023321004,0.0014903871,0.00025417082,0.000115075694,0.00024987877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005731007,0.00038867161,0.0010998317,0.0006874298,0.00011708135,0.0005757446,0.0004155621,0.0005991023,0.001475423],"category_scores_gemma":[0.008230491,0.00015311703,0.0014970319,0.00065406295,0.0005041879,0.0005563916,0.00036696804,0.0005355587,0.00016178921],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.73985255,0.004462511,0.037606798,0.0022399968,0.008554218,0.000114729344,0.00024319351,0.0017036772,0.0025326405,0.0002630448,0.00032360837,0.20210297],"study_design_scores_gemma":[0.13091996,0.64673203,0.2015254,0.00061222154,0.009921711,0.0003957299,0.00030589744,0.002557634,0.0042901724,0.00075510854,0.0019227412,0.000061442865],"about_ca_topic_score_codex":0.00036311935,"about_ca_topic_score_gemma":0.00048436635,"teacher_disagreement_score":0.005731007,"about_ca_system_score_codex":0.0006507167,"about_ca_system_score_gemma":0.0004124553,"threshold_uncertainty_score":0.030308783},"labels":[],"label_agreement":null},{"id":"W2140925893","doi":"10.1177/1352458511434068","title":"Epidemiology in multiple sclerosis has had its day: there are no more unanswered questions - No","year":2011,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"","keywords":"Multiple sclerosis; Epidemiology; Medicine; Clinical neurology; MEDLINE; Psychology; Neuroscience; Psychiatry; Biology; Pathology","score_opus":0.3837436415628885,"score_gpt":0.3428027299823878,"score_spread":0.04094091158050067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140925893","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018007542,0.29568717,0.0014311412,0.6745405,0.024086691,0.000022242537,0.00026969227,0.000049098297,0.00211266],"genre_scores_gemma":[0.075124815,0.21192306,0.0063604,0.58188194,0.119631566,0.00015976402,0.0005773307,0.0000704605,0.00427068],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.96993434,0.019288253,0.0034313428,0.0026466679,0.0036785807,0.0010208496],"domain_scores_gemma":[0.8079728,0.11709243,0.014943719,0.016234705,0.033599474,0.010156927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.070130266,0.0013722545,0.0048795277,0.0035798247,0.0049245595,0.016540747,0.0037283625,0.014616185,0.015288124],"category_scores_gemma":[0.1254857,0.0009289224,0.002720169,0.0057501975,0.01556033,0.036020294,0.00763747,0.0152659025,0.003638553],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000889304,0.00080842467,0.061246414,0.02050753,0.00334672,0.00053451344,0.005701868,0.00049312226,0.00094572664,0.10829363,0.45379347,0.3434394],"study_design_scores_gemma":[0.00041086046,0.000536754,0.051573124,0.029961094,0.0019922312,0.0010475793,0.028016167,0.00053856405,0.0003593793,0.2122948,0.6727595,0.0005100812],"about_ca_topic_score_codex":0.0092576025,"about_ca_topic_score_gemma":0.015795143,"teacher_disagreement_score":0.070130266,"about_ca_system_score_codex":0.0047076014,"about_ca_system_score_gemma":0.014125449,"threshold_uncertainty_score":0.3708887},"labels":[],"label_agreement":null},{"id":"W2141372130","doi":"10.1177/1352458513503598","title":"The impact of sexual dysfunction on health-related quality of life in people with multiple sclerosis","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Multiple sclerosis; Quality of life (healthcare); Medicine; Affect (linguistics); Sexual dysfunction; Population; Multilevel model; Explained variation; Physical disability; Analysis of variance; Multivariate analysis; Multivariate statistics; Gerontology; Demography; Clinical psychology; Psychology; Physical therapy; Psychiatry; Internal medicine; Environmental health","score_opus":0.13997081790795887,"score_gpt":0.33547442895183,"score_spread":0.19550361104387112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141372130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981413,0.000905437,0.000028297036,0.00019183023,0.0000058912033,0.0000062882755,0.0002064029,0.0000015826953,0.0005129371],"genre_scores_gemma":[0.9995359,0.00025224485,0.00003527819,0.000039384722,0.000007983564,0.0000052712608,0.00007868253,4.539132e-7,0.00004485411],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99946994,0.00022456866,0.0000546147,0.00003835554,0.00013803103,0.00007444944],"domain_scores_gemma":[0.9978885,0.0006598927,0.00095691404,0.0000587384,0.00016343851,0.00027247114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090654846,0.00018432968,0.000287594,0.0004708269,0.00032554567,0.0005500464,0.00018931626,0.00022315365,0.0019482169],"category_scores_gemma":[0.004732848,0.00008979486,0.00045074226,0.0006817888,0.00030444752,0.00041617858,0.00056461495,0.0005335255,0.00013568849],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005496197,0.00003575758,0.9944265,0.000031733467,0.000070696384,0.00005649726,0.00013361473,0.00004357148,0.000057908364,0.000012268645,0.00009868533,0.004977932],"study_design_scores_gemma":[0.0000034707673,0.00006878024,0.999241,0.000017880391,0.00002619759,0.00021867114,0.00020722132,0.000068122026,0.000020598838,0.000028628454,0.000097300406,0.000002121601],"about_ca_topic_score_codex":0.0018320411,"about_ca_topic_score_gemma":0.0033267366,"teacher_disagreement_score":0.0019482169,"about_ca_system_score_codex":0.0002645156,"about_ca_system_score_gemma":0.00034687822,"threshold_uncertainty_score":0.0065174103},"labels":[],"label_agreement":null},{"id":"W2141582945","doi":"10.1177/1352458512471877","title":"High rates of physician services utilization at least five years before multiple sclerosis diagnosis","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Multiple sclerosis; Medicine; Family medicine; Psychiatry","score_opus":0.1329821153201995,"score_gpt":0.317162884705423,"score_spread":0.1841807693852235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141582945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99809414,0.00061492954,0.0000801222,0.00015114193,0.0000074885106,0.000004781183,0.00052047684,0.000007754678,0.0005191223],"genre_scores_gemma":[0.9994287,0.00013609971,0.000043666212,0.00002587246,0.00001025882,0.0000026670111,0.00029270837,9.0835204e-7,0.000059067195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876475,0.00030484732,0.00014608029,0.000240746,0.00029574923,0.00024778428],"domain_scores_gemma":[0.9933796,0.0011616978,0.0043099048,0.00019950302,0.00041770478,0.00053158257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001008004,0.00013460394,0.00029001923,0.0010561318,0.0003135623,0.0006756493,0.00039549658,0.0005916474,0.0013972644],"category_scores_gemma":[0.0046113753,0.00016982366,0.00045144054,0.001580575,0.00023078204,0.00040956904,0.00048041585,0.00067810423,0.00015175075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022362889,0.000009997125,0.99860793,0.0000116741,0.00003719736,0.00006335417,0.000059986472,0.000059243805,0.000058269386,0.000020110147,0.000101347294,0.0009485976],"study_design_scores_gemma":[6.216277e-7,0.000009804656,0.99968505,0.000006601394,0.000005238678,0.000088114924,0.000049849736,0.000073796335,0.000014740655,0.0000073924984,0.000057405978,0.0000013559378],"about_ca_topic_score_codex":0.02719515,"about_ca_topic_score_gemma":0.025288863,"teacher_disagreement_score":0.02719515,"about_ca_system_score_codex":0.0008229649,"about_ca_system_score_gemma":0.0005645001,"threshold_uncertainty_score":0.05407375},"labels":[],"label_agreement":null},{"id":"W2141927521","doi":"10.1177/1352458514564488","title":"The incidence and prevalence of comorbid gastrointestinal, musculoskeletal, ocular, pulmonary, and renal disorders in multiple sclerosis: A systematic review","year":2014,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Winnipeg; University of Manitoba","funders":"Canadian Institutes of Health Research; Teva Pharmaceutical Industries","keywords":"Medicine; Irritable bowel syndrome; Population; Fibromyalgia; Incidence (geometry); Comorbidity; Disease; Internal medicine; Physical therapy","score_opus":0.08774498040869426,"score_gpt":0.332461587882921,"score_spread":0.24471660747422674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141927521","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011023581,0.9984555,0.00004943933,0.00007973083,0.000034452525,0.000067347486,0.00011363377,0.0000032894004,0.00009411213],"genre_scores_gemma":[0.013230849,0.9859555,0.0003268411,0.00013463499,0.000045915855,0.00014601549,0.000105520834,0.000001936002,0.000052840656],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9957022,0.0013211513,0.0016997941,0.0003608662,0.0007761982,0.00013980544],"domain_scores_gemma":[0.9866753,0.009142518,0.0027478437,0.00017357508,0.0010929636,0.00016774947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004647344,0.0012672866,0.0070690243,0.009062473,0.0005159542,0.001717079,0.001478558,0.001491278,0.0027046145],"category_scores_gemma":[0.02035382,0.0009314084,0.006418027,0.011629119,0.0005377788,0.0016368671,0.0010754638,0.00070540153,0.00017358981],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001824157,0.00001658409,0.002156291,0.9431978,0.01571221,0.00014007333,0.00015075575,0.00008089291,0.00015779374,0.000102826,0.0010628559,0.037039585],"study_design_scores_gemma":[0.00029763422,0.00036476052,0.020492714,0.70609677,0.2514137,0.0014578761,0.00042368565,0.0001721912,0.00033618812,0.00029767354,0.018582862,0.00006393291],"about_ca_topic_score_codex":0.006959441,"about_ca_topic_score_gemma":0.020094682,"teacher_disagreement_score":0.009062473,"about_ca_system_score_codex":0.002074468,"about_ca_system_score_gemma":0.0060490416,"threshold_uncertainty_score":0.024577796},"labels":[],"label_agreement":null},{"id":"W2142494199","doi":"10.1177/1352458510388543","title":"Intrathecal IgM synthesis in pediatric MS is not a negative prognostic marker of disease progression: quantitative versus qualitative IgM analysis","year":2010,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Multiple sclerosis; Medicine; Intrathecal; Cerebrospinal fluid; Expanded Disability Status Scale; Internal medicine; Gastroenterology; Cohort; Clinically isolated syndrome; Immunology; Surgery","score_opus":0.12973574860272352,"score_gpt":0.3940297134961396,"score_spread":0.26429396489341606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142494199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99930465,0.00029120897,0.00017881456,0.000010083679,0.0000020841437,0.0000033572553,0.00008419563,0.000004367526,0.00012125489],"genre_scores_gemma":[0.9994966,0.00009031299,0.00023266152,0.0000040230448,0.0000053010385,0.000005577173,0.00013719883,0.0000021711394,0.0000261587],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999686,0.00009640611,0.00003229314,0.00006271213,0.000075557306,0.000047023987],"domain_scores_gemma":[0.99806374,0.00069140666,0.00077627,0.00008312842,0.00016501488,0.00022044778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073718856,0.0003426498,0.0002645421,0.0010066638,0.00016108927,0.0003166723,0.00017894265,0.00028389797,0.0007216429],"category_scores_gemma":[0.0026242263,0.00012485917,0.00021482649,0.00051753776,0.0002889627,0.00030307335,0.00020785634,0.00028599988,0.00016264239],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026610182,0.00001108929,0.99583435,0.0000118964235,0.000016913533,0.0001126529,0.000028228083,0.000088190514,0.001233636,0.000008025639,0.00002931625,0.0023595816],"study_design_scores_gemma":[0.000008710896,0.00034080428,0.99631643,0.000009757919,0.000037674934,0.0012927605,0.0000906921,0.0006578984,0.0010138762,0.000025128578,0.00020277494,0.0000034233594],"about_ca_topic_score_codex":0.00091494486,"about_ca_topic_score_gemma":0.0008042564,"teacher_disagreement_score":0.0010066638,"about_ca_system_score_codex":0.00020094746,"about_ca_system_score_gemma":0.00022923948,"threshold_uncertainty_score":0.0038986802},"labels":[],"label_agreement":null},{"id":"W2143237038","doi":"10.1177/1352458512470311","title":"Methods and measures: what’s new for MS?","year":2012,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Rasch model; Ask price; Multiple sclerosis; Psychology; Psychological intervention; Preference; Clinical psychology; Cognitive psychology; Psychiatry; Developmental psychology; Mathematics; Statistics","score_opus":0.5200704806374683,"score_gpt":0.4763480036313983,"score_spread":0.043722477006070015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143237038","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000033015374,0.98855,0.0011238471,0.0074575017,0.0022459084,0.00008386722,0.000053732685,0.000015847885,0.00043624893],"genre_scores_gemma":[0.0010685474,0.9782925,0.008435446,0.0070881625,0.0037551739,0.0005503795,0.000086152715,0.000033893783,0.0006897698],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9560628,0.024934249,0.005906644,0.0023210286,0.010338226,0.00043697996],"domain_scores_gemma":[0.9246618,0.051543776,0.008369435,0.005335825,0.008813209,0.0012760039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04933554,0.0022651183,0.006993827,0.007841022,0.0009720539,0.006960034,0.004748626,0.0067942743,0.0075005824],"category_scores_gemma":[0.09717098,0.0019032655,0.0039832084,0.009946326,0.0076764333,0.015386118,0.0033380855,0.009355567,0.0053455145],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016431314,0.000095221745,0.0006422643,0.10551157,0.0008118308,0.00008958778,0.000565367,0.00014346934,0.00027887875,0.017833,0.061304405,0.8125602],"study_design_scores_gemma":[0.00010854169,0.00010969031,0.0024624835,0.12933007,0.00063506345,0.0005032293,0.00043443637,0.00014642936,0.00015533414,0.026070772,0.8399316,0.000112373484],"about_ca_topic_score_codex":0.005387375,"about_ca_topic_score_gemma":0.006270116,"teacher_disagreement_score":0.04933554,"about_ca_system_score_codex":0.004599248,"about_ca_system_score_gemma":0.008655198,"threshold_uncertainty_score":0.2609144},"labels":[],"label_agreement":null},{"id":"W2143322448","doi":"10.1177/1352458513512709","title":"Using magnetic resonance imaging in animal models to guide drug development in multiple sclerosis","year":2013,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; Ontario Brain Institute; University of Calgary","funders":"Canadian Institutes of Health Research; Alberta Innovates; Multiple Sclerosis Society; Natural Sciences and Engineering Research Council of Canada; Multiple Sclerosis Society of Canada","keywords":"Multiple sclerosis; Remyelination; Medicine; Magnetic resonance imaging; Clinical trial; Drug development; Preclinical research; Drug; Medical physics; Neuroscience; Pathology; Pharmacology; Radiology; Psychology; Internal medicine; Immunology; Central nervous system","score_opus":0.35659155730095476,"score_gpt":0.3726138033485424,"score_spread":0.01602224604758762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143322448","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010784772,0.99847263,0.00026062824,0.00016124513,0.000098805845,0.000014905023,0.00001743395,0.000007618507,0.00085882825],"genre_scores_gemma":[0.0006292679,0.99818134,0.0006616071,0.00012192159,0.00004297863,0.00001566229,0.000018427869,0.0000018413489,0.00032692697],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995555,0.00011386772,0.000079357036,0.000055045188,0.0001756216,0.000020504644],"domain_scores_gemma":[0.99925536,0.0004196973,0.00011489681,0.000027242719,0.00015423943,0.000028461554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012920691,0.0009132034,0.0017681859,0.0043441267,0.00026383458,0.0008745598,0.0009850065,0.001572457,0.0033894775],"category_scores_gemma":[0.001342234,0.00033995666,0.00084242475,0.0028042186,0.0006513803,0.0013744092,0.00053205964,0.0015739452,0.0022851415],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006217543,0.00010901861,0.00023929411,0.050752927,0.00017277412,0.00032941042,0.00008846835,0.00037066292,0.0070527745,0.003956357,0.014830074,0.9220361],"study_design_scores_gemma":[0.00003397153,0.00023497026,0.001497449,0.014126984,0.0003879687,0.0023720001,0.0001230274,0.00013680632,0.0035902634,0.002665687,0.97478944,0.000041517254],"about_ca_topic_score_codex":0.0013405591,"about_ca_topic_score_gemma":0.0024846473,"teacher_disagreement_score":0.0043441267,"about_ca_system_score_codex":0.0005291992,"about_ca_system_score_gemma":0.0009991275,"threshold_uncertainty_score":0.011338949},"labels":[],"label_agreement":null},{"id":"W2143322657","doi":"10.1177/1352458514564489","title":"A systematic review of the incidence and prevalence of cancer in multiple sclerosis","year":2014,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Winnipeg; University of Manitoba","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada; Cleveland Clinic; Cleveland Clinic Foundation; Multiple Sclerosis Society; National Institute of Neurological Disorders and Stroke; Teva Pharmaceutical Industries; Biogen; National Multiple Sclerosis Society; GlaxoSmithKline; Gilead Sciences; Sanofi; EMD Serono","keywords":"Medicine; Incidence (geometry); Population; Multiple sclerosis; Cancer; Prostate cancer; Cancer registry; Epidemiology; Internal medicine; Cervical cancer; Breast cancer; MEDLINE; Oncology; Gynecology; Immunology; Environmental health","score_opus":0.15562907664906814,"score_gpt":0.3693136924138727,"score_spread":0.21368461576480455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143322657","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006469119,0.99843866,0.00010253209,0.00015441158,0.000089958536,0.00023113479,0.00018400083,0.00000519902,0.00014714045],"genre_scores_gemma":[0.0086018145,0.98981,0.0006189201,0.00024683928,0.00006424479,0.00044284324,0.00013145103,0.0000031121147,0.00008077421],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98814327,0.004086456,0.00467069,0.0007420242,0.0020928637,0.00026467998],"domain_scores_gemma":[0.9691523,0.020882208,0.0061329077,0.00044630596,0.003072113,0.00031421255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010116167,0.0019407081,0.010333355,0.016267102,0.0008365142,0.0028853621,0.002137961,0.0020523388,0.00386972],"category_scores_gemma":[0.04812067,0.0012809833,0.0073223975,0.017195065,0.0009464348,0.002579704,0.001656615,0.0011741488,0.0002973843],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010072901,0.00000824847,0.0006624196,0.96445125,0.008453832,0.000101441714,0.00014646107,0.00006002273,0.000111008485,0.00012142987,0.00095136586,0.024831755],"study_design_scores_gemma":[0.00017352751,0.00019825289,0.0050149853,0.8732439,0.10280781,0.00062778225,0.0002883952,0.000070328766,0.00017458122,0.00027280502,0.01709412,0.000033454216],"about_ca_topic_score_codex":0.008623457,"about_ca_topic_score_gemma":0.027022734,"teacher_disagreement_score":0.016267102,"about_ca_system_score_codex":0.0044430993,"about_ca_system_score_gemma":0.013275106,"threshold_uncertainty_score":0.053500056},"labels":[],"label_agreement":null},{"id":"W2143424812","doi":"10.1191/1352458504ms1009oa","title":"Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte/endothelial interactions in an experimental autoimmune encephalomyelitis model","year":2004,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Experimental autoimmune encephalomyelitis; Cannabinoid receptor; Multiple sclerosis; Cannabinoid; Agonist; Myelin oligodendrocyte glycoprotein; Intravital microscopy; Cannabinoid receptor type 2; Immunology; Immune system; Encephalomyelitis; Pharmacology; Chemistry; Receptor; Medicine; Internal medicine; Microcirculation","score_opus":0.0705255941332783,"score_gpt":0.321607670073763,"score_spread":0.2510820759404847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143424812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99740773,0.0008143262,0.00054304313,0.00012469389,0.000049285867,0.000024757026,0.000086546424,0.00004986103,0.00089970184],"genre_scores_gemma":[0.99180764,0.0013597854,0.0018398562,0.000111138615,0.000044330827,0.00006157427,0.00019976831,0.0000131571,0.0045627537],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997397,0.000044372646,0.000021300364,0.000023341992,0.00007889622,0.00009233822],"domain_scores_gemma":[0.99983585,0.000021729878,0.000043277592,0.000016453225,0.000016023585,0.00006665157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021230982,0.00056773593,0.0005022024,0.00042754973,0.00033421296,0.00035609797,0.00026792334,0.00043195483,0.0014999635],"category_scores_gemma":[0.0001965067,0.00021231531,0.00021118588,0.00017936576,0.00030363127,0.0003084401,0.0001781308,0.0013334132,0.0003195446],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010781364,0.00056190434,0.0001862864,0.00004244908,0.0000121171315,0.00012356856,0.000024889358,0.000050865834,0.9955735,0.00010197523,0.00008233247,0.0021620363],"study_design_scores_gemma":[0.00019721911,0.0053881756,0.0042612734,0.000014533727,0.000053144067,0.000369002,0.00005466131,0.0011287618,0.98716795,0.00009427259,0.001261866,0.000009026976],"about_ca_topic_score_codex":0.0011105451,"about_ca_topic_score_gemma":0.0026115843,"teacher_disagreement_score":0.0014999635,"about_ca_system_score_codex":0.00030803337,"about_ca_system_score_gemma":0.00038270507,"threshold_uncertainty_score":0.005017817},"labels":[],"label_agreement":null},{"id":"W2144048982","doi":"10.1177/135245850100700104","title":"Raised cerebrospinal fluid nitrite and nitrate levels in patients with multiple sclerosis: no correlation with disease activity","year":2001,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Nitric Oxide and Endothelin Effects","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Biological Sciences","funders":"","keywords":"Multiple sclerosis; Cerebrospinal fluid; Medicine; Nitrite; Nitrate; Disease; Central nervous system disease; Correlation; Internal medicine; Immunology; Chemistry","score_opus":0.04006739764467384,"score_gpt":0.22659343025380438,"score_spread":0.18652603260913053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144048982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987967,0.00081436563,0.000073746014,0.000041072657,0.0000060097655,0.0000028343973,0.000040582036,0.0000047670687,0.00022007193],"genre_scores_gemma":[0.9994815,0.00021040539,0.000104896986,0.000025780131,0.000019032532,0.0000042268925,0.00006202383,0.0000013354565,0.000090803725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997322,0.00008653444,0.000050937386,0.000046185163,0.000054946442,0.000029279712],"domain_scores_gemma":[0.997666,0.0008449168,0.0008356445,0.00008481255,0.0002094811,0.00035927462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038592136,0.000338482,0.00044785664,0.0006833591,0.00034845158,0.0003995666,0.00017142878,0.00061760814,0.0010509102],"category_scores_gemma":[0.0029485126,0.00018012982,0.000119173725,0.00041428255,0.00044774392,0.00034044543,0.00026790932,0.00037908397,0.00025714003],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009848162,0.00007448582,0.98956656,0.00004309507,0.00005107919,0.00044550348,0.00016796688,0.00003922863,0.0044385525,0.000015528318,0.00007752254,0.0040957145],"study_design_scores_gemma":[0.00003536169,0.0006924985,0.99408406,0.000014128099,0.00005351915,0.0035285945,0.00021879577,0.00022182331,0.0007781902,0.000086714135,0.00027830707,0.000007970426],"about_ca_topic_score_codex":0.0004258395,"about_ca_topic_score_gemma":0.00045888184,"teacher_disagreement_score":0.0010509102,"about_ca_system_score_codex":0.00012738572,"about_ca_system_score_gemma":0.00013036342,"threshold_uncertainty_score":0.0035156608},"labels":[],"label_agreement":null},{"id":"W2144515779","doi":"10.1177/1352458512452920","title":"Reproductive decision making after the diagnosis of multiple sclerosis (MS)","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Multiple Sclerosis Society; Teva Pharmaceutical Industries","keywords":"Multiple sclerosis; Medicine; Clinical decision making; Psychology; Physical medicine and rehabilitation; Intensive care medicine; Psychiatry","score_opus":0.14376768140360913,"score_gpt":0.3340458934095041,"score_spread":0.19027821200589495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144515779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99538004,0.001273228,0.000083684645,0.0012129568,0.000034820634,0.000010592747,0.000040669474,0.0000027909914,0.0019612608],"genre_scores_gemma":[0.99868137,0.0005329637,0.00008152218,0.00028999834,0.000020447362,0.0000040691334,0.000021090917,6.2158193e-7,0.00036788758],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.99933857,0.0004184842,0.000028911698,0.000039761777,0.0000892416,0.00008493885],"domain_scores_gemma":[0.99683785,0.0015186709,0.0011537144,0.000058021113,0.0001299016,0.00030182206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001371524,0.0000981329,0.00011218231,0.00027570224,0.00057295547,0.0005140126,0.00014422974,0.00036846718,0.0027672036],"category_scores_gemma":[0.008325678,0.00009464583,0.00016955829,0.00016573035,0.00042057398,0.00038609616,0.00029474092,0.00055002514,0.00020544052],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026295093,0.0002500815,0.9406148,0.000061979146,0.00004891754,0.0016490474,0.00924611,0.000099447854,0.00060507667,0.000321644,0.0015707703,0.045269158],"study_design_scores_gemma":[0.00003405549,0.0007241767,0.9574813,0.00026640005,0.00006569986,0.007521444,0.02485497,0.0004265644,0.000696885,0.0006270497,0.007270769,0.000030757772],"about_ca_topic_score_codex":0.0024056677,"about_ca_topic_score_gemma":0.0043004476,"teacher_disagreement_score":0.0027672036,"about_ca_system_score_codex":0.00024594518,"about_ca_system_score_gemma":0.00053214456,"threshold_uncertainty_score":0.009257197},"labels":[],"label_agreement":null},{"id":"W2144563695","doi":"10.1177/1352458510379615","title":"Validity of an Internet version of the Multiple Sclerosis Neuropsychological Questionnaire","year":2010,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baycrest Hospital; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research","keywords":"Neuropsychology; Multiple sclerosis; Depression (economics); Receiver operating characteristic; Psychometrics; Psychology; Neuropsychological test; Clinical psychology; Medicine; Neuropsychological assessment; Cognition; Psychiatry; Internal medicine","score_opus":0.12870536134629856,"score_gpt":0.3222738879534721,"score_spread":0.19356852660717355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144563695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99111193,0.0003679871,0.00088824175,0.00017822784,0.00004290526,0.00028412312,0.0014896245,0.000032967393,0.0056039835],"genre_scores_gemma":[0.9955134,0.00018714943,0.0018834935,0.00012689689,0.000019192998,0.00020812504,0.0014546649,0.000010236881,0.0005968715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978346,0.00082847493,0.00024292567,0.00024022195,0.0007667173,0.00008704536],"domain_scores_gemma":[0.9885521,0.0045039267,0.0038241905,0.0005546233,0.0020455865,0.00051967904],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00412755,0.00035559657,0.0004029713,0.0012152542,0.00022914965,0.0007448395,0.0004903773,0.00047342203,0.0021709257],"category_scores_gemma":[0.016533619,0.00017695424,0.0005322247,0.0007507467,0.00035533257,0.0007976776,0.00078647304,0.0006203883,0.000651361],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023825858,0.000374907,0.9763289,0.000054605505,0.00016764239,0.000071008086,0.00028829838,0.0002886684,0.00037630505,0.000084021805,0.0006308502,0.021096561],"study_design_scores_gemma":[0.00005203863,0.00039412625,0.99673367,0.000056351433,0.00003623194,0.0002936978,0.0001900329,0.0007764745,0.00019532893,0.00011708816,0.0011425193,0.00001247858],"about_ca_topic_score_codex":0.0019188192,"about_ca_topic_score_gemma":0.0023162432,"teacher_disagreement_score":0.99587244,"about_ca_system_score_codex":0.00039805652,"about_ca_system_score_gemma":0.00037204046,"threshold_uncertainty_score":0.02182883},"labels":[],"label_agreement":null},{"id":"W2145552726","doi":"10.1191/1352458505ms1211oa","title":"Economic evaluation of Avonex® (interferon beta-1a) in patients following a single demyelinating event","year":2005,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital; Brock University; PharmIdeas (Canada)","funders":"Bayer Canada; IC Design Education Center; Bayer HealthCare; Biogen","keywords":"Medicine; Multiple sclerosis; Cost effectiveness; Cost–utility analysis; Quality-adjusted life year; Cost–benefit analysis; Marginal cost; Psychiatry","score_opus":0.13125389230491277,"score_gpt":0.340622009433365,"score_spread":0.20936811712845224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145552726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9463477,0.025619186,0.00925274,0.0029546835,0.00020981666,0.0019447693,0.0031381042,0.000056626057,0.010476322],"genre_scores_gemma":[0.9961617,0.00169393,0.0010872383,0.00013564926,0.00001785767,0.00019466878,0.0004221643,0.0000038002686,0.00028293554],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9943855,0.004650139,0.00017637847,0.00015262581,0.00031919044,0.00031615814],"domain_scores_gemma":[0.99011713,0.007840855,0.0009219866,0.00012242097,0.0004365423,0.00056107534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008171318,0.0010555082,0.0013496592,0.0011229123,0.00040241578,0.0018382584,0.00093879295,0.0012378065,0.003491893],"category_scores_gemma":[0.025707807,0.00045507815,0.0032456473,0.0011608475,0.0005065355,0.0009221569,0.0010663987,0.0014813795,0.00012522725],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07771312,0.002427553,0.0517151,0.0054269363,0.009876586,0.0010145835,0.00025296898,0.74303323,0.0009470989,0.010057674,0.0031258974,0.09440917],"study_design_scores_gemma":[0.01469835,0.02079702,0.04170788,0.0027910194,0.011250646,0.0011930873,0.0005992021,0.89136875,0.0013471097,0.0069768834,0.0070504686,0.00021963233],"about_ca_topic_score_codex":0.03211961,"about_ca_topic_score_gemma":0.016374238,"teacher_disagreement_score":0.03211961,"about_ca_system_score_codex":0.010857207,"about_ca_system_score_gemma":0.005868717,"threshold_uncertainty_score":0.07877493},"labels":[],"label_agreement":null},{"id":"W2145849448","doi":"10.1191/135248505ms1277oa","title":"The new Global Multiple Sclerosis Severity Score (MSSS) correlates with axonal but not glial biomarkers","year":2006,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Multiple Sclerosis Society; Ministère de la Santé et des Services sociaux","keywords":"Neurofilament; Multiple sclerosis; Medicine; Biomarker; Expanded Disability Status Scale; Pathology; Internal medicine; Oncology; Immunology; Biology; Immunohistochemistry","score_opus":0.07247690757229011,"score_gpt":0.2702592895792274,"score_spread":0.1977823820069373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145849448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982191,0.00049410114,0.00029127125,0.000036534242,0.000009214208,0.000010224958,0.0001347933,0.000009768109,0.00079514127],"genre_scores_gemma":[0.9990689,0.00011556719,0.00030593347,0.000016898528,0.00002163997,0.000008942702,0.0001965566,0.0000021705682,0.000263326],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99969995,0.00010275947,0.000037386915,0.000048982605,0.00008588291,0.00002502321],"domain_scores_gemma":[0.9980108,0.00039711353,0.0010268828,0.0000874596,0.0002181559,0.00025960468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006890538,0.00033920296,0.0003626663,0.0008339976,0.00010291285,0.00025247614,0.000120430566,0.00020566945,0.0013381004],"category_scores_gemma":[0.0028958993,0.00009200205,0.00022246705,0.0003889906,0.00025473887,0.00043180518,0.00038896018,0.00026043886,0.00027248592],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007413408,0.000051275663,0.98411417,0.000048063393,0.00020722074,0.00007110358,0.0000676999,0.00013310973,0.0034898557,0.00003172125,0.00016932213,0.010875129],"study_design_scores_gemma":[0.000012971606,0.00054660055,0.99825436,0.000005921049,0.000036407713,0.00030044556,0.000040799212,0.00017685596,0.00036706947,0.000046746776,0.00020725734,0.0000043940777],"about_ca_topic_score_codex":0.00050454895,"about_ca_topic_score_gemma":0.0012046392,"teacher_disagreement_score":0.0013381004,"about_ca_system_score_codex":0.00013513908,"about_ca_system_score_gemma":0.00014535482,"threshold_uncertainty_score":0.0044763684},"labels":[],"label_agreement":null},{"id":"W2146662840","doi":"10.1177/1352458506070775","title":"MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis","year":2006,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":246,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne","funders":"","keywords":"Observational study; Epidemiology; Medicine; Strengthening the reporting of observational studies in epidemiology; Cohort; Disease registry; Cohort study; Data sharing; Population; Family medicine; MEDLINE; Disease; Alternative medicine; Pathology; Environmental health; Political science","score_opus":0.3314225773228368,"score_gpt":0.41647747663601564,"score_spread":0.08505489931317883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146662840","genre_codex":"dataset","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04729581,0.005558196,0.056331698,0.005167074,0.0012130459,0.0069320397,0.82558554,0.013655791,0.038260773],"genre_scores_gemma":[0.05839041,0.0027775548,0.085108824,0.0011092216,0.0010304649,0.01013741,0.82896787,0.002166238,0.010312052],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98391217,0.0052864435,0.005124459,0.0018003731,0.0032902218,0.0005862703],"domain_scores_gemma":[0.8963712,0.024527762,0.026511464,0.02230478,0.016990233,0.013294567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.029104067,0.00097292993,0.002734958,0.013585786,0.0013853677,0.0046390244,0.003337107,0.0012509187,0.025913619],"category_scores_gemma":[0.061756633,0.0008449149,0.00095592724,0.021375865,0.0006476751,0.0054697883,0.0065907487,0.0022919897,0.012799608],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050597773,0.0008733149,0.06385605,0.0022608684,0.00084225176,0.00038556737,0.0015219287,0.001225264,0.0015440015,0.010752904,0.65164053,0.26003757],"study_design_scores_gemma":[0.0028091609,0.0006245941,0.15397415,0.0012572203,0.000809601,0.00087118574,0.0006065788,0.0022519177,0.002211312,0.0061932523,0.82812434,0.00026665084],"about_ca_topic_score_codex":0.0057068407,"about_ca_topic_score_gemma":0.006059925,"teacher_disagreement_score":0.029104067,"about_ca_system_score_codex":0.0015910987,"about_ca_system_score_gemma":0.0130253695,"threshold_uncertainty_score":0.15391886},"labels":[],"label_agreement":null},{"id":"W2146793337","doi":"10.1177/1352458508092263","title":"Comorbidity, socioeconomic status and multiple sclerosis","year":2008,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":195,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Neurological Disorders and Stroke; National Institute of Allergy and Infectious Diseases","keywords":"Comorbidity; Medicine; Socioeconomic status; Odds ratio; Odds; Population; Multiple sclerosis; Internal medicine; Psychiatry; Logistic regression; Environmental health","score_opus":0.17024175857842802,"score_gpt":0.30374353929628856,"score_spread":0.13350178071786054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146793337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937721,0.0016133294,0.00008272876,0.0007783044,0.000027420047,0.0000127808225,0.00094812043,0.0000063230877,0.0027590154],"genre_scores_gemma":[0.99894255,0.00043231895,0.000061398314,0.000035319536,0.000020793344,0.000006970912,0.00036167755,9.361749e-7,0.00013801715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99962735,0.00011127234,0.00005328142,0.00003606563,0.00010230038,0.00006983528],"domain_scores_gemma":[0.9980665,0.00033864856,0.0008497855,0.000035725203,0.00017304694,0.00053639733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048853864,0.00017070929,0.0002052179,0.0005961327,0.00050609175,0.0004207414,0.00017568107,0.00019341407,0.0044915644],"category_scores_gemma":[0.0043746056,0.00005968035,0.00018705025,0.0010209209,0.00018954546,0.00030518768,0.00049523823,0.000358875,0.00024785407],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050006813,0.000033607772,0.9954941,0.000035134126,0.00005113594,0.00011459562,0.000067086796,0.000050270995,0.00004685723,0.000052775074,0.0003817962,0.0036226285],"study_design_scores_gemma":[0.0000040095574,0.00003034239,0.9989656,0.000026809515,0.000014556396,0.00028155505,0.0000751862,0.00012516003,0.000012739772,0.000057364938,0.00040433567,0.0000024346884],"about_ca_topic_score_codex":0.0052171205,"about_ca_topic_score_gemma":0.0047216467,"teacher_disagreement_score":0.0052171205,"about_ca_system_score_codex":0.00028780408,"about_ca_system_score_gemma":0.0004045156,"threshold_uncertainty_score":0.0150257945},"labels":[],"label_agreement":null},{"id":"W2147284521","doi":"10.1177/1352458508090662","title":"Timing of birth and disease progression in multiple sclerosis","year":2008,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Natural history; Multiple sclerosis; Season of birth; Expanded Disability Status Scale; Medicine; Disease; Cohort; Pediatrics; Demography; Cohort study; Proportional hazards model; Live birth; Survival analysis; Natural history study; Pregnancy; Internal medicine; Biology; Immunology; Psychiatry","score_opus":0.19586384228039783,"score_gpt":0.3246930564400865,"score_spread":0.12882921415968868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147284521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960913,0.0026156392,0.00028813808,0.00007865673,0.0000193329,0.000007954245,0.00038475043,0.000006727999,0.0005074114],"genre_scores_gemma":[0.99865365,0.0005882671,0.00026995366,0.000012011113,0.0000114491095,0.0000072466087,0.00021718192,0.000006093539,0.00023413733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99952626,0.00021368475,0.00004156318,0.000089796595,0.00007481864,0.00005388065],"domain_scores_gemma":[0.9954099,0.0016835799,0.0020083527,0.0002571632,0.00025443293,0.00038656805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001608955,0.00017456447,0.00027954788,0.00053039147,0.00028139268,0.00044196076,0.0003034229,0.00021436876,0.0014462246],"category_scores_gemma":[0.0056401487,0.0001292365,0.00037205537,0.0006588585,0.0002792216,0.00026777037,0.00032858615,0.0003254833,0.00012287208],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090210984,0.000022850305,0.99262625,0.00005769305,0.00014088351,0.00013466063,0.00015126317,0.000146244,0.00078450394,0.00006757898,0.00008979644,0.00487625],"study_design_scores_gemma":[0.0000045602906,0.00011779419,0.9990984,0.000014190863,0.0000533254,0.00019111189,0.000040845935,0.000066105604,0.000118896394,0.000041924774,0.0002505529,0.0000023119114],"about_ca_topic_score_codex":0.0048342296,"about_ca_topic_score_gemma":0.004352303,"teacher_disagreement_score":0.0048342296,"about_ca_system_score_codex":0.00030187,"about_ca_system_score_gemma":0.0004243782,"threshold_uncertainty_score":0.009612203},"labels":[],"label_agreement":null},{"id":"W2147300306","doi":"10.1177/1352458512469694","title":"“Seeing” in NARCOMS: a look at vision-related quality of life in the NARCOMS registry","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Diplopia; Medicine; Quality of life (healthcare); Population; Visual impairment; Optic neuritis; Optometry; Visual acuity; Multiple sclerosis; Ophthalmology; Psychiatry","score_opus":0.1650824893381386,"score_gpt":0.36253505757058274,"score_spread":0.19745256823244414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147300306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9716551,0.0014450407,0.00015234118,0.006240364,0.00007307542,0.00009956452,0.011801854,0.000032755674,0.008499985],"genre_scores_gemma":[0.986937,0.0012841558,0.0003069086,0.0011737407,0.000114273746,0.00017961451,0.009222215,0.000018217885,0.0007639494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847764,0.00052914844,0.00023528094,0.0001415133,0.00033838348,0.00027797872],"domain_scores_gemma":[0.9922603,0.0012925569,0.0036140417,0.00032350645,0.0010685563,0.0014410284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023270394,0.00013145918,0.0003558334,0.0019480018,0.00074116286,0.0009743506,0.0007723917,0.00064081326,0.0030794044],"category_scores_gemma":[0.006885607,0.00012808658,0.000510229,0.0044653625,0.00040523408,0.0015294054,0.0012911771,0.0011036436,0.0004610197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037493315,0.000058457128,0.99177176,0.000045370074,0.000022588636,0.000105798186,0.00047485917,0.000029064608,0.000031715947,0.00007927977,0.0034548831,0.003888837],"study_design_scores_gemma":[0.000003286537,0.000027321013,0.9974523,0.00003317171,0.000007040459,0.000091102185,0.0011866441,0.000037624948,0.00001047287,0.0000226834,0.0011242722,0.0000040245645],"about_ca_topic_score_codex":0.014130455,"about_ca_topic_score_gemma":0.021489624,"teacher_disagreement_score":0.014130455,"about_ca_system_score_codex":0.0006726435,"about_ca_system_score_gemma":0.0011739407,"threshold_uncertainty_score":0.028096378},"labels":[],"label_agreement":null},{"id":"W2148230714","doi":"10.1191/1352458504ms1061oa","title":"Has your patient's multiple sclerosis lesion burden or brain atrophy actually changed?","year":2004,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institutes of Health; National Cancer Institute; National Center for Research Resources; National Institute of Neurological Disorders and Stroke; National Institute of Mental Health; National Institute on Aging","keywords":"Multiple sclerosis; Atrophy; Magnetic resonance imaging; Medicine; Lesion; Brain size; Central nervous system disease; Brain tissue; Nuclear medicine; Radiology; Pathology; Internal medicine; Psychiatry","score_opus":0.2671658653315179,"score_gpt":0.324011680754471,"score_spread":0.05684581542295308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148230714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99267685,0.0013975787,0.0019099403,0.001828539,0.000081126294,0.00001740273,0.00027401545,0.000033153454,0.0017813665],"genre_scores_gemma":[0.9984804,0.0003047091,0.0007035366,0.00024102151,0.00005500255,0.00000782085,0.0000927252,0.0000041271037,0.00011070829],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817693,0.00082112284,0.00023491283,0.0002941276,0.0003660065,0.00010696492],"domain_scores_gemma":[0.98596406,0.0081261275,0.0039692055,0.00059772964,0.0011297617,0.00021313278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035175688,0.00020481875,0.0006636796,0.0004204608,0.00027459548,0.00065083697,0.00024707027,0.0007814305,0.0009412128],"category_scores_gemma":[0.02215992,0.000089550726,0.0003873518,0.00053776184,0.0007077196,0.00065910025,0.00028828715,0.00055960024,0.00027434374],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004991863,0.000048209127,0.954693,0.00013603283,0.00023739981,0.000806753,0.0003687833,0.00036586158,0.0013698997,0.0002135094,0.00061661593,0.04064475],"study_design_scores_gemma":[0.000032993812,0.0010108202,0.9802389,0.0000699976,0.0003012606,0.008671066,0.00067521236,0.0023400378,0.002646973,0.000866075,0.0031066437,0.000039949897],"about_ca_topic_score_codex":0.0007932463,"about_ca_topic_score_gemma":0.0013014575,"teacher_disagreement_score":0.0035175688,"about_ca_system_score_codex":0.00027140861,"about_ca_system_score_gemma":0.0001659046,"threshold_uncertainty_score":0.018602908},"labels":[],"label_agreement":null},{"id":"W2148405577","doi":"10.1177/1352458513513968","title":"Sun exposure and multiple sclerosis risk in Norway and Italy: The EnvIMS study","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Multiple sclerosis; Medicine; Environmental health; Immunology","score_opus":0.07731133212571668,"score_gpt":0.2796404342942833,"score_spread":0.20232910216856664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148405577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99795145,0.00072267296,0.00006115183,0.00004344871,0.000011858328,0.000008655723,0.0006561836,0.0000022520533,0.00054229033],"genre_scores_gemma":[0.99816966,0.0003822401,0.00014741582,0.000026220965,0.000018115248,0.000022379416,0.00091957,0.0000026939138,0.00031180735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99960095,0.0001363716,0.000037897385,0.000099422155,0.00005370286,0.00007163595],"domain_scores_gemma":[0.99936813,0.00008847494,0.00031979498,0.000041863528,0.000058890946,0.00012299084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088513456,0.00034900245,0.0003697928,0.00052129704,0.00028375836,0.00051944074,0.00031154265,0.00031401828,0.0009962559],"category_scores_gemma":[0.00091031194,0.00023535047,0.0005672438,0.0007123547,0.00023470307,0.00026990188,0.0006144178,0.00028298487,0.00019542578],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000162246,0.0000256191,0.9981838,0.000018382943,0.0000646106,0.00006835018,0.00013294912,0.000042532094,0.00015094691,0.000015767855,0.00014141189,0.0009934262],"study_design_scores_gemma":[0.000011527704,0.000059703652,0.9994154,0.000012225738,0.000028471544,0.00006686103,0.00011371752,0.00004125073,0.000015919462,0.000007392295,0.00022622246,0.0000013690734],"about_ca_topic_score_codex":0.029686172,"about_ca_topic_score_gemma":0.031929564,"teacher_disagreement_score":0.029686172,"about_ca_system_score_codex":0.00041766802,"about_ca_system_score_gemma":0.0005345415,"threshold_uncertainty_score":0.059026778},"labels":[],"label_agreement":null},{"id":"W2149681150","doi":"10.1177/1352458512462918","title":"The epidemiology of multiple sclerosis in Latin America and the Caribbean: a systematic review","year":2012,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Epidemiology; Latin Americans; Multiple sclerosis; Incidence (geometry); Etiology; Medicine; Demography; Pediatrics; Geography; Pathology; Psychiatry","score_opus":0.30018572237982794,"score_gpt":0.3783897468268543,"score_spread":0.07820402444702634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149681150","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00088044803,0.99850756,0.00003619656,0.00013820357,0.000030904925,0.00007482255,0.00018529447,0.000003070587,0.00014340942],"genre_scores_gemma":[0.005173052,0.9941918,0.00022208487,0.00013087485,0.00002144152,0.00010782137,0.00010234466,0.0000011262068,0.000049372502],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99807125,0.00056771975,0.0007596252,0.00015018614,0.00037324708,0.00007800148],"domain_scores_gemma":[0.99259233,0.0044379598,0.0016930653,0.000094191084,0.0010430956,0.00013946199],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030380012,0.0011743887,0.0048558135,0.011685358,0.0005280006,0.0016711131,0.0010957667,0.0010860784,0.0034544624],"category_scores_gemma":[0.01310617,0.0007336508,0.0030428027,0.017155478,0.00043227675,0.0012763245,0.0009955396,0.0005389608,0.00022299477],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014014989,0.000018956845,0.0027428884,0.90929466,0.005430008,0.00031081075,0.00030761035,0.000106413296,0.00020691194,0.00018936944,0.0028217672,0.07843038],"study_design_scores_gemma":[0.00023590632,0.00021974256,0.021107154,0.8629438,0.06211478,0.0015447077,0.0009146497,0.00011133621,0.0002589094,0.00028513407,0.05020732,0.000056612014],"about_ca_topic_score_codex":0.017382326,"about_ca_topic_score_gemma":0.050286997,"teacher_disagreement_score":0.017382326,"about_ca_system_score_codex":0.0024688272,"about_ca_system_score_gemma":0.007998729,"threshold_uncertainty_score":0.03456229},"labels":[],"label_agreement":null},{"id":"W2150009720","doi":"10.1177/1352458514524997","title":"Altered functional connectivity and performance variability in relapsing–remitting multiple sclerosis","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; McGill University; Montreal Neurological Institute and Hospital; Dalhousie University","funders":"Dalhousie University; Multiple Sclerosis Society of Canada; Genome Canada","keywords":"Default mode network; Multiple sclerosis; Resting state fMRI; Cognition; Functional connectivity; Effects of sleep deprivation on cognitive performance; Neuroscience; Prefrontal cortex; Task (project management); Psychology; Audiology; Medicine; Psychiatry","score_opus":0.11109152187671933,"score_gpt":0.2726678026500689,"score_spread":0.16157628077334957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150009720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999759,0.000041571748,0.000064255815,0.000008050592,4.435146e-7,0.0000016116379,0.00003397543,0.0000026344705,0.000088447276],"genre_scores_gemma":[0.9998355,0.000015901265,0.000059190563,0.000003599563,0.0000020965992,0.000002299929,0.000054175136,0.0000010851194,0.000026081465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998802,0.000030791467,0.0000146344355,0.00003402397,0.000023676685,0.000016549036],"domain_scores_gemma":[0.99911755,0.00021400557,0.00050485623,0.000039280556,0.00004998539,0.000074224736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022757325,0.00022165442,0.00019513513,0.0005203702,0.00016461685,0.00024223307,0.0001189208,0.00025107976,0.00087792944],"category_scores_gemma":[0.001611942,0.0001006778,0.000103564154,0.00030547124,0.00018578682,0.00020383374,0.00018473313,0.00019888916,0.000081583945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010428834,0.0001574067,0.97345746,0.000040840907,0.00026996262,0.00037344857,0.00055512204,0.0005131712,0.0140037285,0.00006544395,0.00012164792,0.0093989335],"study_design_scores_gemma":[0.0000054208285,0.000109664004,0.99897003,0.0000016377737,0.000013299732,0.0003352782,0.000037259597,0.00024218972,0.00020256755,0.000058219735,0.000022564307,0.000001941113],"about_ca_topic_score_codex":0.00091029453,"about_ca_topic_score_gemma":0.0017318281,"teacher_disagreement_score":0.00091029453,"about_ca_system_score_codex":0.00014273178,"about_ca_system_score_gemma":0.0000622792,"threshold_uncertainty_score":0.0029368997},"labels":[],"label_agreement":null},{"id":"W2150321048","doi":"10.1177/1352458514555789","title":"How safe is natalizumab during pregnancy?","year":2014,"lang":"en","type":"editorial","venue":"Multiple Sclerosis Journal","topic":"Reproductive System and Pregnancy","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Natalizumab; Multiple sclerosis; Pregnancy; Medicine; Clinical neurology; Psychology; Psychiatry; Neuroscience; Biology","score_opus":0.028581727016462218,"score_gpt":0.2267848616105359,"score_spread":0.19820313459407368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150321048","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00722418,0.4133572,0.0015909506,0.5551979,0.007254633,0.0000369055,0.0002396992,0.00012017768,0.014978295],"genre_scores_gemma":[0.115728684,0.56276053,0.004444251,0.2760792,0.029725514,0.00021097268,0.00038832502,0.00014044928,0.010522089],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979964,0.0010518994,0.00020711921,0.00015639847,0.00046451896,0.00012365117],"domain_scores_gemma":[0.99215466,0.004858392,0.0014154208,0.00022686156,0.0007046122,0.00064020226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044555548,0.00039691367,0.0012295833,0.0004981663,0.0010148644,0.001914613,0.0007744277,0.004801686,0.0056402073],"category_scores_gemma":[0.024271116,0.00023995072,0.0005685152,0.0003952045,0.0017271669,0.0030318017,0.00064343505,0.004841222,0.0027574636],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016755342,0.00015771898,0.0062080915,0.0017354718,0.00023910777,0.003212655,0.00047809724,0.0002650496,0.0008813771,0.009942319,0.15087074,0.8243338],"study_design_scores_gemma":[0.00049064023,0.0014728777,0.01250006,0.014806532,0.0004563723,0.015506112,0.0018067951,0.00044198125,0.0010719807,0.03519986,0.91610146,0.00014528893],"about_ca_topic_score_codex":0.0030629537,"about_ca_topic_score_gemma":0.004018432,"teacher_disagreement_score":0.0056402073,"about_ca_system_score_codex":0.0011830713,"about_ca_system_score_gemma":0.0016411501,"threshold_uncertainty_score":0.023563504},"labels":[],"label_agreement":null},{"id":"W2152511465","doi":"10.1177/1352458510362442","title":"Rapid benefits of a new formulation of subcutaneous interferon beta-1a in relapsing—remitting multiple sclerosis","year":2010,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Multiple sclerosis; Medicine; Relapsing remitting; Interferon beta-1a; Post-hoc analysis; Placebo; Internal medicine; Pathology; Interferon beta; Immunology","score_opus":0.12906964744477878,"score_gpt":0.295110106199752,"score_spread":0.1660404587549732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152511465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936706,0.005227982,0.00027521234,0.00013001748,0.00008211243,0.000109717,0.000042012984,0.000019968587,0.00044237208],"genre_scores_gemma":[0.9965209,0.0016819728,0.0008241718,0.00015112406,0.0001669084,0.00011256491,0.000087326196,0.00000741143,0.0004475702],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9996804,0.0001690069,0.000023988801,0.00003586511,0.000058478843,0.000032267715],"domain_scores_gemma":[0.9996282,0.00013273998,0.00012487988,0.000027494043,0.000018349825,0.00006834668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008170642,0.00033831003,0.00093334535,0.00018659423,0.0001260777,0.0002753815,0.0002767454,0.00046308443,0.0014859671],"category_scores_gemma":[0.0008107183,0.00022063937,0.00041583634,0.0001197965,0.00041004116,0.00046421392,0.00016708365,0.0010858068,0.00023161352],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36476177,0.025319437,0.0043957736,0.0017003281,0.0011457278,0.0005965014,0.00028974036,0.0011106967,0.18139005,0.00052286184,0.00096646923,0.41780055],"study_design_scores_gemma":[0.2192606,0.7245746,0.0224271,0.00015105275,0.00078556465,0.001217282,0.000094217954,0.0013114945,0.025382794,0.0004353064,0.0043156417,0.00004416564],"about_ca_topic_score_codex":0.00016299497,"about_ca_topic_score_gemma":0.0003532897,"teacher_disagreement_score":0.0014859671,"about_ca_system_score_codex":0.00014979212,"about_ca_system_score_gemma":0.0001856965,"threshold_uncertainty_score":0.004971087},"labels":[],"label_agreement":null},{"id":"W2153132118","doi":"10.1177/1352458513490550","title":"Preventing brain atrophy should be the gold standard of effective therapy in multiple sclerosis (after the first year of treatment): Commentary","year":2013,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Multiple sclerosis; Atrophy; Medicine; Gold standard (test); Neuroscience; Pathology; Psychology; Internal medicine; Psychiatry","score_opus":0.10980257750327606,"score_gpt":0.30291278108840825,"score_spread":0.1931102035851322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153132118","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010901113,0.0009929686,0.000030861545,0.9805649,0.017783001,0.0000058724286,0.000050199447,0.000010313651,0.0004529225],"genre_scores_gemma":[0.0010120912,0.00055747235,0.00010940247,0.9652665,0.032191038,0.000023202032,0.000015461457,0.000009291852,0.0008155834],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9884791,0.004631708,0.0019315594,0.00122308,0.0027282408,0.0010063186],"domain_scores_gemma":[0.9282212,0.049605116,0.00446961,0.0010607373,0.0110285655,0.005614809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010595818,0.0010314235,0.0032115774,0.0013021015,0.00466714,0.0034188174,0.004852628,0.099907644,0.0057462812],"category_scores_gemma":[0.0828037,0.0010270326,0.0022883562,0.0017374719,0.0049998686,0.0051426888,0.0024908623,0.06615323,0.0054238634],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007917109,0.000021106182,0.0002919496,0.00015235762,0.000034088498,0.00037846572,0.00009743265,0.000050549756,0.000058790207,0.001652421,0.9925672,0.0046165893],"study_design_scores_gemma":[0.0005785174,0.00016031714,0.00201199,0.0029535878,0.00023884128,0.0013753757,0.000670403,0.0005269084,0.00033241903,0.015357696,0.97560805,0.00018595926],"about_ca_topic_score_codex":0.02175327,"about_ca_topic_score_gemma":0.031795155,"teacher_disagreement_score":0.099907644,"about_ca_system_score_codex":0.009194606,"about_ca_system_score_gemma":0.014634589,"threshold_uncertainty_score":0.0667119},"labels":[],"label_agreement":null},{"id":"W2153143281","doi":"10.1177/1352458509103173","title":"Efficacy of intramuscular interferon beta-1a in patients with clinically isolated syndrome: analysis of subgroups based on new risk criteria","year":2009,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; St. Michael's Hospital","funders":"","keywords":"Multiple sclerosis; Medicine; Clinically isolated syndrome; Interferon beta-1a; Magnetic resonance imaging; Internal medicine; Relapsing remitting; Central nervous system disease; McDonald criteria; Population; Interferon beta; Radiology; Immunology","score_opus":0.04562587334698104,"score_gpt":0.30925535537916465,"score_spread":0.2636294820321836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153143281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992219,0.00050285296,0.00004765799,0.000021026199,0.0000040077566,0.0000129466025,0.00002841,0.0000029168984,0.00015823627],"genre_scores_gemma":[0.9994968,0.0000994447,0.00013853496,0.000029133344,0.000016700016,0.000014975423,0.00015946341,0.0000013481531,0.000043613254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99946886,0.00020727728,0.00007201168,0.000111365094,0.00008507114,0.0000554492],"domain_scores_gemma":[0.9987373,0.00046182037,0.00038786815,0.000089009794,0.00007209608,0.00025190227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001005174,0.00045819778,0.0010509848,0.0005158109,0.00021253343,0.00046387906,0.0002511073,0.0004714801,0.00041960532],"category_scores_gemma":[0.0019735037,0.00019737802,0.0007566855,0.00031012375,0.00023049199,0.00035175,0.00027633988,0.0004924682,0.00013650295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027114086,0.00044896296,0.94398284,0.000053463504,0.0006035595,0.00021823608,0.00014899731,0.0003667213,0.00470301,0.00003146082,0.00013470855,0.022193981],"study_design_scores_gemma":[0.0010708065,0.0072826995,0.98800665,0.000016050522,0.00031187458,0.00048133018,0.00013066884,0.0017372273,0.00062293117,0.00007833594,0.0002458169,0.000015626629],"about_ca_topic_score_codex":0.00054493116,"about_ca_topic_score_gemma":0.0007849722,"teacher_disagreement_score":0.0010509848,"about_ca_system_score_codex":0.000270756,"about_ca_system_score_gemma":0.0002460111,"threshold_uncertainty_score":0.0053159},"labels":[],"label_agreement":null},{"id":"W2153591084","doi":"10.1177/1352458513488841","title":"Assessing the validity of a computer-generated cognitive screening instrument for patients with multiple sclerosis","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"IC Design Education Center; Biogen; Abbott Laboratories","keywords":"Stroop effect; Cognition; Multiple sclerosis; Neuropsychology; Audiology; Cognitive test; Physical medicine and rehabilitation; Trail Making Test; Neuropsychological assessment; Paced Auditory Serial Addition Test; Physical therapy; Test (biology); Psychology; Medicine; Psychiatry","score_opus":0.20235209661219367,"score_gpt":0.3236635123413567,"score_spread":0.12131141572916304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153591084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997535,0.00015541003,0.00091267144,0.00007277534,0.000019640413,0.00021650504,0.00022387264,0.0000315972,0.0008325071],"genre_scores_gemma":[0.99666864,0.000065451495,0.0024354565,0.000053904743,0.000022616952,0.00021299298,0.0003772299,0.0000039859437,0.00015976642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981452,0.0007874429,0.00036874547,0.00015825008,0.0004529038,0.000087455024],"domain_scores_gemma":[0.98670584,0.007555843,0.002969561,0.0006170484,0.0017358188,0.00041590555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00335823,0.0004963893,0.000441526,0.0012785279,0.0002929536,0.00055711623,0.0004784817,0.0006005424,0.0017000295],"category_scores_gemma":[0.018227076,0.00015222233,0.00042113505,0.00060003233,0.00044055987,0.00061764085,0.0006401376,0.00051149674,0.00054216536],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009579398,0.0004669541,0.9653193,0.000072033195,0.00011843487,0.00006316635,0.00019024772,0.00035584264,0.0019097512,0.00004256091,0.00032301302,0.030180877],"study_design_scores_gemma":[0.00020739032,0.0025673904,0.9918268,0.000037086953,0.00006240928,0.0005026169,0.00014635925,0.0023273986,0.0015943768,0.00009375168,0.0006192585,0.000015051167],"about_ca_topic_score_codex":0.00079835707,"about_ca_topic_score_gemma":0.0012462331,"teacher_disagreement_score":0.00335823,"about_ca_system_score_codex":0.00037172352,"about_ca_system_score_gemma":0.0005729366,"threshold_uncertainty_score":0.017760217},"labels":[],"label_agreement":null},{"id":"W2154048571","doi":"10.1191/1352458505ms1210oa","title":"A randomized blinded trial of combination therapy with cyclophosphamide in patients with active multiple sclerosis on interferon beta","year":2005,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health; Biogen","keywords":"Multiple sclerosis; Medicine; Interferon beta; Cyclophosphamide; Randomized controlled trial; Interferon beta-1b; Internal medicine; Interferon beta-1a; BETA (programming language); Oncology; Physical therapy; Chemotherapy; Immunology","score_opus":0.08615269954019235,"score_gpt":0.295605311949173,"score_spread":0.20945261240898067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154048571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9773007,0.003910304,0.0012989134,0.00094480754,0.0016070874,0.011756026,0.00088495534,0.00018875544,0.0021084903],"genre_scores_gemma":[0.971629,0.0018012236,0.00340873,0.0014014298,0.001675351,0.01685517,0.00076602754,0.00003221538,0.0024308623],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99561787,0.0030549124,0.0002921214,0.000546674,0.00020439252,0.00028414623],"domain_scores_gemma":[0.9954195,0.0017142864,0.0010868066,0.00047789104,0.00031178683,0.0009897883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049050795,0.0025013194,0.0055868854,0.0007053222,0.0008356953,0.0014250823,0.0011734751,0.0032475821,0.00807975],"category_scores_gemma":[0.0066974997,0.0011341128,0.0020037328,0.0005918234,0.0022223864,0.0013983339,0.0007547908,0.0027732328,0.0011860755],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99478275,0.0018709209,0.00013660909,0.00009756691,0.0002081221,0.0000086743685,0.000011214327,0.000067910056,0.00035376844,0.000023417735,0.00011900437,0.0023200845],"study_design_scores_gemma":[0.9811788,0.018297585,0.00015378273,0.0000076309,0.00007699105,0.000006570622,0.000002696452,0.00010685795,0.00005798972,0.000032348926,0.00007575044,0.0000030696485],"about_ca_topic_score_codex":0.0007675133,"about_ca_topic_score_gemma":0.0011755225,"teacher_disagreement_score":0.00807975,"about_ca_system_score_codex":0.00081885455,"about_ca_system_score_gemma":0.002025308,"threshold_uncertainty_score":0.027029395},"labels":[],"label_agreement":null},{"id":"W2154410602","doi":"10.1177/1352458511410343","title":"The psychosocial and cognitive impact of longstanding ‘benign’ multiple sclerosis","year":2011,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Psychosocial; Depression (economics); Quality of life (healthcare); Cohort; Multiple sclerosis; Beck Depression Inventory; Physical therapy; Expanded Disability Status Scale; Cohort study; Internal medicine; Pediatrics; Psychiatry; Anxiety","score_opus":0.2073903280951165,"score_gpt":0.34303958012011765,"score_spread":0.13564925202500114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154410602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999374,0.00026270296,0.000007580517,0.000036769045,0.0000030488989,0.0000020057544,0.000046962887,7.8889843e-7,0.00026620628],"genre_scores_gemma":[0.99980694,0.000057051217,0.000009020927,0.000011559759,0.000007530627,0.0000015013715,0.000055576023,2.695641e-7,0.000050576593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997472,0.000067209636,0.00002147383,0.00003501345,0.000053385982,0.00007575516],"domain_scores_gemma":[0.99868804,0.00024719504,0.0005287025,0.000032492262,0.00011523826,0.00038836908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054841203,0.00020980107,0.00027389498,0.00050786475,0.00051518856,0.00054596853,0.00014251881,0.00025264497,0.0016183225],"category_scores_gemma":[0.0021079138,0.00007187863,0.00028170485,0.00030897046,0.00043826218,0.00041412917,0.00061588676,0.00040275796,0.00019837893],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004831541,0.00009807445,0.99186826,0.000029230112,0.000051758005,0.000511101,0.00022586278,0.000040746265,0.00050361804,0.00001346327,0.000100596975,0.006074135],"study_design_scores_gemma":[0.000007003448,0.00042897416,0.9981034,0.000005630456,0.000016769312,0.001020729,0.00022216291,0.000024578989,0.00005014544,0.000012586673,0.000105412255,0.0000026665907],"about_ca_topic_score_codex":0.001767803,"about_ca_topic_score_gemma":0.0022929092,"teacher_disagreement_score":0.001767803,"about_ca_system_score_codex":0.00040896665,"about_ca_system_score_gemma":0.00024795168,"threshold_uncertainty_score":0.0054138303},"labels":[],"label_agreement":null},{"id":"W2154470507","doi":"10.1177/1352458507082942","title":"Anti-depressant use in association with interferon and glatiramer acetate treatment in multiple sclerosis","year":2007,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"Health Canada","keywords":"Glatiramer acetate; Multiple sclerosis; Medicine; Depressant; Interferon beta; Pharmacology; Interferon; Immunology","score_opus":0.14164316037404107,"score_gpt":0.30514039776956586,"score_spread":0.1634972373955248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154470507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99339044,0.005598622,0.000059221216,0.00013522597,0.000013569949,0.000021476175,0.0005465533,0.0000047646727,0.00023004488],"genre_scores_gemma":[0.9980276,0.0012416714,0.00014856391,0.000045117464,0.000026860005,0.000019832089,0.00039368405,0.0000011128969,0.00009546268],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809116,0.0009368685,0.00026300707,0.00022566108,0.0003558197,0.00012751688],"domain_scores_gemma":[0.99120504,0.0032321576,0.0045484914,0.00025792458,0.00028189176,0.00047450772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021625431,0.00018260654,0.000670866,0.0009586516,0.000261209,0.0005024423,0.00037295365,0.00046593935,0.001434471],"category_scores_gemma":[0.008837685,0.00017073989,0.0007982628,0.0019420155,0.00029083385,0.00023308273,0.0002567466,0.00056623825,0.00008131211],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008461829,0.00013324925,0.98070717,0.00019206696,0.001209338,0.00010602534,0.000044716628,0.00007895518,0.00024310118,0.000018465587,0.00016940814,0.00863573],"study_design_scores_gemma":[0.00023286715,0.0006855184,0.9979121,0.000027657838,0.0005504149,0.00012334042,0.000024306539,0.00015988555,0.000114278344,0.000024097912,0.00014163277,0.0000038803623],"about_ca_topic_score_codex":0.009019849,"about_ca_topic_score_gemma":0.013661217,"teacher_disagreement_score":0.009019849,"about_ca_system_score_codex":0.00085221743,"about_ca_system_score_gemma":0.0009956425,"threshold_uncertainty_score":0.01793468},"labels":[],"label_agreement":null},{"id":"W2154741407","doi":"10.1177/1352458512446038","title":"Reply: ‘Obstructive sleep apnea is associated with fatigue in multiple sclerosis’ by Kaminska et al.","year":2012,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Obstructive Sleep Apnea Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Multiple sclerosis; Obstructive sleep apnea; Medicine; Physical medicine and rehabilitation; Sleep (system call); Sleep apnea; Cardiology; Physical therapy; Internal medicine; Psychiatry","score_opus":0.09591355103709585,"score_gpt":0.28802544359828797,"score_spread":0.1921118925611921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154741407","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009054906,0.0015189587,0.000084257124,0.9724583,0.024172377,0.000014404156,0.00008786382,0.000042777323,0.0007156397],"genre_scores_gemma":[0.0074978117,0.0012879891,0.00021265342,0.93420637,0.0540948,0.000052708252,0.000071014154,0.000025338437,0.0025512062],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970535,0.0011689101,0.0005123023,0.00039778356,0.00051575736,0.00035179686],"domain_scores_gemma":[0.99197805,0.0044334177,0.00082139525,0.0002809991,0.0016519229,0.0008342333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003184248,0.0012306044,0.0019718816,0.0011690602,0.0029213338,0.0025480436,0.0022084643,0.044945326,0.0046913377],"category_scores_gemma":[0.029670332,0.0009506566,0.0014018159,0.000980054,0.0022702948,0.0040805554,0.0016006608,0.028806096,0.0052697007],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002125948,0.000061115294,0.0020424277,0.00014382195,0.000046378344,0.005355059,0.00025076416,0.00006768854,0.00026223628,0.0005233616,0.9852506,0.005783883],"study_design_scores_gemma":[0.0008445091,0.00057335035,0.012754675,0.0012584252,0.00032590443,0.04384054,0.002172225,0.001862656,0.0010988404,0.009678048,0.9251757,0.00041513343],"about_ca_topic_score_codex":0.0037568107,"about_ca_topic_score_gemma":0.0037127924,"teacher_disagreement_score":0.044945326,"about_ca_system_score_codex":0.0020840345,"about_ca_system_score_gemma":0.0017308894,"threshold_uncertainty_score":0.0168401},"labels":[],"label_agreement":null},{"id":"W2156451473","doi":"10.1177/1352458506074684","title":"Classification of patients with a clinically isolated syndrome based on signs and symptoms is supported by magnetic resonance imaging results","year":2007,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Magnetic resonance imaging; Multiple sclerosis; Radiology; Clinically isolated syndrome; Presentation (obstetrics)","score_opus":0.04156355667155457,"score_gpt":0.29026158711203387,"score_spread":0.2486980304404793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156451473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960542,0.0006186743,0.00064999337,0.00018587278,0.000042397904,0.0001051514,0.00033362565,0.000013657103,0.001996465],"genre_scores_gemma":[0.9981054,0.000118351716,0.0010117706,0.0000650238,0.00004812457,0.000064741085,0.00043912735,0.000004001004,0.00014350691],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850404,0.00044947825,0.00030818066,0.00022539968,0.0003427186,0.00017022873],"domain_scores_gemma":[0.99500173,0.0014868212,0.0018630171,0.00023989612,0.0007411595,0.00066720764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00207278,0.00047980508,0.0008439248,0.0014924875,0.00058093574,0.00064349885,0.00057935074,0.00068898353,0.0032998554],"category_scores_gemma":[0.0058428464,0.00010897524,0.00037639058,0.00076880894,0.00067758706,0.0005656155,0.00065779843,0.00051483314,0.0007888599],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014456405,0.00007526412,0.98803675,0.000058175974,0.00004682446,0.0003497973,0.00010974933,0.000078241865,0.002410925,0.00006952766,0.00035495698,0.006964131],"study_design_scores_gemma":[0.00025722873,0.0011544354,0.98951644,0.00006356065,0.00008880664,0.005883492,0.00025120177,0.00092813745,0.0008675445,0.0002677259,0.00070095476,0.00002043837],"about_ca_topic_score_codex":0.0008278811,"about_ca_topic_score_gemma":0.0008047873,"teacher_disagreement_score":0.0032998554,"about_ca_system_score_codex":0.00035525908,"about_ca_system_score_gemma":0.0005544696,"threshold_uncertainty_score":0.011039138},"labels":[],"label_agreement":null},{"id":"W2157110530","doi":"10.1177/1352458511433918","title":"Factors associated with emotional and behavioral outcomes in adolescents with multiple sclerosis","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; SickKids Foundation; University of Toronto; Montreal Neurological Institute and Hospital; Hospital for Sick Children; York University","funders":"Canadian Institutes of Health Research","keywords":"Psychosocial; Clinical psychology; Psychology; Population; Multiple sclerosis; Depression (economics); Somatization; Expanded Disability Status Scale; Medicine; Psychiatry; Anxiety","score_opus":0.21761513446351352,"score_gpt":0.3287303821970075,"score_spread":0.11111524773349399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157110530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999419,0.00026642325,0.000014858378,0.000043231914,0.0000030460717,0.0000037944346,0.000050509687,7.384778e-7,0.00019836484],"genre_scores_gemma":[0.9996681,0.0001410032,0.00003615568,0.000013853115,0.0000043607974,0.0000051470834,0.00007131085,5.753165e-7,0.000059457907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99969316,0.00010078767,0.000043198266,0.000039182865,0.00007009658,0.000053649153],"domain_scores_gemma":[0.9984902,0.00026094695,0.000856935,0.000025991634,0.00012765694,0.0002383952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047201768,0.00022060405,0.00021901584,0.0005679303,0.00034160787,0.00043138798,0.0001427929,0.00029376269,0.0012117011],"category_scores_gemma":[0.0023011083,0.00011386021,0.00019793832,0.0005621462,0.00019313175,0.00022553006,0.00032597085,0.0005045624,0.000090209134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014423872,0.00001657188,0.99921894,0.0000042373035,0.000007194477,0.000045873127,0.000054453976,0.000005307339,0.000034066677,0.000005028296,0.000018666447,0.0005752218],"study_design_scores_gemma":[0.0000012272342,0.000044560926,0.99937636,0.000008475081,0.000009085111,0.00020658005,0.00023753535,0.000022334745,0.000021963977,0.0000077680625,0.00006336678,7.5550474e-7],"about_ca_topic_score_codex":0.002723209,"about_ca_topic_score_gemma":0.003536928,"teacher_disagreement_score":0.002723209,"about_ca_system_score_codex":0.00017638116,"about_ca_system_score_gemma":0.00026120277,"threshold_uncertainty_score":0.0054147243},"labels":[],"label_agreement":null},{"id":"W2157552088","doi":"10.1177/1352458510395981","title":"Texture analysis differentiates persistent and transient T1 black holes at acute onset in multiple sclerosis: A preliminary study","year":2011,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Calgary","funders":"Multiple Sclerosis Society of Canada; University of Calgary; Teva Pharmaceutical Industries; University of British Columbia; Multiple Sclerosis Society; Biogen","keywords":"Lesion; Multiple sclerosis; Texture (cosmology); Persistence (discontinuity); Medicine; Pathology; Artificial intelligence; Immunology; Computer science","score_opus":0.1465536430655179,"score_gpt":0.28699989364689027,"score_spread":0.14044625058137236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157552088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99930775,0.00015701237,0.0003389239,0.000007241542,0.0000014931202,0.000015785608,0.000025318408,0.0000033426847,0.00014309477],"genre_scores_gemma":[0.99951196,0.00005123355,0.0002931574,0.0000052272467,0.0000062127147,0.0000063721513,0.000053969205,0.0000018647906,0.000070039845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998161,0.000045572233,0.000019730453,0.000030989337,0.00005495855,0.00003257357],"domain_scores_gemma":[0.99912053,0.00028570418,0.00022625258,0.00006772285,0.0001649294,0.00013483732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080676714,0.0002725831,0.0002632441,0.00086541515,0.00021953248,0.0003247063,0.0001325941,0.00032235842,0.0009678403],"category_scores_gemma":[0.001735854,0.00015193317,0.00025047557,0.00034497373,0.00032455157,0.0003871558,0.00026851203,0.00020784425,0.00017438896],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0110783605,0.00072775286,0.85543126,0.00013987874,0.00019451806,0.0010257163,0.0005526126,0.00041073596,0.07980749,0.0000413882,0.00013172699,0.05045847],"study_design_scores_gemma":[0.00006843842,0.0037394331,0.9885643,0.000006389967,0.00006734353,0.0021346407,0.00015271339,0.0009988615,0.004036368,0.000043424476,0.00018035904,0.000007751884],"about_ca_topic_score_codex":0.0007827481,"about_ca_topic_score_gemma":0.00085477834,"teacher_disagreement_score":0.0009678403,"about_ca_system_score_codex":0.00013954051,"about_ca_system_score_gemma":0.000113561044,"threshold_uncertainty_score":0.0042666197},"labels":[],"label_agreement":null},{"id":"W2157779324","doi":"10.1177/1352458509356367","title":"The association between California Verbal Learning Test performance and fibre impairment in multiple sclerosis: evidence from diffusion tensor imaging","year":2010,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bayer Canada; Bayer HealthCare; Sanofi","keywords":"California Verbal Learning Test; Fornix; Verbal learning; Fractional anisotropy; Diffusion MRI; Psychology; Verbal memory; Neuropsychology; Audiology; Memory impairment; White matter; Population; Medicine; Cognition; Neuroscience; Magnetic resonance imaging; Hippocampus","score_opus":0.05880083695575717,"score_gpt":0.2744356159255862,"score_spread":0.21563477896982902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157779324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994247,0.00019302277,0.000053078933,0.000022178667,0.0000021758956,0.000003776698,0.000043686072,0.0000029682312,0.0002544603],"genre_scores_gemma":[0.9996979,0.00006191178,0.000067271605,0.000009410489,0.00000836786,0.0000023393216,0.00008450659,0.0000015778304,0.00006674478],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99949014,0.00010775222,0.00009307665,0.00012990285,0.0001308191,0.00004831595],"domain_scores_gemma":[0.9937103,0.0016270374,0.0031966,0.0004472956,0.00043064493,0.00058813277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010372926,0.00055270933,0.00040301547,0.0017258395,0.00036586198,0.00053798634,0.00045498594,0.00072715554,0.0011721747],"category_scores_gemma":[0.0056827,0.0002224645,0.00019285022,0.0007602546,0.0008830429,0.0005703763,0.000659509,0.00053506705,0.0001922946],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004899729,0.000080856866,0.996197,0.00001508002,0.00011718179,0.00018744235,0.00008456677,0.00008681106,0.00079943973,0.000016837486,0.000032789925,0.0018920898],"study_design_scores_gemma":[0.0000067830283,0.00016067743,0.9988172,0.000002883513,0.000025168936,0.0005945321,0.00002915535,0.00016826844,0.00012159839,0.00003883247,0.00003157536,0.0000033300187],"about_ca_topic_score_codex":0.0021508909,"about_ca_topic_score_gemma":0.0025328863,"teacher_disagreement_score":0.0021508909,"about_ca_system_score_codex":0.00022192004,"about_ca_system_score_gemma":0.00026566864,"threshold_uncertainty_score":0.0054858327},"labels":[],"label_agreement":null},{"id":"W2158300762","doi":"10.1177/1352458510366013","title":"Impact on activities of daily living using a functional electrical stimulation device to improve dropped foot in people with multiple sclerosis, measured by the Canadian Occupational Performance Measure","year":2010,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Balance, Gait, and Falls Prevention","field":"Health Professions","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Multiple Sclerosis Trust","keywords":"Physical medicine and rehabilitation; Physical therapy; Multiple sclerosis; Activities of daily living; Medicine; Foot (prosody); Randomized controlled trial; Functional electrical stimulation; Psychology; Stimulation; Surgery","score_opus":0.06836079110423059,"score_gpt":0.31155739828531115,"score_spread":0.24319660718108055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158300762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99748164,0.0009282679,0.00007051414,0.000081277234,0.000017461016,0.00016556284,0.00015970733,0.000006905363,0.0010887579],"genre_scores_gemma":[0.9985576,0.00041745786,0.00035245303,0.000072050876,0.000013591864,0.00008843439,0.00017609817,8.1547535e-7,0.00032157067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996088,0.00007774061,0.00003101889,0.00002352838,0.0001858826,0.000073096046],"domain_scores_gemma":[0.99960417,0.00007570822,0.00008373393,0.000010681046,0.00009069984,0.00013497684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005627585,0.0002633352,0.00045635222,0.00023356482,0.00037609917,0.00015369878,0.00016235792,0.0002404571,0.0014849006],"category_scores_gemma":[0.0019186757,0.00007899381,0.0003603761,0.00022506222,0.00018351436,0.00008473214,0.00020250329,0.0002613156,0.00009288375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040285204,0.015158648,0.47577634,0.0030107833,0.001770621,0.0005057662,0.0011982096,0.00092050224,0.017301407,0.00008568253,0.0035567281,0.44043007],"study_design_scores_gemma":[0.0029551825,0.03869698,0.954296,0.00010374413,0.00041334666,0.00025696345,0.00017664899,0.00038654843,0.0011541502,0.000032293246,0.0015125715,0.000015621059],"about_ca_topic_score_codex":0.02125815,"about_ca_topic_score_gemma":0.045630746,"teacher_disagreement_score":0.02125815,"about_ca_system_score_codex":0.0004899615,"about_ca_system_score_gemma":0.0009223792,"threshold_uncertainty_score":0.042268813},"labels":[],"label_agreement":null},{"id":"W2158343881","doi":"10.1177/1352458509359726","title":"Does MRI lesion activity regress in secondary progressive multiple sclerosis?","year":2010,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Merck KGaA","keywords":"Multiple sclerosis; Medicine; Lesion; Clinical neurology; Magnetic resonance imaging; Radiology; Pathology; Neuroscience; Psychology; Psychiatry","score_opus":0.09696441350255926,"score_gpt":0.3215835097101504,"score_spread":0.22461909620759113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158343881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98891336,0.007953715,0.00043395712,0.00039766185,0.000038662663,0.00004298866,0.00018509156,0.0000359631,0.001998495],"genre_scores_gemma":[0.9988789,0.00060421106,0.000114071285,0.000087285094,0.00006658512,0.000007678367,0.0001222607,0.000004875038,0.00011412939],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908507,0.0003204813,0.000100523976,0.00019349284,0.00023507723,0.00006530163],"domain_scores_gemma":[0.99285334,0.0022203783,0.0034118104,0.00044947225,0.00064029184,0.00042472794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024449283,0.00021690733,0.0007317659,0.0006755689,0.00018486686,0.0005125558,0.00033743063,0.0005691262,0.0011919963],"category_scores_gemma":[0.011029137,0.00011169014,0.000396599,0.0004950978,0.0005421353,0.00048210815,0.00018125816,0.0005493546,0.0003539363],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067177773,0.00029045314,0.9122692,0.0003288589,0.00038466978,0.00034765407,0.00016048823,0.00026627464,0.00439114,0.00008655825,0.0005224159,0.074234515],"study_design_scores_gemma":[0.000110922505,0.002205908,0.99414104,0.000033505712,0.0001494855,0.0013696469,0.00004846849,0.00034594876,0.0007190617,0.000097178694,0.0007733282,0.000005506566],"about_ca_topic_score_codex":0.00065879006,"about_ca_topic_score_gemma":0.0006059559,"teacher_disagreement_score":0.0024449283,"about_ca_system_score_codex":0.00025557354,"about_ca_system_score_gemma":0.00021586976,"threshold_uncertainty_score":0.012930155},"labels":[],"label_agreement":null},{"id":"W2159596132","doi":"10.1177/1352458514564491","title":"A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview","year":2015,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":399,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Manitoba Health","funders":"Canadian Institutes of Health Research","keywords":"Comorbidity; Medicine; Incidence (geometry); Epidemiology; Population; MEDLINE; Demography; Environmental health; Psychiatry; Pathology","score_opus":0.3153023179724875,"score_gpt":0.38515113024039827,"score_spread":0.06984881226791079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159596132","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00059385726,0.99854505,0.00009919398,0.00015572415,0.00007687775,0.00016769544,0.00022527228,0.0000057137363,0.00013069416],"genre_scores_gemma":[0.0066983853,0.99191976,0.0005656001,0.00019953954,0.000056106343,0.00032437243,0.00016802273,0.0000033939225,0.00006485926],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.990265,0.0029744983,0.004068496,0.0007021349,0.0017284919,0.00026130342],"domain_scores_gemma":[0.9739654,0.017530432,0.005214026,0.00040685583,0.0025816,0.00030165951],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008938432,0.0018310753,0.009384234,0.016671276,0.0007854309,0.0027240575,0.0018134986,0.0017700755,0.0037313888],"category_scores_gemma":[0.03969265,0.0012449968,0.007313516,0.017744351,0.0008346289,0.0027438095,0.0017850482,0.0011772088,0.00028530214],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000106535634,0.000008081452,0.0007435212,0.9603707,0.0075955084,0.00009137947,0.0001446943,0.00006938636,0.00013343971,0.00015531799,0.0012489511,0.029332465],"study_design_scores_gemma":[0.00013199153,0.00016188667,0.006576284,0.8714846,0.09735962,0.0006997594,0.00023729468,0.00008572437,0.00017032775,0.00034018006,0.022714613,0.000037802794],"about_ca_topic_score_codex":0.008300692,"about_ca_topic_score_gemma":0.024699338,"teacher_disagreement_score":0.016671276,"about_ca_system_score_codex":0.0040914705,"about_ca_system_score_gemma":0.012176501,"threshold_uncertainty_score":0.04727149},"labels":[],"label_agreement":null},{"id":"W2159638157","doi":"10.1177/1352458507079658","title":"Ten years of adverse drug reaction reports for the multiple sclerosis immunomodulatory therapies: a Canadian perspective","year":2007,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia Hospital","funders":"Health Canada; Multiple Sclerosis Society","keywords":"Multiple sclerosis; Medicine; Perspective (graphical); Drug; Adverse effect; Intensive care medicine; Pharmacology; Psychiatry","score_opus":0.1014780728284497,"score_gpt":0.3214054326858235,"score_spread":0.2199273598573738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159638157","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17737502,0.5308905,0.0016488904,0.20593527,0.00396283,0.00027088026,0.012904597,0.00027703808,0.06673495],"genre_scores_gemma":[0.6000286,0.35776007,0.0028595265,0.024972955,0.0025129349,0.00007146754,0.004680466,0.000061598825,0.007052329],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99021006,0.00092936395,0.0017705415,0.00093231024,0.0049477946,0.001209983],"domain_scores_gemma":[0.9149325,0.008289351,0.011483092,0.0008817488,0.056651816,0.0077615725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0078714285,0.0007256451,0.0006281898,0.012150254,0.0039214897,0.0062462976,0.002202915,0.0020381196,0.0061944462],"category_scores_gemma":[0.024585815,0.00059407746,0.0006394318,0.01619077,0.0032228075,0.0026297811,0.0015092373,0.002612773,0.0006964928],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005065958,0.00023442981,0.41891232,0.005028412,0.0002564017,0.003705488,0.010645884,0.00086424145,0.0014571112,0.011045764,0.12395699,0.42338637],"study_design_scores_gemma":[0.000039554438,0.00020929705,0.7292994,0.00429499,0.00028266798,0.004319287,0.013693552,0.000596836,0.00043603953,0.0007300421,0.24589282,0.00020538265],"about_ca_topic_score_codex":0.9770493,"about_ca_topic_score_gemma":0.9833952,"teacher_disagreement_score":0.05911487,"about_ca_system_score_codex":0.05911487,"about_ca_system_score_gemma":0.10491189,"threshold_uncertainty_score":0.42891043},"labels":[],"label_agreement":null},{"id":"W2159648344","doi":"10.1191/1352458504ms1065oa","title":"HLA determinants of susceptibility to multiple sclerosis in an Arabian Gulf population","year":2004,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Kuwait University","keywords":"Multiple sclerosis; Human leukocyte antigen; Population; Medicine; Immunology; Environmental health; Antigen","score_opus":0.155047213482379,"score_gpt":0.34552783016132943,"score_spread":0.19048061667895044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159648344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99977535,0.00006556642,0.000018886694,0.000012301978,9.2836683e-7,0.000001548572,0.000010825492,4.6098967e-7,0.000114138165],"genre_scores_gemma":[0.9997856,0.00007651086,0.00004312907,0.000010156618,0.000003899887,0.0000019430684,0.000022366254,3.5046267e-7,0.000056025252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998833,0.000042700507,0.000010994912,0.000020330135,0.00001904031,0.000023586968],"domain_scores_gemma":[0.999757,0.000053467214,0.00009438942,0.000016058055,0.000034143424,0.000045053803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002298665,0.00021868886,0.000100734746,0.00048670845,0.0003444466,0.00021933245,0.00011134465,0.00020430148,0.0015607881],"category_scores_gemma":[0.00063308707,0.00012588273,0.00010127373,0.00039666065,0.0002939123,0.0001421056,0.00019103436,0.00017048724,0.00015497927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032293517,0.0000579921,0.99107975,0.000015892214,0.00004204751,0.00021518319,0.00051200204,0.000050956933,0.0037443817,0.00007421717,0.00007212224,0.003812495],"study_design_scores_gemma":[0.00001343639,0.00014946262,0.99811625,0.00001060203,0.000022429134,0.0006973933,0.00042135903,0.000108376196,0.00017907024,0.000041315267,0.0002379194,0.0000024538633],"about_ca_topic_score_codex":0.0034049982,"about_ca_topic_score_gemma":0.0021242565,"teacher_disagreement_score":0.0034049982,"about_ca_system_score_codex":0.0001427605,"about_ca_system_score_gemma":0.00015011155,"threshold_uncertainty_score":0.0067703724},"labels":[],"label_agreement":null},{"id":"W2160062436","doi":"10.1177/1352458512458555","title":"Prolactin in multiple sclerosis","year":2012,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; University of Calgary","funders":"","keywords":"Multiple sclerosis; Prolactin; Medicine; Pathophysiology; Optic neuritis; Internal medicine; Myelin; Clinically isolated syndrome; Oncology; Central nervous system; Immunology; Hormone","score_opus":0.40745137398099485,"score_gpt":0.37556432567064907,"score_spread":0.03188704831034578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160062436","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000047401612,0.99979264,0.000005356014,0.000047314443,0.000026860333,0.000002897211,0.0000075164926,6.7142537e-7,0.000069334616],"genre_scores_gemma":[0.001001253,0.99879694,0.000039699546,0.000071350085,0.00003333931,0.0000065842987,0.000011335754,3.4762644e-7,0.000039219525],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99870694,0.00043455776,0.00039076793,0.00011266476,0.00030608257,0.00004899573],"domain_scores_gemma":[0.9972525,0.0018097197,0.0005885099,0.000031955056,0.00026445038,0.000052961648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016295562,0.0008878291,0.0028735963,0.0057116915,0.000309677,0.0015388861,0.0008095607,0.0013683744,0.0035992686],"category_scores_gemma":[0.0048570624,0.0004476087,0.0019001196,0.006628772,0.0005584874,0.0011098837,0.00076461036,0.0010201727,0.0004666078],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021692674,0.000038019036,0.0008628051,0.50768816,0.0017881242,0.0003516604,0.00023187605,0.00016685214,0.00038641496,0.0009006533,0.013210594,0.4741579],"study_design_scores_gemma":[0.00031388743,0.00040314996,0.012138455,0.48453426,0.015130042,0.0072487383,0.0006280006,0.00014526263,0.0005732933,0.0022195166,0.47657523,0.00009008953],"about_ca_topic_score_codex":0.0060883826,"about_ca_topic_score_gemma":0.009183401,"teacher_disagreement_score":0.0060883826,"about_ca_system_score_codex":0.0012534509,"about_ca_system_score_gemma":0.0034585553,"threshold_uncertainty_score":0.012105882},"labels":[],"label_agreement":null},{"id":"W2160153676","doi":"10.1177/1352458512461393","title":"Multiple sclerosis and inflammatory bowel diseases: what we know and what we would need to know!","year":2012,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Multiple sclerosis; Etiology; Medicine; Inflammatory bowel disease; Ulcerative colitis; Disease; Magnetic resonance imaging; Inflammatory Bowel Diseases; Pathology; Immunology; Radiology","score_opus":0.04685277910526274,"score_gpt":0.26483531883739825,"score_spread":0.2179825397321355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160153676","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003949172,0.9936593,0.00006941789,0.0042242217,0.0014866905,0.0000019146119,0.000010061331,0.000008171087,0.000500784],"genre_scores_gemma":[0.00047545144,0.99328715,0.00026875816,0.0026395447,0.002489177,0.0000053051867,0.000030917905,0.0000033876183,0.0008003301],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993374,0.00017909518,0.000093921844,0.00008515596,0.00024023432,0.000064152446],"domain_scores_gemma":[0.99645364,0.0019241583,0.00028514164,0.00011845044,0.00083704945,0.00038156987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001463864,0.0012201634,0.002427713,0.002838254,0.0008018501,0.0027378039,0.0016728822,0.0031282206,0.007538492],"category_scores_gemma":[0.0040899725,0.00037861877,0.00086030946,0.0033570093,0.001490175,0.008041898,0.0014776764,0.005447918,0.0049289963],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098050186,0.00007409861,0.00041588605,0.013605771,0.00011042703,0.0004968648,0.00016874087,0.00018284867,0.0004790281,0.004366593,0.20358215,0.7764195],"study_design_scores_gemma":[0.000013721135,0.00005082898,0.0009350369,0.0074822144,0.000068493755,0.0031352346,0.000245861,0.00005803689,0.000064308784,0.0046590106,0.98325896,0.000028229138],"about_ca_topic_score_codex":0.0019716045,"about_ca_topic_score_gemma":0.0025580283,"teacher_disagreement_score":0.007538492,"about_ca_system_score_codex":0.0010444028,"about_ca_system_score_gemma":0.0022400515,"threshold_uncertainty_score":0.025218785},"labels":[],"label_agreement":null},{"id":"W2161512169","doi":"10.1177/1352458514557986","title":"Peginterferon beta-1a in multiple sclerosis: 2-year results from ADVANCE","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"Prothena; Fondation pour l'Aide à la Recherche sur la Sclérose en Plaques; Teva Pharmaceutical Industries; Biogen; Sanofi","keywords":"Medicine; Dosing; Placebo; Regimen; Internal medicine; Multiple sclerosis; Randomized controlled trial; Gastroenterology; Surgery; Pathology; Immunology","score_opus":0.12458225293336551,"score_gpt":0.2962346911310162,"score_spread":0.1716524381976507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161512169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927142,0.0049638613,0.00022403522,0.00020512332,0.00006087118,0.0003242102,0.00073312054,0.00003569836,0.0007389427],"genre_scores_gemma":[0.9911959,0.0023632124,0.000835439,0.00043954334,0.00026968942,0.0003601436,0.0028167847,0.000014477726,0.0017047555],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99913305,0.00041550794,0.00005373463,0.00012623167,0.00013590355,0.00013556119],"domain_scores_gemma":[0.9983563,0.0002268118,0.0005016936,0.00021240798,0.00016164665,0.00054119574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044837315,0.00106236,0.0024108263,0.00033273874,0.0002666334,0.0006858818,0.00050844456,0.0011553443,0.0017495479],"category_scores_gemma":[0.0013593594,0.00031532595,0.0018481622,0.0003569162,0.0004501113,0.000746062,0.00055930804,0.0016057396,0.00037269545],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92153525,0.013173211,0.010658092,0.00035546898,0.0016323419,0.00008666157,0.00007285786,0.00091537705,0.0077140317,0.000053403575,0.0010106793,0.04279268],"study_design_scores_gemma":[0.40289903,0.4749761,0.11141882,0.000084698746,0.0027654476,0.0003235287,0.00004514006,0.00096416514,0.0034623328,0.00010330751,0.0029114627,0.0000459565],"about_ca_topic_score_codex":0.0008060233,"about_ca_topic_score_gemma":0.0011468759,"teacher_disagreement_score":0.0044837315,"about_ca_system_score_codex":0.000450322,"about_ca_system_score_gemma":0.0007007218,"threshold_uncertainty_score":0.023712516},"labels":[],"label_agreement":null},{"id":"W2161822858","doi":"10.1177/1352458512442438","title":"Effects of interferon beta-1b on cognitive performance in patients with a first event suggestive of multiple sclerosis","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Bayer HealthCare; Multiple Sclerosis Society","keywords":"Multiple sclerosis; Interferon beta-1b; Clinically isolated syndrome; Cognition; Placebo; Medicine; Internal medicine; Interferon beta-1a; Effects of sleep deprivation on cognitive performance; Interferon beta; Immunology; Psychiatry; Pathology","score_opus":0.051477351688210514,"score_gpt":0.2659384182336004,"score_spread":0.2144610665453899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161822858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975466,0.0018906344,0.000018571849,0.00007523566,0.000016103742,0.000016187614,0.000031420397,0.000004615991,0.00040070445],"genre_scores_gemma":[0.9992545,0.0003709311,0.000064768785,0.000065200504,0.000025596148,0.000012303088,0.000061408056,6.609273e-7,0.00014467169],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9998317,0.00006817439,0.00001618521,0.000018442974,0.000028971544,0.000036470454],"domain_scores_gemma":[0.999471,0.00018722356,0.00013663466,0.000017615279,0.000032911586,0.00015466972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007706261,0.00040245245,0.0007208195,0.00019406914,0.0002114323,0.00026572842,0.00014927197,0.00033633003,0.0007096028],"category_scores_gemma":[0.0011791342,0.00010803061,0.00049534114,0.0001576099,0.00015327756,0.00012140602,0.00014854457,0.00069243775,0.000104030245],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37864095,0.019405235,0.32352433,0.0010362084,0.0020967678,0.0013445695,0.00057960954,0.0012942702,0.02930972,0.00006484299,0.0010347498,0.24166864],"study_design_scores_gemma":[0.01200762,0.13945521,0.8418739,0.00011986566,0.000911168,0.000703107,0.00010779749,0.0005394158,0.0032517354,0.000055783286,0.0009518709,0.000022526045],"about_ca_topic_score_codex":0.00100942,"about_ca_topic_score_gemma":0.0021530155,"teacher_disagreement_score":0.00100942,"about_ca_system_score_codex":0.00035209354,"about_ca_system_score_gemma":0.00025436608,"threshold_uncertainty_score":0.004075527},"labels":[],"label_agreement":null},{"id":"W2162412742","doi":"10.1177/1352458513507817","title":"Quality of life outcomes with BG-12 (dimethyl fumarate) in patients with relapsing–remitting multiple sclerosis: The DEFINE study","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital; NeuroRx Research (Canada)","funders":"IC Design Education Center; Biogen","keywords":"Dimethyl fumarate; Multiple sclerosis; Medicine; Placebo; Quality of life (healthcare); Expanded Disability Status Scale; Relapsing remitting; Internal medicine; Visual analogue scale; Clinical trial; Physical therapy; Pathology; Psychiatry; Alternative medicine","score_opus":0.12470611725036007,"score_gpt":0.2995743925628379,"score_spread":0.17486827531247784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162412742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935927,0.0045081256,0.00017829947,0.00016751762,0.000019327395,0.0002864387,0.000733074,0.000007450309,0.0005072357],"genre_scores_gemma":[0.99521494,0.001360634,0.0005316759,0.00024223316,0.000063647836,0.00067435094,0.0016092064,0.0000032941382,0.0003001141],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9984067,0.001060637,0.00010887988,0.00014421022,0.00016808302,0.00011150539],"domain_scores_gemma":[0.99848676,0.00027490204,0.00063793745,0.00009399417,0.00012691022,0.0003794795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003234639,0.0008980343,0.0020423303,0.00036674054,0.00032073708,0.00076707196,0.00059973955,0.000702477,0.0010446741],"category_scores_gemma":[0.0017185557,0.0002548866,0.0016353825,0.00056909694,0.00040311363,0.00055506313,0.0009075346,0.0009855274,0.00016855421],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45139349,0.014189614,0.4446014,0.0026399908,0.013279636,0.00023609449,0.0004925456,0.0017495932,0.005917928,0.0003329487,0.002361138,0.062805705],"study_design_scores_gemma":[0.119779065,0.122522525,0.74153376,0.000340275,0.00768213,0.00032924645,0.0003851686,0.0015452647,0.001964416,0.00027307073,0.0035588217,0.00008635854],"about_ca_topic_score_codex":0.0005780074,"about_ca_topic_score_gemma":0.0012385731,"teacher_disagreement_score":0.003234639,"about_ca_system_score_codex":0.00041264645,"about_ca_system_score_gemma":0.0005076794,"threshold_uncertainty_score":0.017106593},"labels":[],"label_agreement":null},{"id":"W2162850888","doi":"10.1177/1352458513505693","title":"Season of infectious mononucleosis and risk of multiple sclerosis at different latitudes; the EnvIMS Study","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"Teva Pharmaceutical Industries","keywords":"Mononucleosis; Odds ratio; Multiple sclerosis; Confidence interval; Medicine; Measles; Demography; Vitamin D and neurology; Internal medicine; Gastroenterology; Immunology; Virus; Vaccination","score_opus":0.07413399038390671,"score_gpt":0.2747479595841738,"score_spread":0.20061396920026708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162850888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986773,0.00050988956,0.000052411615,0.000018038605,0.000008206746,0.0000056982,0.0004508877,0.0000019942545,0.0002754986],"genre_scores_gemma":[0.99931455,0.00013122003,0.00007463819,0.000013653088,0.000009632623,0.000009519936,0.00034974577,0.0000019562917,0.00009518452],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997075,0.00010811259,0.000030720395,0.000077879486,0.000031012165,0.00004474312],"domain_scores_gemma":[0.9991172,0.000096745796,0.00050382817,0.00006987438,0.0000475223,0.00016488213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009556791,0.00031781103,0.00032440276,0.00042369266,0.00028608498,0.0005074329,0.0003095755,0.0003339467,0.00074286107],"category_scores_gemma":[0.0009719807,0.00026122318,0.00048262975,0.00068601384,0.00018823304,0.000234346,0.0003596845,0.00034244964,0.00011071566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032282964,0.00001444459,0.9989197,0.000011784732,0.000097135824,0.000033510067,0.000056578476,0.000017220182,0.00015180063,0.000006475094,0.00006141359,0.0003069743],"study_design_scores_gemma":[0.00001138923,0.00006738182,0.9995259,0.0000070686183,0.000050133887,0.00008069687,0.00007591332,0.000043782384,0.000020957092,0.000006423137,0.00010911239,0.0000012534172],"about_ca_topic_score_codex":0.0075491383,"about_ca_topic_score_gemma":0.007925008,"teacher_disagreement_score":0.0075491383,"about_ca_system_score_codex":0.00018340434,"about_ca_system_score_gemma":0.00025469612,"threshold_uncertainty_score":0.0150104165},"labels":[],"label_agreement":null},{"id":"W2163203687","doi":"10.1177/1352458509106856","title":"Experimental autoimmune encephalomyelitis-induced upregulation of tumor necrosis factor-alpha in the dorsal root ganglia","year":2009,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Apotex (Canada); Children's Hospital Research Institute of Manitoba; University of Manitoba; Health Sciences Centre","funders":"","keywords":"Experimental autoimmune encephalomyelitis; Multiple sclerosis; Medicine; Spinal cord; Tumor necrosis factor alpha; Immunology; Myelin; Central nervous system; Proinflammatory cytokine; Dorsal root ganglion; Myelin basic protein; Encephalomyelitis; Pathology; Inflammation; Endocrinology","score_opus":0.05862987081228601,"score_gpt":0.28571413604125073,"score_spread":0.22708426522896472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163203687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99347657,0.003269887,0.00077583303,0.00008087234,0.000043950702,0.00003046935,0.00038003986,0.000072284456,0.0018701062],"genre_scores_gemma":[0.9947129,0.0018952821,0.0010504207,0.000059887418,0.000021934828,0.00005262283,0.0005099198,0.000010101647,0.0016869003],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982387,0.000021117543,0.000013511232,0.000030512621,0.000052210627,0.00005890696],"domain_scores_gemma":[0.9997793,0.000027628581,0.00007792379,0.000021571648,0.000038318158,0.000055153258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015344194,0.00035383002,0.00025403552,0.0004243044,0.0001345879,0.0003765869,0.00012746737,0.00024454365,0.0013258259],"category_scores_gemma":[0.00015342116,0.000109891866,0.00023594497,0.00018909418,0.00026613384,0.00017490253,0.0001585585,0.00059663126,0.0004761474],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027230917,0.000042454296,0.00039812183,0.00005477614,0.0000073587453,0.00014157344,0.000013218031,0.0000169619,0.99827445,0.000026549364,0.000025397443,0.00072682323],"study_design_scores_gemma":[0.00009628936,0.0021297766,0.039070178,0.000049712504,0.00007696099,0.0012159058,0.00011363018,0.00038952404,0.9551409,0.000110087945,0.0016008874,0.000006113282],"about_ca_topic_score_codex":0.00041486704,"about_ca_topic_score_gemma":0.0005693294,"teacher_disagreement_score":0.0013258259,"about_ca_system_score_codex":0.00050960615,"about_ca_system_score_gemma":0.00020966529,"threshold_uncertainty_score":0.004435301},"labels":[],"label_agreement":null},{"id":"W2163795029","doi":"10.1177/1352458511430704","title":"Consensus statement: evaluation of new and existing therapeutics for pediatric multiple sclerosis","year":2011,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":217,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; SickKids Foundation; University of Ottawa; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Clinical trial; Multiple sclerosis; MEDLINE; Food and drug administration; Intensive care medicine; Family medicine; Orphan drug; Pathology; Psychiatry; Pharmacology; Bioinformatics","score_opus":0.5914290582407363,"score_gpt":0.39444364853626807,"score_spread":0.19698540970446826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163795029","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032039322,0.022856189,0.025712041,0.80729735,0.10692797,0.005778518,0.0044079795,0.00040273537,0.023413291],"genre_scores_gemma":[0.03898323,0.05401616,0.23473817,0.5243629,0.06550657,0.015015351,0.018843366,0.00074370176,0.04779057],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.88652855,0.048479684,0.029144185,0.004206825,0.027049879,0.004590938],"domain_scores_gemma":[0.7126439,0.08406774,0.018206617,0.00705616,0.15709408,0.020931479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.11571016,0.0019074307,0.0030933702,0.0029460771,0.0041417177,0.006228121,0.008394437,0.02382674,0.005885341],"category_scores_gemma":[0.14453532,0.0017263835,0.00653086,0.0028631086,0.004296325,0.004422063,0.007833399,0.02281496,0.007497381],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018610136,0.00020225844,0.0013584889,0.003946473,0.00014770866,0.0005273704,0.0007008738,0.00071094214,0.001367094,0.0062948754,0.8910035,0.093554266],"study_design_scores_gemma":[0.00025197264,0.00022928283,0.0033312512,0.011117645,0.0002258416,0.0010421122,0.0007799699,0.00055167417,0.0012140895,0.009312609,0.9718304,0.000112991635],"about_ca_topic_score_codex":0.0052729337,"about_ca_topic_score_gemma":0.0050337748,"teacher_disagreement_score":0.11571016,"about_ca_system_score_codex":0.0061180037,"about_ca_system_score_gemma":0.054858837,"threshold_uncertainty_score":0.6119411},"labels":[],"label_agreement":null},{"id":"W2163982375","doi":"10.1177/1352458514564486","title":"A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosis","year":2014,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Multiple Sclerosis Society of Canada; Multiple Sclerosis Society; Biogen; Canadian Institutes of Health Research; IC Design Education Center; National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Incidence (geometry); Medicine; Seizure Disorders; Epilepsy; Sleep (system call); Pediatrics; Psychiatry","score_opus":0.07869031043790795,"score_gpt":0.3200282810729547,"score_spread":0.24133797063504678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163982375","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021005892,0.9959785,0.00017847074,0.00023528411,0.00009888336,0.00031794317,0.0008474644,0.000009330229,0.0002335609],"genre_scores_gemma":[0.021495212,0.97586787,0.00096754,0.0003631138,0.000090343514,0.0006367172,0.00046336916,0.000006797186,0.000109057415],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98824966,0.0031840599,0.005680717,0.0008798949,0.0017532433,0.00025239322],"domain_scores_gemma":[0.96597433,0.022264233,0.0075575565,0.0005508463,0.0033081856,0.00034472262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00953796,0.0017629687,0.010725459,0.019071437,0.00079984346,0.0028254476,0.0020471595,0.0017008415,0.0036921583],"category_scores_gemma":[0.040713675,0.0012090609,0.009188044,0.019834658,0.00093159283,0.0024585167,0.0016017853,0.0009579713,0.0002878085],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012654002,0.000010071322,0.001979279,0.96244556,0.015127868,0.00016375698,0.00018033086,0.00007024399,0.00014029443,0.00009530977,0.0008016757,0.018859066],"study_design_scores_gemma":[0.00017523686,0.00019436913,0.012209,0.8047466,0.1679922,0.00084585644,0.00036320067,0.00009032704,0.0001791309,0.00021666617,0.0129440455,0.000043253258],"about_ca_topic_score_codex":0.009198586,"about_ca_topic_score_gemma":0.026298705,"teacher_disagreement_score":0.019071437,"about_ca_system_score_codex":0.003598853,"about_ca_system_score_gemma":0.012103938,"threshold_uncertainty_score":0.05044216},"labels":[],"label_agreement":null},{"id":"W2164081593","doi":"10.1191/1352458505ms1177oa","title":"Reappraisal of Lhermitte’s sign in multiple sclerosis","year":2005,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Multiple Sclerosis Society","keywords":"Multiple sclerosis; Medicine; Natural history; Cohort; McDonald criteria; Pediatrics; Internal medicine; Psychiatry","score_opus":0.16101217365423529,"score_gpt":0.322095995751591,"score_spread":0.1610838220973557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164081593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9407471,0.047286127,0.0028851924,0.0031551563,0.00058547466,0.000095991185,0.0001236993,0.0000745738,0.005046691],"genre_scores_gemma":[0.98728937,0.009155461,0.0017005769,0.0003736741,0.00088748813,0.000032163738,0.00013698019,0.00000863286,0.00041556437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987244,0.0005068695,0.00028738455,0.0001345695,0.00020962037,0.00013704787],"domain_scores_gemma":[0.995839,0.0015543846,0.0011831147,0.00032544605,0.00083013164,0.00026797078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002749027,0.00058810523,0.00058115117,0.004755954,0.0007558395,0.0011390548,0.0010783086,0.0010883299,0.00085289247],"category_scores_gemma":[0.011327951,0.00024653258,0.0002434983,0.0014039236,0.0023423654,0.002490939,0.0012787026,0.0008085153,0.00038293752],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008062958,0.00018234183,0.8091264,0.0009451343,0.000085861706,0.026859315,0.0030650957,0.00023983108,0.00716653,0.0017922538,0.0033853778,0.14634567],"study_design_scores_gemma":[0.00006621536,0.0013492787,0.72798866,0.0007086256,0.00019900249,0.243124,0.0053728316,0.0010461448,0.0021210753,0.002785907,0.015124025,0.000114322094],"about_ca_topic_score_codex":0.00082128646,"about_ca_topic_score_gemma":0.00058015145,"teacher_disagreement_score":0.004755954,"about_ca_system_score_codex":0.00036050173,"about_ca_system_score_gemma":0.00046704925,"threshold_uncertainty_score":0.014538407},"labels":[],"label_agreement":null},{"id":"W2164267257","doi":"10.1177/1352458509359725","title":"Neurofilament light as a prognostic marker in multiple sclerosis","year":2010,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":189,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Biogen; IC Design Education Center; Ministère de la Santé et des Services sociaux; Sanofi","keywords":"Multiple sclerosis; Neurofilament; Medicine; Cerebrospinal fluid; Confidence interval; Odds ratio; Internal medicine; Lumbar puncture; Pathology; Amyotrophic lateral sclerosis; Central nervous system disease; Gastroenterology; Disease; Immunology; Immunohistochemistry","score_opus":0.0951121904387074,"score_gpt":0.29525463731154317,"score_spread":0.20014244687283578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164267257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99805033,0.0014895097,0.00015883177,0.00006656669,0.000012420964,0.0000029247308,0.000032649346,0.000008549196,0.0001783906],"genre_scores_gemma":[0.9995517,0.00019243134,0.00010170345,0.000006750773,0.000026108028,0.0000016991498,0.000049549293,9.791261e-7,0.00006916365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996258,0.00016946264,0.000030098678,0.000052581705,0.000074547315,0.000047390356],"domain_scores_gemma":[0.99722445,0.00095938944,0.0010355483,0.00011856252,0.00023536828,0.00042672316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010486456,0.00043539997,0.0003011482,0.0008174918,0.00027775782,0.00045060308,0.0003044002,0.00052732986,0.0006841534],"category_scores_gemma":[0.0043657697,0.00018123363,0.00021568459,0.00064254465,0.0003561139,0.00042647103,0.00032228316,0.00046482013,0.00022214996],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047649833,0.00001802929,0.99468476,0.000010553998,0.000027508408,0.00019258002,0.000020094241,0.00010073727,0.00049452437,0.000008543385,0.000053863467,0.0039124726],"study_design_scores_gemma":[0.000016180089,0.0003129014,0.9966085,0.000011249051,0.00005900346,0.0013814274,0.00005219969,0.00094179827,0.00033951006,0.00007485245,0.0001937668,0.000008612411],"about_ca_topic_score_codex":0.00085332454,"about_ca_topic_score_gemma":0.0008181039,"teacher_disagreement_score":0.0010486456,"about_ca_system_score_codex":0.0001576177,"about_ca_system_score_gemma":0.00022209572,"threshold_uncertainty_score":0.005545795},"labels":[],"label_agreement":null},{"id":"W2165469641","doi":"10.1177/1352458513508837","title":"Exercising away the blues: can it help multiple sclerosis-related depression?","year":2013,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Multiple Sclerosis Society","keywords":"Multiple sclerosis; Depression (economics); Mood; CLARITY; Medicine; Psychiatry; Physical medicine and rehabilitation; Psychology; Physical therapy; Alternative medicine; Clinical psychology","score_opus":0.24183030058778848,"score_gpt":0.3586178863786763,"score_spread":0.11678758579088783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165469641","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008616165,0.99901927,0.000022039792,0.000564386,0.00011296535,0.000004452294,0.000005289812,0.0000013404339,0.00018422745],"genre_scores_gemma":[0.0008937909,0.9984648,0.00007413183,0.0003523803,0.00009480267,0.0000072192706,0.000005996898,6.171039e-7,0.000106219944],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996172,0.00014308764,0.00008717767,0.00003976069,0.0000837086,0.000029008012],"domain_scores_gemma":[0.99900645,0.0007447737,0.000109994275,0.000015244499,0.000086233544,0.000037330705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012121461,0.0005962095,0.0026743945,0.0014796426,0.00035449938,0.0014438982,0.00090370164,0.0020968046,0.00552009],"category_scores_gemma":[0.0028990903,0.00026678827,0.0015472244,0.0015548288,0.0005280177,0.0017439091,0.0005809629,0.0017646572,0.0009855072],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022011735,0.0000729901,0.00017250539,0.13381903,0.00073031744,0.00015846553,0.0001689141,0.00010259923,0.00042894576,0.0018109288,0.012771092,0.84954405],"study_design_scores_gemma":[0.0005385299,0.00074738666,0.005063055,0.28706846,0.0041879676,0.0024718568,0.0010117707,0.00018734483,0.00052435487,0.006395085,0.6917345,0.00006964991],"about_ca_topic_score_codex":0.0015660222,"about_ca_topic_score_gemma":0.005326834,"teacher_disagreement_score":0.00552009,"about_ca_system_score_codex":0.00044231795,"about_ca_system_score_gemma":0.0012750512,"threshold_uncertainty_score":0.018466473},"labels":[],"label_agreement":null},{"id":"W2166380491","doi":"10.1177/1352458512460602","title":"Susceptibility-weighted imaging in the experimental autoimmune encephalomyelitis model of multiple sclerosis indicates elevated deoxyhemoglobin, iron deposition and demyelination","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; National Research Council Institute for Biodiagnostics; University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Susceptibility weighted imaging; Multiple sclerosis; Medicine; Pathology; Spinal cord; White matter; Experimental autoimmune encephalomyelitis; Hyperintensity; Magnetic resonance imaging; Lesion; Immunology; Radiology","score_opus":0.07558396503557392,"score_gpt":0.2956727301939619,"score_spread":0.220088765158388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166380491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820092,0.004204198,0.0061645554,0.00037204512,0.00013863029,0.0005177813,0.0008255162,0.0003663279,0.00540184],"genre_scores_gemma":[0.96716905,0.0037978105,0.015549134,0.00032053335,0.00007466506,0.0010797778,0.0020091557,0.00006900202,0.009930863],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996407,0.000065091415,0.000037344573,0.000084237916,0.000104512146,0.00006818393],"domain_scores_gemma":[0.9996761,0.000023603458,0.000117118754,0.000030900956,0.00005200906,0.00010023995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000480998,0.0014206824,0.00059622846,0.0013577214,0.0003713525,0.00024007316,0.00033698912,0.00084677985,0.0029308202],"category_scores_gemma":[0.00017369993,0.00035878806,0.00036912132,0.00059967587,0.000569972,0.00041602924,0.0003400346,0.0014849777,0.0006850825],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007697543,0.00041515625,0.00072221126,0.00014708535,0.000023003891,0.00033341584,0.00005566276,0.00004448831,0.995574,0.000104485895,0.00016958537,0.001641192],"study_design_scores_gemma":[0.0003731333,0.010463751,0.05390355,0.00011636777,0.0002056886,0.004606277,0.00013699319,0.0014998016,0.92053276,0.0003263867,0.007799208,0.00003615258],"about_ca_topic_score_codex":0.00054938096,"about_ca_topic_score_gemma":0.0014629498,"teacher_disagreement_score":0.0029308202,"about_ca_system_score_codex":0.0003700536,"about_ca_system_score_gemma":0.00035247556,"threshold_uncertainty_score":0.009804547},"labels":[],"label_agreement":null},{"id":"W2166602371","doi":"10.1177/1352458510365586","title":"Two-year study of cervical cord volume and myelin water in primary progressive multiple sclerosis","year":2010,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; Teva Pharmaceutical Industries","keywords":"Expanded Disability Status Scale; Medicine; Interquartile range; Multiple sclerosis; Spinal cord; White matter; Glatiramer acetate; Placebo; Cord; Internal medicine; Urology; Gastroenterology; Nuclear medicine; Anesthesia; Surgery; Magnetic resonance imaging; Pathology; Radiology","score_opus":0.07348340894632772,"score_gpt":0.3025347368070753,"score_spread":0.2290513278607476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166602371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99913615,0.0003523846,0.000034836958,0.000025619465,0.0000049931596,0.000040177052,0.00012839098,0.0000032617843,0.0002743611],"genre_scores_gemma":[0.99926764,0.00006697168,0.000046512105,0.000028331131,0.000007693774,0.000028345805,0.0002974092,7.7109735e-7,0.00025630818],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99965405,0.000094234,0.000018210552,0.000065484164,0.00009542076,0.00007252018],"domain_scores_gemma":[0.99890494,0.00014478102,0.000245959,0.00006822406,0.00025825025,0.0003777046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096159626,0.00031571038,0.00047577763,0.00043491484,0.0005116043,0.00032188153,0.00031587327,0.00082007854,0.0008464229],"category_scores_gemma":[0.0017808734,0.0001583752,0.000257808,0.00043315615,0.0003583121,0.00024346719,0.00035283933,0.0005801973,0.00017149746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.057529025,0.004034095,0.9118321,0.00012650275,0.00048573076,0.00089129515,0.0006262744,0.00028079704,0.01166841,0.000041045274,0.00043089123,0.012053844],"study_design_scores_gemma":[0.0002575708,0.009418571,0.9893574,0.0000034228378,0.000066447705,0.00013976597,0.00004407063,0.00007504507,0.00034359712,0.000012877877,0.0002750934,0.000006119024],"about_ca_topic_score_codex":0.0064740162,"about_ca_topic_score_gemma":0.00682884,"teacher_disagreement_score":0.0064740162,"about_ca_system_score_codex":0.0006839865,"about_ca_system_score_gemma":0.00059493,"threshold_uncertainty_score":0.012872696},"labels":[],"label_agreement":null},{"id":"W2167412674","doi":"10.1177/1352458506071161","title":"Anxiety disorders and their clinical correlates in multiple sclerosis patients","year":2007,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":421,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Anxiety; Psychiatry; Panic disorder; Generalized anxiety disorder; Anxiety disorder; Psychosocial; Agoraphobia; Psychology; Clinical psychology; Social anxiety; Depression (economics); Medicine","score_opus":0.11303309424381826,"score_gpt":0.3198231508235496,"score_spread":0.20679005657973137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167412674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99840313,0.0008657692,0.00002897372,0.00006910079,0.0000046974365,0.000008054494,0.00014553619,0.000004355346,0.00047049383],"genre_scores_gemma":[0.99956876,0.00019925449,0.000040945055,0.000019878062,0.000015777297,0.000005630775,0.000108728054,6.691313e-7,0.000040351417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99963284,0.00009205421,0.00005785231,0.000054546606,0.000109488494,0.000053287968],"domain_scores_gemma":[0.99856097,0.00027808757,0.00078484335,0.000028932627,0.00014088975,0.00020632747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032849752,0.00021918798,0.00030370336,0.0009962323,0.0003238546,0.00047498825,0.00018039109,0.00039720326,0.0012844617],"category_scores_gemma":[0.0022531655,0.00016464951,0.00018768948,0.0008702833,0.00022027867,0.00033925264,0.00030022426,0.00038596388,0.00020297902],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051873478,0.00001837135,0.9985764,0.000009764946,0.000017265707,0.00011297494,0.000031800806,0.000013234227,0.000104242994,0.0000035371886,0.000044133914,0.0010162917],"study_design_scores_gemma":[0.0000043821065,0.00006632049,0.99858886,0.00000553516,0.000010839499,0.0011152313,0.000084263396,0.000048221773,0.000019000197,0.000006514721,0.000049133483,0.0000016865451],"about_ca_topic_score_codex":0.001466136,"about_ca_topic_score_gemma":0.0016623623,"teacher_disagreement_score":0.001466136,"about_ca_system_score_codex":0.00018376985,"about_ca_system_score_gemma":0.000175667,"threshold_uncertainty_score":0.004296899},"labels":[],"label_agreement":null},{"id":"W2167461562","doi":"10.1177/1352458511432328","title":"Obstructive sleep apnea is associated with fatigue in multiple sclerosis","year":2011,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":139,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; McGill University Health Centre","funders":"Multiple Sclerosis Society of Canada","keywords":"Epworth Sleepiness Scale; Medicine; Obstructive sleep apnea; Polysomnography; Physical therapy; Expanded Disability Status Scale; Excessive daytime sleepiness; Multiple sclerosis; Body mass index; Depression (economics); Multiple Sleep Latency Test; Internal medicine; Sleep disorder; Apnea; Insomnia; Psychiatry","score_opus":0.21585565229932238,"score_gpt":0.292958377297438,"score_spread":0.07710272499811563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167461562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965796,0.0026542852,0.00016658063,0.000082921266,0.000014178121,0.000008348992,0.000098190205,0.000009039896,0.0003868245],"genre_scores_gemma":[0.9993948,0.00033746654,0.00007290393,0.000021413201,0.00003741366,0.000003029352,0.00008016504,0.0000010932731,0.000051750983],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999694,0.00008134952,0.000054854034,0.00006443917,0.00006747051,0.000038018785],"domain_scores_gemma":[0.99808455,0.00042734257,0.0010975887,0.000057823225,0.00013813013,0.00019454221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038752693,0.00030992247,0.00034942062,0.00073400047,0.0003452565,0.00031143276,0.00018093215,0.0004248526,0.0022302757],"category_scores_gemma":[0.0018954093,0.00014783649,0.00036785335,0.00070078194,0.00027897864,0.00021620428,0.0003316806,0.0003898169,0.00013234804],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012734537,0.000018066787,0.9957274,0.00003487174,0.000090372465,0.0002720048,0.00003154193,0.000024998308,0.00053271675,0.000009146038,0.00006078834,0.0030707507],"study_design_scores_gemma":[0.0000040688287,0.000060254082,0.9982047,0.000011934889,0.00005168793,0.0014068855,0.000027551861,0.00009659229,0.000042550066,0.000024266483,0.00006743698,0.000001975252],"about_ca_topic_score_codex":0.0015565449,"about_ca_topic_score_gemma":0.0016943032,"teacher_disagreement_score":0.0022302757,"about_ca_system_score_codex":0.0001395445,"about_ca_system_score_gemma":0.00018888713,"threshold_uncertainty_score":0.007461071},"labels":[],"label_agreement":null},{"id":"W2168030494","doi":"10.1177/1352458514551453","title":"Puberty in females enhances the risk of an outcome of multiple sclerosis in children and the development of central nervous system autoimmunity in mice","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Women's College Hospital; Toronto Rehabilitation Institute; McGill University; Montreal Neurological Institute and Hospital; University of Toronto; SickKids Foundation; University Health Network; University of Manitoba; University of British Columbia; Hospital for Sick Children","funders":"","keywords":"Multiple sclerosis; Medicine; Experimental autoimmune encephalomyelitis; Central nervous system; Menarche; Autoimmunity; Demyelinating disease; Young adult; Acute disseminated encephalomyelitis; Encephalomyelitis; Magnetic resonance imaging; Pediatrics; Physiology; Internal medicine; Disease; Immunology","score_opus":0.07660951780008202,"score_gpt":0.28487256377150033,"score_spread":0.20826304597141831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168030494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99625623,0.0009197494,0.0007110777,0.00015529402,0.000023373112,0.000019691859,0.0008337231,0.000066323395,0.0010145595],"genre_scores_gemma":[0.99392223,0.0011399693,0.0010826099,0.00012517767,0.000023806675,0.000062733,0.00067534443,0.00004819006,0.0029199221],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9996511,0.00007011335,0.000020536017,0.00008483214,0.00008411388,0.0000893005],"domain_scores_gemma":[0.9992694,0.000073748415,0.00037553394,0.00005101276,0.00003420523,0.00019598653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035804237,0.00036267634,0.00032786644,0.00081482617,0.00021441988,0.000399759,0.00021968449,0.00034119436,0.0023377736],"category_scores_gemma":[0.0002659621,0.00025288353,0.00039236445,0.00023808159,0.00033361797,0.00020903669,0.00036603483,0.0007366998,0.00034997836],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004867919,0.0007517702,0.072779745,0.00013948754,0.00011347765,0.0006367235,0.00019934724,0.00030618606,0.9080041,0.00047829718,0.00049091893,0.011232045],"study_design_scores_gemma":[0.00035983245,0.0076590506,0.6535811,0.000084654304,0.00031787367,0.0033785226,0.00037227513,0.0018571528,0.3224669,0.00036486058,0.009497312,0.000060531904],"about_ca_topic_score_codex":0.001239499,"about_ca_topic_score_gemma":0.0017892946,"teacher_disagreement_score":0.0023377736,"about_ca_system_score_codex":0.0003866999,"about_ca_system_score_gemma":0.00046561856,"threshold_uncertainty_score":0.007820666},"labels":[],"label_agreement":null},{"id":"W2168098956","doi":"10.1177/1352458514559297","title":"Validity of four screening scales for major depression in MS","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; Hotchkiss Brain Institute; University of Calgary","funders":"Cumming School of Medicine, University of Calgary; Alberta Innovates - Health Solutions; University of Calgary; Canada Research Chairs; Alberta Health Services","keywords":"Patient Health Questionnaire; Receiver operating characteristic; Depression (economics); Medicine; Hospital Anxiety and Depression Scale; Rating scale; Psychometrics; Anxiety; Physical therapy; Psychiatry; Clinical psychology; Psychology; Depressive symptoms; Internal medicine","score_opus":0.33276547643926696,"score_gpt":0.36493897191115166,"score_spread":0.032173495471884694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168098956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988808,0.002343208,0.0020981708,0.00036795012,0.000114532966,0.0007699334,0.0012466694,0.000066801644,0.004184714],"genre_scores_gemma":[0.99223644,0.00045123094,0.005511609,0.000102793405,0.000034921104,0.00043772065,0.00087566295,0.0000048789857,0.00034467308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994638,0.0025309948,0.0008611597,0.00036712826,0.001415762,0.00018691944],"domain_scores_gemma":[0.98258245,0.009210562,0.00486523,0.0005461136,0.002102947,0.0006926155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009045821,0.00063798943,0.00073975057,0.0023254082,0.00038611772,0.00073022564,0.00080786954,0.0006657591,0.001125727],"category_scores_gemma":[0.025283158,0.0002970007,0.0013024018,0.00089282054,0.0004964361,0.00067156355,0.0009916867,0.0007482796,0.00030167002],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015687196,0.00033186178,0.947907,0.00018539601,0.00071525865,0.00006139261,0.00024932277,0.00044169056,0.0006051455,0.00018673306,0.0007129007,0.04703458],"study_design_scores_gemma":[0.00019795391,0.00093621475,0.9956162,0.00008135176,0.000113464055,0.00028558643,0.00013767359,0.0015409127,0.00021118618,0.00031633643,0.00054720015,0.000016041327],"about_ca_topic_score_codex":0.0012240835,"about_ca_topic_score_gemma":0.0021744333,"teacher_disagreement_score":0.009045821,"about_ca_system_score_codex":0.0005886618,"about_ca_system_score_gemma":0.0005682782,"threshold_uncertainty_score":0.047839463},"labels":[],"label_agreement":null},{"id":"W2168428527","doi":"10.1191/1352458504ms1004oa","title":"Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing-remitting multiple sclerosis","year":2004,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Multiple sclerosis; Relapsing remitting; Medicine; Interferon beta; Interferon beta-1b; Antibody; Immunology; BETA (programming language); Interferon; Interferon beta-1a; Virology","score_opus":0.17562929616522577,"score_gpt":0.350103154021096,"score_spread":0.17447385785587022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168428527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99735284,0.001687759,0.00041851983,0.000073487594,0.000013939052,0.00001603604,0.00023638751,0.000008640769,0.00019250692],"genre_scores_gemma":[0.9989027,0.00028819288,0.00019696202,0.000040314455,0.000020904075,0.000021411826,0.0003611086,0.0000034523828,0.00016475808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946807,0.003976012,0.00023668908,0.00036266775,0.0004543843,0.00028959292],"domain_scores_gemma":[0.9757892,0.011327325,0.0067049554,0.0033794807,0.0014046959,0.0013943057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014406106,0.00045545722,0.0006351232,0.00045421047,0.00034775617,0.00047015524,0.00038887566,0.00048721762,0.00063927035],"category_scores_gemma":[0.018480122,0.0002985522,0.0014891026,0.0004188454,0.00033350126,0.00044780606,0.0005304079,0.0011834776,0.00014461286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033549864,0.0012599553,0.9174912,0.00016788335,0.0051189065,0.00022403273,0.0003800179,0.0017806208,0.0066721397,0.00015541606,0.00038153311,0.032818623],"study_design_scores_gemma":[0.00048864423,0.017823664,0.97477764,0.000033751014,0.0016222014,0.00027272245,0.0000789929,0.0023102586,0.0015894619,0.00017308962,0.00079999963,0.00002940847],"about_ca_topic_score_codex":0.001283094,"about_ca_topic_score_gemma":0.0014290329,"teacher_disagreement_score":0.014406106,"about_ca_system_score_codex":0.00033226516,"about_ca_system_score_gemma":0.00054245244,"threshold_uncertainty_score":0.07618767},"labels":[],"label_agreement":null},{"id":"W2169155838","doi":"10.1177/1352458512469696","title":"Copy number variation in pediatric multiple sclerosis","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of Neurological Disorders and Stroke; Stony Brook University; Multiple Sclerosis Society; University of California, San Francisco; Massachusetts General Hospital; National Multiple Sclerosis Society; Mayo Clinic","keywords":"Multiple sclerosis; Copy-number variation; Variation (astronomy); Clinical neurology; Medicine; Genetics; Biology; Neuroscience; Gene; Genome; Immunology","score_opus":0.04034046466346305,"score_gpt":0.22861915655529438,"score_spread":0.18827869189183133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169155838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902001,0.003627075,0.0019322045,0.00008514909,0.000013664374,0.000023485867,0.0023290282,0.00005811195,0.0017310607],"genre_scores_gemma":[0.995103,0.0012218449,0.0018352092,0.00003535037,0.000014619526,0.000022138578,0.0015143371,0.000016774178,0.00023681916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99949,0.00006841659,0.00004663858,0.00020782938,0.00015167438,0.00003547988],"domain_scores_gemma":[0.99910694,0.00039932286,0.00031651053,0.00004672477,0.00008739532,0.000043074233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028860342,0.00024820218,0.00024041698,0.0014987555,0.00019795191,0.00036715073,0.0002524923,0.00029271236,0.0020646113],"category_scores_gemma":[0.001916262,0.000098700395,0.00018628065,0.0013826624,0.0002181757,0.00017398852,0.0002748692,0.00022843304,0.00022446517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027601424,0.000027780932,0.90341854,0.00018903197,0.000169244,0.005936165,0.0003635055,0.0011786163,0.025323056,0.0006860052,0.0011386842,0.06129341],"study_design_scores_gemma":[0.0000135811215,0.00013896303,0.95387214,0.00006226053,0.00014634176,0.027646791,0.00015663166,0.0012232276,0.008335187,0.0008351466,0.007556003,0.000013782384],"about_ca_topic_score_codex":0.0012728331,"about_ca_topic_score_gemma":0.001192923,"teacher_disagreement_score":0.0020646113,"about_ca_system_score_codex":0.00026791697,"about_ca_system_score_gemma":0.00020456249,"threshold_uncertainty_score":0.0069068074},"labels":[],"label_agreement":null},{"id":"W2169229493","doi":"10.1177/1352458514564490","title":"A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis","year":2014,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":193,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Institute of Neurological Disorders and Stroke; Medical Center, University of Rochester; EMD Serono; National Institutes of Health; MedDay Pharmaceuticals; Technische Universität München; Università degli Studi di Genova; Gentofte Hospital; Bayer HealthCare; Institut National de la Santé et de la Recherche Médicale; Multiple Sclerosis Society of Canada; Cleveland Clinic Foundation; Ironwood Pharmaceuticals, Incorporated; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Multiple Sclerosis Society; European Committee for Treatment and Research in Multiple Sclerosis; Children's Hospital of Philadelphia; NYU Langone Medical Center; Teva Pharmaceutical Industries; University of Rochester; Pfizer; Biogen; Gilead Sciences; Yale University; Eli Lilly and Company; U.S. Department of Defense; Sanofi; University College London; Cleveland Clinic; Canadian Institutes of Health Research; Amylin Pharmaceuticals; Genentech; Vrije Universiteit Amsterdam; National Multiple Sclerosis Society","keywords":"Medicine; Incidence (geometry); Disease; Population; Multiple sclerosis; Psoriasis; MEDLINE; Comorbidity; Epidemiology; Internal medicine; Immunology; Environmental health","score_opus":0.1307681602214866,"score_gpt":0.34034962099568905,"score_spread":0.20958146077420245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169229493","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010948463,0.9978126,0.00012390874,0.00015127998,0.00009065141,0.0002521611,0.00028182828,0.000006579993,0.00018605801],"genre_scores_gemma":[0.013293265,0.98490715,0.00073351356,0.00022980872,0.00006184699,0.0004965341,0.00018160894,0.0000038980393,0.00009230672],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9895564,0.003154684,0.0046245167,0.0006629875,0.0017689054,0.00023254294],"domain_scores_gemma":[0.97410154,0.017369218,0.0052068834,0.0004134492,0.0026361344,0.00027274337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008670078,0.0017984495,0.010036689,0.015325656,0.0007701728,0.002716676,0.0020960234,0.0018156955,0.0039161476],"category_scores_gemma":[0.03972575,0.0012423961,0.007424429,0.017523846,0.0008857572,0.002485774,0.0014787673,0.0009987968,0.00027803308],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000106899264,0.000008649236,0.00088723097,0.96517444,0.010748686,0.000122027726,0.00015685671,0.00006137958,0.00012978751,0.00011231616,0.0008668759,0.021624865],"study_design_scores_gemma":[0.00020051179,0.00020397145,0.0071466733,0.82212543,0.1523203,0.00081599003,0.00031882577,0.000086474996,0.0002115265,0.00024868757,0.016283065,0.000038519745],"about_ca_topic_score_codex":0.007902778,"about_ca_topic_score_gemma":0.024038339,"teacher_disagreement_score":0.015325656,"about_ca_system_score_codex":0.0038548103,"about_ca_system_score_gemma":0.011234042,"threshold_uncertainty_score":0.045852304},"labels":[],"label_agreement":null},{"id":"W2169459006","doi":"10.1177/1352458506070928","title":"Myelin water imaging in multiple sclerosis: quantitative correlations with histopathology","year":2006,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Advanced Neuroimaging Techniques and Applications","field":"Medicine","cited_by":492,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Myelin; Luxol fast blue stain; Multiple sclerosis; Pathology; Relaxometry; Magnetic resonance imaging; Histopathology; Remyelination; Nuclear magnetic resonance; Chemistry; Medicine; Nuclear medicine; Central nervous system; Radiology; Physics; Internal medicine; Immunology; Spin echo","score_opus":0.1417452837391413,"score_gpt":0.3052127361807104,"score_spread":0.16346745244156907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169459006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97918737,0.007429019,0.011996978,0.000086679225,0.000014866393,0.000024529525,0.00017470903,0.00012526599,0.0009605502],"genre_scores_gemma":[0.9948738,0.0008421875,0.003889045,0.000021534783,0.000019152738,0.000013596228,0.00009349475,0.000013518575,0.00023374014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993844,0.00020206472,0.00004815711,0.00011008501,0.0002236661,0.000031650256],"domain_scores_gemma":[0.9973367,0.00087710057,0.0010086973,0.00024172712,0.00042141072,0.000114413255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019650066,0.00037056726,0.00027098897,0.0014477003,0.00013466454,0.0003965283,0.00023547548,0.00042007654,0.0006489172],"category_scores_gemma":[0.004800991,0.0002884733,0.00011006616,0.00067247136,0.00058842084,0.0008001358,0.0003862587,0.0003312695,0.00028416308],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001572667,0.00014032275,0.5269713,0.0003900716,0.00037887215,0.0004405582,0.0002912123,0.00284514,0.40873876,0.000393056,0.00038249863,0.057455566],"study_design_scores_gemma":[0.000025351243,0.0010312103,0.90595686,0.000038346796,0.00014080551,0.0044227634,0.00017060689,0.0056771045,0.07998802,0.0013435854,0.0011616313,0.00004360309],"about_ca_topic_score_codex":0.0003574755,"about_ca_topic_score_gemma":0.0003717285,"teacher_disagreement_score":0.0019650066,"about_ca_system_score_codex":0.00016126462,"about_ca_system_score_gemma":0.00013175634,"threshold_uncertainty_score":0.01039207},"labels":[],"label_agreement":null},{"id":"W2170433606","doi":"10.1177/1352458508093892","title":"Canadian treatment optimization recommendations (TOR) as a predictor of disease breakthrough in patients with multiple sclerosis treated with interferon β-1a: analysis of the PRISMS study","year":2008,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa","funders":"Merck KGaA","keywords":"Multiple sclerosis; Medicine; Disease; Limiting; Physical therapy; Internal medicine; Immunology","score_opus":0.06095092396963838,"score_gpt":0.2680302757092021,"score_spread":0.20707935173956374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170433606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98496544,0.0018732749,0.00023291515,0.0006368089,0.000030355255,0.00017387154,0.008407317,0.000012444225,0.0036674722],"genre_scores_gemma":[0.99496114,0.00035292262,0.00045432738,0.0001302293,0.000018553596,0.000054498778,0.0037397444,0.0000048967386,0.0002836646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970071,0.0007649965,0.0002895895,0.0002785975,0.0013307313,0.0003289842],"domain_scores_gemma":[0.98544747,0.0030440984,0.0057691573,0.00047745486,0.003553119,0.00170864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035928257,0.0003512482,0.00077385525,0.0012516857,0.0010279582,0.0006885067,0.0011595599,0.0006560436,0.001418547],"category_scores_gemma":[0.016534192,0.00019508155,0.0011994444,0.0035209467,0.00048449286,0.00040333485,0.00087704655,0.0013274837,0.00009876451],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010317181,0.00003411378,0.9935573,0.0000825772,0.00023330309,0.000029289327,0.000087551416,0.00034396967,0.000032732773,0.00006898821,0.000831961,0.0036665401],"study_design_scores_gemma":[0.00007948704,0.0001486921,0.9973563,0.00003069096,0.00010351218,0.000058722417,0.00015683807,0.001209812,0.000019864105,0.00002678696,0.0007949903,0.000014323839],"about_ca_topic_score_codex":0.7371622,"about_ca_topic_score_gemma":0.6835982,"teacher_disagreement_score":0.7371622,"about_ca_system_score_codex":0.0073519554,"about_ca_system_score_gemma":0.013863434,"threshold_uncertainty_score":0.5287714},"labels":[],"label_agreement":null},{"id":"W2171821866","doi":"10.1177/1352458512458169","title":"Setting a research agenda for progressive multiple sclerosis: The International Collaborative on Progressive MS","year":2012,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Multiple Sclerosis Society of Canada; University of Toronto","funders":"IC Design Education Center; Innovative Medicines Initiative; Wellcome Trust; Biogen","keywords":"Repurposing; Medicine; Expediting; Clinical trial; Multiple sclerosis; Management; Psychiatry; Pathology","score_opus":0.48127786316580623,"score_gpt":0.4644677317707142,"score_spread":0.01681013139509202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171821866","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000056820085,0.99057275,0.00019195078,0.0071746814,0.001446014,0.000043524404,0.000012022877,0.000007629178,0.0004945535],"genre_scores_gemma":[0.0011181197,0.9916543,0.0018982657,0.004113794,0.000662441,0.00010632688,0.000053682877,0.0000039563856,0.0003891225],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9926911,0.0033210148,0.0013156342,0.00038329719,0.0018163737,0.00047254236],"domain_scores_gemma":[0.98642844,0.0066290116,0.0016122038,0.00046965145,0.0037554204,0.0011053401],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.022953458,0.0014270379,0.0034466034,0.007028958,0.0011445966,0.0043749213,0.0024398048,0.0056182244,0.0035602786],"category_scores_gemma":[0.018501727,0.00066926243,0.0022212246,0.007927794,0.001701333,0.008135867,0.0040256144,0.0061924737,0.001218307],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022124009,0.0001488556,0.00044002495,0.108588874,0.00035477342,0.00034771714,0.0011100874,0.000492677,0.0011862327,0.022893367,0.11641519,0.74780107],"study_design_scores_gemma":[0.00009021874,0.00009368042,0.001185894,0.08200599,0.00045313442,0.0005092264,0.00102631,0.00009704041,0.00022597003,0.007740641,0.9065258,0.000046077777],"about_ca_topic_score_codex":0.005888388,"about_ca_topic_score_gemma":0.009332267,"teacher_disagreement_score":0.97704655,"about_ca_system_score_codex":0.0048786085,"about_ca_system_score_gemma":0.034966577,"threshold_uncertainty_score":0.121391},"labels":[],"label_agreement":null},{"id":"W2172299842","doi":"10.1177/1352458507088104","title":"Magnetic resonance imaging as a surrogate outcome for multiple sclerosis relapses","year":2008,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Allergy and Infectious Diseases; Multiple Sclerosis Society; National Multiple Sclerosis Society","keywords":"Surrogate endpoint; Multiple sclerosis; Magnetic resonance imaging; Medicine; McDonald criteria; Clinical trial; Pathology; Radiology; Immunology","score_opus":0.16700613420333058,"score_gpt":0.32224179365824873,"score_spread":0.15523565945491816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2172299842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9635477,0.006084122,0.023223469,0.00081058824,0.00009530486,0.0005098746,0.0017089903,0.00010325946,0.003916571],"genre_scores_gemma":[0.9945056,0.00033291226,0.0040298677,0.000118030846,0.000046023957,0.00021819472,0.0005575287,0.000013894275,0.00017812492],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9837765,0.012701149,0.00094489957,0.0008569083,0.0015250407,0.00019552288],"domain_scores_gemma":[0.90916824,0.058445502,0.02203675,0.0070350273,0.0018996069,0.0014149364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.033917833,0.0006667897,0.0010965233,0.0009581922,0.0003170324,0.00093685085,0.0007983932,0.00067459093,0.0011987311],"category_scores_gemma":[0.059226297,0.00020365015,0.000906285,0.0011751138,0.0008402078,0.00095606345,0.0010440492,0.0017053166,0.0002341336],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011114736,0.00047595336,0.9389162,0.0006254634,0.0017371266,0.00021238877,0.00022657643,0.0052894424,0.0027945056,0.0018522026,0.00051589677,0.036239527],"study_design_scores_gemma":[0.0007010787,0.015140376,0.94090325,0.00028307815,0.0016601845,0.002055778,0.00014314313,0.020742064,0.0072998465,0.0073774545,0.003609591,0.00008419558],"about_ca_topic_score_codex":0.00018132315,"about_ca_topic_score_gemma":0.00023689351,"teacher_disagreement_score":0.033917833,"about_ca_system_score_codex":0.00037360072,"about_ca_system_score_gemma":0.00066493545,"threshold_uncertainty_score":0.17937678},"labels":[],"label_agreement":null},{"id":"W2173315418","doi":"10.1177/1352458515616701","title":"Inclusion of brain volume loss in a revised measure of ‘no evidence of disease activity’ (NEDA-4) in relapsing–remitting multiple sclerosis","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":288,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"IC Design Education Center; Biogen; Allergan; Eli Lilly and Company","keywords":"Multiple sclerosis; Relapsing remitting; Medicine; Inclusion (mineral); Brain size; Disease; Psychology; Pathology; Magnetic resonance imaging; Immunology; Radiology","score_opus":0.12325563741630512,"score_gpt":0.31995931057430665,"score_spread":0.19670367315800152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2173315418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980352,0.0108425,0.0037415493,0.00024103968,0.00011594145,0.00057132856,0.0026611835,0.00004876048,0.0014257466],"genre_scores_gemma":[0.99538237,0.00046316662,0.0022293718,0.000075022115,0.000047622605,0.000386395,0.0012223861,0.000008065552,0.00018563142],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9833513,0.01122338,0.0017723048,0.0012028179,0.002154069,0.00029611686],"domain_scores_gemma":[0.96713716,0.015173497,0.014570705,0.0013596552,0.0012470651,0.0005119234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01936708,0.0007232474,0.001928543,0.0018848286,0.00024475568,0.0009253033,0.0013273048,0.0006360666,0.0012048308],"category_scores_gemma":[0.021293225,0.00025599985,0.0023623034,0.0015449838,0.0010550644,0.00088568835,0.0011742661,0.0010036243,0.00012287301],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055073515,0.00060422486,0.8321681,0.00359257,0.017015869,0.00039838452,0.0004892891,0.0063284547,0.004278014,0.0004203999,0.0012805532,0.078350574],"study_design_scores_gemma":[0.001392156,0.0065423097,0.97739583,0.00023030028,0.004430021,0.00093671324,0.00008098785,0.0032522457,0.002180982,0.00055522955,0.0029366198,0.00006657585],"about_ca_topic_score_codex":0.00080398703,"about_ca_topic_score_gemma":0.0010000365,"teacher_disagreement_score":0.01936708,"about_ca_system_score_codex":0.0007846091,"about_ca_system_score_gemma":0.0006906537,"threshold_uncertainty_score":0.102424145},"labels":[],"label_agreement":null},{"id":"W2174409614","doi":"10.1177/1352458515602336","title":"Altered resting-state functional connectivity in cognitively preserved pediatric-onset MS patients and relationship to structural damage and cognitive performance","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baycrest Hospital; Montreal Neurological Institute and Hospital; University of Toronto; SickKids Foundation; McGill University; Mental Health Research Canada; Hospital for Sick Children; York University","funders":"","keywords":"Precuneus; Resting state fMRI; Thalamus; Anterior cingulate cortex; Cognition; Multiple sclerosis; Posterior cingulate; Medicine; Neuroscience; Effects of sleep deprivation on cognitive performance; Cortex (anatomy); Cingulate cortex; Audiology; Psychology; Cardiology; Central nervous system; Psychiatry","score_opus":0.1742270362341723,"score_gpt":0.31416682117691375,"score_spread":0.13993978494274145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2174409614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9998216,0.000037245616,0.00002210732,0.0000046962887,3.419431e-7,0.0000011184319,0.0000698085,0.0000014361293,0.000041702813],"genre_scores_gemma":[0.99974555,0.000029136618,0.000051867686,0.0000037562365,0.000001308856,0.0000023581324,0.00013740694,7.3734526e-7,0.000027848688],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999287,0.000010230501,0.000007572496,0.000024262,0.0000128345555,0.000016282012],"domain_scores_gemma":[0.99965477,0.000051023675,0.00019669814,0.000014269952,0.000034002645,0.000049218776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014243607,0.00035416544,0.00024018786,0.00046445406,0.00019772949,0.00027683302,0.00012071409,0.00024326787,0.0009886364],"category_scores_gemma":[0.0008029137,0.00011967022,0.00013197829,0.00037512486,0.00022503475,0.00021333397,0.00015020762,0.00015011383,0.00010715995],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022204038,0.0000230401,0.9946138,0.00001113625,0.000040536564,0.00027390235,0.00010342483,0.00008597884,0.0024152212,0.000009703626,0.000044680677,0.0021565114],"study_design_scores_gemma":[0.0000033947879,0.00008100618,0.9988564,0.0000012668978,0.000008213887,0.000703555,0.00006377876,0.0000808714,0.00016327051,0.0000074691216,0.000029808807,9.4195536e-7],"about_ca_topic_score_codex":0.003322096,"about_ca_topic_score_gemma":0.004468433,"teacher_disagreement_score":0.003322096,"about_ca_system_score_codex":0.0002165356,"about_ca_system_score_gemma":0.00013991277,"threshold_uncertainty_score":0.006605506},"labels":[],"label_agreement":null},{"id":"W2174668862","doi":"10.1177/1352458515603802","title":"Progressive MS: from pathophysiology to drug discovery","year":2015,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Multiple Sclerosis Society of Canada","funders":"","keywords":"Neuroscience; Drug discovery; Disease; Neuroinflammation; Druggability; Neurodegeneration; Multiple sclerosis; Medicine; Engineering ethics; Bioinformatics; Biology; Psychiatry; Genetics; Pathology; Engineering","score_opus":0.19782378144136764,"score_gpt":0.38658791781634333,"score_spread":0.1887641363749757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2174668862","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000033117813,0.99877816,0.000057499634,0.00048163667,0.00017779757,0.00000285676,0.000007981819,0.000004471118,0.00045648176],"genre_scores_gemma":[0.00033769582,0.9988551,0.00011089136,0.00025679555,0.00016048795,0.000004271752,0.000011347988,9.4640683e-7,0.00026239388],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995635,0.00010976077,0.00007292583,0.0000626368,0.00015700405,0.000034114197],"domain_scores_gemma":[0.9990675,0.00053713634,0.00010131332,0.00003491861,0.00018557564,0.000073554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00104988,0.0010148542,0.0020263474,0.0037712567,0.000394532,0.0017418732,0.0011748967,0.0018372505,0.0045095487],"category_scores_gemma":[0.0017243671,0.00033660798,0.0006595348,0.0038467643,0.00093069114,0.0024653652,0.0010875786,0.0025672026,0.002492019],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007121737,0.00007548477,0.00013400434,0.025366819,0.000118989796,0.00023064882,0.000103515784,0.00033723854,0.00072672596,0.006489282,0.055258434,0.91108763],"study_design_scores_gemma":[0.00002055841,0.000067488836,0.0005627099,0.009895097,0.0000996042,0.0009502084,0.000097657095,0.00007915311,0.00017675829,0.005433791,0.9825996,0.000017346689],"about_ca_topic_score_codex":0.0013660482,"about_ca_topic_score_gemma":0.0020794976,"teacher_disagreement_score":0.0045095487,"about_ca_system_score_codex":0.0013183916,"about_ca_system_score_gemma":0.0020243542,"threshold_uncertainty_score":0.015085936},"labels":[],"label_agreement":null},{"id":"W2175006891","doi":"10.1177/1352458515615224","title":"Impaired growth of the cerebellum in pediatric-onset acquired CNS demyelinating disease","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"Canadian Institutes of Health Research; Hospital for Sick Children","keywords":"Multiple sclerosis; Cerebellum; Demyelinating disease; Medicine; Neuroscience; Immunology; Psychology; Internal medicine","score_opus":0.11634667155560653,"score_gpt":0.30502988613374976,"score_spread":0.18868321457814324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2175006891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985393,0.00040640603,0.0006443141,0.000018663344,0.000001301896,0.000003876012,0.00023503981,0.000017896537,0.00013317507],"genre_scores_gemma":[0.99877816,0.00019170108,0.00067682896,0.000003242596,0.0000017879414,0.000005386551,0.00028931786,0.0000059685985,0.000047455498],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997398,0.00008011269,0.000022191056,0.00008004181,0.00004987448,0.000028059509],"domain_scores_gemma":[0.9986517,0.0004950411,0.00062239927,0.00007301623,0.00008881851,0.00006911667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008392395,0.0005056245,0.000279146,0.00082017906,0.00018168865,0.00040500623,0.0002980883,0.00023314428,0.00087361655],"category_scores_gemma":[0.002180792,0.0002035492,0.0003641102,0.0006442536,0.0004027725,0.00034374115,0.00042865422,0.00023250787,0.00010312758],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020874629,0.000016707274,0.99337876,0.000030171745,0.000077589975,0.00015542944,0.00006501411,0.0008605666,0.001121142,0.000043264474,0.000047053476,0.0039956244],"study_design_scores_gemma":[0.000005191702,0.0001507127,0.99630713,0.000010536539,0.000051095773,0.00071766734,0.000056703735,0.0017653833,0.000696197,0.00007384892,0.00016234504,0.0000032127643],"about_ca_topic_score_codex":0.00875414,"about_ca_topic_score_gemma":0.011386213,"teacher_disagreement_score":0.00875414,"about_ca_system_score_codex":0.0006044924,"about_ca_system_score_gemma":0.0005859908,"threshold_uncertainty_score":0.017406344},"labels":[],"label_agreement":null},{"id":"W2203540357","doi":"10.1177/1352458515618020","title":"Interferon beta-1a long-term therapy related to pulmonary arterial hypertension in multiple sclerosis patients","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Medicine; Multiple sclerosis; Lung transplantation; Interferon beta-1b; Internal medicine; Pulmonary hypertension; Interferon beta; BETA (programming language); Lung; Gastroenterology; Pathology; Immunology","score_opus":0.16097800271971083,"score_gpt":0.29112971229749385,"score_spread":0.13015170957778302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2203540357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99716175,0.0012776417,0.00011928464,0.00022220345,0.000015232727,0.000011320638,0.000019132342,0.0000068623344,0.001166776],"genre_scores_gemma":[0.9992206,0.00030535957,0.00008215413,0.00014514313,0.00005204688,0.0000055388946,0.000023692632,0.0000017199784,0.00016371507],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997267,0.00006184799,0.000049303406,0.000042430594,0.00005049658,0.00006906594],"domain_scores_gemma":[0.999138,0.00022358238,0.00031601486,0.00003464079,0.00005353495,0.00023430049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024873708,0.00029328334,0.0004135648,0.00046174866,0.0011430536,0.00063814875,0.0001794898,0.00085195963,0.0009800872],"category_scores_gemma":[0.0013664529,0.00017044628,0.00032689917,0.00042489433,0.00034381603,0.00036094518,0.00034184815,0.0006971904,0.00016310131],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084685464,0.0003426624,0.7484322,0.00010394439,0.00011311737,0.22160313,0.0018696659,0.000115516064,0.0058952593,0.00021969757,0.00042523473,0.02003269],"study_design_scores_gemma":[0.00014106296,0.0013188217,0.48198926,0.00008121705,0.00016886907,0.5108169,0.0009779937,0.0004205398,0.0013746232,0.00027929214,0.0023954848,0.000036058893],"about_ca_topic_score_codex":0.00082823733,"about_ca_topic_score_gemma":0.0009929243,"teacher_disagreement_score":0.0011430536,"about_ca_system_score_codex":0.00034262743,"about_ca_system_score_gemma":0.0002718289,"threshold_uncertainty_score":0.0032786727},"labels":[],"label_agreement":null},{"id":"W2215855864","doi":"10.1177/1352458515621624","title":"Children of chronically ill parents: Relationship between parental multiple sclerosis and childhood developmental health","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Family Support in Illness","field":"Social Sciences","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Vancouver Coastal Health; Vancouver Coastal Health Research Institute; University of British Columbia","funders":"Social Sciences and Humanities Research Council of Canada; Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada; Lawson Foundation; Child and Family Research Institute; Multiple Sclerosis Trust; Multiple Sclerosis Society; Research Manitoba; European Committee for Treatment and Research in Multiple Sclerosis; U.S. Department of Veterans Affairs; Teva Pharmaceutical Industries; Canadian Institute for Advanced Research; Sanofi; National Multiple Sclerosis Society; Biogen","keywords":"Multiple sclerosis; Medicine; Developmental psychology; Psychology; Early childhood; Pediatrics; Psychiatry","score_opus":0.1586364175409802,"score_gpt":0.3048482244957118,"score_spread":0.1462118069547316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2215855864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985055,0.0005357941,0.000036677964,0.00017385882,0.0000057694247,0.0000028988036,0.00027369155,0.0000024420942,0.0004635468],"genre_scores_gemma":[0.9995555,0.00019791177,0.000036579215,0.00001926187,0.000003278613,0.0000022618985,0.000103105056,9.1659376e-7,0.000081110666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995523,0.00013409024,0.000032661585,0.00008167245,0.00009413819,0.00010509237],"domain_scores_gemma":[0.9972082,0.00053907087,0.0014709436,0.00011653262,0.0002479674,0.0004173114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058282085,0.00023758726,0.0001847918,0.00069538684,0.0006763786,0.000688719,0.0003655663,0.00035361148,0.0026285483],"category_scores_gemma":[0.0036739854,0.00024454037,0.00029556346,0.0010921062,0.00037113077,0.0002916791,0.00054219586,0.0008737314,0.000114923736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010700965,0.000005124541,0.99932075,0.0000026761265,0.000014370007,0.000052013136,0.00008404087,0.000010263975,0.000014353517,0.000007955422,0.000048720274,0.0004291338],"study_design_scores_gemma":[8.090833e-7,0.000010612864,0.9994574,0.000010483321,0.000009718306,0.00016184174,0.0002315227,0.000040600356,0.000011476949,0.000009308803,0.00005486511,0.0000013730065],"about_ca_topic_score_codex":0.12404239,"about_ca_topic_score_gemma":0.11428794,"teacher_disagreement_score":0.12404239,"about_ca_system_score_codex":0.0008331104,"about_ca_system_score_gemma":0.0008762873,"threshold_uncertainty_score":0.24664074},"labels":[],"label_agreement":null},{"id":"W2257149495","doi":"10.1177/1352458515606526","title":"Physical activity and pediatric multiple sclerosis: Developing a research agenda","year":2015,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Multiple sclerosis; Neurocognitive; Medicine; Disease; Physical activity; Depression (economics); MEDLINE; Physical therapy; Pediatrics; Psychology; Physical medicine and rehabilitation; Gerontology; Cognition; Psychiatry; Pathology","score_opus":0.5836140953063959,"score_gpt":0.4635964834458713,"score_spread":0.12001761186052456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2257149495","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003666751,0.9978011,0.000057726153,0.0017028039,0.00024752566,0.0000048447546,0.0000044206363,0.0000019905713,0.00014292292],"genre_scores_gemma":[0.00038430613,0.99843377,0.00029587295,0.0005467462,0.00025173568,0.000013552491,0.000008049719,6.5873144e-7,0.00006535123],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998415,0.0006687534,0.0003457081,0.00015465992,0.0003128077,0.00010298584],"domain_scores_gemma":[0.9944694,0.00392728,0.00056317524,0.000084891755,0.00078232546,0.00017287457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005044833,0.0010844459,0.002895883,0.004436856,0.00065248966,0.002961588,0.0014591493,0.004293197,0.0032715406],"category_scores_gemma":[0.0063993265,0.00071013655,0.0017871276,0.0042204447,0.0011231273,0.005384992,0.0019436365,0.0047627767,0.0009587566],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015470918,0.00013834436,0.0006175989,0.12870257,0.00036195983,0.00034000902,0.00059832574,0.00045758492,0.00058805355,0.016573466,0.029448433,0.82201886],"study_design_scores_gemma":[0.00007129338,0.00022396103,0.0023136525,0.18551496,0.00092768023,0.0011651425,0.0012597665,0.00025001247,0.00020919985,0.010904971,0.79710305,0.00005623417],"about_ca_topic_score_codex":0.004277329,"about_ca_topic_score_gemma":0.0063934107,"teacher_disagreement_score":0.005044833,"about_ca_system_score_codex":0.0020511632,"about_ca_system_score_gemma":0.009039262,"threshold_uncertainty_score":0.026679933},"labels":[],"label_agreement":null},{"id":"W2271738643","doi":"10.1177/1352458515623862","title":"MS arising during Tocilizumab therapy for rheumatoid arthritis","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; Université Laval; Hôpital de l'Enfant-Jésus","funders":"","keywords":"Tocilizumab; Medicine; Neuromyelitis optica; Multiple sclerosis; Rheumatoid arthritis; Complication; Immunology; Internal medicine","score_opus":0.09439489377069125,"score_gpt":0.3035789517136868,"score_spread":0.20918405794299555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2271738643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93961066,0.012636422,0.0026681481,0.0037791156,0.00053599285,0.00026423598,0.00013273081,0.0002873048,0.040085375],"genre_scores_gemma":[0.9943756,0.0017188167,0.00038869193,0.0011347284,0.00055369374,0.00001815471,0.000053863056,0.00001781165,0.00173872],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9994553,0.00008730564,0.000061742576,0.00007495702,0.00010450642,0.00021626535],"domain_scores_gemma":[0.99872714,0.00032903577,0.00046546568,0.000099617384,0.000103194536,0.00027543012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002963965,0.0010238567,0.0006210174,0.00094495475,0.0021600185,0.0010260204,0.00046272107,0.0026427472,0.0026273872],"category_scores_gemma":[0.002737374,0.00043067118,0.0008575701,0.0006188543,0.00070068805,0.00083138724,0.00066951854,0.0027450612,0.00087740645],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019398623,0.000059611524,0.013436899,0.00006617974,0.000018685732,0.9791448,0.00027459272,0.000053471667,0.0018106629,0.00022719294,0.0004426099,0.004271252],"study_design_scores_gemma":[0.000038648657,0.00019857462,0.010511031,0.0000409026,0.000052000756,0.985274,0.00012589424,0.00020486847,0.0010999242,0.00025087083,0.0021936283,0.000009572483],"about_ca_topic_score_codex":0.0022727272,"about_ca_topic_score_gemma":0.0026107149,"teacher_disagreement_score":0.0026427472,"about_ca_system_score_codex":0.0013325169,"about_ca_system_score_gemma":0.00075606065,"threshold_uncertainty_score":0.009668171},"labels":[],"label_agreement":null},{"id":"W2274742391","doi":"10.1177/1352458515588582","title":"In multiple sclerosis anxiety, not depression, is related to gender","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; St. Michael's Hospital","funders":"","keywords":"Anxiety; Depression (economics); Hospital Anxiety and Depression Scale; Multiple sclerosis; Population; Etiology; Psychiatry; Psychology; Clinical psychology; Medicine","score_opus":0.24169075816506508,"score_gpt":0.33999098252796994,"score_spread":0.09830022436290486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2274742391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971245,0.001185671,0.00008214019,0.00021802138,0.00002132338,0.000007735524,0.0001212322,0.0000029994012,0.001236414],"genre_scores_gemma":[0.9995165,0.00024662958,0.000021740865,0.00004119157,0.0000148054805,0.0000020750392,0.00004039697,5.956278e-7,0.00011602843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99970657,0.00006861904,0.000028588796,0.000052392832,0.0000694226,0.00007431653],"domain_scores_gemma":[0.99882406,0.00029764112,0.0006166226,0.000049331808,0.00007899177,0.00013340182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039731915,0.000119791934,0.00020367735,0.00043680653,0.00033025976,0.00044064177,0.00011465435,0.00021046204,0.0031725378],"category_scores_gemma":[0.0030295528,0.000111924055,0.00027156467,0.00045618782,0.00028507243,0.00026473487,0.00023639623,0.0003048492,0.00027012534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017962909,0.00002956722,0.98904955,0.000029488709,0.000050139697,0.00023904575,0.00022872706,0.000015515068,0.00050894805,0.000055120647,0.00019056445,0.009423742],"study_design_scores_gemma":[0.0000034748712,0.00008220487,0.998042,0.000015472877,0.000026686308,0.0011819672,0.0002000004,0.00002952114,0.00006410785,0.00011059975,0.00024168775,0.000002315748],"about_ca_topic_score_codex":0.0013629632,"about_ca_topic_score_gemma":0.0021935678,"teacher_disagreement_score":0.0031725378,"about_ca_system_score_codex":0.00021233696,"about_ca_system_score_gemma":0.00018562708,"threshold_uncertainty_score":0.010613203},"labels":[],"label_agreement":null},{"id":"W2281587378","doi":"10.1177/1352458515607652","title":"What to make of cannabis and cognition in MS: In search of clarity amidst the haze","year":2015,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Cannabis; Cognition; Multiple sclerosis; Effects of cannabis; Psychology; CLARITY; Cognitive psychology; Medicine; Psychiatry","score_opus":0.1793932699447606,"score_gpt":0.38107936281476695,"score_spread":0.20168609287000636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2281587378","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000034579516,0.9980813,0.000017528206,0.0014766299,0.00028516678,0.0000010526296,0.00000463924,0.0000010486507,0.000098111945],"genre_scores_gemma":[0.00065830065,0.9973246,0.00007344137,0.0009814185,0.000851428,0.0000026644539,0.00000667446,0.0000011967697,0.000100313744],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99903095,0.00029665048,0.0002493211,0.00014322264,0.00023440948,0.00004553753],"domain_scores_gemma":[0.9947919,0.004032241,0.0004341518,0.000101864665,0.0005111435,0.00012862493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025177966,0.0008808597,0.0031924387,0.0028708377,0.0005989019,0.0026285457,0.0015771601,0.0037484553,0.0025965392],"category_scores_gemma":[0.0057036513,0.0004623003,0.0011134212,0.0029383486,0.0023455436,0.0055172974,0.001214587,0.004074843,0.00078307453],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022225066,0.000063598076,0.0005331475,0.07782109,0.0005247968,0.00031983468,0.00052166235,0.00022036636,0.00055015174,0.010195718,0.037032753,0.8719946],"study_design_scores_gemma":[0.000063671294,0.00012626096,0.0030334524,0.0780273,0.0007212843,0.0025042624,0.0012334696,0.0002272576,0.00029719487,0.019968407,0.89370704,0.00009043692],"about_ca_topic_score_codex":0.0055853995,"about_ca_topic_score_gemma":0.008748137,"teacher_disagreement_score":0.0055853995,"about_ca_system_score_codex":0.0011537519,"about_ca_system_score_gemma":0.00337737,"threshold_uncertainty_score":0.013315499},"labels":[],"label_agreement":null},{"id":"W2293079710","doi":"10.1177/1352458516630396","title":"The relationship of age with the clinical phenotype in multiple sclerosis","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Multiple sclerosis; Age of onset; Medicine; Young adult; Internal medicine; Affect (linguistics); Pediatrics; Disease; Immunology; Psychology","score_opus":0.2938941819590893,"score_gpt":0.35909867901082526,"score_spread":0.06520449705173598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2293079710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99667406,0.0017300141,0.000119304554,0.00010388953,0.000011432726,0.0000055886135,0.00045880195,0.0000058874266,0.00089092273],"genre_scores_gemma":[0.99940085,0.00022554534,0.000055852746,0.00001122712,0.000012813707,0.0000025830357,0.00018750901,0.000002641843,0.00010094055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995078,0.00015454523,0.00006883924,0.00009158256,0.00012578332,0.000051364004],"domain_scores_gemma":[0.9954861,0.0014123078,0.0020925684,0.00020711569,0.00042891636,0.00037305616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075889094,0.00018615741,0.0002551207,0.0007863037,0.00024770666,0.00041656216,0.00024359026,0.00031487594,0.001773752],"category_scores_gemma":[0.0053622713,0.00009837058,0.0002020248,0.0010115481,0.0002298356,0.0003754325,0.00026560784,0.0003391883,0.0002706832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013927596,0.000007756544,0.99776125,0.000010112891,0.000024120893,0.000059278198,0.000041172952,0.000025003854,0.00015380756,0.000008354111,0.000050415234,0.0017194061],"study_design_scores_gemma":[0.0000013839875,0.000033046847,0.9995479,0.0000031684926,0.000011057017,0.00020292107,0.000025087333,0.000039348666,0.000027571945,0.000014834114,0.000092384,0.0000012216943],"about_ca_topic_score_codex":0.0055935946,"about_ca_topic_score_gemma":0.0047725965,"teacher_disagreement_score":0.0055935946,"about_ca_system_score_codex":0.0003069806,"about_ca_system_score_gemma":0.00028453287,"threshold_uncertainty_score":0.0111221075},"labels":[],"label_agreement":null},{"id":"W2293314724","doi":"10.1177/1352458515595876","title":"Viral exposures and MS outcome in a prospective cohort of children with acquired demyelination","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Toronto; SickKids Foundation; Montreal Neurological Institute and Hospital; University of British Columbia; Hospital for Sick Children; McGill University; University of Calgary","funders":"Hospital for Sick Children","keywords":"Multiple sclerosis; Medicine; Cytomegalovirus; Seroprevalence; Herpes simplex virus; Virus; Prospective cohort study; Virology; Immunology; Herpesviridae; Cohort; Viral disease; Serology; Antibody; Internal medicine","score_opus":0.08407825877589259,"score_gpt":0.3126955497438281,"score_spread":0.22861729096793554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2293314724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999607,0.00012788532,0.000017092632,0.0000114606955,0.0000018604027,0.0000021231313,0.00012354778,9.60538e-7,0.00010813874],"genre_scores_gemma":[0.9996141,0.000105734434,0.000026840535,0.000008595752,0.0000037417212,0.0000037535442,0.00016988024,0.0000010077922,0.000066376175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997309,0.000064438595,0.000030072315,0.00006341647,0.000043988086,0.000067179586],"domain_scores_gemma":[0.99924135,0.0001189758,0.00031099786,0.00006404151,0.00008262452,0.00018192492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030183833,0.00025111088,0.000260927,0.0005681168,0.00045491025,0.00050395844,0.00019957227,0.0003186967,0.0011314006],"category_scores_gemma":[0.0012927233,0.00031570497,0.0002996866,0.0006613942,0.00024617603,0.00040587838,0.00034390588,0.0006646791,0.00021245016],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050855753,0.00001741411,0.99946254,0.0000024387653,0.000012083171,0.00007479447,0.00004047585,0.000009933925,0.00010508654,0.000005408079,0.000018967376,0.00019999364],"study_design_scores_gemma":[0.0000037656673,0.0001484306,0.99898535,0.0000044705444,0.000017505894,0.0004795515,0.00016907344,0.00003880831,0.000058269452,0.000008862895,0.00008418189,0.0000016816696],"about_ca_topic_score_codex":0.0060454276,"about_ca_topic_score_gemma":0.004748804,"teacher_disagreement_score":0.0060454276,"about_ca_system_score_codex":0.0002047342,"about_ca_system_score_gemma":0.00029190947,"threshold_uncertainty_score":0.012020469},"labels":[],"label_agreement":null},{"id":"W2307653230","doi":"10.1177/1352458516639759","title":"Lymphomatoid papulosis and fingolimod—A new connection?","year":2016,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Saint-Luc","funders":"","keywords":"Lymphomatoid papulosis; Fingolimod; Multiple sclerosis; Connection (principal bundle); Medicine; Dermatology; Internal medicine; Mathematics; Immunology","score_opus":0.051495471104873805,"score_gpt":0.24060229625556445,"score_spread":0.18910682515069066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2307653230","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021370444,0.09182237,0.0013727125,0.8290435,0.021872316,0.000060124843,0.00018056203,0.00012662106,0.03415142],"genre_scores_gemma":[0.2933635,0.0817751,0.0022521585,0.30481166,0.30708298,0.00008999162,0.00023312484,0.0000550577,0.010336444],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.998546,0.00041271548,0.0002734517,0.00023933135,0.0002677645,0.0002607941],"domain_scores_gemma":[0.99608374,0.0022259185,0.0005619541,0.00019042332,0.00032399298,0.00061384164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00135479,0.00089661166,0.0020755474,0.0015003056,0.0017906637,0.004048527,0.0017720113,0.026916133,0.008029507],"category_scores_gemma":[0.010836171,0.00069602765,0.0013502314,0.0013966804,0.0025376845,0.011123162,0.0015992807,0.018744348,0.0026692154],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083418033,0.00041308432,0.016457845,0.00053981686,0.00018737481,0.70829916,0.00043993632,0.00036100534,0.00082810555,0.022108851,0.18132491,0.06820576],"study_design_scores_gemma":[0.00075231976,0.00029185283,0.0073361024,0.0016262324,0.00028600707,0.6916134,0.0015209079,0.0022469033,0.00037076042,0.04773468,0.24607404,0.00014682156],"about_ca_topic_score_codex":0.0013147227,"about_ca_topic_score_gemma":0.0020812398,"teacher_disagreement_score":0.026916133,"about_ca_system_score_codex":0.0025722305,"about_ca_system_score_gemma":0.0017564404,"threshold_uncertainty_score":0.02686143},"labels":[],"label_agreement":null},{"id":"W2312891533","doi":"10.1177/1352458516641208","title":"Distraction adds to the cognitive burden in multiple sclerosis","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital; Health Sciences Centre; University of Toronto; Carleton University; Sunnybrook Health Science Centre","funders":"","keywords":"Multiple sclerosis; Psychology; Cognitive impairment; Cognition; Distraction; Audiology; Developmental psychology; Physical medicine and rehabilitation; Medicine; Cognitive psychology; Psychiatry","score_opus":0.16257325820934496,"score_gpt":0.3220560803377602,"score_spread":0.15948282212841522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312891533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99677974,0.0014766512,0.0002510034,0.00013909517,0.000022082306,0.000013771234,0.00007278448,0.000018308656,0.0012264779],"genre_scores_gemma":[0.99894696,0.00040072526,0.00026986536,0.00006766783,0.00005097559,0.000010249359,0.000072403396,0.000004739624,0.00017653969],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993063,0.00025931053,0.000069635316,0.000087594264,0.00022385136,0.000053300188],"domain_scores_gemma":[0.99472344,0.0026001474,0.0017625822,0.00025690472,0.00035718712,0.00029974998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009911975,0.00061175734,0.0005981934,0.0010472569,0.000480289,0.00094250456,0.00038504915,0.0005360944,0.0023361347],"category_scores_gemma":[0.008788637,0.00024777916,0.00032819982,0.0006507368,0.00053468347,0.00062531064,0.0011060918,0.00052114576,0.00026709138],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025546832,0.0005039637,0.88281065,0.00056861195,0.00034099363,0.0018816207,0.0012538858,0.0007041098,0.007569413,0.00016811631,0.0008702086,0.10077368],"study_design_scores_gemma":[0.00003196448,0.00053633424,0.99313265,0.00007556276,0.00014909268,0.0029899676,0.0003527805,0.00060388923,0.0008662937,0.00064252043,0.0005977321,0.000021150052],"about_ca_topic_score_codex":0.0016779718,"about_ca_topic_score_gemma":0.0018468914,"teacher_disagreement_score":0.0023361347,"about_ca_system_score_codex":0.00034124526,"about_ca_system_score_gemma":0.00030523833,"threshold_uncertainty_score":0.007815182},"labels":[],"label_agreement":null},{"id":"W2317727574","doi":"10.1177/1352458516641775","title":"Immunological and pathological characterization of fatal rebound MS activity following natalizumab withdrawal","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Multiple sclerosis; Medicine; Pathology; Parenchyma; Immunology; Natalizumab; Pathogenesis; Immune system; Central nervous system; Inflammation; Internal medicine","score_opus":0.07150906413559634,"score_gpt":0.2904811260581463,"score_spread":0.21897206192254998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317727574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965364,0.0013209496,0.0006314953,0.0000643198,0.000014636186,0.000031675092,0.00006503982,0.000025339808,0.0013101789],"genre_scores_gemma":[0.99912053,0.00031259944,0.00017875705,0.00004575545,0.000026428948,0.000008535556,0.000115280025,0.0000035503224,0.00018854633],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.9998234,0.000030472302,0.00002439647,0.000028818476,0.00004575176,0.00004720169],"domain_scores_gemma":[0.999521,0.00012535101,0.00015496775,0.00004433866,0.000066856424,0.00008743687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037571607,0.00039549544,0.00031548232,0.0011897921,0.00033254022,0.0004222377,0.0003012691,0.00055979175,0.0008932924],"category_scores_gemma":[0.00074162637,0.00016239585,0.00022969455,0.0002489404,0.0004855382,0.00023492696,0.00029836266,0.0005587116,0.000323258],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057027317,0.00035584284,0.25556985,0.00029121537,0.00015306837,0.31540227,0.0009137437,0.00037524075,0.39959553,0.00037483984,0.00044659287,0.020819115],"study_design_scores_gemma":[0.00013048484,0.00248224,0.5102761,0.000054991127,0.00021349997,0.4074081,0.00045896095,0.0018586377,0.07351241,0.00049353397,0.0030804893,0.000030578783],"about_ca_topic_score_codex":0.000512515,"about_ca_topic_score_gemma":0.00037886357,"teacher_disagreement_score":0.0011897921,"about_ca_system_score_codex":0.0004041404,"about_ca_system_score_gemma":0.00014181687,"threshold_uncertainty_score":0.002988398},"labels":[],"label_agreement":null},{"id":"W2320749905","doi":"10.1177/1352458516638941","title":"The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":142,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Genentech; F. Hoffmann-La Roche; Sanofi","keywords":"Multiple sclerosis; Medicine; Clinical neurology; Clinical endpoint; Physical medicine and rehabilitation; Expanded Disability Status Scale; Physical therapy; Pediatrics; Psychology; Internal medicine; Neuroscience; Clinical trial; Psychiatry","score_opus":0.10770849510027879,"score_gpt":0.3424609425528899,"score_spread":0.2347524474526111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320749905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800479,0.006642047,0.004095734,0.0002470986,0.00012566145,0.0009880862,0.0035576194,0.00011125791,0.0041845585],"genre_scores_gemma":[0.98719007,0.0010562149,0.0052084,0.0001744152,0.00018504058,0.000936291,0.0038352706,0.000012213749,0.001402235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806887,0.0009949378,0.00016487147,0.00020159695,0.00048581784,0.00008390574],"domain_scores_gemma":[0.9984688,0.00031196684,0.0007910678,0.000075716685,0.00019189884,0.00016059197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048876293,0.0006912902,0.0011773205,0.0007879445,0.00017103285,0.00040483713,0.00039204888,0.00034439945,0.0010488379],"category_scores_gemma":[0.0017657073,0.00007159276,0.00085543224,0.00052171334,0.00031611454,0.00034220616,0.00040232314,0.00075747335,0.00016581554],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18863635,0.0060207243,0.4408904,0.005063247,0.0064528724,0.00051358424,0.0004610391,0.007807008,0.06789046,0.0015308599,0.009873829,0.26485962],"study_design_scores_gemma":[0.012761052,0.09897617,0.84140265,0.00028464416,0.0027287009,0.0017229932,0.00010789253,0.0062577743,0.022301221,0.0011639143,0.012208715,0.000084195315],"about_ca_topic_score_codex":0.00026540787,"about_ca_topic_score_gemma":0.00075747265,"teacher_disagreement_score":0.0048876293,"about_ca_system_score_codex":0.00042781266,"about_ca_system_score_gemma":0.00055176637,"threshold_uncertainty_score":0.025848567},"labels":[],"label_agreement":null},{"id":"W2322148656","doi":"10.1177/1352458515604382","title":"Multiple sclerosis masquerading as Alzheimer-type dementia: Clinical, radiological and pathological findings","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"National Institute of Neurological Disorders and Stroke; National Institute on Aging","keywords":"Autopsy; Medicine; Pathology; Dementia; Multiple sclerosis; Pathological; Magnetic resonance imaging; White matter; Myelin; Neuropathology; Degenerative disease; Alzheimer's disease; Disease; Radiology; Central nervous system; Internal medicine","score_opus":0.42530382815602236,"score_gpt":0.3883962230836556,"score_spread":0.036907605072366734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322148656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956175,0.0011918626,0.00014432437,0.00013608436,0.000008779385,0.000045646495,0.00013107652,0.000018512987,0.0027062627],"genre_scores_gemma":[0.9989128,0.00042234772,0.00019986379,0.00007974582,0.000052206695,0.0000097929815,0.00008219903,0.000003113858,0.00023797013],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.999838,0.000023926683,0.000028382441,0.000039111143,0.000032252803,0.000038286766],"domain_scores_gemma":[0.9995616,0.00008417391,0.00011109346,0.00002943072,0.000070085014,0.00014362433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028319997,0.00067628844,0.00037053652,0.0011760204,0.0006614251,0.00039594507,0.00026573095,0.00070811016,0.0016141128],"category_scores_gemma":[0.0013971844,0.00028656513,0.00018122376,0.0005194675,0.0005619389,0.0004294182,0.00040830966,0.0003493878,0.000420253],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007755772,0.00038629977,0.53516674,0.00020691448,0.000059953312,0.42859274,0.00083263335,0.00015472865,0.0209932,0.00012908522,0.00062271854,0.012079418],"study_design_scores_gemma":[0.000033876793,0.0006940409,0.29208094,0.00003573894,0.000068866466,0.70379966,0.0003793337,0.00015911831,0.0017977844,0.000108077365,0.0008244365,0.000018125886],"about_ca_topic_score_codex":0.0012310622,"about_ca_topic_score_gemma":0.0014875606,"teacher_disagreement_score":0.0016141128,"about_ca_system_score_codex":0.00025128716,"about_ca_system_score_gemma":0.00040667853,"threshold_uncertainty_score":0.0053997636},"labels":[],"label_agreement":null},{"id":"W2325818210","doi":"10.1177/1352458515596600","title":"Diffusion tensor magnetic resonance imaging in very early onset pediatric multiple sclerosis","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Montreal Neurological Institute and Hospital; Hospital for Sick Children","funders":"","keywords":"Diffusion MRI; Corpus callosum; Fractional anisotropy; White matter; Multiple sclerosis; Magnetic resonance imaging; Medicine; Corticospinal tract; Uncinate fasciculus; Pathology; Nuclear medicine; Radiology","score_opus":0.10584403676174865,"score_gpt":0.28655926243313884,"score_spread":0.1807152256713902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325818210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982065,0.0010048114,0.0003349946,0.00005655895,0.0000028207853,0.0000054751645,0.00013170482,0.000009404133,0.00024772706],"genre_scores_gemma":[0.9979231,0.00077568484,0.001043575,0.000009185799,0.0000058940846,0.000006371901,0.00015460997,0.0000041981075,0.00007733127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998159,0.00006467965,0.000019757092,0.000034862118,0.000036773414,0.000028008759],"domain_scores_gemma":[0.9993622,0.00012307141,0.00040032773,0.00002119853,0.000051783853,0.000041448144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005263414,0.00039585907,0.00022759779,0.0005675166,0.00018073179,0.00026926675,0.000126335,0.00019514536,0.00057298824],"category_scores_gemma":[0.001744795,0.00014828771,0.00019689662,0.00045446734,0.0002165705,0.00032706317,0.00021231368,0.00022258119,0.000110050845],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015981558,0.000038424605,0.9807185,0.00010248594,0.000065996326,0.0015968296,0.00026401578,0.00042565007,0.0040260423,0.00014787927,0.00019345673,0.012260955],"study_design_scores_gemma":[0.000006022507,0.00016194032,0.9920839,0.00002688111,0.000047056852,0.005482267,0.00014018321,0.00046042135,0.0011215499,0.00008100642,0.00038552724,0.0000033282765],"about_ca_topic_score_codex":0.003264261,"about_ca_topic_score_gemma":0.0037336443,"teacher_disagreement_score":0.003264261,"about_ca_system_score_codex":0.00025890808,"about_ca_system_score_gemma":0.00037793722,"threshold_uncertainty_score":0.006490469},"labels":[],"label_agreement":null},{"id":"W2326274198","doi":"10.1177/1352458516643392","title":"Contribution of different relapse phenotypes to disability in multiple sclerosis","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Centre Intégré de Santé et de Services Sociaux des Laurentides; Cégep de Lévis; Hôpital Charles-Le Moyne; Université de Montréal; Hôpital Notre-Dame","funders":"National Health and Medical Research Council; National Medical Research Council; University of Tasmania; Univerzita Karlova v Praze; Biogen","keywords":"Multiple sclerosis; Medicine; Incidence (geometry); Internal medicine; Expanded Disability Status Scale; Prospective cohort study; Cohort; Cohort study; Central nervous system disease; Hazard ratio; Confidence interval; Pediatrics; Physical therapy; Immunology","score_opus":0.10061898583111241,"score_gpt":0.30253679249927157,"score_spread":0.20191780666815917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326274198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99915206,0.00039613855,0.00009696847,0.000031353025,0.0000024727003,0.000004370467,0.0001518028,0.0000071648697,0.00015758777],"genre_scores_gemma":[0.9996853,0.000046357916,0.000049596623,0.000007658899,0.0000052695755,0.0000025268655,0.00015738537,0.0000023986754,0.00004351884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833304,0.0007046226,0.00019300933,0.00032298084,0.0002534245,0.00019294475],"domain_scores_gemma":[0.9920682,0.0016007264,0.004726327,0.000517368,0.00045928571,0.000628061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024376253,0.0005204786,0.00052675966,0.0009220721,0.00030733552,0.0007048535,0.00037421976,0.00040688465,0.0012469793],"category_scores_gemma":[0.008280169,0.00017980037,0.0009518085,0.0007628912,0.0003793791,0.0005558923,0.0010055725,0.00069925457,0.00021369655],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023626957,0.000025660212,0.99723935,0.000012254248,0.00014324748,0.000067641515,0.00003792023,0.00008280865,0.000150148,0.000008897676,0.00003478269,0.0019610634],"study_design_scores_gemma":[0.0000031875954,0.0000948389,0.9993352,0.0000052304013,0.000030169607,0.00029247004,0.000032753233,0.00012198839,0.000030868392,0.000018616209,0.000031875483,0.0000026635237],"about_ca_topic_score_codex":0.001481508,"about_ca_topic_score_gemma":0.0017411229,"teacher_disagreement_score":0.0024376253,"about_ca_system_score_codex":0.00022389872,"about_ca_system_score_gemma":0.00024567943,"threshold_uncertainty_score":0.012891531},"labels":[],"label_agreement":null},{"id":"W2330427014","doi":"10.1177/1352458516643398","title":"Response to: Tocilizumab, neuromyelitis optica (NMO), and multiple sclerosis","year":2016,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital de l'Enfant-Jésus; Université Laval; University of British Columbia Hospital","funders":"","keywords":"Neuromyelitis optica; Multiple sclerosis; Tocilizumab; Medicine; Clinical neurology; Dermatology; Immunology; Neuroscience; Psychology; Rheumatoid arthritis","score_opus":0.12306459713387163,"score_gpt":0.29738383556220654,"score_spread":0.1743192384283349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330427014","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012186729,0.004825151,0.00008291706,0.9610123,0.013482971,0.00004355634,0.00015344998,0.000028607259,0.008184288],"genre_scores_gemma":[0.14895527,0.006708916,0.0005129693,0.72781557,0.097301066,0.00010170458,0.00027770817,0.00003316669,0.018293671],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980288,0.0007803422,0.00040273022,0.00016704624,0.00036904283,0.00025204642],"domain_scores_gemma":[0.995869,0.0018731514,0.00058725197,0.00013817371,0.0006670086,0.00086536485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019926128,0.00043353954,0.0011494145,0.00068419025,0.0022628533,0.0015609611,0.0010561604,0.015651677,0.006798929],"category_scores_gemma":[0.01804537,0.00023666164,0.0010473646,0.0008865116,0.0008223428,0.0012621527,0.00068608805,0.0071061617,0.0023794058],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027568217,0.00059445156,0.04653029,0.0007360149,0.00029871624,0.0644757,0.0005608851,0.00040297612,0.0011819922,0.004100818,0.8286379,0.04972344],"study_design_scores_gemma":[0.005275167,0.0016823978,0.08357587,0.003725809,0.0009476628,0.13321845,0.0030297244,0.003936556,0.0019196993,0.019847004,0.74258995,0.00025179365],"about_ca_topic_score_codex":0.003726393,"about_ca_topic_score_gemma":0.005687045,"teacher_disagreement_score":0.015651677,"about_ca_system_score_codex":0.0031034595,"about_ca_system_score_gemma":0.0025296635,"threshold_uncertainty_score":0.022744656},"labels":[],"label_agreement":null},{"id":"W2332060497","doi":"10.1177/1352458515624771","title":"Multi-scale MRI spectrum detects differences in myelin integrity between MS lesion types","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Multiple sclerosis; White matter; Lesion; Myelin; Remyelination; Magnetic resonance imaging; Pathology; Medicine; Expanded Disability Status Scale; Voxel; Grey matter; Radiology; Central nervous system; Internal medicine","score_opus":0.1891996869264372,"score_gpt":0.33099808520348234,"score_spread":0.14179839827704513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332060497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99664176,0.00026975098,0.0024237812,0.000017800696,0.000003882906,0.000010420969,0.000073462725,0.000037096335,0.0005221032],"genre_scores_gemma":[0.9972313,0.0000889167,0.0024359843,0.000011814926,0.000009441211,0.00000784143,0.00008631666,0.00001195917,0.000116495095],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998983,0.000018861816,0.000010862981,0.000030142966,0.000026471249,0.000015306729],"domain_scores_gemma":[0.9994562,0.0001513248,0.00019737586,0.000040406674,0.00007904636,0.000075591335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025526062,0.0002506839,0.00017584616,0.0013311127,0.00012385432,0.000347946,0.00015128193,0.00036662922,0.0021096035],"category_scores_gemma":[0.0009790205,0.00011558963,0.00013578491,0.00031915857,0.00025276566,0.00039205502,0.0002118985,0.00015915757,0.00029856386],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017024347,0.00016967462,0.22516967,0.00023686093,0.00022509492,0.00048975303,0.00031438537,0.0009135255,0.7189193,0.00015176907,0.00026254018,0.051445078],"study_design_scores_gemma":[0.000029856712,0.00053168595,0.93951064,0.000017598586,0.00011551779,0.003428071,0.00019921138,0.0034887998,0.05184838,0.00043437054,0.00037534322,0.000020422583],"about_ca_topic_score_codex":0.00026002276,"about_ca_topic_score_gemma":0.00043656863,"teacher_disagreement_score":0.0021096035,"about_ca_system_score_codex":0.000105351384,"about_ca_system_score_gemma":0.000047587615,"threshold_uncertainty_score":0.0070573688},"labels":[],"label_agreement":null},{"id":"W2332147189","doi":"10.1177/1352458516642315","title":"A prospective cohort study of vitamin D in optic neuritis recovery","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Rockyview General Hospital; University of Calgary","funders":"","keywords":"Optic neuritis; Medicine; Multiple sclerosis; Vitamin D and neurology; Optic nerve; Nerve fiber layer; Cohort; Ophthalmology; Prospective cohort study; Retinal; Confounding; Internal medicine; Gastroenterology; Immunology","score_opus":0.04665004356915166,"score_gpt":0.2868216795533337,"score_spread":0.24017163598418206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332147189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985316,0.0003187354,0.00007278041,0.000034709523,0.000009855179,0.000026784659,0.0007190057,0.0000026016505,0.00028392175],"genre_scores_gemma":[0.9992036,0.000095259216,0.000062998,0.000026737507,0.000007642182,0.000021693639,0.00041791002,0.0000018348462,0.00016235789],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990656,0.00021647834,0.00009469882,0.00029413382,0.00015425148,0.0001749429],"domain_scores_gemma":[0.99862194,0.00018229934,0.00047867876,0.00023110051,0.00018911767,0.00029679187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013963638,0.00033058834,0.00046368034,0.0006776145,0.00086440274,0.00078557985,0.00042147966,0.00055617525,0.0018975448],"category_scores_gemma":[0.0023831858,0.00036847967,0.0007074336,0.0010791981,0.00023768694,0.0006029035,0.0005240281,0.00073280185,0.00034293247],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038990268,0.000054326694,0.99861896,0.000006510812,0.000094958836,0.00008513679,0.000058199053,0.000007886464,0.00012658154,0.000011271603,0.00006604774,0.00048026405],"study_design_scores_gemma":[0.000027381018,0.00021918805,0.9991941,0.000004680268,0.000055245968,0.00018041098,0.00011552482,0.000039435698,0.000020375614,0.000012861147,0.0001276758,0.0000031162203],"about_ca_topic_score_codex":0.008160045,"about_ca_topic_score_gemma":0.0071063903,"teacher_disagreement_score":0.008160045,"about_ca_system_score_codex":0.00031078054,"about_ca_system_score_gemma":0.00044817416,"threshold_uncertainty_score":0.0162251},"labels":[],"label_agreement":null},{"id":"W2335803360","doi":"10.1177/1352458516631037","title":"Peripartum depression in parents with multiple sclerosis and psychiatric disorders in children","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Family Support in Illness","field":"Social Sciences","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Vancouver Coastal Health; Vancouver Coastal Health Research Institute; University of British Columbia","funders":"Canadian Institutes of Health Research; University of British Columbia","keywords":"Depression (economics); Medicine; Psychiatry; Multiple sclerosis; Hazard ratio; Incidence (geometry); Cohort; Confidence interval; Pediatrics; Internal medicine","score_opus":0.03036268675147872,"score_gpt":0.24777330849048187,"score_spread":0.21741062173900316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335803360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975737,0.0014327974,0.000041915242,0.00012796874,0.000010865709,0.000007026236,0.00040529136,0.000002944352,0.00039753685],"genre_scores_gemma":[0.99864835,0.00089278794,0.000059737133,0.00004201938,0.000010496064,0.000008614219,0.00023932073,0.0000012677166,0.00009750327],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994844,0.00014661472,0.00003910559,0.00010530996,0.000119855555,0.000104685925],"domain_scores_gemma":[0.9975816,0.00042435536,0.0014181162,0.00008394839,0.0001879929,0.00030393963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056873146,0.00022230971,0.0004162004,0.0007075746,0.00083196844,0.0006735486,0.0003370402,0.00045623456,0.0019705317],"category_scores_gemma":[0.0034264552,0.00032899834,0.00045628217,0.0012870996,0.00037141712,0.0003449186,0.00050413,0.0009074088,0.0001192392],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028492856,0.0000073781007,0.99897194,0.000007155562,0.000017042248,0.00017966062,0.000092928545,0.000007153358,0.000020912006,0.000005739115,0.00007499898,0.0005865737],"study_design_scores_gemma":[0.0000026990874,0.000027897217,0.99889696,0.000027055468,0.0000137288125,0.0006748395,0.00020769853,0.000026291422,0.000014245881,0.0000075867397,0.00009920178,0.0000017637217],"about_ca_topic_score_codex":0.050504394,"about_ca_topic_score_gemma":0.056653664,"teacher_disagreement_score":0.050504394,"about_ca_system_score_codex":0.0009130647,"about_ca_system_score_gemma":0.0007313079,"threshold_uncertainty_score":0.10042083},"labels":[],"label_agreement":null},{"id":"W2339425991","doi":"10.1177/1352458515624559","title":"High-resolution myelin water imaging in post-mortem multiple sclerosis spinal cord: A case report","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"International Collaboration On Repair Discoveries; University of British Columbia","funders":"","keywords":"Multiple sclerosis; Spinal cord; Myelin; Medicine; Pathology; Myelin sheath; Magnetic resonance imaging; Central nervous system disease; High resolution; Neuroscience; Central nervous system; Anatomy; Radiology; Surgery; Biology; Geology; Internal medicine; Immunology","score_opus":0.09933160481106924,"score_gpt":0.31306267660688436,"score_spread":0.21373107179581513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339425991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98654073,0.0035753688,0.002823676,0.0022934617,0.00027345037,0.00019196162,0.00018906142,0.00013117539,0.0039811805],"genre_scores_gemma":[0.9958891,0.0008427692,0.0012082784,0.0004520659,0.00059451396,0.000031106454,0.0000674607,0.000019635852,0.00089503545],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9989988,0.00009393606,0.00011213228,0.0002968192,0.00016203955,0.00033611385],"domain_scores_gemma":[0.9979188,0.0006285331,0.00051075086,0.0002496528,0.00017613293,0.00051612133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066556374,0.0029530101,0.0017241464,0.004152618,0.0042524985,0.0019508483,0.00241194,0.008392933,0.0024891673],"category_scores_gemma":[0.0040327804,0.0021391443,0.0015882886,0.0018028197,0.0035659263,0.0026871036,0.0018175944,0.003721424,0.0014046584],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028174016,0.00004280998,0.0020290061,0.000034065342,0.0000093264825,0.9963052,0.00022494602,0.00003182764,0.00069977454,0.00005833618,0.00008283418,0.00045357496],"study_design_scores_gemma":[0.0000125860515,0.000138666,0.0034719189,0.000018471914,0.000019675912,0.9951002,0.00012909004,0.00017089912,0.0006287915,0.00009015143,0.00020517147,0.000014448997],"about_ca_topic_score_codex":0.003275337,"about_ca_topic_score_gemma":0.004125083,"teacher_disagreement_score":0.008392933,"about_ca_system_score_codex":0.0022461484,"about_ca_system_score_gemma":0.0009196115,"threshold_uncertainty_score":0.016296983},"labels":[],"label_agreement":null},{"id":"W2339698996","doi":"10.1177/1352458516643396","title":"Astrocytes in multiple sclerosis","year":2016,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; McGill University; Queen's University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Multiple sclerosis; Neuroscience; Myelin; Immune system; Central nervous system; Biology; Oligodendrocyte; Neurodegeneration; Homeostasis; Neuroinflammation; Extracellular matrix; Inflammation; Glial scar; Microglia; Astrocyte; Immunology; Disease; Medicine; Cell biology; Pathology","score_opus":0.28216279110950476,"score_gpt":0.3631466379726531,"score_spread":0.08098384686314836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339698996","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006705234,0.998938,0.00004094186,0.00017155382,0.00014475365,0.0000023829202,0.0000043371897,0.0000038836365,0.00062708196],"genre_scores_gemma":[0.0008610553,0.99818087,0.000106706044,0.00012642409,0.00014975524,0.0000039006477,0.000010454695,8.2860026e-7,0.00056008133],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981314,0.00003303224,0.000033448494,0.000028699807,0.00007404916,0.000017671999],"domain_scores_gemma":[0.9998004,0.00006563456,0.000037192152,0.000006084204,0.00006560765,0.00002523175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038784827,0.0008091932,0.0010614698,0.0025651325,0.00038970658,0.0010889564,0.0005679604,0.0013772662,0.002946782],"category_scores_gemma":[0.0005403707,0.00023074728,0.00034276792,0.0020483765,0.00057461555,0.0012196405,0.0009406328,0.0014489444,0.0019643314],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065540036,0.000051272476,0.0002553566,0.017671015,0.000046837475,0.0005018298,0.00018905808,0.00021379511,0.0023537432,0.0048212153,0.026961297,0.946869],"study_design_scores_gemma":[0.00001470999,0.00007616098,0.0010851884,0.0041646836,0.000073047064,0.0042932187,0.00013493247,0.00005364679,0.00054234435,0.0032651634,0.98628104,0.000015848587],"about_ca_topic_score_codex":0.0015201987,"about_ca_topic_score_gemma":0.0025871214,"teacher_disagreement_score":0.002946782,"about_ca_system_score_codex":0.00054569077,"about_ca_system_score_gemma":0.0013133986,"threshold_uncertainty_score":0.009858012},"labels":[],"label_agreement":null},{"id":"W2373620900","doi":"10.1177/1352458515596457","title":"Biotinidase deficiency mimicking neuromyelitis optica: Initially exhibiting symptoms in adulthood","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Biotin and Related Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nautical Research Society","funders":"","keywords":"Biotinidase deficiency; Neuromyelitis optica; Medicine; Myelopathy; Optic neuropathy; Pediatrics; Magnetic resonance imaging; Multiple sclerosis; Spinal cord; Pathology; Radiology; Ophthalmology; Newborn screening; Optic nerve; Immunology","score_opus":0.052856554682078886,"score_gpt":0.25104364854427685,"score_spread":0.19818709386219796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2373620900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942145,0.0010838824,0.00034036403,0.00025002746,0.000027986915,0.00002551192,0.00012097619,0.000041026284,0.003895743],"genre_scores_gemma":[0.998524,0.0005389928,0.00024345475,0.00011517175,0.00003765018,0.000004341929,0.00006538956,0.0000052864234,0.00046562962],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9998783,0.000009239016,0.000012946659,0.000028404922,0.000012859268,0.00005815841],"domain_scores_gemma":[0.99964905,0.000064779466,0.0000979839,0.00001377163,0.000025429868,0.00014903136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001338802,0.00073608616,0.00034814893,0.0005201914,0.0005658552,0.000445803,0.00020039313,0.00095424836,0.001628738],"category_scores_gemma":[0.0008765775,0.00024245352,0.00016601251,0.00033974607,0.00043560524,0.00051335624,0.0004219295,0.0005578253,0.00040712656],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015688066,0.000049974267,0.21357971,0.00006723817,0.000009119844,0.77304447,0.000654081,0.00006868559,0.0064621414,0.00023387303,0.00044975214,0.0052240444],"study_design_scores_gemma":[0.000009010653,0.000211622,0.08479575,0.000027398706,0.000010205745,0.9125008,0.0004012333,0.00008994183,0.00081093254,0.00015944417,0.0009770289,0.0000066339785],"about_ca_topic_score_codex":0.0013101846,"about_ca_topic_score_gemma":0.0021419483,"teacher_disagreement_score":0.001628738,"about_ca_system_score_codex":0.00027210376,"about_ca_system_score_gemma":0.00031011755,"threshold_uncertainty_score":0.0054486394},"labels":[],"label_agreement":null},{"id":"W2395316927","doi":"10.1177/1352458516649037","title":"Long-term effects of delayed-release dimethyl fumarate in multiple sclerosis: Interim analysis of ENDORSE, a randomized extension study","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; McGill University; NeuroRx Research (Canada)","funders":"National Institute for Health and Care Research; Biogen","keywords":"Glatiramer acetate; Dimethyl fumarate; Medicine; Adverse effect; Multiple sclerosis; Relapsing remitting; Randomized controlled trial; Interim analysis; Placebo; Discontinuation; Internal medicine; Magnetic resonance imaging; Psychiatry; Radiology; Pathology; Alternative medicine","score_opus":0.052789648144250086,"score_gpt":0.28524989981761084,"score_spread":0.23246025167336076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2395316927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99123865,0.002281965,0.0011909254,0.0003177152,0.00018345067,0.001948815,0.0015614348,0.00014052565,0.0011365451],"genre_scores_gemma":[0.9889093,0.00080671324,0.002934623,0.00048063276,0.00022271961,0.002902643,0.0022738394,0.000035283647,0.001434273],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9973277,0.0016702547,0.00017623472,0.0002341364,0.00023406652,0.0003576018],"domain_scores_gemma":[0.99463636,0.0014979622,0.0014719095,0.0010532009,0.0004944878,0.000846111],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011181052,0.0015533793,0.0034730134,0.00045297018,0.0005692662,0.0012299417,0.0008423963,0.0015209775,0.0025194893],"category_scores_gemma":[0.0051285247,0.000609677,0.0028696407,0.0003291461,0.00083930197,0.0010214886,0.0005944119,0.0024863984,0.00060012983],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9581488,0.009323274,0.0046585416,0.00032875966,0.0024035866,0.00009104347,0.00009961534,0.0006804893,0.004667088,0.00010943298,0.0012603704,0.018229099],"study_design_scores_gemma":[0.64796346,0.31919605,0.0222509,0.000062071325,0.0034570275,0.00018903145,0.000071862334,0.001254158,0.003036028,0.00023025527,0.0022379106,0.00005128056],"about_ca_topic_score_codex":0.0002831214,"about_ca_topic_score_gemma":0.0006035848,"teacher_disagreement_score":0.011181052,"about_ca_system_score_codex":0.00044423723,"about_ca_system_score_gemma":0.0011149405,"threshold_uncertainty_score":0.0591318},"labels":[],"label_agreement":null},{"id":"W2401254028","doi":"10.1177/1352458516634873","title":"The Standards of Reporting of Neurological Disorders (STROND) checklist: Application to multiple sclerosis","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Manitoba; Manitoba Health","funders":"","keywords":"Checklist; Strengthening the reporting of observational studies in epidemiology; Epidemiology; Observational study; Guideline; Medicine; Context (archaeology); Descriptive statistics; MEDLINE; Family medicine; Systematic review; Incidence (geometry); Environmental health; Psychology; Pathology","score_opus":0.08181151029064399,"score_gpt":0.3236661811289798,"score_spread":0.24185467083833584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2401254028","genre_codex":"protocol","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013390351,0.032873213,0.34200707,0.07316662,0.018948251,0.44878593,0.051626325,0.004350176,0.01485207],"genre_scores_gemma":[0.029089494,0.009097842,0.39411244,0.006509413,0.001402483,0.54709244,0.011140182,0.0005605068,0.0009950814],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.19222452,0.41256893,0.35594988,0.0058285194,0.030981164,0.0024470661],"domain_scores_gemma":[0.12837707,0.47133943,0.15709153,0.05676377,0.18262967,0.0037985134],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.60557675,0.0032868565,0.006928332,0.024044303,0.005283729,0.008831308,0.010407371,0.008692919,0.009192134],"category_scores_gemma":[0.7921891,0.003661685,0.014800704,0.023394808,0.006794596,0.008343448,0.013267949,0.010431324,0.0034496672],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002414098,0.00051688787,0.01918174,0.25952232,0.004470708,0.00081212557,0.024573997,0.003171495,0.0023894627,0.03809861,0.39520988,0.24963874],"study_design_scores_gemma":[0.005842587,0.00094363844,0.04130554,0.30151054,0.004622557,0.0018364995,0.009784151,0.0072432216,0.0036207854,0.06376088,0.5579108,0.0016188738],"about_ca_topic_score_codex":0.0052250805,"about_ca_topic_score_gemma":0.0063333735,"teacher_disagreement_score":0.39442325,"about_ca_system_score_codex":0.012944595,"about_ca_system_score_gemma":0.05100001,"threshold_uncertainty_score":0.4863941},"labels":[],"label_agreement":null},{"id":"W2401931641","doi":"10.1177/1352458516628656","title":"Perfusion reduction in the absence of structural differences in cognitively impaired versus unimpaired RRMS patients","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Western University; Sunnybrook Health Science Centre","funders":"National Institute of Biomedical Imaging and Bioengineering","keywords":"Cerebral blood flow; Medicine; White matter; Magnetic resonance imaging; Multiple sclerosis; Cardiology; Brain size; Internal medicine; Hyperintensity; Hospital Anxiety and Depression Scale; Expanded Disability Status Scale; Cognitive impairment; Effects of sleep deprivation on cognitive performance; Cognitive decline; Psychology; Nuclear medicine; Cognition; Dementia; Radiology; Anxiety; Disease; Psychiatry","score_opus":0.12396942350784354,"score_gpt":0.3063241538310193,"score_spread":0.18235473032317576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2401931641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994106,0.00013958856,0.000025139136,0.000011210283,0.0000025549061,0.0000030648466,0.000086554806,0.0000032329274,0.00031798688],"genre_scores_gemma":[0.99983346,0.000017610075,0.00001693018,0.0000067443098,0.0000033849703,0.0000017220661,0.00006551203,7.96777e-7,0.00005389012],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99988484,0.000017047869,0.000011544717,0.000041387884,0.00002045596,0.000024611261],"domain_scores_gemma":[0.9994419,0.00011053626,0.0002473439,0.000029062123,0.00005170932,0.0001194046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026219233,0.0003148156,0.00025348316,0.0008170012,0.00024458303,0.0004172551,0.00023614145,0.000344398,0.0032845482],"category_scores_gemma":[0.0011979607,0.00011431516,0.00024798006,0.00030337548,0.00031949588,0.00023310607,0.00023845826,0.0003254253,0.0002487397],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023018147,0.00012720384,0.9860931,0.000038187616,0.00011010548,0.0008510082,0.00019437043,0.000108704466,0.004703776,0.000035864847,0.000129795,0.005306123],"study_design_scores_gemma":[0.00001381827,0.00025990093,0.99851626,0.0000033076415,0.00003056871,0.0007386688,0.00005321966,0.00009553674,0.00020481205,0.000029663097,0.00005192747,0.000002263878],"about_ca_topic_score_codex":0.002894984,"about_ca_topic_score_gemma":0.0025275443,"teacher_disagreement_score":0.0032845482,"about_ca_system_score_codex":0.0002666413,"about_ca_system_score_gemma":0.000186167,"threshold_uncertainty_score":0.010987878},"labels":[],"label_agreement":null},{"id":"W2407833569","doi":"10.1177/1352458515622696","title":"Regional reduction in cortical blood flow among cognitively impaired adults with relapsing-remitting multiple sclerosis patients","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Western University; Sunnybrook Health Science Centre","funders":"National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research","keywords":"Multiple sclerosis; Relapsing remitting; Medicine; Cerebral blood flow; Neuroscience; Psychology; Internal medicine; Immunology","score_opus":0.06829145500142972,"score_gpt":0.2578734595812263,"score_spread":0.1895820045797966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407833569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99958223,0.00013859436,0.00001674872,0.000018110755,0.0000014642462,0.0000043198606,0.00007546586,0.0000031923325,0.00015988866],"genre_scores_gemma":[0.99979323,0.000037220736,0.000019923262,0.0000125904535,0.000004805766,0.0000033526915,0.00008136147,5.7601443e-7,0.00004692733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998667,0.000019819166,0.000016465143,0.00004413724,0.00003150405,0.000021364738],"domain_scores_gemma":[0.9996069,0.0000548196,0.00022277085,0.000018243329,0.000035295565,0.0000620722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019951824,0.00034904573,0.00039157472,0.0010380262,0.00038348915,0.00037357153,0.00024866263,0.00042233008,0.0015700924],"category_scores_gemma":[0.001073986,0.00015528192,0.00022642917,0.00045887835,0.00029733247,0.0002866206,0.00025643123,0.00028137604,0.00024578391],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004266473,0.00007133569,0.9942253,0.000023533667,0.00008989351,0.0003569851,0.00021888698,0.00005093875,0.0017513671,0.000012996128,0.00010906292,0.0026630668],"study_design_scores_gemma":[0.000004746539,0.00006242336,0.99951386,0.0000016205136,0.000011025599,0.0002629513,0.000046606874,0.000032613545,0.000035178837,0.0000077176455,0.000020212818,0.000001006405],"about_ca_topic_score_codex":0.0049025947,"about_ca_topic_score_gemma":0.0053193225,"teacher_disagreement_score":0.0049025947,"about_ca_system_score_codex":0.00024393701,"about_ca_system_score_gemma":0.00016473887,"threshold_uncertainty_score":0.009748101},"labels":[],"label_agreement":null},{"id":"W2409475002","doi":"10.1177/1352458515617249","title":"Are we in need of NEDA?","year":2015,"lang":"en","type":"editorial","venue":"Multiple Sclerosis Journal","topic":"Respiratory Support and Mechanisms","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Multiple sclerosis; Medicine; Psychiatry","score_opus":0.1349304751265959,"score_gpt":0.3102878556201287,"score_spread":0.17535738049353283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2409475002","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000026071928,0.0055789393,0.00006563633,0.07663595,0.91703564,0.0000121753355,0.000021840573,0.000022036762,0.00060178665],"genre_scores_gemma":[0.0003163517,0.004048497,0.00009995906,0.06385148,0.92853665,0.000021809747,0.000017194454,0.000013880609,0.0030942583],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9895111,0.0023202137,0.002192562,0.00081610837,0.0042852033,0.00087479944],"domain_scores_gemma":[0.9576948,0.017025214,0.0034746504,0.0011557715,0.013113412,0.007536103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015328095,0.0031045794,0.005307035,0.0035886376,0.0038913907,0.01051789,0.0045244056,0.034069642,0.009540077],"category_scores_gemma":[0.06284598,0.001634012,0.0035887891,0.0017039193,0.00334082,0.006380686,0.0031796864,0.036976766,0.008109805],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004758345,0.000018309676,0.000062275496,0.0003435346,0.00003792967,0.00016542891,0.000016595928,0.000021753649,0.000030161626,0.00036347032,0.9932227,0.005670227],"study_design_scores_gemma":[0.00020524827,0.000055873224,0.0004808269,0.0011679509,0.00017092266,0.00037743736,0.0000827192,0.0001774613,0.00007509679,0.0014641619,0.99570054,0.000041737825],"about_ca_topic_score_codex":0.0022763007,"about_ca_topic_score_gemma":0.0097361365,"teacher_disagreement_score":0.034069642,"about_ca_system_score_codex":0.0045116576,"about_ca_system_score_gemma":0.007171081,"threshold_uncertainty_score":0.08106369},"labels":[],"label_agreement":null},{"id":"W2417261078","doi":"10.1177/135245850000602s08","title":"ESIMS - An Ongoing Clinical Trial in Secondary Progressive Multiple Sclerosis","year":2000,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Multiple sclerosis; Medicine; Clinical trial; Expanded Disability Status Scale; Placebo; Mallinckrodt; Physical therapy; Surgery; Internal medicine; Alternative medicine; Family medicine; Pathology; Psychiatry","score_opus":0.26454182621445005,"score_gpt":0.39357294003762494,"score_spread":0.1290311138231749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2417261078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95396715,0.009729846,0.0007374663,0.0018979145,0.0008911921,0.021592157,0.0029493084,0.0002853103,0.007949611],"genre_scores_gemma":[0.9392507,0.009036825,0.004799401,0.0029986857,0.0015708192,0.02172948,0.0038180249,0.000032347853,0.016763652],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99907434,0.0004285246,0.000049992093,0.000073424984,0.00018225412,0.00019139619],"domain_scores_gemma":[0.9989498,0.00011454445,0.00013182702,0.000050487804,0.00013077981,0.00062255625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023876238,0.0017221122,0.0026581567,0.00073856546,0.0009397862,0.00082713953,0.00090034714,0.0019866724,0.0061858892],"category_scores_gemma":[0.0014112277,0.00035863149,0.001264172,0.0007366005,0.0014374802,0.00056186074,0.00036463645,0.001855188,0.0010235123],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93412906,0.014712248,0.0010312836,0.0009752072,0.0005387622,0.000084034604,0.00010567436,0.00027210676,0.004519173,0.00040020628,0.002558653,0.04067354],"study_design_scores_gemma":[0.8811517,0.11153336,0.0032996782,0.000044413093,0.00018340515,0.00004010392,0.000025665771,0.00014149063,0.0004817455,0.00012818942,0.0029576714,0.000012632949],"about_ca_topic_score_codex":0.01163005,"about_ca_topic_score_gemma":0.039009284,"teacher_disagreement_score":0.01163005,"about_ca_system_score_codex":0.0013775732,"about_ca_system_score_gemma":0.0054632737,"threshold_uncertainty_score":0.023124754},"labels":[],"label_agreement":null},{"id":"W2462321551","doi":"10.1177/1352458516657440","title":"Determinants of non-adherence to disease-modifying therapies in multiple sclerosis: A cross-Canada prospective study","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Dalhousie University; University of Saskatchewan; University of Calgary; Health Sciences Centre; University of British Columbia","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada","keywords":"Medicine; Confidence interval; Multiple sclerosis; Odds ratio; Disease; Expanded Disability Status Scale; Prospective cohort study; Generalized estimating equation; Internal medicine; Physical therapy; Psychiatry","score_opus":0.13517138438003656,"score_gpt":0.35119361447973524,"score_spread":0.21602223009969868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2462321551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99625945,0.00067643204,0.00007991317,0.0001879114,0.000011354749,0.00004842561,0.0021222462,0.0000053618446,0.0006089575],"genre_scores_gemma":[0.99763036,0.00046025057,0.00017703118,0.000104865394,0.0000065071586,0.000025649817,0.0011315892,0.0000038906483,0.00045972306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987556,0.0001494148,0.00009767699,0.00027489607,0.00038221854,0.00034029956],"domain_scores_gemma":[0.9965737,0.00023962157,0.0007498383,0.00019649454,0.0014306385,0.0008096949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014942389,0.0006087857,0.0006388961,0.0009546526,0.0028689737,0.0016949204,0.0013624271,0.000885826,0.001825472],"category_scores_gemma":[0.0026838738,0.0006467138,0.0010152623,0.0031203346,0.00074854353,0.0004687461,0.0010501943,0.0013488374,0.00023132528],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000088407694,0.000052175168,0.9981887,0.000020640353,0.00008416483,0.000045611225,0.0003059906,0.000030181931,0.00007216252,0.00003396777,0.00028973533,0.0007882525],"study_design_scores_gemma":[0.000014293802,0.00003769936,0.99902296,0.000020860527,0.00004412982,0.000046938247,0.00037123438,0.00018933331,0.00001799791,0.000008725294,0.00021914404,0.0000067208202],"about_ca_topic_score_codex":0.98108566,"about_ca_topic_score_gemma":0.9799131,"teacher_disagreement_score":0.018914342,"about_ca_system_score_codex":0.012557071,"about_ca_system_score_gemma":0.014207118,"threshold_uncertainty_score":0.09110838},"labels":[],"label_agreement":null},{"id":"W2463500418","doi":"10.1177/1352458516653273","title":"Disability progression in aggressive multiple sclerosis","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; McMaster University; Ottawa Hospital; University of British Columbia","funders":"","keywords":"Medicine; Expanded Disability Status Scale; Multiple sclerosis; Odds ratio; Confidence interval; Internal medicine; Logistic regression; Disease; Pediatrics; Immunology","score_opus":0.13234949142063018,"score_gpt":0.3360754455333122,"score_spread":0.20372595411268202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2463500418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958454,0.0015112209,0.00008122256,0.00010935342,0.0000053387566,0.000022911494,0.00051930244,0.000009882532,0.0018954072],"genre_scores_gemma":[0.9987703,0.0003941794,0.000111144494,0.000027814996,0.00000811496,0.000008355703,0.00033765924,0.0000014273916,0.0003410839],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995906,0.00007899451,0.000027972232,0.000061021048,0.0001503376,0.00009098666],"domain_scores_gemma":[0.9980411,0.00014688744,0.0010362066,0.000036894533,0.00040430605,0.00033466882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008414408,0.00037888685,0.00028241452,0.0013160632,0.0005761058,0.0006901152,0.00040912125,0.00030065217,0.0013537343],"category_scores_gemma":[0.0023372497,0.00013468316,0.00022397345,0.0014231415,0.00049543276,0.00040365293,0.0006925381,0.0006273288,0.00021875436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019123808,0.00006425803,0.98696357,0.00007506524,0.000047014917,0.00019517085,0.00037188863,0.0002152932,0.00017994735,0.0000625635,0.00042623724,0.011207752],"study_design_scores_gemma":[0.000005591396,0.00006469715,0.99899036,0.000027538646,0.0000124947555,0.0002775581,0.00011739601,0.00011337349,0.000021813823,0.000040109517,0.00032591287,0.000003151517],"about_ca_topic_score_codex":0.21887046,"about_ca_topic_score_gemma":0.26893657,"teacher_disagreement_score":0.21887046,"about_ca_system_score_codex":0.0015978515,"about_ca_system_score_gemma":0.0023001463,"threshold_uncertainty_score":0.435193},"labels":[],"label_agreement":null},{"id":"W2466196296","doi":"10.1177/1352458516655218","title":"Declines in the diagnosis of primary progressive MS: A critical change in phenotype or critical measurement error?","year":2016,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Manitoba Health","funders":"","keywords":"Multiple sclerosis; Medicine; Phenotype; Primary (astronomy); Physical medicine and rehabilitation; Psychology; Psychiatry; Biology; Genetics","score_opus":0.4005976541909824,"score_gpt":0.40358598576063814,"score_spread":0.0029883315696557222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2466196296","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012515079,0.0043164934,0.00084756274,0.97273195,0.0065321913,0.000014012233,0.000086716456,0.000036701113,0.0029192602],"genre_scores_gemma":[0.33937654,0.0072408947,0.0042154198,0.5328351,0.11379224,0.000087129585,0.0001849335,0.000075297954,0.0021923615],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9848573,0.0071950965,0.0030622846,0.0011624069,0.0031509793,0.0005718989],"domain_scores_gemma":[0.85541904,0.11236937,0.010030432,0.004819518,0.014389294,0.0029723002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020084303,0.0003841174,0.0015859237,0.0010329994,0.0011669786,0.0025890712,0.0021898313,0.013094513,0.0018982288],"category_scores_gemma":[0.20787871,0.00041549752,0.0005278652,0.0012424617,0.0032277266,0.0055272565,0.0013882535,0.012750127,0.000954152],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00145434,0.00047739182,0.1647765,0.0009633671,0.0003418817,0.021559676,0.0034154004,0.00078468135,0.0014176266,0.024844598,0.444319,0.33564556],"study_design_scores_gemma":[0.0016656037,0.002137876,0.24848038,0.006797283,0.0007699177,0.07825085,0.007825621,0.011321923,0.0038267532,0.20332351,0.4351189,0.00048141822],"about_ca_topic_score_codex":0.0030845364,"about_ca_topic_score_gemma":0.0033783428,"teacher_disagreement_score":0.020084303,"about_ca_system_score_codex":0.0022153817,"about_ca_system_score_gemma":0.0025913245,"threshold_uncertainty_score":0.106217206},"labels":[],"label_agreement":null},{"id":"W2469906895","doi":"10.1177/1352458516650992","title":"Brain atrophy after bone marrow transplantation for treatment of multiple sclerosis","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; McGill University; University of Ottawa; Montreal Neurological Institute and Hospital","funders":"","keywords":"Atrophy; Medicine; Multiple sclerosis; Magnetic resonance imaging; Busulfan; Brain size; Transplantation; Hematopoietic stem cell transplantation; Urology; Pathology; Internal medicine; Radiology; Immunology","score_opus":0.09574743666347281,"score_gpt":0.2986649510472075,"score_spread":0.20291751438373473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2469906895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984517,0.00078804424,0.0003676257,0.00005389931,0.0000050600574,0.000020651445,0.00009419384,0.000010066957,0.0002086251],"genre_scores_gemma":[0.9993592,0.00017393265,0.00018660586,0.000019957542,0.000005865688,0.000014520487,0.00016652148,0.0000012988744,0.00007221711],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997795,0.0001155386,0.000012527795,0.00002925804,0.000039432885,0.000023717916],"domain_scores_gemma":[0.99944025,0.00021399897,0.00023867436,0.00002366288,0.00003139298,0.000052067302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011662884,0.0002235617,0.00032129438,0.00015179807,0.00016054168,0.00025958038,0.00020431943,0.00016420597,0.0006837558],"category_scores_gemma":[0.0016768035,0.00006663787,0.0003882491,0.00016485594,0.00011551493,0.00011670325,0.00016405791,0.00026721365,0.000087397595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006642164,0.0007770914,0.9131728,0.0002453669,0.0011413776,0.00088438706,0.00016465677,0.010321351,0.003308005,0.00024681867,0.0006383167,0.062457666],"study_design_scores_gemma":[0.00060023513,0.0070475866,0.9601319,0.000098823264,0.0008473868,0.001424694,0.00009206888,0.024842592,0.0021739379,0.0007734519,0.001953408,0.000013980729],"about_ca_topic_score_codex":0.0020205027,"about_ca_topic_score_gemma":0.0026093195,"teacher_disagreement_score":0.0020205027,"about_ca_system_score_codex":0.0004723499,"about_ca_system_score_gemma":0.00049064524,"threshold_uncertainty_score":0.0061679482},"labels":[],"label_agreement":null},{"id":"W2472793648","doi":"10.1177/1352458516655478","title":"Trajectory of MS disease course for men and women over three eras","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; Centre Hospitalier de l’Université de Montréal; McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Multiple sclerosis; Course (navigation); Disease; Medicine; Physical medicine and rehabilitation; Psychology; Gerontology; Internal medicine; Psychiatry; Physics","score_opus":0.08016473023766907,"score_gpt":0.308326922316592,"score_spread":0.2281621920789229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2472793648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99828535,0.0003424523,0.00018027579,0.00005888495,0.0000016787131,0.000013021602,0.0007672524,0.0000043385116,0.0003468257],"genre_scores_gemma":[0.9989643,0.00011480705,0.00016020471,0.000012286524,0.0000027069566,0.000013949462,0.0005603929,0.0000013133364,0.00017003587],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996712,0.00008890867,0.000031758256,0.00010673631,0.000049118302,0.000052373493],"domain_scores_gemma":[0.99904567,0.00023760264,0.0004911058,0.000068962116,0.00006107439,0.00009548298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015295233,0.00020152345,0.00024235067,0.00060502643,0.00028434684,0.00049024506,0.00025572954,0.00022177516,0.0015927621],"category_scores_gemma":[0.0028917524,0.00011946602,0.00063526724,0.0005565879,0.00013937481,0.00031374593,0.00042759313,0.0002906013,0.00016366293],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019507193,0.000008452698,0.99731123,0.000007975342,0.000091656584,0.000021617167,0.00012985982,0.00011966294,0.000057362915,0.00003780142,0.000068653506,0.0019508293],"study_design_scores_gemma":[0.000011166508,0.000103141574,0.9987802,0.000010312893,0.00007589815,0.00009573778,0.00018318013,0.00038648339,0.0000463482,0.00006506224,0.00023930553,0.0000030985213],"about_ca_topic_score_codex":0.0127435075,"about_ca_topic_score_gemma":0.012482738,"teacher_disagreement_score":0.0127435075,"about_ca_system_score_codex":0.0004806054,"about_ca_system_score_gemma":0.0004437617,"threshold_uncertainty_score":0.02533865},"labels":[],"label_agreement":null},{"id":"W2497655497","doi":"10.1177/1352458516658559","title":"Role of IL-17-producing lymphocytes in severity of multiple sclerosis upon natalizumab treatment","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Natalizumab; Multiple sclerosis; Medicine; Peripheral blood mononuclear cell; Immunology; Discontinuation; Progressive multifocal leukoencephalopathy; Interleukin 17; Cytokine; Internal medicine; Biology; In vitro","score_opus":0.04912672049802235,"score_gpt":0.22933993576441605,"score_spread":0.1802132152663937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2497655497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99867564,0.0008281115,0.00008366174,0.000017730987,0.0000038970325,0.000011531328,0.000056150428,0.0000074904156,0.000315709],"genre_scores_gemma":[0.99947375,0.00018419808,0.000092846305,0.000012866465,0.000011476371,0.000012290961,0.00007055423,0.000001818725,0.00014030944],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983776,0.000053679178,0.000024451745,0.000024131292,0.00003228246,0.000027623504],"domain_scores_gemma":[0.9995987,0.00007753407,0.00018396479,0.000018564393,0.000047063262,0.0000741655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021619006,0.00025926848,0.0002552312,0.00059086183,0.00014284329,0.00024803044,0.00010424345,0.00024906648,0.0014681505],"category_scores_gemma":[0.0005891038,0.00011148286,0.00013888474,0.00022095392,0.00015400098,0.00014950587,0.00014888689,0.00028549752,0.00018358053],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063639744,0.000242157,0.6213392,0.00022490033,0.00016419622,0.0017861812,0.00044077524,0.00039773114,0.34599146,0.00006646799,0.0001655688,0.022817478],"study_design_scores_gemma":[0.000088085384,0.0012733159,0.97600085,0.00003351002,0.00014575341,0.002323486,0.00017939847,0.00041850374,0.018636497,0.000056550292,0.0008345136,0.00000951823],"about_ca_topic_score_codex":0.00024756664,"about_ca_topic_score_gemma":0.00028761922,"teacher_disagreement_score":0.0014681505,"about_ca_system_score_codex":0.00012592103,"about_ca_system_score_gemma":0.00009563216,"threshold_uncertainty_score":0.0049114823},"labels":[],"label_agreement":null},{"id":"W2500435921","doi":"10.1177/1352458516662727","title":"ACCLAIM: A randomized trial of abatacept (CTLA4-Ig) for relapsing-remitting multiple sclerosis","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada); University of Ottawa","funders":"National Institute of Neurological Disorders and Stroke; National Institute of Allergy and Infectious Diseases; Immune Tolerance Network","keywords":"Abatacept; Medicine; Multiple sclerosis; Relapsing remitting; Placebo; Internal medicine; Clinical endpoint; Randomized controlled trial; Immunology; Pathology","score_opus":0.1401142698879682,"score_gpt":0.3230997063552762,"score_spread":0.18298543646730797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2500435921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98511225,0.0041460646,0.00039233346,0.00089816644,0.00085768715,0.0048381984,0.0012192135,0.00020448137,0.0023315568],"genre_scores_gemma":[0.97783035,0.0021306945,0.0021246334,0.0014209338,0.0012759191,0.009694341,0.0019647223,0.00003096702,0.003527429],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991033,0.00051297975,0.00005579263,0.00013682166,0.000078945464,0.000112209156],"domain_scores_gemma":[0.99861586,0.00036336316,0.00034392512,0.00009583465,0.0001132302,0.00046774567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018278342,0.0014718223,0.0022785682,0.0006540699,0.00052112364,0.00090993126,0.00090644223,0.002091192,0.006956875],"category_scores_gemma":[0.0024022565,0.0006098319,0.0010679084,0.00045435163,0.0009561941,0.0008803676,0.00038241694,0.0022240037,0.0010044035],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9864542,0.0029457195,0.00050268654,0.0002887132,0.00031183002,0.000026638918,0.00001714885,0.0001649929,0.0012017362,0.000080802325,0.0007927874,0.007212851],"study_design_scores_gemma":[0.98263586,0.015679676,0.0008070228,0.000014664724,0.00016970863,0.000019258081,0.000004554611,0.00019263636,0.00010847749,0.000034740897,0.00032849933,0.000004869498],"about_ca_topic_score_codex":0.0013468099,"about_ca_topic_score_gemma":0.0025179547,"teacher_disagreement_score":0.006956875,"about_ca_system_score_codex":0.00065616827,"about_ca_system_score_gemma":0.0015729959,"threshold_uncertainty_score":0.02327305},"labels":[],"label_agreement":null},{"id":"W2518294038","doi":"10.1177/1352458516666337","title":"Drinking away fatigue in multiple sclerosis","year":2016,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Multiple sclerosis; Clinical neurology; Medicine; Physical medicine and rehabilitation; Psychology; Neuroscience; Psychiatry","score_opus":0.2298572763530757,"score_gpt":0.31751202773310805,"score_spread":0.08765475138003234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2518294038","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0051246523,0.003723927,0.000035067496,0.9715285,0.01583162,0.000009013776,0.0000643127,0.000007101744,0.0036758909],"genre_scores_gemma":[0.0667799,0.005678327,0.00019792446,0.79583764,0.12163289,0.000047265985,0.00007980834,0.00002791817,0.009718354],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99772674,0.0011150613,0.0004407696,0.00014822763,0.0003334352,0.00023582301],"domain_scores_gemma":[0.9919801,0.004533657,0.0011034062,0.0002572514,0.0007818943,0.0013436682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025270178,0.00035257405,0.0009877608,0.00065381743,0.0027874494,0.0016811283,0.00081104395,0.01727257,0.004461606],"category_scores_gemma":[0.02311255,0.00044898043,0.00063364516,0.00086037704,0.0016029769,0.0018392411,0.0011429377,0.012402589,0.0017777797],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003184698,0.00017979983,0.026637299,0.00035784315,0.00011463562,0.009516855,0.0009864154,0.00007299675,0.0002528851,0.0024312874,0.923958,0.035173453],"study_design_scores_gemma":[0.001227705,0.00065993256,0.10293982,0.0058619175,0.00050782796,0.03018967,0.0064016804,0.0014586798,0.0007471685,0.018408341,0.8313802,0.00021701468],"about_ca_topic_score_codex":0.008136399,"about_ca_topic_score_gemma":0.01676384,"teacher_disagreement_score":0.01727257,"about_ca_system_score_codex":0.0023993452,"about_ca_system_score_gemma":0.002543175,"threshold_uncertainty_score":0.01740849},"labels":[],"label_agreement":null},{"id":"W2522756838","doi":"10.1177/1352458516671028","title":"Negative interaction between smoking and EBV in the risk of multiple sclerosis: The EnvIMS study","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"Multiple Sclerosis Society of Canada","keywords":"Multiple sclerosis; Odds ratio; Mononucleosis; Medicine; Confidence interval; Case-control study; Population; Absolute risk reduction; Relative risk; Demography; Internal medicine; Immunology; Environmental health; Virus","score_opus":0.15600224567026771,"score_gpt":0.32803455477323806,"score_spread":0.17203230910297035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2522756838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99259275,0.006001564,0.00029521078,0.00014974257,0.000021572812,0.000012309543,0.00021108548,0.0000044473586,0.0007112151],"genre_scores_gemma":[0.99889934,0.00065198925,0.00015403675,0.000039522467,0.00003405861,0.000010357504,0.00012159215,0.0000032550704,0.000085769294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963611,0.0021454906,0.00031748164,0.00045682528,0.0005526231,0.00016650265],"domain_scores_gemma":[0.99264413,0.0035553048,0.0022794295,0.0006378671,0.000446635,0.00043668752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004658887,0.00044930258,0.0007219084,0.0008352558,0.00034401834,0.0009796736,0.00055120344,0.00053450686,0.001231119],"category_scores_gemma":[0.007124255,0.00029953066,0.0013329472,0.0010511972,0.00038499208,0.00033263344,0.00074756873,0.0006842512,0.00011463992],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007087966,0.000029310782,0.9946009,0.00009387665,0.0021688659,0.00010899243,0.0000921622,0.00006912049,0.00027562716,0.000057396643,0.00006739452,0.0017277465],"study_design_scores_gemma":[0.00003700242,0.0002702281,0.996445,0.00006516585,0.0019631858,0.00032378174,0.000111318455,0.00018988314,0.00015531323,0.000096419906,0.00033662276,0.0000060909206],"about_ca_topic_score_codex":0.0025958675,"about_ca_topic_score_gemma":0.0029158,"teacher_disagreement_score":0.004658887,"about_ca_system_score_codex":0.00018186217,"about_ca_system_score_gemma":0.00038933355,"threshold_uncertainty_score":0.024638891},"labels":[],"label_agreement":null},{"id":"W2556280554","doi":"10.1177/1352458516679893","title":"Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Hôpital Notre-Dame; Hôpital Charles-Le Moyne","funders":"National Health and Medical Research Council; Biogen; Novartis Pharma; Sanofi","keywords":"Medicine; Nomogram; Concordance; Clinically isolated syndrome; Multiple sclerosis; Proportional hazards model; Expanded Disability Status Scale; Magnetic resonance imaging; Quartile; Internal medicine; Confidence interval; Radiology","score_opus":0.0905137699598752,"score_gpt":0.3398284867819918,"score_spread":0.2493147168221166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556280554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941571,0.0014139733,0.001995659,0.0005493752,0.000022507611,0.000049431175,0.00045296492,0.00005045373,0.0013086584],"genre_scores_gemma":[0.9979771,0.0002909658,0.0013795459,0.000026003063,0.000018229292,0.000015686706,0.00023479863,0.0000038375333,0.000053908636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99778736,0.0012805201,0.00025796823,0.00028540837,0.00028251298,0.00010626252],"domain_scores_gemma":[0.98684144,0.005678882,0.00534468,0.00043227442,0.00084454136,0.0008582403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046474165,0.0005085922,0.00062641746,0.0017880277,0.00032977803,0.001294045,0.0006366731,0.0007001731,0.001061081],"category_scores_gemma":[0.019098086,0.0002459989,0.00040498498,0.0015183194,0.00035759294,0.000969358,0.00088031555,0.00079516025,0.00040133714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009087485,0.000019072178,0.9936214,0.000019413097,0.000022009084,0.000030571773,0.00004213376,0.00031335722,0.00003260263,0.000019848821,0.00019474076,0.005593988],"study_design_scores_gemma":[0.00002265269,0.00029037037,0.98782444,0.00008529915,0.00005853502,0.00052308827,0.00031572054,0.009922662,0.00015069361,0.00041478264,0.0003750447,0.000016746942],"about_ca_topic_score_codex":0.0018428979,"about_ca_topic_score_gemma":0.0021070011,"teacher_disagreement_score":0.0046474165,"about_ca_system_score_codex":0.000359738,"about_ca_system_score_gemma":0.00044885866,"threshold_uncertainty_score":0.024578214},"labels":[],"label_agreement":null},{"id":"W2557619543","doi":"10.1177/1352458516681196","title":"Large differences in adiponectin levels have no clear effect on multiple sclerosis risk: A Mendelian randomization study","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Adipokines, Inflammation, and Metabolic Diseases","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Medical Research Council; Multiple Sclerosis Society of Canada; McGill University","keywords":"Adiponectin; Mendelian randomization; Odds ratio; Medicine; Adipokine; Single-nucleotide polymorphism; Body mass index; Internal medicine; Confidence interval; Confounding; Endocrinology; Oncology; Genetics; Biology; Obesity; Genotype; Insulin resistance; Gene; Genetic variants","score_opus":0.060635920396734176,"score_gpt":0.26942578680178614,"score_spread":0.20878986640505195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557619543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9383467,0.0047519496,0.051499702,0.0011376913,0.00032238287,0.0013025657,0.000437547,0.0001999173,0.002001576],"genre_scores_gemma":[0.9888137,0.00030905657,0.009596023,0.00039627939,0.000075964774,0.00038015403,0.00011280441,0.000028210277,0.0002878768],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.96093357,0.030429656,0.0020818517,0.0036269985,0.0023774204,0.0005504337],"domain_scores_gemma":[0.9454184,0.03673807,0.006601273,0.00973083,0.00090922625,0.00060227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.035442945,0.0012195011,0.0021275543,0.0007847385,0.0006587307,0.00088274427,0.0012707604,0.0018284529,0.003011391],"category_scores_gemma":[0.07647323,0.0007239366,0.002073804,0.0009963689,0.0016486361,0.00072979537,0.000576345,0.0009175906,0.0002981474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13241874,0.0024148095,0.6757283,0.0024119834,0.039066214,0.0076735467,0.0017119335,0.0044769305,0.0146240555,0.027450258,0.0043441462,0.08767911],"study_design_scores_gemma":[0.078481734,0.043839835,0.6027785,0.0010622081,0.06818207,0.026257489,0.0005985791,0.08582334,0.00945525,0.0672755,0.01561353,0.0006319988],"about_ca_topic_score_codex":0.0008776451,"about_ca_topic_score_gemma":0.0005308621,"teacher_disagreement_score":0.035442945,"about_ca_system_score_codex":0.00048511976,"about_ca_system_score_gemma":0.00080329285,"threshold_uncertainty_score":0.18744248},"labels":[],"label_agreement":null},{"id":"W2565583047","doi":"10.1177/1352458516682105","title":"Breaking down the gut microbiome composition in multiple sclerosis","year":2016,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care; University Hospital","funders":"","keywords":"Multiple sclerosis; Gut microbiome; Microbiome; Medicine; Biology; Neuroscience; Computational biology; Immunology; Bioinformatics","score_opus":0.10553095647538918,"score_gpt":0.3000197623369062,"score_spread":0.194488805861517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565583047","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017641971,0.9993291,0.000041600106,0.00022535349,0.000066678556,0.000002786289,0.000009964049,0.0000017417005,0.00014641811],"genre_scores_gemma":[0.0014131668,0.99813205,0.00014541094,0.00014379254,0.00006429862,0.000004010237,0.00001229975,5.6368685e-7,0.000084465275],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99956805,0.00013089606,0.00008871047,0.000061391605,0.000115007206,0.00003596958],"domain_scores_gemma":[0.99920386,0.00042791895,0.00017753949,0.000013224447,0.00014143037,0.000036153022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011219206,0.00069659366,0.0015475898,0.0031087971,0.00028113634,0.0011969894,0.0006479655,0.0011441872,0.0020835209],"category_scores_gemma":[0.002392019,0.00022139547,0.00090346055,0.0023272198,0.00042797852,0.0015196117,0.0007957481,0.00087259786,0.0004751223],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016231522,0.00003342263,0.0011633077,0.10191005,0.00057156046,0.0004038666,0.00023890098,0.00022380923,0.0023616152,0.0021799835,0.011676297,0.8790749],"study_design_scores_gemma":[0.00006357298,0.00042474183,0.014178295,0.12949052,0.0029023497,0.006847645,0.0009499413,0.00022968913,0.0021957208,0.0057197763,0.8369034,0.00009433564],"about_ca_topic_score_codex":0.0014609875,"about_ca_topic_score_gemma":0.002545065,"teacher_disagreement_score":0.0031087971,"about_ca_system_score_codex":0.0005530358,"about_ca_system_score_gemma":0.0020057305,"threshold_uncertainty_score":0.006970048},"labels":[],"label_agreement":null},{"id":"W2568482345","doi":"10.1177/1352458516685169","title":"Smokers with MS have greater decrements in quality of life and disability than non-smokers","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Center for Advancing Translational Sciences; National Institutes of Health; Clinical and Translational Science Collaborative of Cleveland, School of Medicine, Case Western Reserve University; Institute of Clinical and Translational Sciences","keywords":"Multiple sclerosis; Medicine; Quality of life (healthcare); Physical medicine and rehabilitation; Gerontology; Audiology; Psychology; Psychiatry","score_opus":0.18988645705395285,"score_gpt":0.3610899609819429,"score_spread":0.17120350392799005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568482345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982956,0.0004472134,0.0000630121,0.00010392853,0.000008962425,0.000009330617,0.0001344953,0.0000041960798,0.0009332531],"genre_scores_gemma":[0.9990722,0.00020074219,0.000069696325,0.000055271055,0.000011768436,0.0000065576965,0.00012530167,0.0000014171712,0.0004570385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975187,0.00005666526,0.00003397431,0.000037268528,0.00007532773,0.0000448757],"domain_scores_gemma":[0.9989667,0.00023141321,0.00050753966,0.000036541456,0.000110791785,0.00014711905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000625668,0.00017982762,0.000249495,0.0004297788,0.00030657026,0.0004781972,0.00014614017,0.0003472203,0.005560177],"category_scores_gemma":[0.0015817047,0.000091039175,0.00035317655,0.0003642312,0.00019945395,0.0003756502,0.00036240258,0.0003874139,0.00050582143],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008891905,0.00007742436,0.9939136,0.000017862352,0.00005858142,0.00003523485,0.00014031725,0.000017871555,0.0005222707,0.000021925292,0.00008644926,0.00501947],"study_design_scores_gemma":[0.0000037618158,0.00016055375,0.9989034,0.000008493656,0.00003561852,0.0002502349,0.00016057426,0.00004471902,0.00011721788,0.000045270546,0.0002682778,0.0000018757462],"about_ca_topic_score_codex":0.0012208592,"about_ca_topic_score_gemma":0.002375445,"teacher_disagreement_score":0.005560177,"about_ca_system_score_codex":0.00014172561,"about_ca_system_score_gemma":0.00018612939,"threshold_uncertainty_score":0.018600702},"labels":[],"label_agreement":null},{"id":"W2578514106","doi":"10.1177/1352458516688955","title":"Processing speed test: Validation of a self-administered, iPad <sup>®</sup> -based tool for screening cognitive dysfunction in a clinic setting","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"Genentech; Cleveland Clinic; Biogen; Novartis Pharma; National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Cognition; Psychology; Test (biology); Natalizumab; Audiology; Reliability (semiconductor); Technician; Medicine; Physical medicine and rehabilitation; Psychiatry","score_opus":0.15296653992387524,"score_gpt":0.3671240710117765,"score_spread":0.21415753108790128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2578514106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919383,0.00020481781,0.0040146834,0.00007758468,0.00003488538,0.0006675343,0.0009159263,0.000116512834,0.002029689],"genre_scores_gemma":[0.9850965,0.00014814132,0.011229573,0.00016631153,0.000035829456,0.0008606461,0.0014739409,0.000032467036,0.0009566265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845135,0.00048835896,0.0003025996,0.00020247455,0.00049868744,0.00005655939],"domain_scores_gemma":[0.9948494,0.0017801487,0.0013825113,0.00032720857,0.0013852671,0.00027543269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028386763,0.00063972524,0.00042048763,0.001046642,0.00024840483,0.00045871962,0.000567157,0.00071644917,0.0014869281],"category_scores_gemma":[0.008476927,0.00025224325,0.00050674705,0.00041588687,0.00029937678,0.00064745534,0.0005228402,0.0004607833,0.0007019218],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027474381,0.0025587834,0.8955519,0.00020710842,0.00032049615,0.00038672378,0.0005627726,0.0009159187,0.019545292,0.00013369539,0.002073431,0.0749965],"study_design_scores_gemma":[0.00036537866,0.0068690833,0.9807623,0.00003417043,0.00009092175,0.0018713444,0.000110845205,0.003273976,0.005089294,0.00008175044,0.0014254859,0.000025543384],"about_ca_topic_score_codex":0.0007836117,"about_ca_topic_score_gemma":0.0010794419,"teacher_disagreement_score":0.0028386763,"about_ca_system_score_codex":0.00018766783,"about_ca_system_score_gemma":0.00047963747,"threshold_uncertainty_score":0.015012503},"labels":[],"label_agreement":null},{"id":"W2579133420","doi":"10.1177/1352458516681198","title":"Infection-related health care utilization among people with and without multiple sclerosis","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; University of Saskatchewan; Dalhousie University; University of British Columbia","funders":"National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Medicine; Intensive care medicine; Environmental health; Immunology","score_opus":0.09660709667929776,"score_gpt":0.31025616591130445,"score_spread":0.2136490692320067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2579133420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965849,0.0013997103,0.000023373063,0.00019431012,0.000006324099,0.0000070388055,0.001226399,0.0000022650308,0.0005556722],"genre_scores_gemma":[0.9988531,0.0005685772,0.000024801366,0.000052074392,0.000007708912,0.0000048348393,0.00042124646,6.657952e-7,0.00006688837],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999198,0.00014193082,0.00010034377,0.00013016471,0.00021926795,0.00021031222],"domain_scores_gemma":[0.9983902,0.00019518654,0.000877675,0.000046706034,0.00020685562,0.00028349087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056805316,0.00016842874,0.0003278861,0.0011864569,0.00046777728,0.00075892056,0.00033742646,0.0003895164,0.001066252],"category_scores_gemma":[0.0022988599,0.0001611375,0.00048896304,0.0020707815,0.00038326727,0.00039232682,0.00057350565,0.00051424117,0.00010512519],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017894487,0.000010587611,0.9987495,0.000015618762,0.000042709442,0.000019465428,0.00008951279,0.00001855322,0.000016950771,0.0000100717925,0.00007900192,0.00093008124],"study_design_scores_gemma":[0.0000012301147,0.000013191774,0.99959487,0.00001870286,0.000013284682,0.000046887424,0.00017119986,0.000038452195,0.00000799038,0.000010454459,0.000081946586,0.0000016643149],"about_ca_topic_score_codex":0.22949682,"about_ca_topic_score_gemma":0.24897204,"teacher_disagreement_score":0.22949682,"about_ca_system_score_codex":0.001468917,"about_ca_system_score_gemma":0.0013647745,"threshold_uncertainty_score":0.456322},"labels":[],"label_agreement":null},{"id":"W2583347849","doi":"10.1177/1352458517690618","title":"Age Related Multiple Sclerosis Severity Score: Disability ranked by age","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia Hospital","funders":"Neuroförbundet; National Institute for Health and Care Research; Biogen","keywords":"Multiple sclerosis; Medicine; Physical medicine and rehabilitation; Severity of illness; Physical therapy; Internal medicine; Psychiatry","score_opus":0.14896940791720287,"score_gpt":0.32044612576981957,"score_spread":0.1714767178526167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583347849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9449754,0.009297088,0.0062086447,0.0003601551,0.0001638489,0.00092742936,0.029361922,0.00013050897,0.008575131],"genre_scores_gemma":[0.98482597,0.00086584996,0.0048885033,0.00007048691,0.00006972659,0.0006217278,0.0069774496,0.000015397436,0.0016648981],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982387,0.00073210336,0.00028990355,0.00020438385,0.00047181564,0.00006308902],"domain_scores_gemma":[0.9969754,0.0006500227,0.0014826517,0.00017775377,0.000585336,0.0001288856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029337395,0.00042109712,0.00063647656,0.0026983311,0.00016465124,0.00043986665,0.00045216217,0.00023607323,0.0026823347],"category_scores_gemma":[0.004724231,0.0001008571,0.0006805196,0.0024279463,0.00020830413,0.00037386423,0.00042980685,0.00031194714,0.000554039],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016101458,0.00005217382,0.96854746,0.0005210542,0.00119236,0.00008394222,0.00016662982,0.00083845324,0.00058009464,0.000259102,0.0027670886,0.023381436],"study_design_scores_gemma":[0.000109654866,0.0004716692,0.9932603,0.00009116058,0.00031333452,0.00037013707,0.000078753685,0.00083445566,0.00030841166,0.00030395933,0.0038427284,0.000015442643],"about_ca_topic_score_codex":0.003208982,"about_ca_topic_score_gemma":0.0045562736,"teacher_disagreement_score":0.003208982,"about_ca_system_score_codex":0.0004289757,"about_ca_system_score_gemma":0.00043222404,"threshold_uncertainty_score":0.015515268},"labels":[],"label_agreement":null},{"id":"W2585052441","doi":"10.1177/1352458517691620","title":"Similar birth-cohort patterns in Crohn’s disease and multiple sclerosis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Multiple sclerosis; Cohort; Disease; Medicine; Etiology; Crohn's disease; Cohort study; Cohort effect; Demography; Pediatrics; Immunology; Internal medicine","score_opus":0.12330985894434834,"score_gpt":0.31283147856904053,"score_spread":0.1895216196246922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585052441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946042,0.0014343511,0.0008426854,0.00027061006,0.000024263656,0.000024518502,0.001398926,0.000016740141,0.0013836359],"genre_scores_gemma":[0.99786025,0.00037552763,0.00025786803,0.00004078205,0.000007588543,0.000009866198,0.0009602359,0.0000065063496,0.00048145294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990909,0.00022752659,0.000091655136,0.00025297338,0.00013997457,0.00019699331],"domain_scores_gemma":[0.99651045,0.0008799705,0.0010025775,0.00059723225,0.0005694899,0.00044021587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002430469,0.00012372754,0.00024370989,0.0013633047,0.00047434462,0.0005947911,0.0003296891,0.0003304377,0.0022401635],"category_scores_gemma":[0.0057951068,0.00017417375,0.0006559248,0.0011826751,0.0004002902,0.00031069815,0.0005621151,0.00048188854,0.00019274121],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011385764,0.000015300915,0.9949308,0.000017025981,0.00021799865,0.00015728005,0.00047787148,0.00010341725,0.0005464937,0.00047271012,0.00019469394,0.0027524687],"study_design_scores_gemma":[0.0000022124666,0.000014122949,0.9992011,0.000005902185,0.000029329369,0.00011204968,0.00013734755,0.0000854802,0.00005921018,0.000073476614,0.00027641284,0.000003264564],"about_ca_topic_score_codex":0.023032134,"about_ca_topic_score_gemma":0.034323275,"teacher_disagreement_score":0.023032134,"about_ca_system_score_codex":0.0005155602,"about_ca_system_score_gemma":0.00053774903,"threshold_uncertainty_score":0.045796156},"labels":[],"label_agreement":null},{"id":"W2587465654","doi":"10.1177/1352458517691149","title":"The relationship between white matter fiber damage and gray matter perfusion in large-scale functionally defined networks in multiple sclerosis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; University of Manitoba; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; National Institutes of Health; American Heart Association","keywords":"White matter; Multiple sclerosis; Perfusion; Medicine; Lesion; Magnetic resonance imaging; Expanded Disability Status Scale; Neurocognitive; Pathology; Internal medicine; Cardiology; Radiology; Cognition; Psychiatry","score_opus":0.10831501326863688,"score_gpt":0.29599001686783943,"score_spread":0.18767500359920256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587465654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997813,0.000055985325,0.00007343701,0.0000057949896,3.432656e-7,0.0000017200215,0.00002027246,0.000001430354,0.00005968474],"genre_scores_gemma":[0.99982613,0.000025881662,0.00008668431,0.0000020089922,0.0000019542624,0.000002016276,0.000033068376,7.3002684e-7,0.000021537795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99988055,0.000032998443,0.000011772007,0.00003346402,0.000022239437,0.000018886105],"domain_scores_gemma":[0.99866235,0.00042684012,0.0006166886,0.000067509995,0.00009095212,0.0001356222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054013,0.00028724215,0.0001668905,0.00067243417,0.00016144339,0.00022302476,0.00018601067,0.00023695586,0.001147553],"category_scores_gemma":[0.0022225026,0.00013931582,0.00013902837,0.00029374677,0.00039726688,0.0003562849,0.00029980007,0.00020992993,0.00011607531],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044917534,0.000027011436,0.9913145,0.00001813258,0.00011629086,0.000111363806,0.000096310905,0.00034066828,0.004244212,0.000020067759,0.000029778366,0.0032325776],"study_design_scores_gemma":[0.0000042537795,0.000085223546,0.99896085,0.0000017086281,0.000017041328,0.00023305675,0.000023653402,0.00034985013,0.0002674905,0.000038011014,0.000017553995,0.00000135532],"about_ca_topic_score_codex":0.0014995778,"about_ca_topic_score_gemma":0.0024641918,"teacher_disagreement_score":0.0014995778,"about_ca_system_score_codex":0.00017182251,"about_ca_system_score_gemma":0.000117424934,"threshold_uncertainty_score":0.0038388968},"labels":[],"label_agreement":null},{"id":"W2589098388","doi":"10.1177/1352458517692887","title":"Revisiting cognitive reserve and cognition in multiple sclerosis: A closer look at depression","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Carleton University; University of Ottawa; Ottawa Hospital; Health Sciences Centre","funders":"Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; International Progressive MS Alliance","keywords":"Depression (economics); Cognition; Multiple sclerosis; Anxiety; Psychology; Hospital Anxiety and Depression Scale; Cognitive reserve; Clinical psychology; Psychiatry; Developmental psychology; Cognitive impairment","score_opus":0.19022875316633686,"score_gpt":0.34061062439389556,"score_spread":0.1503818712275587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589098388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9211366,0.0693572,0.00022910308,0.0062856767,0.00013230997,0.000026760008,0.00012930889,0.0000063146786,0.002696611],"genre_scores_gemma":[0.9846541,0.013802504,0.0002160735,0.00071920716,0.00019632257,0.000009515015,0.00004796249,0.0000015254167,0.00035270388],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984014,0.000073116236,0.000018698529,0.000015138662,0.00003237083,0.000020440712],"domain_scores_gemma":[0.9995185,0.0002351716,0.00011935091,0.000015994687,0.000051757885,0.000059197817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007964638,0.000165076,0.00052992685,0.0008895624,0.0002448773,0.0006887029,0.00023749372,0.00043706578,0.0011139234],"category_scores_gemma":[0.0011713611,0.00007932928,0.00035217713,0.0007518779,0.00037879153,0.00083116186,0.000282543,0.00076750596,0.00007093845],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039579283,0.00024884974,0.9056961,0.00058729097,0.00027743567,0.0012773108,0.0023106725,0.000098343306,0.0018415453,0.00040416306,0.0012366163,0.08562573],"study_design_scores_gemma":[0.000008667417,0.0002263592,0.99629563,0.00017060942,0.00006804026,0.0007337298,0.0010165925,0.000072541916,0.00009338609,0.00025844722,0.0010511659,0.000004789584],"about_ca_topic_score_codex":0.004443015,"about_ca_topic_score_gemma":0.009231442,"teacher_disagreement_score":0.004443015,"about_ca_system_score_codex":0.00027664806,"about_ca_system_score_gemma":0.00037092177,"threshold_uncertainty_score":0.008834302},"labels":[],"label_agreement":null},{"id":"W2590173415","doi":"10.1177/1352458517694088","title":"Physical activity is associated with a decreased multiple sclerosis risk: The EnvIMS study","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Multiple Sclerosis Society of Canada; Universitetet i Bergen; Novartis Pharmaceuticals Corporation; Multiple Sclerosis Society; Fondazione Italiana Sclerosi Multipla","keywords":"Medicine; Confounding; Multiple sclerosis; Odds ratio; Confidence interval; Mononucleosis; Logistic regression; Physical activity; Obesity; Internal medicine; Case-control study; Demography; Physical therapy; Immunology","score_opus":0.15330873750413465,"score_gpt":0.3312591454995107,"score_spread":0.17795040799537604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590173415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981912,0.0008682927,0.00006336724,0.00006601422,0.000012416711,0.000010789863,0.00035145757,0.000003648714,0.0004328458],"genre_scores_gemma":[0.9989318,0.00032435186,0.00008646277,0.000027473188,0.000028961402,0.000013513835,0.00040271538,0.0000028322975,0.0001818495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994512,0.00020872026,0.00006218067,0.00013755959,0.00007925702,0.00006103046],"domain_scores_gemma":[0.999015,0.00012429726,0.00045865076,0.0001234911,0.0000884781,0.00019016185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010044029,0.0004985416,0.00050471706,0.0007385711,0.00033967287,0.00069835444,0.00039621262,0.00055881403,0.0012139191],"category_scores_gemma":[0.0018139766,0.00039206122,0.00075779756,0.00095769303,0.00023369602,0.00026118758,0.00052124314,0.0005131111,0.00016073145],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074682006,0.00005205129,0.9971444,0.000029347455,0.00052670634,0.0001098785,0.0000742287,0.000027038051,0.00022407521,0.000013199781,0.00011646928,0.0009357343],"study_design_scores_gemma":[0.000045127217,0.00018120049,0.9989938,0.000014765245,0.00029451094,0.0001292451,0.00006614535,0.000055250803,0.00003372798,0.00001314911,0.00017053018,0.000002642188],"about_ca_topic_score_codex":0.0045120837,"about_ca_topic_score_gemma":0.0047814604,"teacher_disagreement_score":0.0045120837,"about_ca_system_score_codex":0.00017404593,"about_ca_system_score_gemma":0.00027174858,"threshold_uncertainty_score":0.0089716315},"labels":[],"label_agreement":null},{"id":"W2590833285","doi":"10.1177/1352458517692885","title":"Concurrent autoimmune hepatitis in multiple sclerosis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Alberta Innovates - Health Solutions","keywords":"Autoimmune hepatitis; Medicine; Liver biopsy; Multiple sclerosis; Hepatitis; Fulminant; Biopsy; Gastroenterology; Immunology; Internal medicine","score_opus":0.14732731596454504,"score_gpt":0.2883125301567545,"score_spread":0.14098521419220947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590833285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6852231,0.27050394,0.0030660345,0.002855718,0.00059537805,0.00009439616,0.0004557268,0.00019423528,0.03701143],"genre_scores_gemma":[0.96750945,0.028726213,0.0009500264,0.00055627566,0.0009818493,0.000018703864,0.00019322532,0.000014764231,0.0010496122],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99941456,0.00012592883,0.0001627084,0.00008814049,0.00014956841,0.00005912734],"domain_scores_gemma":[0.9967277,0.0012112717,0.0014158541,0.00017363534,0.00024777776,0.00022373113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005314195,0.00048580577,0.00045357793,0.0015388619,0.00062971475,0.0007485881,0.0004255581,0.00090995326,0.0043672603],"category_scores_gemma":[0.0032577016,0.00019613364,0.0002928204,0.0018100075,0.0008451786,0.0007801522,0.00067455135,0.00083729025,0.00096614566],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047967414,0.0001443689,0.35321578,0.0038968718,0.00030252652,0.5136761,0.000919935,0.00033516108,0.006740849,0.0018759308,0.0049919453,0.11342085],"study_design_scores_gemma":[0.000029892059,0.000112880225,0.05031224,0.00048203373,0.00016170533,0.93127584,0.00026213445,0.00017534994,0.0011797226,0.0010447265,0.01494725,0.00001627921],"about_ca_topic_score_codex":0.0007266821,"about_ca_topic_score_gemma":0.0009716469,"teacher_disagreement_score":0.0043672603,"about_ca_system_score_codex":0.00029650924,"about_ca_system_score_gemma":0.00049400015,"threshold_uncertainty_score":0.014609933},"labels":[],"label_agreement":null},{"id":"W2591732254","doi":"10.1177/1352458517695469","title":"Risk factors for non-adherence to disease-modifying therapy in pediatric multiple sclerosis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Alberta Children's Hospital; University of Calgary; Hospital for Sick Children","funders":"National Institute of Neurological Disorders and Stroke; National Multiple Sclerosis Society","keywords":"Medicine; Multiple sclerosis; Medication adherence; Disease; Pharmacy; Quality of life (healthcare); Confidence interval; Physical therapy; Internal medicine; Family medicine; Psychiatry","score_opus":0.23040105985153556,"score_gpt":0.36160562775167177,"score_spread":0.1312045679001362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591732254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985405,0.0007962831,0.000048111448,0.00013943645,0.0000042379256,0.000006242043,0.00015590055,0.0000042770253,0.00030493387],"genre_scores_gemma":[0.99932194,0.00030123623,0.0001402163,0.000021572765,0.000008556913,0.000010386184,0.00014519384,0.0000014276095,0.00004949762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993217,0.00020683036,0.00009459202,0.00009016776,0.00020840522,0.00007842269],"domain_scores_gemma":[0.99611354,0.0007876509,0.0024742945,0.00007671059,0.00019965223,0.00034809872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008315761,0.00022209149,0.00026491514,0.000546959,0.00028304502,0.00041452685,0.0002402859,0.00034966905,0.0014510999],"category_scores_gemma":[0.004146905,0.00017108636,0.0002927456,0.0008228304,0.00015745699,0.00027094246,0.0002733005,0.0006951669,0.000088101064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009474576,0.000016118041,0.99883133,0.000006457342,0.000011611183,0.000036699836,0.000031218027,0.000014102437,0.00001749867,0.0000062340973,0.00003899352,0.0009803947],"study_design_scores_gemma":[0.0000015670864,0.000037413567,0.9993742,0.000013960138,0.000017213071,0.00029588316,0.00006140318,0.00010149124,0.000021459844,0.000008063412,0.00006656168,7.948935e-7],"about_ca_topic_score_codex":0.0042778365,"about_ca_topic_score_gemma":0.005194136,"teacher_disagreement_score":0.0042778365,"about_ca_system_score_codex":0.00027578347,"about_ca_system_score_gemma":0.00051262643,"threshold_uncertainty_score":0.008505881},"labels":[],"label_agreement":null},{"id":"W2593373425","doi":"10.1177/1352458517698250","title":"Landscape of MS patient cohorts and registries: Recommendations for maximizing impact","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Multiple Sclerosis Society of Canada","funders":"National Institutes of Health; IC Design Education Center; Eisai; International Progressive MS Alliance; Cleveland Clinic; Multiple Sclerosis Society; Biogen; National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Medicine; MEDLINE; Clinical neurology; Psychology; Psychiatry; Neuroscience; Biology","score_opus":0.15877560452745693,"score_gpt":0.3640429735893991,"score_spread":0.20526736906194215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593373425","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009105691,0.0140420515,0.117761925,0.823641,0.0024973636,0.011492502,0.003406801,0.00395947,0.014093247],"genre_scores_gemma":[0.087157674,0.014852767,0.81,0.058272496,0.0017942812,0.01876421,0.0057080523,0.0007553756,0.0026951707],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.691961,0.24223526,0.03272171,0.007155268,0.019616162,0.006310508],"domain_scores_gemma":[0.42756346,0.26818642,0.040793825,0.0546757,0.17517371,0.033606876],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.35495678,0.0033841191,0.0045778197,0.013351862,0.004815094,0.019067213,0.01143447,0.011535194,0.007733968],"category_scores_gemma":[0.5534693,0.0032909156,0.0067764875,0.013030398,0.00482438,0.030885957,0.018941242,0.015471605,0.0033429405],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089631433,0.0008215134,0.07507026,0.0056794104,0.0012436191,0.00060174725,0.003864777,0.0116171315,0.0007783735,0.038413882,0.3352662,0.5257468],"study_design_scores_gemma":[0.0035602192,0.0016880063,0.09737953,0.061516847,0.0042140656,0.0019048739,0.024162143,0.029162826,0.0024768396,0.18287873,0.5898215,0.0012344426],"about_ca_topic_score_codex":0.022160992,"about_ca_topic_score_gemma":0.028420946,"teacher_disagreement_score":0.64504325,"about_ca_system_score_codex":0.012487564,"about_ca_system_score_gemma":0.070128106,"threshold_uncertainty_score":0.79545313},"labels":[],"label_agreement":null},{"id":"W2595065023","doi":"10.1177/1352458517699289","title":"Body size and physical exercise, and the risk of multiple sclerosis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Helse Vest; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; Forsvaret; Universitetet i Bergen; McGill University Health Centre; McGill University; Harvard T.H. Chan School of Public Health; Biogen; Università degli Studi di Sassari; Sanofi","keywords":"Medicine; Body mass index; Risk factor; Overweight; Cohort; Relative risk; Norwegian; Population; Aerobic exercise; Confidence interval; Cohort study; Lower risk; Internal medicine; Physical fitness; Demography; Physical therapy; Environmental health","score_opus":0.07691653213037271,"score_gpt":0.3022678010100678,"score_spread":0.2253512688796951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595065023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974166,0.0015910581,0.00013722117,0.00013075279,0.000014541769,0.0000061570317,0.00016914053,0.000005086729,0.00052929256],"genre_scores_gemma":[0.9991417,0.00039753396,0.0001153005,0.000018464254,0.000023818915,0.0000037126288,0.00010010758,0.0000010607098,0.00019822453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998504,0.00005858978,0.00001007093,0.000029073832,0.000032675747,0.00001924524],"domain_scores_gemma":[0.9990219,0.0002219485,0.00049566024,0.000051678766,0.00004351477,0.00016532962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000557329,0.00020425377,0.00015381635,0.00029339746,0.00015088978,0.00028082932,0.00013300095,0.00024336483,0.001797949],"category_scores_gemma":[0.0016279598,0.0001280221,0.00025295612,0.00029351635,0.00025502613,0.00014158446,0.00016960438,0.00026843394,0.00012082026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002814453,0.000045362318,0.99636936,0.000020401018,0.00009940381,0.00007137182,0.000033905057,0.000088638175,0.0005739226,0.00003268756,0.000082379425,0.0023011593],"study_design_scores_gemma":[0.0000038119708,0.00007386629,0.99953794,0.000004368396,0.000030087163,0.00009585775,0.00001243784,0.00008363071,0.000036444235,0.00002314962,0.000097427015,0.0000010120291],"about_ca_topic_score_codex":0.0032748545,"about_ca_topic_score_gemma":0.0030911847,"teacher_disagreement_score":0.0032748545,"about_ca_system_score_codex":0.0001409535,"about_ca_system_score_gemma":0.0001965084,"threshold_uncertainty_score":0.006511569},"labels":[],"label_agreement":null},{"id":"W2595770726","doi":"10.1177/1352458517699992","title":"What is the risk of suicide in multiple sclerosis?","year":2017,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Suicide and Self-Harm Studies","field":"Psychology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Health Sciences Centre","funders":"","keywords":"Multiple sclerosis; Medicine; Psychiatry","score_opus":0.15920078828124506,"score_gpt":0.31403154374112946,"score_spread":0.1548307554598844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595770726","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.038987175,0.049848415,0.000096953634,0.8990346,0.005856945,0.000014484779,0.0001429992,0.0000065035097,0.006011842],"genre_scores_gemma":[0.4690159,0.076195635,0.0003457892,0.392892,0.0587246,0.000057741996,0.00012725739,0.000012382254,0.002628643],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99779165,0.0012856454,0.00027950417,0.000106185784,0.00038080226,0.00015624892],"domain_scores_gemma":[0.9768837,0.016047405,0.0026466,0.00057658233,0.002175614,0.0016700908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036061243,0.00018305249,0.0011377843,0.000980117,0.0015648416,0.0021949124,0.00072479603,0.011332673,0.0027399631],"category_scores_gemma":[0.039403442,0.0002563496,0.00073359837,0.0013601733,0.0016511494,0.0024635072,0.00067537476,0.008959277,0.00071392726],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016462859,0.0009612569,0.48662296,0.0032279717,0.0018607778,0.011903423,0.004518285,0.00021071393,0.0005646103,0.011089997,0.28260434,0.19478941],"study_design_scores_gemma":[0.00077154866,0.0018858578,0.64850086,0.012411067,0.0016148489,0.031655017,0.021348584,0.001062199,0.0004972453,0.0869947,0.19290051,0.00035753567],"about_ca_topic_score_codex":0.0050103865,"about_ca_topic_score_gemma":0.008639117,"teacher_disagreement_score":0.011332673,"about_ca_system_score_codex":0.0010731177,"about_ca_system_score_gemma":0.0022040608,"threshold_uncertainty_score":0.019071221},"labels":[],"label_agreement":null},{"id":"W2596347108","doi":"10.1177/1352458517695468","title":"The efficacy of teriflunomide in patients who received prior disease-modifying treatments: Subgroup analyses of the teriflunomide phase 3 TEMSO and TOWER studies","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ottawa Hospital; University of Ottawa","funders":"Javna Agencija za Raziskovalno Dejavnost RS; Sanofi Genzyme; IC Design Education Center; Biogen","keywords":"Teriflunomide; Medicine; Multiple sclerosis; Post-hoc analysis; Subgroup analysis; Internal medicine; Disease; Physical therapy; Fingolimod; Confidence interval; Immunology","score_opus":0.21212312926679472,"score_gpt":0.4196669038568602,"score_spread":0.20754377459006546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596347108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9612757,0.03222676,0.0007505053,0.00027651156,0.00017527235,0.00034711373,0.003457219,0.000026842892,0.0014640685],"genre_scores_gemma":[0.99488884,0.0015630829,0.00038644343,0.00020872513,0.00010885485,0.00022562973,0.0023283295,0.000020088937,0.00026999784],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9939307,0.002909387,0.0014358514,0.00082112657,0.0005251928,0.00037776938],"domain_scores_gemma":[0.99362,0.003580149,0.0012514319,0.00096379034,0.00035744958,0.00022712538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008152866,0.00092883833,0.003711905,0.0010981063,0.00034464878,0.001137462,0.00067773816,0.0008280543,0.0012681609],"category_scores_gemma":[0.009077473,0.00034284536,0.009912649,0.0011378598,0.00026554076,0.0007057711,0.00080073194,0.0011462595,0.00016186466],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24600345,0.0003686234,0.39278087,0.0050923545,0.29898435,0.00069985335,0.00056449696,0.0016654376,0.010968492,0.0002843755,0.0024535283,0.040134158],"study_design_scores_gemma":[0.0133407125,0.009901039,0.79856104,0.0004777768,0.16593227,0.0007908007,0.00060852035,0.0016500322,0.0028888893,0.00086447725,0.0048754797,0.00010900158],"about_ca_topic_score_codex":0.001302462,"about_ca_topic_score_gemma":0.0038394148,"teacher_disagreement_score":0.008152866,"about_ca_system_score_codex":0.000354735,"about_ca_system_score_gemma":0.000506641,"threshold_uncertainty_score":0.043117046},"labels":[],"label_agreement":null},{"id":"W2598013794","doi":"10.1177/1352458517697378","title":"Primary and secondary progressive MS have a similar age at onset of progression – Commentary","year":2017,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Multiple sclerosis; Medicine; Age of onset; Primary (astronomy); Pediatrics; Psychology; Internal medicine; Psychiatry; Disease; Physics","score_opus":0.09066013187015276,"score_gpt":0.3290046580287821,"score_spread":0.23834452615862933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2598013794","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00050593447,0.0007383352,0.000047586807,0.9762114,0.021323154,0.000009729224,0.00012653442,0.00001267978,0.0010246624],"genre_scores_gemma":[0.005131424,0.000979157,0.00014500074,0.91130114,0.08046998,0.00004609725,0.000066578286,0.00001752164,0.0018430596],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9904604,0.0043582846,0.0015214324,0.0008684827,0.0019748968,0.0008165439],"domain_scores_gemma":[0.9096437,0.06563919,0.0053894958,0.0016554351,0.013344589,0.0043276045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009934452,0.00055412884,0.001764857,0.001044782,0.002474322,0.002507527,0.0026262153,0.0317338,0.007992886],"category_scores_gemma":[0.08953536,0.0005708691,0.0010707271,0.001184338,0.0025516297,0.0038544973,0.0017199151,0.03119021,0.005352364],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011279525,0.000027345826,0.0010586753,0.00017129962,0.000040887317,0.0006081036,0.0002611205,0.000038286867,0.000065746535,0.0015860494,0.9894002,0.0066295504],"study_design_scores_gemma":[0.00056765846,0.00020080744,0.0054023224,0.002695105,0.00026680637,0.0033648873,0.0022891336,0.00049689703,0.00040575513,0.013628235,0.9704953,0.00018713633],"about_ca_topic_score_codex":0.013784288,"about_ca_topic_score_gemma":0.015784955,"teacher_disagreement_score":0.0317338,"about_ca_system_score_codex":0.0038107883,"about_ca_system_score_gemma":0.0073380666,"threshold_uncertainty_score":0.05253905},"labels":[],"label_agreement":null},{"id":"W2599683897","doi":"10.1177/1352458516684559","title":"Primary and secondary progressive MS have a similar age at onset of progression – NO","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Multiple sclerosis; Age of onset; Medicine; Primary (astronomy); Pathology; Disease; Physics; Immunology","score_opus":0.08869963894558287,"score_gpt":0.3373501405600668,"score_spread":0.24865050161448393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2599683897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97624856,0.004262726,0.000489752,0.00041298007,0.00017463995,0.00009540028,0.001375992,0.000032351174,0.01690751],"genre_scores_gemma":[0.98901105,0.0010286769,0.00024765756,0.00030671293,0.00009071191,0.000060847226,0.001215279,0.000015148758,0.008023991],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881077,0.0002647982,0.00019243069,0.00020341465,0.00023897098,0.0002897064],"domain_scores_gemma":[0.99637526,0.00062436174,0.001417579,0.0003610275,0.0006916273,0.00053013023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015208436,0.00032307004,0.00060718576,0.001168163,0.0009111896,0.0012407433,0.00039757811,0.0009144834,0.008896344],"category_scores_gemma":[0.004202938,0.00022081513,0.0009047424,0.00080629834,0.00040404408,0.0009988053,0.0006420901,0.00079689664,0.0027532815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011118895,0.0014558107,0.8926956,0.0007525782,0.00075680943,0.0027415142,0.0021970067,0.00015222786,0.0199798,0.0013235565,0.0023489927,0.06447732],"study_design_scores_gemma":[0.000116516916,0.0011271887,0.98486,0.00006553158,0.00016681878,0.003113694,0.0007195579,0.000040998995,0.001123231,0.000415766,0.008228298,0.000022328619],"about_ca_topic_score_codex":0.004650327,"about_ca_topic_score_gemma":0.003803276,"teacher_disagreement_score":0.008896344,"about_ca_system_score_codex":0.00045886418,"about_ca_system_score_gemma":0.0006375159,"threshold_uncertainty_score":0.029761255},"labels":[],"label_agreement":null},{"id":"W2600492335","doi":"10.1177/1352458517702553","title":"Multiple sclerosis and suicide","year":2017,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Psychiatry; Suicide prevention; Poison control; Population; Injury prevention; Depression (economics); Epidemiology; Multiple sclerosis; Context (archaeology); Clinical psychology; Psychology; Medical emergency; Internal medicine; Environmental health","score_opus":0.45172974809226096,"score_gpt":0.41261152124362754,"score_spread":0.03911822684863342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2600492335","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010628416,0.9991381,0.000015943042,0.0002482057,0.00008662442,0.000004433235,0.0000130699655,0.0000015144741,0.00038577788],"genre_scores_gemma":[0.0012613252,0.9983374,0.000036976755,0.0001434338,0.0000724373,0.0000060350226,0.000016760994,4.9729107e-7,0.00012514074],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9991924,0.0002875598,0.00017870395,0.00007181786,0.0002339743,0.00003556324],"domain_scores_gemma":[0.9986872,0.00079598353,0.0002607377,0.00002868759,0.00017130216,0.000056085308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011449886,0.0006259212,0.0013451743,0.0022754204,0.00037136313,0.0013125975,0.0006556182,0.0010894383,0.005316924],"category_scores_gemma":[0.0031012634,0.00019244866,0.00095775875,0.0022873257,0.00071773666,0.0009821062,0.0007936054,0.0011723259,0.00082457566],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000064764296,0.0000480769,0.0009553354,0.08596406,0.0005402481,0.00016497406,0.00027862866,0.00019313632,0.0001282431,0.004340931,0.027746687,0.8795749],"study_design_scores_gemma":[0.00007334932,0.0002679248,0.007999941,0.1267263,0.0011442096,0.0039826296,0.00069122866,0.00011391223,0.0002587198,0.0058322344,0.8528641,0.000045537374],"about_ca_topic_score_codex":0.0030275239,"about_ca_topic_score_gemma":0.0043755323,"teacher_disagreement_score":0.005316924,"about_ca_system_score_codex":0.00077215914,"about_ca_system_score_gemma":0.002294463,"threshold_uncertainty_score":0.01778686},"labels":[],"label_agreement":null},{"id":"W2601833078","doi":"10.1177/1352458517697831","title":"Oral rather than intravenous corticosteroids should be used to treat MS relapses – Commentary","year":2017,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Calgary","funders":"","keywords":"Multiple sclerosis; Medicine; Intensive care medicine; Psychiatry","score_opus":0.2559505459955563,"score_gpt":0.3557977262619254,"score_spread":0.09984718026636913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2601833078","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014343191,0.00094893924,0.000026907375,0.97696483,0.021303605,0.0000056138992,0.000028851931,0.000007986961,0.00056976225],"genre_scores_gemma":[0.0012816587,0.00046298807,0.00009232052,0.94918495,0.048246965,0.000017757566,0.000012029588,0.00000902767,0.00069219136],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9818541,0.007261033,0.0037854942,0.0018699076,0.0036776762,0.0015517283],"domain_scores_gemma":[0.868123,0.09387864,0.008990099,0.0021112654,0.018580599,0.008316346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013920891,0.00090447307,0.0028030733,0.0014809212,0.005106738,0.004401264,0.0041534877,0.08681248,0.0072909687],"category_scores_gemma":[0.12859419,0.0011520935,0.0020473192,0.0016462887,0.0058635618,0.005055221,0.0028673727,0.072044685,0.0059611113],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007698549,0.000019821406,0.0004174837,0.00021100695,0.00006126957,0.00061301346,0.00018889176,0.000046560344,0.00009118038,0.0017127657,0.99092126,0.0056398795],"study_design_scores_gemma":[0.0006542733,0.00012982663,0.0018837043,0.0036907194,0.00034442896,0.0021537899,0.0009734969,0.00039521244,0.00038196688,0.012475759,0.9767304,0.00018639668],"about_ca_topic_score_codex":0.010405966,"about_ca_topic_score_gemma":0.017376324,"teacher_disagreement_score":0.08681248,"about_ca_system_score_codex":0.008063189,"about_ca_system_score_gemma":0.01173623,"threshold_uncertainty_score":0.07362157},"labels":[],"label_agreement":null},{"id":"W2604614383","doi":"10.1177/1352458517703800","title":"Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Hôpital Notre-Dame; Clinique Neuro-Outaouais","funders":"Novartis Pharma; University of Tasmania","keywords":"Expanded Disability Status Scale; Interquartile range; Medicine; Natural history; Multiple sclerosis; Pediatrics; Internal medicine; Physical therapy","score_opus":0.0737981939040684,"score_gpt":0.31860321862702035,"score_spread":0.24480502472295196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604614383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852798,0.00023194261,0.012146088,0.0004536407,0.000022072414,0.00015243959,0.0011340672,0.00008441241,0.00049555115],"genre_scores_gemma":[0.9946355,0.0000829436,0.0033024421,0.00002130424,0.000015778336,0.00011927453,0.0015656617,0.000019469991,0.00023765997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99737406,0.0015229442,0.00011568966,0.00041905596,0.00030044213,0.00026777538],"domain_scores_gemma":[0.99157614,0.0053485213,0.0012267857,0.0008480703,0.0004872562,0.00051331945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012561695,0.00083240384,0.0009234177,0.0022500737,0.00085661374,0.0015644319,0.0010247441,0.0007694627,0.0029454094],"category_scores_gemma":[0.01271569,0.00030026576,0.0027919183,0.0014870451,0.0007877613,0.00071078114,0.0018349516,0.0015047932,0.0005413701],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092114066,0.0001934216,0.96407354,0.00004941156,0.0005628418,0.000105207044,0.00039756764,0.014796436,0.0003069829,0.0007155262,0.0008979422,0.016980002],"study_design_scores_gemma":[0.00017704909,0.0008004577,0.5787912,0.000118496166,0.0004928569,0.00040810613,0.0011453273,0.4105189,0.00028873558,0.0056809336,0.0015013415,0.00007664124],"about_ca_topic_score_codex":0.011490328,"about_ca_topic_score_gemma":0.005390989,"teacher_disagreement_score":0.012561695,"about_ca_system_score_codex":0.0012310675,"about_ca_system_score_gemma":0.001822555,"threshold_uncertainty_score":0.06643337},"labels":[],"label_agreement":null},{"id":"W2605062403","doi":"10.1177/1352458517703802","title":"Pilot trial of intravenous autologous culture-expanded mesenchymal stem cell transplantation in multiple sclerosis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; National Institutes of Health; Cleveland Clinic; National Multiple Sclerosis Society; U.S. Department of Defense","keywords":"Multiple sclerosis; Medicine; Tolerability; Mesenchymal stem cell; Transplantation; Expanded Disability Status Scale; Adverse effect; Clinical trial; Magnetic resonance imaging; Internal medicine; Oncology; Surgery; Pathology; Immunology; Radiology","score_opus":0.17463848792741368,"score_gpt":0.31318252920312345,"score_spread":0.13854404127570977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605062403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99580115,0.00024650048,0.00055271597,0.00014589175,0.00008932638,0.0023036916,0.00017271658,0.000064109685,0.0006239246],"genre_scores_gemma":[0.9955799,0.00020626569,0.00084474985,0.00015530246,0.00017900775,0.0019246899,0.00040505241,0.0000135451455,0.00069147965],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992224,0.00037793742,0.000045493947,0.00012513968,0.00007300085,0.00015597104],"domain_scores_gemma":[0.99898416,0.0002587315,0.00014788347,0.00017319844,0.00007953603,0.0003564558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018371458,0.0017443274,0.0014553394,0.00057204365,0.00065763894,0.0008624064,0.00082970975,0.0015469225,0.0029238542],"category_scores_gemma":[0.0013226337,0.0005118411,0.00059085374,0.00039201466,0.0018132,0.0006665924,0.00044561754,0.0026669824,0.00085164595],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.591385,0.23198225,0.005760598,0.00042370777,0.0004198703,0.00095857226,0.00047670645,0.001877478,0.11178162,0.0002960086,0.0013409697,0.053297218],"study_design_scores_gemma":[0.122470826,0.8661671,0.0029016957,0.000012512029,0.00007755545,0.00017049896,0.000030279443,0.00063071685,0.0069320463,0.000051894265,0.0005451197,0.000009629668],"about_ca_topic_score_codex":0.00067333714,"about_ca_topic_score_gemma":0.00049355347,"teacher_disagreement_score":0.0029238542,"about_ca_system_score_codex":0.00052073837,"about_ca_system_score_gemma":0.0012223934,"threshold_uncertainty_score":0.009781241},"labels":[],"label_agreement":null},{"id":"W2607056035","doi":"10.1177/1352458517702534","title":"Metabolites predict lesion formation and severity in relapsing-remitting multiple sclerosis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"IC Design Education Center; Biogen Idec; Multiple Sclerosis Society; Multiple Sclerosis Scientific Research Foundation; Biogen","keywords":"Multiple sclerosis; Creatine; Lesion; White matter; Choline; Diffusion MRI; Magnetic resonance imaging; Medicine; Hyperintensity; Pathology; Nuclear medicine; Fluid-attenuated inversion recovery; Glutamate receptor; Pathological; Internal medicine; Radiology","score_opus":0.16962576831782925,"score_gpt":0.32282527498752683,"score_spread":0.1531995066696976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607056035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991473,0.00041371473,0.000103112296,0.000024013078,0.0000041402554,0.00000930855,0.00008641663,0.000009373339,0.00020263926],"genre_scores_gemma":[0.9993917,0.00010622074,0.00022823432,0.000009860686,0.0000074805967,0.0000049717687,0.00013632642,0.000002063428,0.0001132068],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998826,0.000028853183,0.00002037931,0.000025750222,0.000027431835,0.000014956192],"domain_scores_gemma":[0.9982528,0.00027010872,0.00094484224,0.00005657738,0.00019973822,0.00027594488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047585633,0.00051192427,0.00033221004,0.0006727461,0.00020894066,0.00037752942,0.00018511363,0.0005337305,0.0016884812],"category_scores_gemma":[0.0024271344,0.00019406433,0.00019887742,0.00033515674,0.00022007442,0.0003460315,0.00026766572,0.00042795853,0.00041001046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010222847,0.00009916754,0.9908098,0.00003813447,0.000088949106,0.00015081094,0.0000608877,0.00023224273,0.0033390352,0.000009868051,0.00009876342,0.0040500048],"study_design_scores_gemma":[0.000014833275,0.00031047966,0.99803597,0.000006786577,0.000035098357,0.0005576493,0.000044747354,0.00028293446,0.00058970915,0.00004153847,0.00007618245,0.0000042229494],"about_ca_topic_score_codex":0.0008827717,"about_ca_topic_score_gemma":0.0011430848,"teacher_disagreement_score":0.0016884812,"about_ca_system_score_codex":0.00018272272,"about_ca_system_score_gemma":0.00013554301,"threshold_uncertainty_score":0.0056485534},"labels":[],"label_agreement":null},{"id":"W2609394914","doi":"10.1177/1352458517703799","title":"Treatment response to dimethyl fumarate is characterized by disproportionate CD8+ T cell reduction in MS","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"Deutsche Forschungsgemeinschaft; Teva Pharmaceutical Industries; CSL Behring; Bayer","keywords":"Dimethyl fumarate; CD8; Multiple sclerosis; CD19; Lymphocyte; Flow cytometry; Immune system; Immunology; Medicine; Internal medicine; Gastroenterology","score_opus":0.09730746843317647,"score_gpt":0.3382122425898248,"score_spread":0.24090477415664832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2609394914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985189,0.000946697,0.00009704278,0.00001792567,0.000002963935,0.0000064590963,0.000069853646,0.000004964869,0.00033517985],"genre_scores_gemma":[0.9996464,0.00013249047,0.0000526879,0.00001057956,0.00000620661,0.0000040448313,0.000065336826,0.0000012250082,0.00008102031],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997483,0.00007486703,0.00003815816,0.000051507937,0.000054513795,0.00003278768],"domain_scores_gemma":[0.99908066,0.00022430829,0.00052319525,0.000039035327,0.00006957525,0.000063287036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047867355,0.0001359942,0.00027216604,0.00053857977,0.00019230724,0.00025757164,0.00014745383,0.00028672093,0.0014755629],"category_scores_gemma":[0.0012047585,0.00008689781,0.00021686514,0.0003390323,0.00016638206,0.00017893291,0.00011508022,0.00021137283,0.00025121984],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023006375,0.00008788565,0.9645341,0.000076431716,0.00007691593,0.0004953122,0.00014695287,0.00009048221,0.013342722,0.000029040157,0.00010932634,0.018710207],"study_design_scores_gemma":[0.00001641112,0.0009606099,0.99242437,0.000012118945,0.00006443739,0.0029032633,0.00008111734,0.00010899792,0.0028701155,0.00004216664,0.00051264296,0.0000037952943],"about_ca_topic_score_codex":0.00032132442,"about_ca_topic_score_gemma":0.00029699417,"teacher_disagreement_score":0.0014755629,"about_ca_system_score_codex":0.00014720448,"about_ca_system_score_gemma":0.00007796131,"threshold_uncertainty_score":0.004936278},"labels":[],"label_agreement":null},{"id":"W2610258417","doi":"10.1177/1352458517707266","title":"Stop inflammation and you stop neurodegeneration in MS – YES","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia","funders":"","keywords":"Neurodegeneration; Multiple sclerosis; Inflammation; Medicine; Neuroscience; Disease; Psychology; Immunology; Internal medicine","score_opus":0.119391536382494,"score_gpt":0.3212886906120689,"score_spread":0.20189715422957488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610258417","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032718632,0.113469556,0.0007098746,0.80690396,0.030902198,0.00009627295,0.0009694428,0.00021753601,0.014012495],"genre_scores_gemma":[0.31451127,0.10771064,0.006306325,0.44438195,0.054299723,0.0006494566,0.0012926036,0.0002544928,0.070593566],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976446,0.0012730845,0.00028820758,0.00014926282,0.00048454964,0.00016033888],"domain_scores_gemma":[0.98834604,0.0046724305,0.0013389948,0.00076549983,0.0029079951,0.0019689235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059056245,0.00038113366,0.0011118005,0.00050924334,0.0010212829,0.0015907616,0.00059085485,0.0035287063,0.017122714],"category_scores_gemma":[0.021262024,0.00024491534,0.0007812574,0.0006102572,0.0012555268,0.0035541907,0.0009676131,0.0041235415,0.004892251],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005778134,0.0014846482,0.020637717,0.007015293,0.001516151,0.00033762443,0.0015700905,0.00012047995,0.0016914872,0.010246291,0.5930512,0.35655084],"study_design_scores_gemma":[0.005779825,0.0057718297,0.08539851,0.013318666,0.0030930298,0.0016863801,0.005366276,0.00023624867,0.004362612,0.02906003,0.8456589,0.0002677702],"about_ca_topic_score_codex":0.0013120363,"about_ca_topic_score_gemma":0.0036544183,"teacher_disagreement_score":0.017122714,"about_ca_system_score_codex":0.0004728312,"about_ca_system_score_gemma":0.0016490733,"threshold_uncertainty_score":0.057281196},"labels":[],"label_agreement":null},{"id":"W2614325279","doi":"10.1177/1352458517711274","title":"A contemporary profile of primary progressive multiple sclerosis participants from the NARCOMS Registry","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Multiple sclerosis; Cohort; Population; Cohort study; Clinical trial; Physical therapy; Internal medicine; Pediatrics; Psychiatry","score_opus":0.2960447778843172,"score_gpt":0.34373061538578487,"score_spread":0.047685837501467654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2614325279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993008,0.00031046045,0.00016805764,0.00040016038,0.000015442873,0.0000636861,0.004463652,0.000019801057,0.0015508957],"genre_scores_gemma":[0.9937874,0.00037684385,0.00025146472,0.00034014063,0.00003596788,0.0001693458,0.004704559,0.000011019094,0.00032321276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804926,0.00047197877,0.00029339944,0.00043208973,0.0005199814,0.00023332844],"domain_scores_gemma":[0.9962643,0.0005448059,0.0018485201,0.00028796616,0.000559388,0.0004949536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002590202,0.0001702832,0.0004822497,0.0011015933,0.0007910478,0.00090232975,0.0006722942,0.00040994695,0.0026243762],"category_scores_gemma":[0.0059950477,0.00015954411,0.000328583,0.0023082516,0.00027054286,0.000998439,0.00092106627,0.00044134507,0.0006011821],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004214406,0.000028889683,0.996307,0.000028311082,0.000023533557,0.00009827678,0.00042608162,0.000017585238,0.00011667863,0.00003640745,0.00094778626,0.0019274149],"study_design_scores_gemma":[0.0000062469617,0.00007188958,0.9967945,0.00003231263,0.000016911688,0.00060751056,0.001327039,0.00007592286,0.00004298704,0.000035623067,0.0009823517,0.000006622194],"about_ca_topic_score_codex":0.007917982,"about_ca_topic_score_gemma":0.008265639,"teacher_disagreement_score":0.007917982,"about_ca_system_score_codex":0.00039843272,"about_ca_system_score_gemma":0.0008000081,"threshold_uncertainty_score":0.015743792},"labels":[],"label_agreement":null},{"id":"W2626123729","doi":"10.1177/1352458517715811","title":"Impact of immunoablation and autologous hematopoietic stem cell transplantation on gray and white matter atrophy in multiple sclerosis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; McGill University; University of Ottawa; Montreal Neurological Institute and Hospital","funders":"Multiple Sclerosis Society of Canada","keywords":"Atrophy; Multiple sclerosis; Medicine; White matter; Busulfan; Transplantation; Magnetic resonance imaging; Hematopoietic stem cell transplantation; Lesion; Pathology; Urology; Internal medicine; Radiology; Immunology","score_opus":0.07639960166252388,"score_gpt":0.29790946314600264,"score_spread":0.22150986148347876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2626123729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99875164,0.00059209944,0.00042861135,0.000035808487,0.0000040916952,0.000010151507,0.00005195695,0.000014957323,0.0001107483],"genre_scores_gemma":[0.9994548,0.00010015203,0.00029313954,0.000010406424,0.0000036554134,0.000008297848,0.000059664908,0.0000020304346,0.00006775921],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99947244,0.0003228281,0.000019865573,0.000067578214,0.00006324173,0.00005401455],"domain_scores_gemma":[0.9983467,0.001120702,0.00030189287,0.000062845786,0.00004065228,0.00012715723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018401449,0.0003335973,0.00042718023,0.0002615008,0.00011496055,0.00032395555,0.00034408472,0.00021269766,0.00062821707],"category_scores_gemma":[0.002472155,0.00012296937,0.0007688415,0.00013567,0.00038093133,0.00023250122,0.0002349028,0.0003372121,0.00007623038],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04948567,0.0031152945,0.6965314,0.00035485727,0.004490005,0.00033766846,0.00015475815,0.102223374,0.02140777,0.0006400554,0.0004131421,0.12084593],"study_design_scores_gemma":[0.0016597224,0.05950901,0.72287494,0.0000907747,0.0040310626,0.0006994946,0.00010980263,0.18311062,0.02498055,0.0011113134,0.0017775599,0.000045091587],"about_ca_topic_score_codex":0.0030416513,"about_ca_topic_score_gemma":0.003186902,"teacher_disagreement_score":0.0030416513,"about_ca_system_score_codex":0.0007649343,"about_ca_system_score_gemma":0.00073363894,"threshold_uncertainty_score":0.00973171},"labels":[],"label_agreement":null},{"id":"W2737769420","doi":"10.1177/1352458517722056","title":"Dilemmas in medical ethics in the age of big data","year":2017,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Dalhousie University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Multiple sclerosis; Medical ethics; Medicine; Big data; Psychology; Psychiatry; Computer science; Data mining","score_opus":0.7476369067734334,"score_gpt":0.4815545852736984,"score_spread":0.26608232149973504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2737769420","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014220843,0.00047549486,0.00010168045,0.99700767,0.0017095831,0.0000017363609,0.000006272663,0.0000027711083,0.0005526515],"genre_scores_gemma":[0.0071466086,0.0009600841,0.00051446486,0.9697742,0.020747203,0.000020312724,0.000009422936,0.0000145602735,0.000813162],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.96598065,0.019432366,0.0026639786,0.0019572992,0.00797138,0.0019942557],"domain_scores_gemma":[0.74443144,0.21755515,0.0071184714,0.0038303745,0.012358805,0.014705776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04083303,0.0005199827,0.0016402238,0.0013018355,0.009534456,0.013397242,0.0026247045,0.07431107,0.0052702483],"category_scores_gemma":[0.16834968,0.0009492257,0.0012400333,0.0015981878,0.024646629,0.016541397,0.0057418505,0.08473778,0.0024030223],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050083185,0.000043521075,0.0010894536,0.0001104842,0.000035026907,0.0021359096,0.002545629,0.00016292698,0.00011963487,0.0498184,0.92988974,0.013999211],"study_design_scores_gemma":[0.00010266238,0.000043295393,0.0008206477,0.0010242773,0.000026398286,0.0035755204,0.0065151714,0.0010076518,0.00016819384,0.25503278,0.73155016,0.00013322319],"about_ca_topic_score_codex":0.004156455,"about_ca_topic_score_gemma":0.0059908414,"teacher_disagreement_score":0.07431107,"about_ca_system_score_codex":0.0071328944,"about_ca_system_score_gemma":0.011880507,"threshold_uncertainty_score":0.21594828},"labels":[],"label_agreement":null},{"id":"W2739122096","doi":"10.1177/1352458517707264","title":"The use of clinical databases in disease outcomes research: Is the ethics of IRB review keeping up?","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Confidentiality; Terminology; Harmonization; Conflation; Context (archaeology); Informed consent; Research ethics; Clinical research; Biobank; Medicine; Engineering ethics; Alternative medicine; Political science; Law; Pathology; Psychiatry; Bioinformatics","score_opus":0.9763579248607197,"score_gpt":0.7180419072027514,"score_spread":0.2583160176579683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739122096","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006583811,0.019191446,0.04434792,0.90155995,0.006091623,0.0009940029,0.00012350625,0.00013740813,0.020970328],"genre_scores_gemma":[0.3352688,0.03232187,0.13274987,0.45804387,0.020716049,0.010662094,0.00035566045,0.0010118015,0.008870046],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.11414766,0.7640164,0.046186943,0.008869356,0.062455412,0.0043242835],"domain_scores_gemma":[0.07326746,0.7311656,0.041053254,0.07244992,0.06895388,0.013109881],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.75833297,0.0007219191,0.0039962544,0.0060600922,0.011864101,0.036885682,0.007230645,0.018319018,0.0025012458],"category_scores_gemma":[0.79402137,0.002569615,0.0020439287,0.009882823,0.061064307,0.029530339,0.016646203,0.03078868,0.0031319924],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072625466,0.00030341838,0.010635808,0.005051368,0.0005356087,0.00091292284,0.110098206,0.0007460726,0.0016342989,0.38412133,0.15239662,0.33283818],"study_design_scores_gemma":[0.0005034409,0.00034356271,0.01080589,0.026856484,0.00030409882,0.0022928002,0.032680225,0.0024601335,0.0018924661,0.4164083,0.5048907,0.00056190946],"about_ca_topic_score_codex":0.008816775,"about_ca_topic_score_gemma":0.0077282363,"teacher_disagreement_score":0.981681,"about_ca_system_score_codex":0.017269414,"about_ca_system_score_gemma":0.09381225,"threshold_uncertainty_score":0.29801852},"labels":[],"label_agreement":null},{"id":"W2741187342","doi":"10.1177/1352458517713147","title":"Reconstitution of the peripheral immune repertoire following withdrawal of fingolimod","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Fingolimod; Multiple sclerosis; Medicine; Immune system; Immunology; CD8; Peripheral; Lymphocyte; Internal medicine","score_opus":0.08186413505668487,"score_gpt":0.3069887066488017,"score_spread":0.2251245715921168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741187342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987231,0.00062841753,0.00016667023,0.000015679836,0.000002857766,0.000010315736,0.00005397961,0.000014243742,0.00038478556],"genre_scores_gemma":[0.9994023,0.00013200565,0.00012601101,0.000024060542,0.00000621195,0.000009487046,0.00011601208,0.0000031586972,0.00018089655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983716,0.000039854753,0.000020009022,0.000028188493,0.000039330032,0.00003545986],"domain_scores_gemma":[0.99942493,0.00012879704,0.00024874764,0.000047458027,0.0000711394,0.000078904326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041004756,0.00017180253,0.00031188826,0.00035789935,0.00017248602,0.0002945679,0.00012564349,0.00017607685,0.0015848555],"category_scores_gemma":[0.0008898303,0.00007458176,0.00013558593,0.00017581598,0.00017279763,0.00022464266,0.00016127016,0.0003751261,0.0002869244],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008256802,0.00040526316,0.4800738,0.00021375825,0.00013054772,0.001707777,0.00061406085,0.00030257806,0.3931374,0.000075391195,0.00029218962,0.114790455],"study_design_scores_gemma":[0.00006473269,0.0047737476,0.94000137,0.000038072896,0.000101368576,0.0061748726,0.00022351452,0.00045307883,0.046781424,0.00012169323,0.0012546611,0.000011347963],"about_ca_topic_score_codex":0.0002809466,"about_ca_topic_score_gemma":0.00028400467,"teacher_disagreement_score":0.0015848555,"about_ca_system_score_codex":0.00016461153,"about_ca_system_score_gemma":0.00011591724,"threshold_uncertainty_score":0.0053018928},"labels":[],"label_agreement":null},{"id":"W2741653274","doi":"","title":"Effects of mid sagittal plane selection on corpus callosal area","year":2006,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Advanced Neuroimaging Techniques and Applications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sagittal plane; Corpus callosum; Selection (genetic algorithm); Medicine; Artificial intelligence; Anatomy; Computer science","score_opus":0.06509693910491117,"score_gpt":0.2850036577089702,"score_spread":0.21990671860405903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741653274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97983927,0.00108116,0.01462092,0.00023645096,0.000112792986,0.00004493373,0.0013278333,0.00074263726,0.0019938443],"genre_scores_gemma":[0.9926916,0.0002716204,0.004690739,0.000045639095,0.00001542478,0.000031305488,0.0007329839,0.00046686188,0.0010539441],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9994904,0.00018785552,0.000031160223,0.00007640202,0.00014435589,0.00006976987],"domain_scores_gemma":[0.99300283,0.005531804,0.00048138853,0.00036280847,0.00044488182,0.00017624664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009159484,0.00046488058,0.00037877256,0.00043644736,0.00019492835,0.00059867674,0.00022834093,0.00035107543,0.003946254],"category_scores_gemma":[0.012441636,0.00020825844,0.00028274886,0.0007619431,0.00037203994,0.0002766462,0.0003894297,0.0005454607,0.0006677016],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04736753,0.0005385873,0.04391485,0.00065852545,0.00043600053,0.0009121179,0.0006027234,0.04709527,0.6612256,0.0007341732,0.0038423103,0.1926724],"study_design_scores_gemma":[0.0003258944,0.0031964465,0.60641915,0.000076016084,0.00047997938,0.0015276737,0.00031118147,0.123280495,0.26014626,0.0008872128,0.0032229933,0.00012664968],"about_ca_topic_score_codex":0.004952425,"about_ca_topic_score_gemma":0.0032016553,"teacher_disagreement_score":0.004952425,"about_ca_system_score_codex":0.00031019532,"about_ca_system_score_gemma":0.0005140067,"threshold_uncertainty_score":0.013201475},"labels":[],"label_agreement":null},{"id":"W2742808332","doi":"10.1177/1352458517723718","title":"The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability","year":2017,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Neurological Disorders and Stroke; Medical Research Council; U.S. Food and Drug Administration; National Institute for Health and Care Research; National Multiple Sclerosis Society","keywords":"Clinical trial; Medicine; Multiple sclerosis; MEDLINE; Physical medicine and rehabilitation; Physical therapy; Medical physics; Psychiatry; Pathology","score_opus":0.44987644071959876,"score_gpt":0.39835689658703183,"score_spread":0.05151954413256693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2742808332","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0053809057,0.7632702,0.14466451,0.013727048,0.0031253344,0.011390259,0.010878496,0.00062194036,0.046941366],"genre_scores_gemma":[0.06413396,0.490322,0.38966966,0.0076096784,0.0014121553,0.030505393,0.007813391,0.00015956335,0.0083742635],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9619157,0.022305513,0.0064391093,0.0014783527,0.007546598,0.00031463263],"domain_scores_gemma":[0.96107095,0.020619662,0.0048911204,0.0021150394,0.010903006,0.00040015794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.047040578,0.0016257602,0.0028190545,0.015257302,0.0006042666,0.003267904,0.002453217,0.0015854321,0.004185204],"category_scores_gemma":[0.053086042,0.0005076358,0.0038726914,0.012539812,0.001429648,0.002476232,0.0029989732,0.003039596,0.0017276584],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033054344,0.00016843388,0.005821905,0.07681475,0.0026353686,0.00009518793,0.0008576241,0.0010818213,0.0012002115,0.07394876,0.027341591,0.8097038],"study_design_scores_gemma":[0.00025216755,0.0008988654,0.016585995,0.06804224,0.003811057,0.0005606022,0.0009653645,0.0015633075,0.0019091981,0.042001486,0.8632788,0.00013082029],"about_ca_topic_score_codex":0.0041589523,"about_ca_topic_score_gemma":0.0068595763,"teacher_disagreement_score":0.047040578,"about_ca_system_score_codex":0.0036193565,"about_ca_system_score_gemma":0.01222752,"threshold_uncertainty_score":0.24877733},"labels":[],"label_agreement":null},{"id":"W2744553073","doi":"10.1177/1352458517723717","title":"Global loss of myelin water over 5 years in multiple sclerosis normal-appearing white matter","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"International Collaboration On Repair Discoveries; Child and Family Research Institute; University of British Columbia","funders":"","keywords":"Multiple sclerosis; White matter; Myelin; Magnetic resonance imaging; Nuclear medicine; Medicine; Nuclear magnetic resonance; Internal medicine; Pathology; Central nervous system; Physics; Radiology","score_opus":0.0957134897978565,"score_gpt":0.30535267081058715,"score_spread":0.20963918101273066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2744553073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994727,0.00032119534,0.000047966376,0.000008607363,0.0000014243527,0.0000041131575,0.00006872582,0.0000051777606,0.000070219874],"genre_scores_gemma":[0.9997112,0.00006974244,0.000045306897,0.0000056037934,0.000002309978,0.000003096064,0.00010996339,9.589612e-7,0.00005181009],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999908,0.000016236289,0.000009544531,0.000028392928,0.00001974874,0.00001804971],"domain_scores_gemma":[0.99961746,0.000037161346,0.00021394854,0.000015751875,0.000046861303,0.00006892891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043722353,0.00024808364,0.00027680717,0.0008311875,0.00025029102,0.00026536992,0.00019756838,0.00034707884,0.00065004634],"category_scores_gemma":[0.0007958967,0.000105934756,0.00017089755,0.00044057288,0.0002589999,0.000404171,0.00027120116,0.00019711509,0.000113110276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015131918,0.00010793095,0.9827011,0.000051961306,0.00014354299,0.0006216959,0.0002769596,0.00022857852,0.006085429,0.00001114946,0.000101476,0.008157069],"study_design_scores_gemma":[0.0000056817717,0.00037869412,0.99868447,0.00000241197,0.000031214924,0.00045965766,0.000056004337,0.00006822025,0.00024085684,0.000012745057,0.00005783332,0.0000022496017],"about_ca_topic_score_codex":0.0032649296,"about_ca_topic_score_gemma":0.0027779948,"teacher_disagreement_score":0.0032649296,"about_ca_system_score_codex":0.00028614444,"about_ca_system_score_gemma":0.00016587802,"threshold_uncertainty_score":0.00649184},"labels":[],"label_agreement":null},{"id":"W2745030665","doi":"10.1177/1352458517723991","title":"On-road assessment of fitness-to-drive in persons with MS with cognitive impairment: A prospective study","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Older Adults Driving Studies","field":"Health Professions","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Cognitive impairment; Physical medicine and rehabilitation; Cognition; Prospective cohort study; Cognitive Assessment System; Medicine; Psychology; Physical therapy; Audiology; Gerontology; Neuroscience; Psychiatry; Internal medicine","score_opus":0.09570227893758988,"score_gpt":0.4052311585412595,"score_spread":0.30952887960366965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2745030665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992374,0.00021349144,0.000039930226,0.000015074447,0.0000037480524,0.000030329376,0.00012557482,0.0000014187145,0.0003331852],"genre_scores_gemma":[0.9994299,0.00010517846,0.00007258908,0.000026622434,0.000009538666,0.000025194991,0.00019100652,8.347099e-7,0.00013913565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99935216,0.00020596564,0.00010332611,0.0001235184,0.00011688377,0.00009822272],"domain_scores_gemma":[0.99832517,0.00029813545,0.00057121355,0.0001692031,0.0003159867,0.000320276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001585611,0.00046504394,0.0004630357,0.00085495354,0.0007882486,0.0008576359,0.000336411,0.0008325149,0.0014936912],"category_scores_gemma":[0.0029646861,0.00043595125,0.0007181581,0.0008018876,0.0003223154,0.00079295906,0.0005954422,0.0008665625,0.00049524085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002569771,0.0002118635,0.99854076,0.000012889281,0.000058176793,0.000050590254,0.00008799216,0.000013638197,0.000034991783,0.0000065892177,0.000028251538,0.00069735],"study_design_scores_gemma":[0.000035475154,0.0010910322,0.99790275,0.00001657172,0.00009016124,0.0002612891,0.00030000423,0.00010419224,0.0000311058,0.000014410424,0.00014677369,0.0000061149517],"about_ca_topic_score_codex":0.0045917076,"about_ca_topic_score_gemma":0.0061013605,"teacher_disagreement_score":0.0045917076,"about_ca_system_score_codex":0.0002619722,"about_ca_system_score_gemma":0.00037678477,"threshold_uncertainty_score":0.009129941},"labels":[],"label_agreement":null},{"id":"W2752579839","doi":"10.1177/1352458517711775","title":"Physician-assisted death should be available to people with MS – YES","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Winnipeg Regional Health Authority","funders":"","keywords":"Multiple sclerosis; Medicine; MEDLINE; Medical emergency; Psychiatry; Political science","score_opus":0.23483256454492915,"score_gpt":0.3488085247754639,"score_spread":0.11397596023053477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752579839","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.37323743,0.015774056,0.0017780294,0.40755942,0.013635366,0.0011200878,0.007421337,0.00054444396,0.17892991],"genre_scores_gemma":[0.8203399,0.007846187,0.0034170626,0.1099458,0.0049788635,0.0009987076,0.003288845,0.000051196894,0.04913344],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99851185,0.00072442536,0.00016521812,0.000117395975,0.00015793875,0.00032314993],"domain_scores_gemma":[0.98804235,0.0035059182,0.001972791,0.000722926,0.0016559246,0.004100094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014805469,0.0001637555,0.00035061018,0.00053374475,0.0023654036,0.00087362697,0.00061535044,0.0032581247,0.031088011],"category_scores_gemma":[0.017798379,0.00022553006,0.0007031216,0.00043220998,0.00043028448,0.0017529648,0.0009852904,0.002104426,0.003722276],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006033364,0.0030839972,0.19646539,0.0029338473,0.00027877034,0.0022925942,0.0020144046,0.00025247727,0.0007743806,0.0039541665,0.48337078,0.2985458],"study_design_scores_gemma":[0.0041167396,0.0040377458,0.5601316,0.004510206,0.0004102395,0.004534254,0.009192536,0.00039093566,0.00131391,0.006718473,0.4044697,0.00017355515],"about_ca_topic_score_codex":0.0042654485,"about_ca_topic_score_gemma":0.009242447,"teacher_disagreement_score":0.031088011,"about_ca_system_score_codex":0.00051201624,"about_ca_system_score_gemma":0.00253403,"threshold_uncertainty_score":0.10399979},"labels":[],"label_agreement":null},{"id":"W2753561811","doi":"10.1177/1352458517728811","title":"Unexpected additive effects of minocycline and hydroxychloroquine in models of multiple sclerosis: Prospective combination treatment for progressive disease?","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; University of Calgary","funders":"U.S. Food and Drug Administration","keywords":"Minocycline; Hydroxychloroquine; Multiple sclerosis; Medicine; Experimental autoimmune encephalomyelitis; Pharmacology; Neurotoxicity; Microglia; Toxicity; Immunology; Internal medicine; Disease; Inflammation; Chemistry; Antibiotics","score_opus":0.09880776252245432,"score_gpt":0.3255740117319261,"score_spread":0.2267662492094718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2753561811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9616441,0.033150084,0.0020854834,0.0004151959,0.00019317887,0.00046117546,0.00016646391,0.00006321367,0.0018211416],"genre_scores_gemma":[0.9802838,0.013069557,0.00417728,0.00016879922,0.00015498341,0.0002466803,0.00017706717,0.000012822789,0.0017089692],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9996685,0.000115476316,0.000033666758,0.000053486347,0.00006894787,0.000059814294],"domain_scores_gemma":[0.9997733,0.000037914626,0.000060280607,0.000025987263,0.000036629815,0.00006590802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008042867,0.00055095,0.0010876335,0.00042783286,0.00023538726,0.00053904013,0.00053380936,0.00049136084,0.0013955203],"category_scores_gemma":[0.00022058198,0.00014636372,0.000518283,0.00027704,0.00038338074,0.00043468436,0.00024867686,0.0008995399,0.00021153776],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019780004,0.008084017,0.0023675617,0.0017749981,0.00049143407,0.0003426489,0.00016185343,0.0005193812,0.8664168,0.00042377156,0.0005058948,0.09913158],"study_design_scores_gemma":[0.0062171416,0.28569832,0.022806315,0.00035234969,0.0022079244,0.001181925,0.00025304357,0.0016285252,0.65993696,0.00057710195,0.019077823,0.00006264128],"about_ca_topic_score_codex":0.00031196885,"about_ca_topic_score_gemma":0.0018570245,"teacher_disagreement_score":0.0013955203,"about_ca_system_score_codex":0.00024754304,"about_ca_system_score_gemma":0.0004358906,"threshold_uncertainty_score":0.004668474},"labels":[],"label_agreement":null},{"id":"W2753716024","doi":"10.1177/1352458517728812","title":"Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cegep de Saint Jerome; Clinique Neuro-Outaouais; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Université de Montréal; Hôpital Notre-Dame","funders":"National Health and Medical Research Council; Sanofi Genzyme; Bayer HealthCare; Multiple Sclerosis Society; Canadian Institutes of Health Research; Teva Pharmaceutical Industries; Multiple Sclerosis Society of Canada; Univerzita Karlova v Praze; Fondazione Italiana Sclerosi Multipla; Biogen; Sanofi","keywords":"Fingolimod; Natalizumab; Medicine; Multiple sclerosis; Cladribine; Internal medicine; Gastroenterology; Immunology","score_opus":0.2605903277885955,"score_gpt":0.3522453158798759,"score_spread":0.09165498809128042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2753716024","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915603,0.0032907513,0.0028855053,0.00016540672,0.00007340257,0.0002423083,0.00085364055,0.000020038728,0.00090862636],"genre_scores_gemma":[0.9982679,0.00031525583,0.0004917089,0.0000791616,0.0000268625,0.000065467306,0.0004917947,0.0000037835277,0.00025798441],"study_design_codex":"randomized_trial","study_design_gemma":"systematic_review","domain_scores_codex":[0.9973122,0.0018651343,0.00017662029,0.00036563663,0.0001800456,0.00010035431],"domain_scores_gemma":[0.9966869,0.0016599947,0.001080308,0.00033208064,0.000096943375,0.00014383062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004759415,0.0003415214,0.00076709467,0.0002755803,0.00013150231,0.00061435305,0.0003470595,0.00038327134,0.0026623406],"category_scores_gemma":[0.006026526,0.00018575422,0.003070495,0.00032286774,0.00025380647,0.00029329312,0.00037980574,0.00046418543,0.00015247132],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.618017,0.00102759,0.20925267,0.001503178,0.049173914,0.00026342014,0.00014019442,0.033177152,0.0075174216,0.0014862673,0.002266757,0.07617447],"study_design_scores_gemma":[0.096361354,0.09441339,0.6083445,0.0006085089,0.05117468,0.0014978935,0.00026686073,0.11533396,0.012457006,0.0060579358,0.013350905,0.0001330675],"about_ca_topic_score_codex":0.00086446083,"about_ca_topic_score_gemma":0.0008950598,"teacher_disagreement_score":0.004759415,"about_ca_system_score_codex":0.0005736696,"about_ca_system_score_gemma":0.000467984,"threshold_uncertainty_score":0.025170505},"labels":[],"label_agreement":null},{"id":"W2754752946","doi":"10.1177/1352458517728343","title":"Two-year results from a phase 2 extension study of oral amiselimod in relapsing multiple sclerosis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"Mitsubishi Tanabe Pharma Corporation","keywords":"Multiple sclerosis; Medicine; Extension (predicate logic); Computer science; Immunology","score_opus":0.24047715458720315,"score_gpt":0.3765974129036126,"score_spread":0.13612025831640945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754752946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99674416,0.00094848336,0.00021867544,0.00010338908,0.000038425336,0.0006946105,0.00071397953,0.00003165476,0.0005067073],"genre_scores_gemma":[0.9940076,0.00052861683,0.0005387248,0.00041184237,0.00010081097,0.0008252652,0.002595314,0.000012134076,0.0009796029],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9987155,0.0006613017,0.00010774143,0.00014264495,0.00016712115,0.0002056186],"domain_scores_gemma":[0.9966807,0.0006968526,0.0007170438,0.00036709613,0.0003991995,0.0011390967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005868417,0.0012351172,0.0023563637,0.00037894014,0.00042893933,0.0006527521,0.00053392025,0.0012357768,0.0018649581],"category_scores_gemma":[0.0034688425,0.000435837,0.0012666169,0.00028623556,0.0005706256,0.00070054055,0.00048651668,0.0016942273,0.00049779867],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8516981,0.038786113,0.025724143,0.00047571628,0.0020068842,0.000497251,0.00044859698,0.0010711949,0.021638092,0.00008134744,0.0027343563,0.054838173],"study_design_scores_gemma":[0.31922993,0.5143291,0.15841655,0.000047662827,0.0015293675,0.0005211792,0.00009032197,0.0007961408,0.0025273245,0.00014159831,0.0023164416,0.000054519736],"about_ca_topic_score_codex":0.00076300575,"about_ca_topic_score_gemma":0.0010324543,"teacher_disagreement_score":0.005868417,"about_ca_system_score_codex":0.00045244454,"about_ca_system_score_gemma":0.0007218479,"threshold_uncertainty_score":0.031035542},"labels":[],"label_agreement":null},{"id":"W2761348774","doi":"10.1177/1352458517735191","title":"Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"European Regional Development Fund; Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya; Generalitat de Catalunya; Bayer HealthCare; Instituto de Salud Carlos III; Oryzon Genomics; Teva Pharmaceutical Industries; Red Española de Esclerosis Múltiple; Biogen; Celgene; Sanofi","keywords":"Medicine; Incidence (geometry); Neuromyelitis optica; Pediatrics; Multiple sclerosis; Epidemiology; Myelin oligodendrocyte glycoprotein; Population; Internal medicine; Immunology; Environmental health","score_opus":0.13099493612578322,"score_gpt":0.3941934759163016,"score_spread":0.2631985397905184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761348774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819983,0.010899719,0.00093282165,0.00050479773,0.00010939112,0.00006137972,0.0031813206,0.000026667152,0.0022855834],"genre_scores_gemma":[0.99329525,0.0027700777,0.0007556061,0.0001535773,0.00005977823,0.00004363287,0.0027655468,0.000006250403,0.0001502432],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99528944,0.0016440521,0.0009518366,0.0008518545,0.0008771925,0.00038574482],"domain_scores_gemma":[0.9876913,0.0024529733,0.005968316,0.0005967089,0.0026748965,0.0006158748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006157461,0.00035648383,0.00047138304,0.0034972215,0.00029310948,0.0015172788,0.0008665526,0.00044104244,0.00053903426],"category_scores_gemma":[0.009463597,0.00031143395,0.0006057153,0.0021825004,0.00046301918,0.0005452725,0.0011245892,0.00043077755,0.00012614949],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059647293,0.000009429466,0.99430335,0.000080858714,0.00006126997,0.000051307445,0.00008624858,0.00028724538,0.000065769585,0.000056343437,0.00053219864,0.0044063106],"study_design_scores_gemma":[0.0000034781378,0.000019964575,0.9986222,0.00010636807,0.00001898607,0.00015651682,0.0001667677,0.00025762795,0.000022784956,0.0000152091325,0.00060619006,0.000003986359],"about_ca_topic_score_codex":0.0964763,"about_ca_topic_score_gemma":0.06983904,"teacher_disagreement_score":0.0964763,"about_ca_system_score_codex":0.0035911105,"about_ca_system_score_gemma":0.0016237816,"threshold_uncertainty_score":0.1918295},"labels":[],"label_agreement":null},{"id":"W2765125400","doi":"10.1177/1352458517729451","title":"The optic nerve should be included as one of the typical CNS regions for establishing dissemination in space when diagnosing MS – No","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Multiple sclerosis; Optic nerve; Neuroscience; Medicine; Space (punctuation); Pathology; Computer science; Anatomy; Psychology; Immunology","score_opus":0.20074789457623185,"score_gpt":0.3762916006386692,"score_spread":0.17554370606243733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765125400","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8600283,0.027940968,0.021390561,0.020514943,0.0023103503,0.0005741373,0.00054429006,0.00049616344,0.066200234],"genre_scores_gemma":[0.9668003,0.006883348,0.018526858,0.003228581,0.0013960671,0.00009295471,0.0002396329,0.000071916955,0.002760334],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99888223,0.00026819154,0.00027164625,0.00009939891,0.00025373034,0.00022483294],"domain_scores_gemma":[0.99558604,0.0017294271,0.0005768879,0.00034329158,0.0011809402,0.000583456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019195107,0.0012705299,0.00093274354,0.0031645165,0.0017680479,0.0013049813,0.0010277325,0.003497065,0.0029510257],"category_scores_gemma":[0.010263519,0.0004227363,0.00063165056,0.0010325069,0.0020083475,0.005597033,0.000748561,0.0019248028,0.0014397064],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030776998,0.00050101976,0.47442728,0.002415553,0.00020658788,0.30466104,0.0018498905,0.0012071438,0.09114581,0.0022585625,0.012775291,0.105474085],"study_design_scores_gemma":[0.00020156922,0.0018646204,0.2952018,0.0027549644,0.0006789412,0.58167046,0.009348749,0.006274089,0.044813953,0.013869586,0.043014262,0.0003070192],"about_ca_topic_score_codex":0.0052607176,"about_ca_topic_score_gemma":0.0069554443,"teacher_disagreement_score":0.0052607176,"about_ca_system_score_codex":0.00044624283,"about_ca_system_score_gemma":0.0013055427,"threshold_uncertainty_score":0.010460198},"labels":[],"label_agreement":null},{"id":"W2767123116","doi":"10.1177/1352458517739976","title":"An overview of biosimilars and non-biologic complex drugs in Europe, the United States, and Canada and their relevance to multiple sclerosis","year":2017,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biosimilar; Reimbursement; Multiple sclerosis; Business; Relevance (law); Public economics; Healthcare system; Competition (biology); Health care; Risk analysis (engineering); Industrial organization; Medicine; Economics; Political science; Economic growth; Immunology","score_opus":0.2728565278470762,"score_gpt":0.35153841585718654,"score_spread":0.07868188801011033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767123116","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011723792,0.9965229,0.00013578129,0.00038212226,0.00016625707,0.000008492864,0.000035714478,0.000008594048,0.002623034],"genre_scores_gemma":[0.0006332699,0.99778974,0.00030219238,0.00028905773,0.00009716011,0.0000059548042,0.000033968125,0.0000019790702,0.0008466196],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992525,0.00008560461,0.000119659184,0.00009302089,0.00039120013,0.00005799754],"domain_scores_gemma":[0.99876666,0.00053860224,0.00018889774,0.000025650395,0.0003814249,0.00009873903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010866848,0.0010235582,0.001044908,0.0071032727,0.00074164267,0.0018622935,0.0008871576,0.0018309079,0.004777421],"category_scores_gemma":[0.0015259999,0.00035908323,0.0007442747,0.008148773,0.0010153275,0.0020424293,0.00075694587,0.0025298921,0.0014218282],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060469785,0.00008145827,0.0003531195,0.023070797,0.000068399546,0.0003680618,0.00023241111,0.0004399774,0.0018307522,0.012727697,0.04096091,0.91980594],"study_design_scores_gemma":[0.000004224342,0.000044090033,0.0008695432,0.0051637846,0.000049882856,0.00083872187,0.0000844154,0.000060311653,0.00033583315,0.0010990992,0.9914349,0.000015283109],"about_ca_topic_score_codex":0.027187128,"about_ca_topic_score_gemma":0.04387509,"teacher_disagreement_score":0.9728129,"about_ca_system_score_codex":0.0038281407,"about_ca_system_score_gemma":0.0075799776,"threshold_uncertainty_score":0.054057777},"labels":[],"label_agreement":null},{"id":"W2767204380","doi":"10.1177/1352458517740211","title":"Effects of an individual 12-week community-located “start-to-run” program on physical capacity, walking, fatigue, cognitive function, brain volumes, and structures in persons with multiple sclerosis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Universiteit Hasselt","keywords":"Physical medicine and rehabilitation; Cognition; Physical therapy; Paced Auditory Serial Addition Test; Expanded Disability Status Scale; Montreal Cognitive Assessment; Psychology; Multiple sclerosis; Quality of life (healthcare); Medicine; Audiology; Cognitive impairment; Neuroscience","score_opus":0.1370018357750346,"score_gpt":0.32639049733939524,"score_spread":0.18938866156436063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767204380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979278,0.00040833637,0.00014726684,0.000047254616,0.000036086643,0.0010865276,0.00008680884,0.000028369606,0.00023147855],"genre_scores_gemma":[0.9943387,0.00041866448,0.0013411824,0.00013671047,0.00008423692,0.0028751113,0.00017207308,0.0000051970337,0.00062805536],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994716,0.00020935149,0.000043237036,0.00013494311,0.00004702332,0.00009383883],"domain_scores_gemma":[0.9992455,0.00015162975,0.000106791435,0.000050765102,0.00004057987,0.00040466388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008132112,0.0010734623,0.0016520048,0.00053541985,0.0006717844,0.0003293514,0.0006753487,0.0011653651,0.0038837201],"category_scores_gemma":[0.0012350043,0.00042605918,0.0008952262,0.0002623356,0.00051875995,0.00034974105,0.00065725326,0.0009471523,0.00026482044],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7833384,0.1435894,0.004122279,0.001192478,0.00096856157,0.00007992043,0.00016988484,0.00053745456,0.0049281614,0.000037848422,0.00033811294,0.06069747],"study_design_scores_gemma":[0.31008562,0.65162426,0.035299234,0.000112263115,0.0007028332,0.000037783095,0.00008839517,0.0006292773,0.0010069286,0.000056812853,0.00033431393,0.000022270415],"about_ca_topic_score_codex":0.0018541277,"about_ca_topic_score_gemma":0.0038424507,"teacher_disagreement_score":0.0038837201,"about_ca_system_score_codex":0.00035644646,"about_ca_system_score_gemma":0.00076801877,"threshold_uncertainty_score":0.012992322},"labels":[],"label_agreement":null},{"id":"W2767375489","doi":"10.1177/1352458517739990","title":"The NAIMS cooperative pilot project: Design, implementation and future directions","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; National Institutes of Health","keywords":"Standardization; Protocol (science); Magnetic resonance imaging; Medical physics; Computer science; Reproducibility; Pace; Multiple sclerosis; Medicine; Radiology; Pathology; Physics; Operating system","score_opus":0.1965319599313926,"score_gpt":0.38722713264915065,"score_spread":0.19069517271775804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767375489","genre_codex":"protocol","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23595665,0.0006410367,0.062074378,0.006577084,0.00093794113,0.6733656,0.0066373535,0.00074929494,0.013060669],"genre_scores_gemma":[0.12636855,0.0004682134,0.22763926,0.001727695,0.00023288398,0.6347752,0.004775228,0.00019318206,0.0038197432],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.87563366,0.101220235,0.004845642,0.0029118431,0.009353725,0.0060349354],"domain_scores_gemma":[0.8770999,0.021863878,0.0067323395,0.01774221,0.057220828,0.019340815],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.19344923,0.0021581796,0.0015603222,0.00216415,0.0054549556,0.004438158,0.006969117,0.0030260058,0.00850691],"category_scores_gemma":[0.09099276,0.0016279666,0.0016296532,0.0027974665,0.004276208,0.0033399912,0.0064334525,0.0031799085,0.0033887397],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07866215,0.12624857,0.14609496,0.0052597863,0.00079494057,0.001772583,0.025236432,0.007849809,0.008684453,0.01876679,0.05818705,0.5224425],"study_design_scores_gemma":[0.080627434,0.3698633,0.22145759,0.0059290873,0.001775402,0.00070744747,0.053016488,0.0154946605,0.027892543,0.02212485,0.20032132,0.0007898659],"about_ca_topic_score_codex":0.02668282,"about_ca_topic_score_gemma":0.029789345,"teacher_disagreement_score":0.19344923,"about_ca_system_score_codex":0.008843676,"about_ca_system_score_gemma":0.07390545,"threshold_uncertainty_score":0.9946207},"labels":[],"label_agreement":null},{"id":"W2782707227","doi":"10.1177/1352458517737369","title":"Gut microbiome and pediatric multiple sclerosis","year":2018,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Multiple sclerosis; Microbiome; Gut microbiome; Gut flora; Immune system; Gut–brain axis; Gut bacteria; Biology; Immunology; Medicine; Bioinformatics","score_opus":0.11438906571410544,"score_gpt":0.29741713897060706,"score_spread":0.1830280732565016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782707227","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001268924,0.99862456,0.00003911031,0.0005322353,0.00018264525,0.0000018259785,0.000008703377,0.0000033245094,0.00048067776],"genre_scores_gemma":[0.0012440652,0.9976332,0.0000971181,0.00024350424,0.00026362855,0.0000034417467,0.000016606678,9.917658e-7,0.00049738784],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99982613,0.000041857318,0.000027880671,0.000032997184,0.00005371624,0.000017347018],"domain_scores_gemma":[0.999696,0.00013530426,0.000054527845,0.000007093067,0.00007122937,0.00003580432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045504124,0.0005181338,0.0007127173,0.0015340114,0.00028105915,0.0009338955,0.00038525733,0.0011518213,0.0029685334],"category_scores_gemma":[0.0010543901,0.00014368683,0.00033742745,0.0011453158,0.0004073494,0.0011030781,0.00080539257,0.0014292412,0.0010865327],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007299453,0.00005506302,0.000966853,0.010305107,0.00008026742,0.00035982917,0.00012600493,0.00013672307,0.0006115406,0.005004075,0.03221599,0.9500656],"study_design_scores_gemma":[0.000011391213,0.0000875869,0.003781105,0.00925969,0.00013125525,0.0042840443,0.0001574635,0.0000744913,0.0003292483,0.0030232645,0.97883934,0.000021201693],"about_ca_topic_score_codex":0.0014098361,"about_ca_topic_score_gemma":0.0021302872,"teacher_disagreement_score":0.0029685334,"about_ca_system_score_codex":0.0004981623,"about_ca_system_score_gemma":0.0010776807,"threshold_uncertainty_score":0.00993067},"labels":[],"label_agreement":null},{"id":"W2782758061","doi":"10.1177/1352458517737397","title":"Americas Committee for Treatment and Research in Multiple Sclerosis Forum 2017: Environmental factors, genetics, and epigenetics in MS susceptibility and clinical course","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Multiple sclerosis; Epigenetics; Multidisciplinary approach; Medicine; Neuroscience; Library science; Psychology; Biology; Genetics; Psychiatry; Gene; Sociology; Social science; Computer science","score_opus":0.3667981618820302,"score_gpt":0.42834221320703714,"score_spread":0.061544051325006954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782758061","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005644645,0.047182273,0.0017420895,0.5910708,0.34506652,0.00039197126,0.0009644024,0.00022284543,0.012794573],"genre_scores_gemma":[0.010353695,0.10983744,0.0121295955,0.28988352,0.5196356,0.0017452633,0.0033854614,0.0006054408,0.052423928],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97218984,0.009494249,0.0042525767,0.0010592076,0.010743788,0.0022602633],"domain_scores_gemma":[0.84628654,0.04007746,0.0144020915,0.0041232337,0.0707192,0.02439144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.054083306,0.0013380125,0.0028763423,0.004732576,0.004513423,0.0094304485,0.004295407,0.016899291,0.011290539],"category_scores_gemma":[0.081077136,0.0009620434,0.0025429053,0.003876022,0.0039102575,0.0044677737,0.0072748554,0.029447742,0.005431838],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007578211,0.000060552476,0.000641217,0.00025901408,0.000031791064,0.00007880949,0.0001288517,0.000040124516,0.00020188125,0.0015450065,0.95935273,0.037584223],"study_design_scores_gemma":[0.00007063944,0.000052641863,0.0026168795,0.0017997603,0.00008033987,0.00012985645,0.0002276879,0.00008881422,0.00020214438,0.0028894441,0.9917681,0.00007368872],"about_ca_topic_score_codex":0.01136262,"about_ca_topic_score_gemma":0.024532089,"teacher_disagreement_score":0.054083306,"about_ca_system_score_codex":0.0057744975,"about_ca_system_score_gemma":0.028989581,"threshold_uncertainty_score":0.28602326},"labels":[],"label_agreement":null},{"id":"W2783474205","doi":"10.1177/1352458517737391","title":"An introduction to the microbiome and MS","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Multiple sclerosis; Microbiome; Disease; Neuroimmunology; Human microbiome; Autoimmune disease; Intervention (counseling); Immunology; Biology; Gut microbiome; Neuroscience; Gut flora; Medicine; Central nervous system; Bioinformatics; Psychiatry; Pathology","score_opus":0.02469856201168886,"score_gpt":0.25868815176849075,"score_spread":0.2339895897568019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783474205","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00084957125,0.91957647,0.002540525,0.027214887,0.032936357,0.00005312454,0.00046340423,0.0001123268,0.016253304],"genre_scores_gemma":[0.0042637303,0.89410174,0.0048096855,0.022972908,0.044743534,0.00009086971,0.0006108013,0.00007571927,0.02833102],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996276,0.00011556755,0.0000435694,0.00007138403,0.000092456765,0.000049380014],"domain_scores_gemma":[0.99889815,0.0006233141,0.00009766262,0.000033466997,0.00013947547,0.00020799076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007539956,0.0011607751,0.0010036826,0.0021046365,0.0008717531,0.0018928364,0.0008224675,0.0031101361,0.019056274],"category_scores_gemma":[0.0018094288,0.00035422135,0.0007954937,0.0016066135,0.0009930701,0.0024445225,0.001939161,0.004672677,0.0070389654],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019983569,0.00021427344,0.0012453336,0.00492193,0.00006854295,0.0007754551,0.000650895,0.000295338,0.0034133259,0.027412998,0.56654257,0.39425948],"study_design_scores_gemma":[0.000005585849,0.00008282276,0.00097361306,0.0018212418,0.000012133259,0.0011120692,0.00009962208,0.000039778908,0.00011323164,0.0085489005,0.98717207,0.000018914352],"about_ca_topic_score_codex":0.0012801784,"about_ca_topic_score_gemma":0.00271848,"teacher_disagreement_score":0.019056274,"about_ca_system_score_codex":0.00078474823,"about_ca_system_score_gemma":0.0011440074,"threshold_uncertainty_score":0.06374955},"labels":[],"label_agreement":null},{"id":"W2784161421","doi":"10.1177/1352458517737373","title":"Mendelian randomization in multiple sclerosis: A causal role for vitamin D and obesity?","year":2018,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Mendelian randomization; Causal inference; Multiple sclerosis; Confounding; Causation; Disease; Causality (physics); Marginal structural model; Medicine; Epidemiology; Bioinformatics; Genetic variants; Biology; Genetics; Psychiatry; Pathology; Gene","score_opus":0.17799827357021936,"score_gpt":0.34449216425094664,"score_spread":0.16649389068072729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2784161421","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009051539,0.9971072,0.00061888114,0.0016360399,0.00022629031,0.000006435458,0.00001625263,0.0000052743535,0.00029319074],"genre_scores_gemma":[0.0029384678,0.9947344,0.0007693784,0.0008539942,0.0004976231,0.000023788756,0.000020372028,0.0000038795138,0.00015809393],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9958513,0.0025212003,0.0004973442,0.00041700833,0.0006394625,0.00007373864],"domain_scores_gemma":[0.9814354,0.016811129,0.0007994585,0.00035955617,0.000511398,0.00008311003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0072756647,0.00071926217,0.0030903427,0.0020625894,0.00031031837,0.0014704473,0.0018748188,0.0024226452,0.0029934535],"category_scores_gemma":[0.020786734,0.00035156545,0.0016748162,0.003071428,0.002273161,0.0017075595,0.0007897677,0.002452972,0.0005408948],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002223389,0.000043435284,0.0012926081,0.05988346,0.0020623568,0.00048005424,0.00020967118,0.0007608535,0.00026090664,0.042613216,0.018296368,0.87387466],"study_design_scores_gemma":[0.00031642363,0.0003308871,0.006031821,0.08090107,0.004905232,0.008253771,0.00039302924,0.0008478023,0.00071575807,0.13492079,0.7622179,0.0001656642],"about_ca_topic_score_codex":0.0027749648,"about_ca_topic_score_gemma":0.002706973,"teacher_disagreement_score":0.0072756647,"about_ca_system_score_codex":0.0012436381,"about_ca_system_score_gemma":0.002493437,"threshold_uncertainty_score":0.038477898},"labels":[],"label_agreement":null},{"id":"W2785343395","doi":"10.1177/1352458517751652","title":"Anxiety is more important than depression in MS – Yes","year":2018,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Depression (economics); Multiple sclerosis; Anxiety; Psychology; Clinical psychology; Medicine; Psychiatry","score_opus":0.1695190595445297,"score_gpt":0.3830606096105337,"score_spread":0.21354155006600398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785343395","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012555435,0.9992508,0.0000131746265,0.00033072731,0.00012821605,0.0000038911044,0.000022740713,7.157611e-7,0.00012409384],"genre_scores_gemma":[0.005157868,0.9932092,0.00012681354,0.0010775549,0.0002736507,0.000012074102,0.00004105412,9.4988184e-7,0.0001008138],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982273,0.0006128725,0.0006106421,0.00017755688,0.0003143154,0.00005728292],"domain_scores_gemma":[0.99353194,0.0049723275,0.0010791877,0.000059446953,0.00029101883,0.000066014414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025639043,0.00086122024,0.003596139,0.0023872035,0.000311951,0.0018730743,0.00090466137,0.0019866177,0.005282118],"category_scores_gemma":[0.010406065,0.0004938325,0.0028528816,0.0030768802,0.0007919974,0.0018121843,0.0007934939,0.0016570165,0.00035563452],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048325953,0.000051152827,0.0029373607,0.5901113,0.01336003,0.00020199594,0.0003749653,0.00012077354,0.00025329046,0.0016506062,0.016213264,0.37424198],"study_design_scores_gemma":[0.00093044987,0.00037851618,0.025724648,0.64409864,0.0693802,0.0025927457,0.0013632184,0.00015885316,0.00034775567,0.0042485436,0.25062898,0.00014740258],"about_ca_topic_score_codex":0.004388018,"about_ca_topic_score_gemma":0.0140807815,"teacher_disagreement_score":0.005282118,"about_ca_system_score_codex":0.000964855,"about_ca_system_score_gemma":0.002393904,"threshold_uncertainty_score":0.017670393},"labels":[],"label_agreement":null},{"id":"W2787084164","doi":"10.1177/1352458518757089","title":"The contribution of secondhand tobacco smoke exposure to pediatric multiple sclerosis risk","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Montreal Neurological Institute and Hospital; University of Toronto; University of Manitoba; McGill University; Hospital for Sick Children","funders":"","keywords":"Medicine; Multiple sclerosis; Odds ratio; Secondhand smoke; Confidence interval; Risk factor; Environmental health; Clinically isolated syndrome; Tobacco smoke; Internal medicine; Immunology","score_opus":0.08171314972602026,"score_gpt":0.29659562535028866,"score_spread":0.2148824756242684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2787084164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99658895,0.0023561376,0.00012706633,0.00010486658,0.000009532447,0.000005169246,0.00020748955,0.0000073995907,0.0005934329],"genre_scores_gemma":[0.9988526,0.0007551186,0.00015288978,0.00001064366,0.000013135509,0.000003425831,0.00013200856,0.0000031897164,0.00007694361],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995067,0.00013715013,0.000039701205,0.000099836994,0.00012612218,0.00009039387],"domain_scores_gemma":[0.9980861,0.0005129726,0.00088587485,0.000081300976,0.00013665837,0.0002969686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003994691,0.00042240662,0.00033772225,0.0007685785,0.00023270413,0.0005719899,0.00030341855,0.00036743665,0.0018264002],"category_scores_gemma":[0.0018693792,0.00019374097,0.00068636343,0.0008443442,0.00020692142,0.00023548715,0.00036129216,0.00054690737,0.00014967361],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032597334,0.0000069904063,0.9982486,0.000008597132,0.000047985173,0.000089212466,0.000020826712,0.000029901532,0.00010338745,0.000013926911,0.00002240397,0.0013756023],"study_design_scores_gemma":[0.000001882763,0.00005038076,0.9985663,0.000012456895,0.000059889888,0.0008172919,0.000060382237,0.00014418432,0.0001029173,0.00002475715,0.00015774475,0.0000017467729],"about_ca_topic_score_codex":0.0061402884,"about_ca_topic_score_gemma":0.0038975189,"teacher_disagreement_score":0.0061402884,"about_ca_system_score_codex":0.0003305502,"about_ca_system_score_gemma":0.0005823844,"threshold_uncertainty_score":0.012209117},"labels":[],"label_agreement":null},{"id":"W2788783358","doi":"10.1177/1352458518760715","title":"Convergent effects of a functional C3 variant on brain atrophy, demyelination, and cognitive impairment in multiple sclerosis","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Marshall Space Flight Center","keywords":"Multiple sclerosis; Expanded Disability Status Scale; White matter; Atrophy; Fractional anisotropy; Psychology; Clinically isolated syndrome; Paced Auditory Serial Addition Test; Magnetic resonance imaging; Medicine; Effects of sleep deprivation on cognitive performance; Voxel-based morphometry; Neuroscience; Cognition; Pathology; Cognitive impairment; Radiology; Psychiatry","score_opus":0.04636843942022612,"score_gpt":0.24225988541371635,"score_spread":0.19589144599349023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2788783358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992618,0.0002893931,0.00005718702,0.000031660682,0.0000025394077,0.0000038906055,0.000121614234,0.000004220788,0.00022779044],"genre_scores_gemma":[0.99962854,0.000055986005,0.00009378753,0.00002050008,0.0000053091862,0.0000029419766,0.000119440345,0.000004762828,0.00006858293],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99949706,0.0001445595,0.0000481382,0.00016319536,0.00011477268,0.00003235102],"domain_scores_gemma":[0.9976744,0.00078562036,0.00072932366,0.0002221297,0.00024211427,0.0003464626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096753845,0.00061519886,0.00051497057,0.00055131246,0.00032385025,0.0004333912,0.00041491055,0.00064425304,0.001674884],"category_scores_gemma":[0.0027479802,0.00014983983,0.00062230404,0.0004554214,0.00052612566,0.00016356762,0.00046480884,0.0004966238,0.00021447058],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013278876,0.00034879707,0.9185861,0.00010500499,0.0017797465,0.0011720406,0.00025929493,0.0005250157,0.05382516,0.00008164059,0.00016430784,0.009874044],"study_design_scores_gemma":[0.0000337351,0.0002726071,0.9980666,0.0000065524146,0.00020412443,0.00048068693,0.00003155145,0.00017519802,0.0006176667,0.000063737745,0.000042488347,0.0000050751482],"about_ca_topic_score_codex":0.003526864,"about_ca_topic_score_gemma":0.0030037102,"teacher_disagreement_score":0.003526864,"about_ca_system_score_codex":0.00029311396,"about_ca_system_score_gemma":0.00028416904,"threshold_uncertainty_score":0.0070126653},"labels":[],"label_agreement":null},{"id":"W2789148846","doi":"10.1177/1352458518756517","title":"MSJ 2018—editorial comment","year":2018,"lang":"fr","type":"editorial","venue":"Multiple Sclerosis Journal","topic":"Healthcare Systems and Public Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Multiple sclerosis; Medicine; Psychology; Computer science; Cognitive science; Psychiatry","score_opus":0.10011285183027074,"score_gpt":0.3329264860226557,"score_spread":0.23281363419238493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789148846","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000056814457,0.0013413407,0.000053911954,0.16502927,0.8315369,0.000019695128,0.00008858267,0.00006446572,0.0018090493],"genre_scores_gemma":[0.0007374792,0.0012278673,0.00009906341,0.10036882,0.88873255,0.000037928792,0.00006846822,0.000068027584,0.008659835],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9842466,0.0025636577,0.0024280234,0.0015289325,0.007345174,0.0018876025],"domain_scores_gemma":[0.9373399,0.020036029,0.00809787,0.0022467359,0.025889618,0.006389865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014470392,0.0031532494,0.0041556614,0.0052727684,0.007159815,0.012710872,0.0052853283,0.046781387,0.039271828],"category_scores_gemma":[0.1041435,0.0014428494,0.0037747894,0.0024688402,0.0042297593,0.0049354155,0.0037143433,0.024617558,0.026519893],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024107896,0.000008186833,0.000031808526,0.000070563976,0.000012113279,0.00011038437,0.000013923005,0.000006569879,0.000013011996,0.00014543154,0.99829704,0.0012669162],"study_design_scores_gemma":[0.00019494118,0.000034158358,0.00049289723,0.0007575227,0.00009463563,0.00034402686,0.00010733761,0.00015927275,0.00013619644,0.0012664788,0.9963767,0.000035671117],"about_ca_topic_score_codex":0.0053331032,"about_ca_topic_score_gemma":0.011319927,"teacher_disagreement_score":0.046781387,"about_ca_system_score_codex":0.0072756056,"about_ca_system_score_gemma":0.0076824618,"threshold_uncertainty_score":0.13137734},"labels":[],"label_agreement":null},{"id":"W2791285120","doi":"10.1177/1352458518755564","title":"Studying the blood–brain barrier will provide new insights into neurodegeneration – No","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Diet and metabolism studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Neurodegeneration; Multiple sclerosis; Blood–brain barrier; Neuroscience; Medicine; Psychology; Disease; Pathology; Central nervous system; Immunology","score_opus":0.057492595791054674,"score_gpt":0.26372072859207074,"score_spread":0.20622813280101607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791285120","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86785704,0.102368556,0.0074325735,0.0094994195,0.0011947785,0.000056313977,0.00033526594,0.00008952775,0.011166439],"genre_scores_gemma":[0.9504948,0.034931526,0.005693659,0.0027854545,0.0008377114,0.000070111084,0.00018852632,0.000043007407,0.0049553276],"study_design_codex":"bench_or_experimental","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9997764,0.00009543498,0.000019062038,0.000045795445,0.00003150223,0.000031764324],"domain_scores_gemma":[0.99934536,0.00017241745,0.00022433006,0.00008037947,0.00007067507,0.00010691574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064467004,0.0004862065,0.00071827444,0.0005552168,0.0004865507,0.0010452803,0.00040579037,0.0010641381,0.0026644315],"category_scores_gemma":[0.0006898653,0.00014929005,0.00033539024,0.00036304162,0.0011313084,0.0026286994,0.0006059928,0.0011936153,0.0002607519],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014428769,0.002126288,0.038228508,0.0032859507,0.001226935,0.0020963375,0.000743593,0.00047746056,0.7421411,0.033368777,0.0039207493,0.15795548],"study_design_scores_gemma":[0.00083783886,0.008976261,0.26549357,0.00095811486,0.0018114742,0.0048201536,0.004478109,0.002237478,0.521223,0.096829206,0.09218551,0.00014934305],"about_ca_topic_score_codex":0.0008454037,"about_ca_topic_score_gemma":0.0011238855,"teacher_disagreement_score":0.0026644315,"about_ca_system_score_codex":0.00056032103,"about_ca_system_score_gemma":0.0004639925,"threshold_uncertainty_score":0.008913338},"labels":[],"label_agreement":null},{"id":"W2794078189","doi":"10.1177/1352458518763089","title":"Effect of <i>HLA-DRB1</i> alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Bundesministerium für Bildung und Forschung","keywords":"Allele; HLA-DRB1; Human leukocyte antigen; BETA (programming language); Multiple sclerosis; Antibody; Interferon beta; Genetics; Immunology; Medicine; Virology; Biology; Gene; Antigen; Computer science","score_opus":0.12935881680211836,"score_gpt":0.3512733435486762,"score_spread":0.22191452674655782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794078189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99629277,0.0022236963,0.00027580492,0.00025842575,0.000039842675,0.000036381938,0.00014566383,0.0000072319253,0.0007202625],"genre_scores_gemma":[0.9990864,0.0002140185,0.00021779386,0.0001335163,0.000024230654,0.000029302711,0.00014625209,0.0000052029686,0.00014325204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9892229,0.008515033,0.00047835775,0.0009463267,0.00043866842,0.0003987651],"domain_scores_gemma":[0.97017944,0.022475194,0.004361196,0.0011097661,0.0004521733,0.0014221658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012005409,0.00039964792,0.00095332455,0.00019928951,0.00029562943,0.001092088,0.00042275386,0.0008227234,0.0019265274],"category_scores_gemma":[0.017559534,0.00020785457,0.0020086449,0.00044549545,0.00051701884,0.0005224601,0.00031947487,0.0011176218,0.00015443287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3640849,0.000899556,0.57817537,0.00049763813,0.016034335,0.0004789926,0.00022513952,0.0018259091,0.004609189,0.00045423862,0.0012566608,0.031458095],"study_design_scores_gemma":[0.021996513,0.049953684,0.8875292,0.00023170172,0.0274084,0.0010270564,0.00021794363,0.004663312,0.0025564004,0.0011729161,0.003171905,0.00007093302],"about_ca_topic_score_codex":0.00047946628,"about_ca_topic_score_gemma":0.0005759345,"teacher_disagreement_score":0.012005409,"about_ca_system_score_codex":0.0002367332,"about_ca_system_score_gemma":0.00044071235,"threshold_uncertainty_score":0.063491404},"labels":[],"label_agreement":null},{"id":"W2794124086","doi":"10.1177/1352458518761185","title":"Severe hypertriglyceridemia associated with teriflunomide in a patient with multiple sclerosis: A case report","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Teriflunomide; Hypertriglyceridemia; Medicine; Multiple sclerosis; Adverse effect; Leflunomide; Pediatrics; Internal medicine; Dermatology; Psychiatry; Rheumatoid arthritis","score_opus":0.04525619744027388,"score_gpt":0.23622787660334787,"score_spread":0.190971679163074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794124086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799626,0.0077030193,0.0027860252,0.0020424295,0.00024157345,0.000121737736,0.000118176606,0.00016914734,0.00685536],"genre_scores_gemma":[0.99426705,0.0023240757,0.0011545555,0.00060693023,0.00076322665,0.000022207996,0.000056238256,0.000019266876,0.00078653917],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9993967,0.000085007334,0.00010352512,0.00014650988,0.00009615778,0.00017212663],"domain_scores_gemma":[0.998456,0.00044088357,0.00047414843,0.00014772582,0.00009604601,0.00038512537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038937104,0.0018522254,0.001164525,0.0023091072,0.0026919034,0.0016815572,0.0008382577,0.0040267617,0.00207811],"category_scores_gemma":[0.0025307236,0.0012641384,0.0011935589,0.0015693016,0.0013837821,0.002101686,0.0013791891,0.0024648611,0.00078287534],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025161944,0.000031286276,0.0073425225,0.000027266577,0.000009999274,0.99075866,0.00016077257,0.00003200616,0.0006070839,0.000045942434,0.00015790416,0.00080135994],"study_design_scores_gemma":[0.0000051480934,0.00002793808,0.0017111179,0.0000066693424,0.000010685536,0.9976706,0.000060162776,0.00006355946,0.00020325415,0.000034954825,0.00020076342,0.000005182837],"about_ca_topic_score_codex":0.0013354269,"about_ca_topic_score_gemma":0.0015530932,"teacher_disagreement_score":0.0040267617,"about_ca_system_score_codex":0.00066693843,"about_ca_system_score_gemma":0.0006464509,"threshold_uncertainty_score":0.0069519877},"labels":[],"label_agreement":null},{"id":"W2798153306","doi":"10.1177/1352458518770086","title":"The link between depression and performance on the Symbol Digit Modalities Test: Mechanisms and clinical significance","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Spatial Neglect and Hemispheric Dysfunction","field":"Neuroscience","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Psychology; Depression (economics); Symbol (formal); Audiology; Contrast (vision); Cognitive psychology; Developmental psychology; Medicine; Artificial intelligence; Computer science","score_opus":0.0998675238780978,"score_gpt":0.2777022262227237,"score_spread":0.17783470234462592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2798153306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99847645,0.0006973706,0.00014138094,0.000121254714,0.000005320503,0.000014913383,0.00012268567,0.0000058650467,0.00041465572],"genre_scores_gemma":[0.99955314,0.00014852785,0.00009429263,0.000021308964,0.000011513197,0.000004744744,0.000072060764,9.5091633e-7,0.000093405586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997476,0.000060371163,0.00003351712,0.000061410996,0.00007033792,0.000026850672],"domain_scores_gemma":[0.9979534,0.00068436505,0.0010190206,0.00009019471,0.00013026343,0.00012269674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050900073,0.00033161198,0.00038055345,0.0006282194,0.000183851,0.00044054558,0.00030631988,0.00053781003,0.002078187],"category_scores_gemma":[0.0031896452,0.00017274772,0.00022512337,0.00037675083,0.00043618592,0.00031306618,0.0002678955,0.00044862533,0.00020947526],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020455115,0.0003412284,0.9824175,0.000039611867,0.0001944005,0.0008420352,0.00007209081,0.00010712007,0.006051476,0.000074169475,0.00007377703,0.0077409553],"study_design_scores_gemma":[0.000023995131,0.0003079407,0.9980464,0.0000043878576,0.000039707407,0.00089554465,0.000018552719,0.00018019397,0.00039808266,0.000052670235,0.000030118514,0.0000024198494],"about_ca_topic_score_codex":0.0012440343,"about_ca_topic_score_gemma":0.0009622272,"teacher_disagreement_score":0.002078187,"about_ca_system_score_codex":0.0002421481,"about_ca_system_score_gemma":0.00021450229,"threshold_uncertainty_score":0.0069521666},"labels":[],"label_agreement":null},{"id":"W2799623984","doi":"10.1177/1352458518772913","title":"Rebound disease in multiple sclerosis","year":2018,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Prion Diseases and Protein Misfolding","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal Neurological Institute and Hospital","funders":"","keywords":"Multiple sclerosis; Disease; Medicine; Clinical neurology; Neuroscience; Psychology; Psychiatry; Pathology","score_opus":0.07265709129540794,"score_gpt":0.2474981076029974,"score_spread":0.17484101630758947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799623984","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02588624,0.022701586,0.00070515345,0.89483315,0.03843109,0.00004180907,0.000066977846,0.00013100464,0.017202973],"genre_scores_gemma":[0.25582466,0.01344549,0.0010814968,0.4352582,0.26839536,0.000088846355,0.000116568684,0.000074307005,0.02571518],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994406,0.00017823222,0.000084708074,0.00006929355,0.00011239604,0.00011478503],"domain_scores_gemma":[0.99694127,0.0019156772,0.00028411124,0.00018748347,0.00028130432,0.00039005827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011123705,0.0006985921,0.001144765,0.00075125805,0.0015590591,0.0015499797,0.0009900886,0.022589607,0.0028431492],"category_scores_gemma":[0.007071006,0.0003331555,0.0006670064,0.000404819,0.0015946537,0.0017558009,0.0007375263,0.011348685,0.001420765],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013087685,0.0002379825,0.0058682547,0.00040654957,0.00008670043,0.29740578,0.00047401674,0.00027630464,0.0030348343,0.013011254,0.63352686,0.044362683],"study_design_scores_gemma":[0.0016082503,0.00064366095,0.016707161,0.0010477582,0.00028135933,0.28343678,0.0007613572,0.0038993328,0.002377393,0.04856163,0.64051515,0.00016016793],"about_ca_topic_score_codex":0.00082492887,"about_ca_topic_score_gemma":0.001198355,"teacher_disagreement_score":0.022589607,"about_ca_system_score_codex":0.0017946518,"about_ca_system_score_gemma":0.00056121603,"threshold_uncertainty_score":0.013021171},"labels":[],"label_agreement":null},{"id":"W2801634700","doi":"10.1177/1352458518768722","title":"Factors affecting continuation of clean intermittent catheterisation in people with multiple sclerosis: Results of the COSMOS mixed-methods study","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Pelvic floor disorders treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Multiple Sclerosis Society","keywords":"Discontinuation; Medicine; Continuation; Multiple sclerosis; Cohort; Longitudinal study; Incidence (geometry); Pediatrics; Intensive care medicine; Internal medicine; Psychiatry; Pathology","score_opus":0.07257689750385679,"score_gpt":0.3123649645039088,"score_spread":0.23978806700005204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801634700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99910283,0.0003137109,0.0000832172,0.000044929617,0.000006301618,0.00010606029,0.00016396277,0.0000016337884,0.00017741644],"genre_scores_gemma":[0.9987914,0.0002406147,0.0002417982,0.000057884594,0.000010468793,0.00024642338,0.00017936609,0.0000019309446,0.00023012861],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.99745494,0.0014623952,0.00036503718,0.00018207415,0.00029656122,0.00023901125],"domain_scores_gemma":[0.99586016,0.001476534,0.0014514301,0.00031789177,0.00050487363,0.00038912005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006013951,0.00048059673,0.0008474047,0.0011640127,0.00088722486,0.0013029614,0.00043896792,0.00083318865,0.0012337662],"category_scores_gemma":[0.008159698,0.0005277462,0.0019617716,0.0011202487,0.00036045222,0.0008303856,0.0013671564,0.0005621658,0.00019760831],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007755978,0.00049214525,0.98722523,0.00015853287,0.00028642904,0.00011027332,0.0048896265,0.000022756316,0.00014605247,0.00002858561,0.00011076912,0.005754055],"study_design_scores_gemma":[0.00010603532,0.0014810594,0.9872869,0.00012019902,0.00029618051,0.0002938877,0.00967304,0.00020038837,0.00008047279,0.000041977975,0.00039669292,0.000023128645],"about_ca_topic_score_codex":0.0059151053,"about_ca_topic_score_gemma":0.0081155645,"teacher_disagreement_score":0.006013951,"about_ca_system_score_codex":0.0006255953,"about_ca_system_score_gemma":0.0009431864,"threshold_uncertainty_score":0.031805158},"labels":[],"label_agreement":null},{"id":"W2801723726","doi":"10.1177/1352458518770085","title":"A 24-month advanced magnetic resonance imaging study of multiple sclerosis patients treated with alemtuzumab","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"International Collaboration On Repair Discoveries; University of British Columbia","funders":"Sanofi Genzyme; Dartmouth College","keywords":"Multiple sclerosis; Alemtuzumab; White matter; Medicine; Corpus callosum; Magnetic resonance imaging; Fractional anisotropy; Myelin; Diffusion MRI; Pathology; Nuclear medicine; Radiology; Central nervous system; Internal medicine","score_opus":0.06147646944500618,"score_gpt":0.2814101738456547,"score_spread":0.21993370440064852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801723726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992556,0.0001770411,0.000023976776,0.00005448527,0.000007692441,0.000018851022,0.00008118831,0.0000028564277,0.00037817768],"genre_scores_gemma":[0.9993129,0.00007851104,0.000038363447,0.000056078123,0.000021624952,0.000014287672,0.0001617725,0.0000013999482,0.0003151215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997873,0.00003832712,0.00002506421,0.00005803345,0.000039372917,0.000051975574],"domain_scores_gemma":[0.9991912,0.00006683207,0.00019744608,0.000037311693,0.00010950695,0.00039765114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040314437,0.00045101906,0.00081377866,0.000719772,0.0010555479,0.00060020824,0.00029726923,0.0011799465,0.0010614238],"category_scores_gemma":[0.0012829016,0.00026894425,0.00043815185,0.0006671889,0.00030450238,0.00054534944,0.0003533638,0.0009777779,0.00044674866],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051207836,0.001967436,0.97487766,0.000045159348,0.00018931252,0.006169041,0.0012685658,0.00011577873,0.0048698946,0.00002694719,0.00027433626,0.005074948],"study_design_scores_gemma":[0.000090719026,0.0029087327,0.99349594,0.000006222704,0.00006101889,0.002392825,0.00026823697,0.00010322862,0.00018732941,0.000020011934,0.00045353893,0.000012146837],"about_ca_topic_score_codex":0.0032952668,"about_ca_topic_score_gemma":0.0023395447,"teacher_disagreement_score":0.0032952668,"about_ca_system_score_codex":0.00046770147,"about_ca_system_score_gemma":0.0003128854,"threshold_uncertainty_score":0.00655216},"labels":[],"label_agreement":null},{"id":"W2802045380","doi":"10.1177/1352458518771257","title":"We should focus more on finding therapeutic targets for the non-inflammatory damage in MS – Commentary","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Multiple sclerosis; Focus (optics); Medicine; Neuroscience; Psychology; Intensive care medicine; Immunology; Physics","score_opus":0.16352540032864646,"score_gpt":0.3594872247878945,"score_spread":0.19596182445924806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802045380","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010242238,0.010573603,0.00009657978,0.92539585,0.0631102,0.000009741197,0.00009738119,0.000017378135,0.0005967164],"genre_scores_gemma":[0.0012043086,0.0061043757,0.00022930803,0.8985128,0.09247562,0.00002995969,0.000037701604,0.000013583531,0.0013923412],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99114406,0.0039337305,0.0013949465,0.00091286685,0.0020968725,0.0005175601],"domain_scores_gemma":[0.88155985,0.085613415,0.0042801024,0.0015788546,0.022595715,0.0043719853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012532515,0.0009282261,0.0025702934,0.0011323666,0.0020870455,0.00271042,0.003990155,0.030073773,0.009347311],"category_scores_gemma":[0.08068369,0.0005208905,0.0018338137,0.0010657508,0.005025154,0.006530136,0.0024639785,0.038569834,0.00415761],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010225118,0.000019583493,0.00009472429,0.0009713977,0.0000586418,0.00013310794,0.00008553783,0.000046702116,0.000117951175,0.0024215886,0.9857184,0.010230112],"study_design_scores_gemma":[0.00040512782,0.00012500177,0.0008036799,0.004887525,0.00026056156,0.00058209,0.00042885437,0.00014430805,0.00031334822,0.017553741,0.9743927,0.00010300169],"about_ca_topic_score_codex":0.009025114,"about_ca_topic_score_gemma":0.013080071,"teacher_disagreement_score":0.030073773,"about_ca_system_score_codex":0.003838866,"about_ca_system_score_gemma":0.008633977,"threshold_uncertainty_score":0.06627905},"labels":[],"label_agreement":null},{"id":"W2802785428","doi":"10.1177/1352458518767323","title":"Disease-modifying therapy in multiple sclerosis: Two guidelines (almost) passing in the night","year":2018,"lang":"en","type":"editorial","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Manitoba","funders":"","keywords":"Multiple sclerosis; Disease; Medicine; Fingolimod; Physical medicine and rehabilitation; Internal medicine; Psychiatry","score_opus":0.26410210078706653,"score_gpt":0.38624842131320664,"score_spread":0.1221463205261401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802785428","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000022330412,0.012671255,0.000105224644,0.041374464,0.94547033,0.000017585724,0.00003642603,0.000028079327,0.00027436728],"genre_scores_gemma":[0.00023630336,0.011194541,0.00020141882,0.048391636,0.9379701,0.000037853344,0.00003116916,0.00003282492,0.0019041292],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97444123,0.0073676896,0.0059315152,0.0014289635,0.009653847,0.0011768185],"domain_scores_gemma":[0.9009295,0.050878488,0.008331841,0.0025478466,0.028685002,0.008627256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.028517157,0.0046581733,0.009085612,0.005902876,0.0038486796,0.012073664,0.0063618068,0.03035493,0.0056864624],"category_scores_gemma":[0.078817,0.0019647279,0.0061165197,0.0035387909,0.004571058,0.007111621,0.003081295,0.038591184,0.006334559],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008410592,0.000028493436,0.000039034036,0.00072335143,0.000075953016,0.00009592738,0.00002518653,0.000021479564,0.000053896103,0.00025885037,0.98979455,0.008799159],"study_design_scores_gemma":[0.00037671244,0.00011133125,0.00054301403,0.004479817,0.00039162522,0.00042832122,0.00015457654,0.00018518571,0.00014277804,0.0016889941,0.9914358,0.000061853236],"about_ca_topic_score_codex":0.003439954,"about_ca_topic_score_gemma":0.010517344,"teacher_disagreement_score":0.03035493,"about_ca_system_score_codex":0.004444943,"about_ca_system_score_gemma":0.008611382,"threshold_uncertainty_score":0.15081495},"labels":[],"label_agreement":null},{"id":"W2803403988","doi":"10.1177/1352458518773511","title":"Predictive validity of NEDA in the 16- and 21-year follow-up from the pivotal trial of interferon beta-1b","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University; University of British Columbia","funders":"","keywords":"Medicine; Expanded Disability Status Scale; Internal medicine; Interferon beta-1b; Multiple sclerosis; Clinical trial; Randomization; Randomized controlled trial; Central nervous system disease; Physical therapy; Interferon beta","score_opus":0.1605793611357558,"score_gpt":0.3254991434787016,"score_spread":0.16491978234294583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803403988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99629265,0.001708736,0.0002961925,0.00016689293,0.00006237244,0.000024798,0.00064588786,0.00000517754,0.0007973038],"genre_scores_gemma":[0.99875355,0.0001400501,0.00016191065,0.000045261422,0.00003449651,0.000027338894,0.00073611684,0.0000026818436,0.00009850581],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9933576,0.003906528,0.0005838024,0.00085219427,0.00092578155,0.00037407922],"domain_scores_gemma":[0.93576056,0.038718246,0.017913058,0.0028371455,0.0024266324,0.0023443254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018584775,0.00049550715,0.0008215886,0.0006841906,0.00042515015,0.0013125176,0.000710301,0.0008681518,0.0011746158],"category_scores_gemma":[0.04228711,0.00022433294,0.0011457709,0.0006968287,0.0005625096,0.00094561634,0.001185705,0.0017302781,0.00022478683],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040602684,0.00006147145,0.9909016,0.000029672065,0.00026240016,0.00004013279,0.000055724227,0.0004182028,0.000069527065,0.000064901906,0.00019797975,0.0038380788],"study_design_scores_gemma":[0.00034038463,0.0011873638,0.99310815,0.00007168112,0.0004515031,0.00028875013,0.00007629898,0.003077858,0.00024185897,0.0003710087,0.00076228875,0.00002287381],"about_ca_topic_score_codex":0.00073895336,"about_ca_topic_score_gemma":0.0011535563,"teacher_disagreement_score":0.018584775,"about_ca_system_score_codex":0.00036895717,"about_ca_system_score_gemma":0.0004978654,"threshold_uncertainty_score":0.09828687},"labels":[],"label_agreement":null},{"id":"W2805565017","doi":"10.1177/1352458518779952","title":"Detection and clinical correlation of leukocortical lesions in pediatric-onset multiple sclerosis on multi-contrast MRI","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Hospital for Sick Children; York University; SickKids Foundation; Montreal Neurological Institute and Hospital; University of Toronto; McGill University","funders":"","keywords":"Medicine; Fluid-attenuated inversion recovery; Multiple sclerosis; Magnetic resonance imaging; Nuclear medicine; Neuroradiology; Hyperintensity; CLs upper limits; White matter; Radiology; Lesion; Neurology; Pathology; Ophthalmology","score_opus":0.15982527478503064,"score_gpt":0.35428345154272295,"score_spread":0.1944581767576923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805565017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99955326,0.00014381683,0.000081153965,0.000012559456,0.0000012451637,0.000004094081,0.00006350614,0.0000043925843,0.00013592376],"genre_scores_gemma":[0.99953866,0.000079398465,0.00023352918,0.0000070154724,0.0000043398013,0.0000044762764,0.00009724737,0.000001964153,0.000033541513],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999616,0.00006634852,0.000054788845,0.00011780218,0.00009844486,0.00004655868],"domain_scores_gemma":[0.9979765,0.00031997706,0.0012453052,0.00006174749,0.00021519992,0.00018127839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005320107,0.00046373252,0.00028698484,0.0010941598,0.000294274,0.00042536866,0.000292235,0.00043734087,0.001700899],"category_scores_gemma":[0.0031019358,0.00023918963,0.00017001954,0.0004984829,0.00035210562,0.0005776244,0.00037113167,0.00025912168,0.00023974078],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009210087,0.000012882074,0.99638295,0.000011371806,0.000013862994,0.00059788354,0.000049032384,0.00004009673,0.001553314,0.0000064065193,0.00002928966,0.0012107199],"study_design_scores_gemma":[0.0000047759027,0.000092105045,0.9930026,0.00000836725,0.0000118638845,0.006013257,0.00013018583,0.00013540489,0.00051816826,0.000010910381,0.0000699133,0.0000023512468],"about_ca_topic_score_codex":0.0014567884,"about_ca_topic_score_gemma":0.0021213847,"teacher_disagreement_score":0.001700899,"about_ca_system_score_codex":0.00021039923,"about_ca_system_score_gemma":0.00023676817,"threshold_uncertainty_score":0.005690098},"labels":[],"label_agreement":null},{"id":"W2809275981","doi":"10.1177/1352458518781999","title":"Focal and diffuse cervical spinal cord damage in patients with early relapsing–remitting MS: A multicentre magnetisation transfer ratio study","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Polytechnique Montréal; Métis National Council","funders":"","keywords":"Magnetization transfer; Multiple sclerosis; Medicine; Sagittal plane; Nuclear medicine; Spinal cord; Lesion; Relapsing remitting; Central nervous system disease; Magnetic resonance imaging; Radiology; Pathology; Surgery","score_opus":0.05180050972590085,"score_gpt":0.28576131476966604,"score_spread":0.2339608050437652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809275981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99956983,0.0001510372,0.000036003006,0.00001011698,0.0000017020643,0.000018344783,0.000048429047,0.0000020400846,0.00016236209],"genre_scores_gemma":[0.9996762,0.00004251103,0.000064013926,0.000012633227,0.0000072630696,0.000012129019,0.00010717136,0.0000014185582,0.00007668671],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995079,0.00011709145,0.00005862045,0.00015941804,0.00009524353,0.00006173588],"domain_scores_gemma":[0.9990752,0.00016812258,0.0003085281,0.000106864405,0.00014801238,0.00019322743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008234512,0.0007052802,0.00063617545,0.0013048876,0.0006555914,0.00047844934,0.0004633571,0.0009433945,0.0014906524],"category_scores_gemma":[0.002184919,0.0003660446,0.00043525928,0.0006853303,0.0004715237,0.0004556617,0.00054352195,0.000396044,0.00041693106],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029098168,0.0002738176,0.9878591,0.000057879985,0.0002141036,0.0010104269,0.00046272448,0.0000827302,0.0033979132,0.000015323818,0.000088291374,0.0036279797],"study_design_scores_gemma":[0.00006429138,0.0006487382,0.9975107,0.0000048726424,0.000064568194,0.00134367,0.000098357326,0.00006377094,0.00011234345,0.00000947826,0.000074017276,0.000005340335],"about_ca_topic_score_codex":0.0034119927,"about_ca_topic_score_gemma":0.0034761075,"teacher_disagreement_score":0.0034119927,"about_ca_system_score_codex":0.00042404965,"about_ca_system_score_gemma":0.0002552494,"threshold_uncertainty_score":0.0067842603},"labels":[],"label_agreement":null},{"id":"W2809364847","doi":"10.1177/1352458518783667","title":"Predicting risk of secondary progression in multiple sclerosis: A nomogram","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital","funders":"Neuroförbundet; Biogen","keywords":"Multiple sclerosis; Nomogram; Medicine; Oncology; Immunology","score_opus":0.10441723568976612,"score_gpt":0.32042407872798306,"score_spread":0.21600684303821693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809364847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8457972,0.0034295968,0.13703415,0.0020715685,0.0002695577,0.0005256746,0.0048826816,0.0007236618,0.0052660145],"genre_scores_gemma":[0.9636444,0.00051111815,0.033500426,0.0000965147,0.000092948474,0.0001429636,0.0016367888,0.000034972378,0.0003399609],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99716777,0.0018505089,0.00015944162,0.00032279897,0.00038662652,0.00011294238],"domain_scores_gemma":[0.9822174,0.012764753,0.0019759785,0.00084203715,0.0015755091,0.0006242528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010761969,0.0010805344,0.0010555374,0.0038831965,0.000559008,0.0019242577,0.00088543695,0.00082441216,0.0013010046],"category_scores_gemma":[0.029215563,0.0002587055,0.0013404774,0.0014157319,0.0006273617,0.0011660514,0.0009617763,0.0009310255,0.0005716918],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008290509,0.00013290899,0.87384593,0.00019661493,0.0006080559,0.00020583699,0.00020304389,0.052490287,0.00042419764,0.0010262564,0.0040863105,0.06595159],"study_design_scores_gemma":[0.00022999238,0.0013483934,0.46520033,0.00040654125,0.0008026344,0.0011629931,0.00061092485,0.51601416,0.0012006661,0.005609047,0.0072582997,0.0001559796],"about_ca_topic_score_codex":0.0035380358,"about_ca_topic_score_gemma":0.0030791922,"teacher_disagreement_score":0.010761969,"about_ca_system_score_codex":0.00057142624,"about_ca_system_score_gemma":0.0009666834,"threshold_uncertainty_score":0.056915343},"labels":[],"label_agreement":null},{"id":"W2809452711","doi":"10.1177/1352458518783345","title":"A framework for measurement and harmonization of pediatric multiple sclerosis etiologic research studies: The Pediatric MS Tool-Kit","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institut Universitaire de Gériatrie de Montréal; McGill University; Public Health Ontario; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; University of Toronto; Royal Victoria Hospital; McGill University Health Centre","funders":"National Institute of Neurological Disorders and Stroke; Multiple Sclerosis International Federation; National Multiple Sclerosis Society","keywords":"Medicine; Harmonization; Comparability; Etiology; Multiple sclerosis; Sample (material); Medical physics; Environmental health; Pathology; Immunology","score_opus":0.5242408385769554,"score_gpt":0.41497392807491307,"score_spread":0.10926691050204229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809452711","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014512993,0.010966345,0.8522406,0.037839986,0.0024479632,0.064174935,0.004592878,0.0024536438,0.010770623],"genre_scores_gemma":[0.014707328,0.0009001446,0.9510997,0.0010582855,0.00013603515,0.03070657,0.0011508842,0.00009786458,0.00014321087],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.25878507,0.5567633,0.14624728,0.00935647,0.02514428,0.0037036696],"domain_scores_gemma":[0.17934977,0.63099086,0.04809549,0.04522697,0.08779067,0.008546302],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.6364676,0.004805794,0.007183854,0.03462845,0.0062198066,0.015391949,0.010618407,0.0065828767,0.0027648755],"category_scores_gemma":[0.6548666,0.0046733264,0.012488846,0.024216224,0.013068927,0.01745442,0.03263982,0.01021668,0.001220629],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065013045,0.00076795876,0.032419372,0.060527764,0.0035338146,0.00072589767,0.073711835,0.00844896,0.0024638835,0.20200539,0.061030567,0.5537145],"study_design_scores_gemma":[0.001655768,0.001925887,0.042850874,0.10310062,0.0029485815,0.0013566405,0.048614405,0.015778014,0.003019844,0.3666685,0.41075405,0.001326925],"about_ca_topic_score_codex":0.006854439,"about_ca_topic_score_gemma":0.0068392553,"teacher_disagreement_score":0.36353242,"about_ca_system_score_codex":0.02215528,"about_ca_system_score_gemma":0.073534764,"threshold_uncertainty_score":0.44830024},"labels":[],"label_agreement":null},{"id":"W2867129155","doi":"10.1177/1352458518783662","title":"Five years before multiple sclerosis onset: Phenotyping the prodrome","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Dalhousie University; University of Saskatchewan; University of Manitoba; Saskatchewan Health Quality Council; Manitoba Health; University of British Columbia","funders":"National Multiple Sclerosis Society","keywords":"Medicine; Multiple sclerosis; Cohort; Prodrome; Confidence interval; Population; Cohort study; Specialty; Internal medicine; Relative risk; Pediatrics; Psychiatry; Psychosis","score_opus":0.10413390768599322,"score_gpt":0.3019182711405465,"score_spread":0.19778436345455325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2867129155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975921,0.00059693475,0.00016969771,0.0000684109,0.000009297883,0.00002774255,0.0007945244,0.000007708362,0.0007335984],"genre_scores_gemma":[0.9987551,0.00017734065,0.0001861732,0.0000265304,0.000005925567,0.0000058102023,0.00066170143,0.000002177376,0.00017926724],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99925095,0.00012116329,0.00005383813,0.00016452438,0.00021020566,0.00019919378],"domain_scores_gemma":[0.9984164,0.00014096478,0.0009101045,0.000057953213,0.0002384658,0.00023603848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073743175,0.00041220099,0.00037525734,0.0012047207,0.00074364187,0.00063700206,0.0006885162,0.00041566038,0.0010507976],"category_scores_gemma":[0.0020778705,0.00021809728,0.00053339865,0.0014341604,0.0003361627,0.00031933206,0.00062639115,0.0005701138,0.0001401141],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001379706,0.000012126697,0.99768496,0.000015639253,0.000029849216,0.0002691551,0.00013618851,0.00006193844,0.00025504097,0.000033267308,0.0001080851,0.0012558016],"study_design_scores_gemma":[0.0000023002256,0.000035876557,0.9992055,0.000009022897,0.000015574624,0.00037158348,0.00010207356,0.00006279802,0.000041667176,0.000019533541,0.00013164114,0.0000024293208],"about_ca_topic_score_codex":0.23558524,"about_ca_topic_score_gemma":0.27303946,"teacher_disagreement_score":0.23558524,"about_ca_system_score_codex":0.0015035793,"about_ca_system_score_gemma":0.0019965768,"threshold_uncertainty_score":0.46842796},"labels":[],"label_agreement":null},{"id":"W2883099048","doi":"10.1177/1352458518791683","title":"Multiple sclerosis disease progression: Contributions from a hypoxia–inflammation cycle","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Multiple sclerosis; Hypoxia (environmental); Medicine; Inflammation; Disease; Neuroscience; Pathology; Internal medicine; Psychology; Immunology; Chemistry; Oxygen","score_opus":0.035066947406308224,"score_gpt":0.25354632373801106,"score_spread":0.21847937633170283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883099048","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5960281,0.3190885,0.019695098,0.02368368,0.0017835554,0.00053789775,0.0011917468,0.00047335812,0.03751806],"genre_scores_gemma":[0.9348972,0.051264297,0.0037365593,0.0016052698,0.0013034377,0.00015416976,0.00026670788,0.000033252163,0.0067391363],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996594,0.000100524994,0.000021465108,0.00004982436,0.00007917033,0.000089672474],"domain_scores_gemma":[0.9993899,0.000115407034,0.00015244528,0.000027528124,0.00013513774,0.00017956208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005532483,0.00040830384,0.00077986496,0.0006246051,0.00049599056,0.0013034095,0.00032107974,0.00073272677,0.0023193946],"category_scores_gemma":[0.00062719913,0.00020273859,0.00036242194,0.0002838376,0.00052517623,0.0009671393,0.00094392494,0.00087714853,0.00033733516],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064302287,0.00172765,0.07910856,0.0038394856,0.0005998135,0.004678568,0.0027401727,0.0033726534,0.4244666,0.054699417,0.018147925,0.40018883],"study_design_scores_gemma":[0.00070757064,0.008355236,0.64926845,0.0016453777,0.00077124476,0.006734956,0.0031216023,0.011789071,0.07095702,0.08661346,0.15979482,0.00024117448],"about_ca_topic_score_codex":0.0007941622,"about_ca_topic_score_gemma":0.0011114241,"teacher_disagreement_score":0.0023193946,"about_ca_system_score_codex":0.00071358617,"about_ca_system_score_gemma":0.0007117162,"threshold_uncertainty_score":0.007759154},"labels":[],"label_agreement":null},{"id":"W2884754452","doi":"10.1177/1352458518789884","title":"Efficacy and safety of ozanimod in multiple sclerosis: Dose-blinded extension of a randomized phase II study","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; McGill University; NeuroRx Research (Canada)","funders":"Bayer HealthCare; CSL Behring; IC Design Education Center; Teva Pharmaceutical Industries; Biogen; Sanofi; European Commission; Pfizer","keywords":"Medicine; Placebo; Tolerability; Internal medicine; Adverse effect; Pathology; Alternative medicine","score_opus":0.17247687603535283,"score_gpt":0.36080886889632013,"score_spread":0.1883319928609673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884754452","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9540488,0.002334599,0.0026413444,0.0006824692,0.00067864225,0.035051662,0.0022105447,0.00028429306,0.00206769],"genre_scores_gemma":[0.9337274,0.0022939676,0.007058778,0.001452381,0.0010104653,0.04740662,0.0023198263,0.000071977935,0.004658651],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99689025,0.0018707018,0.00023963873,0.0004158905,0.0002820765,0.00030135617],"domain_scores_gemma":[0.99585295,0.0009119136,0.0012890949,0.0005899442,0.0005638141,0.00079236814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0071610967,0.00288702,0.004316667,0.0007410577,0.000809965,0.0012330161,0.0014429642,0.0029447246,0.007124032],"category_scores_gemma":[0.0052186577,0.0012595268,0.002539584,0.0006331076,0.0014758328,0.001526361,0.000653175,0.0029734857,0.0015324296],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96834433,0.016909495,0.00052881066,0.00035670897,0.00052959396,0.000026550373,0.00006269241,0.00019411677,0.0043063527,0.00005332055,0.00053751824,0.008150447],"study_design_scores_gemma":[0.9035905,0.093538105,0.0012315032,0.000022060955,0.00023029426,0.000023919823,0.0000109482335,0.00020850122,0.0005662802,0.000067972025,0.0004978029,0.000012157878],"about_ca_topic_score_codex":0.00055744365,"about_ca_topic_score_gemma":0.001240916,"teacher_disagreement_score":0.0071610967,"about_ca_system_score_codex":0.00097223633,"about_ca_system_score_gemma":0.002414129,"threshold_uncertainty_score":0.037871957},"labels":[],"label_agreement":null},{"id":"W2887418736","doi":"10.1177/1352458518792423","title":"Validation of the preference-based multiple sclerosis index","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; McGill University Health Centre; McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Convergent validity; Construct validity; Quality of life (healthcare); Multiple sclerosis; Medicine; Clinical psychology; Discriminant validity; Polychoric correlation; Confirmatory factor analysis; External validity; Psychology; Correlation; Physical therapy; Psychometrics; Structural equation modeling; Statistics; Psychiatry; Mathematics; Social psychology","score_opus":0.23015394229862984,"score_gpt":0.3071217690284271,"score_spread":0.07696782672979724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887418736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866303,0.00034110606,0.004005322,0.00017723726,0.00005407638,0.0017645564,0.0017109984,0.000035333036,0.0052810307],"genre_scores_gemma":[0.9899296,0.00013554883,0.0065063066,0.00008969985,0.000031046187,0.0014344581,0.0012062564,0.000012673524,0.0006543549],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9948778,0.0021769402,0.00060251064,0.00034415856,0.0018231425,0.00017546813],"domain_scores_gemma":[0.9854917,0.006150439,0.0025507594,0.0011220024,0.0040686745,0.00061638764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012073834,0.0003847217,0.00047551238,0.0013857306,0.0005292726,0.00067442,0.0007767854,0.0004889901,0.0030052143],"category_scores_gemma":[0.0294942,0.00016234662,0.0010059519,0.0010602166,0.0004914597,0.0006401403,0.0011118265,0.0007026109,0.0004508196],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014264486,0.0008000453,0.9235286,0.0002219602,0.00032420302,0.00007884057,0.0010252292,0.0008924027,0.00118954,0.00053809123,0.0010741353,0.068900526],"study_design_scores_gemma":[0.0002986344,0.0023333605,0.98890847,0.00010495918,0.00009960809,0.00026739715,0.0005419576,0.0032350877,0.001075851,0.0005153699,0.0025852923,0.000034050765],"about_ca_topic_score_codex":0.004044534,"about_ca_topic_score_gemma":0.0056327586,"teacher_disagreement_score":0.012073834,"about_ca_system_score_codex":0.00091301516,"about_ca_system_score_gemma":0.001468642,"threshold_uncertainty_score":0.063853264},"labels":[],"label_agreement":null},{"id":"W2887970423","doi":"10.1177/1352458518792772","title":"Taking the tester out of the SDMT: A proof of concept fully automated approach to assessing processing speed in people with MS","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Psychology; Multiple sclerosis; Audiology; Sample (material); Cognition; Medicine; Neuroscience; Psychiatry","score_opus":0.12016024699213118,"score_gpt":0.3354420667650865,"score_spread":0.2152818197729553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887970423","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72642016,0.0017051965,0.25354353,0.0014535178,0.00045710325,0.0068753473,0.0014841575,0.0022445573,0.0058164084],"genre_scores_gemma":[0.5676047,0.0007129545,0.42208946,0.0007606563,0.00016521741,0.004832712,0.00084314134,0.00012044275,0.0028706472],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.995777,0.002301161,0.00028596615,0.00028588815,0.0012285553,0.00012138144],"domain_scores_gemma":[0.9932935,0.0035035473,0.0006460066,0.0005689615,0.001595701,0.0003922279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0072416263,0.00087652274,0.00062271615,0.0006826463,0.0002281564,0.0009255573,0.0014273511,0.0008966022,0.0038367657],"category_scores_gemma":[0.010861233,0.00035492663,0.0006187859,0.00019305738,0.0006848087,0.0009753323,0.0012247482,0.0007813929,0.00064274645],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008192104,0.0077345157,0.059407227,0.0026170807,0.00046054317,0.0010326377,0.0015927441,0.0019767757,0.23394765,0.002124233,0.006934564,0.67397994],"study_design_scores_gemma":[0.008315008,0.15601653,0.21803553,0.0020311016,0.0016226042,0.014329616,0.0016171408,0.042998035,0.47809964,0.0048250877,0.0715778,0.0005319918],"about_ca_topic_score_codex":0.000661577,"about_ca_topic_score_gemma":0.0013496733,"teacher_disagreement_score":0.0072416263,"about_ca_system_score_codex":0.00023998438,"about_ca_system_score_gemma":0.0014551426,"threshold_uncertainty_score":0.038297832},"labels":[],"label_agreement":null},{"id":"W2889115949","doi":"10.1177/1352458518796676","title":"Pediatric-onset multiple sclerosis is associated with reduced parental health–related quality of life and family functioning","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; SickKids Foundation; Hospital for Sick Children; Montreal Children's Hospital; University of Toronto","funders":"Multiple Sclerosis Society; Multiple Sclerosis Scientific Research Foundation","keywords":"Medicine; Quality of life (healthcare); Interquartile range; Multiple sclerosis; Worry; Psychosocial; Pediatrics; Cohort; Disease; Clinically isolated syndrome; Clinical psychology; Psychiatry; Internal medicine; Anxiety","score_opus":0.1856118286288732,"score_gpt":0.3317250055304869,"score_spread":0.14611317690161368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889115949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99903727,0.00042053868,0.00004656622,0.00006263642,0.000004503835,0.0000016576839,0.0001425716,0.0000031954858,0.00028109364],"genre_scores_gemma":[0.9996433,0.00015551943,0.000049086775,0.000007617575,0.0000038293565,0.0000020479229,0.000099816556,0.0000010436182,0.000037697562],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999356,0.00022744742,0.00006536669,0.00012375775,0.00013717888,0.00009035714],"domain_scores_gemma":[0.99533683,0.0006916524,0.0030571232,0.00014813073,0.00032002764,0.00044632488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007086242,0.00030257448,0.0002726431,0.00055283395,0.0003291326,0.00058223953,0.00023336624,0.0002604602,0.0022002868],"category_scores_gemma":[0.0041833203,0.00016248724,0.00038088902,0.00076303846,0.0003487341,0.00031534611,0.0005070606,0.0005571008,0.0001255162],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003221476,0.0000096756785,0.9986834,0.000009820591,0.000031767744,0.00006636353,0.000081590406,0.000019978674,0.00007489899,0.000007768838,0.000047834335,0.00093464454],"study_design_scores_gemma":[7.4397445e-7,0.000023322153,0.99948174,0.0000059720164,0.00001244178,0.0002575658,0.000095392024,0.000029361901,0.000028147022,0.0000071499408,0.000057124267,0.0000010722849],"about_ca_topic_score_codex":0.003804028,"about_ca_topic_score_gemma":0.0031639466,"teacher_disagreement_score":0.003804028,"about_ca_system_score_codex":0.00032247647,"about_ca_system_score_gemma":0.0003269662,"threshold_uncertainty_score":0.00756377},"labels":[],"label_agreement":null},{"id":"W2889534785","doi":"10.1177/1352458518798048","title":"gMS-Classifier1 does not predict disability progression in multiple sclerosis","year":2018,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Multiple sclerosis; Medicine; Physical medicine and rehabilitation; Clinical neurology; Psychology; Neuroscience; Psychiatry","score_opus":0.16620321737933225,"score_gpt":0.3293705557566568,"score_spread":0.16316733837732456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889534785","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9363794,0.008790582,0.00036514457,0.035025157,0.001215717,0.00004301012,0.00060053245,0.000039612205,0.017540842],"genre_scores_gemma":[0.9891939,0.0010515968,0.00031968037,0.006224575,0.0012395241,0.000015230514,0.00017794369,0.000008566356,0.001768949],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995184,0.0001670972,0.000070099566,0.000068861635,0.00012284919,0.0000527095],"domain_scores_gemma":[0.99689317,0.0014311448,0.00045724868,0.0002028753,0.0007352486,0.00028023875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078808,0.00019445737,0.0004851177,0.00038173,0.00045093757,0.00043915233,0.00041124588,0.0012831056,0.0017119298],"category_scores_gemma":[0.0066879774,0.00008111362,0.00016036253,0.00041013185,0.0002989327,0.00043189325,0.00015326646,0.0008907999,0.00066087185],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036436333,0.00030151248,0.8559165,0.00032805433,0.00011055758,0.020127105,0.00046686237,0.00036288038,0.004082965,0.00094192434,0.030758249,0.082959734],"study_design_scores_gemma":[0.00043257067,0.0024778221,0.86652756,0.0005045589,0.0002928556,0.06608276,0.00082963647,0.004720002,0.002594903,0.004744815,0.05073389,0.000058750727],"about_ca_topic_score_codex":0.0014962159,"about_ca_topic_score_gemma":0.0015244866,"teacher_disagreement_score":0.0017119298,"about_ca_system_score_codex":0.0003814497,"about_ca_system_score_gemma":0.00029290613,"threshold_uncertainty_score":0.005726993},"labels":[],"label_agreement":null},{"id":"W2893128590","doi":"10.1177/1352458518802544","title":"Autologous hematopoietic stem cell transplantation improves fatigue in multiple sclerosis","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Multiple sclerosis; Hematopoietic stem cell transplantation; Medicine; Transplantation; Stem cell; Hematopoietic cell; Haematopoiesis; Immunology; Oncology; Internal medicine; Biology; Genetics","score_opus":0.13427755147901307,"score_gpt":0.30304183444857696,"score_spread":0.1687642829695639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2893128590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949905,0.00356878,0.00018935734,0.00015611488,0.00003263305,0.000057762947,0.000108759814,0.00003725816,0.0008588321],"genre_scores_gemma":[0.99827504,0.0008119567,0.00021439357,0.00007587915,0.00002367527,0.000023752296,0.00018488368,0.0000021750266,0.000388257],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9999546,0.0000092221235,0.0000033814827,0.0000051067286,0.000016914672,0.000010876115],"domain_scores_gemma":[0.9999213,0.000017019218,0.000017096945,0.000006811755,0.000012901723,0.000024969531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021751021,0.00017474,0.00021834759,0.00012482036,0.0001411562,0.00010749892,0.00012176369,0.00010232932,0.001734686],"category_scores_gemma":[0.00031970826,0.000025202935,0.00012274655,0.00012583988,0.0001656095,0.00006837551,0.00009491924,0.0003105027,0.00010750076],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035198875,0.008015832,0.04335868,0.001166232,0.0005796698,0.0005534854,0.00037326152,0.0023010464,0.08773709,0.00030304384,0.0077694915,0.81264323],"study_design_scores_gemma":[0.009662667,0.09935489,0.8329674,0.00033045345,0.00073724735,0.0019228087,0.00024453172,0.003685346,0.035342462,0.00069288374,0.015035336,0.000023984858],"about_ca_topic_score_codex":0.0036888518,"about_ca_topic_score_gemma":0.007416944,"teacher_disagreement_score":0.0036888518,"about_ca_system_score_codex":0.00029585132,"about_ca_system_score_gemma":0.00038731474,"threshold_uncertainty_score":0.007334769},"labels":[],"label_agreement":null},{"id":"W2894758097","doi":"10.1177/1352458518801764","title":"2018 Editors’ commentary","year":2018,"lang":"en","type":"editorial","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Multiple sclerosis; Medicine; Psychiatry","score_opus":0.0765972082841851,"score_gpt":0.32485519521864165,"score_spread":0.24825798693445655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2894758097","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000046040754,0.0030423712,0.00005798108,0.27444792,0.71960586,0.000027795124,0.000085637716,0.00004026495,0.002646132],"genre_scores_gemma":[0.0007263878,0.0022379267,0.00013771416,0.30183232,0.68369246,0.00011126118,0.000068403795,0.000078874706,0.011114655],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9688766,0.006343167,0.0045124153,0.00319741,0.013873229,0.0031972404],"domain_scores_gemma":[0.8929458,0.040518284,0.013509837,0.0032836401,0.039890315,0.009852015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023686757,0.003309551,0.005061631,0.0052806325,0.0074039395,0.016172944,0.006801061,0.057362724,0.04187006],"category_scores_gemma":[0.17543192,0.0016984078,0.0037864898,0.002733113,0.0054483963,0.006763252,0.0053106965,0.037061103,0.030001406],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013090769,0.0000039932434,0.000025382082,0.00010120699,0.000010831867,0.00008107082,0.0000281694,0.0000057421275,0.000009600456,0.00022358024,0.9979114,0.0015859407],"study_design_scores_gemma":[0.00009899158,0.000014642185,0.00021316033,0.0013483625,0.000069018744,0.00021778802,0.00014137207,0.000060982526,0.00007274234,0.0016373687,0.9960924,0.000033067176],"about_ca_topic_score_codex":0.0036390144,"about_ca_topic_score_gemma":0.007722936,"teacher_disagreement_score":0.057362724,"about_ca_system_score_codex":0.008258875,"about_ca_system_score_gemma":0.013203928,"threshold_uncertainty_score":0.1400693},"labels":[],"label_agreement":null},{"id":"W2894814928","doi":"10.1177/1352458518796675","title":"Infection risk with alemtuzumab decreases over time: pooled analysis of 6-year data from the CAMMS223, CARE-MS I, and CARE-MS II studies and the CAMMS03409 extension study","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Alemtuzumab; Medicine; Multiple sclerosis; Internal medicine; Interferon beta-1a; Upper respiratory tract infection; Gastroenterology; Immunology; Interferon beta; Transplantation","score_opus":0.08629071658810852,"score_gpt":0.3352252956619442,"score_spread":0.24893457907383568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2894814928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8297009,0.16183679,0.0027513974,0.00030080377,0.00017739843,0.00017181881,0.0038356467,0.00010353303,0.0011216518],"genre_scores_gemma":[0.99112236,0.0059511187,0.0004673029,0.00014532861,0.0001379803,0.00008105304,0.0019145298,0.000021400368,0.0001588557],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98421246,0.008672346,0.0024594609,0.0027801543,0.001451446,0.00042418644],"domain_scores_gemma":[0.95500135,0.018869627,0.01904469,0.004223357,0.0020919235,0.0007690508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024371266,0.0013281791,0.004701169,0.0021298889,0.00024212316,0.0017203335,0.0007662833,0.0013153276,0.0013341499],"category_scores_gemma":[0.020932037,0.0007395716,0.014714462,0.0028652414,0.0004666939,0.00090697565,0.00084115705,0.0011665896,0.00016949364],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06381539,0.00012834965,0.67688763,0.0034894776,0.21783139,0.0002349562,0.0001639985,0.0024866487,0.0017562594,0.00011040347,0.0012213268,0.03187423],"study_design_scores_gemma":[0.0021737919,0.0034223164,0.88934314,0.00044643597,0.09960077,0.00050625636,0.0000740222,0.0017117377,0.0007479765,0.00022259256,0.0016825437,0.000068514346],"about_ca_topic_score_codex":0.0010084818,"about_ca_topic_score_gemma":0.0014063362,"teacher_disagreement_score":0.024371266,"about_ca_system_score_codex":0.00038295376,"about_ca_system_score_gemma":0.0005522602,"threshold_uncertainty_score":0.12888914},"labels":[],"label_agreement":null},{"id":"W2895845951","doi":"10.1177/1352458518803785","title":"Recommendations for cognitive screening and management in multiple sclerosis care","year":2018,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":406,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Toronto","funders":"","keywords":"Multiple sclerosis; Medicine; Cognition; Physical medicine and rehabilitation; Intensive care medicine; Psychiatry","score_opus":0.4229201343831565,"score_gpt":0.41052095395330507,"score_spread":0.012399180429851442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895845951","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014008612,0.022847781,0.010442538,0.888054,0.021014111,0.0076996055,0.0035069708,0.0012693825,0.04376476],"genre_scores_gemma":[0.016468657,0.074842,0.28678787,0.5295285,0.013849711,0.034125354,0.010125024,0.0004626831,0.033810228],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9685933,0.016421152,0.005515599,0.0009957033,0.0062665073,0.002207712],"domain_scores_gemma":[0.89476866,0.029969748,0.0077004507,0.002024476,0.053322356,0.012214376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023144418,0.002586226,0.0025910076,0.005241024,0.0029882283,0.004954498,0.009777171,0.021255188,0.02739202],"category_scores_gemma":[0.11454397,0.0013702993,0.008576098,0.0033599634,0.0017073211,0.005995784,0.006531912,0.024396995,0.014476722],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011473927,0.0007257937,0.0014873578,0.0040065055,0.00019003087,0.000298761,0.00042634018,0.00081507873,0.000118905926,0.0025096256,0.8256381,0.16366863],"study_design_scores_gemma":[0.0025967958,0.00037491124,0.009627554,0.09808899,0.0010339881,0.0004432494,0.0021762785,0.0020803222,0.0004162998,0.01875937,0.86406094,0.00034123444],"about_ca_topic_score_codex":0.035797957,"about_ca_topic_score_gemma":0.047184512,"teacher_disagreement_score":0.035797957,"about_ca_system_score_codex":0.011020102,"about_ca_system_score_gemma":0.047769174,"threshold_uncertainty_score":0.12240088},"labels":[],"label_agreement":null},{"id":"W2896814303","doi":"10.1177/1352458518798147","title":"Silent lesions on MRI imaging – Shifting goal posts for treatment decisions in multiple sclerosis","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Hôtel-Dieu de Montréal","funders":"EMD Serono; Canadian Institutes of Health Research; IC Design Education Center; Teva Pharmaceutical Industries; Multiple Sclerosis Society; Biogen","keywords":"Multiple sclerosis; Magnetic resonance imaging; Medicine; Neuroimaging; Psychology; Physical medicine and rehabilitation; Radiology; Psychiatry","score_opus":0.20165026201569453,"score_gpt":0.35534809528170225,"score_spread":0.15369783326600772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896814303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9750416,0.0051210346,0.005932866,0.008943197,0.0001175288,0.00010059542,0.00021392331,0.000055864122,0.00447333],"genre_scores_gemma":[0.9963527,0.000497295,0.0024576767,0.0004410185,0.000077573364,0.000023179224,0.00007367761,0.000008448432,0.000068566325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98751616,0.008506274,0.0009662943,0.0008274314,0.001718902,0.00046502196],"domain_scores_gemma":[0.9315673,0.045538552,0.015985223,0.0014134246,0.0031513474,0.002344175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016878106,0.00035901752,0.0006117947,0.0016867587,0.0006909431,0.0025105989,0.0013310468,0.0011571826,0.001916616],"category_scores_gemma":[0.08268849,0.0003372403,0.0005127476,0.00093150587,0.00085026585,0.0023247912,0.0014488747,0.001836075,0.00043259087],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011122737,0.00031429867,0.8971851,0.00024847782,0.00022717759,0.0005179308,0.0009684701,0.0016647946,0.00031730332,0.00091939967,0.0029718578,0.09355287],"study_design_scores_gemma":[0.00016995243,0.00089577044,0.9536306,0.0013558845,0.00036857792,0.0026654312,0.0030383507,0.020398533,0.0014212935,0.012442984,0.0035259572,0.000086526496],"about_ca_topic_score_codex":0.0027254634,"about_ca_topic_score_gemma":0.0029586186,"teacher_disagreement_score":0.016878106,"about_ca_system_score_codex":0.0011717282,"about_ca_system_score_gemma":0.0019025248,"threshold_uncertainty_score":0.089261055},"labels":[],"label_agreement":null},{"id":"W2898018722","doi":"10.1177/1352458518807061","title":"Diet quality and risk of multiple sclerosis in two cohorts of US women","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute; Sanofi Genzyme; Multiple Sclerosis Society of Canada; Harvard University","keywords":"Multiple sclerosis; Medicine; Quality (philosophy); Environmental health; Psychiatry","score_opus":0.1418311949610307,"score_gpt":0.3572747824964705,"score_spread":0.2154435875354398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898018722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99898046,0.000404015,0.000046182755,0.000035983972,0.000006403233,0.000007715682,0.0002781728,0.0000016587297,0.00023941744],"genre_scores_gemma":[0.99918014,0.00017474951,0.00007222303,0.000032074127,0.000011034571,0.000015646223,0.00030160137,0.0000014254316,0.00021108004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997036,0.000107215805,0.000027793025,0.00006165576,0.000045894718,0.000053839816],"domain_scores_gemma":[0.99925154,0.0001125584,0.0002955186,0.00007539997,0.00010382645,0.0001610542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073643343,0.00033689642,0.00032922393,0.00075362925,0.00040195647,0.00047467346,0.00022944306,0.00041108674,0.0009749825],"category_scores_gemma":[0.0018278855,0.00035497555,0.00056458404,0.000873106,0.00019667672,0.00027612448,0.0004178008,0.00039960758,0.00013268391],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031720533,0.000028054297,0.9986528,0.000006609317,0.00012967724,0.000038738013,0.00006863442,0.000011278373,0.00015055624,0.000008172165,0.000040034563,0.00054818956],"study_design_scores_gemma":[0.000022786317,0.00012341894,0.999382,0.0000053172243,0.000072233845,0.00008945407,0.00009046202,0.000054319073,0.000027310194,0.000013562542,0.00011715578,0.0000020331759],"about_ca_topic_score_codex":0.007889953,"about_ca_topic_score_gemma":0.007474218,"teacher_disagreement_score":0.007889953,"about_ca_system_score_codex":0.0002105052,"about_ca_system_score_gemma":0.00024940842,"threshold_uncertainty_score":0.015688062},"labels":[],"label_agreement":null},{"id":"W2899172313","doi":"10.1177/1352458518809326","title":"International consensus on quality standards for brain health-focused care in multiple sclerosis","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Sanofi Genzyme; Novartis Pharma; Genentech; National Institutes of Health; TG Therapeutics; CSL Behring; IC Design Education Center; National Institute of Neurological Disorders and Stroke; Teva Pharmaceutical Industries; Merck KGaA; Atara Biotherapeutics; MedDay Pharmaceuticals; GlaxoSmithKline; Biogen; Celgene; Sanofi","keywords":"Multiple sclerosis; Consensus conference; Medicine; Quality (philosophy); MEDLINE; Political science; Psychiatry; Internal medicine","score_opus":0.23355792287178148,"score_gpt":0.4088597309730535,"score_spread":0.17530180810127202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899172313","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016022962,0.14503525,0.2331665,0.47560915,0.031634573,0.013210507,0.003246411,0.0013152034,0.08075946],"genre_scores_gemma":[0.18568873,0.07749765,0.6407105,0.052260775,0.003396141,0.019796522,0.008298124,0.00066014804,0.011691455],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.7640788,0.10567113,0.06252095,0.004554002,0.055922,0.0072531523],"domain_scores_gemma":[0.66077864,0.12575059,0.026685545,0.013634838,0.16003607,0.013114293],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.27374035,0.0020445366,0.0034105512,0.009868415,0.003934508,0.008775205,0.01180547,0.010476997,0.003297405],"category_scores_gemma":[0.232333,0.0013902567,0.0075046653,0.006972764,0.005913908,0.005967328,0.013967081,0.015322376,0.001530737],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039855667,0.0006490415,0.010240045,0.028899103,0.0006001903,0.00091311784,0.023458458,0.005709071,0.0024699024,0.12066442,0.24836929,0.55762875],"study_design_scores_gemma":[0.00031791985,0.00063528423,0.027140237,0.09849216,0.00083933613,0.0014837858,0.0143146245,0.004420741,0.0032006903,0.08983773,0.7588374,0.00048009094],"about_ca_topic_score_codex":0.016400464,"about_ca_topic_score_gemma":0.009125547,"teacher_disagreement_score":0.27374035,"about_ca_system_score_codex":0.021329595,"about_ca_system_score_gemma":0.0862126,"threshold_uncertainty_score":0.8956075},"labels":[],"label_agreement":null},{"id":"W2900475353","doi":"10.1177/1352458518813105","title":"Area postrema syndrome: A short history of a pearl in demyelinating diseases","year":2018,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Area postrema; Pearl; Medicine; Multiple sclerosis; Demyelinating disease; Internal medicine; Central nervous system; History; Immunology","score_opus":0.26060707284448437,"score_gpt":0.36125533825183737,"score_spread":0.100648265407353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900475353","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009855374,0.9982804,0.000035216704,0.00051731576,0.00063399295,0.0000015101955,0.0000086351565,0.000002462395,0.00042181028],"genre_scores_gemma":[0.0010312727,0.9967991,0.00011177232,0.000658062,0.0011135319,0.000003020447,0.00001924192,0.000001629555,0.00026234443],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997106,0.00006146938,0.00008160698,0.00005179035,0.00007154038,0.00002294101],"domain_scores_gemma":[0.9989396,0.00064839364,0.00015603131,0.000020424619,0.00015942755,0.000076117736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005100189,0.0007495461,0.0013903275,0.0033738199,0.0005045035,0.0014376417,0.0007040758,0.0013989846,0.0036979811],"category_scores_gemma":[0.0018017996,0.0002326653,0.0004288692,0.0036480923,0.00079973787,0.0025638249,0.0009115695,0.0020434365,0.0009929617],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013838473,0.000069233916,0.00096265844,0.039259244,0.00019223244,0.0027296725,0.0005684427,0.00028239368,0.0011365438,0.0068375682,0.11269512,0.83512855],"study_design_scores_gemma":[0.000013328792,0.00006339701,0.0013562676,0.011974346,0.00016250295,0.012085596,0.00028208457,0.00004365748,0.00017180781,0.0020568282,0.9717656,0.000024563727],"about_ca_topic_score_codex":0.00079755485,"about_ca_topic_score_gemma":0.0014892586,"teacher_disagreement_score":0.0036979811,"about_ca_system_score_codex":0.00051923207,"about_ca_system_score_gemma":0.0014052766,"threshold_uncertainty_score":0.012371004},"labels":[],"label_agreement":null},{"id":"W2900575151","doi":"10.1177/1352458518810924","title":"Month-of-birth-effect in multiple sclerosis in Austria","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Multiple sclerosis; Demography; Population; Birth rate; Cohort; Medicine; Geography; Pediatrics; Fertility; Pathology","score_opus":0.14880176159725086,"score_gpt":0.3217018510036634,"score_spread":0.17290008940641252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900575151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949155,0.0031653387,0.00023029612,0.00009498918,0.000018539831,0.0000040397877,0.0009894788,0.0000074257027,0.000574423],"genre_scores_gemma":[0.998569,0.0005755427,0.00015806276,0.000013671921,0.00000764821,0.0000041818785,0.00054013426,0.0000053829485,0.00012646335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989736,0.00041847065,0.0001652351,0.00020472986,0.00013222148,0.000105679086],"domain_scores_gemma":[0.99717367,0.0008345219,0.0014365537,0.00021920218,0.0001568352,0.00017923926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014147486,0.00011129168,0.00035861935,0.0014869757,0.0001908472,0.00055894407,0.0002461725,0.00020193431,0.0014833509],"category_scores_gemma":[0.005204934,0.00012805019,0.0005224471,0.0016866687,0.00019469559,0.00028217124,0.0005372121,0.00031753725,0.00018172455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019568192,0.0000100805255,0.99460405,0.00003846641,0.00012807202,0.000080732505,0.00010268064,0.00013521942,0.0001661748,0.00007726948,0.00017407862,0.0042875465],"study_design_scores_gemma":[0.000002215661,0.000027696597,0.9991209,0.000016617127,0.00003131926,0.00017177565,0.00006691371,0.000090082176,0.000040313804,0.000036937196,0.00039341892,0.0000018040308],"about_ca_topic_score_codex":0.004644261,"about_ca_topic_score_gemma":0.0049044397,"teacher_disagreement_score":0.004644261,"about_ca_system_score_codex":0.00038812828,"about_ca_system_score_gemma":0.00029875035,"threshold_uncertainty_score":0.009234488},"labels":[],"label_agreement":null},{"id":"W2901155618","doi":"10.1177/1352458518808189","title":"Ocrelizumab reduces progression of upper extremity impairment in patients with primary progressive multiple sclerosis: Findings from the phase III randomized ORATORIO trial","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Bayer HealthCare; Acorda Therapeutics","keywords":"Ocrelizumab; Medicine; Placebo; Multiple sclerosis; Physical therapy; Internal medicine; Psychiatry; Alternative medicine","score_opus":0.05233094733037293,"score_gpt":0.30837759811251214,"score_spread":0.25604665078213923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901155618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9611117,0.032414444,0.00035162637,0.0011086342,0.00023764292,0.0012984662,0.0010468522,0.000047294325,0.0023833383],"genre_scores_gemma":[0.9855547,0.009257881,0.00080008834,0.0010415523,0.00029337592,0.001270742,0.00096253055,0.000012682986,0.0008064169],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99877805,0.0007750969,0.00011222185,0.00011643336,0.00010312267,0.0001149822],"domain_scores_gemma":[0.9976775,0.00079586694,0.0009258038,0.00014623218,0.00017200563,0.00028266673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004029656,0.0009404151,0.0019568456,0.00019045745,0.00025932607,0.0008092317,0.00055215386,0.0008613097,0.0020920518],"category_scores_gemma":[0.0033351916,0.0002733008,0.002503975,0.0003699467,0.00047954376,0.00041387856,0.00028775007,0.0016129982,0.0002666408],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9173576,0.0038719848,0.009773488,0.004418683,0.009241372,0.00009646114,0.00014043045,0.00056936993,0.0037784635,0.00014691352,0.0019102268,0.048695035],"study_design_scores_gemma":[0.8629748,0.095082715,0.029343942,0.00043902776,0.008410526,0.00017774732,0.000054386346,0.00041312713,0.00078445545,0.00016703231,0.002127772,0.000024425728],"about_ca_topic_score_codex":0.0007521424,"about_ca_topic_score_gemma":0.0019225403,"teacher_disagreement_score":0.004029656,"about_ca_system_score_codex":0.00059584563,"about_ca_system_score_gemma":0.0010707302,"threshold_uncertainty_score":0.021311164},"labels":[],"label_agreement":null},{"id":"W2903065994","doi":"10.1177/1352458518809301","title":"Vitamin D deficiency is an etiological factor for MS – Yes","year":2018,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Multiple sclerosis; Etiology; Medicine; vitamin D deficiency; Vitamin D and neurology; Internal medicine; Immunology","score_opus":0.37464956853101894,"score_gpt":0.4168246800033832,"score_spread":0.042175111472364246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903065994","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001886291,0.9994295,0.00001955947,0.00012769773,0.0000545964,0.0000047920475,0.000036038487,0.0000011114214,0.0001380136],"genre_scores_gemma":[0.0031439574,0.99629754,0.00013488042,0.00021893441,0.00007573368,0.000009121128,0.00004567467,5.007925e-7,0.00007354297],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9993073,0.0001498366,0.00026784933,0.000111391906,0.00013266598,0.00003103412],"domain_scores_gemma":[0.99668807,0.0025292262,0.0005288261,0.00004216428,0.0001736942,0.00003798172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013584587,0.0008588797,0.0026839208,0.003735997,0.00028676985,0.0010644443,0.00089106645,0.0014326792,0.004380167],"category_scores_gemma":[0.0052440404,0.0004464626,0.001860025,0.0035108377,0.0005226536,0.001048706,0.00072100735,0.0010321711,0.00034688084],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057435915,0.00009894631,0.0061383815,0.45751885,0.009548279,0.00041002134,0.00017829379,0.00017457343,0.00050858135,0.0013028563,0.011734943,0.511812],"study_design_scores_gemma":[0.0008864133,0.0005451359,0.034496013,0.40768602,0.0967394,0.005940446,0.0009620188,0.00023264917,0.0010236931,0.004242353,0.4470656,0.00018031789],"about_ca_topic_score_codex":0.0031483339,"about_ca_topic_score_gemma":0.007879022,"teacher_disagreement_score":0.004380167,"about_ca_system_score_codex":0.00059517956,"about_ca_system_score_gemma":0.0017077585,"threshold_uncertainty_score":0.014653146},"labels":[],"label_agreement":null},{"id":"W2905522261","doi":"10.1177/1352458518814117","title":"Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":214,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"","keywords":"Multiple sclerosis; Magnetic resonance imaging; Medicine; Pathology; Neuroscience; Nuclear magnetic resonance; Radiology; Physics; Psychology","score_opus":0.0872391206309767,"score_gpt":0.31939167437962634,"score_spread":0.23215255374864963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905522261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99833614,0.00038700423,0.000695784,0.000018025856,0.0000029559185,0.000019139261,0.00004501531,0.00001101267,0.00048491004],"genre_scores_gemma":[0.99817264,0.000091922986,0.0015278943,0.0000066396015,0.000007919237,0.000008486788,0.00007086437,0.0000022329607,0.00011139115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99971575,0.00008894274,0.000041667787,0.000054525488,0.00007529421,0.000023708848],"domain_scores_gemma":[0.9982869,0.0005299104,0.00069953105,0.00010398373,0.00023222707,0.00014746154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014880848,0.00031706563,0.000212753,0.0016828985,0.00019438953,0.00050710357,0.00031270136,0.00031304796,0.0014645569],"category_scores_gemma":[0.0025359073,0.00011208191,0.00013883205,0.0005847979,0.00036519795,0.0003763958,0.0002940062,0.00027539066,0.00020226651],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033527642,0.000048660717,0.9802813,0.00005930709,0.00005234162,0.00012945401,0.00012231704,0.00022963225,0.008301681,0.000080545346,0.0001082253,0.0102512725],"study_design_scores_gemma":[0.000016163493,0.0002603861,0.9928063,0.00002099746,0.0000581714,0.0017037985,0.00014369481,0.0018058235,0.0027181262,0.00015172118,0.00030760994,0.0000071943123],"about_ca_topic_score_codex":0.0006133742,"about_ca_topic_score_gemma":0.0014739073,"teacher_disagreement_score":0.0016828985,"about_ca_system_score_codex":0.00015156117,"about_ca_system_score_gemma":0.00017575278,"threshold_uncertainty_score":0.00786984},"labels":[],"label_agreement":null},{"id":"W2905971247","doi":"10.1177/1352458518820628","title":"Jacques Jean Lhermitte and Lhermitte’s sign","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Neurology and Historical Studies","field":"Neuroscience","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Sign (mathematics); The Renaissance; Neuropathology; Neuropsychiatry; Neurology; Classics; History; Philosophy; Medicine; Art history; Psychiatry; Pathology","score_opus":0.11358815295851477,"score_gpt":0.2573895085338174,"score_spread":0.14380135557530266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905971247","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.038251515,0.27034447,0.0027115897,0.46169996,0.05242135,0.000059346337,0.00014620884,0.000117616975,0.17424805],"genre_scores_gemma":[0.46928886,0.15532422,0.0034661926,0.13504916,0.08017548,0.00008750211,0.00013090913,0.00016490946,0.15631267],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9991191,0.00027257626,0.000056425728,0.0001749119,0.00026083205,0.000116059644],"domain_scores_gemma":[0.9984118,0.0006073448,0.00013257567,0.0000611212,0.00044692305,0.00034027293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013862592,0.0002937868,0.0003704394,0.0017509842,0.0020525935,0.0019617623,0.0003267568,0.0031171234,0.0044421754],"category_scores_gemma":[0.0070662075,0.00016070066,0.00018835047,0.00076411467,0.0038685107,0.0029518453,0.0011794459,0.004358037,0.0012149469],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010216208,0.00008104602,0.00990502,0.0003277617,0.00003459652,0.027247244,0.007908087,0.00015452593,0.00118386,0.19820023,0.6144443,0.14041106],"study_design_scores_gemma":[0.000009650821,0.000030622574,0.0026200635,0.00041822562,0.0000060532548,0.042778105,0.00121142,0.00007421601,0.00022003197,0.009780216,0.9428129,0.000038534352],"about_ca_topic_score_codex":0.0076372717,"about_ca_topic_score_gemma":0.009559024,"teacher_disagreement_score":0.0076372717,"about_ca_system_score_codex":0.0017749167,"about_ca_system_score_gemma":0.0017310022,"threshold_uncertainty_score":0.015185595},"labels":[],"label_agreement":null},{"id":"W2909806674","doi":"10.1177/1352458518819096","title":"MSJ 2019 - Editorial comment","year":2019,"lang":"fr","type":"editorial","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Multiple sclerosis; MEDLINE; Medicine; Epistemology; Psychology; Cognitive science; Computer science; Philosophy; Psychiatry; Political science","score_opus":0.06745257905109638,"score_gpt":0.3148455261255324,"score_spread":0.24739294707443604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909806674","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000047335932,0.0013552507,0.000050368657,0.15843491,0.8376293,0.00002748659,0.00016247638,0.00007094528,0.0022218258],"genre_scores_gemma":[0.00067053834,0.0012736297,0.0000969212,0.13713537,0.84764487,0.00005316032,0.000101201535,0.00008214181,0.0129421335],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98551756,0.0026570617,0.00196103,0.0012936499,0.0068551623,0.0017155786],"domain_scores_gemma":[0.94817615,0.019975884,0.0054368274,0.0018890144,0.019120038,0.005402127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014665364,0.003909242,0.0049126917,0.0058398475,0.0067398995,0.013140234,0.005297647,0.052427627,0.049356848],"category_scores_gemma":[0.09035872,0.0019657866,0.0045869676,0.0027912464,0.003840688,0.0038076942,0.0032139397,0.025765276,0.036928866],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028991226,0.000004682308,0.000020429628,0.00006967871,0.000012457287,0.000075982265,0.000009813214,0.0000059548142,0.000011723169,0.000111388115,0.99882823,0.0008205944],"study_design_scores_gemma":[0.00032407328,0.00003822103,0.00047739557,0.00082844036,0.00012497582,0.00026314048,0.0000853779,0.0001695997,0.000119838296,0.0013174352,0.99621,0.000041490595],"about_ca_topic_score_codex":0.008006709,"about_ca_topic_score_gemma":0.015953207,"teacher_disagreement_score":0.052427627,"about_ca_system_score_codex":0.008137654,"about_ca_system_score_gemma":0.0072446475,"threshold_uncertainty_score":0.16511512},"labels":[],"label_agreement":null},{"id":"W2920869320","doi":"10.1177/1352458519868990","title":"Risk of secondary progressive multiple sclerosis: A longitudinal study","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cegep de Saint Jerome; Jewish General Hospital; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Université de Montréal; Hôpital Notre-Dame","funders":"National Health and Medical Research Council; University of Tasmania","keywords":"Multiple sclerosis; Medicine; Expanded Disability Status Scale; Hazard ratio; Proportional hazards model; Internal medicine; Magnetic resonance imaging; Cohort; Cohort study; Progressive disease; Confidence interval; Pediatrics; Disease; Immunology; Radiology","score_opus":0.11040849336922892,"score_gpt":0.3169504138556149,"score_spread":0.20654192048638598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2920869320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982065,0.0005210895,0.00019911921,0.00011575089,0.000012139981,0.000014423983,0.0005807856,0.000006127562,0.00034399857],"genre_scores_gemma":[0.9987606,0.00021698697,0.00016292853,0.000059494585,0.000022689208,0.000020662936,0.0005800145,0.0000029706468,0.00017354042],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913883,0.00036741642,0.000053636842,0.00019082693,0.00013174777,0.00011760297],"domain_scores_gemma":[0.9975085,0.00036507874,0.0009036802,0.00034175237,0.0003793057,0.0005015277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023937614,0.00028447673,0.00042097954,0.00042954454,0.0005587075,0.00071975036,0.00043714102,0.0005722356,0.0012371023],"category_scores_gemma":[0.003304468,0.00033269814,0.0007278177,0.0007234073,0.00020077202,0.00056195573,0.0004880776,0.0012287678,0.00024251892],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039118453,0.00006678784,0.998133,0.000008058414,0.00020612165,0.00008703362,0.00006302016,0.000032345994,0.00011376922,0.0000237397,0.00013017387,0.0007447931],"study_design_scores_gemma":[0.00004427862,0.00037302732,0.9981188,0.000012378818,0.00014824048,0.00041001497,0.00008819453,0.00035828058,0.00004122913,0.000060670613,0.00033824172,0.0000065421737],"about_ca_topic_score_codex":0.0032121178,"about_ca_topic_score_gemma":0.0023726332,"teacher_disagreement_score":0.0032121178,"about_ca_system_score_codex":0.0002176546,"about_ca_system_score_gemma":0.00046329552,"threshold_uncertainty_score":0.012659609},"labels":[],"label_agreement":null},{"id":"W2923518038","doi":"10.1177/1352458519832249","title":"Disease-modifying therapies should be stopped in NMOSD patients in remission – No","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Multiple sclerosis; Medicine; Disease; Internal medicine; Immunology","score_opus":0.08961643620473426,"score_gpt":0.282346713426991,"score_spread":0.19273027722225677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2923518038","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8320747,0.05896992,0.0025895461,0.035970148,0.0038739094,0.0003148433,0.0013163429,0.0005314767,0.06435908],"genre_scores_gemma":[0.9712842,0.00591856,0.0024042972,0.011213183,0.0011953858,0.00009130009,0.0008965411,0.00004437352,0.00695216],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999571,0.00009538071,0.00008307932,0.000052201405,0.00009421225,0.00010410141],"domain_scores_gemma":[0.9989794,0.00030359207,0.00018536701,0.000058414713,0.00019344415,0.0002797544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000658888,0.0003600176,0.0014038193,0.00033523538,0.0008379047,0.0005525834,0.00032649338,0.0011104599,0.0037792302],"category_scores_gemma":[0.0018241154,0.00010188493,0.0007317746,0.00023329216,0.00033069644,0.00043797566,0.00022548383,0.0013942424,0.0010061216],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025498046,0.002458084,0.280696,0.0021105174,0.0010692363,0.011981914,0.00035852368,0.00044092062,0.033252303,0.0023375226,0.051697522,0.5880995],"study_design_scores_gemma":[0.00417543,0.006887177,0.776499,0.0022259164,0.0017008035,0.025839008,0.00076264323,0.0014423826,0.010576777,0.0072899424,0.16244388,0.00015698577],"about_ca_topic_score_codex":0.0012705511,"about_ca_topic_score_gemma":0.0039933533,"teacher_disagreement_score":0.0037792302,"about_ca_system_score_codex":0.0005322996,"about_ca_system_score_gemma":0.00078732974,"threshold_uncertainty_score":0.012642801},"labels":[],"label_agreement":null},{"id":"W2944804677","doi":"10.1177/1352458519845107","title":"The neurologist’s role in disabling multiple sclerosis: A qualitative study of patient and care provider perspectives","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"McGill University","keywords":"Multiple sclerosis; Thematic analysis; Medicine; Qualitative research; Exploratory research; Family medicine; MEDLINE; Disease; Psychiatry","score_opus":0.09075567390144422,"score_gpt":0.3319135197590911,"score_spread":0.24115784585764688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944804677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847424,0.0013076145,0.0019309049,0.006388278,0.00013525867,0.00020592273,0.00016455965,0.000016974924,0.005108091],"genre_scores_gemma":[0.9949058,0.0011384909,0.00070834515,0.0015458709,0.000033938526,0.00020198639,0.000046539215,0.000019740533,0.001399309],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.97626686,0.019540498,0.0005209637,0.00066698284,0.00095371745,0.0020510769],"domain_scores_gemma":[0.9415908,0.049749296,0.0026424807,0.00048660117,0.0023147603,0.0032161027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02096609,0.00059089117,0.0008770926,0.0014627401,0.010647928,0.005201565,0.0019362064,0.0026527517,0.0034503872],"category_scores_gemma":[0.03343881,0.0008737692,0.00044402762,0.0015665137,0.010031431,0.0055877385,0.0053207963,0.0045821173,0.0003196397],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024752419,0.000022274977,0.0012289974,0.00008285343,0.0000030575927,0.00040912093,0.9962184,0.000012346613,0.00020644837,0.0005080965,0.00022871897,0.0010549093],"study_design_scores_gemma":[0.0000031252805,0.000022009539,0.00035406384,0.00008980298,0.0000022092868,0.00011614899,0.99735117,0.000026564478,0.000061350096,0.00009305381,0.0018754026,0.0000050027024],"about_ca_topic_score_codex":0.013341232,"about_ca_topic_score_gemma":0.01868745,"teacher_disagreement_score":0.02096609,"about_ca_system_score_codex":0.0058226804,"about_ca_system_score_gemma":0.00753147,"threshold_uncertainty_score":0.11088067},"labels":[],"label_agreement":null},{"id":"W2945419470","doi":"10.1177/1352458519845836","title":"Measures of general and abdominal obesity and disability severity in a large population of people with multiple sclerosis","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Multiple Sclerosis Society","keywords":"Abdominal obesity; Medicine; Waist; Odds ratio; Comorbidity; Body mass index; Obesity; Metabolic syndrome; Confidence interval; Internal medicine; Population; Waist-to-height ratio; Physical therapy; Environmental health","score_opus":0.0630373176336571,"score_gpt":0.27980652368067455,"score_spread":0.21676920604701744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945419470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997661,0.0002971511,0.00016247232,0.000100679434,0.000007909834,0.00003946222,0.0013363604,0.0000100894495,0.00038469504],"genre_scores_gemma":[0.9981791,0.00016579809,0.00035188728,0.00005206214,0.000020982032,0.00009604923,0.0009904662,0.0000024135377,0.0001414169],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853325,0.00071741914,0.00019469818,0.00018311723,0.00029360302,0.00007780359],"domain_scores_gemma":[0.99652475,0.00060687773,0.0019952229,0.000277123,0.00027469225,0.00032124735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020634425,0.0004208267,0.0005177838,0.0014899897,0.0004957235,0.00050011673,0.00047532163,0.00055432273,0.0019011064],"category_scores_gemma":[0.0053161373,0.00036192132,0.0004365332,0.0019638808,0.00036048074,0.00047305186,0.00071236154,0.0006669311,0.00042859378],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000319158,0.000025669386,0.99892384,0.000012222394,0.00005319449,0.00001617113,0.000038827577,0.000020794223,0.000052678544,0.0000040615523,0.00009166525,0.0007289366],"study_design_scores_gemma":[0.0000066267517,0.000053317443,0.99955934,0.000005352543,0.000019298812,0.00012870666,0.000067370645,0.000073760246,0.000014443242,0.000011035863,0.00005883187,0.0000018736604],"about_ca_topic_score_codex":0.0033200225,"about_ca_topic_score_gemma":0.004622446,"teacher_disagreement_score":0.0033200225,"about_ca_system_score_codex":0.00019930149,"about_ca_system_score_gemma":0.00026454564,"threshold_uncertainty_score":0.010912657},"labels":[],"label_agreement":null},{"id":"W2945832654","doi":"10.1177/1352458519848100","title":"Three-dimensional MRI sequences in MS diagnosis and research","year":2019,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; Université de Sherbrooke; University of British Columbia","funders":"Canada Research Chairs; National Multiple Sclerosis Society","keywords":"Fluid-attenuated inversion recovery; Multiple sclerosis; Susceptibility weighted imaging; Magnetic resonance imaging; Medicine; Computer science; Nuclear medicine; Nuclear magnetic resonance; Radiology; Physics","score_opus":0.44453599453735654,"score_gpt":0.44510855752473405,"score_spread":0.0005725629873775118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945832654","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000035314413,0.99920446,0.00008717085,0.00017788194,0.00016437746,0.0000028740315,0.000008769721,0.00000462826,0.00031460868],"genre_scores_gemma":[0.00047671053,0.99858296,0.00028395886,0.00018811988,0.00024742915,0.000006151089,0.000018827179,0.000001681308,0.00019421642],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999225,0.00018319114,0.00020449334,0.0001066253,0.00024681643,0.000033815122],"domain_scores_gemma":[0.99841046,0.00090578396,0.00022816185,0.00004109536,0.00035476947,0.000059647315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015555767,0.0010816752,0.001962132,0.006476311,0.00033963594,0.001613777,0.0012507912,0.0017247398,0.0032884704],"category_scores_gemma":[0.0027066052,0.00035310048,0.00072008173,0.005664926,0.0012445581,0.0021017222,0.0009903441,0.0019684818,0.0023447236],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006385742,0.000036989226,0.00029949174,0.028564883,0.00010162346,0.00020904285,0.00011575068,0.0002366517,0.0007715737,0.0033635565,0.024985308,0.9412512],"study_design_scores_gemma":[0.000018459163,0.00007664841,0.0016223032,0.017064627,0.0002290812,0.0028382603,0.0001640913,0.0001104885,0.0004386002,0.0047194907,0.9726783,0.000039739458],"about_ca_topic_score_codex":0.0023343808,"about_ca_topic_score_gemma":0.002389069,"teacher_disagreement_score":0.006476311,"about_ca_system_score_codex":0.0008586011,"about_ca_system_score_gemma":0.0018121636,"threshold_uncertainty_score":0.0110010505},"labels":[],"label_agreement":null},{"id":"W2948407181","doi":"10.1177/1352458519852722","title":"Developing a crosswalk between the RAND-12 and the health utilities index for multiple sclerosis","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Institute of Neurological Disorders and Stroke; Biogen","keywords":"Schema crosswalk; Intraclass correlation; Statistics; Bland–Altman plot; Concordance; Psychology; Population; Pearson product-moment correlation coefficient; Index (typography); Gerontology; Medicine; Mathematics; Limits of agreement; Psychometrics; Geography; Computer science; Environmental health; Nuclear medicine; Internal medicine","score_opus":0.19891477684675718,"score_gpt":0.3414105658524792,"score_spread":0.14249578900572202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948407181","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54372007,0.0023243607,0.43211374,0.0006937793,0.00047972615,0.0033855615,0.0062396326,0.0032032414,0.007839875],"genre_scores_gemma":[0.62027234,0.00048169232,0.3674058,0.00021166426,0.00004826596,0.00515743,0.0054260017,0.0003863054,0.0006104366],"study_design_codex":"observational","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9667199,0.022065664,0.0033761743,0.0035388886,0.0038764442,0.00042301402],"domain_scores_gemma":[0.8617022,0.102721,0.0113962805,0.009510814,0.013918684,0.00075104856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.055326037,0.0014069069,0.0010521781,0.0050067436,0.0006679737,0.002211961,0.0011799628,0.00074940507,0.0025512474],"category_scores_gemma":[0.13609202,0.0007916148,0.0031586406,0.004326877,0.00069659104,0.0019685726,0.0025185836,0.0018135451,0.0008250354],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016005995,0.0007628514,0.5969283,0.0014405354,0.0057583186,0.000113504364,0.0021184052,0.032148585,0.0019019638,0.0058690244,0.009430119,0.34192783],"study_design_scores_gemma":[0.00088303094,0.0050632693,0.6789648,0.0025604037,0.002644123,0.0008304608,0.002061258,0.22940665,0.012242712,0.019929303,0.0447633,0.0006506748],"about_ca_topic_score_codex":0.0015031162,"about_ca_topic_score_gemma":0.0021853298,"teacher_disagreement_score":0.055326037,"about_ca_system_score_codex":0.0010785918,"about_ca_system_score_gemma":0.0018507703,"threshold_uncertainty_score":0.2925955},"labels":[],"label_agreement":null},{"id":"W2952776165","doi":"10.1177/1352458519851428","title":"A pharmacogenetic study implicates <i>NINJ2</i> in the response to Interferon-β in multiple sclerosis","year":2019,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"European Social Fund; Ministerio de Economía y Competitividad; Fondazione Italiana Sclerosi Multipla","keywords":"Multiple sclerosis; Pharmacogenetics; Interferon; Immunology; Medicine; Biomarker; Gene expression; Gene; Internal medicine; Oncology; Genotype; Biology; Genetics","score_opus":0.38506351680437056,"score_gpt":0.4197018806197647,"score_spread":0.034638363815394146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952776165","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98587936,0.0080693,0.001651048,0.00063037383,0.00018060555,0.00003737417,0.0020516696,0.000044064593,0.0014561473],"genre_scores_gemma":[0.99719524,0.0007205672,0.00071051565,0.0001857265,0.00008276961,0.000019636384,0.00067280093,0.000019067955,0.00039359834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992536,0.0002452245,0.00007091621,0.00029564407,0.00008176602,0.000052964475],"domain_scores_gemma":[0.9983975,0.00082695525,0.00043949598,0.00016224777,0.00006884472,0.00010495934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011959899,0.000499762,0.00069513207,0.0004887804,0.00040850646,0.0006082588,0.00039283675,0.000686774,0.0033110897],"category_scores_gemma":[0.0024126766,0.00018756246,0.0018600092,0.0011669798,0.00041628926,0.00019030606,0.00021285244,0.0007228708,0.00026554277],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026802579,0.00021342761,0.87805146,0.001056632,0.018974705,0.0013506477,0.0002116694,0.001869249,0.031583205,0.0007434874,0.0021645322,0.036978394],"study_design_scores_gemma":[0.0008320004,0.000915293,0.969335,0.0001630402,0.01495231,0.0014766672,0.00008442748,0.0035545279,0.0033067304,0.0013821849,0.003952128,0.000045545985],"about_ca_topic_score_codex":0.0024096007,"about_ca_topic_score_gemma":0.00318268,"teacher_disagreement_score":0.0033110897,"about_ca_system_score_codex":0.0002748936,"about_ca_system_score_gemma":0.00024190833,"threshold_uncertainty_score":0.011076748},"labels":[],"label_agreement":null},{"id":"W2962487873","doi":"10.1177/1352458519851981","title":"Characterizing lymphocyte counts and infection rates with long-term teriflunomide treatment: Pooled analysis of clinical trials","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Sanofi Genzyme; Sanofi","keywords":"Teriflunomide; Medicine; Internal medicine; Lymphocyte; Placebo; Multiple sclerosis; Clinical trial; Immunology; Gastroenterology; Pathology","score_opus":0.2252455712472101,"score_gpt":0.42345615740461867,"score_spread":0.19821058615740858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2962487873","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26349252,0.6943332,0.029114315,0.00067353214,0.0007535178,0.0021200473,0.0065916833,0.000362225,0.002559017],"genre_scores_gemma":[0.9577454,0.029031647,0.005621996,0.0005236924,0.00043617483,0.0021250886,0.0039823265,0.00008752296,0.00044633896],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.90500975,0.065504305,0.01512728,0.0074935504,0.0062065064,0.0006585664],"domain_scores_gemma":[0.8773217,0.0853637,0.025201032,0.007110548,0.004365639,0.00063741254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07775576,0.0025297657,0.0098950965,0.0045439545,0.00031200214,0.0027710553,0.0013112244,0.0018050075,0.0014303657],"category_scores_gemma":[0.08010057,0.0011787674,0.023892788,0.0051832595,0.0008256929,0.0017143609,0.0015972628,0.0014512892,0.00020118651],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028581057,0.00006863988,0.08701421,0.014295348,0.8400669,0.00011684101,0.000110203866,0.0025209263,0.0012318224,0.000114939096,0.0007878233,0.025091317],"study_design_scores_gemma":[0.006788912,0.005269426,0.17598099,0.0022797224,0.798103,0.0006044189,0.00017358824,0.0038369687,0.0018085456,0.0009794085,0.0040049125,0.00017018562],"about_ca_topic_score_codex":0.0006603581,"about_ca_topic_score_gemma":0.0009320075,"teacher_disagreement_score":0.07775576,"about_ca_system_score_codex":0.00074026186,"about_ca_system_score_gemma":0.0007967489,"threshold_uncertainty_score":0.41121668},"labels":[],"label_agreement":null},{"id":"W2962683137","doi":"10.1177/1352458519863133","title":"Biomarkers of intestinal barrier function in multiple sclerosis are associated with disease activity","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Barrier Structure and Function Studies","field":"Neuroscience","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; University of Calgary","funders":"Canadian Institutes of Health Research; Alberta Innovates - Health Solutions; Hotchkiss Brain Institute","keywords":"Occludin; Tight junction; Multiple sclerosis; Intestinal permeability; Neuroinflammation; Blood–brain barrier; Barrier function; Internal medicine; Dysbiosis; Endocrinology; Enterocyte; Chemistry; Medicine; Immunology; Biology; Central nervous system; Disease; Small intestine; Biochemistry; Cell biology","score_opus":0.08007929884411687,"score_gpt":0.23184999914244667,"score_spread":0.15177070029832979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2962683137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996382,0.0029328847,0.0001130792,0.00004057007,0.00000517483,0.000009669737,0.00020189754,0.000012964192,0.00030164205],"genre_scores_gemma":[0.9991873,0.00035707475,0.00018749665,0.000012017862,0.000008591901,0.000006793797,0.00014022227,0.0000016503483,0.000098804645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997987,0.000053707496,0.00002932643,0.00004373365,0.000044420744,0.000030043797],"domain_scores_gemma":[0.9983695,0.0001756335,0.0011074262,0.000046057772,0.0001328248,0.00016856201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003430957,0.0003848009,0.000535354,0.00089408265,0.00025226633,0.00048723991,0.00019296737,0.00045389237,0.0012549621],"category_scores_gemma":[0.0013815798,0.00013743286,0.0002164132,0.0009477906,0.00025046576,0.00028811872,0.00035325164,0.00040013247,0.00021198438],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006037324,0.000041579566,0.9905505,0.000119903925,0.00014338117,0.00015625972,0.00007847145,0.000051888677,0.0037090753,0.0000138851165,0.00007005897,0.0044612107],"study_design_scores_gemma":[0.000004879432,0.00013109064,0.9987405,0.0000099182225,0.00004911602,0.0004961349,0.00003974594,0.000055577133,0.00031514707,0.00002682966,0.00012861681,0.0000025660622],"about_ca_topic_score_codex":0.0008308633,"about_ca_topic_score_gemma":0.0008244669,"teacher_disagreement_score":0.0012549621,"about_ca_system_score_codex":0.00019670617,"about_ca_system_score_gemma":0.000098995144,"threshold_uncertainty_score":0.0041983128},"labels":[],"label_agreement":null},{"id":"W2964398132","doi":"10.1177/1352458519867320","title":"Profiles of cortical inflammation in multiple sclerosis by <sup>11</sup> C-PBR28 MR-PET and 7 Tesla imaging","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Polytechnique Montréal","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health; Fondation pour l'Aide à la Recherche sur la Sclérose en Plaques; National Multiple Sclerosis Society; National Institute on Drug Abuse; U.S. Department of Defense","keywords":"Neuroinflammation; Multiple sclerosis; Lesion; Microglia; Cortex (anatomy); Inflammation; Pathology; Medicine; Cerebral cortex; Neuroscience; Internal medicine; Psychology; Immunology","score_opus":0.05690443575896179,"score_gpt":0.27756441131024523,"score_spread":0.22065997555128344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964398132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99924856,0.00022732411,0.000244745,0.000013934323,6.1057375e-7,0.0000060425937,0.000032723638,0.0000075865514,0.00021849603],"genre_scores_gemma":[0.999428,0.000079453835,0.000355588,0.000009463028,0.000002495282,0.000008357729,0.00005238093,0.0000025540883,0.0000617456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99982387,0.000055780234,0.000017573902,0.000040814284,0.000029811425,0.00003229963],"domain_scores_gemma":[0.9995011,0.0000956618,0.00020272705,0.000031570533,0.00008591169,0.00008301118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053261267,0.0003874571,0.00026237385,0.0007961581,0.00021850025,0.00045360168,0.00016949525,0.00038153515,0.00094723766],"category_scores_gemma":[0.0010552865,0.00028648018,0.00015780449,0.0003389027,0.00042642874,0.00029049718,0.0003032037,0.00021705651,0.00022876218],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005589297,0.00018509323,0.7950626,0.00015960142,0.0003054921,0.0028978798,0.0009616045,0.0009587079,0.18020703,0.00009850911,0.00018963734,0.013384443],"study_design_scores_gemma":[0.000047014866,0.000587513,0.98328537,0.00001616594,0.000082077924,0.0053019403,0.0002579483,0.0011645773,0.0089238165,0.00011592175,0.00019778319,0.000019944899],"about_ca_topic_score_codex":0.0010567855,"about_ca_topic_score_gemma":0.00126831,"teacher_disagreement_score":0.0010567855,"about_ca_system_score_codex":0.00027522244,"about_ca_system_score_gemma":0.00019454437,"threshold_uncertainty_score":0.0031688213},"labels":[],"label_agreement":null},{"id":"W2964883388","doi":"10.1177/1352458519866613","title":"Age-related decreases in relapses among adults with relapsing-onset multiple sclerosis","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Javna Agencija za Raziskovalno Dejavnost RS; National Center for Advancing Translational Sciences; University of Minnesota","keywords":"Multiple sclerosis; Expanded Disability Status Scale; Medicine; Age of onset; Young adult; Disease; Pediatrics; Internal medicine; Psychiatry","score_opus":0.05265890524238829,"score_gpt":0.2615956523236744,"score_spread":0.2089367470812861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964883388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766732,0.0127789425,0.0012950228,0.0009238637,0.00001142116,0.000084951986,0.00336566,0.000045884044,0.0048211175],"genre_scores_gemma":[0.9974815,0.0015233951,0.00026607973,0.00005672528,0.0000037026198,0.0000149507305,0.0005188964,0.0000018249864,0.00013293658],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988589,0.00057230436,0.0001196957,0.00016914992,0.00021182594,0.00006808248],"domain_scores_gemma":[0.9938267,0.0032400896,0.0017912103,0.00017169358,0.00084462686,0.00012571868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035078393,0.00018539572,0.00033685516,0.0009654431,0.00018856376,0.0005751693,0.00037304024,0.00041374876,0.001567808],"category_scores_gemma":[0.014471743,0.00013254961,0.00076184253,0.00082210277,0.00017169722,0.0004674606,0.00030067711,0.00041021808,0.00012459823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077979726,0.000079581,0.92801,0.0011526387,0.001002166,0.00038042123,0.0011495978,0.024876995,0.00043719992,0.0009477569,0.0013706381,0.03981311],"study_design_scores_gemma":[0.00006285671,0.00033953224,0.97640026,0.00046785813,0.00061282725,0.00068255793,0.00096549327,0.015736846,0.0003524474,0.0013832981,0.0029681327,0.000027988444],"about_ca_topic_score_codex":0.06546934,"about_ca_topic_score_gemma":0.078090385,"teacher_disagreement_score":0.06546934,"about_ca_system_score_codex":0.0013697651,"about_ca_system_score_gemma":0.0013964289,"threshold_uncertainty_score":0.13017648},"labels":[],"label_agreement":null},{"id":"W2964973090","doi":"10.1177/1352458520985238","title":"Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with ‘aggressive’ multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"National Institute for Health and Care Research","keywords":"Medicine; Multiple sclerosis; Expanded Disability Status Scale; Transplantation; Magnetic resonance imaging; Internal medicine; Hematopoietic stem cell transplantation; Stem cell; Disease; Surgery; Oncology; Radiology; Immunology","score_opus":0.07899143060625634,"score_gpt":0.2774198866422497,"score_spread":0.19842845603599335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964973090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979091,0.0014738317,0.00011762839,0.00004510372,0.000005460999,0.000013851745,0.00002463606,0.000007997006,0.00040227312],"genre_scores_gemma":[0.9994111,0.00027971226,0.00014705554,0.000045189918,0.00002148781,0.000008042352,0.00004746751,7.896338e-7,0.000039149512],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99982065,0.000079080535,0.000022151175,0.000020240419,0.000035915324,0.000022042836],"domain_scores_gemma":[0.99931943,0.00023074949,0.0002464996,0.00003510832,0.00003416228,0.00013408407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047198555,0.00014433265,0.0002969067,0.00029993642,0.00023493392,0.00034171063,0.00013452568,0.00024368527,0.0005571441],"category_scores_gemma":[0.0011742937,0.00006072172,0.00014344686,0.00030174598,0.00026661358,0.0001641557,0.00013619455,0.0002742279,0.00013513908],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065377085,0.00066234206,0.8483779,0.00028580287,0.00015833194,0.007559039,0.0007337446,0.00074633106,0.009355846,0.00018677175,0.0010235468,0.124372594],"study_design_scores_gemma":[0.0015356891,0.025605202,0.9087953,0.00016927245,0.00034474224,0.049449265,0.0005823804,0.0024104973,0.0054915403,0.0004991138,0.005088524,0.00002845879],"about_ca_topic_score_codex":0.0002875589,"about_ca_topic_score_gemma":0.00033704808,"teacher_disagreement_score":0.0005571441,"about_ca_system_score_codex":0.00015392742,"about_ca_system_score_gemma":0.00027873644,"threshold_uncertainty_score":0.0024961233},"labels":[],"label_agreement":null},{"id":"W2970176706","doi":"10.1177/1352458519861267","title":"Beyond supervised therapy: Promoting behavioral changes in people with MS","year":2019,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Behavior change; Psychological intervention; Randomized controlled trial; Rehabilitation; Behavior change methods; Intervention (counseling); Persuasion; Psychology; Physical medicine and rehabilitation; Medicine; Behaviour change; Physical therapy; Clinical psychology; Nursing; Social psychology","score_opus":0.2404851620463508,"score_gpt":0.37338002650246044,"score_spread":0.13289486445610965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970176706","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019945703,0.99890304,0.000058519363,0.00022877546,0.00010801981,0.000025626658,0.000012600723,0.0000032783637,0.00046067798],"genre_scores_gemma":[0.0025688491,0.99633944,0.0003640011,0.00034808423,0.00009621001,0.000047461635,0.000018799685,0.0000016589247,0.00021538153],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99863666,0.0006374403,0.00025899222,0.000105182306,0.0003037615,0.00005784649],"domain_scores_gemma":[0.9986914,0.0009707408,0.00017108851,0.000019572668,0.000105749525,0.000041559124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017993307,0.00074285327,0.0021777132,0.003497562,0.00044392125,0.0019411674,0.00081856677,0.0020274094,0.004707325],"category_scores_gemma":[0.0035389487,0.0003184695,0.002138541,0.002762643,0.0004883068,0.0015593324,0.0007865926,0.0017877682,0.00067363563],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001500082,0.00014031968,0.00014908149,0.25981414,0.0007074131,0.00007704768,0.00025784323,0.0001348381,0.000519434,0.0020106952,0.005817273,0.7302219],"study_design_scores_gemma":[0.0005394935,0.001072153,0.0073299916,0.3960162,0.005846822,0.0016804395,0.00064539333,0.00027680106,0.001153324,0.0041782223,0.58119464,0.00006645164],"about_ca_topic_score_codex":0.0028326185,"about_ca_topic_score_gemma":0.00692785,"teacher_disagreement_score":0.004707325,"about_ca_system_score_codex":0.0007804166,"about_ca_system_score_gemma":0.0024619035,"threshold_uncertainty_score":0.015747607},"labels":[],"label_agreement":null},{"id":"W2972393403","doi":"10.1177/1352458519876701","title":"Clinical outcome measures in SPMS trials: An analysis of the IMPACT and ASCEND original trial data sets","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Expanded Disability Status Scale; Multiple sclerosis; Clinical trial; Internal medicine; Logistic regression; Placebo; Oncology; Medicine; Psychology; Physical therapy; Immunology; Alternative medicine; Pathology","score_opus":0.5834111246289764,"score_gpt":0.5235805873865089,"score_spread":0.05983053724246745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972393403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.654109,0.20834136,0.02123916,0.004356596,0.0007550166,0.018656975,0.083901346,0.0009007409,0.00773978],"genre_scores_gemma":[0.9236922,0.009035529,0.011819926,0.0015589229,0.000334061,0.018799452,0.03329814,0.00026933206,0.0011924412],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.77118,0.17972802,0.023058182,0.0068998095,0.016748728,0.0023853488],"domain_scores_gemma":[0.6881427,0.24634495,0.0397578,0.018097464,0.0059300903,0.0017269333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.13517506,0.0022975053,0.011054401,0.0036767214,0.0007157855,0.0033004656,0.0020168023,0.001953286,0.0046175644],"category_scores_gemma":[0.21709412,0.0009265313,0.012333916,0.0056199483,0.0015010429,0.0025200262,0.0025315543,0.0030108958,0.00045504078],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.47974417,0.0009960585,0.06564148,0.049193185,0.320312,0.0007708138,0.00048630574,0.0075191027,0.0014880741,0.0017792071,0.012513506,0.059556067],"study_design_scores_gemma":[0.36812416,0.029713463,0.22148223,0.010240919,0.30053398,0.0023060313,0.00052461156,0.015310937,0.0023092157,0.0059063006,0.042980976,0.00056717487],"about_ca_topic_score_codex":0.00058361713,"about_ca_topic_score_gemma":0.0014602768,"teacher_disagreement_score":0.13517506,"about_ca_system_score_codex":0.001597729,"about_ca_system_score_gemma":0.002427235,"threshold_uncertainty_score":0.7148826},"labels":[],"label_agreement":null},{"id":"W2973206099","doi":"10.1177/1352458519876038","title":"Disparities in management and outcomes of myocardial infarction in multiple sclerosis: A matched cohort study","year":2019,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Vancouver Coastal Health; University of Manitoba","funders":"Multiple Sclerosis Society of Canada","keywords":"Medicine; Myocardial infarction; Hazard ratio; Cohort; Internal medicine; Odds ratio; Population; Cohort study; Retrospective cohort study; Revascularization; Confidence interval; Confounding; Cardiology","score_opus":0.1842097792581606,"score_gpt":0.3525435107377221,"score_spread":0.16833373147956152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973206099","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010973882,0.98797685,0.000072021336,0.0003734268,0.000055773377,0.000031098563,0.00023650474,0.0000017103491,0.0002787241],"genre_scores_gemma":[0.15057655,0.84801,0.00035591534,0.00033411453,0.00011407281,0.00008386979,0.00043332353,0.0000016200742,0.00009057579],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985796,0.0006562676,0.00022458695,0.00016280287,0.00028596426,0.00009069886],"domain_scores_gemma":[0.9975395,0.0014625569,0.00057841465,0.000053736898,0.00027168888,0.00009404553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029036023,0.00044833013,0.0016940112,0.0019520909,0.00026553392,0.00069136295,0.00065559044,0.0006852487,0.0011713008],"category_scores_gemma":[0.007668632,0.00022358814,0.0023422877,0.003425747,0.00020761073,0.0003765246,0.0005565234,0.00043237195,0.000047905887],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023891646,0.00022428342,0.16084565,0.23327194,0.10106197,0.00043028776,0.00074921094,0.0008118345,0.00037360008,0.0023706388,0.0083071655,0.48916423],"study_design_scores_gemma":[0.0015445666,0.000835068,0.5860083,0.17442618,0.18492627,0.0012149523,0.0011035398,0.0009278941,0.00043803488,0.0026455913,0.045797758,0.00013189486],"about_ca_topic_score_codex":0.03977322,"about_ca_topic_score_gemma":0.056501865,"teacher_disagreement_score":0.03977322,"about_ca_system_score_codex":0.0013221721,"about_ca_system_score_gemma":0.0032918577,"threshold_uncertainty_score":0.07908344},"labels":[],"label_agreement":null},{"id":"W2980722980","doi":"10.1177/1352458519877810","title":"The long-term outcomes of CIS patients in the Barcelona inception cohort: Looking back to recognize aggressive MS","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Instituto de Salud Carlos III; Siemens; Agència de Gestió d'Ajuts Universitaris i de Recerca; European Committee for Treatment and Research in Multiple Sclerosis; Oryzon Genomics; Teva Pharmaceutical Industries; Red Española de Esclerosis Múltiple; Biogen; Celgene; European Regional Development Fund; Sanofi; F. Hoffmann-La Roche; Genzyme","keywords":"Medicine; Interquartile range; Hazard ratio; Multiple sclerosis; Expanded Disability Status Scale; Cohort; Confidence interval; Internal medicine; Magnetic resonance imaging; Natural history; McDonald criteria; Lesion; Proportional hazards model; Cohort study; Surgery; Radiology; Psychiatry","score_opus":0.06686895839198086,"score_gpt":0.31560788350117713,"score_spread":0.24873892510919626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980722980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991462,0.00026401578,0.000040926814,0.000042204552,0.0000057539282,0.0000036663766,0.0002510691,0.0000026071227,0.000243413],"genre_scores_gemma":[0.9990452,0.00013087876,0.0000352412,0.000018783534,0.000015590638,0.0000046463206,0.00062751095,0.0000021555757,0.000119944634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996916,0.00007123164,0.000023603958,0.00009646045,0.000048755,0.0000684251],"domain_scores_gemma":[0.9985991,0.00019180698,0.00057220785,0.0001085619,0.00019067967,0.00033761104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007619569,0.00035011835,0.00044197575,0.000848973,0.00042764793,0.00079515536,0.0003790639,0.0005045516,0.0012941449],"category_scores_gemma":[0.0021277596,0.000239324,0.0004281801,0.0005522807,0.00020750762,0.00047829046,0.0004594027,0.00059066934,0.0002571964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037556572,0.000023206174,0.9979297,0.000005083975,0.00003522509,0.00011525413,0.000043674252,0.00008040121,0.00014625562,0.000008838834,0.00009788621,0.0011388444],"study_design_scores_gemma":[0.000015901169,0.00014085646,0.9990336,0.000007901139,0.000034172182,0.0002846885,0.00011935196,0.0002034645,0.000025158954,0.000016067906,0.00011437469,0.000004572946],"about_ca_topic_score_codex":0.009513725,"about_ca_topic_score_gemma":0.009098235,"teacher_disagreement_score":0.009513725,"about_ca_system_score_codex":0.00043804914,"about_ca_system_score_gemma":0.00029468615,"threshold_uncertainty_score":0.018916726},"labels":[],"label_agreement":null},{"id":"W2980983689","doi":"10.1177/1352458519872895","title":"MOG-IgG myelitis coexisting with systemic lupus erythematosus in the post-partum setting","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Transverse myelitis; Medicine; Neuromyelitis optica; Myelitis; Pathology; Myelin oligodendrocyte glycoprotein; Cerebrospinal fluid; Immunology; Antibody; Spinal cord; Multiple sclerosis; Disease; Experimental autoimmune encephalomyelitis","score_opus":0.05262883973412667,"score_gpt":0.27972925782657765,"score_spread":0.22710041809245096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980983689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98873293,0.0039919815,0.00021633817,0.001058727,0.00005749286,0.00004631499,0.00008629145,0.000026381886,0.0057834038],"genre_scores_gemma":[0.9984877,0.0007614729,0.00013607275,0.00020352387,0.00016296013,0.000008409403,0.00003363014,0.0000025218321,0.00020366852],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99967194,0.000063543,0.000035548932,0.000053855776,0.000040387808,0.00013482363],"domain_scores_gemma":[0.99863404,0.00041412993,0.00045605082,0.00005638016,0.00005421711,0.0003852102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041826884,0.0007701607,0.000497168,0.0008298355,0.0012612381,0.0006301074,0.00043135078,0.0013816383,0.0034602091],"category_scores_gemma":[0.0029294451,0.0004286896,0.00031195843,0.0005900759,0.0010833745,0.0006353235,0.0006283646,0.0012207556,0.00051067176],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023987524,0.000070278875,0.19622986,0.0000810484,0.0000151586,0.79928434,0.0002836592,0.000043665495,0.0011374401,0.00009983584,0.00032977975,0.0021851151],"study_design_scores_gemma":[0.000039278282,0.0003483004,0.15253545,0.000082563274,0.000037538623,0.84482545,0.0005646358,0.00013039653,0.00042959882,0.00016483838,0.0008305892,0.000011314605],"about_ca_topic_score_codex":0.0015711122,"about_ca_topic_score_gemma":0.0022777228,"teacher_disagreement_score":0.0034602091,"about_ca_system_score_codex":0.00070883567,"about_ca_system_score_gemma":0.0008377758,"threshold_uncertainty_score":0.01157552},"labels":[],"label_agreement":null},{"id":"W2981852969","doi":"10.1177/1352458519879094","title":"Computerized neuropsychological assessment devices in multiple sclerosis: A systematic review","year":2019,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Neuropsychology; Neuropsychological assessment; Cognition; Cognitive test; Reliability (semiconductor); Test (biology); Psychology; Neuropsychological test; Medicine; Psychometrics; Modalities; Clinical psychology; Multiple sclerosis; Physical medicine and rehabilitation; Psychiatry","score_opus":0.3668732935728513,"score_gpt":0.41753565496428635,"score_spread":0.05066236139143504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981852969","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036375877,0.99914706,0.000045213405,0.00008216751,0.000039248647,0.000073214185,0.00011148744,0.0000035462072,0.0001342161],"genre_scores_gemma":[0.0040679206,0.99524885,0.00026897067,0.00012222028,0.000035425754,0.00012257644,0.000085145824,0.0000016163741,0.000047249807],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9965833,0.000938131,0.0013287977,0.00026809127,0.00078103546,0.000100737605],"domain_scores_gemma":[0.98035634,0.014842348,0.0028498585,0.00019667322,0.0015802678,0.00017452604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004488936,0.0011524261,0.004871214,0.011086089,0.0004782225,0.0017617539,0.0017717894,0.0014381923,0.0042435434],"category_scores_gemma":[0.022033183,0.000652629,0.0036219761,0.011479928,0.00066002907,0.0018179925,0.0010734766,0.0007905614,0.00033275303],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013366928,0.000024221592,0.00069545757,0.8866502,0.00258008,0.00009114609,0.0001186367,0.00007344133,0.00011188474,0.00018596124,0.001853536,0.1074817],"study_design_scores_gemma":[0.00022270062,0.0002359802,0.006379674,0.92030466,0.034163244,0.00081820914,0.00028570305,0.000101189675,0.00021300094,0.00031842367,0.03691606,0.000041242805],"about_ca_topic_score_codex":0.0065833265,"about_ca_topic_score_gemma":0.016258452,"teacher_disagreement_score":0.011086089,"about_ca_system_score_codex":0.002177385,"about_ca_system_score_gemma":0.0076784464,"threshold_uncertainty_score":0.023739994},"labels":[],"label_agreement":null},{"id":"W2983107219","doi":"10.1177/1352458519881761","title":"Diroximel fumarate (DRF) in patients with relapsing–remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital; McGill University; NeuroRx Research (Canada)","funders":"National Center for Advancing Translational Sciences; Biogen","keywords":"Tolerability; Medicine; Dimethyl fumarate; Adverse effect; Discontinuation; Multiple sclerosis; Internal medicine; Relapsing remitting; Interim analysis; Clinical endpoint; Bioequivalence; Confidence interval; Phases of clinical research; Clinical trial; Gastroenterology; Pharmacokinetics; Immunology","score_opus":0.0795667792310148,"score_gpt":0.29880832560620435,"score_spread":0.21924154637518956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983107219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922994,0.004535302,0.00037202702,0.00027508428,0.00003687969,0.00044879434,0.0007531723,0.000044864842,0.0012344818],"genre_scores_gemma":[0.99486697,0.0012429967,0.00097369694,0.0004774905,0.00008247279,0.00028894667,0.0015587652,0.000010281573,0.00049847574],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99915147,0.00043643508,0.00009326161,0.0000772989,0.00016038577,0.00008112893],"domain_scores_gemma":[0.9984138,0.00036273105,0.00059458136,0.00011171981,0.00020170279,0.00031535336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046386635,0.00066263333,0.0012663956,0.00026054465,0.00037783166,0.0006662999,0.00041121044,0.0007441793,0.0010603075],"category_scores_gemma":[0.002294272,0.000237395,0.0010650697,0.0002916021,0.00028469594,0.00067056395,0.0003286134,0.0014872582,0.00034429654],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5602466,0.021389568,0.09210005,0.0014894162,0.0041315993,0.00066353276,0.00076508214,0.0022712923,0.033541404,0.00020194982,0.005115108,0.2780843],"study_design_scores_gemma":[0.23117933,0.4734004,0.26414555,0.00022117296,0.0038927668,0.0018213546,0.00022105065,0.0027506305,0.013853074,0.00032568816,0.008082552,0.000106459316],"about_ca_topic_score_codex":0.00034782878,"about_ca_topic_score_gemma":0.0010128258,"teacher_disagreement_score":0.0046386635,"about_ca_system_score_codex":0.0003500738,"about_ca_system_score_gemma":0.00053466967,"threshold_uncertainty_score":0.024531841},"labels":[],"label_agreement":null},{"id":"W2983891338","doi":"10.1177/1352458519881759","title":"Efficacy of alemtuzumab over 6 years in relapsing–remitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studies","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Bayer HealthCare; Sanofi","keywords":"Alemtuzumab; Multiple sclerosis; Medicine; Expanded Disability Status Scale; Regimen; Post-hoc analysis; Internal medicine; Relapsing remitting; Physical therapy; Transplantation; Psychiatry","score_opus":0.06957542812171856,"score_gpt":0.31114459657918003,"score_spread":0.24156916845746146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983891338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99815446,0.0013281913,0.00004139983,0.00003645215,0.000019194284,0.000047758556,0.00019510751,0.000003919375,0.00017350822],"genre_scores_gemma":[0.99906105,0.00015193134,0.00007155862,0.00003235286,0.00004687946,0.00004981553,0.00048384644,0.0000024280037,0.00010012241],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952297,0.0029937276,0.0003910631,0.00052449486,0.000528791,0.00033223772],"domain_scores_gemma":[0.99054587,0.00448293,0.0025026463,0.0006880073,0.0008684628,0.0009120232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009328521,0.0007001921,0.002093387,0.0009079981,0.0004073496,0.00095281063,0.00061663263,0.000697224,0.0008112067],"category_scores_gemma":[0.008153132,0.00024376916,0.003180102,0.0007408935,0.000434175,0.00074959826,0.00061320385,0.0010388518,0.000116275805],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.39224598,0.0022814965,0.5596645,0.00046037592,0.01685134,0.00028236845,0.00035500817,0.0013657709,0.0028102645,0.000066177054,0.00093453785,0.022682184],"study_design_scores_gemma":[0.010844614,0.07573243,0.90419346,0.00005263616,0.005429184,0.00023305677,0.0001577961,0.001345664,0.0008703448,0.00006552944,0.0010269687,0.000048220278],"about_ca_topic_score_codex":0.00090974785,"about_ca_topic_score_gemma":0.001400713,"teacher_disagreement_score":0.009328521,"about_ca_system_score_codex":0.000583,"about_ca_system_score_gemma":0.00066206517,"threshold_uncertainty_score":0.049334466},"labels":[],"label_agreement":null},{"id":"W2989609353","doi":"10.1177/1352458519888610","title":"Efficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, and TOPAZ studies","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Bayer HealthCare; Sanofi","keywords":"Alemtuzumab; Multiple sclerosis; Medicine; Relapsing remitting; Magnetic resonance imaging; Physical therapy; Internal medicine; Pediatrics; Surgery; Radiology; Psychiatry","score_opus":0.06075411837023619,"score_gpt":0.33638989736329816,"score_spread":0.27563577899306196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989609353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7187508,0.27394873,0.0014466592,0.0002132008,0.0003030044,0.00028802262,0.0035427506,0.0000721164,0.001434717],"genre_scores_gemma":[0.98606396,0.011211717,0.00049451285,0.000122001264,0.00017540876,0.00016225211,0.0015365998,0.000016196338,0.00021737939],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98907286,0.0062317126,0.0020067974,0.0014240997,0.0009512146,0.0003132105],"domain_scores_gemma":[0.9833197,0.009550513,0.0042773723,0.0015350016,0.0009154473,0.00040188746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015504478,0.0014807209,0.0076096207,0.0026413414,0.00022105167,0.001496803,0.0007357541,0.000996257,0.0014770707],"category_scores_gemma":[0.014739551,0.0006140972,0.01672447,0.0024228906,0.00032622297,0.0006723086,0.0009099447,0.000831575,0.00016798254],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10852088,0.00013347114,0.13067411,0.007646071,0.72608346,0.0001819131,0.00008492887,0.001250699,0.0012193667,0.00007897555,0.0007500928,0.023375988],"study_design_scores_gemma":[0.012409711,0.00634487,0.298882,0.00081195094,0.67698896,0.00031864422,0.000089634974,0.0011630411,0.00072950043,0.00025046285,0.0019491413,0.00006197114],"about_ca_topic_score_codex":0.001188768,"about_ca_topic_score_gemma":0.0018692823,"teacher_disagreement_score":0.015504478,"about_ca_system_score_codex":0.0004435346,"about_ca_system_score_gemma":0.00045948985,"threshold_uncertainty_score":0.0819965},"labels":[],"label_agreement":null},{"id":"W2989646803","doi":"10.1177/1352458519886070","title":"Trigeminal neuralgia associated with multiple sclerosis: A multimodal assessment of brainstem plaques and response to Gamma Knife radiosurgery","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Trigeminal Neuralgia and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network","funders":"Multiple Sclerosis Society","keywords":"Medicine; Trigeminal neuralgia; Fractional anisotropy; Fluid-attenuated inversion recovery; Brainstem; Radiosurgery; Trigeminal nerve; Diffusion MRI; Multiple sclerosis; Nuclear medicine; Tractography; Radiology; Surgery; Magnetic resonance imaging; Internal medicine; Radiation therapy","score_opus":0.0485729125166182,"score_gpt":0.2690953399081118,"score_spread":0.22052242739149358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989646803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993345,0.00014506157,0.000093012204,0.000015394618,0.0000012447299,0.000011384856,0.000026652613,0.000002748105,0.00037001248],"genre_scores_gemma":[0.9997538,0.000048040576,0.00010831285,0.000005136834,0.000004609048,0.0000066208577,0.00003250724,5.7221615e-7,0.00004026612],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99989545,0.000022309318,0.000015103707,0.000020410636,0.000029562063,0.000017112847],"domain_scores_gemma":[0.9996774,0.0000504641,0.00015035656,0.00001454668,0.000044790868,0.00006232489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036979775,0.00029632557,0.00025210812,0.0005588977,0.00026894963,0.00025042612,0.00013489574,0.00025009637,0.000939336],"category_scores_gemma":[0.00092088245,0.0000798248,0.00014920709,0.00028923337,0.00020648823,0.00030834452,0.00023011869,0.00022517725,0.00008530484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011577273,0.00016432597,0.9608921,0.00007885988,0.00010023485,0.0024337708,0.00036379616,0.0003814988,0.020131145,0.00003679864,0.000108024025,0.014151748],"study_design_scores_gemma":[0.000015676858,0.00036822094,0.9949005,0.000011916082,0.000038818736,0.003149193,0.00017052624,0.0003934487,0.000817396,0.000038881273,0.00008776356,0.0000076514325],"about_ca_topic_score_codex":0.00092508254,"about_ca_topic_score_gemma":0.0013578539,"teacher_disagreement_score":0.000939336,"about_ca_system_score_codex":0.00023981396,"about_ca_system_score_gemma":0.0001709528,"threshold_uncertainty_score":0.0031424165},"labels":[],"label_agreement":null},{"id":"W2991623378","doi":"10.1177/1352458519892555","title":"Leveraging real-world data to investigate multiple sclerosis disease behavior, prognosis, and treatment","year":2019,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"European Committee for Treatment and Research in Multiple Sclerosis; National Multiple Sclerosis Society","keywords":"Observational study; Standardization; Real world data; Clinical trial; Harmonization; Disease; Multiple sclerosis; Medicine; MEDLINE; Randomized controlled trial; Data science; Scope (computer science); Medical physics; Computer science; Pathology; Psychiatry","score_opus":0.5877955149699188,"score_gpt":0.4225676752915705,"score_spread":0.16522783967834825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991623378","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012775102,0.99834776,0.00031881593,0.0005340832,0.0001406634,0.00006471828,0.00016022802,0.0000055387977,0.00030043643],"genre_scores_gemma":[0.0026740916,0.9946051,0.0014557785,0.0006140676,0.00020734646,0.00017524163,0.0001984152,0.0000039383403,0.00006607601],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98405343,0.007833431,0.004087091,0.0011440845,0.0026695442,0.00021230266],"domain_scores_gemma":[0.8463429,0.13733521,0.008085917,0.002311179,0.0055127963,0.0004119829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027448924,0.0012618154,0.006643158,0.009186204,0.00041154158,0.0032271284,0.002076049,0.0022520456,0.0031699724],"category_scores_gemma":[0.07858767,0.00062746374,0.004221114,0.009339032,0.0012788732,0.002906369,0.0013328939,0.002496286,0.0006063311],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019753186,0.00008304699,0.0018845449,0.3570937,0.007039878,0.00007291671,0.0001747932,0.0005070706,0.00025522595,0.004207953,0.0068409606,0.6216423],"study_design_scores_gemma":[0.00031152306,0.00049012026,0.011831524,0.57851744,0.025167553,0.0007172232,0.0005980977,0.0004633197,0.00061281974,0.0119156595,0.36922115,0.00015355057],"about_ca_topic_score_codex":0.0034293237,"about_ca_topic_score_gemma":0.006344177,"teacher_disagreement_score":0.027448924,"about_ca_system_score_codex":0.001961051,"about_ca_system_score_gemma":0.007468833,"threshold_uncertainty_score":0.1451655},"labels":[],"label_agreement":null},{"id":"W2994697016","doi":"10.1177/1352458519892914","title":"CNS demyelination after initiating the tyrosine kinase inhibitor imatinib: A report of two cases","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Imatinib; Medicine; Multiple sclerosis; Tyrosine-kinase inhibitor; Myelin oligodendrocyte glycoprotein; Optic neuritis; Tyrosine kinase; Oligodendrocyte; Magnetic resonance imaging; Central nervous system; Pathology; Myelin; Immunology; Internal medicine; Radiology; Experimental autoimmune encephalomyelitis; Cancer; Receptor","score_opus":0.04754278601143761,"score_gpt":0.2807703694467234,"score_spread":0.2332275834352858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994697016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809403,0.0048139472,0.0027865304,0.001057905,0.0002614596,0.00027817578,0.00015109725,0.0001439612,0.009566672],"genre_scores_gemma":[0.99472755,0.0018144967,0.00086399104,0.00055267505,0.0005613498,0.00006625642,0.00011152313,0.000028951528,0.0012732255],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9983045,0.00019061303,0.00024659256,0.00040128396,0.00020562162,0.00065137236],"domain_scores_gemma":[0.9967894,0.0007216721,0.0007921661,0.00043294873,0.00022331075,0.0010404428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008317616,0.0033397677,0.0013463263,0.0030248913,0.0030657856,0.002669727,0.0022563857,0.0064608264,0.0018320665],"category_scores_gemma":[0.004451709,0.0017779372,0.0016393502,0.0020856396,0.003308439,0.0019821357,0.0028291848,0.0033681185,0.0013254624],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049980375,0.00010076354,0.0068156747,0.000038159433,0.000019454648,0.99043876,0.00043772248,0.000039827806,0.0006262407,0.0001000723,0.00011921862,0.0012141925],"study_design_scores_gemma":[0.000020313602,0.00010185427,0.0043542283,0.000014611901,0.000022390017,0.994365,0.00017576515,0.00008165345,0.00038840208,0.00007583096,0.00038694873,0.000013060043],"about_ca_topic_score_codex":0.002653563,"about_ca_topic_score_gemma":0.0023482665,"teacher_disagreement_score":0.0064608264,"about_ca_system_score_codex":0.0017369377,"about_ca_system_score_gemma":0.00088372384,"threshold_uncertainty_score":0.012602448},"labels":[],"label_agreement":null},{"id":"W2995945588","doi":"10.1177/1352458519895450","title":"Differential item functioning of the Arm function in Multiple Sclerosis Questionnaire (AMSQ) by language, a study in six countries","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Differential item functioning; Polytomous Rasch model; German; Logistic regression; Multiple sclerosis; Item response theory; Psychology; Medicine; Psychometrics; Clinical psychology; Linguistics; Psychiatry; Internal medicine","score_opus":0.052022623413905754,"score_gpt":0.2788268553317233,"score_spread":0.22680423191781754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995945588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992945,0.00014357844,0.000071682734,0.0000146455295,0.0000025526367,0.000014789324,0.00029118714,9.742158e-7,0.0001660152],"genre_scores_gemma":[0.9992155,0.000053450538,0.000111745976,0.00001211595,0.0000023712707,0.000026411404,0.00053925236,0.0000013029949,0.000037878617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969175,0.0015680726,0.00050089846,0.0004112235,0.00038471093,0.00021765873],"domain_scores_gemma":[0.99556446,0.0015485651,0.0017699064,0.0002613185,0.00049483485,0.00036101456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004459872,0.00058438105,0.0006608202,0.002099615,0.0005039426,0.0008765666,0.00037776935,0.0004559318,0.0008679876],"category_scores_gemma":[0.010086501,0.00033858523,0.00092068984,0.002390151,0.0008457151,0.00085210375,0.0013445946,0.00040049962,0.00022544837],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036147935,0.00005018108,0.99586135,0.000048976297,0.00015511733,0.00013229504,0.0009444341,0.00013050808,0.00019109095,0.000036470625,0.00009831445,0.0019898475],"study_design_scores_gemma":[0.00006805133,0.00030474187,0.9969758,0.000024585803,0.00006188999,0.00049584237,0.0012555885,0.0003381219,0.00011164979,0.00005820289,0.00029223764,0.000013223983],"about_ca_topic_score_codex":0.001993477,"about_ca_topic_score_gemma":0.0016883591,"teacher_disagreement_score":0.004459872,"about_ca_system_score_codex":0.00049929344,"about_ca_system_score_gemma":0.00038367638,"threshold_uncertainty_score":0.023586333},"labels":[],"label_agreement":null},{"id":"W2996608443","doi":"10.1177/1352458519895985","title":"Neighbourhood environments and the risk of hospital admission for cardiometabolic and mental health comorbidities in multiple sclerosis: A population cohort analysis using linked administrative data","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of New Brunswick","funders":"Diabetes Canada; Fondation de la recherche en santé du Nouveau-Brunswick","keywords":"Neighbourhood (mathematics); Medicine; Confidence interval; Ethnically diverse; Cohort; Proportional hazards model; Mental health; Cohort study; Demography; Population; Environmental health; Gerontology; Internal medicine; Psychiatry","score_opus":0.135644812071875,"score_gpt":0.3398744522146869,"score_spread":0.20422964014281186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996608443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989793,0.00012251355,0.00008350963,0.000027920118,0.0000037559284,0.000006873793,0.00063859124,0.00000240676,0.00013505093],"genre_scores_gemma":[0.9991912,0.00009721876,0.000096389274,0.000011165287,0.0000034731936,0.000008248642,0.00047264702,0.0000018670621,0.00011782109],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99948466,0.00013783337,0.000043058764,0.000100984165,0.000103321465,0.00013014754],"domain_scores_gemma":[0.99881244,0.00016880929,0.00038213786,0.00019122871,0.00021140903,0.00023404931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007304633,0.0002910874,0.0003441131,0.0008698181,0.00083334144,0.0009723308,0.0006011976,0.0003104965,0.00074931997],"category_scores_gemma":[0.0021442499,0.00035729716,0.00076485955,0.0018773475,0.00034072693,0.00036973305,0.00081758795,0.00065799686,0.000107509586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007099192,0.000015612297,0.999119,0.0000036498143,0.000093703886,0.000031315503,0.00006687888,0.000040099647,0.000062823354,0.000010696998,0.000057938603,0.00042738504],"study_design_scores_gemma":[0.000009794343,0.000034422832,0.9990403,0.0000066238354,0.00006740422,0.000064634536,0.0002499417,0.00035339606,0.00003080929,0.000019749034,0.00011743873,0.0000054588645],"about_ca_topic_score_codex":0.54591006,"about_ca_topic_score_gemma":0.61849916,"teacher_disagreement_score":0.54591006,"about_ca_system_score_codex":0.0017591738,"about_ca_system_score_gemma":0.0026035951,"threshold_uncertainty_score":0.9135283},"labels":[],"label_agreement":null},{"id":"W2998946058","doi":"10.1177/1352458519898591","title":"New applications for independent activities of daily living in measuring disability in multiple sclerosis","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Activities of daily living; Expanded Disability Status Scale; Psychology; Scale (ratio); Rehabilitation; Physical therapy; Medicine; Gerontology; Physical medicine and rehabilitation; Multiple sclerosis; Psychiatry","score_opus":0.22564459639587997,"score_gpt":0.315331861443545,"score_spread":0.08968726504766505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998946058","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40712786,0.14749332,0.25158322,0.0112455925,0.010360656,0.01835874,0.04835295,0.005032238,0.10044537],"genre_scores_gemma":[0.5348297,0.022862902,0.3847028,0.0022278607,0.001408025,0.023780527,0.012303541,0.00049194397,0.01739276],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9882626,0.0064104544,0.0016378872,0.0007039791,0.0026346215,0.0003504286],"domain_scores_gemma":[0.98728335,0.0072082817,0.0021409485,0.00046964985,0.0024974546,0.0004003297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014280639,0.0021023252,0.0012987736,0.005441066,0.0008088713,0.0016544533,0.00133804,0.0012323521,0.006225592],"category_scores_gemma":[0.027147109,0.00061158364,0.0024334106,0.004614677,0.00067371235,0.0024176673,0.0026136618,0.0029203005,0.0025439057],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017318869,0.0007301867,0.3318461,0.002593334,0.0007574305,0.0005289715,0.0012282499,0.0038024774,0.0022855282,0.007851805,0.037068576,0.60957545],"study_design_scores_gemma":[0.000522279,0.002495216,0.7960666,0.0026176437,0.0004741064,0.0044506732,0.001465115,0.02111844,0.0015215146,0.016921842,0.15201837,0.00032820806],"about_ca_topic_score_codex":0.0028049508,"about_ca_topic_score_gemma":0.006078464,"teacher_disagreement_score":0.014280639,"about_ca_system_score_codex":0.0011526973,"about_ca_system_score_gemma":0.0012280581,"threshold_uncertainty_score":0.07552409},"labels":[],"label_agreement":null},{"id":"W3000484916","doi":"10.1177/1352458519898340","title":"World Health Organization Essential Medicines List: Multiple sclerosis disease-modifying therapies application","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Multiple Sclerosis Society of Canada","funders":"","keywords":"Fingolimod; Medicine; Multiple sclerosis; Glatiramer acetate; Ocrelizumab; Alternative medicine; Public health; Family medicine; Disease; Nursing; Psychiatry; Pathology","score_opus":0.11990439016570688,"score_gpt":0.31856710071957195,"score_spread":0.19866271055386509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000484916","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004230962,0.0612689,0.00459257,0.1542968,0.01992116,0.005252152,0.2606449,0.0024994207,0.48729306],"genre_scores_gemma":[0.061137162,0.11611187,0.03903924,0.16566451,0.02623611,0.009187004,0.4165254,0.0009649867,0.1651338],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99525523,0.0011694388,0.00090863166,0.00019784573,0.0020890238,0.00037986398],"domain_scores_gemma":[0.9817886,0.003910215,0.0032749616,0.0005533576,0.008836243,0.0016365435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004417084,0.0010409624,0.0011389903,0.0032465898,0.00089176936,0.002748835,0.0014751843,0.0029179854,0.060311988],"category_scores_gemma":[0.019088425,0.00032627926,0.0011421851,0.0049824566,0.00056992937,0.0017438135,0.001545712,0.0035315007,0.04236951],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017249338,0.00009086036,0.0011026765,0.0016063032,0.000026221664,0.00008863969,0.000025233994,0.00012349055,0.0002497022,0.0021578788,0.89962626,0.0947303],"study_design_scores_gemma":[0.00018505598,0.00009608565,0.00648052,0.0013908767,0.000026067684,0.0001302153,0.000021171121,0.00009484846,0.00020369266,0.0011928132,0.99015945,0.00001932641],"about_ca_topic_score_codex":0.00726577,"about_ca_topic_score_gemma":0.006484941,"teacher_disagreement_score":0.060311988,"about_ca_system_score_codex":0.0020466403,"about_ca_system_score_gemma":0.010592775,"threshold_uncertainty_score":0.20176369},"labels":[],"label_agreement":null},{"id":"W3000974005","doi":"10.1177/1352458519881558","title":"A roadmap to precision medicine for multiple sclerosis","year":2020,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"U.S. Department of Defense","keywords":"Multiple sclerosis; Precision medicine; Disease; Medicine; Clinical phenotype; Intensive care medicine; MEDLINE; Phenotype; Pathology; Psychiatry; Biology","score_opus":0.382301072029657,"score_gpt":0.40815659315791053,"score_spread":0.02585552112825351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000974005","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005125359,0.99423766,0.0005310522,0.0032173826,0.0005714047,0.000012283161,0.000028952674,0.000025877185,0.0013240876],"genre_scores_gemma":[0.00067450415,0.995197,0.0013370168,0.0016740642,0.000570399,0.000018897,0.00004473673,0.000005520749,0.00047790044],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99797016,0.0008186682,0.00025866198,0.00018898126,0.0006429914,0.00012053623],"domain_scores_gemma":[0.99082327,0.006510038,0.0005242319,0.00021589328,0.0016121429,0.00031448048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054725464,0.0011106546,0.0021875945,0.0043873307,0.0005762851,0.0026621341,0.0014551821,0.0033837624,0.010057376],"category_scores_gemma":[0.006961175,0.00034842733,0.0018903814,0.003789844,0.0012925738,0.0044518886,0.0018131592,0.0054158205,0.003987344],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007585714,0.00008277565,0.00014823947,0.029752292,0.00019671416,0.0001660778,0.00014315575,0.00030515055,0.00078400655,0.018618276,0.054130103,0.89559734],"study_design_scores_gemma":[0.000023113602,0.0000806221,0.00044042547,0.015262822,0.0001745015,0.0005543697,0.00011028913,0.000097727534,0.00018370367,0.01094711,0.97209984,0.000025342439],"about_ca_topic_score_codex":0.0018046809,"about_ca_topic_score_gemma":0.0024369424,"teacher_disagreement_score":0.010057376,"about_ca_system_score_codex":0.0022506702,"about_ca_system_score_gemma":0.005416848,"threshold_uncertainty_score":0.03364533},"labels":[],"label_agreement":null},{"id":"W3001018322","doi":"10.1177/1352458519898108","title":"Recovery of cognitive function after relapse in multiple sclerosis","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Mallinckrodt Pharmaceuticals","keywords":"Multiple sclerosis; Cognition; Expanded Disability Status Scale; Psychology; Verbal memory; Medicine; Paced Auditory Serial Addition Test; Audiology; Cognitive impairment; Physical therapy; Physical medicine and rehabilitation; Internal medicine; Psychiatry","score_opus":0.13872051101130903,"score_gpt":0.2850871877057934,"score_spread":0.14636667669448436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001018322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99926907,0.0004022367,0.00002757001,0.000022214796,0.0000027863023,0.000006552612,0.000039531857,0.000007818822,0.00022233416],"genre_scores_gemma":[0.9996952,0.000097723205,0.00002821173,0.000016520038,0.000006605107,0.0000043220375,0.00008014701,0.0000011163096,0.000070290385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997563,0.000052249037,0.000021854461,0.000030249807,0.00007169096,0.00006765798],"domain_scores_gemma":[0.9991886,0.0001270605,0.00034072614,0.00004757703,0.00013512559,0.00016088548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063593086,0.0002611801,0.0005722855,0.00062133215,0.0003451683,0.000361639,0.0002985539,0.00031192185,0.00082808424],"category_scores_gemma":[0.0016527371,0.00007325281,0.00030273173,0.0003134189,0.0002674754,0.00020037117,0.00025124548,0.00040820768,0.00022243481],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039564925,0.00056199025,0.9458424,0.000104843864,0.00019098521,0.0016081572,0.0004850424,0.00019013435,0.0055054487,0.000020255016,0.00038816364,0.041146107],"study_design_scores_gemma":[0.00002345453,0.0013694986,0.9960836,0.0000114175655,0.000055646342,0.0013324729,0.00012040846,0.00014903354,0.0006594958,0.000028421233,0.00016138083,0.000005187519],"about_ca_topic_score_codex":0.0020996889,"about_ca_topic_score_gemma":0.0020485616,"teacher_disagreement_score":0.0020996889,"about_ca_system_score_codex":0.0003696952,"about_ca_system_score_gemma":0.00022983519,"threshold_uncertainty_score":0.0041749477},"labels":[],"label_agreement":null},{"id":"W3002308644","doi":"10.1177/1352458519899040","title":"A critical analysis of helminth immunotherapy in multiple sclerosis","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Parasites and Host Interactions","field":"Immunology and Microbiology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; University of British Columbia; Memorial University of Newfoundland; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Multiple sclerosis; Immunology; Immunotherapy; Helminths; Population; Helminth infections; Helminthiasis; Immune system; Medicine; Biology; Environmental health","score_opus":0.10892685066362992,"score_gpt":0.3036617548643474,"score_spread":0.19473490420071746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3002308644","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11112613,0.7758118,0.004788986,0.062224492,0.0044651665,0.00023474112,0.000242091,0.0001137965,0.0409928],"genre_scores_gemma":[0.54133934,0.41639456,0.0034947824,0.011043031,0.009085149,0.00017280845,0.00016609445,0.000048511913,0.018255686],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996151,0.00018868624,0.000025568683,0.0000241444,0.00008782277,0.000058668014],"domain_scores_gemma":[0.999374,0.00031845502,0.00006189868,0.00002751556,0.00014219986,0.00007591285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015818118,0.00028702506,0.0003259513,0.00075184926,0.00031200066,0.0011035926,0.00024818277,0.00061437796,0.004216845],"category_scores_gemma":[0.0013836755,0.0001165838,0.00024529579,0.00038184336,0.0007135665,0.0008306863,0.00034959754,0.0011479203,0.00037154532],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035075725,0.0005156134,0.0038639214,0.0045704767,0.00016474401,0.0014627554,0.00036353123,0.0010611167,0.09914153,0.09287393,0.04068979,0.751785],"study_design_scores_gemma":[0.00048578627,0.007003012,0.042138845,0.0029818343,0.0003830619,0.004038136,0.0010031165,0.0021655646,0.056517,0.045511816,0.8377274,0.00004434179],"about_ca_topic_score_codex":0.0004580801,"about_ca_topic_score_gemma":0.0009864053,"teacher_disagreement_score":0.004216845,"about_ca_system_score_codex":0.00092801434,"about_ca_system_score_gemma":0.0014794095,"threshold_uncertainty_score":0.0141067505},"labels":[],"label_agreement":null},{"id":"W3002601601","doi":"10.1177/1352458519871817","title":"New imaging approaches for precision diagnosis and disease staging of MS?","year":2020,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Multiple sclerosis; Magnetic resonance imaging; Medicine; Clinical Practice; Disease; Radiology; Pathology; Physical therapy","score_opus":0.3218536051451092,"score_gpt":0.37672179464467476,"score_spread":0.05486818949956557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3002601601","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000036162543,0.9981926,0.00015994559,0.0009988705,0.0002732741,0.000004632356,0.000010850306,0.000005098129,0.0003186065],"genre_scores_gemma":[0.00043277277,0.99786395,0.0005583798,0.0005390191,0.00036643562,0.000008925649,0.000018901655,0.0000018413183,0.0002097344],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99919003,0.00025241356,0.00013918147,0.000109696535,0.0002622804,0.00004643492],"domain_scores_gemma":[0.9984895,0.0006957707,0.00017847591,0.00007115983,0.00050074095,0.00006439456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023949835,0.0009301335,0.0023658404,0.003780354,0.0003475911,0.0017748163,0.0014267205,0.001771775,0.00408919],"category_scores_gemma":[0.003129959,0.00041386927,0.0011190722,0.002918478,0.0012403505,0.003825056,0.0010308371,0.0032382372,0.0024539442],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007695767,0.000049537055,0.0002650093,0.025004046,0.00020294411,0.00010316378,0.0000951101,0.00016196728,0.0006557711,0.007439574,0.028774576,0.9371714],"study_design_scores_gemma":[0.000037349047,0.00011925179,0.0016380501,0.023465138,0.00034700756,0.0015846506,0.00020542605,0.00017129142,0.0003194038,0.008873911,0.96318376,0.000054868506],"about_ca_topic_score_codex":0.002610125,"about_ca_topic_score_gemma":0.0031200233,"teacher_disagreement_score":0.00408919,"about_ca_system_score_codex":0.0010888532,"about_ca_system_score_gemma":0.0023125075,"threshold_uncertainty_score":0.013679683},"labels":[],"label_agreement":null},{"id":"W3002970851","doi":"10.1177/1352458519887324","title":"Precision medicine in the multiple sclerosis clinic: Selecting the right patient for the right treatment","year":2020,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Multiple sclerosis; Medicine; Disease; Physical therapy; Clinically isolated syndrome; Intensive care medicine; Pediatrics; Internal medicine; Psychiatry","score_opus":0.272236738966037,"score_gpt":0.3963751725921657,"score_spread":0.1241384336261287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3002970851","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007431472,0.9974138,0.00014661464,0.0013350262,0.00020851858,0.000012897063,0.000017203129,0.0000066210782,0.0007850947],"genre_scores_gemma":[0.0011367905,0.9968208,0.00055827503,0.00091388647,0.0002327947,0.000022741056,0.000024703955,0.0000021754133,0.00028788557],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99850094,0.00073620444,0.00026096118,0.000098841345,0.00035669882,0.00004637627],"domain_scores_gemma":[0.99650204,0.0025428007,0.0003308489,0.00007050128,0.00047577496,0.00007803275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022035104,0.0006531713,0.0021886763,0.0020557733,0.00034064005,0.0017270582,0.000973324,0.0017812686,0.005008053],"category_scores_gemma":[0.007395117,0.00023972846,0.0010886934,0.0017280221,0.0005438272,0.0016426336,0.0006940306,0.0019050392,0.001472146],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011935393,0.000057090947,0.0002286837,0.079869345,0.00036936218,0.00020553358,0.00017224935,0.00022613523,0.00047053586,0.003844343,0.04376308,0.87067425],"study_design_scores_gemma":[0.00009124764,0.0000951679,0.0011096706,0.12439799,0.000976716,0.0017697413,0.00031619126,0.00012902153,0.00027430226,0.005022441,0.86578196,0.00003550458],"about_ca_topic_score_codex":0.0015005892,"about_ca_topic_score_gemma":0.002857701,"teacher_disagreement_score":0.005008053,"about_ca_system_score_codex":0.0008983779,"about_ca_system_score_gemma":0.0024066486,"threshold_uncertainty_score":0.016753554},"labels":[],"label_agreement":null},{"id":"W3003152238","doi":"10.1177/1352458519888178","title":"Biosensors to monitor MS activity","year":2020,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Wearable computer; Relevance (law); Biosensor; Reliability (semiconductor); Multiple sclerosis; Computer science; Wireless; Accelerometer; Medicine; Telecommunications; Nanotechnology; Embedded system; Psychiatry","score_opus":0.2543470391733045,"score_gpt":0.39229217857652643,"score_spread":0.13794513940322195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003152238","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014197083,0.99739146,0.0004996137,0.00031117263,0.00037607085,0.000010934217,0.000034187116,0.000015176026,0.0012192966],"genre_scores_gemma":[0.0020632562,0.99522215,0.0007348945,0.00037882398,0.00026660584,0.00002641284,0.000058744925,0.0000031220281,0.0012459907],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990657,0.00022976742,0.00010921308,0.0001565529,0.00038896158,0.000049830258],"domain_scores_gemma":[0.99911875,0.0004884405,0.00012774351,0.00003337105,0.0002045976,0.000027054097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015229586,0.0012173564,0.001770101,0.0037850225,0.0002444103,0.0014786694,0.0010140786,0.0017714604,0.0046773893],"category_scores_gemma":[0.0023919551,0.00037105984,0.0012484798,0.0028370263,0.0005782951,0.0014857661,0.0007813102,0.0022655127,0.003137057],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007869849,0.000102305705,0.00039968907,0.028895648,0.00028928,0.00017183166,0.000094211864,0.00034876948,0.0054242075,0.006099124,0.023417933,0.93467844],"study_design_scores_gemma":[0.000026907614,0.00018213176,0.0013653983,0.007680622,0.00033740923,0.0014748812,0.00010953306,0.0001994189,0.0034722304,0.0033447396,0.98176306,0.000043545606],"about_ca_topic_score_codex":0.0010117186,"about_ca_topic_score_gemma":0.0013774493,"teacher_disagreement_score":0.0046773893,"about_ca_system_score_codex":0.0005944048,"about_ca_system_score_gemma":0.0008246947,"threshold_uncertainty_score":0.015647411},"labels":[],"label_agreement":null},{"id":"W3005471950","doi":"10.1177/1352458519900961","title":"Lymphocytic colitis in the setting of teriflunomide use for relapsing multiple sclerosis","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Microscopic Colitis","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Teriflunomide; Medicine; Adverse effect; Multiple sclerosis; Internal medicine; Gastroenterology; Dermatology; Immunology","score_opus":0.15090907807652312,"score_gpt":0.2765302207836492,"score_spread":0.12562114270712607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005471950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766211,0.008943752,0.001884612,0.0022244586,0.000108113,0.000070640504,0.000037560527,0.00011099287,0.0099987],"genre_scores_gemma":[0.997323,0.0012938185,0.0003071004,0.00042152393,0.00019590442,0.0000059004133,0.000015240479,0.000005840476,0.0004317364],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997551,0.000053564592,0.000026829885,0.00003458601,0.000035780533,0.00009421423],"domain_scores_gemma":[0.9991773,0.0002089877,0.00031179667,0.000045074077,0.00003338628,0.00022343406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030216944,0.0005515539,0.0005676002,0.0007056678,0.0012870842,0.0006535548,0.00029456988,0.0012769694,0.0010798805],"category_scores_gemma":[0.0016877305,0.00027628485,0.00039751764,0.0005061701,0.00071617815,0.0007323422,0.00053622935,0.0012115291,0.0002968869],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014562771,0.0000521632,0.02653856,0.000062203195,0.0000154114,0.96699286,0.00024225925,0.00006338567,0.0017198564,0.00017608775,0.00030231418,0.0036892598],"study_design_scores_gemma":[0.000025881138,0.00022328677,0.014998459,0.000034488065,0.000025948953,0.9823866,0.00021411237,0.00020025589,0.0005542187,0.00014203167,0.0011866647,0.000008110115],"about_ca_topic_score_codex":0.0008601783,"about_ca_topic_score_gemma":0.0016979405,"teacher_disagreement_score":0.0012870842,"about_ca_system_score_codex":0.000480278,"about_ca_system_score_gemma":0.0003243539,"threshold_uncertainty_score":0.003612578},"labels":[],"label_agreement":null},{"id":"W3006847841","doi":"10.1177/1352458520910360","title":"Moving exercise research in multiple sclerosis forward (the MoXFo initiative): Developing consensus statements for research","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; University of Ottawa","funders":"","keywords":"General partnership; Scope (computer science); Terminology; Multiple sclerosis; Quality (philosophy); Thematic analysis; Process (computing); Medicine; Public relations; Psychology; Qualitative research; Medical education; Political science; Computer science; Sociology","score_opus":0.6474070569278462,"score_gpt":0.4671535757464389,"score_spread":0.18025348118140727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006847841","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022133058,0.048092656,0.117677405,0.74879354,0.020431792,0.024423951,0.0016404295,0.00055202324,0.01625523],"genre_scores_gemma":[0.18554372,0.030777901,0.6453735,0.08649472,0.0044787563,0.037408832,0.0045559662,0.00047491505,0.0048916508],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.57357705,0.28005674,0.083451845,0.009324681,0.043244846,0.010344836],"domain_scores_gemma":[0.49640676,0.24411087,0.0510009,0.018299324,0.14819062,0.041991506],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.6345937,0.0018491606,0.0036395313,0.012621811,0.008369412,0.01462324,0.009498095,0.012375767,0.0030516058],"category_scores_gemma":[0.4568067,0.0018137031,0.005346199,0.0070320433,0.008968295,0.014522471,0.029138835,0.017253779,0.0011937591],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007070252,0.0006824074,0.009315301,0.035629846,0.0010193326,0.0010435352,0.08722567,0.0027132218,0.0026500947,0.11404176,0.17889415,0.5660776],"study_design_scores_gemma":[0.0009436242,0.0007764881,0.011941372,0.13893916,0.00067981903,0.000671617,0.07819262,0.004687681,0.0017684309,0.20183618,0.55892646,0.0006365483],"about_ca_topic_score_codex":0.008081802,"about_ca_topic_score_gemma":0.007946098,"teacher_disagreement_score":0.36540627,"about_ca_system_score_codex":0.024513615,"about_ca_system_score_gemma":0.14101014,"threshold_uncertainty_score":0.45061105},"labels":[],"label_agreement":null},{"id":"W3007003980","doi":"10.1177/1352458520908037","title":"Concussion in adolescence and the risk of multiple sclerosis: A retrospective cohort study","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Institute for Clinical Evaluative Sciences; Lawson Health Research Institute; London Health Sciences Centre","funders":"Institute for Clinical Evaluative Sciences; Ontario Ministry of Health and Long-Term Care; Roche Canada","keywords":"Concussion; Medicine; Retrospective cohort study; Multiple sclerosis; Hazard ratio; Emergency department; Poison control; Young adult; Injury prevention; Cohort; Cohort study; Physical therapy; Pediatrics; Internal medicine; Emergency medicine; Confidence interval; Psychiatry","score_opus":0.07583156032293883,"score_gpt":0.28721318304441756,"score_spread":0.21138162272147873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007003980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998738,0.00018438295,0.000039606824,0.000023466646,0.0000032257885,0.000022919196,0.00072038843,0.0000014388984,0.00026667063],"genre_scores_gemma":[0.9989359,0.0002650853,0.00006270956,0.000019963056,0.0000044025537,0.000019072657,0.00058184913,0.0000013328092,0.00010966716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995789,0.00006580747,0.000042960113,0.00009533081,0.00010494663,0.00011199193],"domain_scores_gemma":[0.99895465,0.00007388539,0.00044797835,0.00009941909,0.00021193516,0.00021199985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005151778,0.00023734974,0.00032095148,0.00081871374,0.0007882873,0.0006955926,0.00037477308,0.0003172997,0.0007838442],"category_scores_gemma":[0.0014638773,0.00039970985,0.00038788782,0.001437706,0.0002682858,0.00030230978,0.0004274342,0.0005104323,0.00011943094],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027562151,0.000010797355,0.9995627,0.000003232707,0.000017778482,0.000039040606,0.0000665955,0.0000056644785,0.000028431292,0.0000054119123,0.000045844772,0.0001869137],"study_design_scores_gemma":[0.0000061755973,0.000036334994,0.99925035,0.000011035798,0.000024364079,0.00017426202,0.00024777948,0.00005158766,0.000014337416,0.000004899114,0.00017677023,0.000002037407],"about_ca_topic_score_codex":0.24080539,"about_ca_topic_score_gemma":0.28106698,"teacher_disagreement_score":0.24080539,"about_ca_system_score_codex":0.0012448065,"about_ca_system_score_gemma":0.0019566668,"threshold_uncertainty_score":0.4788075},"labels":[],"label_agreement":null},{"id":"W3009271960","doi":"10.1177/1352458520910500","title":"Adherence to laboratory monitoring among people taking oral drugs for multiple sclerosis: A Canadian population-based study","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; University of British Columbia Hospital","funders":"Multiple Sclerosis Society of Canada","keywords":"Teriflunomide; Fingolimod; Medicine; Urinalysis; Population; Odds ratio; Logistic regression; Internal medicine; Confidence interval; Medical prescription; Multiple sclerosis; Urine; Pharmacology; Immunology; Environmental health","score_opus":0.16945299019508916,"score_gpt":0.33423518974410954,"score_spread":0.16478219954902038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009271960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99213684,0.0012099892,0.00013673192,0.0004643242,0.000016944603,0.00007512266,0.0033215813,0.000010506264,0.0026281145],"genre_scores_gemma":[0.9979511,0.000549436,0.0001493601,0.000111481924,0.0000070121896,0.000017622038,0.0008755801,0.000002224801,0.00033632826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821424,0.00012805518,0.00011699411,0.00022454013,0.0010109497,0.0003052313],"domain_scores_gemma":[0.99718875,0.0001416357,0.0008408248,0.000101993406,0.0012804281,0.0004464288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013150502,0.0003583524,0.00048787036,0.0012427014,0.0019471378,0.0010697009,0.0012601502,0.00061815226,0.0014948417],"category_scores_gemma":[0.0038153566,0.00035067988,0.0008821477,0.004564328,0.00048090628,0.00041719267,0.00062900485,0.00095682614,0.00017154177],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044026325,0.000045077857,0.9962219,0.00003961895,0.00006854333,0.000031708914,0.00028544312,0.000038562062,0.00006567171,0.000027882592,0.00041409108,0.0027173336],"study_design_scores_gemma":[0.0000062014396,0.000022830682,0.99922633,0.000021268585,0.00002569455,0.000031529515,0.00023010612,0.00012968379,0.000015450825,0.000006105418,0.0002792477,0.0000055882383],"about_ca_topic_score_codex":0.97984695,"about_ca_topic_score_gemma":0.97291476,"teacher_disagreement_score":0.020153046,"about_ca_system_score_codex":0.00993983,"about_ca_system_score_gemma":0.011644024,"threshold_uncertainty_score":0.07211888},"labels":[],"label_agreement":null},{"id":"W3010156703","doi":"10.1177/1352458520905759","title":"Detection of central vein should be part of MS diagnostic criteria – Commentary","year":2020,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; U.S. Department of Health and Human Services; National Institutes of Health; National Institute of Neurological Disorders and Stroke; St. Michael’s Hospital Foundation","keywords":"Multiple sclerosis; Medicine; Psychiatry","score_opus":0.10414636677289922,"score_gpt":0.27588157467710367,"score_spread":0.17173520790420443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010156703","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031992784,0.00064329855,0.00005658318,0.96581626,0.031552836,0.000010190622,0.000051049366,0.00001440805,0.0015354143],"genre_scores_gemma":[0.0027984565,0.0004088056,0.00013301904,0.93143976,0.06344161,0.000022020024,0.000025837455,0.000013822607,0.0017167598],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99402034,0.0015949174,0.0012007514,0.0009847175,0.0012393063,0.0009599939],"domain_scores_gemma":[0.9660998,0.020795641,0.0023887572,0.0007906076,0.006032537,0.0038927335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047511393,0.0010828137,0.0024538892,0.0015272611,0.0057236543,0.0044851834,0.0037370936,0.1484001,0.008886936],"category_scores_gemma":[0.05982926,0.0014485429,0.002144103,0.001299693,0.004324298,0.0042545707,0.002166504,0.0796559,0.009235272],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005757641,0.000023298275,0.0009992932,0.00010114086,0.00003595207,0.0042358986,0.00022844323,0.00009637142,0.00019244978,0.002014321,0.9878825,0.004132742],"study_design_scores_gemma":[0.00037000224,0.00012262599,0.0037404806,0.0024604627,0.0002575962,0.011057873,0.0012529364,0.0012693134,0.00053991773,0.016708957,0.961963,0.0002567809],"about_ca_topic_score_codex":0.014612222,"about_ca_topic_score_gemma":0.021109298,"teacher_disagreement_score":0.1484001,"about_ca_system_score_codex":0.007427799,"about_ca_system_score_gemma":0.0072634346,"threshold_uncertainty_score":0.053892672},"labels":[],"label_agreement":null},{"id":"W3012424809","doi":"10.1177/1352458520910499","title":"Data harmonization for collaborative research among MS registries: A case study in employment","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Harmonization; Logistic regression; Medicine; Pooling; Odds; German; Family medicine; Demography; Computer science; Geography; Internal medicine; Artificial intelligence","score_opus":0.5846707141859904,"score_gpt":0.4511840854524142,"score_spread":0.1334866287335762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012424809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77020204,0.015629765,0.11757488,0.062394835,0.0006134632,0.019023957,0.0010872324,0.00023041922,0.01324344],"genre_scores_gemma":[0.90673095,0.0022738778,0.07671463,0.004673249,0.00016010649,0.008581071,0.00040760898,0.00006249503,0.0003960216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.35964188,0.57878613,0.032952473,0.0067105787,0.016466873,0.005442128],"domain_scores_gemma":[0.39227408,0.4099665,0.0739929,0.09647015,0.022140859,0.005155573],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.48647842,0.00061870983,0.0015716905,0.0037829517,0.0057781315,0.0066259834,0.0048802714,0.0068960516,0.0022069728],"category_scores_gemma":[0.47493985,0.0012700477,0.0035133408,0.009428693,0.0042703385,0.0079890825,0.01303693,0.003988382,0.000388549],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033700787,0.002431706,0.58049434,0.008850657,0.0027740924,0.014916475,0.08965267,0.0035082863,0.001467914,0.05669933,0.01292263,0.22291175],"study_design_scores_gemma":[0.0070142737,0.009270195,0.385911,0.05443843,0.005793389,0.045690954,0.1769901,0.027764034,0.009390124,0.0759081,0.20074943,0.0010800322],"about_ca_topic_score_codex":0.0067338627,"about_ca_topic_score_gemma":0.0062359613,"teacher_disagreement_score":0.51352155,"about_ca_system_score_codex":0.0055625425,"about_ca_system_score_gemma":0.022867663,"threshold_uncertainty_score":0.6332635},"labels":[],"label_agreement":null},{"id":"W3012883704","doi":"10.1177/1352458520912172","title":"Conversion of diffusely abnormal white matter to focal lesions is linked to progression in secondary progressive multiple sclerosis","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières; Université du Québec à Montréal; McGill University; Montreal Neurological Institute and Hospital","funders":"Multiple Sclerosis Society; International Progressive MS Alliance","keywords":"Multiple sclerosis; White matter; Medicine; Pathology; Magnetic resonance imaging; Radiology; Immunology","score_opus":0.10768496490222064,"score_gpt":0.313285688856675,"score_spread":0.2056007239544544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012883704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992933,0.00018816162,0.0001599704,0.00002376392,0.0000021486455,0.000004935472,0.000095692645,0.000011353767,0.0002206617],"genre_scores_gemma":[0.9994423,0.00006279186,0.00018705578,0.0000066746134,0.000006456265,0.0000039824895,0.00017485356,0.000002559167,0.000113252376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998274,0.000032464155,0.000019327417,0.000053946147,0.00004750712,0.000019272973],"domain_scores_gemma":[0.9983891,0.00020665568,0.0009617023,0.000077942444,0.00018006013,0.00018461303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000499596,0.00023418537,0.0002644271,0.00075933256,0.00023436343,0.00040878713,0.00022706004,0.00029397648,0.0016146518],"category_scores_gemma":[0.0021371779,0.00015162521,0.00020179784,0.0004900306,0.0003056023,0.0003036521,0.00037474863,0.0004339069,0.00021978232],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046643073,0.000059566242,0.9842418,0.000046772988,0.00009829921,0.0002757766,0.00014547686,0.00019719376,0.0049881223,0.000032762357,0.00016479692,0.009283035],"study_design_scores_gemma":[0.0000040422524,0.0000716872,0.99900335,0.0000034744687,0.000012266504,0.00045665674,0.000025573856,0.0001655847,0.00016129421,0.000040818682,0.000053349362,0.000001950575],"about_ca_topic_score_codex":0.0018019996,"about_ca_topic_score_gemma":0.003243109,"teacher_disagreement_score":0.0018019996,"about_ca_system_score_codex":0.00018526602,"about_ca_system_score_gemma":0.00017777548,"threshold_uncertainty_score":0.0054015517},"labels":[],"label_agreement":null},{"id":"W3013550746","doi":"10.1177/1352458520914822","title":"Do subcortical gray matter volumes and aerobic capacity account for cognitive-motor coupling in multiple sclerosis?","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Cognition; Aerobic exercise; Effects of sleep deprivation on cognitive performance; Physical medicine and rehabilitation; Neurorehabilitation; Psychology; Aerobic capacity; Functional magnetic resonance imaging; Magnetic resonance imaging; Neuroscience; Audiology; Medicine; Physical therapy; Rehabilitation; Psychiatry","score_opus":0.18210119674070857,"score_gpt":0.309509039072983,"score_spread":0.12740784233227442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013550746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99851614,0.00038405592,0.00031691883,0.000096446674,0.0000058432042,0.000006393339,0.000100943864,0.000008656335,0.00056470896],"genre_scores_gemma":[0.99969685,0.000039659935,0.00012074328,0.000016225926,0.000008978087,0.0000035565129,0.00006329371,0.0000023655991,0.000048348164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999796,0.000055105917,0.00002432926,0.000053660042,0.000040196643,0.000030800147],"domain_scores_gemma":[0.99792296,0.00084338535,0.00071277464,0.00020856137,0.00009053322,0.00022174304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086130307,0.0004540806,0.0003564551,0.00085475313,0.0001926552,0.0006095126,0.0005152586,0.0005054154,0.0018520164],"category_scores_gemma":[0.0045193867,0.0002149482,0.00044258096,0.0005151302,0.0004982193,0.00057284406,0.0006277801,0.00043728336,0.00018297903],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029072422,0.000040179693,0.9939319,0.000025415753,0.00020365175,0.000124661,0.0001110877,0.00034832951,0.0005859837,0.000085068685,0.00005697358,0.004196018],"study_design_scores_gemma":[0.000004928702,0.000058537687,0.9983204,0.0000072389003,0.000044861645,0.00015491023,0.000060374678,0.0009398716,0.000080593396,0.000274478,0.000051578296,0.0000022287275],"about_ca_topic_score_codex":0.0025010388,"about_ca_topic_score_gemma":0.0032293855,"teacher_disagreement_score":0.0025010388,"about_ca_system_score_codex":0.000159104,"about_ca_system_score_gemma":0.00026807666,"threshold_uncertainty_score":0.006195605},"labels":[],"label_agreement":null},{"id":"W3013906966","doi":"10.1177/1352458520914844","title":"The multiple sclerosis prodrome: Emerging evidence, challenges, and opportunities","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of British Columbia","funders":"","keywords":"Prodrome; Multiple sclerosis; Disease; Medicine; Psychiatry; Psychology; Pathology; Psychosis","score_opus":0.47325557987791134,"score_gpt":0.33089414307172144,"score_spread":0.1423614368061899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013906966","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00060030376,0.9574636,0.00023540069,0.039508723,0.001582194,0.000010317101,0.000051034625,0.000007237048,0.0005412507],"genre_scores_gemma":[0.014078193,0.9549879,0.001654662,0.017413676,0.011461858,0.0000446146,0.00009983571,0.000011079419,0.0002481755],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9903957,0.0046037845,0.002161675,0.00089025754,0.0015917802,0.00035688974],"domain_scores_gemma":[0.8407394,0.1286292,0.010613851,0.0019419768,0.01470576,0.0033698096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03872508,0.00087386003,0.003688237,0.0046185707,0.0010522177,0.0053825304,0.0023684956,0.0047321515,0.0054222615],"category_scores_gemma":[0.06152088,0.000579483,0.001289881,0.004525943,0.00435643,0.012895673,0.0031698414,0.005884097,0.0009606023],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010276239,0.00021273285,0.011118249,0.055816926,0.0009650811,0.0009634107,0.00086829474,0.0003297428,0.0006048895,0.028868264,0.04455255,0.85467225],"study_design_scores_gemma":[0.00031531914,0.0010946254,0.023374429,0.17927845,0.0032844213,0.0038321181,0.009021509,0.001102925,0.0005767377,0.104814865,0.67304415,0.0002604983],"about_ca_topic_score_codex":0.002409307,"about_ca_topic_score_gemma":0.0068685217,"teacher_disagreement_score":0.03872508,"about_ca_system_score_codex":0.0021336582,"about_ca_system_score_gemma":0.0078005213,"threshold_uncertainty_score":0.20480025},"labels":[],"label_agreement":null},{"id":"W3015051092","doi":"10.1177/1352458520908163","title":"Fatigue, sleep disorders, anaemia and pain in the multiple sclerosis prodrome","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Health Sciences Centre; University of British Columbia; University of Saskatchewan; Dalhousie University; University of British Columbia Hospital","funders":"National Multiple Sclerosis Society","keywords":"Medicine; Prodrome; Multiple sclerosis; Population; Cohort; Internal medicine; Physical therapy; Pediatrics; Odds ratio; Psychiatry; Psychosis","score_opus":0.14336869398935742,"score_gpt":0.2943785699359468,"score_spread":0.15100987594658938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015051092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99730635,0.0015374258,0.000045498127,0.00011411839,0.0000072123526,0.000018434255,0.00051517773,0.0000034721509,0.00045222288],"genre_scores_gemma":[0.99880266,0.00044988396,0.00009362608,0.00003572218,0.000010269813,0.000007473151,0.00042757418,9.829048e-7,0.00017192576],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99967265,0.00006216301,0.000042674536,0.00006924291,0.00009234726,0.000060908314],"domain_scores_gemma":[0.99870753,0.00013478969,0.0008052249,0.00003787016,0.00012728146,0.00018735355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054245273,0.0002765816,0.00030278572,0.0009653272,0.0005029284,0.0005084797,0.00030125587,0.00033837662,0.0020110148],"category_scores_gemma":[0.0014688659,0.0002495378,0.00032511208,0.0012270982,0.00028960782,0.00024064998,0.00040781507,0.00048916374,0.0001530763],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009583086,0.000019552057,0.9980889,0.000031412063,0.00003214076,0.00015929544,0.000049951548,0.000019038887,0.00015592817,0.0000142476665,0.00007204357,0.0012615748],"study_design_scores_gemma":[0.0000036467568,0.00003553307,0.9994899,0.0000103709435,0.000011049661,0.00030563504,0.00003082927,0.000020129808,0.000010832149,0.000012613454,0.000068462534,9.2668586e-7],"about_ca_topic_score_codex":0.04969893,"about_ca_topic_score_gemma":0.06817311,"teacher_disagreement_score":0.04969893,"about_ca_system_score_codex":0.00062856474,"about_ca_system_score_gemma":0.00092280464,"threshold_uncertainty_score":0.098819256},"labels":[],"label_agreement":null},{"id":"W3016039455","doi":"","title":"Myelin oligodendrocyte glycoprotein antibody-associated disease in a multi-ethnic Canadian cohort","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Myelin oligodendrocyte glycoprotein; Multiple sclerosis; Cohort; Medicine; Glycoprotein; Ethnic group; Antibody; Myelin-associated glycoprotein; Myelin; Oligodendrocyte; Disease; Immunology; Biology; Internal medicine; Genetics; Central nervous system; Political science","score_opus":0.07631188518667102,"score_gpt":0.3026599706343902,"score_spread":0.22634808544771917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016039455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940303,0.000596787,0.00013072025,0.00043620358,0.000027454362,0.000029138131,0.0023978893,0.000011291106,0.0023400923],"genre_scores_gemma":[0.9969445,0.0004922774,0.000171894,0.00016085192,0.000015208451,0.000019218684,0.0007504267,0.000010058865,0.0014355361],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990239,0.0000582432,0.0000399094,0.00025384984,0.00020671629,0.00041738924],"domain_scores_gemma":[0.9987929,0.000053477426,0.00019345435,0.000063992746,0.0005149738,0.00038121748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005947885,0.000877771,0.00076983345,0.0017887044,0.0070429468,0.0021045392,0.0017195728,0.0010227609,0.004508763],"category_scores_gemma":[0.0014256991,0.0007914123,0.00091096223,0.0038308783,0.001021128,0.00071847194,0.0011420574,0.0014483236,0.00051208143],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031440723,0.000091298985,0.9916237,0.000028924347,0.00013655149,0.0006741072,0.0018842022,0.00008375158,0.0010583069,0.00031466788,0.0015337056,0.0022563974],"study_design_scores_gemma":[0.000024415485,0.00006101424,0.9934638,0.000038991508,0.00010020397,0.0006701542,0.0035095774,0.00027230495,0.00007999036,0.00011162272,0.0016287364,0.000039039398],"about_ca_topic_score_codex":0.9803631,"about_ca_topic_score_gemma":0.97785723,"teacher_disagreement_score":0.019636929,"about_ca_system_score_codex":0.012835393,"about_ca_system_score_gemma":0.017421428,"threshold_uncertainty_score":0.09312773},"labels":[],"label_agreement":null},{"id":"W3016748202","doi":"10.1177/1352458520912171","title":"Weighting evidence in MS: Obesity and neurodegeneration","year":2020,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Neurodegeneration; Multiple sclerosis; Weighting; Medicine; Obesity; Neuroscience; Psychology; Internal medicine; Disease; Psychiatry","score_opus":0.21706599298497856,"score_gpt":0.3126813619604641,"score_spread":0.09561536897548553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016748202","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022716382,0.0016029354,0.000085358595,0.98535603,0.011876822,0.000006931016,0.000035467398,0.0000075744956,0.0008017375],"genre_scores_gemma":[0.004760368,0.0013478796,0.0004509216,0.9054154,0.08650513,0.000035711902,0.000023226214,0.000019494782,0.0014417896],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9715532,0.015433353,0.0049211406,0.00170963,0.00515003,0.0012326105],"domain_scores_gemma":[0.7548293,0.19334847,0.012032035,0.0042597647,0.020575907,0.014954583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03549237,0.0010713668,0.003504301,0.0031842447,0.004675425,0.0077236923,0.0028807372,0.062406383,0.0070468355],"category_scores_gemma":[0.20587042,0.0011890188,0.0015010893,0.0029022056,0.007875727,0.008783201,0.005185439,0.04663342,0.0034390697],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016263197,0.00003843827,0.0021556094,0.0003827297,0.00015537153,0.0010659095,0.00028264822,0.000076424236,0.00013607938,0.006353396,0.96460897,0.024581734],"study_design_scores_gemma":[0.0011064244,0.00019728238,0.0064880126,0.0050951247,0.0005274895,0.004817586,0.0016003201,0.0017965157,0.00034172263,0.13082649,0.846894,0.0003090575],"about_ca_topic_score_codex":0.008076136,"about_ca_topic_score_gemma":0.016657555,"teacher_disagreement_score":0.062406383,"about_ca_system_score_codex":0.008051778,"about_ca_system_score_gemma":0.009611898,"threshold_uncertainty_score":0.18770385},"labels":[],"label_agreement":null},{"id":"W3018479719","doi":"10.1177/1352458520915629","title":"Exercise and lifestyle physical activity recommendations for people with multiple sclerosis throughout the disease course","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":324,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Multiple sclerosis; Medicine; Expert opinion; Physical activity; Physical therapy; Exercise prescription; MEDLINE; Rehabilitation; Physical disability; Disease; Expanded Disability Status Scale; Gerontology; Physical medicine and rehabilitation; Family medicine; Psychology; Psychiatry","score_opus":0.1294885872704747,"score_gpt":0.34478317273044207,"score_spread":0.21529458545996738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3018479719","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022889128,0.06617543,0.024415553,0.76128155,0.019251212,0.005638436,0.0067855935,0.0021970533,0.09136608],"genre_scores_gemma":[0.1689663,0.20116188,0.32711127,0.18044646,0.011885665,0.016301958,0.014930221,0.0003774583,0.07881885],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974197,0.00097473577,0.0005098362,0.00010779432,0.00077524985,0.00021272094],"domain_scores_gemma":[0.993648,0.0013192493,0.0011516731,0.000081856226,0.0027166,0.001082547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004358784,0.0010289213,0.00088800414,0.001841459,0.0008377355,0.0012814294,0.0018185584,0.0040529747,0.0069814892],"category_scores_gemma":[0.013388875,0.00037620333,0.0010221413,0.0006985818,0.0003066001,0.0016689632,0.0013249221,0.0052283825,0.0042636367],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012662266,0.00086040323,0.0055992077,0.002486659,0.00008141777,0.00038404402,0.00042573942,0.0007060772,0.0004819089,0.00076284626,0.66262174,0.32546332],"study_design_scores_gemma":[0.0016974454,0.0011041838,0.0669679,0.033020124,0.00071021006,0.0015773246,0.002540731,0.0033209906,0.0009194533,0.0072763525,0.8806333,0.00023195753],"about_ca_topic_score_codex":0.0069892085,"about_ca_topic_score_gemma":0.02135031,"teacher_disagreement_score":0.0069892085,"about_ca_system_score_codex":0.0012187005,"about_ca_system_score_gemma":0.0050576944,"threshold_uncertainty_score":0.023355424},"labels":[],"label_agreement":null},{"id":"W3022190080","doi":"10.1177/1352458520917936","title":"Autologous hematopoietic stem cell transplantation for multiple sclerosis: A current perspective","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Multiple sclerosis; Medicine; Hematopoietic stem cell transplantation; Intensive care medicine; Transplantation; Clinical trial; Alemtuzumab; Regimen; Stem cell; Conditioning regimen; Disease; Physical therapy; Oncology; Immunology; Surgery; Internal medicine","score_opus":0.15730785025834546,"score_gpt":0.319929875146604,"score_spread":0.16262202488825853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022190080","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004091859,0.9397712,0.0007095076,0.05362362,0.003031514,0.000011968306,0.000055613255,0.000029364175,0.002357981],"genre_scores_gemma":[0.004985102,0.9645542,0.0014976901,0.014467821,0.0134392725,0.00003616705,0.000060195547,0.000013300598,0.0009461337],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988232,0.00041589377,0.00020424822,0.00015096729,0.00033968646,0.0000659872],"domain_scores_gemma":[0.9876462,0.0075218026,0.00064367155,0.0003275546,0.0029476287,0.0009130283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0072920695,0.0006218463,0.0015023284,0.0012436623,0.00069281895,0.003004644,0.0011672743,0.0031834503,0.0067513436],"category_scores_gemma":[0.008131936,0.00022464052,0.0007931658,0.0013761282,0.002175176,0.0065657296,0.0010407646,0.006277513,0.002644832],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057188346,0.0003116428,0.0010544881,0.008490066,0.00018100499,0.0003469598,0.00016470636,0.00046252043,0.0013489218,0.027167238,0.11520098,0.8446996],"study_design_scores_gemma":[0.00017764105,0.000902288,0.0020184743,0.011303215,0.00040527523,0.0011462923,0.0005253534,0.0004948376,0.0005044573,0.031167882,0.9512905,0.000063696774],"about_ca_topic_score_codex":0.0010201542,"about_ca_topic_score_gemma":0.0023110788,"teacher_disagreement_score":0.0072920695,"about_ca_system_score_codex":0.0011226315,"about_ca_system_score_gemma":0.0029074992,"threshold_uncertainty_score":0.038564622},"labels":[],"label_agreement":null},{"id":"W3023412322","doi":"10.1177/1352458520917935","title":"Exercise training and cognitive performance in persons with multiple sclerosis: A systematic review and multilevel meta-analysis of clinical trials","year":2020,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Acadia University","funders":"","keywords":"PsycINFO; Meta-analysis; Cognition; Physical medicine and rehabilitation; Medicine; Randomized controlled trial; MEDLINE; Cognitive training; Modalities; Physical therapy; Effects of sleep deprivation on cognitive performance; Confidence interval; Expanded Disability Status Scale; Multiple sclerosis; Psychology; Internal medicine; Psychiatry","score_opus":0.7010631597860706,"score_gpt":0.4794287810853546,"score_spread":0.221634378700716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023412322","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005010531,0.9925021,0.0009370719,0.00021146472,0.00015596313,0.00054066814,0.00040763107,0.00003281293,0.00020163102],"genre_scores_gemma":[0.20218329,0.7851859,0.006269591,0.0009960321,0.00033833488,0.0034744109,0.0011305514,0.000051576644,0.0003703423],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9800947,0.01069654,0.005431511,0.0016060071,0.0017267916,0.0004444743],"domain_scores_gemma":[0.9655797,0.025241463,0.005643426,0.0011520782,0.001967168,0.00041611856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023701407,0.0033058315,0.024901297,0.009582018,0.0009075631,0.0043313396,0.0026701307,0.0026727251,0.0035399457],"category_scores_gemma":[0.053841677,0.0017832188,0.05020003,0.009827262,0.0008597788,0.0022813387,0.0024926388,0.0022144997,0.0003303939],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014316342,0.00002747245,0.0024485907,0.24651408,0.742004,0.00007026913,0.00006302784,0.0003462522,0.00014205616,0.000089210196,0.00027444417,0.006588982],"study_design_scores_gemma":[0.00050692173,0.00016465297,0.0021445993,0.01939757,0.9766921,0.000049360435,0.000030135498,0.00015825329,0.000060226146,0.00015421277,0.000625109,0.000016952625],"about_ca_topic_score_codex":0.006804753,"about_ca_topic_score_gemma":0.014230063,"teacher_disagreement_score":0.024901297,"about_ca_system_score_codex":0.0033812067,"about_ca_system_score_gemma":0.0052360767,"threshold_uncertainty_score":0.12534654},"labels":[],"label_agreement":null},{"id":"W3029529282","doi":"10.1177/1352458520923970","title":"Five-year longitudinal changes in quantitative spinal cord MRI in multiple sclerosis","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Institute of Biomedical Imaging and Bioengineering; National Institute of Neurological Disorders and Stroke; National Institutes of Health; National Multiple Sclerosis Society","keywords":"Fractional anisotropy; Expanded Disability Status Scale; Multiple sclerosis; Medicine; Magnetic resonance imaging; Diffusion MRI; Nuclear medicine; Spinal cord; Effective diffusion coefficient; Internal medicine; Radiology","score_opus":0.290651520924661,"score_gpt":0.35783177858425835,"score_spread":0.06718025765959734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3029529282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988312,0.00045587102,0.00023327443,0.000018129518,0.0000033622957,0.0000092149,0.00023639816,0.000015425507,0.00019701311],"genre_scores_gemma":[0.99935013,0.000050035662,0.00012350085,0.000005401873,0.0000025376326,0.00000581444,0.00035678162,0.0000014598464,0.00010441344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996561,0.00008837788,0.000035387293,0.00007956153,0.000089470064,0.000051114912],"domain_scores_gemma":[0.99801624,0.00028714244,0.00094163493,0.000138356,0.00040772386,0.00020885197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021176774,0.00026189702,0.0002217872,0.00073128974,0.00027204564,0.000408884,0.0002767438,0.00038001913,0.0007294387],"category_scores_gemma":[0.0031202768,0.00011812594,0.00034107565,0.00041879964,0.00019177167,0.00036631603,0.0002970729,0.00037110213,0.00020580755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008154371,0.000115394396,0.98584205,0.000042504133,0.00024272589,0.00010652053,0.0002320546,0.00048909127,0.002761181,0.000021656277,0.00014536988,0.009185929],"study_design_scores_gemma":[0.000003635839,0.00024977603,0.99892956,0.0000035772318,0.00003910468,0.000094740666,0.00003162092,0.00022457291,0.00031149946,0.000011404775,0.00009675402,0.0000035762494],"about_ca_topic_score_codex":0.004041696,"about_ca_topic_score_gemma":0.0046617137,"teacher_disagreement_score":0.004041696,"about_ca_system_score_codex":0.0004949534,"about_ca_system_score_gemma":0.00029439016,"threshold_uncertainty_score":0.011199474},"labels":[],"label_agreement":null},{"id":"W3031469252","doi":"10.1177/1352458520923945","title":"Frailty in ageing persons with multiple sclerosis","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Multiple sclerosis; Expanded Disability Status Scale; Ageing; Life expectancy; Gerontology; Frailty Index; Quality of life (healthcare); Cross-sectional study; Healthy ageing; Physical therapy; Internal medicine; Population; Pathology; Environmental health","score_opus":0.1994803860134822,"score_gpt":0.30531104961280514,"score_spread":0.10583066359932294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031469252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974879,0.0017818214,0.00009506174,0.00008565251,0.000008550532,0.000009867992,0.00010953985,0.000002032518,0.00041954927],"genre_scores_gemma":[0.9994624,0.00033616595,0.000056384753,0.000017799091,0.000010554366,0.000004539597,0.000063583146,3.7397888e-7,0.000048150032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99971074,0.00009695424,0.000037386315,0.000044411157,0.00007260526,0.000037859496],"domain_scores_gemma":[0.9983041,0.00032879043,0.00087013684,0.00006245779,0.00017702355,0.0002573129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009163351,0.00019402435,0.00036233006,0.00087248604,0.0002999982,0.00042272202,0.00016054015,0.0001940808,0.0013518783],"category_scores_gemma":[0.0038338727,0.000064692686,0.00020455742,0.0006167825,0.00023265155,0.0003063935,0.00049902155,0.0002834701,0.00009428955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016134097,0.00004761182,0.99013305,0.00007505371,0.000064697255,0.000108388645,0.00027907334,0.00004619231,0.00021511504,0.000032414016,0.00013337907,0.008703744],"study_design_scores_gemma":[0.0000030035733,0.00016510164,0.99908006,0.000036998685,0.00002264909,0.00028093765,0.000102529884,0.00006320407,0.000032231364,0.00006556144,0.00014572225,0.0000019209726],"about_ca_topic_score_codex":0.0016462753,"about_ca_topic_score_gemma":0.0018815814,"teacher_disagreement_score":0.0016462753,"about_ca_system_score_codex":0.00016038607,"about_ca_system_score_gemma":0.00024101509,"threshold_uncertainty_score":0.004846096},"labels":[],"label_agreement":null},{"id":"W3035067402","doi":"10.1177/1352458520930620","title":"The introduction of new medications in pediatric multiple sclerosis: Open issues and challenges","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Fingolimod; Multiple sclerosis; Medicine; Observational study; Randomized controlled trial; Clinical trial; Clinical endpoint; Intensive care medicine; Endpoint Determination; Internal medicine; Psychiatry","score_opus":0.2516052943651522,"score_gpt":0.3397042158387649,"score_spread":0.0880989214736127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035067402","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031272403,0.55933404,0.00597181,0.41671038,0.0102395825,0.00012544512,0.00048718206,0.00008728373,0.0039171744],"genre_scores_gemma":[0.072675705,0.61155987,0.04926882,0.20732296,0.055119723,0.0009766013,0.00069538783,0.00030227666,0.0020785676],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9080504,0.05775973,0.014930169,0.0053861137,0.012766505,0.0011069588],"domain_scores_gemma":[0.41271022,0.50121695,0.021905035,0.012512534,0.0437284,0.007926861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.16181064,0.0006429425,0.0035427813,0.0018122438,0.0010749671,0.0069775237,0.0044357674,0.007865242,0.0074719437],"category_scores_gemma":[0.24839285,0.00062001386,0.0022468443,0.0023917935,0.00562995,0.01565386,0.004113495,0.01232415,0.0015235825],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014684257,0.00030380877,0.0048198085,0.015647069,0.00039286277,0.0005378985,0.0010192053,0.00073786464,0.00044604577,0.035827514,0.06723174,0.8715678],"study_design_scores_gemma":[0.00066496053,0.0020750868,0.012607439,0.061373916,0.0008485952,0.0022516865,0.00274386,0.0017930211,0.0011032448,0.055514704,0.858817,0.00020657819],"about_ca_topic_score_codex":0.004464498,"about_ca_topic_score_gemma":0.005282469,"teacher_disagreement_score":0.16181064,"about_ca_system_score_codex":0.004455159,"about_ca_system_score_gemma":0.013433305,"threshold_uncertainty_score":0.8557467},"labels":[],"label_agreement":null},{"id":"W3035357197","doi":"10.1177/1352458520926955","title":"Disability outcomes of early cerebellar and brainstem symptoms in multiple sclerosis","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cegep de Saint Jerome; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Multiple sclerosis; Brainstem; Medicine; Cerebellum; Clinical neurology; Physical medicine and rehabilitation; Neuroscience; Psychology; Internal medicine; Psychiatry","score_opus":0.14258555670110581,"score_gpt":0.29936628059456466,"score_spread":0.15678072389345885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035357197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99874,0.0006753173,0.000043439726,0.00005865401,0.0000034351579,0.000003968507,0.00028065432,0.0000025979116,0.00019192828],"genre_scores_gemma":[0.9996425,0.000074011536,0.000015125482,0.0000072692274,0.0000061133105,0.000002550262,0.00021296719,6.095563e-7,0.000038832284],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99932504,0.00022249084,0.000067224326,0.00013172431,0.00011707829,0.00013642306],"domain_scores_gemma":[0.9954651,0.0006988121,0.002803824,0.00013283953,0.00023496826,0.0006644973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012626667,0.00035752237,0.0004033127,0.0007950368,0.00031446523,0.00066845416,0.0004696001,0.00045451277,0.0012196394],"category_scores_gemma":[0.0037524246,0.0001348749,0.0006642447,0.00083623896,0.00032492526,0.00052166067,0.0007691068,0.00064823945,0.00013643541],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003332785,0.000027847405,0.9976489,0.00002017497,0.00010202462,0.00013507354,0.000028726718,0.00014670278,0.00005411943,0.000015250084,0.000060753537,0.0014270582],"study_design_scores_gemma":[0.000009075465,0.000109296125,0.99920684,0.000010156704,0.000042381358,0.00028811654,0.000040159168,0.00015490648,0.000024840265,0.00005367391,0.000056720746,0.00000383031],"about_ca_topic_score_codex":0.0037797955,"about_ca_topic_score_gemma":0.0048848423,"teacher_disagreement_score":0.0037797955,"about_ca_system_score_codex":0.0005162799,"about_ca_system_score_gemma":0.0005021952,"threshold_uncertainty_score":0.0075156093},"labels":[],"label_agreement":null},{"id":"W3037232559","doi":"10.1177/1352458520934070","title":"Discontinuing cannabis improves depression in people with multiple sclerosis: A short report","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Waterloo; University of Toronto; Centre for Addiction and Mental Health; Sunnybrook Health Science Centre","funders":"Multiple Sclerosis Society of Canada","keywords":"Cannabis; Depression (economics); Anxiety; Psychiatry; Medicine; Multiple sclerosis; Mood; Tetrahydrocannabinol; Psychology; Internal medicine; Cannabinoid","score_opus":0.07809733676582667,"score_gpt":0.28706166501119806,"score_spread":0.2089643282453714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037232559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965313,0.0023099307,0.00005139403,0.00013248432,0.00001996197,0.000109225635,0.00015548719,0.0000059894246,0.0006842402],"genre_scores_gemma":[0.9976749,0.001340927,0.00019303776,0.00014174083,0.000035178535,0.000057401125,0.0001458264,8.4797205e-7,0.00041019783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99961877,0.00012552443,0.000057056473,0.000027197299,0.000136167,0.000035233228],"domain_scores_gemma":[0.99863154,0.00039410358,0.0005146079,0.000058745318,0.00017082573,0.00023011022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009712638,0.00015546755,0.0005914146,0.00031899154,0.00030649838,0.00027677548,0.00014397746,0.00038474976,0.0013317671],"category_scores_gemma":[0.0024872713,0.00013654787,0.0004543627,0.0003367442,0.00014745131,0.0002299404,0.0002222686,0.00038388435,0.00015046693],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014463241,0.002303199,0.8637797,0.0009683522,0.0012322277,0.00030257314,0.0006272105,0.00009486519,0.004296324,0.00002414594,0.00067897025,0.111229144],"study_design_scores_gemma":[0.00045068795,0.010000928,0.9878535,0.000044392902,0.0003541583,0.00017729629,0.00017709385,0.00007049805,0.00031496683,0.000020314668,0.0005280223,0.000008076264],"about_ca_topic_score_codex":0.0015858366,"about_ca_topic_score_gemma":0.0062095434,"teacher_disagreement_score":0.0015858366,"about_ca_system_score_codex":0.00016248088,"about_ca_system_score_gemma":0.00024366619,"threshold_uncertainty_score":0.0051365495},"labels":[],"label_agreement":null},{"id":"W3037684639","doi":"10.1177/1352458520930371","title":"A novel in-home digital treatment to improve processing speed in people with multiple sclerosis: A pilot study","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Randomized controlled trial; Medicine; Multiple sclerosis; Clinical trial; Physical therapy; Internal medicine; Psychiatry","score_opus":0.14528856648769448,"score_gpt":0.30289676692479794,"score_spread":0.15760820043710347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037684639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99535614,0.0009282902,0.0002888553,0.000114455666,0.00008329829,0.0022073346,0.00023697724,0.000032674507,0.00075194304],"genre_scores_gemma":[0.99116397,0.0016273629,0.002323828,0.000336072,0.00020698507,0.0029544737,0.00026842905,0.0000074447953,0.0011115052],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99949455,0.00022172488,0.00005704057,0.000077366894,0.00005946834,0.000089760004],"domain_scores_gemma":[0.9993262,0.00023478309,0.00011307034,0.000059019025,0.00007097117,0.00019587977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010186222,0.00078981364,0.0013942815,0.00049885485,0.00038633365,0.0005912847,0.0007654717,0.0009831941,0.005820252],"category_scores_gemma":[0.0011572983,0.00034905472,0.0012232832,0.0003764073,0.0006227179,0.00066488504,0.00038552904,0.0011793223,0.00052468537],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.61495584,0.21990176,0.0036533633,0.003014498,0.0014123527,0.00028465965,0.0004687427,0.00037335342,0.02094634,0.000111789705,0.0006068353,0.1342705],"study_design_scores_gemma":[0.21301892,0.77409005,0.009838095,0.000053143445,0.00057010486,0.00009770726,0.00010071917,0.00025735414,0.0013261158,0.000038669645,0.000595642,0.000013382761],"about_ca_topic_score_codex":0.0013272681,"about_ca_topic_score_gemma":0.0025765563,"teacher_disagreement_score":0.005820252,"about_ca_system_score_codex":0.00033381206,"about_ca_system_score_gemma":0.0006746015,"threshold_uncertainty_score":0.019470632},"labels":[],"label_agreement":null},{"id":"W3041549013","doi":"10.1177/1352458520936934","title":"Temporal profile of lymphocyte counts and relationship with infections with fingolimod therapy in paediatric patients with multiple sclerosis: Results from the PARADIG <i>MS</i> study","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"Bayer Vital; Novartis Pharma; EMD Serono; National Multiple Sclerosis Society; Genentech; National Institutes of Health; Servier; Race to Erase MS; Acorda Therapeutics; Sanofi; GW Pharmaceuticals; MedDay Pharmaceuticals; Chugai Pharmaceutical; Lourie Foundation; GlaxoSmithKline; University of Texas Health Science Center at Houston; Biogen; Celgene; Patient-Centered Outcomes Research Institute; Sanofi Genzyme; F. Hoffmann-La Roche; Alexion Pharmaceuticals; Teva Pharmaceutical Industries; Merck KGaA","keywords":"Fingolimod; Medicine; Multiple sclerosis; Internal medicine; Incidence (geometry); Nadir; Adverse effect; Gastroenterology; Immunology","score_opus":0.09472200258372511,"score_gpt":0.2616161970653984,"score_spread":0.1668941944816733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3041549013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998026,0.0009829103,0.00009019998,0.00002564893,0.000002879372,0.00001798621,0.00043375962,0.0000044228605,0.00041628038],"genre_scores_gemma":[0.99879223,0.00029643593,0.00012328284,0.000026166803,0.0000094453635,0.000021897362,0.0006442441,0.0000033743838,0.000083038736],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99910694,0.0003112474,0.00011580416,0.00014353737,0.00022836043,0.000094182695],"domain_scores_gemma":[0.9963477,0.00075754075,0.002093602,0.00016137035,0.00035920425,0.0002805803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013826493,0.00019407061,0.00047266402,0.00034334714,0.00018230264,0.00048618123,0.00021347906,0.00031103395,0.00074997946],"category_scores_gemma":[0.0033411502,0.00014780393,0.00037307473,0.00071447046,0.00020204003,0.00032315264,0.0003070599,0.00069306133,0.00013726429],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033170434,0.00008735633,0.98559487,0.00007727807,0.00012959352,0.00022217349,0.00026119506,0.00013417043,0.0012584056,0.00002362003,0.00020986632,0.0086844],"study_design_scores_gemma":[0.00005873293,0.0012014477,0.9968939,0.0000114027625,0.00005987192,0.0006736857,0.00008508071,0.00008561718,0.00034475423,0.000014263108,0.00056567055,0.0000055681853],"about_ca_topic_score_codex":0.0010171236,"about_ca_topic_score_gemma":0.0010393042,"teacher_disagreement_score":0.0013826493,"about_ca_system_score_codex":0.00033578233,"about_ca_system_score_gemma":0.0003361904,"threshold_uncertainty_score":0.007312238},"labels":[],"label_agreement":null},{"id":"W3041724293","doi":"10.1177/1352458520936823","title":"Prediction of on-treatment disability worsening in RRMS with the MAGNIMS score","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches","funders":"","keywords":"Medicine; Cohort; Internal medicine; Magnetic resonance imaging; Multiple sclerosis; Hazard ratio; Proportional hazards model; Radiology; Confidence interval; Immunology","score_opus":0.22460600148215748,"score_gpt":0.2984047855449266,"score_spread":0.07379878406276913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3041724293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984561,0.00036895552,0.00017326529,0.0000574988,0.000008887893,0.0000111238405,0.00038520913,0.000006978403,0.0005318881],"genre_scores_gemma":[0.9990926,0.0000709604,0.00018868208,0.0000121662715,0.000017784669,0.000006841133,0.0005075915,0.0000022749268,0.00010117972],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991855,0.00033041218,0.00006876967,0.00013377119,0.00019143408,0.000090164416],"domain_scores_gemma":[0.9966112,0.00086602254,0.0016429427,0.00021159713,0.00033453165,0.00033363746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018420191,0.00050774787,0.0005478556,0.0007761202,0.00015738778,0.0004814615,0.00048978615,0.000370613,0.0017090915],"category_scores_gemma":[0.0044161533,0.00014693508,0.00079472584,0.00047551427,0.00019046543,0.00030714014,0.00053569727,0.00053690164,0.00028324776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056820444,0.000019334531,0.99627703,0.000015314197,0.00011271416,0.000025486852,0.0000152021385,0.0002664472,0.00014914168,0.00001606338,0.0001337567,0.0024012858],"study_design_scores_gemma":[0.000026631173,0.0002005404,0.9971879,0.000015297997,0.000111451816,0.00019257808,0.000030041252,0.0018358878,0.0001398307,0.000068358546,0.0001844968,0.0000069734224],"about_ca_topic_score_codex":0.0017547098,"about_ca_topic_score_gemma":0.0024220909,"teacher_disagreement_score":0.0018420191,"about_ca_system_score_codex":0.00024318763,"about_ca_system_score_gemma":0.00022294569,"threshold_uncertainty_score":0.009741664},"labels":[],"label_agreement":null},{"id":"W3048383521","doi":"10.1177/1352458520948212","title":"Clinical and MRI characteristics of multiple sclerosis in patients of Middle Eastern and North African ancestry residing in Ontario, Canada","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Multiple sclerosis; Expanded Disability Status Scale; Internal medicine; Disease; Incidence (geometry); Magnetic resonance imaging; Demography; Pediatrics; Psychiatry; Radiology","score_opus":0.22152345841337936,"score_gpt":0.28927499766777953,"score_spread":0.06775153925440017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048383521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968245,0.00031396234,0.000021215277,0.00009255182,0.0000049615705,0.000021359578,0.0012988487,0.0000035641895,0.0014189453],"genre_scores_gemma":[0.99877244,0.00016133615,0.00004105737,0.000050427887,0.000004669222,0.000009254429,0.0006002125,0.0000020244388,0.0003586732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99963903,0.000021023783,0.00003088493,0.00006678262,0.00011577946,0.00012647493],"domain_scores_gemma":[0.9989059,0.00006300517,0.0002642772,0.000028736727,0.00038138262,0.00035675024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024689225,0.000321988,0.00036031805,0.0009123938,0.0022422748,0.000746951,0.00066541816,0.00037652822,0.002086707],"category_scores_gemma":[0.0011397451,0.00022927161,0.0002722849,0.0019905157,0.00056443043,0.00027382164,0.0005053096,0.0003245602,0.00030477103],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010927608,0.00002003135,0.99752027,0.000015941805,0.000021849753,0.00023679005,0.00040292004,0.000035287383,0.0003172259,0.000020678017,0.00036017373,0.0009396217],"study_design_scores_gemma":[0.000005909054,0.000019999912,0.99887687,0.000007938303,0.00001101082,0.00020672272,0.0005234608,0.000054582655,0.0000218287,0.000007626987,0.00026042186,0.0000037122998],"about_ca_topic_score_codex":0.9426606,"about_ca_topic_score_gemma":0.9630118,"teacher_disagreement_score":0.05733937,"about_ca_system_score_codex":0.008194647,"about_ca_system_score_gemma":0.009130791,"threshold_uncertainty_score":0.11535406},"labels":[],"label_agreement":null},{"id":"W3048874536","doi":"10.1177/1352458520948221","title":"Autofluorescence spectroscopy as a proxy for chronic white matter pathology","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Autofluorescence; Pathology; White matter; Medicine; Physics; Magnetic resonance imaging; Radiology; Optics","score_opus":0.0802062746089193,"score_gpt":0.3177231954661517,"score_spread":0.2375169208572324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048874536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978361,0.0045842235,0.014188564,0.000097144446,0.000030732568,0.00007494731,0.00029602795,0.00012605461,0.0022413053],"genre_scores_gemma":[0.9886232,0.0011952898,0.009092075,0.000051392446,0.000014099697,0.00005130983,0.00020570628,0.000014578935,0.00075237267],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99967444,0.00010640553,0.00003810367,0.00006151618,0.00008299889,0.0000365715],"domain_scores_gemma":[0.9990707,0.00025946164,0.00031897196,0.0000782927,0.00017233504,0.00010027884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010454133,0.0004346162,0.00020286236,0.0016442671,0.0003508096,0.0004405439,0.00032615924,0.0006114542,0.0016763102],"category_scores_gemma":[0.00071070046,0.00014489346,0.00015069926,0.00064074795,0.0006651401,0.00055672316,0.00036912324,0.0005461297,0.0002779668],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066583237,0.00015302844,0.07123308,0.00028311045,0.00006331294,0.00037578397,0.00026238404,0.00022272811,0.9161236,0.00046386273,0.00021685725,0.009936388],"study_design_scores_gemma":[0.000028809392,0.001748394,0.38877007,0.0000980157,0.00013130081,0.0057922937,0.00061176624,0.004201742,0.59489584,0.00096796727,0.0027198961,0.00003397549],"about_ca_topic_score_codex":0.00079526484,"about_ca_topic_score_gemma":0.0012417979,"teacher_disagreement_score":0.0016763102,"about_ca_system_score_codex":0.00034059686,"about_ca_system_score_gemma":0.00033982703,"threshold_uncertainty_score":0.0056078434},"labels":[],"label_agreement":null},{"id":"W3087424718","doi":"10.1177/1352458520958353","title":"Rehabilitation should be prescribed acutely in motor relapses – Commentary","year":2020,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Cerebral Palsy and Movement Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of Ottawa","funders":"","keywords":"Rehabilitation; Physical medicine and rehabilitation; Multiple sclerosis; Medicine; Physical therapy; Psychology; Psychiatry","score_opus":0.10861580316933336,"score_gpt":0.2849973764605974,"score_spread":0.17638157329126405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087424718","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026160578,0.0005587202,0.000028979483,0.98131573,0.016467163,0.000005551541,0.000024016497,0.000010619474,0.0013275451],"genre_scores_gemma":[0.0018920868,0.00037624632,0.000077072626,0.9635367,0.03255869,0.000018914623,0.00001299983,0.000011776748,0.0015155333],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99335194,0.0017177792,0.0013353598,0.0009636649,0.0012700576,0.0013612307],"domain_scores_gemma":[0.9592214,0.024472088,0.0029962575,0.00073295686,0.006425178,0.006152068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053448654,0.00092099875,0.0022125146,0.0012897084,0.008829718,0.0055735447,0.004154971,0.14835276,0.011714338],"category_scores_gemma":[0.066012986,0.0013066087,0.0024246387,0.0014836207,0.006014541,0.005329604,0.003243627,0.0970166,0.007744474],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038765367,0.000022462607,0.00061550684,0.00008987734,0.000030098823,0.0024561144,0.0002787093,0.00007920544,0.00009766892,0.0021271938,0.99007857,0.004085838],"study_design_scores_gemma":[0.00032549075,0.00009040164,0.0027139212,0.0026939225,0.00016087259,0.005894944,0.0017743572,0.0006444957,0.000258396,0.014355815,0.97087693,0.00021040611],"about_ca_topic_score_codex":0.02362817,"about_ca_topic_score_gemma":0.04640123,"teacher_disagreement_score":0.14835276,"about_ca_system_score_codex":0.010110263,"about_ca_system_score_gemma":0.014681419,"threshold_uncertainty_score":0.07335544},"labels":[],"label_agreement":null},{"id":"W3088365521","doi":"10.1177/1352458520961534","title":"Anxiety and depression affect performance on the symbol digit modalities test over time in MS and other immune disorders","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Health Sciences Centre; University of Manitoba","funders":"Institute of Musculoskeletal Health and Arthritis; Canadian Institutes of Health Research; Crohn's and Colitis Canada; Multiple Sclerosis Society of Canada","keywords":"Anxiety; Depression (economics); Hospital Anxiety and Depression Scale; Multiple sclerosis; Medicine; Cognition; Rheumatoid arthritis; Affect (linguistics); Psychology; Psychiatry; Cohort; Clinical psychology; Internal medicine","score_opus":0.051820976834586724,"score_gpt":0.2649230280613283,"score_spread":0.21310205122674156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088365521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99932826,0.00020289469,0.00002788598,0.000039172035,0.000005051649,0.0000066682915,0.00015058884,0.0000024030842,0.00023712784],"genre_scores_gemma":[0.99956375,0.00007892605,0.000058779187,0.000020912203,0.000007245981,0.0000071910326,0.00016382222,8.0748265e-7,0.0000985984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99936575,0.00025679995,0.00007061143,0.00012890503,0.0000922976,0.00008559414],"domain_scores_gemma":[0.99645424,0.0007565236,0.002013266,0.00015906745,0.00022103757,0.000395823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001136248,0.00037227853,0.0003060061,0.00060928345,0.00043659506,0.00081765186,0.00032592457,0.0005560131,0.0011816572],"category_scores_gemma":[0.0050414633,0.00027089674,0.0008341538,0.0006329191,0.0002574371,0.0004388857,0.0005506914,0.00073506654,0.00020984006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020265125,0.000067745605,0.9983235,0.000007154328,0.00008391146,0.000024771345,0.00006149723,0.000038576694,0.000069790505,0.0000063127573,0.00005084738,0.0010633073],"study_design_scores_gemma":[0.0000037588031,0.00007312307,0.9997019,0.0000026688242,0.00002140651,0.000040444793,0.000029585754,0.00007672585,0.000013118335,0.000010720125,0.000024915438,0.0000016793902],"about_ca_topic_score_codex":0.0052706935,"about_ca_topic_score_gemma":0.0073459414,"teacher_disagreement_score":0.0052706935,"about_ca_system_score_codex":0.00035341215,"about_ca_system_score_gemma":0.00022703665,"threshold_uncertainty_score":0.010480046},"labels":[],"label_agreement":null},{"id":"W3091784113","doi":"10.1177/1352458520963880","title":"Effect of mood and anxiety disorders on health care utilization in multiple sclerosis","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; University of Calgary; University of Manitoba","funders":"Institute of Musculoskeletal Health and Arthritis; Canadian Institutes of Health Research","keywords":"Medicine; Anxiety; Multiple sclerosis; Cohort; Mood disorders; Mood; Psychiatry; Cohort study; Drug; Health care; Family medicine; Internal medicine","score_opus":0.11208832246764051,"score_gpt":0.326842431443815,"score_spread":0.21475410897617447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091784113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99691284,0.0019554673,0.00004315292,0.00020542547,0.0000069798275,0.0000067173273,0.00040221756,0.000003135332,0.0004639018],"genre_scores_gemma":[0.9991653,0.00047813784,0.000043539865,0.00004124057,0.000012586831,0.0000036459721,0.00018800891,9.4490576e-7,0.00006653482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983234,0.0007925767,0.00013274637,0.00014955936,0.00034692872,0.00025482525],"domain_scores_gemma":[0.99277943,0.0026233315,0.0028197085,0.00028074192,0.0005344836,0.0009624205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016562728,0.00018781211,0.00029630776,0.00085859007,0.00033008002,0.0007373977,0.00033069233,0.00034334336,0.0012038437],"category_scores_gemma":[0.007010036,0.00016615885,0.001027667,0.0010606418,0.00037383658,0.00024462293,0.00054418005,0.0005747538,0.000075880154],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010782627,0.000026199363,0.9980247,0.000015303887,0.00021777602,0.00002475831,0.000028698514,0.000076961696,0.000033217188,0.000011208561,0.0000456462,0.0013876875],"study_design_scores_gemma":[0.0000017004901,0.000029211391,0.9997842,0.0000057038405,0.00002989511,0.00002244327,0.000018452443,0.000063909516,0.00000686418,0.000005484059,0.000031184638,8.867745e-7],"about_ca_topic_score_codex":0.1163113,"about_ca_topic_score_gemma":0.14395529,"teacher_disagreement_score":0.1163113,"about_ca_system_score_codex":0.00120769,"about_ca_system_score_gemma":0.0011576236,"threshold_uncertainty_score":0.23126858},"labels":[],"label_agreement":null},{"id":"W3093711806","doi":"10.1177/1352458520964774","title":"Long-term prognostic counselling in people with multiple sclerosis using an online analytical processing tool","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Worry; Multiple sclerosis; Cohort; Expanded Disability Status Scale; Coping (psychology); Anxiety; Likert scale; Personalized medicine; Physical therapy; Disease; Cohort study; Clinical psychology; Internal medicine; Psychology; Psychiatry; Bioinformatics","score_opus":0.23851307364063584,"score_gpt":0.3350935979117455,"score_spread":0.09658052427110964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093711806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968264,0.0002559789,0.00042136526,0.00029161648,0.0000073473566,0.00020639892,0.0002839396,0.000045523528,0.0016614967],"genre_scores_gemma":[0.99509275,0.00033828802,0.003455873,0.00009345195,0.000013412717,0.0003049566,0.00026509268,0.0000041866956,0.00043187063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983955,0.0010020329,0.00013978446,0.0000798669,0.00027814385,0.00010476922],"domain_scores_gemma":[0.99226826,0.0054014605,0.001166177,0.00019248812,0.00046997267,0.0005016382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031374756,0.00024269935,0.00032503088,0.0006745938,0.0003696934,0.0007377491,0.00030923655,0.0002999479,0.0035338253],"category_scores_gemma":[0.014743858,0.00012748501,0.00028895857,0.0005741904,0.00019750284,0.0005439698,0.00081155926,0.00031633466,0.00047100842],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024681992,0.0024125911,0.5346579,0.0009149857,0.00011427121,0.00031123194,0.010816748,0.0002983881,0.0012159161,0.00010245805,0.0030932394,0.443594],"study_design_scores_gemma":[0.0006057046,0.0048758914,0.9727907,0.00074122864,0.00023626583,0.0007368497,0.008291639,0.0028794862,0.0012051597,0.0005218874,0.0070214537,0.00009357359],"about_ca_topic_score_codex":0.0045375465,"about_ca_topic_score_gemma":0.008679974,"teacher_disagreement_score":0.0045375465,"about_ca_system_score_codex":0.00054003915,"about_ca_system_score_gemma":0.0009130077,"threshold_uncertainty_score":0.016592741},"labels":[],"label_agreement":null},{"id":"W3096216217","doi":"10.1177/1352458521992507","title":"Clinical predictors of driving simulator performance in drivers with multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Older Adults Driving Studies","field":"Health Professions","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Driving simulator; Recall; Multiple sclerosis; Psychology; Poison control; Driving simulation; Cognition; Physical medicine and rehabilitation; Audiology; Simulation; Cognitive psychology; Computer science; Medicine; Medical emergency","score_opus":0.13313182955281228,"score_gpt":0.3553455391069187,"score_spread":0.2222137095541064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096216217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99962294,0.00006044613,0.000032141907,0.000019335925,0.0000028072193,0.0000037408945,0.00005353274,0.0000023606176,0.00020258401],"genre_scores_gemma":[0.9997793,0.000023778743,0.000022060514,0.0000043760397,0.0000030604267,0.0000032470937,0.00009507461,5.797716e-7,0.000068586865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99976116,0.000046032725,0.00003571914,0.000046487217,0.00006941394,0.000041158415],"domain_scores_gemma":[0.99791914,0.00048169238,0.0008638373,0.00007160634,0.00038269794,0.00028094454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039324086,0.0003474016,0.00020248609,0.0006654714,0.00036130234,0.0006248501,0.0002694057,0.00050408964,0.0019518464],"category_scores_gemma":[0.004505415,0.00012927495,0.00022925694,0.0003758694,0.00023152078,0.00042009377,0.00042972266,0.00045703855,0.0003422424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007105947,0.000027348697,0.9986181,0.000004078398,0.000014282424,0.00004357279,0.000061964805,0.000055200904,0.000082516475,0.0000048236684,0.000036965783,0.0009799616],"study_design_scores_gemma":[0.0000043733785,0.00018396332,0.99820936,0.000006275931,0.000019360155,0.00040358922,0.00029868024,0.0005738493,0.00012867965,0.0000435491,0.00012319586,0.0000051497727],"about_ca_topic_score_codex":0.004098152,"about_ca_topic_score_gemma":0.003902335,"teacher_disagreement_score":0.004098152,"about_ca_system_score_codex":0.00021821668,"about_ca_system_score_gemma":0.00033213088,"threshold_uncertainty_score":0.008148611},"labels":[],"label_agreement":null},{"id":"W3097860851","doi":"10.1177/1352458520969099","title":"Exercise and the brain in multiple sclerosis","year":2020,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Multiple sclerosis; Remyelination; Neuroscience; Physical medicine and rehabilitation; Medicine; Cognition; Neuroprotection; Psychology; Physical therapy; Psychiatry; Central nervous system","score_opus":0.2268798585612717,"score_gpt":0.34646035468046077,"score_spread":0.11958049611918906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097860851","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000042814452,0.9996644,0.000010976279,0.00007629999,0.000039533734,0.0000016673843,0.0000037761738,0.000001184786,0.00015933675],"genre_scores_gemma":[0.00054386165,0.99915314,0.00003492637,0.000075797994,0.00004189214,0.0000033852682,0.0000071589757,3.5221754e-7,0.00013954208],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996685,0.0000969348,0.00006666565,0.000040167568,0.00010436008,0.000023370018],"domain_scores_gemma":[0.9995689,0.00024252658,0.00009828047,0.000007844578,0.00006228259,0.000020160738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060913945,0.0008420661,0.0015943858,0.003184048,0.00031141198,0.001278945,0.00064745964,0.0014176908,0.0038484712],"category_scores_gemma":[0.0012364472,0.00028404908,0.00088779436,0.0030400066,0.00044031529,0.0011160026,0.00077847904,0.0010777187,0.0008865467],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001131737,0.000066427856,0.00027405896,0.10890128,0.0003875296,0.00016794863,0.00014942391,0.00034081747,0.0007059811,0.002731129,0.015385958,0.8707763],"study_design_scores_gemma":[0.00005316394,0.00022993199,0.0043649036,0.083302714,0.0010495231,0.002144758,0.0002570692,0.00013253033,0.00033192275,0.003829825,0.9042691,0.000034514655],"about_ca_topic_score_codex":0.0028649168,"about_ca_topic_score_gemma":0.0050788876,"teacher_disagreement_score":0.0038484712,"about_ca_system_score_codex":0.00071022625,"about_ca_system_score_gemma":0.0017689007,"threshold_uncertainty_score":0.012874365},"labels":[],"label_agreement":null},{"id":"W3099273656","doi":"10.1177/1352458520970841","title":"Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2525,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Biogen; Novartis; Multiple Sclerosis Society; Roche; Medical Research Council; Associazione Italiana Sclerosi Multipla; Sanofi; Merck; Bristol-Myers Squibb; University of Tasmania; National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Medicine; Epidemiology; Incidence (geometry); Compendium; Environmental health; Population; Demography; Gerontology; Geography; Pathology","score_opus":0.12565249177555743,"score_gpt":0.2900817352026255,"score_spread":0.16442924342706805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3099273656","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.060565464,0.3336218,0.004622371,0.17336524,0.007930628,0.00036769197,0.3456243,0.0013060109,0.0725965],"genre_scores_gemma":[0.34100127,0.38143525,0.024849856,0.024774041,0.011298938,0.00091070787,0.19959499,0.00049741456,0.01563762],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99885833,0.00033714902,0.00021491671,0.00010541596,0.00039263192,0.00009158269],"domain_scores_gemma":[0.9944349,0.0012926648,0.0014123176,0.0002461834,0.0020096055,0.0006043424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002834373,0.00053302204,0.00042631026,0.007276564,0.0003231828,0.0018253503,0.00064434204,0.0005015614,0.0068317708],"category_scores_gemma":[0.006999065,0.0001938047,0.0007021951,0.012145385,0.0003366152,0.0018350527,0.0012137723,0.0013148015,0.0018174725],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012853669,0.000031065236,0.10832353,0.0041920836,0.00022720997,0.0002184313,0.0012466244,0.00043068215,0.0005629183,0.0046433494,0.68115306,0.1988425],"study_design_scores_gemma":[0.000020479883,0.00005824564,0.43362042,0.0037465927,0.0001709758,0.0008534462,0.0016591848,0.00034074564,0.00022136107,0.0037663227,0.555493,0.00004923253],"about_ca_topic_score_codex":0.03141179,"about_ca_topic_score_gemma":0.046737257,"teacher_disagreement_score":0.03141179,"about_ca_system_score_codex":0.0014685211,"about_ca_system_score_gemma":0.0032077571,"threshold_uncertainty_score":0.06245792},"labels":[],"label_agreement":null},{"id":"W3100414769","doi":"10.1177/1352458520971819","title":"Siponimod: Disentangling disability and relapses in secondary progressive multiple sclerosis","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"Novartis Pharma","keywords":"Medicine; Multiple sclerosis; Placebo; Confounding; Marginal structural model; Internal medicine; Physical therapy; Oncology; Pathology; Alternative medicine; Immunology","score_opus":0.05395101021926731,"score_gpt":0.23880066277696482,"score_spread":0.1848496525576975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3100414769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9711613,0.0023903893,0.022029355,0.00047447826,0.000039643743,0.00089115865,0.00074088183,0.0001434692,0.0021293191],"genre_scores_gemma":[0.9939739,0.00039817762,0.0045231516,0.00008916315,0.00002109614,0.00026834398,0.00024524136,0.000008793811,0.00047210057],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.99279,0.006240279,0.00012336983,0.00034506145,0.00039303926,0.00010829834],"domain_scores_gemma":[0.9886342,0.008797254,0.0015284485,0.0006513651,0.00010914644,0.0002795633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019493643,0.0006712436,0.0011407221,0.00041249738,0.00026192723,0.00070717244,0.00061824033,0.0006132915,0.003343741],"category_scores_gemma":[0.01401207,0.00025886833,0.0024149811,0.0004182748,0.00062173314,0.00067664107,0.00082858826,0.0012458919,0.00017055472],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.41381216,0.0025382894,0.20327188,0.0030097032,0.024086041,0.00055753184,0.0005466585,0.039737016,0.012623313,0.008589484,0.0019862575,0.28924173],"study_design_scores_gemma":[0.078579254,0.120410636,0.43603534,0.00069089426,0.0312219,0.0016323962,0.00034428123,0.2594164,0.019154808,0.04313254,0.009152031,0.00022960227],"about_ca_topic_score_codex":0.0005491867,"about_ca_topic_score_gemma":0.0009775818,"teacher_disagreement_score":0.019493643,"about_ca_system_score_codex":0.00042661192,"about_ca_system_score_gemma":0.0011525622,"threshold_uncertainty_score":0.103093445},"labels":[],"label_agreement":null},{"id":"W3104676108","doi":"10.1177/1352458520972557","title":"The use and quality of reporting of propensity score methods in multiple sclerosis literature: A review","year":2020,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Centre for Advancing Health Outcomes; McGill University; University of British Columbia","funders":"","keywords":"Multiple sclerosis; Propensity score matching; Medicine; MEDLINE; Internal medicine; Psychiatry","score_opus":0.7278211866591483,"score_gpt":0.48034093295878966,"score_spread":0.24748025370035864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3104676108","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004811179,0.9976871,0.00045980077,0.0007162236,0.0001687312,0.00009916112,0.00017855423,0.000007766951,0.00020156578],"genre_scores_gemma":[0.008441934,0.9883478,0.0017394887,0.00063987233,0.00016591612,0.00038793735,0.00022136385,0.000010427126,0.00004519223],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9016148,0.039259337,0.042775854,0.003376798,0.012223307,0.00074985984],"domain_scores_gemma":[0.55764395,0.35839993,0.05615576,0.0054153847,0.02158708,0.00079795],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.07746134,0.0012640734,0.0059167063,0.023567319,0.0008780002,0.00520549,0.0034528112,0.002820017,0.0029125107],"category_scores_gemma":[0.29350877,0.001299568,0.0061645093,0.024118846,0.0023642248,0.0049172537,0.0029802718,0.0016519371,0.0003828061],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017881476,0.000019167994,0.0023783108,0.77543604,0.0039459113,0.0000982532,0.00070185465,0.00017795837,0.00018763734,0.0011089026,0.0036232122,0.21214399],"study_design_scores_gemma":[0.0001282046,0.00012640478,0.0052764653,0.9264426,0.019037614,0.00058928714,0.00065314694,0.00017152938,0.00033274552,0.0015730441,0.045602042,0.00006694715],"about_ca_topic_score_codex":0.005258243,"about_ca_topic_score_gemma":0.0065712063,"teacher_disagreement_score":0.92253864,"about_ca_system_score_codex":0.0047255405,"about_ca_system_score_gemma":0.014631741,"threshold_uncertainty_score":0.40965962},"labels":[],"label_agreement":null},{"id":"W3107056180","doi":"10.1177/1352458520973618","title":"Quantifying cognition and fatigue to enhance the sensitivity of the EDSS during relapses","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Expanded Disability Status Scale; Cohort; Medicine; Cognition; Physical therapy; Prospective cohort study; Psychology; Internal medicine; Psychiatry","score_opus":0.19355678102126586,"score_gpt":0.3466896427692886,"score_spread":0.15313286174802274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107056180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99726945,0.000571607,0.0008647239,0.000033081345,0.000016911921,0.00007871359,0.00025822385,0.000046740308,0.0008604381],"genre_scores_gemma":[0.9980463,0.00012620719,0.0013251016,0.0000317473,0.000017521892,0.000050674258,0.00018776236,0.000004856914,0.00020988115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995912,0.00015078022,0.000046849258,0.000079150355,0.00008804122,0.000043968685],"domain_scores_gemma":[0.9990151,0.00027731922,0.00033958102,0.00006213154,0.00019488856,0.00011104257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014655392,0.00058892695,0.00057532307,0.0012314111,0.00018920889,0.0004950367,0.00029115428,0.00044372425,0.0011287933],"category_scores_gemma":[0.0025828541,0.00012296655,0.0004688699,0.00041807728,0.00018280029,0.00027256281,0.00041201105,0.00037456272,0.00023104537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026011504,0.00044742785,0.9396737,0.00016069596,0.00022587152,0.00011515481,0.0002360803,0.0005001787,0.008347143,0.000024667343,0.00047199609,0.047195915],"study_design_scores_gemma":[0.000038154347,0.001587523,0.99473935,0.000019666526,0.00008930962,0.00031572432,0.00009697483,0.000965223,0.0018537744,0.000039416584,0.00024093578,0.000013849738],"about_ca_topic_score_codex":0.0012890471,"about_ca_topic_score_gemma":0.0030545187,"teacher_disagreement_score":0.0014655392,"about_ca_system_score_codex":0.00020542173,"about_ca_system_score_gemma":0.00017467303,"threshold_uncertainty_score":0.0077506304},"labels":[],"label_agreement":null},{"id":"W3107138502","doi":"10.1177/1352458520974360","title":"Youth with multiple sclerosis have low levels of fitness","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Queen's University; Hospital for Sick Children","funders":"","keywords":"Cardiorespiratory fitness; Physical fitness; Medicine; Multiple sclerosis; Depression (economics); Physical therapy; Body mass index; Population; Cardiovascular fitness; Grip strength; Internal medicine; Psychology; Psychiatry","score_opus":0.22115601735784982,"score_gpt":0.2986393585801804,"score_spread":0.07748334122233061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107138502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99819046,0.00041237698,0.0000522376,0.00014541433,0.000016015138,0.000008552377,0.00025421075,0.000008724152,0.00091199216],"genre_scores_gemma":[0.99917775,0.00016768283,0.000057831487,0.00005643582,0.000010876956,0.000008578587,0.0001819248,0.000001536121,0.00033727483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997167,0.00003853148,0.00003242566,0.000054618544,0.00006096289,0.00009668612],"domain_scores_gemma":[0.9992829,0.00009488667,0.0003059307,0.000017419963,0.00012939537,0.00016948498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025684744,0.00028243984,0.00036034707,0.00048188807,0.0004902194,0.0006094013,0.00013729872,0.0003642069,0.004549112],"category_scores_gemma":[0.0013961318,0.00012959092,0.00024615068,0.0005058619,0.00024087446,0.00029749493,0.00040549706,0.0003809442,0.00043884723],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045801462,0.00004405024,0.99301153,0.000025670251,0.000027038126,0.00011324776,0.00015936674,0.000019070563,0.0003215225,0.000021354655,0.00028705032,0.005924353],"study_design_scores_gemma":[0.000002858254,0.00007690583,0.99916136,0.000012761434,0.00001582079,0.00023544834,0.00015292756,0.00003158907,0.00003973805,0.000015982187,0.0002533321,0.0000012770608],"about_ca_topic_score_codex":0.004718029,"about_ca_topic_score_gemma":0.005845617,"teacher_disagreement_score":0.004718029,"about_ca_system_score_codex":0.00021757845,"about_ca_system_score_gemma":0.00026159332,"threshold_uncertainty_score":0.0152183175},"labels":[],"label_agreement":null},{"id":"W3107949646","doi":"10.1177/1352458520975323","title":"Accurate classification of secondary progression in multiple sclerosis using a decision tree","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital","funders":"Canadian Institutes of Health Research","keywords":"Concordance; Medicine; Decision tree; Cohort; Clinical phenotype; Classifier (UML); Multiple sclerosis; Disease; Artificial intelligence; Phenotype; Internal medicine; Computer science","score_opus":0.32070783175027995,"score_gpt":0.36771289318905503,"score_spread":0.047005061438775086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107949646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75425994,0.0014169419,0.23812245,0.00095814123,0.00018407348,0.00033793328,0.0013205449,0.0010237864,0.0023762535],"genre_scores_gemma":[0.9249359,0.000258875,0.07276317,0.0001325631,0.00006388673,0.00010871302,0.0013818734,0.00003343703,0.00032161153],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9969131,0.0015556819,0.0003389869,0.0003772375,0.00058956037,0.0002254932],"domain_scores_gemma":[0.98171484,0.014329928,0.0009291165,0.00046577753,0.002149771,0.0004105982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008756163,0.0007617166,0.001168374,0.0031993643,0.0005525008,0.0014489673,0.000821261,0.0009369659,0.0008333637],"category_scores_gemma":[0.019039283,0.00025615757,0.0009103184,0.0011859717,0.00029988325,0.0010919553,0.0005817394,0.0009130081,0.0005215878],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027341365,0.00085675693,0.3014193,0.00033409195,0.0007224408,0.00039722782,0.00033403872,0.22666934,0.0028981518,0.0014751684,0.0065752547,0.4555841],"study_design_scores_gemma":[0.00009108749,0.00039858712,0.0210477,0.0000890091,0.00017328166,0.00020687403,0.00007133697,0.9722864,0.0013065817,0.0036337832,0.00066732324,0.00002803214],"about_ca_topic_score_codex":0.004167736,"about_ca_topic_score_gemma":0.002675602,"teacher_disagreement_score":0.008756163,"about_ca_system_score_codex":0.0010566401,"about_ca_system_score_gemma":0.0012010725,"threshold_uncertainty_score":0.046307564},"labels":[],"label_agreement":null},{"id":"W3113005255","doi":"10.1177/1352458520973633","title":"Psychological resilience explains functional variability across people with multiple sclerosis – No","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Resilience and Mental Health","field":"Psychology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Multiple sclerosis; Psychology; Psychological resilience; Resilience (materials science); Clinical psychology; Medicine; Physical medicine and rehabilitation; Psychiatry; Psychotherapist","score_opus":0.1328820797603175,"score_gpt":0.3473958744580898,"score_spread":0.2145137946977723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113005255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99860877,0.00018660574,0.00011584382,0.00024471173,0.000020373915,0.000005125561,0.00010109418,0.0000036979277,0.0007138898],"genre_scores_gemma":[0.999762,0.00002560485,0.000028262117,0.00002405128,0.000006444893,0.0000017966147,0.00004921776,0.00000167488,0.000100890684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992526,0.0002187079,0.000068756584,0.0001723924,0.000082403305,0.00020513497],"domain_scores_gemma":[0.99648726,0.001268354,0.00095105823,0.00050038396,0.00028697556,0.00050592737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001079629,0.0003772581,0.00044845068,0.00081997266,0.0007807725,0.0012604017,0.0004739417,0.0006780625,0.002947467],"category_scores_gemma":[0.010111232,0.00023019793,0.0009005608,0.00084232085,0.0007866065,0.0009098319,0.0011737227,0.0009987929,0.00026237787],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026525938,0.000095456686,0.99226236,0.000019837407,0.00028869908,0.00012729481,0.00088408665,0.00018195299,0.00036641874,0.00019726243,0.0001435813,0.0051677045],"study_design_scores_gemma":[0.00000453574,0.000048530586,0.99781466,0.000013253537,0.00006114339,0.000111652764,0.00091775035,0.00033110785,0.000049056685,0.0005067206,0.00013533403,0.000006057498],"about_ca_topic_score_codex":0.013531646,"about_ca_topic_score_gemma":0.013465469,"teacher_disagreement_score":0.013531646,"about_ca_system_score_codex":0.00051900547,"about_ca_system_score_gemma":0.00047677464,"threshold_uncertainty_score":0.026905775},"labels":[],"label_agreement":null},{"id":"W3113197914","doi":"10.1177/1352458520972573","title":"Temporal profile of serum neurofilament light in multiple sclerosis: Implications for patient monitoring","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"Biogen","keywords":"Multiple sclerosis; Medicine; Neurofilament; Neuroscience; Physical medicine and rehabilitation; Internal medicine; Psychology; Immunology","score_opus":0.20735537095226855,"score_gpt":0.32083496704267067,"score_spread":0.11347959609040212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113197914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911662,0.0022267604,0.0023064944,0.00040244433,0.00002862398,0.000050216004,0.0009403634,0.000053167914,0.0028258334],"genre_scores_gemma":[0.99681705,0.00039738935,0.0017884269,0.00012618334,0.000033340148,0.000043915254,0.00051191624,0.0000072920293,0.00027448605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991398,0.00038507537,0.00010321582,0.00012944237,0.00018560463,0.00005685189],"domain_scores_gemma":[0.9967243,0.00094630464,0.0015905635,0.00012612854,0.00044085493,0.00017195524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027836678,0.00020886256,0.0005172742,0.00063588266,0.00022053234,0.00052176684,0.0002625931,0.00031040597,0.0010781207],"category_scores_gemma":[0.005608456,0.00010515808,0.00022626497,0.0010684346,0.00017117267,0.00061444234,0.00031653707,0.00048027158,0.00022792809],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019477401,0.00008227457,0.9702002,0.000060582963,0.000089642446,0.00015381706,0.00011086881,0.00039605962,0.0025154888,0.00010203413,0.0004639251,0.023877438],"study_design_scores_gemma":[0.000041203773,0.000415497,0.9942492,0.000031080326,0.00006036812,0.00050839054,0.000115534494,0.0023242265,0.0011191155,0.0001946645,0.0009302108,0.000010522711],"about_ca_topic_score_codex":0.0017054505,"about_ca_topic_score_gemma":0.0026787336,"teacher_disagreement_score":0.0027836678,"about_ca_system_score_codex":0.000355827,"about_ca_system_score_gemma":0.00035337915,"threshold_uncertainty_score":0.014721632},"labels":[],"label_agreement":null},{"id":"W3119307399","doi":"10.1177/1352458520981300","title":"Determinants of therapeutic lag in multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cegep de Saint Jerome; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Université de Montréal","funders":"National Health and Medical Research Council; Multiple Sclerosis International Federation; Agence Nationale de la Recherche; Fondation pour l'Aide à la Recherche sur la Sclérose en Plaques; Teva Pharmaceutical Industries; Biogen; Sanofi","keywords":"Medicine; Multiple sclerosis; Expanded Disability Status Scale; Therapeutic effect; Internal medicine; Disease; Incidence (geometry); Lag time; Physical therapy; Immunology","score_opus":0.19633632886975733,"score_gpt":0.3327823514985605,"score_spread":0.13644602262880318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119307399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982638,0.00070885476,0.00036285992,0.00009539161,0.000003584242,0.000008675873,0.00019055801,0.000005539531,0.00036080895],"genre_scores_gemma":[0.9997416,0.0000493182,0.00007251042,0.000009616047,0.000005243303,0.0000030113374,0.00009593115,0.0000015731545,0.000021160902],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983615,0.00064608327,0.00022309586,0.00026617813,0.00033748176,0.00016556309],"domain_scores_gemma":[0.98110205,0.0063948524,0.010481376,0.0006399376,0.0004968036,0.0008848918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028968593,0.00017623036,0.00032760366,0.0005297743,0.00021631231,0.0005618522,0.00027445835,0.0003154017,0.0016504294],"category_scores_gemma":[0.012799373,0.0000922563,0.00042897675,0.0008204065,0.00030098628,0.00042222263,0.00042440573,0.0006203061,0.00014832221],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004097563,0.00004046157,0.99425477,0.00002066013,0.0000776122,0.0000623901,0.00008602808,0.0003588521,0.00022872839,0.00005383803,0.000059119022,0.004347673],"study_design_scores_gemma":[0.000008576671,0.00024052826,0.9981127,0.000009860726,0.000036516696,0.0003808004,0.00007029379,0.00063773675,0.00010956613,0.00017629539,0.00021311856,0.0000040201344],"about_ca_topic_score_codex":0.0010558617,"about_ca_topic_score_gemma":0.0006561868,"teacher_disagreement_score":0.0028968593,"about_ca_system_score_codex":0.00042373105,"about_ca_system_score_gemma":0.0005038725,"threshold_uncertainty_score":0.015320241},"labels":[],"label_agreement":null},{"id":"W3120065428","doi":"10.1177/1352458520983584","title":"An enrichment strategy for clinical trials in SPMS","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"Alberta Innovates - Health Solutions; Hotchkiss Brain Institute, University of Calgary","keywords":"Expanded Disability Status Scale; Multiple sclerosis; Clinical trial; Logistic regression; Psychology; Cohort; Baseline (sea); Physical therapy; Internal medicine; Medicine; Physical medicine and rehabilitation; Psychiatry; Biology","score_opus":0.6108981091022821,"score_gpt":0.5257717155352305,"score_spread":0.08512639356705165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120065428","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07641555,0.012244174,0.7374218,0.019335242,0.002518384,0.113985024,0.004702875,0.005974435,0.027402524],"genre_scores_gemma":[0.25793126,0.0011869017,0.64699215,0.005281008,0.00085368304,0.08335588,0.001257924,0.00031914882,0.002822068],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.5640862,0.3838436,0.027014578,0.008491744,0.0138594955,0.0027043654],"domain_scores_gemma":[0.37448233,0.526162,0.031486925,0.040355034,0.021363717,0.0061499956],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.30915326,0.0023843062,0.0058677746,0.009037097,0.0014394671,0.0045254575,0.0023538666,0.0033143219,0.016238863],"category_scores_gemma":[0.60030466,0.0019290202,0.0040182946,0.0056004366,0.0023085338,0.005818768,0.007912047,0.0033453687,0.0034291297],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04256122,0.0014203703,0.045699477,0.023248898,0.014395573,0.0014300913,0.0039290795,0.017749628,0.0049849893,0.047901936,0.02722096,0.76945776],"study_design_scores_gemma":[0.04854851,0.01735997,0.06288382,0.017598221,0.026067123,0.0025045555,0.0016337914,0.21078838,0.012151112,0.33687797,0.26269406,0.0008925435],"about_ca_topic_score_codex":0.00088654284,"about_ca_topic_score_gemma":0.0014720907,"teacher_disagreement_score":0.30915326,"about_ca_system_score_codex":0.002801204,"about_ca_system_score_gemma":0.010522803,"threshold_uncertainty_score":0.85193706},"labels":[],"label_agreement":null},{"id":"W3120800281","doi":"10.1177/1352458520981370","title":"Comparative responsiveness of the health utilities index and the RAND-12 for multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Health Sciences Centre","funders":"","keywords":"Health Utilities Index; Psychology; Multiple sclerosis; Quality of life (healthcare); Expanded Disability Status Scale; Physical therapy; Index (typography); Medicine; Gerontology; Health related quality of life; Internal medicine; Psychiatry; Disease","score_opus":0.22071223929618813,"score_gpt":0.3529659023259332,"score_spread":0.1322536630297451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120800281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9218501,0.0145119,0.043245245,0.0021163044,0.00047164716,0.0016675123,0.0063436413,0.00031856913,0.009475098],"genre_scores_gemma":[0.99114215,0.0005513191,0.00512235,0.00021118384,0.00009333579,0.0010738295,0.0015337286,0.00006295721,0.00020917183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.88426274,0.09820899,0.0041510095,0.0034200223,0.008905276,0.0010519335],"domain_scores_gemma":[0.84618044,0.11677054,0.019503,0.0105491085,0.005890644,0.0011062832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.110817894,0.0010566139,0.0015706463,0.0036554572,0.00038876093,0.0016530677,0.0011841011,0.0010330107,0.00159042],"category_scores_gemma":[0.22371039,0.00034790224,0.0033398387,0.0038748996,0.0015140127,0.00195219,0.0023784642,0.0018317943,0.00048301916],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007614806,0.00046875217,0.8382965,0.0010043676,0.010012705,0.00014813957,0.00146488,0.018873774,0.00062460516,0.0040249047,0.004052022,0.11341455],"study_design_scores_gemma":[0.00061269104,0.0041789017,0.95720536,0.00055594003,0.0015590423,0.0006363719,0.00070663565,0.020987311,0.0010010261,0.006218385,0.0061040777,0.00023422373],"about_ca_topic_score_codex":0.0013654968,"about_ca_topic_score_gemma":0.00066632277,"teacher_disagreement_score":0.110817894,"about_ca_system_score_codex":0.001547312,"about_ca_system_score_gemma":0.0012656022,"threshold_uncertainty_score":0.58606803},"labels":[],"label_agreement":null},{"id":"W3121899751","doi":"10.1177/1352458520988637","title":"Characterisation of MS phenotypes across the age span using a novel data set integrating 34 clinical trials (NO.MS cohort): Age is a key contributor to presentation","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"Novartis Pharma","keywords":"Medicine; Multiple sclerosis; Cohort; Disease; Internal medicine; Clinical trial; Clinical phenotype; Phenotype; Young adult; Age of onset; Pediatrics; Psychiatry","score_opus":0.5241666445560712,"score_gpt":0.4965403499852401,"score_spread":0.0276262945708311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121899751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9419834,0.0031469516,0.004203804,0.0006921848,0.000059224196,0.00036136192,0.048374746,0.00013507088,0.0010433095],"genre_scores_gemma":[0.936771,0.0005847151,0.008295729,0.00040755316,0.0000656198,0.00063722103,0.052780196,0.000044475884,0.00041351034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99451536,0.0029511014,0.0009879363,0.0009536276,0.00042116627,0.00017080162],"domain_scores_gemma":[0.97420645,0.010488012,0.008224284,0.0043681287,0.0015363785,0.0011767987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012771175,0.000539145,0.0012850319,0.0014182917,0.00036381444,0.001481733,0.0006793358,0.0007232295,0.0014104607],"category_scores_gemma":[0.028773384,0.00026676588,0.0013797954,0.0016499244,0.00039373094,0.0007281784,0.0011436397,0.0007411467,0.0003477699],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034649346,0.00016525997,0.9616842,0.0005185886,0.0023367172,0.00022033099,0.00017540422,0.0051816367,0.0012108963,0.00037180836,0.0061617782,0.018508472],"study_design_scores_gemma":[0.00086449203,0.0012181042,0.96808195,0.00021466672,0.0016990534,0.0013428011,0.00017492921,0.012750316,0.0010954035,0.001054757,0.011428803,0.00007474502],"about_ca_topic_score_codex":0.0031184885,"about_ca_topic_score_gemma":0.0052428837,"teacher_disagreement_score":0.012771175,"about_ca_system_score_codex":0.0005206795,"about_ca_system_score_gemma":0.0010482939,"threshold_uncertainty_score":0.06754124},"labels":[],"label_agreement":null},{"id":"W3123369010","doi":"10.1177/1352458520987539","title":"A comparison of clinical outcomes in PPMS in the INFORMS original trial data set","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Expanded Disability Status Scale; Multiple sclerosis; Logistic regression; Paced Auditory Serial Addition Test; Psychology; Test (biology); Clinical trial; Set (abstract data type); Clinical Practice; Physical therapy; Medicine; Cognition; Physical medicine and rehabilitation; Cognitive impairment; Internal medicine; Psychiatry","score_opus":0.5862866117347195,"score_gpt":0.5240522166809142,"score_spread":0.06223439505380535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3123369010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9624961,0.00884112,0.0018750075,0.0007850382,0.00029809464,0.0021083038,0.019194456,0.00009633509,0.00430555],"genre_scores_gemma":[0.9643177,0.0011645813,0.0018656639,0.00055554404,0.0002159323,0.003615153,0.026868438,0.000045567253,0.0013514999],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.97854555,0.016435862,0.0019610217,0.0012048745,0.0013994261,0.00045317525],"domain_scores_gemma":[0.97293085,0.017052341,0.0042121373,0.0033820951,0.0014402389,0.0009823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02538216,0.0009595933,0.003597701,0.0008789494,0.00049021305,0.0012227276,0.0009165905,0.0013997842,0.0065968647],"category_scores_gemma":[0.037527118,0.00038183044,0.003806857,0.0009209838,0.0007999566,0.0012459963,0.0011662057,0.0015383763,0.00060020934],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9049491,0.0013788346,0.03327025,0.004011369,0.024932208,0.00027039493,0.00020958763,0.0022678291,0.0013499609,0.0007576979,0.0072613475,0.019341309],"study_design_scores_gemma":[0.5916631,0.11740155,0.21010692,0.0012486953,0.039898816,0.0018179814,0.00040588813,0.008208124,0.002256172,0.003034195,0.023686852,0.0002716944],"about_ca_topic_score_codex":0.0006319432,"about_ca_topic_score_gemma":0.0014249404,"teacher_disagreement_score":0.02538216,"about_ca_system_score_codex":0.00086072966,"about_ca_system_score_gemma":0.0012043621,"threshold_uncertainty_score":0.13423532},"labels":[],"label_agreement":null},{"id":"W3123635300","doi":"","title":"Perceptions of risk and adherence to care in ms patients during the COVID-19 pandemic: a cross-sectional study","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Long-Term Effects of COVID-19","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pandemic; Specialty; Cross-sectional study; Family medicine; Coronavirus disease 2019 (COVID-19); Health care; Pediatrics; Emergency medicine; Internal medicine; Disease","score_opus":0.07922829740323901,"score_gpt":0.3430223437525423,"score_spread":0.2637940463493033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3123635300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992362,0.000068092086,0.000026432084,0.00014570556,0.0000061013457,0.000019240297,0.00015094,9.06616e-7,0.0003464346],"genre_scores_gemma":[0.9994698,0.00007234767,0.000058631973,0.0001390567,0.000007979002,0.000021286633,0.000119872544,0.000001175235,0.00010989722],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980496,0.0006709299,0.00029121348,0.00021627448,0.00042689667,0.0003450142],"domain_scores_gemma":[0.99199754,0.0014592108,0.0036054624,0.0002668676,0.0008690246,0.0018018701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024966125,0.00023602709,0.00049753656,0.0010310821,0.0014938947,0.0016796483,0.0004763415,0.0013586067,0.001740416],"category_scores_gemma":[0.009359794,0.0006073053,0.0008535262,0.0011477339,0.0007392911,0.0015997621,0.001095366,0.0021118151,0.00026189903],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028218588,0.0001856564,0.9969111,0.000010053973,0.00003728233,0.000030598956,0.0020719282,0.000020106902,0.000036424004,0.000014457398,0.00008412832,0.0005701217],"study_design_scores_gemma":[0.0000070146257,0.00024672737,0.9900275,0.000019411198,0.00001648559,0.00011527498,0.009072785,0.00018988493,0.000025298825,0.00001902165,0.00024899992,0.000011630219],"about_ca_topic_score_codex":0.026946668,"about_ca_topic_score_gemma":0.025143689,"teacher_disagreement_score":0.026946668,"about_ca_system_score_codex":0.0010774995,"about_ca_system_score_gemma":0.0013180728,"threshold_uncertainty_score":0.05357963},"labels":[],"label_agreement":null},{"id":"W3124877733","doi":"10.1177/1352458520988632","title":"A multiple sclerosis disease progression measure based on cumulative disability","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia Hospital","funders":"Canadian Institutes of Health Research","keywords":"Quartile; Multiple sclerosis; Metric (unit); Receiver operating characteristic; Medicine; Cohort; Severity of illness; Longitudinal study; Disease; Cohort study; Physical therapy; Statistics; Internal medicine; Confidence interval; Mathematics; Pathology","score_opus":0.16517394554296938,"score_gpt":0.34511297365983373,"score_spread":0.17993902811686435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3124877733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9242309,0.005339906,0.032402653,0.00045939983,0.00020891539,0.0008168868,0.0154102,0.0008486776,0.020282593],"genre_scores_gemma":[0.98123163,0.00046968358,0.013488164,0.000046265563,0.00006756,0.00031921262,0.0034467548,0.000027100923,0.00090354594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973454,0.00090932066,0.00032155603,0.00025593248,0.0010897799,0.00007795948],"domain_scores_gemma":[0.9921496,0.0027411752,0.002946857,0.0003786299,0.0014513619,0.00033236662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037751517,0.0006853937,0.00065297796,0.004597284,0.00027081434,0.0008004431,0.0004649648,0.00036704485,0.001887218],"category_scores_gemma":[0.010684394,0.00010536184,0.000984534,0.0022789584,0.00035488314,0.00078408595,0.00065710605,0.0006907389,0.00056229037],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012064455,0.00023495946,0.86889195,0.0005150889,0.0012542047,0.00009150016,0.00029316903,0.0068827984,0.00257484,0.001087697,0.004136502,0.11283098],"study_design_scores_gemma":[0.000068035726,0.0014240602,0.9782059,0.00012462497,0.0002876231,0.0007650319,0.00015890904,0.01038757,0.0013495801,0.0014257501,0.0057478747,0.000055008124],"about_ca_topic_score_codex":0.0025314267,"about_ca_topic_score_gemma":0.003922123,"teacher_disagreement_score":0.004597284,"about_ca_system_score_codex":0.0006805897,"about_ca_system_score_gemma":0.0006761073,"threshold_uncertainty_score":0.019965112},"labels":[],"label_agreement":null},{"id":"W3125193724","doi":"","title":"COVID19 on U.S. and canadian neurologists' therapeutic approach to multiple sclerosis: A survey of knowledge, attitudes, and practices","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Multiple sclerosis; Pandemic; Coronavirus disease 2019 (COVID-19); Family medicine; Inclusion (mineral); Psychiatry; Psychology; Disease; Internal medicine","score_opus":0.31540868239944825,"score_gpt":0.3585578166816011,"score_spread":0.043149134282152835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3125193724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938558,0.0003234064,0.00003136792,0.00096449075,0.000014081626,0.00007614895,0.0012339979,0.0000039801866,0.0034967174],"genre_scores_gemma":[0.996651,0.0007058324,0.0001264905,0.0007979489,0.000015505235,0.000048150185,0.000575228,0.0000035276391,0.0010763572],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799263,0.00028560628,0.00017575517,0.0001282049,0.0008351125,0.00058266125],"domain_scores_gemma":[0.9912999,0.0009818277,0.0024216997,0.000104069775,0.0026500602,0.0025424375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019230584,0.00020297825,0.000250114,0.0012556394,0.0030165552,0.001320652,0.0007568287,0.00072700076,0.0022454283],"category_scores_gemma":[0.0061333785,0.00039200872,0.0004451692,0.0021618311,0.0009893931,0.00064419134,0.0010019318,0.0010254927,0.00035611444],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009279502,0.00016482487,0.96157473,0.000103095495,0.000042367443,0.00015999709,0.025350237,0.000053724645,0.0003628273,0.00007953372,0.0028190697,0.009196767],"study_design_scores_gemma":[0.0000091100055,0.000090874586,0.97085327,0.000054713233,0.000008687127,0.00007045728,0.025911992,0.00010724556,0.000045003217,0.000009441233,0.0028239968,0.000015220203],"about_ca_topic_score_codex":0.9234917,"about_ca_topic_score_gemma":0.9386678,"teacher_disagreement_score":0.07650828,"about_ca_system_score_codex":0.010234314,"about_ca_system_score_gemma":0.016040154,"threshold_uncertainty_score":0.15391767},"labels":[],"label_agreement":null},{"id":"W3127248578","doi":"10.1177/1352458521993066","title":"Serum neurofilament light in MS: The first true blood-based biomarker?","year":2021,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Multiple sclerosis; Medicine; Biomarker; Lumbar puncture; Cerebrospinal fluid; Biomarker discovery; Expert opinion; Oncology; Intensive care medicine; Internal medicine; Immunology; Proteomics","score_opus":0.2015667470640221,"score_gpt":0.355650558478286,"score_spread":0.15408381141426392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127248578","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004123773,0.9993672,0.00004122967,0.0002831398,0.00011675585,0.0000022834672,0.0000117565305,0.0000022019844,0.00013429495],"genre_scores_gemma":[0.00047680794,0.9990037,0.000120462035,0.00019287907,0.00008500778,0.000005016997,0.000014285731,8.615456e-7,0.00010099315],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994777,0.00014909935,0.00012170109,0.000070865455,0.00014969773,0.000031074866],"domain_scores_gemma":[0.9984731,0.0009568909,0.00018107357,0.00003804122,0.0003077831,0.000043089745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001617881,0.00071739237,0.0023782765,0.0023843832,0.00022023795,0.0013111613,0.00088182965,0.0013360127,0.0024794634],"category_scores_gemma":[0.0038751736,0.00030562325,0.00090863556,0.0022631385,0.0004966034,0.0015523295,0.00060678116,0.001598254,0.00096012605],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016391139,0.000031399995,0.0003366319,0.08335732,0.000502205,0.00012420668,0.000077717516,0.0001706131,0.0007952151,0.002633084,0.02517637,0.8866314],"study_design_scores_gemma":[0.0000562429,0.00018250807,0.0027813648,0.07509605,0.0015514961,0.0014040914,0.00019009154,0.00014259673,0.0006566698,0.0038832133,0.91401285,0.000042802196],"about_ca_topic_score_codex":0.0016905956,"about_ca_topic_score_gemma":0.002527369,"teacher_disagreement_score":0.0024794634,"about_ca_system_score_codex":0.00065309525,"about_ca_system_score_gemma":0.0019805913,"threshold_uncertainty_score":0.008556247},"labels":[],"label_agreement":null},{"id":"W3127617025","doi":"","title":"The canadian prospective cohort (CANPROCO) study to understand progression in multiple sclerosis: rationale and baseline characteristics","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Multiple sclerosis; Expanded Disability Status Scale; Clinically isolated syndrome; Cohort; Prospective cohort study; Internal medicine; Cohort study; Physical therapy; Observational study; Disease; Clinical trial; Immunology","score_opus":0.14083598730910388,"score_gpt":0.3140552544641764,"score_spread":0.17321926715507255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127617025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8181033,0.0037652636,0.006085073,0.0024081843,0.00040860457,0.029197365,0.12044456,0.00012342425,0.019464282],"genre_scores_gemma":[0.92012274,0.0015988189,0.011861952,0.0018216735,0.00017638634,0.021373574,0.034683667,0.00006726555,0.008293923],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99653363,0.0007193567,0.00023973423,0.0008878398,0.0010578049,0.0005617116],"domain_scores_gemma":[0.9971937,0.00020283795,0.0003202647,0.00036839957,0.0013782172,0.0005365578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004490595,0.0014120586,0.00083790434,0.0016494485,0.006445497,0.0015264926,0.0025143714,0.0014099617,0.004823441],"category_scores_gemma":[0.0070313574,0.00080618163,0.0012975496,0.0040941876,0.0013676423,0.000732039,0.0016872543,0.0013662791,0.0006191517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031995317,0.00032041193,0.9582796,0.00042454567,0.0006325416,0.00031258183,0.001462699,0.0005129882,0.0008133506,0.002712242,0.020074895,0.011254711],"study_design_scores_gemma":[0.0011584276,0.0006051569,0.97120506,0.00023460152,0.00046379658,0.0003387374,0.0009775764,0.0007892682,0.00019101765,0.00073965744,0.023240346,0.00005625686],"about_ca_topic_score_codex":0.9010709,"about_ca_topic_score_gemma":0.91839397,"teacher_disagreement_score":0.9010709,"about_ca_system_score_codex":0.009414986,"about_ca_system_score_gemma":0.027130561,"threshold_uncertainty_score":0.19902337},"labels":[],"label_agreement":null},{"id":"W3128676251","doi":"10.1177/1352458521989090","title":"Pro-inflammatory adiponectin in pediatric-onset multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Adipokines, Inflammation, and Metabolic Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Memorial University of Newfoundland; Montreal Neurological Institute and Hospital; SickKids Foundation; University of Toronto; McGill University; Hospital for Sick Children; Institute of Infection and Immunity","funders":"National Institutes of Health; Immune Tolerance Network; Canadian Institutes of Health Research; Multiple Sclerosis Scientific Research Foundation; Multiple Sclerosis Society of Canada; American Academy of Neurology; University of Pennsylvania; National Multiple Sclerosis Society","keywords":"Adipokine; Multiple sclerosis; Medicine; Microglia; Adiponectin; CD14; Immunology; Immune system; Inflammation; Myeloid; Internal medicine; Endocrinology; Leptin","score_opus":0.058398732882190954,"score_gpt":0.25798489118946694,"score_spread":0.199586158307276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128676251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99812835,0.0014468806,0.000083428706,0.000035266625,0.000003987014,0.0000029986552,0.00014928365,0.000004056654,0.00014566857],"genre_scores_gemma":[0.99877614,0.00078484364,0.00022074381,0.000015980582,0.000008323596,0.000004797257,0.00013605769,0.0000013409897,0.000051690102],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998472,0.00003916749,0.000019024104,0.00004124463,0.000031466803,0.000021899054],"domain_scores_gemma":[0.99960035,0.00006295909,0.00023644282,0.0000121500825,0.000037155998,0.000051018076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023603631,0.0003208212,0.00026462384,0.00056507153,0.00022962861,0.00029159017,0.00013814602,0.00022537788,0.00076926325],"category_scores_gemma":[0.00053154107,0.00014597931,0.00017114753,0.00068465795,0.0002017057,0.00016631433,0.00023272587,0.00033493957,0.00008992021],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021177373,0.000024230418,0.9943506,0.000043906006,0.000022157943,0.00033743025,0.00006228198,0.000062075254,0.002024988,0.000022458104,0.000063354055,0.0027748449],"study_design_scores_gemma":[0.0000057114726,0.00018698155,0.9963814,0.000016244037,0.000037507674,0.0019967735,0.00012532294,0.000105586354,0.0008335548,0.000028528892,0.0002804691,0.0000019470856],"about_ca_topic_score_codex":0.0013991372,"about_ca_topic_score_gemma":0.0014737808,"teacher_disagreement_score":0.0013991372,"about_ca_system_score_codex":0.00019767466,"about_ca_system_score_gemma":0.00023990544,"threshold_uncertainty_score":0.0027820468},"labels":[],"label_agreement":null},{"id":"W3130180415","doi":"10.1177/1352458521995484","title":"The relative contributions of obesity, vitamin D, leptin, and adiponectin to multiple sclerosis risk: A Mendelian randomization mediation analysis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Jewish General Hospital","funders":"Medical Research Council; Fonds de Recherche du Québec - Santé; National Institutes of Health; National Multiple Sclerosis Society; Public Health Agency; European Commission; King's College London; National Institute of Neurological Disorders and Stroke; Jewish General Hospital; National Institute for Health and Care Research; Multiple Sclerosis Society of Canada; Public Health Agency of Canada; University of California, San Francisco; Cancer Research UK; Multiple Sclerosis Society; Wellcome Trust; Canadian Institutes of Health Research; Compute Canada","keywords":"Adiponectin; Mendelian randomization; Internal medicine; Medicine; Vitamin D and neurology; Leptin; Obesity; Endocrinology; Odds ratio; Body mass index; Confidence interval; Biology; Insulin resistance; Genotype; Genetics","score_opus":0.048247771415054035,"score_gpt":0.29500742974744193,"score_spread":0.2467596583323879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130180415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8668091,0.0053466866,0.121364206,0.001442677,0.00018061508,0.0010592791,0.0008101368,0.00054915255,0.002438097],"genre_scores_gemma":[0.9759591,0.0005438491,0.021849753,0.00016528666,0.00006410764,0.0006444374,0.00017570629,0.000031664058,0.0005661109],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.97111523,0.024751592,0.0005192106,0.0019007807,0.0011374179,0.0005758033],"domain_scores_gemma":[0.9716774,0.024539165,0.00159679,0.0015256095,0.00045632175,0.00020480774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027121136,0.0020331135,0.0020314974,0.0016266844,0.0005509473,0.00090344547,0.0018685724,0.0009806649,0.0048631784],"category_scores_gemma":[0.03942289,0.00072163634,0.0060160942,0.0009415066,0.0007248738,0.0006316322,0.0011034928,0.0010959378,0.00025927735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05026939,0.0009857359,0.66939944,0.0016671608,0.10408987,0.0037983286,0.001381072,0.018673502,0.008692003,0.020256188,0.0032436417,0.117543645],"study_design_scores_gemma":[0.016635336,0.015530117,0.33860293,0.0005919952,0.14491759,0.009022903,0.0008817877,0.40682936,0.0065389657,0.050838184,0.009218432,0.00039244455],"about_ca_topic_score_codex":0.004057547,"about_ca_topic_score_gemma":0.0012016859,"teacher_disagreement_score":0.027121136,"about_ca_system_score_codex":0.00057509413,"about_ca_system_score_gemma":0.0010441308,"threshold_uncertainty_score":0.14343202},"labels":[],"label_agreement":null},{"id":"W3130831844","doi":"10.1177/1352458521993075","title":"Mendelian randomization provides no evidence for a causal role in the bidirectional relationship between depression and multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Institute of Mental Health","keywords":"Mendelian randomization; Major depressive disorder; Odds ratio; Depression (economics); Multiple sclerosis; Body mass index; Medicine; Pleiotropy; Odds; Genetic predisposition; Internal medicine; Logistic regression; Psychiatry; Genetics; Genotype; Biology; Genetic variants; Disease","score_opus":0.2607154706881714,"score_gpt":0.35896128066074595,"score_spread":0.09824580997257454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130831844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5856243,0.016397849,0.36804444,0.00848585,0.0019998245,0.0024781094,0.0029453577,0.0013767591,0.012647619],"genre_scores_gemma":[0.95355713,0.001298001,0.04148976,0.0012854605,0.00033134382,0.000813143,0.00047502117,0.000086539716,0.000663506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.8808035,0.09272354,0.0042622774,0.013848117,0.00694386,0.0014186781],"domain_scores_gemma":[0.83703715,0.12552112,0.015522375,0.01922037,0.0019307636,0.0007681849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08021909,0.0015064355,0.0032496327,0.0017499102,0.0009888673,0.0022695311,0.0020052027,0.0023720711,0.0068828748],"category_scores_gemma":[0.17553322,0.000912013,0.0035667892,0.0019564712,0.0037841252,0.0022634282,0.0014203171,0.0020339168,0.00061385205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02359518,0.0006607002,0.60636926,0.0051914887,0.07086445,0.0074668447,0.0020284033,0.011490893,0.006468742,0.10662808,0.009258913,0.1499771],"study_design_scores_gemma":[0.017257206,0.009236821,0.34428394,0.003213147,0.053263206,0.01821968,0.0015882938,0.1507866,0.005109209,0.36744496,0.029068345,0.00052865007],"about_ca_topic_score_codex":0.0018640424,"about_ca_topic_score_gemma":0.0014643018,"teacher_disagreement_score":0.08021909,"about_ca_system_score_codex":0.0009327719,"about_ca_system_score_gemma":0.0014039631,"threshold_uncertainty_score":0.42424417},"labels":[],"label_agreement":null},{"id":"W3136131376","doi":"10.1177/13524585211002097","title":"Cognitive impairment, the central vein sign, and paramagnetic rim lesions in RIS","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto; St. Michael's Hospital","funders":"National Institutes of Health","keywords":"Medicine; Multiple sclerosis; Clinically isolated syndrome; Hyperintensity; Internal medicine; Magnetic resonance imaging; Cohort; Cardiology; Pathology; Radiology; Psychiatry","score_opus":0.09904922201738842,"score_gpt":0.3192905582572728,"score_spread":0.2202413362398844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136131376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99964654,0.000071539,0.000042484073,0.000016890071,0.0000015219487,0.0000037790064,0.00003138437,0.0000025211207,0.00018324012],"genre_scores_gemma":[0.99982613,0.000019955882,0.00005384282,0.000006261732,0.0000043177097,0.0000020098564,0.000045126366,5.872703e-7,0.00004178927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996834,0.000076918506,0.000045252822,0.000064445,0.00008249081,0.000047478177],"domain_scores_gemma":[0.99806553,0.00041409177,0.0009827497,0.000070924776,0.00022071342,0.00024594364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006724169,0.0005658385,0.0003104752,0.0011566014,0.00028712742,0.00045746242,0.00031785466,0.00040696358,0.0020806221],"category_scores_gemma":[0.0043010293,0.00015054931,0.00031507623,0.0005241108,0.00041020865,0.00045134788,0.0005409899,0.00043920797,0.00024122543],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015631066,0.00004945281,0.9974704,0.000013029956,0.000033317203,0.000335719,0.00007189539,0.00004088584,0.0003718836,0.000011811494,0.000031655898,0.0014137479],"study_design_scores_gemma":[0.000007591108,0.00021511421,0.9969618,0.000009582964,0.00002317217,0.002155982,0.00012805294,0.0002831744,0.0001372494,0.000037226986,0.000037833503,0.0000032639985],"about_ca_topic_score_codex":0.0023941249,"about_ca_topic_score_gemma":0.002403962,"teacher_disagreement_score":0.0023941249,"about_ca_system_score_codex":0.0001760374,"about_ca_system_score_gemma":0.00031062827,"threshold_uncertainty_score":0.006960392},"labels":[],"label_agreement":null},{"id":"W3136546709","doi":"10.1177/1352458521999970","title":"Prioritizing progressive MS rehabilitation research: A call from the International Progressive MS Alliance","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; University of Manitoba; Memorial University of Newfoundland; Queen's University","funders":"National Institutes of Health; Teva Pharmaceutical Industries; Mylan; Biogen; Celgene; Merck KGaA; Sanofi; National Multiple Sclerosis Society","keywords":"Psychosocial; Quality of life (healthcare); Affect (linguistics); Rehabilitation; Alliance; Multiple sclerosis; Medicine; Depression (economics); Physical medicine and rehabilitation; Physical therapy; Psychology; Gerontology; Psychiatry; Nursing; Political science","score_opus":0.2032232779312036,"score_gpt":0.3883511078204405,"score_spread":0.18512782988923693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136546709","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046881504,0.0066134203,0.0010850555,0.98437446,0.006049287,0.00012904605,0.00003444345,0.00006740421,0.0011780233],"genre_scores_gemma":[0.01868922,0.026704457,0.031410974,0.89847255,0.018454304,0.0013038008,0.0003815732,0.0002058853,0.004377216],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.71400076,0.18262203,0.031272426,0.010022577,0.041672338,0.020409841],"domain_scores_gemma":[0.388132,0.2584289,0.021096407,0.03301231,0.09985826,0.19947208],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.37569088,0.0026436953,0.0057534534,0.0067039304,0.011675225,0.029791575,0.010288622,0.05002309,0.010203784],"category_scores_gemma":[0.23700272,0.0027525863,0.005232476,0.0045540724,0.01834763,0.032000277,0.04334439,0.07838528,0.0045094886],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041716106,0.00084756623,0.0037162157,0.0031596706,0.00020307746,0.0011145952,0.010426023,0.00041210203,0.0018556729,0.020061834,0.8127505,0.14503549],"study_design_scores_gemma":[0.00046287975,0.00049863383,0.004653365,0.00948799,0.00014266983,0.0009983188,0.020606067,0.00048392065,0.0004010776,0.03993758,0.92200893,0.00031863493],"about_ca_topic_score_codex":0.00519594,"about_ca_topic_score_gemma":0.0070311283,"teacher_disagreement_score":0.37569088,"about_ca_system_score_codex":0.011450382,"about_ca_system_score_gemma":0.15195619,"threshold_uncertainty_score":0.7698843},"labels":[],"label_agreement":null},{"id":"W3137966630","doi":"10.1177/13524585211001780","title":"Cervical cord myelin abnormality is associated with clinical disability in multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"International Collaboration On Repair Discoveries; University of British Columbia","funders":"Multiple Sclerosis Society of Canada","keywords":"Multiple sclerosis; Expanded Disability Status Scale; Medicine; Myelin; Spinal cord; White matter; Magnetic resonance imaging; Neurology; Internal medicine; Pathology; Radiology; Central nervous system; Immunology","score_opus":0.24686773606196313,"score_gpt":0.36538634391960534,"score_spread":0.1185186078576422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137966630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987155,0.00063877343,0.00012185741,0.000038319205,0.0000022165814,0.000008886651,0.00013203236,0.000007029477,0.0003352909],"genre_scores_gemma":[0.99955636,0.00010266283,0.00015587026,0.000007650131,0.0000055129576,0.0000053578797,0.00011457214,0.0000019856266,0.000050044557],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99972004,0.000052631716,0.000043552653,0.000073833195,0.00008738159,0.000022590553],"domain_scores_gemma":[0.9967879,0.0005770315,0.0019772088,0.00012824936,0.00032912963,0.00020051083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006044651,0.00024193924,0.00021696794,0.0011575978,0.00026462812,0.00034972257,0.00025628752,0.0003546914,0.00161705],"category_scores_gemma":[0.0037851625,0.00008308469,0.00010383767,0.0008292174,0.00045970865,0.00026913048,0.00039997287,0.00019817628,0.00017210357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047768676,0.000027798578,0.9883201,0.00008234374,0.00010189382,0.00017479646,0.000121301615,0.00011112965,0.005418809,0.000022080008,0.00009172172,0.005050206],"study_design_scores_gemma":[0.000004306637,0.00010762035,0.9986059,0.000008532022,0.000021323029,0.0004939604,0.000048369155,0.00010756083,0.0004859379,0.000037733716,0.00007632793,0.0000025942602],"about_ca_topic_score_codex":0.0024262008,"about_ca_topic_score_gemma":0.002815124,"teacher_disagreement_score":0.0024262008,"about_ca_system_score_codex":0.0003551749,"about_ca_system_score_gemma":0.00024144657,"threshold_uncertainty_score":0.0054095387},"labels":[],"label_agreement":null},{"id":"W3139293378","doi":"10.1177/13524585211001781","title":"Childhood obesity and multiple sclerosis: A Mendelian randomization study","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Jewish General Hospital","funders":"Medical Research Council; European Commission; King's College London; UK Research and Innovation; Fonds de Recherche du Québec - Santé; National Multiple Sclerosis Society; University of Bristol; Multiple Sclerosis Society of Canada; Multiple Sclerosis Society; Wellcome Trust; Canadian Institutes of Health Research; National Institute for Health and Care Research","keywords":"Mendelian randomization; Body mass index; Medicine; Odds ratio; Obesity; Childhood obesity; Biobank; Confidence interval; Multiple sclerosis; Young adult; Internal medicine; Demography; Overweight; Bioinformatics; Genetics; Genotype; Biology; Genetic variants","score_opus":0.08790835501972588,"score_gpt":0.28955257383391286,"score_spread":0.20164421881418698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3139293378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9018864,0.0060249963,0.085382,0.00095457834,0.0002985599,0.0016551479,0.0014283243,0.00047485673,0.0018950698],"genre_scores_gemma":[0.975983,0.000642132,0.021499183,0.0002460219,0.00008183889,0.0006790151,0.00044663192,0.00006456626,0.00035765296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.95218164,0.039084505,0.0016303309,0.0041418727,0.0024928416,0.00046871588],"domain_scores_gemma":[0.9547569,0.029714495,0.0067018885,0.007234972,0.0011007066,0.00049100776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03015464,0.0012766066,0.0018443677,0.0013823997,0.00070917176,0.0010859454,0.0012875354,0.0011907915,0.0030843168],"category_scores_gemma":[0.06834198,0.0007361692,0.0022361863,0.002216472,0.00095269585,0.0005695386,0.0006095916,0.0008755999,0.0002768705],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04421747,0.0010546411,0.80243933,0.0013175095,0.04259817,0.006143462,0.0011366863,0.006844644,0.00562714,0.0128333215,0.006563474,0.069224074],"study_design_scores_gemma":[0.032809913,0.01727095,0.6442804,0.0008227336,0.05112021,0.028050475,0.0006615972,0.16774426,0.0036534446,0.036915705,0.016150592,0.00051965273],"about_ca_topic_score_codex":0.0033887525,"about_ca_topic_score_gemma":0.0019309345,"teacher_disagreement_score":0.03015464,"about_ca_system_score_codex":0.0006690733,"about_ca_system_score_gemma":0.0010271217,"threshold_uncertainty_score":0.15947491},"labels":[],"label_agreement":null},{"id":"W3143332518","doi":"10.1177/1352458516654311","title":"Haematopoietic stem cell transplants should be a second-line therapy for highly active MS – YES","year":2016,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Stem cell; Multiple sclerosis; Haematopoiesis; Medicine; Oncology; Immunology; Biology; Cell biology","score_opus":0.31619425303300763,"score_gpt":0.38615720263639114,"score_spread":0.0699629496033835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3143332518","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004229459,0.9966434,0.00007852633,0.0016676999,0.00049611425,0.000007631649,0.000038382266,0.0000039130014,0.0006414146],"genre_scores_gemma":[0.010812475,0.9814719,0.0006479378,0.0045529334,0.0013564482,0.000022976856,0.00014345178,0.0000029952198,0.0009890022],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99969244,0.000095854186,0.00008294081,0.000046412748,0.000067340436,0.000015011673],"domain_scores_gemma":[0.99912864,0.0005622004,0.00015759158,0.000017947516,0.000103975086,0.000029729052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075253705,0.00035607946,0.0014999692,0.00054182304,0.00018384802,0.0005141863,0.0005767648,0.0013622208,0.004041128],"category_scores_gemma":[0.0021423989,0.00011579561,0.00074050174,0.00047065702,0.00031036392,0.00070946885,0.00023876718,0.0012347543,0.00088578375],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095481705,0.0000947322,0.00096646463,0.069773935,0.0012214708,0.00054549455,0.00004909807,0.0001720541,0.002150741,0.0019250088,0.05004275,0.8721034],"study_design_scores_gemma":[0.001473187,0.000870349,0.012702088,0.09599623,0.005545262,0.0085197035,0.00031418144,0.00024081042,0.0025872788,0.0064371326,0.8652319,0.0000819199],"about_ca_topic_score_codex":0.0007001658,"about_ca_topic_score_gemma":0.0021075306,"teacher_disagreement_score":0.004041128,"about_ca_system_score_codex":0.00026286062,"about_ca_system_score_gemma":0.0008600525,"threshold_uncertainty_score":0.0135189295},"labels":[],"label_agreement":null},{"id":"W3153467397","doi":"10.1177/13524585211045545","title":"Characterizing 1-year development of cervical cord atrophy across different MS phenotypes: A voxel-wise, multicentre analysis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Chugai Pharmaceutical; Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica; Ministero della Salute; Coloplast; Vrije Universiteit Amsterdam; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; Eli Lilly and Company; Bristol-Myers Squibb; Fondazione Italiana Sclerosi Multipla; Medical Research Council; Biogen; Celgene; Alexion Pharmaceuticals; Sanofi; National Institute for Health and Care Research; Teva Pharmaceutical Industries; Argenx","keywords":"Atrophy; Medicine; Spinal cord; Cord; Multiple sclerosis; Voxel-based morphometry; Voxel; Magnetic resonance imaging; Pathology; Internal medicine; Surgery; Radiology; White matter","score_opus":0.08491925645508731,"score_gpt":0.31831939783294166,"score_spread":0.23340014137785436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3153467397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991555,0.00013136504,0.00032052834,0.0000074297345,0.0000015709882,0.000019790737,0.00028280754,0.000012725605,0.00006838789],"genre_scores_gemma":[0.9978655,0.000044319884,0.0008626318,0.00000577272,0.0000035847465,0.00002867276,0.0010862843,0.000012192654,0.000090957925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990957,0.00023293999,0.00009458506,0.0003750426,0.00012299683,0.000078783],"domain_scores_gemma":[0.99766624,0.0004700273,0.00072353164,0.000637031,0.0002864426,0.00021680711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024403331,0.00052468985,0.0006452485,0.0014493805,0.0005043797,0.00059124635,0.00094058807,0.0006116384,0.0010483634],"category_scores_gemma":[0.0035523844,0.00029907865,0.0009645921,0.0010811131,0.00047180135,0.00044297814,0.0009039303,0.00037750762,0.00027660455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022054664,0.00010887748,0.9718589,0.00008692167,0.0011233357,0.00042343835,0.00041143494,0.0008419455,0.0120399045,0.0000367719,0.00027294637,0.010590136],"study_design_scores_gemma":[0.000017281562,0.0004030868,0.99761057,0.0000032303376,0.00014700902,0.00049971865,0.000054443994,0.0005930204,0.00052813813,0.000016834982,0.00011843844,0.000008231251],"about_ca_topic_score_codex":0.003805217,"about_ca_topic_score_gemma":0.0068360227,"teacher_disagreement_score":0.003805217,"about_ca_system_score_codex":0.0004900652,"about_ca_system_score_gemma":0.00034466042,"threshold_uncertainty_score":0.012905896},"labels":[],"label_agreement":null},{"id":"W3155515376","doi":"10.1177/13524585211008760","title":"Current status of neuroprotective and neuroregenerative strategies in multiple sclerosis: A systematic review","year":2021,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Neurogenesis and neuroplasticity mechanisms","field":"Neuroscience","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Children's Hospital Research Institute of Manitoba; Centre Hospitalier de l’Université de Montréal; University of British Columbia","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada","keywords":"Multiple sclerosis; Neuroprotection; Neuroscience; Medicine; Physical medicine and rehabilitation; Psychology; Immunology","score_opus":0.2547972047859393,"score_gpt":0.3291347734752768,"score_spread":0.0743375686893375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155515376","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015254688,0.9993944,0.000043844728,0.00011230814,0.00004805753,0.000036640908,0.00009118769,0.00000412524,0.00011679045],"genre_scores_gemma":[0.0015538459,0.99795866,0.00013922913,0.00013511264,0.000034950812,0.000060038496,0.00007150081,0.0000014265948,0.00004516592],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9975044,0.00073268614,0.0009751125,0.00021072663,0.00045200053,0.00012517365],"domain_scores_gemma":[0.98884565,0.007890487,0.0018091813,0.00012298695,0.0011387452,0.00019289037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046334662,0.0015583497,0.0073681516,0.01012826,0.0005147208,0.002328118,0.0020821781,0.0019758174,0.0063060345],"category_scores_gemma":[0.014766651,0.00075462996,0.0045448192,0.010410928,0.0006108223,0.0021653643,0.0012054949,0.00095106475,0.0006390023],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016129318,0.000015099792,0.00023327065,0.905157,0.0025788595,0.000079254176,0.000089073204,0.00008200621,0.00014998148,0.00024063599,0.0022939565,0.08891946],"study_design_scores_gemma":[0.00017294547,0.0002133104,0.002202169,0.9054815,0.03670244,0.00045779117,0.00021240867,0.00008668878,0.0002072015,0.00043454237,0.053790804,0.00003819051],"about_ca_topic_score_codex":0.005609462,"about_ca_topic_score_gemma":0.015460155,"teacher_disagreement_score":0.01012826,"about_ca_system_score_codex":0.0023696034,"about_ca_system_score_gemma":0.009542768,"threshold_uncertainty_score":0.024504423},"labels":[],"label_agreement":null},{"id":"W3156047582","doi":"10.1177/13524585211010390","title":"Effect of continuous positive airway pressure treatment of obstructive sleep apnea-hypopnea in multiple sclerosis: A randomized, double-blind, placebo-controlled trial (SAMS-PAP study)","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Centre Hospitalier de l’Université de Montréal; McGill University Health Centre","funders":"","keywords":"Continuous positive airway pressure; Obstructive sleep apnea; Medicine; Double blind; Hypopnea; Randomized controlled trial; Multiple sclerosis; Placebo; Anesthesia; Apnea; Polysomnography; Internal medicine; Pathology","score_opus":0.06188024008347666,"score_gpt":0.31193524505193665,"score_spread":0.25005500496846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3156047582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96173006,0.028630046,0.0007358991,0.0009803761,0.0014495517,0.003587081,0.000840099,0.00018873588,0.0018579517],"genre_scores_gemma":[0.97661656,0.009929376,0.0019449241,0.0012914218,0.001666339,0.0061799777,0.00060425117,0.000019386758,0.0017477619],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993267,0.00034654984,0.0000745831,0.00012733693,0.0000633342,0.000061533734],"domain_scores_gemma":[0.9991247,0.0003292434,0.00024037843,0.00005320189,0.000067006884,0.00018549107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014924308,0.0012077654,0.003841615,0.00047814753,0.00044423598,0.000983962,0.00092232693,0.0024756396,0.0064478945],"category_scores_gemma":[0.0019267328,0.00057009206,0.0018671667,0.0004291657,0.00097126793,0.0008064297,0.00030975885,0.0021337364,0.00060844293],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96702194,0.004057443,0.00040235763,0.003235107,0.0015940772,0.000049535407,0.000029633633,0.00013303285,0.0019723752,0.000071905866,0.00048177355,0.020950783],"study_design_scores_gemma":[0.9710877,0.026929313,0.0009695936,0.000070747636,0.0004079518,0.00002082966,0.00000768698,0.000119214106,0.00015387234,0.000036851965,0.00019080414,0.000005508804],"about_ca_topic_score_codex":0.0004732368,"about_ca_topic_score_gemma":0.00087387924,"teacher_disagreement_score":0.0064478945,"about_ca_system_score_codex":0.00033495136,"about_ca_system_score_gemma":0.0009255666,"threshold_uncertainty_score":0.021570325},"labels":[],"label_agreement":null},{"id":"W3164755758","doi":"10.1177/13524585211016726","title":"Care consumption of people with multiple sclerosis: A multichannel sequence analysis in a population-based setting in British Columbia, Canada","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Okanagan University College; University of British Columbia, Okanagan Campus; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Comorbidity; Consumption (sociology); Cohort; Population; Health care; Gerontology; Multidisciplinary approach; Cohort study; Demography; Family medicine; Environmental health; Psychiatry; Internal medicine","score_opus":0.056995659457140475,"score_gpt":0.2717866004100312,"score_spread":0.21479094095289075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164755758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952218,0.0003420572,0.00018551262,0.00014058665,0.0000067444917,0.000055821067,0.0036138867,0.000006184415,0.00042733693],"genre_scores_gemma":[0.9966942,0.00028104533,0.00037258622,0.000077005396,0.0000036603697,0.00004706195,0.002126615,0.000005853673,0.0003919614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859065,0.0002592791,0.00013889887,0.00029686946,0.00032275837,0.000391597],"domain_scores_gemma":[0.9966995,0.0003221462,0.0005343718,0.00019461122,0.0016074624,0.0006418959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013891727,0.00048184925,0.00075122726,0.0020597568,0.0026048166,0.0014866883,0.001408279,0.0005609254,0.0015318795],"category_scores_gemma":[0.0038537888,0.0005033337,0.00087608234,0.006552847,0.0007315177,0.00044964193,0.0014754744,0.0009489422,0.00020976106],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010729228,0.00003134251,0.995539,0.000035696747,0.00010854852,0.000061800914,0.00070014317,0.00019018509,0.0001075326,0.000053667554,0.00053260557,0.0025320472],"study_design_scores_gemma":[0.000011916698,0.000026021587,0.9973869,0.000033787248,0.0000388656,0.000039930692,0.0012539361,0.0007660517,0.000030646333,0.000027985407,0.00037218188,0.0000118498565],"about_ca_topic_score_codex":0.9931641,"about_ca_topic_score_gemma":0.9941849,"teacher_disagreement_score":0.02059015,"about_ca_system_score_codex":0.02059015,"about_ca_system_score_gemma":0.022112295,"threshold_uncertainty_score":0.14939266},"labels":[],"label_agreement":null},{"id":"W3172159066","doi":"10.1177/13524585211020221","title":"Genes and environment in multiple sclerosis: Impact of temporal changes in the sex ratio on recurrence risks","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Demographic Trends and Gender Preferences","field":"Social Sciences","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Proband; Multiple sclerosis; Demography; Relative risk; Medicine; Family history; Internal medicine; Confidence interval; Genetics; Biology; Psychiatry; Gene","score_opus":0.2354180301001107,"score_gpt":0.3266725144321339,"score_spread":0.09125448433202321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172159066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99847883,0.0005142956,0.00019531819,0.000086308086,0.000005382585,0.000002988127,0.00026174105,0.0000040373875,0.0004511273],"genre_scores_gemma":[0.999597,0.00009920846,0.00009388668,0.000010683964,0.0000056319973,0.000001991034,0.000077978184,0.0000026766747,0.000111093585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990447,0.00044866008,0.000060706632,0.00019722895,0.00016159867,0.00008704469],"domain_scores_gemma":[0.9973508,0.0009136529,0.0011408002,0.00023085828,0.00015975401,0.00020413003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012624934,0.00013457584,0.0001673828,0.00058955624,0.00017118017,0.0003375085,0.00019451616,0.00022202606,0.0016220479],"category_scores_gemma":[0.0058853854,0.000114885275,0.00029441767,0.00069490756,0.0002630933,0.0003472314,0.00026285963,0.0002603373,0.0001429591],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019687526,0.000013951755,0.99524564,0.000006515774,0.0000853593,0.0000898843,0.000106264495,0.000093246745,0.0004129458,0.00006041502,0.0000499929,0.0036389884],"study_design_scores_gemma":[0.0000010829827,0.000051029703,0.9993906,0.0000018635758,0.000014130141,0.00015639723,0.00006065906,0.00015669478,0.00006177622,0.000026863696,0.00007727796,0.0000015887407],"about_ca_topic_score_codex":0.005043167,"about_ca_topic_score_gemma":0.0066248723,"teacher_disagreement_score":0.005043167,"about_ca_system_score_codex":0.0001973368,"about_ca_system_score_gemma":0.00024502396,"threshold_uncertainty_score":0.010027647},"labels":[],"label_agreement":null},{"id":"W3172962533","doi":"10.1177/13524585211023345","title":"Characterization of multiple sclerosis neuroinflammation and neurodegeneration with relaxation and diffusion basis spectrum imaging","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"International Collaboration On Repair Discoveries; University of British Columbia; University of British Columbia Hospital","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Multiple sclerosis; White matter; Corpus callosum; Diffusion MRI; Neuroinflammation; Myelin; Magnetic resonance imaging; Neurodegeneration; Medicine; T2 relaxation; Pathology; Clinically isolated syndrome; Neuroscience; Central nervous system; Psychology; Radiology; Internal medicine","score_opus":0.04730690347125414,"score_gpt":0.24148815448525948,"score_spread":0.19418125101400535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172962533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99188435,0.0016052403,0.005329157,0.000052540294,0.0000050675726,0.00004730839,0.00025837103,0.00005547414,0.00076247094],"genre_scores_gemma":[0.98623496,0.0007092471,0.012396828,0.00002220852,0.0000143554,0.000059770373,0.00023274675,0.000018937313,0.00031096194],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99983084,0.00004806266,0.000015028148,0.000038701462,0.000051952713,0.000015438338],"domain_scores_gemma":[0.9994466,0.00009991357,0.00023786626,0.000040742078,0.000115171024,0.000059732625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010452564,0.00039096188,0.00027375665,0.0014315124,0.00018831706,0.000452766,0.00024111853,0.0003330961,0.0010185557],"category_scores_gemma":[0.0014183215,0.00013765752,0.00020222293,0.0006260784,0.00036870176,0.0006053653,0.00029661952,0.00028403822,0.00014928194],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002855439,0.000353678,0.4177605,0.0012540253,0.00059137406,0.00084442523,0.0011150927,0.0026790607,0.43991795,0.00065794674,0.00078410044,0.13118643],"study_design_scores_gemma":[0.00010052229,0.0018496902,0.913076,0.000093795956,0.00023861669,0.0076445513,0.00049133686,0.0069937184,0.066355914,0.001435605,0.0016462951,0.000073882155],"about_ca_topic_score_codex":0.00082125876,"about_ca_topic_score_gemma":0.0012656221,"teacher_disagreement_score":0.0014315124,"about_ca_system_score_codex":0.000213252,"about_ca_system_score_gemma":0.00020153729,"threshold_uncertainty_score":0.0055279136},"labels":[],"label_agreement":null},{"id":"W3185484305","doi":"10.1177/13524585211031791","title":"High prevalence of comorbidities at diagnosis in immigrants with multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Toronto Western Hospital; University of Toronto; University Health Network; North York General Hospital; University of Waterloo; St. Michael's Hospital","funders":"Multiple Sclerosis Society of Canada","keywords":"Medicine; Comorbidity; Anxiety; Multiple sclerosis; COPD; Population; Depression (economics); Diabetes mellitus; Immigration; Mood disorders; Disease; Mood; Internal medicine; Psychiatry; Physical therapy","score_opus":0.10233025610374344,"score_gpt":0.28516143321338017,"score_spread":0.18283117710963673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185484305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989029,0.00029363303,0.000021430013,0.00009892934,0.0000058300907,0.0000035843896,0.00016329835,0.0000015679182,0.00050882885],"genre_scores_gemma":[0.9995011,0.00018870631,0.000037438484,0.000041525647,0.0000073260708,0.0000029290045,0.00015257177,6.9089543e-7,0.000067735666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997081,0.000052080064,0.00003352021,0.000052817737,0.00008299053,0.00007053727],"domain_scores_gemma":[0.9989961,0.000107297696,0.00048059298,0.000029110945,0.00019134962,0.00019549207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038997282,0.0001306859,0.00021848692,0.0007885495,0.00088898244,0.0005304084,0.00022941067,0.00026661687,0.0014837274],"category_scores_gemma":[0.001655911,0.000109988105,0.00017104443,0.0009786843,0.00029443591,0.00024833117,0.0004689611,0.00032157692,0.00008840141],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023153405,0.0000053101803,0.9983694,0.000009890776,0.000015153777,0.00010319506,0.00019589798,0.000007099737,0.00011468376,0.000014948833,0.00010666423,0.0010347203],"study_design_scores_gemma":[0.0000013365807,0.000009542747,0.9991435,0.000015795511,0.0000072712965,0.00016997475,0.00047946666,0.00002210554,0.00001645841,0.000011061222,0.00012148046,0.0000020133032],"about_ca_topic_score_codex":0.12127925,"about_ca_topic_score_gemma":0.17642629,"teacher_disagreement_score":0.12127925,"about_ca_system_score_codex":0.00097370753,"about_ca_system_score_gemma":0.0010483839,"threshold_uncertainty_score":0.24114662},"labels":[],"label_agreement":null},{"id":"W3185886878","doi":"10.1177/13524585211031801","title":"MRI brain volume loss, lesion burden, and clinical outcome in secondary progressive multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Multiple sclerosis; Expanded Disability Status Scale; Magnetic resonance imaging; Medicine; Logistic regression; Brain size; Physical medicine and rehabilitation; Neuroimaging; Physical therapy; Internal medicine; Psychology; Radiology; Psychiatry","score_opus":0.17610571536707592,"score_gpt":0.37490502779668583,"score_spread":0.1987993124296099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185886878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99857056,0.000762759,0.000060479717,0.0000704026,0.000005727445,0.000008177909,0.00014687428,0.0000047693993,0.00037022075],"genre_scores_gemma":[0.9995491,0.00009926352,0.00005496583,0.000013389244,0.000012003667,0.000007668563,0.00015316442,0.0000011032072,0.00010927821],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99948287,0.00022272237,0.000057400055,0.00006451004,0.00011855078,0.00005394448],"domain_scores_gemma":[0.99540734,0.0010791115,0.0024431907,0.00021243736,0.0003235069,0.0005344563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017307799,0.00025153358,0.00033447848,0.0006558926,0.00018989659,0.00032225365,0.00025767184,0.0003379936,0.0015284357],"category_scores_gemma":[0.0057074064,0.000089611036,0.00033270798,0.00045530548,0.00028730897,0.0002968153,0.0003398081,0.0005374433,0.0002905498],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017940993,0.00018479732,0.9920133,0.00004648957,0.0001703503,0.00011180532,0.0000653689,0.00021154934,0.00048579357,0.000018398057,0.00015393728,0.0047439835],"study_design_scores_gemma":[0.000020073132,0.00045359894,0.99879956,0.000007709468,0.000031721487,0.00024341211,0.000019685689,0.0002024322,0.000107338405,0.000043310112,0.00006874232,0.0000023942728],"about_ca_topic_score_codex":0.0012007505,"about_ca_topic_score_gemma":0.001269596,"teacher_disagreement_score":0.0017307799,"about_ca_system_score_codex":0.00025871486,"about_ca_system_score_gemma":0.00021335778,"threshold_uncertainty_score":0.009153366},"labels":[],"label_agreement":null},{"id":"W3190031979","doi":"10.1177/13524585211032803","title":"CONCERTO: A randomized, placebo-controlled trial of oral laquinimod in relapsing-remitting multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Pediatric health and respiratory diseases","field":"Health Professions","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Placebo; Clinical endpoint; Tolerability; Multiple sclerosis; Hazard ratio; Adverse effect; Randomized controlled trial; Internal medicine; Confidence interval; Surgery; Anesthesia; Pathology; Immunology","score_opus":0.13549377302478785,"score_gpt":0.36847004121873417,"score_spread":0.23297626819394632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3190031979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9706171,0.01565315,0.00095072173,0.0012203668,0.0014147311,0.003975353,0.0024281163,0.0003163587,0.0034239644],"genre_scores_gemma":[0.9769314,0.005955192,0.0026370038,0.0017174176,0.0011747231,0.005712128,0.0019360681,0.000042627464,0.0038934036],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994997,0.00026138467,0.00003935521,0.00009405434,0.000047249046,0.000058269045],"domain_scores_gemma":[0.9991499,0.00018240772,0.00025581085,0.000066798915,0.000053430973,0.00029150504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017999362,0.0014779859,0.0024558136,0.00045496254,0.00045182154,0.0010530049,0.00079899223,0.0015325046,0.0065376423],"category_scores_gemma":[0.0016287628,0.0005390628,0.0015341034,0.0002789938,0.00094478653,0.0007420824,0.00047972117,0.002110232,0.00075867295],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9853424,0.0018599553,0.00031560162,0.00078558445,0.0006891917,0.000028353235,0.000027900698,0.00013854321,0.0034845073,0.00010481234,0.0005979079,0.0066252123],"study_design_scores_gemma":[0.9672368,0.029352412,0.0014662767,0.000041590527,0.00052443,0.000028116692,0.000013302605,0.00019842376,0.00032860006,0.00006405677,0.00073383865,0.000012145496],"about_ca_topic_score_codex":0.00069108955,"about_ca_topic_score_gemma":0.0014032319,"teacher_disagreement_score":0.0065376423,"about_ca_system_score_codex":0.0004804808,"about_ca_system_score_gemma":0.00083631143,"threshold_uncertainty_score":0.021870613},"labels":[],"label_agreement":null},{"id":"W3190957947","doi":"10.1177/13524585211035740","title":"Ocrelizumab treatment for relapsing-remitting multiple sclerosis after a suboptimal response to previous disease-modifying therapy: A nonrandomized controlled trial","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Ocrelizumab; Multiple sclerosis; Internal medicine; Clinical trial; Population; Relapsing remitting; Magnetic resonance imaging; Disease; Lesion; Oncology; Surgery; Radiology; Immunology; Rituximab","score_opus":0.1405478466227287,"score_gpt":0.33812543360792224,"score_spread":0.19757758698519354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3190957947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98313403,0.010171666,0.000622197,0.00047693308,0.00043506912,0.0036308388,0.0005025977,0.000060069004,0.0009666847],"genre_scores_gemma":[0.99014825,0.0035016963,0.0010341518,0.00061623566,0.0004440061,0.003073215,0.0003994464,0.000010586738,0.00077229016],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9982181,0.0011748772,0.00014426855,0.00021682444,0.00011501883,0.00013084688],"domain_scores_gemma":[0.99796766,0.0007281611,0.00063157507,0.00022754578,0.0001818924,0.000263107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041555553,0.0010487795,0.0025251785,0.00033958978,0.0004331153,0.0010044904,0.000676555,0.001655471,0.002793149],"category_scores_gemma":[0.0036528427,0.00041742378,0.0022448876,0.00041913876,0.00094653486,0.0006181125,0.0003285705,0.001363378,0.00045738762],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9787764,0.003842926,0.0016020723,0.0009429722,0.0023113342,0.00004876222,0.000042632484,0.00017548332,0.0011944672,0.00008058783,0.00036139062,0.010621091],"study_design_scores_gemma":[0.95408565,0.041686475,0.0023337197,0.00005630076,0.00088508177,0.000044632216,0.000012206563,0.0002601881,0.00017775163,0.00007661812,0.00037295988,0.000008431671],"about_ca_topic_score_codex":0.0006389871,"about_ca_topic_score_gemma":0.0011726795,"teacher_disagreement_score":0.0041555553,"about_ca_system_score_codex":0.0006208633,"about_ca_system_score_gemma":0.0010658148,"threshold_uncertainty_score":0.021976948},"labels":[],"label_agreement":null},{"id":"W3193036633","doi":"10.1177/13524585211034826","title":"White matter microstructural differences in children and genetic risk for multiple sclerosis: A population-based study","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; Olav Thon Stiftelsen; IXICO; H. Lundbeck A/S; Genentech; Vlaamse regering; Innovative Medicines Initiative; University College London Hospitals NHS Foundation Trust; Vetenskapsrådet; Eisai; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; Fonds Wetenschappelijk Onderzoek; Servier; Stichting MS Research; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Research Foundation; UK Dementia Research Institute; European Federation of Pharmaceutical Industries and Associations; National Institute on Aging; National Institute for Health and Care Research; Northern California Institute for Research and Education; Pfizer; Biogen; BioClinica; Alzheimer's Drug Discovery Foundation; ZonMw; Universiteit Antwerpen; Alzheimer's Association; Stiftelsen för Gamla Tjänarinnor; Hjärnfonden; European Commission; Familjen Erling-Perssons Stiftelse; University of Southern California; Novartis Pharmaceuticals Corporation; Eusko Jaurlaritza; U.S. Department of Defense; Eli Lilly and Company; Bristol-Myers Squibb; F. Hoffmann-La Roche; Alzheimer's Disease Neuroimaging Initiative; Meso Scale Diagnostics; Foundation for the National Institutes of Health","keywords":"Fractional anisotropy; Corpus callosum; White matter; Diffusion MRI; Multiple sclerosis; Population; Medicine; Magnetic resonance imaging; Pathology; Radiology; Psychiatry","score_opus":0.060965245182280026,"score_gpt":0.282307210293065,"score_spread":0.22134196511078497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193036633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995011,0.00006612852,0.000049609902,0.000015538932,0.000001785918,0.0000061784017,0.00023889114,0.0000030912151,0.00011770991],"genre_scores_gemma":[0.9992816,0.00010515773,0.00013466217,0.00001547023,0.000006417196,0.000015454229,0.0003449499,0.0000039302054,0.00009246867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994006,0.00012054495,0.000062851555,0.00022478876,0.00012604854,0.00006514259],"domain_scores_gemma":[0.99878067,0.00023473502,0.0005888932,0.00011955764,0.00011260368,0.00016357198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074506167,0.00065078,0.0005961319,0.0016245975,0.0007072452,0.00071942195,0.0004513184,0.00089522277,0.0017564914],"category_scores_gemma":[0.002386896,0.0005790245,0.0005844496,0.001801244,0.00060565356,0.0006682933,0.00057125936,0.00067304424,0.00032917404],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006520043,0.000033390672,0.9986733,0.000006751302,0.00007156033,0.00016584445,0.00017859305,0.000029067727,0.00024035646,0.000013666831,0.000045180506,0.0004770582],"study_design_scores_gemma":[0.000005726743,0.0000816776,0.99906915,0.0000039034862,0.000033413147,0.0004958227,0.00014580949,0.00004590944,0.000034966823,0.000012356619,0.00006835727,0.0000030162332],"about_ca_topic_score_codex":0.008357398,"about_ca_topic_score_gemma":0.006574108,"teacher_disagreement_score":0.008357398,"about_ca_system_score_codex":0.00040427851,"about_ca_system_score_gemma":0.0003077915,"threshold_uncertainty_score":0.016617537},"labels":[],"label_agreement":null},{"id":"W3195795521","doi":"10.1177/13524585211014459","title":"Do isolated cognitive relapses exist? – No","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Multiple sclerosis; Cognition; Medicine; Immunology; Psychiatry","score_opus":0.12194201583929307,"score_gpt":0.3292829252593618,"score_spread":0.20734090942006875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195795521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7974263,0.097643524,0.0014570805,0.060621668,0.003190181,0.00012521679,0.0026043057,0.00009246001,0.03683931],"genre_scores_gemma":[0.97933686,0.008005968,0.00053667906,0.007852976,0.00201975,0.00004898484,0.000864666,0.000028807688,0.0013053888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99462944,0.0018964104,0.0009034279,0.0013087621,0.0006917468,0.00057034375],"domain_scores_gemma":[0.9604627,0.016996533,0.010203455,0.006702456,0.0037901176,0.0018448003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0121272905,0.00033509705,0.0013730584,0.0019650578,0.0013134367,0.0031907263,0.0017419611,0.0024326167,0.011282428],"category_scores_gemma":[0.04029575,0.00053239847,0.0013414545,0.0026431708,0.0027904622,0.005968485,0.0018648437,0.002351333,0.0013429993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004478065,0.0007887845,0.7023311,0.0046003605,0.007705509,0.0018672141,0.0043138727,0.00016429156,0.00049027917,0.011431165,0.03096141,0.23086782],"study_design_scores_gemma":[0.0005698435,0.0006549602,0.906884,0.004090793,0.004083808,0.006018016,0.010595547,0.00042561922,0.00039984923,0.026009236,0.04008021,0.00018814148],"about_ca_topic_score_codex":0.006140888,"about_ca_topic_score_gemma":0.009694902,"teacher_disagreement_score":0.0121272905,"about_ca_system_score_codex":0.0009872458,"about_ca_system_score_gemma":0.0015048769,"threshold_uncertainty_score":0.06413603},"labels":[],"label_agreement":null},{"id":"W3196329862","doi":"10.1177/13524585211037909","title":"Long-term safety and efficacy of dimethyl fumarate for up to 13 years in patients with relapsing-remitting multiple sclerosis: Final ENDORSE study results","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"Biogen","keywords":"Dimethyl fumarate; Medicine; Multiple sclerosis; Relapsing remitting; Adverse effect; Placebo; Confidence interval; Internal medicine; Relative risk; Gastroenterology; Pediatrics; Psychiatry; Pathology; Alternative medicine","score_opus":0.10069297423574002,"score_gpt":0.31201764632132717,"score_spread":0.21132467208558714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196329862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985655,0.010117391,0.0003319268,0.00038606144,0.000048730162,0.00017543032,0.0015954905,0.000026887057,0.0016629453],"genre_scores_gemma":[0.99679667,0.0010775581,0.00034550607,0.00016230262,0.00006104392,0.000075511925,0.0010273359,0.0000049269033,0.00044920805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99739563,0.0014605863,0.00022659854,0.0003022678,0.00044008534,0.0001748488],"domain_scores_gemma":[0.9907392,0.002795165,0.003814465,0.00087624526,0.0010141636,0.0007607472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011331471,0.00058961107,0.0018150815,0.00030812353,0.00037838134,0.00084865635,0.000505899,0.00071067613,0.0014118495],"category_scores_gemma":[0.0069165085,0.00028600343,0.0016623456,0.00037723762,0.00043045633,0.00074509607,0.00065035804,0.0011607757,0.00025958457],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29637855,0.0025222013,0.5217926,0.0024893708,0.015426607,0.0002849969,0.00068079657,0.0016338737,0.006341832,0.00028668635,0.0035005908,0.14866187],"study_design_scores_gemma":[0.039665096,0.09482066,0.8391556,0.0004187978,0.010536591,0.00080176425,0.00029883182,0.001515538,0.0040158546,0.00030646825,0.008356281,0.000108538974],"about_ca_topic_score_codex":0.00074796024,"about_ca_topic_score_gemma":0.00196702,"teacher_disagreement_score":0.011331471,"about_ca_system_score_codex":0.0005401884,"about_ca_system_score_gemma":0.00046609435,"threshold_uncertainty_score":0.059927225},"labels":[],"label_agreement":null},{"id":"W3196759432","doi":"10.1177/13524585211041108","title":"Risk factors for peripartum depression in women with multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Toronto; St. Michael's Hospital","funders":"National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Depression (economics); Medicine; Psychiatry; Psychology; Physical medicine and rehabilitation","score_opus":0.09636819362826436,"score_gpt":0.29667640407320645,"score_spread":0.20030821044494207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196759432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954608,0.003296766,0.000112900656,0.00029536494,0.000017773027,0.000009026683,0.00024873787,0.0000072532753,0.0005513901],"genre_scores_gemma":[0.9990484,0.00062500424,0.00009099422,0.00004630568,0.000018111614,0.000007099432,0.00009028334,0.0000011777806,0.00007267933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99973816,0.00008821856,0.000031039628,0.00004915374,0.000051715673,0.000041770694],"domain_scores_gemma":[0.9988123,0.0002778911,0.0006484205,0.000048981274,0.00007548897,0.00013689575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046431902,0.00017177206,0.0002754424,0.00048046347,0.00033866128,0.00036713496,0.00023273431,0.00034128773,0.0011330573],"category_scores_gemma":[0.0028740186,0.00018714552,0.00034759426,0.00072739366,0.00019967754,0.0002312133,0.0002789438,0.00063473557,0.00012268804],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003619532,0.000008878838,0.99831533,0.00000850896,0.000019156665,0.00009802503,0.00003045505,0.000009180519,0.00004863414,0.0000063912,0.000056468423,0.0013627508],"study_design_scores_gemma":[0.0000036531587,0.00005840535,0.9986355,0.000020198426,0.000029067793,0.0008847072,0.000100882105,0.00009961575,0.000021929282,0.000022074313,0.00012191043,0.00000208965],"about_ca_topic_score_codex":0.002925662,"about_ca_topic_score_gemma":0.0037934124,"teacher_disagreement_score":0.002925662,"about_ca_system_score_codex":0.00019617478,"about_ca_system_score_gemma":0.0002466772,"threshold_uncertainty_score":0.0058172345},"labels":[],"label_agreement":null},{"id":"W3198279588","doi":"10.1177/13524585211017020","title":"Slowly expanding lesions are a marker of progressive MS – No","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"","keywords":"Multiple sclerosis; Medicine; Pathology; Neuroscience; Psychology; Psychiatry","score_opus":0.11723377009200073,"score_gpt":0.3338459565445452,"score_spread":0.21661218645254446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198279588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991631,0.0020431885,0.00022883096,0.00009514309,0.000032433814,0.000029046822,0.00023050168,0.000016885613,0.0056929607],"genre_scores_gemma":[0.99808335,0.00035209034,0.0002703463,0.000024192757,0.000045015113,0.000007410729,0.00019080541,0.0000036802069,0.0010231308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999383,0.00022510014,0.000076880424,0.000091553404,0.00015728678,0.000066255925],"domain_scores_gemma":[0.99425983,0.001240658,0.002900763,0.00033483029,0.0006255018,0.00063847774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013787105,0.0004115141,0.0004522016,0.0017518679,0.00038696264,0.00092169136,0.000359896,0.00059099623,0.002511595],"category_scores_gemma":[0.0046032537,0.00019938093,0.00024995668,0.0009068357,0.0005182484,0.0006897847,0.0003904836,0.00072419713,0.0004528998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004325088,0.00031875022,0.95826566,0.00026706592,0.000209981,0.0010761083,0.000528223,0.00012962661,0.02006127,0.0003933588,0.00031256746,0.014112281],"study_design_scores_gemma":[0.000024646382,0.00071318203,0.99373263,0.000028479737,0.000113875496,0.0017829126,0.00022963503,0.00014204373,0.0017422553,0.00026109006,0.0012194976,0.00000983389],"about_ca_topic_score_codex":0.0012073048,"about_ca_topic_score_gemma":0.001435286,"teacher_disagreement_score":0.002511595,"about_ca_system_score_codex":0.00023062149,"about_ca_system_score_gemma":0.0003301244,"threshold_uncertainty_score":0.008402109},"labels":[],"label_agreement":null},{"id":"W3198414947","doi":"10.1177/13524585211035951","title":"The multiple sclerosis prodrome is just unspecific symptoms in radiologically isolated syndrome patients – No","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital","funders":"Alcon; Biogen; EMD Serono; Novartis; Genzyme","keywords":"Prodrome; Multiple sclerosis; Medicine; Clinically isolated syndrome; Pediatrics; Psychiatry; Psychosis","score_opus":0.09516910512073876,"score_gpt":0.279761138026281,"score_spread":0.18459203290554224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198414947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852058,0.0030529753,0.00013694893,0.0007891392,0.00014082438,0.000021713355,0.00020687509,0.000015215299,0.010430437],"genre_scores_gemma":[0.99787664,0.0005712592,0.00012744231,0.00025844737,0.00016350969,0.0000073784713,0.00020597067,0.0000048064485,0.00078449136],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996244,0.000073581105,0.00006448325,0.00007742521,0.00008807361,0.00007206053],"domain_scores_gemma":[0.9989405,0.00029216753,0.00029990554,0.00008673152,0.00018150578,0.0001991942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051405106,0.00041141373,0.00058081286,0.0008230983,0.0006170742,0.00061526394,0.00031928334,0.0007582306,0.0056143133],"category_scores_gemma":[0.0027830072,0.00018691117,0.00034309796,0.0005067881,0.0005164187,0.0009861351,0.00031069698,0.00067564455,0.0009742002],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038486486,0.0005049417,0.9093768,0.0005177552,0.00022809525,0.013124261,0.0010248573,0.00009590954,0.015378249,0.00058566383,0.0026150437,0.05269968],"study_design_scores_gemma":[0.00012173704,0.0011486656,0.96015364,0.0001232289,0.00015736224,0.030779144,0.000793628,0.00010017722,0.0016116927,0.000664049,0.004321443,0.000025285179],"about_ca_topic_score_codex":0.0009699275,"about_ca_topic_score_gemma":0.0014306369,"teacher_disagreement_score":0.0056143133,"about_ca_system_score_codex":0.00028378647,"about_ca_system_score_gemma":0.0004172414,"threshold_uncertainty_score":0.018781722},"labels":[],"label_agreement":null},{"id":"W3201723867","doi":"10.1177/13524585211049986","title":"Prediction of multiple sclerosis outcomes when switching to ocrelizumab","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Cegep de Saint Jerome","funders":"Novartis Pharma; Sanofi Genzyme; EMD Serono; Dokuz Eylül Üniversitesi; University of Tasmania; Multiple Sclerosis Society of Canada; Canadian Institutes of Health Research; Teva Pharmaceutical Industries; Biogen; Celgene; Sanofi","keywords":"Ocrelizumab; Multiple sclerosis; Medicine; Clinical neurology; Internal medicine; Psychology; Neuroscience; Immunology","score_opus":0.17819417445610608,"score_gpt":0.30784838709603873,"score_spread":0.12965421263993265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201723867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992685,0.00015494764,0.00005810138,0.000060018825,0.000004966232,0.0000036930094,0.00019001501,0.0000036328777,0.00025615568],"genre_scores_gemma":[0.99947387,0.00005359014,0.000051075727,0.000013895486,0.0000090239255,0.0000030241217,0.00031064008,0.0000012938343,0.0000835348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996424,0.00009448117,0.00003319784,0.00009366227,0.000067948335,0.00006830165],"domain_scores_gemma":[0.99719197,0.00056084315,0.001581574,0.00012423111,0.00019206386,0.00034927062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009645011,0.00028223044,0.0002826882,0.00041613635,0.0001915087,0.0005597496,0.00024698832,0.0003884144,0.0018599568],"category_scores_gemma":[0.0038457667,0.00012372826,0.00062051043,0.00037681925,0.00015869174,0.00036640718,0.00037757566,0.00069182465,0.00024360999],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035087066,0.000036654284,0.9973367,0.000006586534,0.000035476038,0.0000270485,0.000019445588,0.00013530611,0.000112888825,0.000008007601,0.00008068547,0.0018502065],"study_design_scores_gemma":[0.000021550257,0.00017687284,0.99828315,0.00001012598,0.000052342337,0.00017440958,0.000048690486,0.0009313503,0.00012289984,0.000040606414,0.0001346502,0.0000033572924],"about_ca_topic_score_codex":0.0018355525,"about_ca_topic_score_gemma":0.0015817825,"teacher_disagreement_score":0.0018599568,"about_ca_system_score_codex":0.00024063115,"about_ca_system_score_gemma":0.00029175114,"threshold_uncertainty_score":0.0062221885},"labels":[],"label_agreement":null},{"id":"W3203173550","doi":"10.1177/13524585211048397","title":"Cardiorespiratory fitness and free-living physical activity are not associated with cognition in persons with progressive multiple sclerosis: Baseline analyses from the CogEx study","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Multiple Sclerosis Society of Canada","keywords":"Cardiorespiratory fitness; Multiple sclerosis; Physical activity; Cognition; Baseline (sea); Medicine; Physical therapy; Gerontology; Physical medicine and rehabilitation; Physical fitness; Psychology; Psychiatry; Biology","score_opus":0.19073963861643262,"score_gpt":0.33986981178646947,"score_spread":0.14913017317003685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203173550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988298,0.00029900644,0.0000551985,0.000033005064,0.0000055028595,0.000012661858,0.000500934,0.0000044572944,0.0002594557],"genre_scores_gemma":[0.9989826,0.00006254018,0.000058529662,0.00002070592,0.00000886255,0.000012771776,0.0007374033,0.0000017894778,0.0001147588],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99955684,0.00012511329,0.000057800928,0.00009931523,0.00009486907,0.00006606413],"domain_scores_gemma":[0.9989838,0.00020354324,0.00033872944,0.00010517483,0.00012496421,0.00024381993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013085827,0.00053146103,0.00056954514,0.0005999746,0.00047179233,0.0007290714,0.00034010218,0.000622917,0.0012082596],"category_scores_gemma":[0.0020178698,0.00029281594,0.0009793988,0.00072250894,0.0002333182,0.00033898104,0.00056154426,0.0006794805,0.00020231032],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074224046,0.00007155429,0.9976525,0.000013867558,0.0003489264,0.000041263116,0.000048658472,0.000050842766,0.00014799809,0.0000073054803,0.000071137954,0.00080378074],"study_design_scores_gemma":[0.000018442064,0.000097571356,0.9996822,0.0000017489651,0.000055454897,0.000026320622,0.000018591883,0.0000433488,0.000012314059,0.0000052464175,0.00003770496,0.0000012031746],"about_ca_topic_score_codex":0.0049639684,"about_ca_topic_score_gemma":0.0066142054,"teacher_disagreement_score":0.0049639684,"about_ca_system_score_codex":0.00023050891,"about_ca_system_score_gemma":0.00027869898,"threshold_uncertainty_score":0.009870112},"labels":[],"label_agreement":null},{"id":"W3204879978","doi":"10.1177/13524585211049397","title":"Interpreting change on the Symbol Digit Modalities Test in people with relapsing multiple sclerosis using the reliable change methodology","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Cognition; Reliability (semiconductor); Psychology; Clinical trial; Raw score; Cognitive decline; Test (biology); Physical therapy; Physical medicine and rehabilitation; Medicine; Audiology; Statistics; Internal medicine; Psychiatry; Disease; Raw data; Mathematics; Power (physics)","score_opus":0.42373511052857754,"score_gpt":0.350789731827612,"score_spread":0.07294537870096557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204879978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98472553,0.00079618813,0.012226919,0.000105008374,0.000026952848,0.0004093507,0.0003068304,0.000037620994,0.0013654606],"genre_scores_gemma":[0.9929598,0.00010931101,0.006505775,0.000031425836,0.000017325112,0.00016392054,0.00013155179,0.000005554782,0.00007529649],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9869358,0.009054671,0.0011888554,0.0006031431,0.002026495,0.00019110764],"domain_scores_gemma":[0.9656611,0.018761389,0.009242348,0.0022416227,0.003754882,0.00033875846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027341837,0.0006102843,0.00050014775,0.0027295803,0.0004063898,0.00097117905,0.0006103872,0.0006334459,0.0006971576],"category_scores_gemma":[0.049631692,0.00019884897,0.0008482489,0.0014378416,0.0007946471,0.0007911273,0.0009597473,0.0006993112,0.0002725789],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007317946,0.00014420888,0.9727003,0.00010573685,0.00024244685,0.00005567579,0.0004132641,0.0005174543,0.0005518576,0.00011234363,0.00016276058,0.024262186],"study_design_scores_gemma":[0.0001410214,0.0032386165,0.9861261,0.00009134806,0.00026174216,0.00056057674,0.00042826962,0.0045456826,0.0030535418,0.00091840065,0.00060008187,0.000034512905],"about_ca_topic_score_codex":0.0007638606,"about_ca_topic_score_gemma":0.0017197873,"teacher_disagreement_score":0.027341837,"about_ca_system_score_codex":0.0003454142,"about_ca_system_score_gemma":0.000662958,"threshold_uncertainty_score":0.1445992},"labels":[],"label_agreement":null},{"id":"W3207434524","doi":"10.1177/13524585211026875","title":"Air pollution is a risk factor for multiple sclerosis – No","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Air Quality and Health Impacts","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Multiple sclerosis; Risk factor; Medicine; Air pollution; Environmental health; Environmental science; Internal medicine; Immunology; Chemistry","score_opus":0.13961186234561968,"score_gpt":0.2918916959101515,"score_spread":0.15227983356453184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207434524","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98386776,0.0075215604,0.0004033249,0.00073340116,0.00020160274,0.000017089165,0.00072103617,0.000035118836,0.006499161],"genre_scores_gemma":[0.9964359,0.0012443223,0.0003051455,0.0001071326,0.00022840922,0.0000065199656,0.00036418845,0.0000060413045,0.0013022975],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99948573,0.00014276938,0.000075499105,0.0000897024,0.00013881022,0.00006743909],"domain_scores_gemma":[0.9978276,0.00037105018,0.0008734086,0.00015918935,0.0003792384,0.00038944068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005197939,0.00051399786,0.00050768716,0.0010471427,0.0005483606,0.0009663942,0.00038670175,0.00088839437,0.003887692],"category_scores_gemma":[0.0018980027,0.0002450452,0.0008159606,0.0013964954,0.000303217,0.00042429188,0.000394884,0.00077211135,0.000646641],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059823826,0.00018095197,0.99087536,0.00008125447,0.0003348656,0.00038748517,0.000038291295,0.000034941648,0.0020904823,0.000050946182,0.000255151,0.005072059],"study_design_scores_gemma":[0.000008561814,0.0001683036,0.99770916,0.000017649985,0.00020198704,0.00072960265,0.00006242634,0.00009471087,0.0002381517,0.000128207,0.0006357008,0.0000054025363],"about_ca_topic_score_codex":0.004233573,"about_ca_topic_score_gemma":0.0032306968,"teacher_disagreement_score":0.004233573,"about_ca_system_score_codex":0.00020417142,"about_ca_system_score_gemma":0.000365417,"threshold_uncertainty_score":0.013005614},"labels":[],"label_agreement":null},{"id":"W3213370463","doi":"10.1177/13524585211055787","title":"Administrative data for observational research in multiple sclerosis: Opportunities and challenges","year":2021,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Medical Coding and Health Information","field":"Health Professions","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Multiple sclerosis; Observational study; Medicine; MEDLINE; Data science; Physical medicine and rehabilitation; Computer science; Psychiatry; Political science; Pathology","score_opus":0.9765090372684502,"score_gpt":0.5564637936436005,"score_spread":0.42004524362484963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213370463","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038484943,0.009152201,0.0077457316,0.9622834,0.009401758,0.00019831501,0.004482556,0.0001525967,0.0027349885],"genre_scores_gemma":[0.10172346,0.024203874,0.08847239,0.7080624,0.06340513,0.0026953851,0.008148461,0.00039762564,0.0028912143],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.58522373,0.30154586,0.05952864,0.0073987423,0.042563178,0.0037398667],"domain_scores_gemma":[0.08731865,0.80972016,0.022713449,0.027978051,0.04565073,0.0066190395],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.2650798,0.0008475371,0.003591189,0.0060784323,0.0045822826,0.011412238,0.010310372,0.0173502,0.0047659106],"category_scores_gemma":[0.63976413,0.0017757837,0.0029565052,0.01123525,0.0063675633,0.0153274555,0.008521369,0.018896548,0.0023462377],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051342434,0.0003849493,0.08869749,0.004489653,0.00066539063,0.0008988777,0.0053238487,0.00094681757,0.0004888714,0.05729944,0.68935525,0.15093598],"study_design_scores_gemma":[0.0006392821,0.00033471783,0.06430819,0.022488687,0.0004989748,0.0016231312,0.011072241,0.010347117,0.0007336549,0.17937878,0.70788723,0.00068803015],"about_ca_topic_score_codex":0.03716521,"about_ca_topic_score_gemma":0.04776461,"teacher_disagreement_score":0.7349202,"about_ca_system_score_codex":0.0063020824,"about_ca_system_score_gemma":0.026663058,"threshold_uncertainty_score":0.90628743},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":["metaresearch"],"domain":"methods","study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W3217358002","doi":"10.1177/13524585211059766","title":"Charting a global research strategy for progressive MS—An international progressive MS Alliance proposal","year":2021,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Multiple Sclerosis Society of Canada; Sunnybrook Hospital","funders":"Multiple Sclerosis Society; National Institute for Health and Care Research; International Progressive MS Alliance","keywords":"Alliance; Multiple sclerosis; Political science; Medicine; Psychiatry","score_opus":0.47006041406506316,"score_gpt":0.5162722029167015,"score_spread":0.04621178885163835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217358002","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00068519445,0.50441694,0.01253278,0.421977,0.04641184,0.0042481143,0.00066075235,0.00034438106,0.008723025],"genre_scores_gemma":[0.012852085,0.5951913,0.1453987,0.21109268,0.012474238,0.00983227,0.0024528492,0.00017778637,0.01052799],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9563015,0.022275573,0.009015527,0.0017471261,0.008389214,0.0022709104],"domain_scores_gemma":[0.9236742,0.031563092,0.008453655,0.0034708807,0.025888411,0.006949694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.13197267,0.0025495503,0.004645141,0.010597173,0.0021949105,0.01036286,0.0061940644,0.016931232,0.005733529],"category_scores_gemma":[0.070455596,0.0014999527,0.007841582,0.008177287,0.0048327018,0.022049028,0.01161815,0.01723793,0.003890213],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038977643,0.00045625315,0.00090465037,0.09008301,0.00070534745,0.00066582265,0.0021032828,0.0012645972,0.0022494544,0.12239846,0.3300901,0.44868925],"study_design_scores_gemma":[0.00024956546,0.00022838208,0.0010410319,0.068031184,0.0006376726,0.00041506294,0.001059915,0.000374821,0.00034624618,0.026137289,0.90139586,0.00008292207],"about_ca_topic_score_codex":0.0046093403,"about_ca_topic_score_gemma":0.004332559,"teacher_disagreement_score":0.13197267,"about_ca_system_score_codex":0.009806357,"about_ca_system_score_gemma":0.12235693,"threshold_uncertainty_score":0.69794655},"labels":[],"label_agreement":null},{"id":"W4200021580","doi":"10.1177/13524585211063403","title":"Disease-modifying drugs for multiple sclerosis and subsequent health service use","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University; University of Calgary; University of Manitoba; University of Alberta; University of Saskatchewan; Alberta Health Services; University of British Columbia Hospital; Saskatchewan Health Quality Council; University of British Columbia","funders":"Canadian Institutes of Health Research; Agency for Healthcare Research and Quality","keywords":"Medicine; Fingolimod; Multiple sclerosis; Hazard ratio; Confidence interval; Medical prescription; Population; Proportional hazards model; Teriflunomide; Disease; Pediatrics; Internal medicine; Environmental health; Psychiatry","score_opus":0.2395934882397914,"score_gpt":0.34361747662807185,"score_spread":0.10402398838828045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200021580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880414,0.0027294485,0.00009024109,0.0004508162,0.000015988491,0.000035003475,0.006214981,0.000013447968,0.0024087033],"genre_scores_gemma":[0.99783105,0.000504368,0.000077172605,0.00005748714,0.000010738757,0.000008277268,0.0011276725,0.0000015518286,0.0003817613],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99928087,0.0000930782,0.000070856906,0.00008861887,0.00026463496,0.00020189317],"domain_scores_gemma":[0.99783427,0.00019463389,0.0013078941,0.000057925,0.00033058017,0.0002747111],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054277544,0.00020254093,0.00026272883,0.000646915,0.00041034634,0.00056753797,0.00048094869,0.0003249863,0.002326194],"category_scores_gemma":[0.0030424064,0.00014307366,0.0005964456,0.0015886448,0.0001883237,0.0002176216,0.00033885083,0.0007234573,0.00020220153],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009328041,0.00003110707,0.99710244,0.00003594837,0.00012192891,0.000025614445,0.00003347189,0.000051277108,0.000065965425,0.00002362181,0.00023041066,0.0021848176],"study_design_scores_gemma":[0.0000036367742,0.000023009947,0.99940383,0.000014605717,0.00003269559,0.0000502125,0.000029164852,0.000103712824,0.000024283469,0.0000062222944,0.00030639523,0.0000021376557],"about_ca_topic_score_codex":0.5073479,"about_ca_topic_score_gemma":0.5656822,"teacher_disagreement_score":0.5073479,"about_ca_system_score_codex":0.0028999932,"about_ca_system_score_gemma":0.0030904764,"threshold_uncertainty_score":0.99110687},"labels":[],"label_agreement":null},{"id":"W4200247492","doi":"10.1177/13524585211063623","title":"Impact of clinical outcomes and imaging measures on health-related quality of life in secondary progressive MS","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Context (archaeology); Quality of life (healthcare); Expanded Disability Status Scale; Logistic regression; Medicine; Clinical trial; Multiple sclerosis; Physical therapy; Modalities; Physical medicine and rehabilitation; Psychology; Internal medicine; Psychiatry","score_opus":0.27832148381240585,"score_gpt":0.46042742203661463,"score_spread":0.18210593822420879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200247492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841166,0.012052365,0.00042502335,0.0007134036,0.00007485349,0.00018881785,0.0006813825,0.000010917361,0.0017366686],"genre_scores_gemma":[0.9981845,0.00065946014,0.00031380236,0.00012139522,0.000075772485,0.00015915929,0.0003620475,0.0000028166667,0.00012105222],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98713905,0.0088988645,0.0011049254,0.0005724321,0.0017686632,0.0005159945],"domain_scores_gemma":[0.9598919,0.023118742,0.012051813,0.00079469825,0.0019534759,0.0021892772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019327223,0.00057304447,0.0014642801,0.0009882028,0.0003087705,0.0011032053,0.000367023,0.0006259609,0.0020257756],"category_scores_gemma":[0.026962552,0.00012227354,0.0025255878,0.0010186242,0.0006350045,0.00069421023,0.00083691924,0.0012020688,0.00023937854],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028550038,0.0016600125,0.91427135,0.0011454965,0.00501752,0.000079939986,0.00015840455,0.0010904234,0.000491666,0.00018096062,0.00057419646,0.04677997],"study_design_scores_gemma":[0.0008851673,0.015035457,0.979507,0.00027625612,0.0015910941,0.00019961652,0.00008562203,0.00087905815,0.00049053406,0.00023820603,0.0007877831,0.000024167575],"about_ca_topic_score_codex":0.00050755794,"about_ca_topic_score_gemma":0.0008295873,"teacher_disagreement_score":0.019327223,"about_ca_system_score_codex":0.0006828438,"about_ca_system_score_gemma":0.0008930673,"threshold_uncertainty_score":0.10221332},"labels":[],"label_agreement":null},{"id":"W4200597408","doi":"10.1177/13524585211061335","title":"Autoimmunity and long-term safety and efficacy of alemtuzumab for multiple sclerosis: Benefit/risk following review of trial and post-marketing data","year":2021,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"bluebird bio; Wellcome Trust; National Institute for Health and Care Research; Sanofi","keywords":"Alemtuzumab; Autoimmunity; Multiple sclerosis; Medicine; Immunology; Adverse effect; Autoimmune disease; Disease; Internal medicine; Antibody","score_opus":0.23129013255489264,"score_gpt":0.3909515843284551,"score_spread":0.15966145177356247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200597408","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014472695,0.99946743,0.000032082065,0.0001160887,0.00005822512,0.000015461203,0.000037678565,0.0000020995824,0.0001262308],"genre_scores_gemma":[0.0016016877,0.9979595,0.000116943964,0.0001566137,0.000044051663,0.000018249115,0.00003788791,0.0000013484847,0.00006376982],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9986463,0.000367514,0.00047170342,0.00013263743,0.0003430832,0.000038750437],"domain_scores_gemma":[0.9929952,0.004815159,0.0011703197,0.00010695885,0.00083194167,0.00008035968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038582508,0.0007445066,0.003456142,0.0033963784,0.00020188116,0.0014223929,0.0011497511,0.0009651493,0.0022703663],"category_scores_gemma":[0.010244249,0.00039557272,0.002260115,0.0044927523,0.00043456466,0.0011637349,0.0005689958,0.0009943845,0.0004560389],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061485847,0.000035675,0.00043728584,0.39067322,0.003221259,0.00015274853,0.00015515693,0.00021436388,0.00088740385,0.0011047848,0.011594366,0.5909088],"study_design_scores_gemma":[0.00047732098,0.0008770774,0.008825515,0.45934457,0.034453664,0.0017467313,0.00036586987,0.0002817376,0.0011805929,0.002379461,0.4899624,0.00010509572],"about_ca_topic_score_codex":0.0016533447,"about_ca_topic_score_gemma":0.0041335775,"teacher_disagreement_score":0.0038582508,"about_ca_system_score_codex":0.0012366617,"about_ca_system_score_gemma":0.0025570334,"threshold_uncertainty_score":0.020404637},"labels":[],"label_agreement":null},{"id":"W4206659757","doi":"10.1177/13524585211061861","title":"Body mass index as a predictor of MS activity and progression among participants in BENEFIT","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"National Institute of Neurological Disorders and Stroke; Deutsche Forschungsgemeinschaft; Multiple Sclerosis Society; National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Body mass index; Obesity; Clinical neurology; Physical activity; Young adult","score_opus":0.08401648301470017,"score_gpt":0.33218769735216047,"score_spread":0.2481712143374603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206659757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991806,0.0003521537,0.00003610725,0.000055605287,0.000007720667,0.0000051434254,0.00011761136,0.0000019914555,0.00024295962],"genre_scores_gemma":[0.99967253,0.000076726086,0.000028592132,0.00001465631,0.000010830255,0.0000044342487,0.00011767139,9.240098e-7,0.00007367158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997397,0.00008547173,0.000020894413,0.000048760365,0.000052402665,0.000052735046],"domain_scores_gemma":[0.99866307,0.0003715617,0.0004570178,0.000046849214,0.00008825819,0.0003733295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090266514,0.00022640222,0.000311179,0.0005645679,0.00028081058,0.0005047844,0.0002101334,0.0003908024,0.002035211],"category_scores_gemma":[0.00243469,0.00011960462,0.00041257328,0.00052723085,0.00017587902,0.00029845856,0.00037907076,0.0006436973,0.00018728546],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034829095,0.00002454977,0.9983088,0.0000068740096,0.000039177256,0.000021718655,0.000024858304,0.0000149285215,0.000095254545,0.000006426589,0.000041055533,0.0010680561],"study_design_scores_gemma":[0.000012332818,0.00016068814,0.9993754,0.000006135434,0.000051711795,0.00008460462,0.0000611122,0.00011861594,0.00002339068,0.00001768739,0.00008695898,0.0000013064114],"about_ca_topic_score_codex":0.0014929425,"about_ca_topic_score_gemma":0.0015842664,"teacher_disagreement_score":0.002035211,"about_ca_system_score_codex":0.0001143712,"about_ca_system_score_gemma":0.00019716189,"threshold_uncertainty_score":0.0068084},"labels":[],"label_agreement":null},{"id":"W4210827259","doi":"10.1177/13524585211069070","title":"Productivity loss among people with early multiple sclerosis: A Canadian study","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; University of Toronto; Centre for Advancing Health Outcomes; St. Michael's Hospital; University of Calgary; St. Paul's Hospital; University of British Columbia","funders":"Government of Alberta; Biogen Idec; Multiple Sclerosis Society of Canada; Fondation Brain Canada; Roche","keywords":"Presenteeism; Absenteeism; Productivity; Work productivity; Medicine; Demography; Psychology; Economics","score_opus":0.07662898989530774,"score_gpt":0.2656726939159828,"score_spread":0.18904370402067505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210827259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933088,0.0009305823,0.00009807779,0.00031059003,0.000011353111,0.00007527591,0.0037050212,0.000005580712,0.0015546083],"genre_scores_gemma":[0.99709165,0.00077238586,0.00014670865,0.00010810163,0.000007524801,0.000026471289,0.0013497358,0.0000025151762,0.0004949093],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993051,0.000042076303,0.000042404852,0.00008632739,0.00030810214,0.00021604077],"domain_scores_gemma":[0.9987369,0.000053495292,0.00025299902,0.000038995222,0.0005838653,0.00033371773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093266217,0.0003939027,0.00049232197,0.0016466375,0.0027963305,0.001132226,0.0009341452,0.00042365247,0.0013376762],"category_scores_gemma":[0.0017991731,0.0003251809,0.0005942406,0.004602056,0.00045389065,0.00051764434,0.000871646,0.0007906623,0.00020498032],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000075669624,0.00006390204,0.99293184,0.00006774978,0.000043239317,0.00010875693,0.000959897,0.00004698035,0.00011828962,0.0000450909,0.0005935139,0.004945051],"study_design_scores_gemma":[0.000008920012,0.000028331526,0.9986299,0.000028485381,0.000016893262,0.00005588268,0.0006876408,0.000094933166,0.00001661582,0.000010994113,0.00041585887,0.000005627718],"about_ca_topic_score_codex":0.98215425,"about_ca_topic_score_gemma":0.98519903,"teacher_disagreement_score":0.01784575,"about_ca_system_score_codex":0.010954347,"about_ca_system_score_gemma":0.014582956,"threshold_uncertainty_score":0.079479754},"labels":[],"label_agreement":null},{"id":"W4210943743","doi":"10.1177/13524585211061521","title":"The health-related quality of life of children with multiple sclerosis is mediated by the health-related quality of life of their parents","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Ontario; University of Toronto; SickKids Foundation; University of Manitoba","funders":"Multiple Sclerosis Scientific Research Foundation","keywords":"Medicine; Quality of life (healthcare); Multiple sclerosis; Health related quality of life; Pediatrics; Disease; Clinical psychology; Psychiatry; Internal medicine","score_opus":0.1579992410503456,"score_gpt":0.33570217654894824,"score_spread":0.17770293549860264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210943743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969127,0.0013022145,0.00024885655,0.0002917608,0.000007848326,0.00000578877,0.00029398853,0.000004973209,0.0009317999],"genre_scores_gemma":[0.9992501,0.0004097184,0.00012020573,0.00001578244,0.0000026288415,0.000003152643,0.00010908853,0.0000011633385,0.00008818241],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99936086,0.00025826544,0.00003125651,0.00007950982,0.00014024356,0.00012992471],"domain_scores_gemma":[0.9977392,0.0005590938,0.0010692244,0.00012727197,0.00024042769,0.0002647531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010391036,0.00031559603,0.00029966634,0.0004519028,0.00041307134,0.0006885742,0.0003631228,0.00018576025,0.0020821404],"category_scores_gemma":[0.004712942,0.00016430354,0.0004642606,0.0004732348,0.0005651865,0.0003769847,0.0005678653,0.00048771646,0.00010906776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042010415,0.000020233587,0.9939984,0.000031201987,0.0001363021,0.0000469596,0.00033642835,0.00017533192,0.00015704516,0.00011369194,0.00012976192,0.0048127365],"study_design_scores_gemma":[0.0000023763203,0.00003746595,0.9988539,0.000026125083,0.00004436222,0.00008935957,0.00028256988,0.00021930199,0.00007590129,0.00008152935,0.00028328004,0.0000037569116],"about_ca_topic_score_codex":0.074864835,"about_ca_topic_score_gemma":0.08268517,"teacher_disagreement_score":0.074864835,"about_ca_system_score_codex":0.0012481718,"about_ca_system_score_gemma":0.0014077546,"threshold_uncertainty_score":0.14885813},"labels":[],"label_agreement":null},{"id":"W4211236523","doi":"10.1177/13524585211069167","title":"Cortical lesion hotspots and association of subpial lesions with disability in multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières; McGill University; Université du Québec à Montréal; Montreal Neurological Institute and Hospital","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health; National Multiple Sclerosis Society","keywords":"Lesion; Multiple sclerosis; Expanded Disability Status Scale; Medicine; White matter; Magnetic resonance imaging; Pathology; Hyperintensity; Radiology","score_opus":0.14036150020807972,"score_gpt":0.30658480126019444,"score_spread":0.16622330105211472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211236523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99961936,0.00014566748,0.000039325667,0.000011276915,8.894146e-7,0.0000039714787,0.000035493813,0.0000034357174,0.00014065465],"genre_scores_gemma":[0.9998293,0.000036381334,0.000041418432,0.0000045737434,0.0000040642644,0.0000026952193,0.00004138444,0.0000010776329,0.000039111696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998313,0.00003571521,0.000019273415,0.000034538083,0.00004532626,0.000033803193],"domain_scores_gemma":[0.99821764,0.0002861402,0.0009998381,0.00008128843,0.00014582604,0.0002692849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030210032,0.0002867846,0.00022200638,0.0012433999,0.00025380866,0.00033533992,0.00020336083,0.00030007286,0.0022537874],"category_scores_gemma":[0.0017497028,0.00021695862,0.00012247647,0.000426845,0.00039058115,0.00024881275,0.00038928757,0.00021833197,0.00027826088],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042869686,0.000040110495,0.99244446,0.000023796365,0.0000574082,0.00039084977,0.000104985775,0.00008292246,0.0031141446,0.000013529593,0.000079170524,0.0032200473],"study_design_scores_gemma":[0.0000052362407,0.00006961608,0.99841976,0.0000023798993,0.000010813609,0.0011630189,0.00003462537,0.000065567685,0.00017686652,0.000019726249,0.00003030716,0.0000019726972],"about_ca_topic_score_codex":0.0018095098,"about_ca_topic_score_gemma":0.0028135427,"teacher_disagreement_score":0.0022537874,"about_ca_system_score_codex":0.0001858871,"about_ca_system_score_gemma":0.00019076059,"threshold_uncertainty_score":0.0075396895},"labels":[],"label_agreement":null},{"id":"W4214570861","doi":"10.1177/13524585221079731","title":"Safety experience with continued exposure to ofatumumab in patients with relapsing forms of multiple sclerosis for up to 3.5 years","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"Novartis Pharma","keywords":"Ofatumumab; Medicine; Adverse effect; Tolerability; Internal medicine; Incidence (geometry); Multiple sclerosis; Teriflunomide; Progressive multifocal leukoencephalopathy; Cumulative incidence; Rituximab; Immunology; Cohort; Fingolimod","score_opus":0.06044288357844394,"score_gpt":0.27766240448708823,"score_spread":0.2172195209086443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214570861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99786985,0.0009984865,0.00012816236,0.0001255001,0.00000955725,0.0000133694775,0.000101112666,0.000005755073,0.0007482599],"genre_scores_gemma":[0.9992194,0.00023477947,0.00006295149,0.00010067691,0.000030097286,0.000008104307,0.00017725465,0.0000017861063,0.00016489916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991505,0.00023930387,0.000095952004,0.00014297366,0.00023148715,0.00013969724],"domain_scores_gemma":[0.9944055,0.0016100366,0.0025335485,0.0002436989,0.00047507338,0.00073207595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017046211,0.00023503743,0.0004930287,0.00025672113,0.00060702063,0.0006598862,0.00022537292,0.00046266866,0.0014146604],"category_scores_gemma":[0.004907678,0.00010774564,0.0007463703,0.00039110426,0.00033664602,0.000435955,0.00044517027,0.00070885586,0.00023468965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004279061,0.00038527788,0.9482628,0.0000978068,0.00033216464,0.0012121439,0.00082276243,0.0003734982,0.0023194393,0.000053729575,0.00034782232,0.041513428],"study_design_scores_gemma":[0.00050883397,0.0125427265,0.9704094,0.000045939843,0.0005998756,0.009348003,0.0003400199,0.0007889965,0.0013242624,0.0001378221,0.0039253277,0.000028826747],"about_ca_topic_score_codex":0.0009963742,"about_ca_topic_score_gemma":0.00084507547,"teacher_disagreement_score":0.0017046211,"about_ca_system_score_codex":0.0005810568,"about_ca_system_score_gemma":0.00045764341,"threshold_uncertainty_score":0.009014964},"labels":[],"label_agreement":null},{"id":"W4214890189","doi":"10.1177/13524585221078497","title":"Emergency department use by persons with MS: A population-based descriptive study with a focus on infection-related visits","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; University of Saskatchewan; Nova Scotia Health Authority; Dalhousie University; University of British Columbia Hospital","funders":"Canadian Institutes of Health Research","keywords":"Emergency department; Medicine; Multiple sclerosis; Emergency medicine; Population; Pediatrics; Environmental health; Immunology; Psychiatry","score_opus":0.04755716566227545,"score_gpt":0.2595398068259643,"score_spread":0.21198264116368884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214890189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99726427,0.0003990974,0.00003510937,0.000055599296,0.0000024386889,0.000021347754,0.0016637029,0.0000034382304,0.00055495015],"genre_scores_gemma":[0.99891865,0.0003010874,0.00004412168,0.00005111293,0.0000053417157,0.000014399709,0.0005318653,0.0000012863703,0.00013221373],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99927765,0.00011079975,0.00011735623,0.0001106209,0.00022461626,0.00015897205],"domain_scores_gemma":[0.9986927,0.0001596084,0.00059385423,0.00004824592,0.0002592136,0.00024645284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038628798,0.00019430206,0.00034342948,0.0014535893,0.00063091086,0.0009038838,0.00048587966,0.0004466005,0.0010104092],"category_scores_gemma":[0.0017556077,0.00032932972,0.00032113577,0.0028040812,0.00029022945,0.00062651746,0.00058051175,0.0005468545,0.00018414925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017503304,0.000019944231,0.9987613,0.00001683639,0.000018721996,0.00005682802,0.00021295139,0.000015938458,0.000045258494,0.000006190821,0.000117953496,0.000710577],"study_design_scores_gemma":[0.0000012927494,0.000017910732,0.9993055,0.000011954262,0.0000053268814,0.00009525222,0.00041514824,0.000037408212,0.0000086237515,0.0000030418853,0.00009616789,0.000002445767],"about_ca_topic_score_codex":0.39326242,"about_ca_topic_score_gemma":0.5121275,"teacher_disagreement_score":0.39326242,"about_ca_system_score_codex":0.0020955717,"about_ca_system_score_gemma":0.0017913535,"threshold_uncertainty_score":0.7819468},"labels":[],"label_agreement":null},{"id":"W4214909359","doi":"10.1177/13524585221075990","title":"Pathways to cures for multiple sclerosis: A research roadmap","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Multiple sclerosis; Medicine; Political science; Public relations; Psychiatry","score_opus":0.3983067987374694,"score_gpt":0.3840609125952333,"score_spread":0.014245886142236097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214909359","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030823033,0.12553434,0.01229226,0.8259638,0.012731514,0.0013196565,0.001428958,0.00058062753,0.017066536],"genre_scores_gemma":[0.10232127,0.4589524,0.20912991,0.18813042,0.010250352,0.007986702,0.009605621,0.00034606407,0.013277249],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.981093,0.010513265,0.0017178294,0.0009991168,0.003360195,0.002316573],"domain_scores_gemma":[0.9054841,0.04247873,0.00396595,0.0025322288,0.028305387,0.017233761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.055758823,0.0022719263,0.001872428,0.0067430027,0.004349802,0.01157798,0.0037310787,0.009872861,0.018815428],"category_scores_gemma":[0.060552876,0.0009529645,0.0039441516,0.0049268547,0.0036037466,0.015517235,0.011009293,0.015576584,0.004907764],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004144404,0.0007722483,0.004394328,0.016945453,0.0003438536,0.00056190277,0.0022669118,0.004801868,0.00084139727,0.11925929,0.40639067,0.44300762],"study_design_scores_gemma":[0.0003036661,0.00090603076,0.004912132,0.02966898,0.00056714227,0.00047129873,0.005461259,0.0021483514,0.00061724614,0.120824955,0.8339233,0.000195643],"about_ca_topic_score_codex":0.0096924715,"about_ca_topic_score_gemma":0.01471711,"teacher_disagreement_score":0.055758823,"about_ca_system_score_codex":0.01111254,"about_ca_system_score_gemma":0.11186825,"threshold_uncertainty_score":0.29488432},"labels":[],"label_agreement":null},{"id":"W4220781181","doi":"10.1177/13524585221085732","title":"Radiologically isolated syndrome and the possibility of preclinical disease activity in aquaporin-4 antibody NMOSD","year":2022,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Multiple sclerosis; Medicine; Antibody; Disease; Aquaporin 4; Immunology; Pathology; Neuroscience; Psychology","score_opus":0.04264261778015071,"score_gpt":0.28190948201065247,"score_spread":0.23926686423050175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220781181","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14725617,0.0072701364,0.0024371494,0.76981384,0.027724095,0.0001445558,0.00044448767,0.0002621527,0.04464749],"genre_scores_gemma":[0.6893469,0.0033315914,0.0025427097,0.1978339,0.09294417,0.000111149246,0.00024019575,0.00011387235,0.013535587],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9990345,0.00026611888,0.0001358101,0.00015166166,0.00020804691,0.00020393908],"domain_scores_gemma":[0.9961785,0.002311367,0.0002137451,0.00018916189,0.0004165864,0.00069066364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012883843,0.0010675788,0.0014305674,0.0014197959,0.001828701,0.0014379334,0.0020968763,0.026756614,0.0023411412],"category_scores_gemma":[0.011877507,0.00071279675,0.0014513307,0.0006304038,0.00232688,0.0022049556,0.000751731,0.0113710705,0.0013103342],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003241119,0.00011928903,0.0060991147,0.00007650707,0.000034444405,0.9443572,0.0001302143,0.00023420097,0.0009894385,0.002340163,0.041805215,0.0034901316],"study_design_scores_gemma":[0.000383703,0.00032749074,0.013018212,0.00019452896,0.00010670086,0.9306706,0.00030554907,0.004750544,0.0014134512,0.008814743,0.03992062,0.00009377265],"about_ca_topic_score_codex":0.0029709716,"about_ca_topic_score_gemma":0.0027970022,"teacher_disagreement_score":0.026756614,"about_ca_system_score_codex":0.0025447009,"about_ca_system_score_gemma":0.001117725,"threshold_uncertainty_score":0.018463194},"labels":[],"label_agreement":null},{"id":"W4220926696","doi":"10.1177/13524585221076717","title":"Effect of siponimod on magnetic resonance imaging measures of neurodegeneration and myelination in secondary progressive multiple sclerosis: Gray matter atrophy and magnetization transfer ratio analyses from the EXPAND phase 3 trial","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"Novartis Pharmaceuticals Corporation","keywords":"Atrophy; White matter; Multiple sclerosis; Magnetic resonance imaging; Magnetization transfer; Medicine; Neurodegeneration; Pathology; Radiology; Disease; Immunology","score_opus":0.0797690790076609,"score_gpt":0.3194440112167253,"score_spread":0.23967493220906438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220926696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935255,0.0032401136,0.00023372409,0.00012200842,0.000039286457,0.0005068871,0.0009616092,0.000048572998,0.0013221962],"genre_scores_gemma":[0.9951139,0.0013005034,0.00060111075,0.00019751284,0.00008133903,0.00067378883,0.0010271478,0.0000124888975,0.0009921832],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996816,0.00016631171,0.000029115618,0.00003725966,0.00004379689,0.000041873143],"domain_scores_gemma":[0.99931836,0.0002129944,0.00020886316,0.000054073524,0.0000597351,0.000146013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015626447,0.00077429967,0.0014789539,0.00027349708,0.00018908859,0.0004547568,0.00028064972,0.00060499506,0.0032527463],"category_scores_gemma":[0.0011615333,0.00019194288,0.0012141232,0.00019679229,0.00032606564,0.0005061559,0.000250984,0.0011810558,0.0003480389],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.85796785,0.005846113,0.0077457945,0.0018930227,0.0038381836,0.0001789989,0.00017404435,0.0014563497,0.027428128,0.00020228526,0.0019400605,0.09132919],"study_design_scores_gemma":[0.36969897,0.48754707,0.116523504,0.00032293942,0.0063013416,0.000560641,0.00011240856,0.0025172608,0.011615756,0.000498416,0.0042316504,0.000070029615],"about_ca_topic_score_codex":0.00028862187,"about_ca_topic_score_gemma":0.0010288493,"teacher_disagreement_score":0.0032527463,"about_ca_system_score_codex":0.00026479494,"about_ca_system_score_gemma":0.00042912012,"threshold_uncertainty_score":0.010881543},"labels":[],"label_agreement":null},{"id":"W4221089070","doi":"10.1177/13524585221079533","title":"Stability of the gut microbiota in persons with paediatric-onset multiple sclerosis and related demyelinating diseases","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; University of Saskatchewan; Public Health Agency of Canada; University of Manitoba; Hospital for Sick Children; University of British Columbia","funders":"","keywords":"Multiple sclerosis; Clinically isolated syndrome; Feces; Gut flora; Medicine; Biology; Gastroenterology; Internal medicine; Immunology; Microbiology","score_opus":0.02774466175595077,"score_gpt":0.21948787709098894,"score_spread":0.19174321533503816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221089070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994436,0.00023603313,0.000060263428,0.000011030282,0.0000019545116,0.0000026217263,0.00011141784,0.0000018140555,0.0001312371],"genre_scores_gemma":[0.9996333,0.00009124098,0.00008890293,0.0000063371913,0.0000032448056,0.0000028452546,0.000112045884,0.0000010480491,0.0000610439],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99964356,0.000088204586,0.0000418936,0.000095723444,0.00007129631,0.000059322614],"domain_scores_gemma":[0.9992176,0.000116544266,0.0004222327,0.000038921793,0.0001045329,0.00009997874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038740778,0.00022656543,0.00028304046,0.0007225668,0.00034927094,0.00046115505,0.00012399601,0.00028664028,0.0011385818],"category_scores_gemma":[0.0020662467,0.00014748717,0.00019080644,0.00062263035,0.00023194677,0.00032553205,0.00040505818,0.0002433913,0.00018268632],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002878135,0.000018342258,0.9940597,0.00002158235,0.000028659724,0.00024439092,0.00022800169,0.000029642046,0.0019832298,0.000010030466,0.000039661165,0.0030489156],"study_design_scores_gemma":[0.0000015555289,0.00012727558,0.99844533,0.0000052455316,0.000011172136,0.00081209483,0.00021804636,0.00003494669,0.00024601215,0.000009440435,0.00008721376,0.0000015808403],"about_ca_topic_score_codex":0.0015690059,"about_ca_topic_score_gemma":0.0013007481,"teacher_disagreement_score":0.0015690059,"about_ca_system_score_codex":0.00020203175,"about_ca_system_score_gemma":0.00015040928,"threshold_uncertainty_score":0.0038089156},"labels":[],"label_agreement":null},{"id":"W4223522335","doi":"10.1177/13524585221085733","title":"Recommendations for the use of propensity score methods in multiple sclerosis research","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia; McGill University; Jewish General Hospital","funders":"","keywords":"Propensity score matching; Covariate; Matching (statistics); Context (archaeology); Weighting; Medicine; Comparative effectiveness research; Computer science; Machine learning; Alternative medicine; Surgery; Pathology","score_opus":0.9297887613391248,"score_gpt":0.5353901558312687,"score_spread":0.3943986055078561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223522335","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014091068,0.070061296,0.26631206,0.5667848,0.038734186,0.0144780455,0.0094865635,0.0045084967,0.028225502],"genre_scores_gemma":[0.0064998586,0.050072815,0.7776668,0.123044744,0.007703208,0.0203174,0.0037330796,0.001063988,0.009898135],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.7289345,0.19503061,0.04112048,0.004279704,0.028235832,0.0023988355],"domain_scores_gemma":[0.26089397,0.49876672,0.03643902,0.028674815,0.1665127,0.008712821],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.23675625,0.0040524863,0.0050734957,0.011593548,0.002296502,0.007337914,0.011403284,0.024345871,0.0332117],"category_scores_gemma":[0.66290313,0.003530853,0.015722906,0.010481957,0.0061100964,0.012848098,0.006514989,0.025848066,0.022005994],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044479698,0.00031665122,0.0013871415,0.019075342,0.0008121732,0.00030733415,0.0010956802,0.0029690554,0.00030517273,0.017804306,0.67254233,0.28293997],"study_design_scores_gemma":[0.002315733,0.00033665984,0.0034759792,0.1529035,0.0021457223,0.0005753282,0.0009828593,0.0053903935,0.0008840467,0.10679239,0.7235422,0.0006552189],"about_ca_topic_score_codex":0.015958171,"about_ca_topic_score_gemma":0.01731948,"teacher_disagreement_score":0.76324373,"about_ca_system_score_codex":0.0057311677,"about_ca_system_score_gemma":0.03609441,"threshold_uncertainty_score":0},"labels":[{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"opus","categories":["metaresearch"],"domain":"methods","study_design":"theoretical_or_conceptual","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"split"},{"id":"W4224239226","doi":"10.1177/13524585221091060","title":"All Bruton’s tyrosine kinase inhibitors have similar efficacy and risks: No","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Bruton's tyrosine kinase; Tyrosine kinase; Medicine; Multiple sclerosis; Internal medicine; Immunology; Receptor","score_opus":0.11141581419808595,"score_gpt":0.31920957465301625,"score_spread":0.2077937604549303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224239226","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27060285,0.45218378,0.012489865,0.08839549,0.00596435,0.0003359599,0.0019063235,0.00042034092,0.16770104],"genre_scores_gemma":[0.8391608,0.08656097,0.004135813,0.01789187,0.0059472416,0.00015944256,0.0010576473,0.00008225038,0.045004003],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99917966,0.00029526185,0.000088709836,0.00009190514,0.00023207792,0.000112425005],"domain_scores_gemma":[0.9974368,0.0012005972,0.0005381924,0.0002589758,0.00026275372,0.00030272632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014665793,0.0004185175,0.0008783018,0.00034377785,0.00041255206,0.0012848495,0.00048350624,0.0014403475,0.0103402175],"category_scores_gemma":[0.0024652856,0.00013932672,0.0013967176,0.00033148113,0.0006101345,0.0009145022,0.0005346251,0.0018440244,0.0024046302],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0111248605,0.0008009689,0.010448248,0.0018720049,0.0014903363,0.0012407288,0.000079659476,0.00096209126,0.016312767,0.013618647,0.023784071,0.91826564],"study_design_scores_gemma":[0.0070978245,0.012436634,0.10582936,0.0015322566,0.0035241144,0.01726042,0.00053018937,0.0018694676,0.036697924,0.027788073,0.7852535,0.00018020146],"about_ca_topic_score_codex":0.000494827,"about_ca_topic_score_gemma":0.0013382611,"teacher_disagreement_score":0.0103402175,"about_ca_system_score_codex":0.00077030965,"about_ca_system_score_gemma":0.00054033234,"threshold_uncertainty_score":0.034591436},"labels":[],"label_agreement":null},{"id":"W4225751437","doi":"10.1177/13524585221084577","title":"Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cegep de Saint Jerome; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Université de Montréal","funders":"National Health and Medical Research Council; Genentech","keywords":"Medicine; Proportional hazards model; Disease; Internal medicine; Metric (unit); Multiple sclerosis; Severity of illness; Prospective cohort study","score_opus":0.12851125022154924,"score_gpt":0.30454718590989277,"score_spread":0.17603593568834353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225751437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9674553,0.0015411281,0.026598644,0.0007814911,0.000075691896,0.000069768954,0.0011035516,0.00043636595,0.001938037],"genre_scores_gemma":[0.99549437,0.00013812412,0.003781332,0.00003419969,0.00003099781,0.000012688762,0.0003017486,0.000012314718,0.0001942651],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977393,0.0014080874,0.00011724475,0.00037720648,0.00027505774,0.000083022824],"domain_scores_gemma":[0.9924426,0.0046611135,0.0013257602,0.00063498813,0.0006219066,0.0003135899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051552514,0.00097498484,0.0011393158,0.00107592,0.00029878426,0.0009194026,0.0005233315,0.0004605049,0.0014327113],"category_scores_gemma":[0.013664584,0.00029815483,0.0009542652,0.0006830117,0.00030903172,0.00074503757,0.0012394111,0.00089536904,0.00039856683],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009377364,0.00017695839,0.8784112,0.00013016835,0.0009050636,0.000085581116,0.000101094265,0.044165224,0.00050985866,0.00029041592,0.0015175547,0.07276929],"study_design_scores_gemma":[0.00011024033,0.0015991114,0.49458793,0.00016016379,0.00086589844,0.00051839603,0.000101451675,0.4951637,0.0013795184,0.0032943685,0.0021424254,0.00007677015],"about_ca_topic_score_codex":0.004327079,"about_ca_topic_score_gemma":0.0053496156,"teacher_disagreement_score":0.0051552514,"about_ca_system_score_codex":0.0004494821,"about_ca_system_score_gemma":0.0009950512,"threshold_uncertainty_score":0.02726388},"labels":[],"label_agreement":null},{"id":"W4226197684","doi":"10.1177/13524585221083194","title":"Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data up to &gt;5 years","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"Sanofi Genzyme; Innosuisse - Schweizerische Agentur für Innovationsförderung; European Commission; Sanofi; Bayer HealthCare; Eli Lilly and Company; CSL Behring; Biogen; Merck KGaA; Teva Pharmaceutical Industries; Novartis; Pfizer; National Research Foundation","keywords":"Medicine; Placebo; Hazard ratio; Internal medicine; Multiple sclerosis; Confidence interval; Pathology; Immunology","score_opus":0.04661293181743509,"score_gpt":0.25671859306409295,"score_spread":0.21010566124665786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226197684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966073,0.001786296,0.00010033284,0.000044060245,0.000009688836,0.0001850387,0.00079071155,0.0000148100635,0.00046169412],"genre_scores_gemma":[0.9963844,0.00065246865,0.00025249796,0.00009410805,0.0000472493,0.00022351314,0.001919918,0.000004898176,0.00042100615],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9993424,0.0002935855,0.00007206193,0.0001039201,0.000112519265,0.00007548468],"domain_scores_gemma":[0.9975472,0.00053759996,0.0009496038,0.0003102903,0.00021435702,0.00044093156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034533546,0.00064581266,0.0014756978,0.00041019358,0.00028831905,0.0004956999,0.00036405382,0.0005913007,0.0018051345],"category_scores_gemma":[0.0019650925,0.00019732515,0.0013524785,0.00044190037,0.000412626,0.00061149994,0.00040712536,0.000940717,0.00034526078],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7135045,0.007588036,0.13315336,0.0015600495,0.006390157,0.00041704654,0.00042590933,0.00186077,0.022300992,0.00013914345,0.0018250832,0.11083488],"study_design_scores_gemma":[0.08234789,0.25581625,0.64601207,0.00017989978,0.0051098173,0.0007286664,0.00012896485,0.0013141718,0.004994651,0.00021891328,0.0030765797,0.00007208681],"about_ca_topic_score_codex":0.00041082586,"about_ca_topic_score_gemma":0.0009825807,"teacher_disagreement_score":0.0034533546,"about_ca_system_score_codex":0.0003752121,"about_ca_system_score_gemma":0.0007194781,"threshold_uncertainty_score":0.01826334},"labels":[],"label_agreement":null},{"id":"W4229375736","doi":"10.1177/13524585221088190","title":"The relationship between processing speed and verbal and non-verbal new learning and memory in progressive multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Multiple Sclerosis Society of Canada","keywords":"Verbal memory; California Verbal Learning Test; Multiple sclerosis; Verbal learning; Cognitive psychology; Psychology; Cognition; Neuroscience; Psychiatry","score_opus":0.137524982595279,"score_gpt":0.32410062158974456,"score_spread":0.18657563899446555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229375736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995104,0.0002553551,0.000050386043,0.000014182317,0.0000022396432,0.000007805658,0.00004526079,0.000002329209,0.00011196289],"genre_scores_gemma":[0.9996983,0.00005430083,0.00008062617,0.00000825138,0.0000066114735,0.000008736489,0.00007643424,9.0854337e-7,0.00006595513],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914837,0.00034084014,0.000102004946,0.00014433579,0.00019595158,0.00006853332],"domain_scores_gemma":[0.99226016,0.00355936,0.0029737481,0.00028694532,0.00046908582,0.00045072238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029319741,0.00038961723,0.0003962965,0.0009340908,0.0002043163,0.00044946562,0.00024554852,0.0005240606,0.0012719774],"category_scores_gemma":[0.011169137,0.00021745337,0.0003892445,0.0005582888,0.00038347088,0.0004198742,0.0004702382,0.0004746459,0.00018334246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033160523,0.00020172184,0.99187016,0.000021514696,0.00025988245,0.000055061755,0.000037860576,0.00024937748,0.00045658794,0.000010598587,0.000047154746,0.0034739505],"study_design_scores_gemma":[0.00006472081,0.0011191816,0.9979583,0.000004609119,0.000058335587,0.00017680974,0.000016594988,0.00039191806,0.00012953392,0.000035440982,0.000041433716,0.00000318327],"about_ca_topic_score_codex":0.00076323806,"about_ca_topic_score_gemma":0.00068153895,"teacher_disagreement_score":0.0029319741,"about_ca_system_score_codex":0.00017902625,"about_ca_system_score_gemma":0.00022774671,"threshold_uncertainty_score":0.01550591},"labels":[],"label_agreement":null},{"id":"W4235924992","doi":"10.1177/135245850200800105","title":"International consensus statement on the use of disease-modifying agents in multiple sclerosis","year":2002,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Statement (logic); Multiple sclerosis; Voting; Consensus conference; Medicine; Family medicine; Alternative medicine; Disease; MEDLINE; Political science; Psychiatry; Pathology; Internal medicine; Law","score_opus":0.5148747468519949,"score_gpt":0.3560688506872489,"score_spread":0.15880589616474594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235924992","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0041986243,0.15938689,0.09842675,0.4988671,0.16142516,0.015651833,0.0072983704,0.0009308981,0.05381441],"genre_scores_gemma":[0.050034925,0.19625422,0.50788105,0.1082367,0.032413896,0.03432687,0.026295219,0.0007914225,0.043765735],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.8968389,0.0451648,0.02762475,0.002168707,0.025170054,0.003032724],"domain_scores_gemma":[0.8231293,0.047379695,0.013848588,0.004360281,0.09952244,0.011759674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.112399906,0.0028795158,0.005306816,0.0074732737,0.00318118,0.0057245633,0.01150047,0.015886318,0.006054029],"category_scores_gemma":[0.11661433,0.0017910525,0.0067592594,0.0058072046,0.00338553,0.0037618058,0.0056645824,0.022569392,0.006998829],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053582917,0.00031742832,0.0015984337,0.015584356,0.0005577393,0.0011395657,0.0016929662,0.00149054,0.0016021576,0.011517847,0.71009237,0.2538707],"study_design_scores_gemma":[0.00050405023,0.0003010864,0.0038669496,0.025653897,0.00086657493,0.0013854288,0.0010320764,0.00086209155,0.0011199568,0.015056683,0.9491949,0.00015615659],"about_ca_topic_score_codex":0.0074552433,"about_ca_topic_score_gemma":0.004950346,"teacher_disagreement_score":0.112399906,"about_ca_system_score_codex":0.007064802,"about_ca_system_score_gemma":0.05159561,"threshold_uncertainty_score":0.5944346},"labels":[],"label_agreement":null},{"id":"W4242063709","doi":"10.1177/1352458514547847","title":"ACTRIMS-ECTRIMS MSBoston 2014: Late Breaking News Oral Presentations","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Diverse Scientific and Economic Studies","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; University of British Columbia Hospital; McGill University; NeuroRx Research (Canada)","funders":"","keywords":"Multiple sclerosis; Medicine; Psychiatry","score_opus":0.10847462147527044,"score_gpt":0.23383507208192714,"score_spread":0.12536045060665668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242063709","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004045425,0.09009944,0.0027560226,0.15122929,0.4108932,0.0008784294,0.0052760676,0.0035028334,0.33131933],"genre_scores_gemma":[0.009283417,0.04470593,0.0016747155,0.06426564,0.20099181,0.00056400173,0.0049103955,0.00066694187,0.67293704],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988397,0.00020291291,0.000080955004,0.00013573894,0.0005378249,0.00020290168],"domain_scores_gemma":[0.9974988,0.00028909722,0.00024027993,0.00010319794,0.0006575152,0.0012110602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025985467,0.001106691,0.0009704909,0.0010104332,0.0009504678,0.0054879365,0.0013696705,0.0062871785,0.2224505],"category_scores_gemma":[0.004025337,0.00046365912,0.0011965983,0.0005712487,0.0005593984,0.0020129315,0.0014847527,0.0054720845,0.12611216],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004801111,0.00013518755,0.000094880226,0.00040912922,0.000021412758,0.0001452341,0.00001353934,0.00005189793,0.000818457,0.00085850654,0.9000729,0.09689881],"study_design_scores_gemma":[0.00013821964,0.00018946549,0.00034134276,0.0002831672,0.000012343642,0.00010409879,0.00001569027,0.00006199784,0.00029858688,0.0004917075,0.9980552,0.0000081915105],"about_ca_topic_score_codex":0.00058122154,"about_ca_topic_score_gemma":0.0011212769,"teacher_disagreement_score":0.2224505,"about_ca_system_score_codex":0.0013100111,"about_ca_system_score_gemma":0.0015887484,"threshold_uncertainty_score":0.744171},"labels":[],"label_agreement":null},{"id":"W4247909607","doi":"10.1177/135245850200800109","title":"The role of MRI as a surrogate outcome measure in multiple sclerosis","year":2002,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Multiple sclerosis; Medicine; Magnetic resonance imaging; Surrogate endpoint; Clinical trial; Disease; Pathology; Radiology; Psychiatry","score_opus":0.16351152194505092,"score_gpt":0.30151295343829293,"score_spread":0.138001431493242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247909607","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029887928,0.5950915,0.13727857,0.20841038,0.0111817345,0.0012429536,0.0005469012,0.00016204795,0.016197952],"genre_scores_gemma":[0.60614204,0.16094445,0.13330749,0.070209265,0.021958973,0.0038562915,0.00034997478,0.00018998516,0.0030415417],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.700491,0.2700243,0.010962956,0.0032342789,0.014617114,0.0006703713],"domain_scores_gemma":[0.44982314,0.49017683,0.028876033,0.011452742,0.018029759,0.0016414865],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.33215907,0.00095264585,0.0035236026,0.0022708338,0.0009349599,0.0060269656,0.001771969,0.004267142,0.0006516348],"category_scores_gemma":[0.3224772,0.0003650848,0.0013530531,0.0029602493,0.0077321096,0.005151083,0.0033171582,0.00878629,0.00027381146],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00571721,0.00042594303,0.027659591,0.011942235,0.00167366,0.00051621406,0.0035950139,0.0053432155,0.003090883,0.17557411,0.026269473,0.7381924],"study_design_scores_gemma":[0.0017861023,0.018645233,0.06612559,0.043931764,0.0032502501,0.0048041833,0.0033563662,0.030222049,0.011856518,0.4573988,0.3572735,0.0013496423],"about_ca_topic_score_codex":0.0010644738,"about_ca_topic_score_gemma":0.0008476041,"teacher_disagreement_score":0.33215907,"about_ca_system_score_codex":0.0030092688,"about_ca_system_score_gemma":0.004346307,"threshold_uncertainty_score":0.8235668},"labels":[],"label_agreement":null},{"id":"W4253683908","doi":"10.1177/1352458511422292","title":"Oral presentations","year":2011,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Oropharyngeal Anatomy and Pathologies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Eisai Canada; Serono Symposia International Foundation; Università di Catania; Medical Research Council; Eisai; Sanofi; Associazione Italiana Sclerosi Multipla; Teva Pharmaceutical Industries; Fondazione Italiana Sclerosi Multipla; Biogen","keywords":"Medicine; Multiple sclerosis; Dermatology; Psychiatry","score_opus":0.26785581781360907,"score_gpt":0.3018293690132866,"score_spread":0.03397355119967754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253683908","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026875765,0.020249788,0.0023108104,0.013830322,0.031853456,0.0003466943,0.00501439,0.0015824388,0.9221245],"genre_scores_gemma":[0.012097564,0.009698368,0.0012742855,0.008524127,0.009883716,0.00017315007,0.0036419292,0.0006408121,0.954066],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994899,0.00008596917,0.000040247272,0.000093561655,0.00020682077,0.00008342722],"domain_scores_gemma":[0.9987924,0.00019460353,0.000077465476,0.00013833294,0.00042129113,0.00037585903],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005954471,0.0010478052,0.0010268849,0.0012494453,0.0011843414,0.0036395246,0.0015654542,0.0028468557,0.7847205],"category_scores_gemma":[0.0034989167,0.00038672905,0.0009392505,0.00075993594,0.00042346935,0.0022523198,0.0024748011,0.0024905885,0.54133826],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012348655,0.00006456507,0.00029037832,0.0003124309,0.000010019503,0.0009961538,0.000048606173,0.000059737373,0.0005631979,0.0020759914,0.83943194,0.15602341],"study_design_scores_gemma":[0.000026582591,0.000032843313,0.00033663368,0.00030015822,0.000006139482,0.0021709946,0.00007114067,0.00004681158,0.0001698934,0.0013354921,0.9954941,0.000009207582],"about_ca_topic_score_codex":0.00090293476,"about_ca_topic_score_gemma":0.0011472891,"teacher_disagreement_score":0.21527952,"about_ca_system_score_codex":0.00089580467,"about_ca_system_score_gemma":0.001053485,"threshold_uncertainty_score":0.30707008},"labels":[],"label_agreement":null},{"id":"W4255607453","doi":"10.1177/135245850100700102","title":"A meta-analysis of genomic screens in multiple sclerosis","year":2001,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of Neurological Disorders and Stroke; National Multiple Sclerosis Society","keywords":"Linkage (software); Genetics; Genetic linkage; Multiplex; Lod score; Genotyping; Genome; Biology; Chromosome; Gene mapping; Gene; Genotype","score_opus":0.5874270890392274,"score_gpt":0.39705306277301433,"score_spread":0.19037402626621303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255607453","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021795845,0.97575086,0.00095035863,0.00036236874,0.00014678684,0.00008414994,0.0005425603,0.00003502971,0.00033213792],"genre_scores_gemma":[0.42301792,0.57073367,0.0038154428,0.000563673,0.00022310838,0.00030815304,0.0010249957,0.000023026889,0.000290122],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9906047,0.006902514,0.0008577498,0.00077993015,0.00070182007,0.00015322487],"domain_scores_gemma":[0.99004364,0.00790134,0.0008633382,0.00053792034,0.0005193738,0.00013436536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010932423,0.001738534,0.00754817,0.003943395,0.00026689717,0.0014010059,0.0010251572,0.0010130338,0.0014132485],"category_scores_gemma":[0.019014759,0.0007191138,0.00967737,0.0061107106,0.0002458603,0.00057862117,0.0006438884,0.00062076625,0.00015638326],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054300185,0.000060166873,0.03487741,0.086865984,0.7793588,0.00074786006,0.00013005678,0.0025493978,0.00092417025,0.00040022048,0.0033726653,0.08528323],"study_design_scores_gemma":[0.0015480539,0.0006791897,0.04128956,0.006124252,0.9417538,0.0006403854,0.00008212476,0.0006451929,0.0005498491,0.0007521914,0.005896787,0.000038601236],"about_ca_topic_score_codex":0.004419455,"about_ca_topic_score_gemma":0.009813852,"teacher_disagreement_score":0.010932423,"about_ca_system_score_codex":0.0012472443,"about_ca_system_score_gemma":0.0013640929,"threshold_uncertainty_score":0.057816923},"labels":[],"label_agreement":null},{"id":"W4280538986","doi":"10.1177/13524585221093789","title":"Serum MOG-IgG in children meeting multiple sclerosis diagnostic criteria","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Queen's University; Montreal Neurological Institute and Hospital; SickKids Foundation; University of Toronto; McGill University; Hospital for Sick Children","funders":"","keywords":"Multiple sclerosis; Medicine; Immunology","score_opus":0.09069882192185148,"score_gpt":0.29772870070088264,"score_spread":0.20702987877903117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280538986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993975,0.00022981259,0.000038237646,0.000032420132,0.0000074383693,0.000006952153,0.00010626351,0.0000047851445,0.00017653362],"genre_scores_gemma":[0.9996232,0.00009732379,0.000088859306,0.000017002207,0.000008738482,0.0000075447692,0.00012657113,0.0000014337561,0.00002931359],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99933285,0.00012990371,0.00007669636,0.00015857413,0.0001577617,0.00014421534],"domain_scores_gemma":[0.99748456,0.0006179592,0.0011032077,0.00008602297,0.00023213537,0.00047605383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008661415,0.00061505905,0.00054405065,0.0011418283,0.00063550466,0.00070729037,0.00045620825,0.0008092634,0.0010571601],"category_scores_gemma":[0.0047157323,0.0004137105,0.0003457944,0.0009578431,0.00058419927,0.00062148314,0.00046222558,0.000877052,0.00021913908],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005396965,0.000015786387,0.9987826,0.0000063693114,0.0000062016957,0.00038761582,0.00007298202,0.000027797889,0.0001420794,0.000006806789,0.000057229958,0.00044045088],"study_design_scores_gemma":[0.000015251002,0.00030871414,0.9925216,0.000020369633,0.00002896476,0.006204629,0.0003013443,0.00018131449,0.00018350164,0.00002393131,0.000204697,0.00000557437],"about_ca_topic_score_codex":0.0054192175,"about_ca_topic_score_gemma":0.0030368953,"teacher_disagreement_score":0.0054192175,"about_ca_system_score_codex":0.0005859994,"about_ca_system_score_gemma":0.0007067564,"threshold_uncertainty_score":0.010775387},"labels":[],"label_agreement":null},{"id":"W4281725428","doi":"10.1177/13524585221097561","title":"Ocrelizumab reduces thalamic volume loss in patients with RMS and PPMS","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McGill University; NeuroRx Research (Canada)","funders":"F. Hoffmann-La Roche","keywords":"Ocrelizumab; Medicine; Placebo; Multiple sclerosis; Thalamus; Anesthesia; White matter; Internal medicine; Magnetic resonance imaging; Pathology; Radiology","score_opus":0.035560739451013075,"score_gpt":0.2502481043547009,"score_spread":0.21468736490368784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281725428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900982,0.0070101283,0.00053472153,0.00022518811,0.000043870015,0.000097936594,0.00020598783,0.00006495029,0.001718917],"genre_scores_gemma":[0.99873894,0.00049318525,0.00033266723,0.00008945655,0.000022836286,0.000025680965,0.00012213533,0.0000036687886,0.00017147858],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99971145,0.00013865632,0.000024653009,0.00003072198,0.00006488702,0.000029612711],"domain_scores_gemma":[0.9994418,0.00015785324,0.0002492137,0.000035700647,0.00005011781,0.000065244385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072422676,0.00028282247,0.00059497845,0.00016593812,0.00007135496,0.00022249484,0.00016632004,0.00016977233,0.0011118222],"category_scores_gemma":[0.0014379176,0.000090080364,0.00056135486,0.00012419066,0.00016397425,0.00017059977,0.00014695765,0.00035689797,0.00011643859],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1563091,0.0038836056,0.108177364,0.002243779,0.0041165776,0.0007344109,0.0005471484,0.0039571715,0.09425957,0.00028153413,0.0035599635,0.6219298],"study_design_scores_gemma":[0.025561938,0.16574503,0.7616162,0.00041108308,0.0027214382,0.004129952,0.00048380223,0.008663498,0.021860365,0.00063440047,0.008105354,0.00006700087],"about_ca_topic_score_codex":0.0006442121,"about_ca_topic_score_gemma":0.0016012776,"teacher_disagreement_score":0.0011118222,"about_ca_system_score_codex":0.00033235166,"about_ca_system_score_gemma":0.00021977749,"threshold_uncertainty_score":0.0038301349},"labels":[],"label_agreement":null},{"id":"W4283692377","doi":"10.1177/13524585221102584","title":"Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Up to 5 years of follow-up in the DAYBREAK open-label extension trial","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"Innosuisse - Schweizerische Agentur für Innovationsförderung; EMD Serono; Multiple Sclerosis International Federation; Allergan; Shionogi; National Research Foundation; Janssen Pharmaceuticals; Atara Biotherapeutics; European Committee for Treatment and Research in Multiple Sclerosis; Bristol-Myers Squibb; CSL Behring; Biogen; Celgene; Alexion Pharmaceuticals; Teva Pharmaceutical Industries; Mylan; TG Therapeutics; Pfizer; Bayer HealthCare; European Commission; Sanofi; MedDay Pharmaceuticals; National Multiple Sclerosis Society","keywords":"Medicine; Adverse effect; Internal medicine; Tolerability; Pediatrics","score_opus":0.18876421411032954,"score_gpt":0.3523233674991694,"score_spread":0.1635591533888399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283692377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957178,0.0017554221,0.00015264853,0.00015744049,0.000054038635,0.00034072204,0.001115498,0.000016568598,0.00068982295],"genre_scores_gemma":[0.99556524,0.00061183464,0.00025946766,0.00020097391,0.00009001732,0.00043260696,0.0021840578,0.000005913337,0.00064991595],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99861,0.0006870447,0.00010913495,0.0002194633,0.00016514047,0.00020911597],"domain_scores_gemma":[0.99523807,0.00091150525,0.0018742263,0.00046581647,0.00046831756,0.0010421438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066139423,0.0006772178,0.0019222642,0.00024353265,0.000735371,0.0010190872,0.00060372433,0.0013599725,0.0031522617],"category_scores_gemma":[0.00456321,0.0003118841,0.001671086,0.0003704249,0.0005315132,0.0012798511,0.000701749,0.0019666296,0.00055084075],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8828722,0.004499572,0.064354815,0.0007001976,0.0026878125,0.0002096502,0.00026534617,0.0005936507,0.0029930093,0.00009904431,0.0021450908,0.03857963],"study_design_scores_gemma":[0.274043,0.22889344,0.48037615,0.0002752865,0.0046806447,0.00081861863,0.0002818077,0.0018710663,0.0021871799,0.00057367707,0.0058925254,0.00010664522],"about_ca_topic_score_codex":0.0003865578,"about_ca_topic_score_gemma":0.000802719,"teacher_disagreement_score":0.0066139423,"about_ca_system_score_codex":0.00044382052,"about_ca_system_score_gemma":0.000603701,"threshold_uncertainty_score":0.03497827},"labels":[],"label_agreement":null},{"id":"W4283819672","doi":"10.1177/13524585221095427","title":"Therapy with mesenchymal stem cell transplantation in multiple sclerosis is ready for prime time: No","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Mesenchymal stem cell; Multiple sclerosis; Transplantation; Medicine; Stem cell; Surgery; Pathology; Immunology; Biology","score_opus":0.1541644099101174,"score_gpt":0.2887168242659134,"score_spread":0.13455241435579599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283819672","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13098879,0.51684105,0.018285802,0.25598645,0.025596796,0.00019446977,0.0006360033,0.00055005733,0.0509207],"genre_scores_gemma":[0.6712577,0.21046436,0.017413128,0.043414116,0.018626919,0.00043088273,0.00048377027,0.00018820929,0.037720937],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992167,0.0003273931,0.00006708755,0.000083878236,0.00021260926,0.000092406066],"domain_scores_gemma":[0.9982697,0.0008687748,0.00017347663,0.00013319039,0.00023005469,0.00032483097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029340142,0.00026783627,0.0006355827,0.00032769362,0.00068251,0.0018689851,0.0006406658,0.0022239129,0.009808409],"category_scores_gemma":[0.0026115307,0.00012100034,0.00047032107,0.00026329604,0.0014720837,0.0024239582,0.0007965872,0.0027381983,0.0015812779],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047266614,0.0011583944,0.0018750542,0.0019264575,0.00015154538,0.00071267644,0.00035279707,0.0006006955,0.028478488,0.06884145,0.07520044,0.81597537],"study_design_scores_gemma":[0.0013315331,0.006431908,0.0071491846,0.0036423171,0.00047358565,0.0029355688,0.0013506552,0.0018698579,0.040862925,0.084224895,0.84958905,0.00013850817],"about_ca_topic_score_codex":0.00038316444,"about_ca_topic_score_gemma":0.0009811331,"teacher_disagreement_score":0.009808409,"about_ca_system_score_codex":0.00055255,"about_ca_system_score_gemma":0.0015137964,"threshold_uncertainty_score":0.032812417},"labels":[],"label_agreement":null},{"id":"W4285726642","doi":"10.1177/13524585221109761","title":"Minocycline treatment in clinically isolated syndrome and serum NfL, GFAP, and metalloproteinase levels","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Calgary","funders":"Multiple Sclerosis Society of Canada; Government of Alberta","keywords":"Minocycline; Medicine; Glial fibrillary acidic protein; Biomarker; Gastroenterology; Clinically isolated syndrome; Internal medicine; Multiple sclerosis; Lesion; Matrix metalloproteinase; Pathology; Immunology; Biology; Immunohistochemistry; Antibiotics","score_opus":0.1407432342174484,"score_gpt":0.33239278824394647,"score_spread":0.19164955402649808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285726642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984113,0.0012401277,0.00002703432,0.000022494745,0.00000538102,0.00000891943,0.00005583396,0.000002721658,0.0002262846],"genre_scores_gemma":[0.999691,0.00011198355,0.00004187881,0.00001693744,0.000007499383,0.000008180677,0.00006499878,7.299365e-7,0.000056675482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996805,0.00010509783,0.000051830295,0.000060155053,0.000057561294,0.00004482972],"domain_scores_gemma":[0.9986914,0.00030140238,0.00056105416,0.000039042305,0.00010256519,0.00030449982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048450672,0.00029226925,0.0006357548,0.00032841266,0.000282778,0.00031998576,0.00013592406,0.00037805756,0.0007557642],"category_scores_gemma":[0.0015055335,0.00012491323,0.00031103424,0.0002887339,0.00019666698,0.00019735695,0.00015022252,0.00041798703,0.00010926346],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03371879,0.00077103364,0.92040056,0.00023109224,0.0004891007,0.0008562784,0.000269437,0.0002578684,0.019476922,0.000021822536,0.00031336077,0.023193656],"study_design_scores_gemma":[0.0005054332,0.008883903,0.9857793,0.000028327799,0.00018691143,0.0012834931,0.00009329556,0.0002233396,0.0025998098,0.000020533558,0.00038675318,0.000008952816],"about_ca_topic_score_codex":0.00065550074,"about_ca_topic_score_gemma":0.0012445647,"teacher_disagreement_score":0.0007557642,"about_ca_system_score_codex":0.00037308663,"about_ca_system_score_gemma":0.00023367016,"threshold_uncertainty_score":0.0027068853},"labels":[],"label_agreement":null},{"id":"W4287377875","doi":"10.1177/13524585221105465","title":"The MSIS-29 and SF-36 as outcomes in secondary progressive MS trials","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Prom; Medicine; Expanded Disability Status Scale; Population; Clinical trial; Physical therapy; Multiple sclerosis; Physical medicine and rehabilitation; Internal medicine; Psychiatry","score_opus":0.1580228270206503,"score_gpt":0.36068609069299035,"score_spread":0.20266326367234005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4287377875","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32056805,0.56234473,0.010515585,0.02856047,0.008476733,0.028694361,0.015156187,0.0003071,0.025376765],"genre_scores_gemma":[0.8694777,0.040016733,0.014301738,0.007919836,0.0031505635,0.05772568,0.004902135,0.00010694572,0.0023987761],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.82942265,0.1434102,0.015372528,0.003352426,0.006984471,0.0014577038],"domain_scores_gemma":[0.8824439,0.07531521,0.026019739,0.004591983,0.008668187,0.002961019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.10224539,0.001260679,0.0050271447,0.002627622,0.0007801154,0.0031341563,0.0012567927,0.0029094396,0.005279836],"category_scores_gemma":[0.15447342,0.00048358206,0.006496909,0.0036667401,0.0012531894,0.0026217427,0.0018924276,0.0035442747,0.0008145731],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44376224,0.0029283848,0.06819015,0.09210493,0.08962113,0.00036601897,0.0009187239,0.0047393558,0.0020451592,0.009303457,0.03228474,0.25373572],"study_design_scores_gemma":[0.4861543,0.085884735,0.20471838,0.048948064,0.0491304,0.0011064238,0.00091124844,0.0071101356,0.0022313213,0.02527623,0.08815225,0.00037641986],"about_ca_topic_score_codex":0.0007483838,"about_ca_topic_score_gemma":0.0017925459,"teacher_disagreement_score":0.10224539,"about_ca_system_score_codex":0.0016863389,"about_ca_system_score_gemma":0.0033447172,"threshold_uncertainty_score":0.5407318},"labels":[],"label_agreement":null},{"id":"W4288050735","doi":"10.1177/13524585221111677","title":"Prediction of relapse activity when switching to cladribine for multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; Université de Montréal; Cegep de Saint Jerome","funders":"","keywords":"Cladribine; Medicine; Hazard ratio; Natalizumab; Teriflunomide; Glatiramer acetate; Internal medicine; Multiple sclerosis; Confidence interval; Oncology; Fingolimod; Disease; Immunology","score_opus":0.2039220264750162,"score_gpt":0.30667357104742776,"score_spread":0.10275154457241156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4288050735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988285,0.00025017557,0.00011363198,0.000050936742,0.0000046398004,0.000006228672,0.00048812822,0.0000063619423,0.00025138143],"genre_scores_gemma":[0.9990889,0.00007940938,0.00009328414,0.00001518435,0.000008154896,0.000004006872,0.0006504981,0.0000017796773,0.000058848218],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99953353,0.00015548604,0.00006085478,0.000105934625,0.000085374275,0.000058699938],"domain_scores_gemma":[0.99572045,0.0014572885,0.0020080304,0.00026655293,0.00019600808,0.00035175798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011001832,0.00019565025,0.00030999133,0.0004843876,0.00015983266,0.0004576585,0.0002584863,0.00026497577,0.0018817184],"category_scores_gemma":[0.0039024185,0.00012748635,0.00062556844,0.0004390217,0.00014030274,0.0002507642,0.00033316883,0.0006153681,0.00025148535],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040904357,0.000022875347,0.9961212,0.0000091133925,0.000035682453,0.000021745967,0.000016540258,0.00018679246,0.00013522153,0.000009230312,0.000120244775,0.0029122143],"study_design_scores_gemma":[0.000020651973,0.00014328942,0.9974152,0.000012573282,0.00004733473,0.00020069747,0.000041872627,0.0016992873,0.00016373827,0.000044828277,0.00020719056,0.0000033183999],"about_ca_topic_score_codex":0.0016529701,"about_ca_topic_score_gemma":0.002179435,"teacher_disagreement_score":0.0018817184,"about_ca_system_score_codex":0.00024252564,"about_ca_system_score_gemma":0.0002855182,"threshold_uncertainty_score":0.0062949657},"labels":[],"label_agreement":null},{"id":"W4288490422","doi":"10.1177/13524585221110585","title":"Permanent tissue damage in multiple sclerosis lesions is associated with reduced pre-lesion myelin and axon volume fractions","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Polytechnique Montréal; Montreal Neurological Institute and Hospital","funders":"Canadian Institutes of Health Research; Novartis Pharmaceuticals Canada; Natural Sciences and Engineering Research Council of Canada; Mitacs; Myelin Repair Foundation","keywords":"Multiple sclerosis; Myelin; Axon; Lesion; Pathology; Myelin sheath; Medicine; Anatomy; Central nervous system; Immunology; Internal medicine","score_opus":0.12847332958124513,"score_gpt":0.3127205270181618,"score_spread":0.18424719743691664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4288490422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994978,0.00019771773,0.000079523976,0.000010835149,0.000001994656,0.000002452388,0.000039914394,0.0000052098285,0.00016456016],"genre_scores_gemma":[0.9996582,0.00006566924,0.00008774963,0.0000033243628,0.000004665757,0.0000021017481,0.00006591149,0.0000017028236,0.000110757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99988306,0.000016621969,0.000014459375,0.000034456076,0.00002983054,0.000021621221],"domain_scores_gemma":[0.99797386,0.00020023675,0.0013008864,0.00009552666,0.00018697896,0.00024246448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039609344,0.00021563382,0.00024166398,0.00066658325,0.00025436003,0.00035974657,0.00017218186,0.0003618354,0.0019221187],"category_scores_gemma":[0.0015565865,0.00012913474,0.00013760346,0.00038446614,0.00029895178,0.0003731014,0.00028938812,0.00039816735,0.00028940936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001513483,0.00018568081,0.95978653,0.00007950006,0.00010858465,0.0005026277,0.0002604274,0.0001342916,0.02437108,0.000034221288,0.0001110483,0.01291248],"study_design_scores_gemma":[0.0000026471907,0.00025393866,0.9978822,0.000003551415,0.000012881701,0.0008507872,0.000037999496,0.000048316815,0.00082161534,0.00002997151,0.000054169734,0.00000204914],"about_ca_topic_score_codex":0.0006757424,"about_ca_topic_score_gemma":0.00089515373,"teacher_disagreement_score":0.0019221187,"about_ca_system_score_codex":0.00016140954,"about_ca_system_score_gemma":0.00013533352,"threshold_uncertainty_score":0.006430149},"labels":[],"label_agreement":null},{"id":"W4292466559","doi":"10.1177/13524585221112605","title":"Machine learning classification of multiple sclerosis in children using optical coherence tomography","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Toronto Metropolitan University; SickKids Foundation; University of Toronto; Vector Institute; University of Manitoba; Hospital for Sick Children","funders":"","keywords":"Multiple sclerosis; Optical coherence tomography; Random forest; Retinal; Clinically isolated syndrome; Demyelinating Disorder; Medicine; Artificial intelligence; Pattern recognition (psychology); Computer science; Ophthalmology; Pathology","score_opus":0.13601664714928968,"score_gpt":0.3078742062840037,"score_spread":0.171857559134714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292466559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99510753,0.00030209974,0.003485211,0.000096416,0.000011170333,0.000026107491,0.0005372527,0.00004785276,0.00038638557],"genre_scores_gemma":[0.9947507,0.000105017,0.004558747,0.000012737966,0.0000095117975,0.000019551555,0.0004201914,0.0000044331855,0.0001191718],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99967027,0.00011645827,0.000035603192,0.000057865404,0.000071364484,0.00004835813],"domain_scores_gemma":[0.99835014,0.0008840599,0.00040046466,0.000061877035,0.00021755285,0.00008595586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082481693,0.00043008904,0.00029113513,0.0014778994,0.00016679682,0.00040230472,0.00022430043,0.00032511487,0.0007178827],"category_scores_gemma":[0.0033062133,0.000090316214,0.0003680254,0.0004891791,0.00017947696,0.0003053352,0.00022980363,0.0004047378,0.00022667911],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024336486,0.00007709439,0.9497381,0.000039478273,0.00007240959,0.00025273164,0.000100874095,0.0053415224,0.0021386147,0.00010887894,0.0007046524,0.04118227],"study_design_scores_gemma":[0.000026147229,0.0003714494,0.8697138,0.00007600303,0.00008497911,0.0012828704,0.0004941342,0.12096455,0.005266344,0.0005893963,0.0011074517,0.000022858234],"about_ca_topic_score_codex":0.004534403,"about_ca_topic_score_gemma":0.0038537653,"teacher_disagreement_score":0.004534403,"about_ca_system_score_codex":0.0004315659,"about_ca_system_score_gemma":0.00035698104,"threshold_uncertainty_score":0.009015977},"labels":[],"label_agreement":null},{"id":"W4293113303","doi":"10.1177/13524585221116269","title":"Use of follow-on disease-modifying treatments for multiple sclerosis: Consensus recommendations","year":2022,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Transparency (behavior); Pharmacovigilance; MEDLINE; Intensive care medicine; Political science; Psychiatry; Drug","score_opus":0.619448626281781,"score_gpt":0.420262667192634,"score_spread":0.199185959089147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293113303","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010346404,0.89839315,0.0055312295,0.07972962,0.0064101825,0.0020292948,0.0014656767,0.00015302129,0.005253107],"genre_scores_gemma":[0.01513985,0.9162045,0.039289773,0.020332778,0.0011767444,0.0031122619,0.002697803,0.00005791011,0.0019884217],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9666607,0.01360738,0.010572102,0.0015873926,0.006658286,0.0009141241],"domain_scores_gemma":[0.91791135,0.038345046,0.01305422,0.0018008698,0.02641242,0.0024760768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.054705568,0.0020190033,0.0045015262,0.008791466,0.0013319586,0.003976925,0.007728444,0.007383575,0.0051177917],"category_scores_gemma":[0.101777695,0.0012335982,0.008971296,0.006257769,0.0015467855,0.005326546,0.0036223617,0.006462183,0.002238282],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031941338,0.00017591956,0.0018520897,0.30897048,0.0027662031,0.00030764326,0.0009773845,0.0011186303,0.0006002753,0.00670205,0.12096083,0.55524904],"study_design_scores_gemma":[0.00040011562,0.00013936123,0.003079361,0.62764025,0.0060409806,0.00046611502,0.00073040987,0.0005140284,0.0005257753,0.009447697,0.35090423,0.00011168788],"about_ca_topic_score_codex":0.011430149,"about_ca_topic_score_gemma":0.014311897,"teacher_disagreement_score":0.054705568,"about_ca_system_score_codex":0.0067487634,"about_ca_system_score_gemma":0.033326816,"threshold_uncertainty_score":0.2893142},"labels":[],"label_agreement":null},{"id":"W4297183615","doi":"10.1177/13524585221125369","title":"Neurodegeneration and humoral response proteins in cerebrospinal fluid associate with pediatric-onset multiple sclerosis and not monophasic demyelinating syndromes in childhood","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Stichting MS Research","keywords":"Multiple sclerosis; Proteome; Medicine; Neurodegeneration; Cerebrospinal fluid; Proteomics; Immunology; Biology; Disease; Bioinformatics; Internal medicine; Biochemistry","score_opus":0.07314315901523498,"score_gpt":0.2720557763605013,"score_spread":0.19891261734526633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297183615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992286,0.0002332987,0.000089892616,0.000015425125,0.0000022048773,0.0000046357222,0.00021367939,0.0000045509178,0.00020759458],"genre_scores_gemma":[0.99878937,0.00021296307,0.00042795727,0.00001836246,0.000004597511,0.0000073588626,0.00043566842,0.0000050691265,0.00009866014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99964476,0.000040077273,0.00003663275,0.000094846575,0.000121213125,0.000062490566],"domain_scores_gemma":[0.99909496,0.00011444316,0.0004960557,0.0000280251,0.00014980463,0.00011669267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004399679,0.0005699106,0.0003016102,0.001379178,0.00043375118,0.00052737835,0.00031020775,0.00032313413,0.001045595],"category_scores_gemma":[0.0012349149,0.00018596918,0.0002686859,0.0011706594,0.0005014089,0.00023960484,0.00037330133,0.00032364563,0.00015311498],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023365866,0.000024906078,0.98499924,0.00003798408,0.000059028094,0.0009948009,0.00013327875,0.0000709067,0.011353954,0.000041770534,0.00011847129,0.0019320403],"study_design_scores_gemma":[0.00000659382,0.000070272465,0.99442035,0.00001178695,0.000028449344,0.0030511229,0.0001477612,0.00014096379,0.0018549314,0.000021937498,0.00024336766,0.0000025737393],"about_ca_topic_score_codex":0.012212273,"about_ca_topic_score_gemma":0.012218366,"teacher_disagreement_score":0.012212273,"about_ca_system_score_codex":0.00066325726,"about_ca_system_score_gemma":0.0007491419,"threshold_uncertainty_score":0.024282396},"labels":[],"label_agreement":null},{"id":"W4298087646","doi":"10.1177/13524585221125382","title":"Recurrent disability progression endpoints in multiple sclerosis clinical trials","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Multiple sclerosis; Clinical trial; Proportional hazards model; Randomized controlled trial; Expanded Disability Status Scale; Marginal structural model; Clinical endpoint; Physical therapy; Physical medicine and rehabilitation; Internal medicine; Confidence interval; Psychiatry","score_opus":0.5092941805457951,"score_gpt":0.468741093657901,"score_spread":0.04055308688789411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4298087646","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2622882,0.21024792,0.43729258,0.0069980742,0.003666862,0.05016557,0.007687413,0.0015465951,0.020106787],"genre_scores_gemma":[0.8263318,0.00881204,0.10510214,0.0019454319,0.0007453742,0.052230842,0.0034700923,0.0001830554,0.0011792054],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.6010383,0.36960775,0.014911261,0.0034829339,0.01033505,0.00062469003],"domain_scores_gemma":[0.61936706,0.3220762,0.034460623,0.012719514,0.009462849,0.0019138656],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.25534868,0.0011635814,0.0036850316,0.0017397873,0.00050493964,0.0019284886,0.0019127293,0.0017760788,0.003946531],"category_scores_gemma":[0.29083005,0.0003978543,0.0069170487,0.0018841916,0.0011311446,0.0017167135,0.00214416,0.0036159377,0.0004392783],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26630217,0.0025791102,0.038720753,0.06976785,0.09351637,0.00036687375,0.0011948618,0.06444764,0.0030925116,0.030866636,0.016881874,0.41226336],"study_design_scores_gemma":[0.21226348,0.14617464,0.098685406,0.022549102,0.04981332,0.0016411437,0.00048666444,0.2138684,0.009012342,0.16031347,0.08439448,0.0007976586],"about_ca_topic_score_codex":0.0002737253,"about_ca_topic_score_gemma":0.0003416204,"teacher_disagreement_score":0.7446513,"about_ca_system_score_codex":0.0014535589,"about_ca_system_score_gemma":0.0027180691,"threshold_uncertainty_score":0.91828763},"labels":[],"label_agreement":null},{"id":"W4307232309","doi":"10.1177/13524585221129963","title":"Low socioeconomic status was associated with a higher mortality risk in multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Dalhousie University; University of Saskatchewan; University of British Columbia Hospital; Okanagan University College; Nova Scotia Health Authority; University of British Columbia, Okanagan Campus; University of British Columbia","funders":"Canadian Institutes of Health Research; Fondation pour l'Aide à la Recherche sur la Sclérose en Plaques","keywords":"Socioeconomic status; Hazard ratio; Medicine; Confidence interval; Proportional hazards model; Multiple sclerosis; Demography; Internal medicine; Environmental health; Population","score_opus":0.11544156771061344,"score_gpt":0.29510060760051626,"score_spread":0.17965903988990284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307232309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988674,0.0003438915,0.000065239656,0.00014539073,0.000006694725,0.0000028758088,0.00021128038,0.0000018917749,0.0003554706],"genre_scores_gemma":[0.99977535,0.000061892904,0.00002190504,0.0000085140855,0.000005649023,0.0000014492983,0.000074221905,3.9691125e-7,0.000050623636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996563,0.00011376532,0.000040844505,0.000051159306,0.00007128852,0.000066628934],"domain_scores_gemma":[0.9982457,0.00033863235,0.0009145302,0.00008815722,0.00015762555,0.00025536228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000671091,0.00014413419,0.00020072378,0.0005304428,0.00030312422,0.00047229565,0.00018007711,0.00024126729,0.0024053426],"category_scores_gemma":[0.0034320136,0.00010127025,0.00040978304,0.0005823772,0.0002141802,0.00020016362,0.0004749025,0.00053255557,0.00011389355],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087561304,0.000011140318,0.9988675,0.000009765277,0.000050194503,0.0000362332,0.000029709325,0.00001909097,0.00006246598,0.000016298833,0.0000365334,0.00077348785],"study_design_scores_gemma":[0.0000025139234,0.000028730929,0.9995933,0.0000067972196,0.000021616212,0.00007450651,0.000055126227,0.000086710344,0.000030127534,0.00003411033,0.00006545434,0.0000010789516],"about_ca_topic_score_codex":0.005771304,"about_ca_topic_score_gemma":0.0052033667,"teacher_disagreement_score":0.005771304,"about_ca_system_score_codex":0.00023417268,"about_ca_system_score_gemma":0.00034879975,"threshold_uncertainty_score":0.011475444},"labels":[],"label_agreement":null},{"id":"W4307407860","doi":"10.1177/13524585221122207","title":"Polypharmacy and multiple sclerosis: A population-based study","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia Hospital","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada; Michael Smith Health Research BC","keywords":"Polypharmacy; Medicine; Odds ratio; Interquartile range; Population; Confidence interval; Internal medicine; Cohort; Pediatrics; Environmental health","score_opus":0.14314994726282745,"score_gpt":0.32806266336094864,"score_spread":0.18491271609812118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307407860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966311,0.0009820517,0.00011197635,0.0001902812,0.000010550957,0.00003115529,0.0014003912,0.000005215089,0.0006372059],"genre_scores_gemma":[0.9985399,0.00052983995,0.000116822535,0.0000947459,0.000018322055,0.000021797085,0.0005774733,0.0000017703885,0.000099320976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990765,0.00016659126,0.0001289721,0.00022445756,0.0002811626,0.0001223053],"domain_scores_gemma":[0.99797827,0.00022248087,0.0009913271,0.00012757178,0.00031585072,0.0003644502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010116984,0.00029135257,0.00038583053,0.0013359007,0.000717341,0.0010680803,0.00048509776,0.00079421944,0.0011917085],"category_scores_gemma":[0.002536852,0.00035056873,0.0006559304,0.0032981639,0.000438418,0.0007965409,0.00067262264,0.0010131733,0.00027032575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023982899,0.000025976917,0.999119,0.000016208352,0.00008657858,0.000023594193,0.000056882975,0.000011930406,0.000026581329,0.000009366229,0.00009060854,0.00050929625],"study_design_scores_gemma":[0.0000048738207,0.000036043897,0.99945563,0.000014946014,0.00004236851,0.00011523646,0.00011025226,0.000053070602,0.000005905107,0.000015629923,0.00014362225,0.000002542983],"about_ca_topic_score_codex":0.06661614,"about_ca_topic_score_gemma":0.0722059,"teacher_disagreement_score":0.06661614,"about_ca_system_score_codex":0.0010147695,"about_ca_system_score_gemma":0.0014046577,"threshold_uncertainty_score":0.13245678},"labels":[],"label_agreement":null},{"id":"W4308548584","doi":"10.1177/13524585221135883","title":"A journey with no roadmap—The need for validated criteria of the MS prodrome","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Prodrome; Prodromal Stage; Intervention (counseling); Stage (stratigraphy); Medicine; Multiple sclerosis; Disease; Psychology; Psychiatry; Cognitive impairment; Pathology","score_opus":0.12507845671618195,"score_gpt":0.31617450492836724,"score_spread":0.1910960482121853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308548584","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008288408,0.07543929,0.027764307,0.8648313,0.013863234,0.0015924765,0.0007311666,0.0006205254,0.0068692416],"genre_scores_gemma":[0.15095149,0.06813876,0.48212624,0.26859257,0.013572912,0.0068968977,0.0046745427,0.0006847488,0.00436183],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.89101,0.06205085,0.019207792,0.0053755837,0.01868051,0.0036752229],"domain_scores_gemma":[0.5665589,0.18865371,0.020097045,0.031134164,0.15984379,0.03371235],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.21135649,0.0028677557,0.007473433,0.010409188,0.0056158784,0.015431767,0.01099142,0.013532149,0.0063959407],"category_scores_gemma":[0.30471808,0.0023321684,0.0031835882,0.0031168703,0.0124425385,0.032140948,0.013137155,0.036150225,0.0038870953],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006427781,0.0013140326,0.03302295,0.0074596074,0.00038198908,0.0013689955,0.0060262354,0.0021936216,0.0020378726,0.05302114,0.34716827,0.54536253],"study_design_scores_gemma":[0.0009146718,0.002859234,0.05749178,0.053539015,0.0005490059,0.005687541,0.042801995,0.008268495,0.0013820343,0.28706977,0.5380103,0.0014261835],"about_ca_topic_score_codex":0.02603371,"about_ca_topic_score_gemma":0.0194345,"teacher_disagreement_score":0.21135649,"about_ca_system_score_codex":0.011568248,"about_ca_system_score_gemma":0.070394054,"threshold_uncertainty_score":0.9725379},"labels":[],"label_agreement":null},{"id":"W4310295951","doi":"10.1177/13524585221137502","title":"Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"EMD Serono; Multiple Sclerosis Society; Università di Catania; Multiple Sclerosis Society of Canada; H. Lundbeck A/S; International Progressive MS Alliance; Universität Basel; Merck KGaA; Univerzita Karlova v Praze; Biogen; Celgene; Alexion Pharmaceuticals; Teva Pharmaceutical Industries; GlaxoSmithKline; Sanofi; Fondation Brain Canada; Pfizer","keywords":"Teriflunomide; Cladribine; Fingolimod; Medicine; Discontinuation; Multiple sclerosis; Dimethyl fumarate; Internal medicine; Hazard ratio; Clinical trial; Confidence interval; Immunology","score_opus":0.2799543506146697,"score_gpt":0.3646852724158959,"score_spread":0.08473092180122616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310295951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.962537,0.0077539263,0.0004250793,0.00018586677,0.000034836976,0.00028550782,0.02636643,0.000036405956,0.002374844],"genre_scores_gemma":[0.9739136,0.0022040533,0.0004649406,0.00015133385,0.00005193828,0.0002545141,0.022672819,0.000026097287,0.0002607906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.990213,0.0050035766,0.0013728531,0.0013395515,0.0018429938,0.00022804007],"domain_scores_gemma":[0.9747791,0.008607925,0.012142038,0.0019900925,0.0016957836,0.00078507146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011159331,0.00036277625,0.001520788,0.0009029684,0.00022886929,0.0011363741,0.0008695016,0.00048593176,0.002046916],"category_scores_gemma":[0.019348446,0.0002445714,0.0022979588,0.0018541259,0.00027262882,0.0008606705,0.0007494318,0.0005759526,0.00036841788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14727826,0.0007802347,0.77316916,0.0028164252,0.019405795,0.00009690389,0.00026913025,0.0016708137,0.0011859747,0.00029381205,0.005071427,0.04796199],"study_design_scores_gemma":[0.01377729,0.0093589835,0.9599612,0.0004768429,0.009160082,0.00039542918,0.00016336371,0.0014591684,0.0010561899,0.0001313685,0.0040097586,0.000050363324],"about_ca_topic_score_codex":0.0020998297,"about_ca_topic_score_gemma":0.0025732191,"teacher_disagreement_score":0.011159331,"about_ca_system_score_codex":0.00072205707,"about_ca_system_score_gemma":0.0007186942,"threshold_uncertainty_score":0.059016883},"labels":[],"label_agreement":null},{"id":"W4312095631","doi":"10.1177/13524585221137500","title":"Magnetization transfer saturation reveals subclinical optic nerve injury in pediatric-onset multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Calgary; McGill University; University of Toronto; Montreal Neurological Institute and Hospital; Hospital for Sick Children","funders":"Ontario Institute for Regenerative Medicine; Stem Cell Network; Multiple Sclerosis Scientific Research Foundation; National Multiple Sclerosis Society","keywords":"Subclinical infection; Optic neuritis; Multiple sclerosis; White matter; Magnetic resonance imaging; Optic nerve; Magnetization transfer; Medicine; Ophthalmology; Nuclear medicine; Pathology; Radiology","score_opus":0.11076823799718633,"score_gpt":0.3151943155756983,"score_spread":0.204426077578512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312095631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99965346,0.00010961352,0.00011875796,0.00000644798,6.9601134e-7,0.0000018080488,0.000033326618,0.0000038896956,0.000071993265],"genre_scores_gemma":[0.9997377,0.000057801684,0.00013752894,0.000003750916,0.0000019622391,0.0000022326853,0.000039630024,0.0000014466201,0.000017977272],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999747,0.00007499778,0.000028278597,0.000057835856,0.00005647465,0.000035429246],"domain_scores_gemma":[0.9977404,0.00058938714,0.0013557844,0.00006987491,0.00014195198,0.00010261968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007239791,0.00044250843,0.00026854966,0.0008424938,0.000156902,0.00031102952,0.00019773516,0.00020230141,0.0009370695],"category_scores_gemma":[0.0026338603,0.00016054398,0.00021027568,0.00045088795,0.0003906547,0.00033276447,0.0003362146,0.0001911424,0.000072044626],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015495268,0.000014712973,0.99579996,0.000023439601,0.00003315332,0.00022298635,0.00007535726,0.000076300974,0.0015844284,0.00001537208,0.000018987814,0.0019802547],"study_design_scores_gemma":[0.0000040231566,0.00020601704,0.99658126,0.000009869634,0.000041838695,0.0014650958,0.00012825773,0.00047071272,0.000994097,0.00004663764,0.00004992064,0.000002273352],"about_ca_topic_score_codex":0.0023140481,"about_ca_topic_score_gemma":0.0026313572,"teacher_disagreement_score":0.0023140481,"about_ca_system_score_codex":0.00027610472,"about_ca_system_score_gemma":0.0003505659,"threshold_uncertainty_score":0.004601121},"labels":[],"label_agreement":null},{"id":"W4315699728","doi":"10.1177/13524585221144742","title":"Plasma neurofilament light chain in children with relapsing MS receiving teriflunomide or placebo: A post hoc analysis of the randomized TERIKIDS trial","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"Sanofi","keywords":"Teriflunomide; Medicine; Placebo; Multiple sclerosis; Post-hoc analysis; Internal medicine; Mallinckrodt; Lesion; Gastroenterology; Nuclear medicine; Surgery; Pathology; Immunology; Fingolimod","score_opus":0.052434812144482666,"score_gpt":0.28791079438869954,"score_spread":0.23547598224421687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315699728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974292,0.0012590239,0.00015565935,0.00011709268,0.00009064328,0.00032072366,0.0003378332,0.000021297496,0.00026855283],"genre_scores_gemma":[0.9969296,0.00057364395,0.00046408433,0.00012950829,0.00015844281,0.0006678081,0.0005226561,0.000013296309,0.00054101174],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9983455,0.0010128815,0.000106065534,0.00022021704,0.000094764044,0.0002206301],"domain_scores_gemma":[0.9977064,0.001070136,0.0005481829,0.00019339434,0.00010832797,0.0003734545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029182963,0.0013436403,0.004602618,0.00031652654,0.00031584618,0.0008876447,0.0006959245,0.0010228095,0.0034221283],"category_scores_gemma":[0.0028505127,0.0005256998,0.0030425193,0.0003303552,0.0007541379,0.00081460376,0.0004164653,0.0020985145,0.0003619258],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9899742,0.0010803826,0.0027023426,0.00014192222,0.001372736,0.000030645595,0.000026978467,0.00014624966,0.0010334317,0.000020661568,0.00013770905,0.0033326354],"study_design_scores_gemma":[0.6951473,0.25152516,0.04406778,0.000052649902,0.0051299506,0.00013323367,0.00012412207,0.0011382883,0.0017138439,0.00013216659,0.0007950406,0.00004038703],"about_ca_topic_score_codex":0.0007563845,"about_ca_topic_score_gemma":0.0011227251,"teacher_disagreement_score":0.004602618,"about_ca_system_score_codex":0.00073037564,"about_ca_system_score_gemma":0.00091957214,"threshold_uncertainty_score":0.015433669},"labels":[],"label_agreement":null},{"id":"W4317434080","doi":"10.1177/13524585221144413","title":"Family health conditions and parental occupational status modify the relationship between pediatric-onset multiple sclerosis and parental health-related quality of life","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Ontario; University of Toronto; SickKids Foundation; University of Manitoba","funders":"Multiple Sclerosis Society; Multiple Sclerosis Society of Canada","keywords":"Medicine; Quality of life (healthcare); Multiple sclerosis; Psychological intervention; Socioeconomic status; Health related quality of life; Pediatrics; Psychiatry; Population; Disease; Internal medicine; Environmental health","score_opus":0.36361244332769493,"score_gpt":0.40322223284810377,"score_spread":0.039609789520408833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317434080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986261,0.00045353835,0.00007915497,0.00012864379,0.0000050559775,0.0000034146437,0.00016309622,0.0000030875844,0.00053791766],"genre_scores_gemma":[0.99951863,0.00015873661,0.0000788156,0.000013901105,0.0000032099329,0.000002083672,0.00010003672,9.408851e-7,0.00012372079],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995332,0.00015503142,0.000026505706,0.00006690967,0.000087443106,0.0001309693],"domain_scores_gemma":[0.9977998,0.00062215043,0.0008880049,0.00011479413,0.00016911874,0.0004059637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007061707,0.00027079214,0.00017668481,0.00035884572,0.00043125395,0.00058076414,0.00035038948,0.00028125668,0.0034632196],"category_scores_gemma":[0.00423455,0.00015084332,0.00051886623,0.00042323951,0.00028292442,0.000288105,0.00041798444,0.00047052337,0.000098910685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003156984,0.000013386571,0.9986979,0.000004515997,0.00004624959,0.00003444784,0.000051062318,0.00004337307,0.00004506689,0.000018311535,0.000036709145,0.0009773979],"study_design_scores_gemma":[0.0000012863154,0.00001859685,0.99956876,0.000007792131,0.000026812966,0.000056754816,0.000093275914,0.000113388734,0.000023666375,0.000015198425,0.000073299176,0.0000011983536],"about_ca_topic_score_codex":0.077051006,"about_ca_topic_score_gemma":0.106575206,"teacher_disagreement_score":0.077051006,"about_ca_system_score_codex":0.0008152366,"about_ca_system_score_gemma":0.0014633908,"threshold_uncertainty_score":0.15320504},"labels":[],"label_agreement":null},{"id":"W4317726029","doi":"10.1177/13524585221146270","title":"The Canadian Multiple Sclerosis Pregnancy Study: First-trimester miscarriages in women with multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of British Columbia","funders":"","keywords":"Multiple sclerosis; Miscarriage; Pregnancy; Medicine; Obstetrics; First trimester; Population; Gynecology; Abortion; Gestation; Psychiatry; Biology","score_opus":0.11699582429014671,"score_gpt":0.289420003314446,"score_spread":0.1724241790242993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317726029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96314913,0.014744227,0.00021522742,0.0021738478,0.00006121984,0.00027796588,0.010696089,0.000021783933,0.008660499],"genre_scores_gemma":[0.992007,0.0045670713,0.00034100222,0.00035145384,0.000022406004,0.00009718998,0.0019470638,0.000005786211,0.0006610822],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99872524,0.0001995684,0.000107475964,0.00012453146,0.0006662667,0.00017694512],"domain_scores_gemma":[0.9974795,0.0004509888,0.001120394,0.00010702565,0.0005307892,0.0003113467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001265202,0.0002045272,0.00033365996,0.0012442442,0.0012511826,0.0005309122,0.000821148,0.0005001003,0.0019031162],"category_scores_gemma":[0.0061746393,0.00021233798,0.00031313184,0.0024405038,0.00034936398,0.00033920154,0.00048116903,0.0006823725,0.0001564729],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003131275,0.00003431411,0.9885638,0.00016766296,0.00008184256,0.000133273,0.0004817959,0.0000324903,0.00010153438,0.0001253206,0.0021424019,0.007822539],"study_design_scores_gemma":[0.000023736276,0.000038753522,0.9971623,0.00017301271,0.00006312059,0.00036298583,0.00036638023,0.00010179548,0.000064252315,0.00003164044,0.0016049185,0.0000072114344],"about_ca_topic_score_codex":0.75466913,"about_ca_topic_score_gemma":0.7760779,"teacher_disagreement_score":0.24533087,"about_ca_system_score_codex":0.004046492,"about_ca_system_score_gemma":0.007119581,"threshold_uncertainty_score":0.4935513},"labels":[],"label_agreement":null},{"id":"W4318191253","doi":"10.1177/13524585221149886","title":"Should trigeminal neuralgia be considered a clinically isolated syndrome?","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Trigeminal Neuralgia and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Toronto Western Hospital; University of Toronto; University Health Network","funders":"Institute of Neurosciences, Mental Health and Addiction; Canadian Institutes of Health Research; Biogen; Bristol-Myers Squibb","keywords":"Medicine; Trigeminal neuralgia; Multiple sclerosis; Magnetic resonance imaging; Confusion; Clinically isolated syndrome; Lesion; Dermatology; Radiology; Pediatrics; Surgery; Psychiatry; Psychology","score_opus":0.23247750599618605,"score_gpt":0.34816085855762907,"score_spread":0.11568335256144302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318191253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6158315,0.093970895,0.013361441,0.19329073,0.01566561,0.00047558203,0.00024106221,0.0004340941,0.06672906],"genre_scores_gemma":[0.946157,0.0132083045,0.0036338952,0.019556144,0.015765898,0.000060582566,0.0001097649,0.000046889105,0.0014615932],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.998577,0.00033648463,0.00022208485,0.00019248658,0.00031153654,0.00036038234],"domain_scores_gemma":[0.99726415,0.001196068,0.00042147574,0.00011552235,0.0004738445,0.0005289844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014096274,0.0009294855,0.001348395,0.0018021478,0.0020808456,0.0020545148,0.0011191495,0.0076519796,0.0025119472],"category_scores_gemma":[0.0129775,0.00040958132,0.00064861984,0.0009269998,0.0033983106,0.0036875515,0.0012107003,0.0051408084,0.0010609395],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039837416,0.00011328889,0.06386871,0.0003613429,0.0000510841,0.86773115,0.0012306514,0.0002686251,0.0034837248,0.003494654,0.013562545,0.045435827],"study_design_scores_gemma":[0.00007279963,0.00014602972,0.012165855,0.0005906868,0.00003580135,0.9645868,0.0024338742,0.00094193965,0.0006901875,0.006544992,0.011743531,0.000047579535],"about_ca_topic_score_codex":0.0020062537,"about_ca_topic_score_gemma":0.0024718882,"teacher_disagreement_score":0.0076519796,"about_ca_system_score_codex":0.0013140811,"about_ca_system_score_gemma":0.0020248774,"threshold_uncertainty_score":0.009534299},"labels":[],"label_agreement":null},{"id":"W4319657027","doi":"10.1177/13524585231154251","title":"A spoonful of sugar: The risks of negative health outcomes of polypharmacy in MS is a bitter reality","year":2023,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Polypharmacy; Medicine; Sugar; Environmental health; Food science; Chemistry; Intensive care medicine","score_opus":0.4001819585483665,"score_gpt":0.4381822156936194,"score_spread":0.0380002571452529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319657027","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00050432514,0.0010706836,0.000044334753,0.99176776,0.0058231493,0.000002049117,0.000019480252,0.0000066624993,0.0007616433],"genre_scores_gemma":[0.0073593594,0.001570738,0.00018572494,0.9320492,0.057301104,0.000013847014,0.0000195231,0.0000151965305,0.0014851725],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9917243,0.003993711,0.0011569627,0.000677659,0.0019893397,0.00045804103],"domain_scores_gemma":[0.92108446,0.058156706,0.0047118827,0.0018914668,0.0067213583,0.0074340785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009889459,0.00063906744,0.0023740195,0.0011344764,0.004487737,0.0043475083,0.0017635184,0.04348488,0.0055092424],"category_scores_gemma":[0.08372215,0.00070178905,0.0011741555,0.0011782432,0.00436624,0.0071993074,0.0022005371,0.053191572,0.0031765956],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023863229,0.0001032758,0.005689506,0.00018693577,0.00014720773,0.003679457,0.0006451569,0.00006741011,0.0002320685,0.004717821,0.9469019,0.037390735],"study_design_scores_gemma":[0.0006093042,0.0004449399,0.013284859,0.0027074788,0.00035637835,0.01403241,0.004584931,0.0009962599,0.00039248422,0.058150884,0.9040854,0.00035466923],"about_ca_topic_score_codex":0.007062381,"about_ca_topic_score_gemma":0.009874352,"teacher_disagreement_score":0.04348488,"about_ca_system_score_codex":0.00335172,"about_ca_system_score_gemma":0.0045784866,"threshold_uncertainty_score":0.05230105},"labels":[],"label_agreement":null},{"id":"W4320856208","doi":"10.1177/13524585231153992","title":"Comparative effectiveness of natalizumab on cognition in multiple sclerosis: A cohort study","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia","funders":"Biogen; Sanofi; Novartis","keywords":"Natalizumab; Medicine; Odds ratio; Multiple sclerosis; Confidence interval; Internal medicine; Cohort; Logistic regression; Cognition; Physical therapy; Immunology; Psychiatry","score_opus":0.20783570689909384,"score_gpt":0.35965672994533526,"score_spread":0.15182102304624143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320856208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99699664,0.0019508445,0.00006325231,0.00003778809,0.000016711163,0.00004021593,0.0006245358,0.0000027683939,0.0002672221],"genre_scores_gemma":[0.99810815,0.0007682414,0.00009414724,0.00004002116,0.000029481567,0.000044026303,0.0008017151,0.0000024990718,0.00011178033],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996406,0.0019247986,0.0003614186,0.0005475745,0.0005562325,0.00020386976],"domain_scores_gemma":[0.99250424,0.0021220106,0.0029022887,0.000993551,0.0007225573,0.0007553483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005220262,0.0005371811,0.0010394076,0.0010299257,0.000513184,0.0009766853,0.00058150414,0.0008501687,0.0012537171],"category_scores_gemma":[0.011208097,0.00037581462,0.002046767,0.0013804671,0.00030648638,0.00051854237,0.0005167979,0.000646784,0.0002188647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033964008,0.00058549986,0.946782,0.00022335423,0.010180767,0.000171529,0.0001895487,0.00018660717,0.00048296296,0.00005942895,0.00027806562,0.0068962793],"study_design_scores_gemma":[0.0019867045,0.0054234033,0.98686975,0.00006191045,0.0041745123,0.0003063362,0.00012078908,0.0003433323,0.00016220933,0.000047781687,0.00047796432,0.000025246576],"about_ca_topic_score_codex":0.0050326884,"about_ca_topic_score_gemma":0.0043220916,"teacher_disagreement_score":0.005220262,"about_ca_system_score_codex":0.0006715917,"about_ca_system_score_gemma":0.00057252776,"threshold_uncertainty_score":0.027607739},"labels":[],"label_agreement":null},{"id":"W4321329773","doi":"10.1177/13524585231151953","title":"A national case–control study investigating demographic and environmental factors associated with NMOSD","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; University of New Brunswick; University of Calgary; Ottawa Hospital; Health Sciences Centre; London Health Sciences Centre; McGill University Health Centre; University of Ottawa; University of British Columbia; Western University; University of Toronto; Sunnybrook Health Science Centre; St. Michael's Hospital","funders":"","keywords":"Neuromyelitis optica; Medicine; Odds ratio; Menarche; Confidence interval; Logistic regression; Multiple sclerosis; Case-control study; Demography; Pediatrics; Internal medicine; Immunology","score_opus":0.13204145722125427,"score_gpt":0.29929219046200556,"score_spread":0.1672507332407513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321329773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99814606,0.00027256957,0.00020874811,0.00003467991,0.000010637835,0.00007622022,0.000570287,0.000004606844,0.00067638286],"genre_scores_gemma":[0.9977642,0.00023140178,0.0003828674,0.00008494864,0.00001293825,0.00009229771,0.0011377829,0.0000028376983,0.0002905932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863404,0.00032608106,0.00010988912,0.00041754756,0.0003528256,0.00015953465],"domain_scores_gemma":[0.9985043,0.00024306298,0.00032266552,0.0001830789,0.0004802714,0.00026667255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013566008,0.00034154797,0.0005099251,0.00096754025,0.0014329077,0.000633126,0.00067452824,0.00057976396,0.0014921629],"category_scores_gemma":[0.0029249387,0.0005318606,0.00036303542,0.0016716239,0.000586719,0.00028232732,0.00039328847,0.0005335331,0.0001915962],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019492784,0.00012294731,0.99764436,0.000023298846,0.0001244844,0.0002544951,0.00016379496,0.000016268212,0.00043605236,0.00003019794,0.00025019233,0.0007389947],"study_design_scores_gemma":[0.00005367977,0.00017212455,0.9984843,0.00001203191,0.00007298659,0.00046917636,0.00019387674,0.00008849724,0.000051561878,0.000013132507,0.00038386002,0.000004775978],"about_ca_topic_score_codex":0.21000867,"about_ca_topic_score_gemma":0.21780734,"teacher_disagreement_score":0.21000867,"about_ca_system_score_codex":0.0017990934,"about_ca_system_score_gemma":0.0015770136,"threshold_uncertainty_score":0.41757262},"labels":[],"label_agreement":null},{"id":"W4321376795","doi":"10.1177/13524585231151394","title":"Comparative effectiveness in multiple sclerosis: A methodological comparison","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cegep de Saint Jerome; Jewish General Hospital; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Université de Montréal","funders":"National Health and Medical Research Council; Canadian Institutes of Health Research; Novartis Pharma; EMD Serono; Grifols; Multiple Sclerosis Australia; Università di Catania; Multiple Sclerosis Society of Canada; Atara Biotherapeutics; Univerzita Karlova v Praze; Medical Research Council; Biogen; Celgene; Sanofi Genzyme; F. Hoffmann-La Roche; Monash University; Alexion Pharmaceuticals; Teva Pharmaceutical Industries; Bayer HealthCare; European Commission; Sanofi; Mylan; Bristol-Myers Squibb","keywords":"Propensity score matching; Marginal structural model; Fingolimod; Observational study; Medicine; Natalizumab; Hazard ratio; Confounding; Multiple sclerosis; Internal medicine; Confidence interval; Disease; Psychiatry","score_opus":0.5957892208114504,"score_gpt":0.446046245875831,"score_spread":0.14974297493561933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321376795","genre_codex":"review","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06684758,0.68792945,0.19259085,0.010907213,0.009172299,0.017367836,0.0028584953,0.00029376784,0.012032587],"genre_scores_gemma":[0.7893046,0.05943428,0.110059716,0.005570321,0.0028974374,0.030176332,0.001327452,0.00021953517,0.0010102538],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.30980626,0.61348337,0.03574864,0.009149229,0.030737981,0.0010745645],"domain_scores_gemma":[0.32653335,0.59628415,0.040923163,0.023427024,0.01147666,0.001355593],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.39691672,0.002186967,0.011154806,0.009449232,0.0010016923,0.006433925,0.0035505076,0.004994487,0.0073115462],"category_scores_gemma":[0.5793188,0.0011879705,0.02309433,0.009183982,0.0055271024,0.0045343013,0.0054504196,0.0033736771,0.0003573791],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055153802,0.0005231428,0.04226818,0.1392462,0.5144992,0.0002598433,0.0019198521,0.006356007,0.0005632764,0.06245066,0.005448695,0.17131118],"study_design_scores_gemma":[0.078256875,0.021721762,0.043775354,0.104554266,0.41528553,0.0018332438,0.0028873337,0.02426607,0.0021455532,0.25775158,0.04679374,0.00072878646],"about_ca_topic_score_codex":0.0013009178,"about_ca_topic_score_gemma":0.000882001,"teacher_disagreement_score":0.60308325,"about_ca_system_score_codex":0.006295746,"about_ca_system_score_gemma":0.0045573707,"threshold_uncertainty_score":0.7437091},"labels":[],"label_agreement":null},{"id":"W4321996644","doi":"10.1177/13524585231154780","title":"Acute central nervous system inflammation following COVID-19 vaccination: An observational cohort study","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Long-Term Effects of COVID-19","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Multiple sclerosis; Neuromyelitis optica; Acute disseminated encephalomyelitis; Vaccination; Myelitis; Transverse myelitis; Immunology; Cohort; Internal medicine; Myelin oligodendrocyte glycoprotein; Pediatrics; Experimental autoimmune encephalomyelitis","score_opus":0.10433635395973619,"score_gpt":0.343096173128407,"score_spread":0.23875981916867084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321996644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992004,0.00014100471,0.00006584896,0.000019142662,0.0000057249886,0.000022125549,0.00040049947,0.0000014077132,0.00014393589],"genre_scores_gemma":[0.99908304,0.00012136287,0.000074346215,0.000035740624,0.000011073735,0.000021585633,0.00058205804,0.000001659147,0.00006913894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988763,0.00025874205,0.00013277555,0.0003045071,0.00021243126,0.00021526293],"domain_scores_gemma":[0.99696237,0.00039154655,0.0014213425,0.0003431062,0.00033322425,0.0005484155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001239584,0.00038266255,0.00049292983,0.0006645255,0.00070218014,0.00078643596,0.00057086605,0.0005736289,0.0012507805],"category_scores_gemma":[0.0027388039,0.00044608527,0.00054797134,0.001308149,0.000405344,0.00066312135,0.0007131521,0.0007448732,0.00030399562],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012647672,0.000025644209,0.9993099,0.0000075600406,0.00004327574,0.000072812065,0.00006715423,0.000007735551,0.000094881194,0.0000044028707,0.00004810629,0.00019203468],"study_design_scores_gemma":[0.000018489667,0.00022990198,0.998816,0.000011455821,0.00004613606,0.00033318126,0.0002568012,0.000093378454,0.000029707764,0.0000071762984,0.0001531029,0.0000046542655],"about_ca_topic_score_codex":0.01917498,"about_ca_topic_score_gemma":0.02014851,"teacher_disagreement_score":0.01917498,"about_ca_system_score_codex":0.0006171124,"about_ca_system_score_gemma":0.0010091388,"threshold_uncertainty_score":0.038126767},"labels":[],"label_agreement":null},{"id":"W4322500069","doi":"10.1177/13524585221146430","title":"Primary results of a phase-III, randomized controlled trial of the Behavioral Intervention for increasing Physical Activity in Multiple Sclerosis project","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Multiple Sclerosis Society","keywords":"Randomized controlled trial; Medicine; Physical therapy; Multiple sclerosis; Intervention (counseling); Social cognitive theory; Physical activity; Clinical trial; Psychology; Internal medicine; Psychiatry; Developmental psychology","score_opus":0.19678577947251366,"score_gpt":0.3930734756397024,"score_spread":0.19628769616718875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322500069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6241367,0.010801488,0.0089271935,0.0024961287,0.0026523527,0.32488027,0.014104055,0.0008212982,0.01118052],"genre_scores_gemma":[0.609357,0.0027921603,0.014014627,0.0019060208,0.00064938836,0.36613372,0.0024192159,0.000080561,0.0026473107],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98656565,0.009245044,0.0011733909,0.0012071703,0.0009941917,0.0008145867],"domain_scores_gemma":[0.9919883,0.0035289666,0.001987278,0.0006051516,0.0009809847,0.00090933207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015018774,0.003371326,0.0056118346,0.001262378,0.0013499813,0.0018234296,0.0013087398,0.0033880298,0.013037758],"category_scores_gemma":[0.02134191,0.0010243634,0.0036995064,0.0010912457,0.0017994813,0.0016043856,0.0011402125,0.0035677077,0.0013872802],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96110356,0.01290089,0.00090272416,0.003328148,0.002305512,0.00003173853,0.000073945965,0.00035644468,0.00065168436,0.00020126051,0.0011363479,0.017007679],"study_design_scores_gemma":[0.9611368,0.035020124,0.0013088053,0.00017676676,0.0012040067,0.000011986597,0.000014704196,0.0001428359,0.0002792556,0.00017970477,0.0005168074,0.00000825943],"about_ca_topic_score_codex":0.0013098726,"about_ca_topic_score_gemma":0.0017302945,"teacher_disagreement_score":0.015018774,"about_ca_system_score_codex":0.00116831,"about_ca_system_score_gemma":0.004099721,"threshold_uncertainty_score":0.07942784},"labels":[],"label_agreement":null},{"id":"W4322617305","doi":"10.1177/13524585231151951","title":"Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cegep de Saint Jerome; Jewish General Hospital; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; St. Michael's Hospital; Université de Montréal","funders":"National Health and Medical Research Council; Allergan; EMD Serono; Università di Catania; Eisai; Canadian Institutes of Health Research; Ipsen; Fonds Wetenschappelijk Onderzoek; Koning Boudewijnstichting; Mazandaran University of Medical Sciences; Multiple Sclerosis Australia; Multiple Sclerosis Society; Trish Multiple Sclerosis Research Foundation; Multiple Sclerosis Society of Canada; Vlaamse regering; Amicus Therapeutics; International Progressive MS Alliance; Mylan; National Research Foundation; Novartis Pharma; Fondation Brain Canada; Merck KGaA; Univerzita Karlova v Praze; Bristol-Myers Squibb; University of Melbourne; Celgene; Fondazione Italiana Sclerosi Multipla; Biogen; Grifols; F. Hoffmann-La Roche; Monash University; Dementia Australia; Genesis Pharma; Alexion Pharmaceuticals; National Institute for Health and Care Research; Royal Melbourne Hospital Neuroscience Foundation; Medical Research Council; Teva Pharmaceutical Industries; Bayer HealthCare; Sanofi; Sanofi Genzyme; Universität Basel","keywords":"Medicine; Multiple sclerosis; Hazard ratio; Relapsing remitting; Confidence interval; Proportional hazards model; Internal medicine; Pediatrics; Clinically isolated syndrome; Disease; Physical therapy; Psychiatry","score_opus":0.1165934781784118,"score_gpt":0.3131029049408966,"score_spread":0.19650942676248478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322617305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974936,0.001682512,0.00007035076,0.0001633042,0.000009509235,0.000008062566,0.00023091734,0.0000055755277,0.00033610387],"genre_scores_gemma":[0.9993699,0.00028612267,0.00005010828,0.000019583593,0.00001763454,0.0000038822122,0.00016297415,0.0000014223738,0.00008828698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99943537,0.0002018029,0.00005980149,0.00010561475,0.000089124864,0.000108291875],"domain_scores_gemma":[0.9954893,0.00093599455,0.0026356964,0.00024187814,0.00018250122,0.0005146228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011452318,0.0003591452,0.00045240083,0.00061558565,0.00032089703,0.0005450446,0.00035024688,0.00038389955,0.0017805955],"category_scores_gemma":[0.0042129206,0.00026229385,0.0010674945,0.0006733198,0.00027981054,0.00044566553,0.0006699606,0.0009991546,0.0001763023],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006263746,0.000049049173,0.995194,0.000045009194,0.00016528557,0.000057244084,0.00007915633,0.000075346674,0.00010009715,0.00001732111,0.00011016075,0.0034808565],"study_design_scores_gemma":[0.000009200084,0.000082502185,0.9994236,0.000014695147,0.00006260761,0.000113413575,0.00004984511,0.000116902615,0.0000231415,0.000041766234,0.00005932755,0.0000030422827],"about_ca_topic_score_codex":0.002837852,"about_ca_topic_score_gemma":0.0046633473,"teacher_disagreement_score":0.002837852,"about_ca_system_score_codex":0.00023173193,"about_ca_system_score_gemma":0.000289416,"threshold_uncertainty_score":0.006056607},"labels":[],"label_agreement":null},{"id":"W4362521630","doi":"10.1177/13524585231161494","title":"Long-term follow-up of patients with relapsing multiple sclerosis from the CLARITY/CLARITY Extension cohort of CLASSIC-MS: An ambispective study","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Teva Pharmaceutical Industries; Biogen; Merck KGaA; Daiichi Sankyo Europe; Sanofi; National Multiple Sclerosis Society; Merck; EMD Serono; Multiple Sclerosis International Federation; Acorda Therapeutics; TG Therapeutics; Pfizer","keywords":"CLARITY; Multiple sclerosis; Cohort; Medicine; Term (time); Cohort study; Internal medicine; Immunology","score_opus":0.11665255913186826,"score_gpt":0.3097119977977462,"score_spread":0.19305943866587796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362521630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99950564,0.000088266715,0.000027631055,0.000009212456,0.0000027042524,0.0000062840627,0.00022648943,0.0000012736264,0.00013237243],"genre_scores_gemma":[0.9988115,0.00006510562,0.000045870864,0.000027196646,0.000013292423,0.000010193812,0.0008671341,0.0000016493876,0.00015794818],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999577,0.00007777143,0.00004194478,0.0001351214,0.00008778132,0.00008041513],"domain_scores_gemma":[0.9990614,0.00011625045,0.0002756887,0.00015262075,0.00013015734,0.0002638308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008186478,0.00033524816,0.0004964529,0.00058980857,0.000626702,0.00056531635,0.0003324816,0.00048352635,0.0011799807],"category_scores_gemma":[0.0014251005,0.00026533325,0.00048759862,0.0005598849,0.00021615379,0.0007122709,0.0005509211,0.0005087303,0.00038233236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012532065,0.00015115128,0.99481636,0.00001038019,0.00013636028,0.00022636761,0.00017205185,0.000033619533,0.00093243655,0.000009612135,0.00014074882,0.0021176084],"study_design_scores_gemma":[0.000034702705,0.00040114546,0.99875546,0.0000028608906,0.000052711926,0.00031036767,0.00013444772,0.00006919112,0.000056420577,0.000006469697,0.00017197453,0.000004286923],"about_ca_topic_score_codex":0.0027537947,"about_ca_topic_score_gemma":0.003097081,"teacher_disagreement_score":0.0027537947,"about_ca_system_score_codex":0.00024263782,"about_ca_system_score_gemma":0.00020139014,"threshold_uncertainty_score":0.005475521},"labels":[],"label_agreement":null},{"id":"W4362716945","doi":"10.1177/13524585231164296","title":"Management of vascular risk in people with multiple sclerosis at the time of diagnosis in England: A population-based study","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Imperial College London; Department of Health and Social Care; National Institute for Health and Care Research","keywords":"Medicine; Diabetes mellitus; Multiple sclerosis; Population; Internal medicine; Blood pressure; Confidence interval; Type 2 diabetes; Vascular disease; Endocrinology; Environmental health; Psychiatry","score_opus":0.05471533934303182,"score_gpt":0.28309148441163984,"score_spread":0.228376145068608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362716945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977296,0.00072053267,0.0000582439,0.0001831755,0.0000088183715,0.000019829497,0.00081641396,0.00000208547,0.00046141224],"genre_scores_gemma":[0.9988362,0.00041235934,0.000057320485,0.000092060625,0.00001463704,0.00002548029,0.00036840336,0.0000010614347,0.00019253691],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991371,0.00023006693,0.00016549841,0.00015740846,0.00017942183,0.00013057326],"domain_scores_gemma":[0.9973809,0.00027938242,0.0014179337,0.00011577677,0.00039892108,0.00040706267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079738995,0.0002383973,0.00063641224,0.0010360847,0.00053123746,0.00091464893,0.0004296768,0.0005800439,0.0014264577],"category_scores_gemma":[0.0032023173,0.00047173636,0.0005340521,0.0015736223,0.00035161857,0.0012472502,0.00097083213,0.0007193088,0.00025901894],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006134476,0.000035320616,0.9981894,0.00004159441,0.000048016387,0.00010660035,0.0005314577,0.000009704569,0.0000732439,0.000012802837,0.0001360718,0.0007543438],"study_design_scores_gemma":[0.000007673146,0.00005124833,0.9991541,0.000028320916,0.000017848139,0.00012915951,0.00045586666,0.000023365346,0.000008521787,0.000009153135,0.00011113547,0.0000035989904],"about_ca_topic_score_codex":0.05881024,"about_ca_topic_score_gemma":0.061436012,"teacher_disagreement_score":0.05881024,"about_ca_system_score_codex":0.00087750005,"about_ca_system_score_gemma":0.0006886852,"threshold_uncertainty_score":0.11693585},"labels":[],"label_agreement":null},{"id":"W4363645587","doi":"10.1177/13524585231162262","title":"Lesion-level correspondence and longitudinal properties of paramagnetic rim and slowly expanding lesions in multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital; NeuroRx Research (Canada)","funders":"Biogen","keywords":"Multiple sclerosis; Lesion; Nuclear medicine; Medicine; Concordance; Pathology; Internal medicine; Immunology","score_opus":0.3883739203172658,"score_gpt":0.34031671523631557,"score_spread":0.04805720508095024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4363645587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989299,0.00026160319,0.0003018308,0.000009178123,0.0000014806143,0.00000912057,0.000094883195,0.000014258816,0.00037779473],"genre_scores_gemma":[0.9994708,0.0000420006,0.0002708192,0.0000048156703,0.0000059614076,0.0000057998013,0.000105017774,0.0000044247963,0.0000903908],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997063,0.00007187742,0.000040915165,0.00008086491,0.00006861935,0.00003133926],"domain_scores_gemma":[0.9972466,0.00043080573,0.0016865488,0.00018929862,0.00027703823,0.00016971695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010358153,0.00017995267,0.00022715986,0.0011034396,0.0001814309,0.00041806576,0.00018824165,0.0002772784,0.0014005876],"category_scores_gemma":[0.0025230881,0.00017912957,0.00012991582,0.0004963041,0.00022795331,0.00041260239,0.00030511586,0.0002542943,0.00031647162],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014536658,0.00008430411,0.9624071,0.00007359282,0.00013665314,0.0003089607,0.00027679343,0.0003157387,0.023923134,0.000049736445,0.00011687726,0.010853436],"study_design_scores_gemma":[0.0000068246286,0.00026015373,0.9965796,0.0000037715536,0.000025512392,0.00091739534,0.000053123636,0.0003726464,0.001619065,0.000036487007,0.0001219452,0.0000034763175],"about_ca_topic_score_codex":0.0008131759,"about_ca_topic_score_gemma":0.0010034847,"teacher_disagreement_score":0.0014005876,"about_ca_system_score_codex":0.00016833849,"about_ca_system_score_gemma":0.00013545774,"threshold_uncertainty_score":0.005477965},"labels":[],"label_agreement":null},{"id":"W4365810870","doi":"10.1177/13524585231164295","title":"Employment status, productivity loss, and associated factors among people with multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; University of Toronto; Centre for Advancing Health Outcomes; St. Michael's Hospital; University of Calgary; St. Paul's Hospital; University of British Columbia","funders":"Multiple Sclerosis Society of Canada; Michael Smith Health Research BC; Fondation Brain Canada; Government of Alberta; University of Calgary; Biogen Idec; Roche","keywords":"Multiple sclerosis; Productivity; Medicine; Physical medicine and rehabilitation; Environmental health; Psychiatry; Economics","score_opus":0.09547479280071636,"score_gpt":0.28804981876593977,"score_spread":0.1925750259652234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365810870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99652797,0.0015794946,0.000033584012,0.00021868681,0.000010270373,0.000016943353,0.0008360181,0.0000025366082,0.00077453017],"genre_scores_gemma":[0.9991041,0.0003618692,0.000027736944,0.000023513092,0.0000059514737,0.000009045286,0.00035210067,6.357192e-7,0.00011500393],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99945766,0.00008023104,0.00004366281,0.000051513056,0.00021589515,0.00015113667],"domain_scores_gemma":[0.9986761,0.00018867501,0.0005904504,0.00004031146,0.00022247534,0.00028183174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010962626,0.00017455831,0.00034186523,0.0009773476,0.00067930925,0.00060707296,0.00042830152,0.00028115482,0.0012435622],"category_scores_gemma":[0.0037205524,0.000110792535,0.00031480542,0.0014295486,0.0002728868,0.00028427583,0.00046603926,0.00055536855,0.00013494257],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044892997,0.000030735915,0.99735224,0.000022302373,0.000028780385,0.000036322883,0.00010652579,0.000029600527,0.000021511094,0.00001044476,0.00012423912,0.002192356],"study_design_scores_gemma":[0.000001939888,0.000026905944,0.99963343,0.0000123037735,0.000009664769,0.000032067815,0.00013192052,0.000036711415,0.0000046106693,0.000011643404,0.00009742908,0.0000012634908],"about_ca_topic_score_codex":0.10514786,"about_ca_topic_score_gemma":0.11482458,"teacher_disagreement_score":0.10514786,"about_ca_system_score_codex":0.0010369493,"about_ca_system_score_gemma":0.0014012861,"threshold_uncertainty_score":0.2090717},"labels":[],"label_agreement":null},{"id":"W4367188801","doi":"10.1177/13524585231167740","title":"The Barancik lecture: Comorbidity in multiple sclerosis—Looking backward, looking forward","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Multiple Sclerosis Society","keywords":"Comorbidity; Medicine; Quality of life (healthcare); Multiple sclerosis; Disease; Psychological intervention; Intensive care medicine; Psychiatry; Internal medicine; Nursing","score_opus":0.1265485348171381,"score_gpt":0.31131437490942754,"score_spread":0.18476584009228944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367188801","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027071347,0.17957017,0.00044160621,0.6624979,0.15326296,0.00001208246,0.00007742968,0.000027806449,0.0038393913],"genre_scores_gemma":[0.0075717773,0.2650841,0.0012633989,0.25308266,0.45752463,0.00006436422,0.00013467582,0.00009485772,0.015179497],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957912,0.0019307336,0.00044576233,0.00040931773,0.0011119595,0.00031109108],"domain_scores_gemma":[0.9800434,0.009830153,0.000724243,0.00036613247,0.004838305,0.0041977996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011509847,0.0010826498,0.00174456,0.0023931696,0.0014989482,0.0045237355,0.0014030795,0.004825557,0.009215241],"category_scores_gemma":[0.034620605,0.0005194655,0.0009934315,0.0012198118,0.0028607585,0.0100486735,0.0032456734,0.019534545,0.0040690806],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000091608694,0.000022293501,0.00037028242,0.00036842242,0.000046351233,0.000111544185,0.00012009246,0.00003920232,0.00006729982,0.0025906658,0.94489825,0.051274117],"study_design_scores_gemma":[0.00012527716,0.00010223127,0.0032394624,0.004186149,0.00013981317,0.0012717339,0.00071271573,0.00018924172,0.00012752735,0.01631582,0.97350997,0.00008008995],"about_ca_topic_score_codex":0.0057033645,"about_ca_topic_score_gemma":0.009319557,"teacher_disagreement_score":0.011509847,"about_ca_system_score_codex":0.003398674,"about_ca_system_score_gemma":0.004984913,"threshold_uncertainty_score":0.060870647},"labels":[],"label_agreement":null},{"id":"W4372347164","doi":"10.1177/13524585231162586","title":"Ocrelizumab-treated patients with relapsing multiple sclerosis show volume loss rates similar to healthy aging","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NeuroRx Research (Canada); McGill University; University of British Columbia","funders":"F. Hoffmann-La Roche","keywords":"Ocrelizumab; Multiple sclerosis; Medicine; Internal medicine; Brain size; Neurodegeneration; White matter; Disease; Magnetic resonance imaging; Immunology; Rituximab","score_opus":0.09598644962089338,"score_gpt":0.30515463604979015,"score_spread":0.20916818642889679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4372347164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99839276,0.0009854194,0.00006830154,0.000014855101,0.000004075261,0.000015356281,0.000116241354,0.000004211824,0.00039866634],"genre_scores_gemma":[0.9995301,0.0001266417,0.000057332083,0.000023836245,0.0000064332976,0.000007863973,0.00015781072,0.0000010657538,0.00008889274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996333,0.00014568704,0.000036094338,0.00008213525,0.000067406356,0.000035285662],"domain_scores_gemma":[0.99878484,0.0002390017,0.0006794064,0.000089615896,0.00010179129,0.000105428415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092559605,0.00016245563,0.00040803416,0.00027788946,0.00019825186,0.00021501728,0.00013335743,0.00021088407,0.00081517646],"category_scores_gemma":[0.0011081657,0.000081936276,0.00028308306,0.00024434322,0.00019027322,0.00018771239,0.0001577598,0.00021798543,0.00010849993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071568987,0.00027126507,0.96381134,0.00011341448,0.0006876329,0.0002571877,0.00023171573,0.00024558158,0.0068109655,0.000041284853,0.0003534328,0.02001935],"study_design_scores_gemma":[0.00018304725,0.0020852254,0.9960502,0.000009934766,0.00013655571,0.00041859472,0.000053629148,0.00013350172,0.0005134304,0.00003266886,0.00037962,0.000003602948],"about_ca_topic_score_codex":0.0008338022,"about_ca_topic_score_gemma":0.001497463,"teacher_disagreement_score":0.00092559605,"about_ca_system_score_codex":0.00018376723,"about_ca_system_score_gemma":0.00013927624,"threshold_uncertainty_score":0.004895091},"labels":[],"label_agreement":null},{"id":"W4377565847","doi":"10.1177/13524585231166834","title":"Comparison of MRI T2-lesion evolution in pediatric MOGAD, NMOSD, and MS","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; Università degli Studi di Sassari; University College London","keywords":"Medicine; Multiple sclerosis; Neuromyelitis optica; Lesion; Magnetic resonance imaging; Optic neuritis; Radiology; Pathology; Psychiatry","score_opus":0.16180857687691566,"score_gpt":0.36998464860034486,"score_spread":0.2081760717234292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377565847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99942064,0.0002472226,0.00003928869,0.000005945019,0.0000017823104,0.0000049859295,0.00007783435,0.0000016352467,0.00020067263],"genre_scores_gemma":[0.9993979,0.00012360101,0.00011321387,0.000007884176,0.000008459752,0.000009489429,0.00029523676,0.000002616798,0.000041639643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995957,0.00009610056,0.00006401244,0.0001009481,0.000069462316,0.00007375393],"domain_scores_gemma":[0.9979925,0.00051072094,0.0008750542,0.00006336502,0.00020290891,0.00035542645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077834225,0.00031469887,0.00032566427,0.00116987,0.00021182094,0.0003699055,0.00019530972,0.000397856,0.00078076875],"category_scores_gemma":[0.0033833652,0.0001625049,0.0002476717,0.0006072356,0.00031348012,0.00049077737,0.00031368254,0.0002499774,0.00020860106],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047630788,0.000025241683,0.996461,0.000012828452,0.000022592196,0.00045000226,0.00006332477,0.000061207014,0.00039063275,0.000008552015,0.00003549769,0.0019928874],"study_design_scores_gemma":[0.000012781283,0.00034276507,0.9956701,0.000005894737,0.000027472599,0.0032730557,0.00009156154,0.00013683934,0.00027697906,0.000009784285,0.00014975511,0.0000030037106],"about_ca_topic_score_codex":0.0011066524,"about_ca_topic_score_gemma":0.0010476805,"teacher_disagreement_score":0.00116987,"about_ca_system_score_codex":0.00034226733,"about_ca_system_score_gemma":0.00019925703,"threshold_uncertainty_score":0.0041163564},"labels":[],"label_agreement":null},{"id":"W4379966936","doi":"10.1177/13524585231175975","title":"Clinical course of multiple sclerosis and patient experiences during breast cancer treatment","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Institutes of Health; National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Breast cancer; Medicine; Oncology; Cancer; Internal medicine; Psychiatry","score_opus":0.16626702301207255,"score_gpt":0.37074975278318534,"score_spread":0.2044827297711128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379966936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99777955,0.00042721993,0.000048919333,0.000531406,0.0000071113673,0.000012575525,0.000060723727,0.0000022553188,0.0011302461],"genre_scores_gemma":[0.99946135,0.00027952285,0.00004437324,0.00008171184,0.0000032104683,0.000008746663,0.00002857993,9.1414006e-7,0.00009167959],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983693,0.0010038909,0.00013612462,0.0000817642,0.00021636853,0.00019261951],"domain_scores_gemma":[0.99542457,0.001894095,0.0015725145,0.00007010127,0.00035835075,0.0006803127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017625039,0.00008198091,0.00023092907,0.00048682097,0.0014713366,0.0013356534,0.0003259152,0.0003294054,0.0011745034],"category_scores_gemma":[0.008861173,0.00012214173,0.00021495187,0.00067551766,0.0009943566,0.0009052977,0.0011456694,0.000670394,0.000088155764],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002134086,0.00017888715,0.6568608,0.00033740958,0.000075922624,0.002275322,0.31605843,0.00017729035,0.0007960908,0.00054176286,0.0016960689,0.02078861],"study_design_scores_gemma":[0.00001398701,0.00037325686,0.44359818,0.00029591194,0.000035503912,0.005298507,0.5429585,0.00023592573,0.00037685977,0.00031509667,0.0064457497,0.000052425163],"about_ca_topic_score_codex":0.0057247262,"about_ca_topic_score_gemma":0.0083681345,"teacher_disagreement_score":0.0057247262,"about_ca_system_score_codex":0.001380479,"about_ca_system_score_gemma":0.0013791701,"threshold_uncertainty_score":0.011382818},"labels":[],"label_agreement":null},{"id":"W4380730561","doi":"10.1177/13524585231176732","title":"Glial fibrillary acidic protein and multiple sclerosis progression independent of acute inflammation","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NeuroRx Research (Canada)","funders":"Biogen","keywords":"Multiple sclerosis; Expanded Disability Status Scale; Glial fibrillary acidic protein; Biomarker; Medicine; Magnetic resonance imaging; Internal medicine; Oncology; Lesion; Inflammation; Pathology; Gastroenterology; Immunology; Immunohistochemistry; Radiology; Biology","score_opus":0.09247211466150403,"score_gpt":0.31597513072361,"score_spread":0.22350301606210599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380730561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987618,0.00073218875,0.00009905083,0.000057553163,0.0000040633495,0.0000043877335,0.00012890837,0.0000042443253,0.0002077441],"genre_scores_gemma":[0.9994455,0.00015124053,0.00016660751,0.000013107669,0.000007599243,0.000004997097,0.000097545555,0.000001168023,0.000112276284],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997321,0.00010776412,0.000023300912,0.00005343336,0.000051437546,0.000031888627],"domain_scores_gemma":[0.9973652,0.00054985285,0.0015041454,0.000117788724,0.00021893714,0.00024419406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094026496,0.00030300952,0.00021654241,0.00042265147,0.0002006989,0.00035774332,0.00022611463,0.00032717636,0.0011878307],"category_scores_gemma":[0.0028825663,0.00012914633,0.0002052559,0.00047494523,0.00026678498,0.0003171863,0.00027285377,0.00048974645,0.00015243673],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007607647,0.000065235065,0.99418795,0.000043970642,0.00012321009,0.00005716386,0.000067367815,0.00008167778,0.0011639255,0.00003236069,0.000056146277,0.0033603106],"study_design_scores_gemma":[0.000007639059,0.0001969369,0.998882,0.0000107722035,0.00004533101,0.00019507569,0.000025758723,0.00025591376,0.00022858504,0.000060697435,0.000089510584,0.0000018498532],"about_ca_topic_score_codex":0.0021594781,"about_ca_topic_score_gemma":0.002047324,"teacher_disagreement_score":0.0021594781,"about_ca_system_score_codex":0.00020002242,"about_ca_system_score_gemma":0.0003557488,"threshold_uncertainty_score":0.0049726367},"labels":[],"label_agreement":null},{"id":"W4385230144","doi":"10.1177/13524585231182708","title":"Quality of life should be the primary outcome for disease modifying therapy trials in MS—No","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Multiple sclerosis; Medicine; Quality of life (healthcare); Disease; Clinical trial; Outcome (game theory); Intensive care medicine; Physical therapy; Internal medicine; Psychiatry","score_opus":0.6951723443484941,"score_gpt":0.4761179336233026,"score_spread":0.21905441072519144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385230144","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18541177,0.43943056,0.008005452,0.26514938,0.04550516,0.0039440608,0.0068752463,0.00021889311,0.04545956],"genre_scores_gemma":[0.85847944,0.03261117,0.009181387,0.068070665,0.017432826,0.0054431204,0.0027368267,0.000094638366,0.0059499615],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9163058,0.064226605,0.0101474505,0.002419424,0.005636066,0.0012646626],"domain_scores_gemma":[0.8950965,0.06707887,0.015611233,0.0054011806,0.0110706985,0.005741568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06927708,0.0009972084,0.0063728546,0.0014846801,0.0020982986,0.003867987,0.0010910876,0.005978505,0.008084605],"category_scores_gemma":[0.11662647,0.00053080847,0.004892177,0.0014831462,0.001912268,0.004097903,0.0015344043,0.0045205904,0.0020741592],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1818645,0.004174104,0.10350462,0.037451472,0.028821766,0.0004331148,0.00078263925,0.0014979802,0.0017412772,0.011121074,0.088042356,0.5405651],"study_design_scores_gemma":[0.13323903,0.06472311,0.43760756,0.035002775,0.034523565,0.0016235748,0.0014433014,0.0041515413,0.0055347476,0.05195682,0.22946085,0.000733115],"about_ca_topic_score_codex":0.0009219649,"about_ca_topic_score_gemma":0.0020399983,"teacher_disagreement_score":0.06927708,"about_ca_system_score_codex":0.0020134107,"about_ca_system_score_gemma":0.0035941217,"threshold_uncertainty_score":0.36637658},"labels":[],"label_agreement":null},{"id":"W4385564318","doi":"10.1177/13524585231190771","title":"Within-person fluctuations over three years in depression, anxiety, fatigue, and health-related quality of life in multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Toronto; St. Michael's Hospital; University of Manitoba","funders":"Institute of Musculoskeletal Health and Arthritis; Canadian Institutes of Health Research; Crohn's and Colitis Canada","keywords":"Multiple sclerosis; Depression (economics); Anxiety; Quality of life (healthcare); Psychology; Medicine; Clinical psychology; Psychiatry; Physical medicine and rehabilitation; Psychotherapist","score_opus":0.31198383347636255,"score_gpt":0.36934854967965136,"score_spread":0.05736471620328881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385564318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990723,0.00041847865,0.00013755202,0.00004106656,0.0000036733886,0.000006777072,0.00018886711,0.0000035589376,0.000127693],"genre_scores_gemma":[0.9995214,0.00010033757,0.0001135042,0.000015437106,0.000004218053,0.000014119798,0.00017210281,7.244689e-7,0.000058322126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991122,0.000460346,0.00009140151,0.00012997515,0.0001328301,0.00007334421],"domain_scores_gemma":[0.997387,0.0008739263,0.001148011,0.0001964326,0.00017322291,0.00022143657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025946703,0.00015623064,0.00027107578,0.0003954255,0.00026103944,0.00051167037,0.0002665615,0.0002939824,0.0007745181],"category_scores_gemma":[0.006203608,0.0001731539,0.0005016508,0.00057928584,0.00017913041,0.00037154922,0.0004808593,0.00048179252,0.000104087405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025265475,0.00006439682,0.9950852,0.000030518684,0.0002307439,0.000020196721,0.00014573362,0.00016710993,0.00011440039,0.000012903879,0.000091366914,0.0037847878],"study_design_scores_gemma":[0.00000584771,0.00011046242,0.9993755,0.000007999468,0.00004860386,0.000036774043,0.00006581497,0.00019972996,0.000048164537,0.000019891002,0.00007872492,0.0000025294723],"about_ca_topic_score_codex":0.004348309,"about_ca_topic_score_gemma":0.0057972944,"teacher_disagreement_score":0.004348309,"about_ca_system_score_codex":0.00035305048,"about_ca_system_score_gemma":0.00027026134,"threshold_uncertainty_score":0.013722062},"labels":[],"label_agreement":null},{"id":"W4385683574","doi":"10.1177/13524585231189674","title":"Intermediate outcomes for clinical trials of multiple sclerosis rehabilitation interventions: Conceptual and practical considerations","year":2023,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Multiple sclerosis; Psychological intervention; Rehabilitation; Physical medicine and rehabilitation; Clinical trial; Medicine; Physical therapy; Psychology; Psychiatry; Pathology","score_opus":0.8079637921712822,"score_gpt":0.5836405470830165,"score_spread":0.22432324508826573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385683574","genre_codex":"review","genre_gemma":"review","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001415107,0.8978561,0.028423473,0.059081003,0.004910957,0.005145554,0.00035976403,0.00012694781,0.0026809399],"genre_scores_gemma":[0.11530014,0.4420105,0.30724722,0.07124436,0.00994363,0.051978845,0.0010564831,0.00015366556,0.0010651151],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.37539732,0.52570736,0.06324998,0.0054123835,0.028756605,0.0014764284],"domain_scores_gemma":[0.18516746,0.7635501,0.025984949,0.008266769,0.014927913,0.0021028437],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.5120862,0.0027120742,0.016326008,0.007736215,0.0023599819,0.014979513,0.007569299,0.010614356,0.0035186752],"category_scores_gemma":[0.5921003,0.0018445211,0.0076676775,0.007588235,0.007883533,0.01378692,0.0063849287,0.015787635,0.0007657636],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003056127,0.00037111162,0.0036331245,0.24756195,0.0071805497,0.0002581357,0.0031616064,0.0018430287,0.0005498613,0.12480928,0.02822225,0.579353],"study_design_scores_gemma":[0.00469011,0.0018519422,0.0066745244,0.5241206,0.01299983,0.0007473152,0.0033011024,0.0052214437,0.00074777077,0.23042439,0.20885946,0.00036154073],"about_ca_topic_score_codex":0.00148453,"about_ca_topic_score_gemma":0.002991836,"teacher_disagreement_score":0.4879138,"about_ca_system_score_codex":0.008719343,"about_ca_system_score_gemma":0.022032397,"threshold_uncertainty_score":0.6016846},"labels":[],"label_agreement":null},{"id":"W4385683760","doi":"10.1177/13524585231189671","title":"Improving the efficiency of clinical trials in multiple sclerosis","year":2023,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact; University of Calgary; University of Manitoba","funders":"Sanofi Genzyme; Chugai Pharmaceutical; EMD Serono; National Institutes of Health; University College London; Genentech; Multiple Sclerosis Society; European Committee for Treatment and Research in Multiple Sclerosis; Teva Pharmaceutical Industries; National Institute for Health and Care Research; Regeneron Pharmaceuticals; H. Lundbeck A/S; Patient-Centered Outcomes Research Institute; Medical Research Council; Biogen; Merck KGaA; University College London Hospitals NHS Foundation Trust; Rosetrees Trust; U.S. Department of Defense; Sanofi; National Multiple Sclerosis Society","keywords":"Clinical trial; Multiple sclerosis; Medicine; Clinical study design; Sample size determination; Pathology","score_opus":0.7150611902149508,"score_gpt":0.5047581805542488,"score_spread":0.21030300966070203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385683760","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038864263,0.98818773,0.006616099,0.002443095,0.0003782415,0.0004474459,0.000032110955,0.000040899646,0.0014658185],"genre_scores_gemma":[0.025211295,0.9354658,0.031933524,0.00368479,0.0010409687,0.0020678535,0.000075470605,0.00005273121,0.0004676447],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.7153847,0.25265336,0.013093963,0.0037076732,0.014341579,0.0008186971],"domain_scores_gemma":[0.42780706,0.5333883,0.02119224,0.007462849,0.009119686,0.0010298564],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.1987726,0.0016600799,0.00528045,0.0053380327,0.0005028268,0.004180149,0.0029859873,0.0043765837,0.004620779],"category_scores_gemma":[0.32598728,0.0011502041,0.0039613126,0.0049021435,0.0038689077,0.0050300197,0.0027683843,0.0047612335,0.0009755749],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080647785,0.000108614506,0.0008103435,0.12904763,0.0027045135,0.00006111181,0.00033913803,0.0035509348,0.0003523832,0.0275395,0.008640408,0.82603896],"study_design_scores_gemma":[0.0047035376,0.0022489815,0.008546779,0.41490683,0.010396024,0.0013556235,0.00045746966,0.006136772,0.001647348,0.11934057,0.43005195,0.00020809648],"about_ca_topic_score_codex":0.0012937518,"about_ca_topic_score_gemma":0.0010978371,"teacher_disagreement_score":0.8012274,"about_ca_system_score_codex":0.005095521,"about_ca_system_score_gemma":0.010119463,"threshold_uncertainty_score":0.98805606},"labels":[],"label_agreement":null},{"id":"W4385683865","doi":"10.1177/13524585231189670","title":"Participant diversity in clinical trials of rehabilitation interventions for people with multiple sclerosis: A scoping review","year":2023,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"Multiple Sclerosis Society; European Committee for Treatment and Research in Multiple Sclerosis","keywords":"CINAHL; Psychological intervention; Rehabilitation; Generalizability theory; Medicine; Clinical trial; MEDLINE; Randomized controlled trial; Intervention (counseling); Physical therapy; Psychology; Clinical psychology; Physical medicine and rehabilitation; Gerontology; Psychiatry; Developmental psychology; Pathology","score_opus":0.8013474077247474,"score_gpt":0.5555542466176322,"score_spread":0.24579316110711524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385683865","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006730104,0.99501944,0.00071241957,0.00068670604,0.00028956367,0.00204891,0.00011484735,0.00001301147,0.00044204082],"genre_scores_gemma":[0.012783196,0.9741741,0.0038174146,0.00090566155,0.00018051684,0.0077179153,0.00023610864,0.00001418558,0.00017090843],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.8187622,0.104103915,0.054476395,0.0039841845,0.017537573,0.0011357768],"domain_scores_gemma":[0.5892553,0.35674602,0.032804858,0.0049999063,0.01518775,0.0010062343],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.13942292,0.0025650836,0.012626964,0.017912362,0.0020143432,0.008474671,0.0035552885,0.0060512037,0.0037229569],"category_scores_gemma":[0.33473796,0.002468496,0.009116669,0.019457584,0.0031683468,0.007533478,0.0047241566,0.0030904484,0.00052050635],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028380126,0.000036050395,0.000594533,0.89001155,0.0044577196,0.00007454906,0.0007734179,0.00014643066,0.00014118635,0.0007841042,0.0013145872,0.101382],"study_design_scores_gemma":[0.00019703481,0.00014447114,0.00085357425,0.974445,0.012342961,0.00010178647,0.00038201662,0.0000717426,0.00011772243,0.00060571975,0.010714253,0.00002369446],"about_ca_topic_score_codex":0.0045781345,"about_ca_topic_score_gemma":0.0115188295,"teacher_disagreement_score":0.8605771,"about_ca_system_score_codex":0.007595701,"about_ca_system_score_gemma":0.030431274,"threshold_uncertainty_score":0.7373477},"labels":[],"label_agreement":null},{"id":"W4385684499","doi":"10.1177/13524585231189678","title":"Enhancing involvement of people with multiple sclerosis in clinical trial design","year":2023,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Mental Health and Patient Involvement","field":"Health Professions","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Institute for Health and Care Research","keywords":"Clinical trial; Medicine; Clinical study design; Multiple sclerosis; Physical therapy; Pathology; Psychiatry","score_opus":0.7573874463475445,"score_gpt":0.4968671606159275,"score_spread":0.260520285731617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385684499","genre_codex":"review","genre_gemma":"review","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0068237986,0.8701078,0.031297226,0.059221856,0.0033009977,0.008358173,0.00021910162,0.00035463978,0.020316407],"genre_scores_gemma":[0.19234815,0.5811529,0.1419231,0.04751487,0.004001342,0.030195853,0.00029970938,0.00022779085,0.002336187],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.38527566,0.5661828,0.02683058,0.003780337,0.016373329,0.0015573106],"domain_scores_gemma":[0.20575967,0.7260388,0.032243393,0.015675481,0.016305126,0.0039775064],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.40352848,0.0009602952,0.0025972384,0.0033674317,0.0013457887,0.006582911,0.0029435237,0.0046809404,0.00530809],"category_scores_gemma":[0.50150853,0.0010444974,0.0026484116,0.0035005668,0.004295933,0.00834949,0.0070601306,0.0048910743,0.0009582776],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088045734,0.00024884747,0.0030137338,0.15610147,0.0016154972,0.00011691913,0.0059020533,0.00042373157,0.0005919336,0.011202496,0.012191941,0.80771095],"study_design_scores_gemma":[0.0037412962,0.0017792013,0.009032627,0.51412547,0.005633702,0.0011359252,0.0030051223,0.0007803802,0.0013861217,0.028178532,0.43106073,0.00014094969],"about_ca_topic_score_codex":0.0012590117,"about_ca_topic_score_gemma":0.0027829343,"teacher_disagreement_score":0.59647155,"about_ca_system_score_codex":0.0035710572,"about_ca_system_score_gemma":0.028890004,"threshold_uncertainty_score":0.7355556},"labels":[],"label_agreement":null},{"id":"W4385684744","doi":"10.1177/13524585231189677","title":"Enhancing diversity of clinical trial populations in multiple sclerosis","year":2023,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of Manitoba","funders":"","keywords":"Clinical trial; Health equity; Diversity (politics); Inclusion (mineral); Ethnic group; Cultural diversity; Equity (law); Medicine; Family medicine; Alternative medicine; MEDLINE; Psychology; Gerontology; Public health; Political science; Nursing; Social psychology; Pathology","score_opus":0.7515324232508435,"score_gpt":0.4915612959204515,"score_spread":0.25997112733039196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385684744","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0054315436,0.94980013,0.008168119,0.020293886,0.0016868344,0.0069969376,0.00020740453,0.000084167754,0.007331014],"genre_scores_gemma":[0.14340293,0.7302004,0.06807566,0.023683792,0.002377428,0.030422235,0.00055273034,0.00006949403,0.001215379],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.64796466,0.31209186,0.021820588,0.0032219195,0.013479927,0.0014210821],"domain_scores_gemma":[0.5405255,0.39928028,0.034811955,0.010862148,0.01115198,0.0033681104],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.25655743,0.0008795115,0.0036679457,0.0037353847,0.0012956767,0.0055196034,0.0032540483,0.0035592488,0.0051762643],"category_scores_gemma":[0.3277967,0.0008688172,0.004435498,0.004157061,0.003156238,0.006084485,0.006445906,0.0040990766,0.0004956061],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001609876,0.00021371552,0.0036113732,0.17012058,0.0032809975,0.000103814,0.002568516,0.0011038599,0.0004563055,0.015320199,0.010478361,0.7911324],"study_design_scores_gemma":[0.005738232,0.0020297316,0.015540456,0.6551511,0.010032321,0.0008185987,0.0017431325,0.00096763525,0.0010884593,0.034510933,0.27225372,0.0001256592],"about_ca_topic_score_codex":0.0012986573,"about_ca_topic_score_gemma":0.0024186715,"teacher_disagreement_score":0.74344254,"about_ca_system_score_codex":0.0033481377,"about_ca_system_score_gemma":0.018899009,"threshold_uncertainty_score":0.91679704},"labels":[],"label_agreement":null},{"id":"W4385684876","doi":"10.1177/13524585231189673","title":"Assessing heterogeneity of treatment effect in multiple sclerosis trials","year":2023,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"European Committee for Treatment and Research in Multiple Sclerosis; National Multiple Sclerosis Society","keywords":"Covariate; Multiple sclerosis; Clinical trial; Treatment effect; Medicine; Random effects model; Set (abstract data type); Statistics; Computer science; Meta-analysis; Mathematics; Internal medicine","score_opus":0.9378935239878043,"score_gpt":0.6287405873391883,"score_spread":0.3091529366486161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385684876","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026929725,0.9924077,0.005334576,0.0008172283,0.00020970912,0.00022336793,0.00012396449,0.000029150777,0.0005849946],"genre_scores_gemma":[0.022426158,0.96243924,0.011441216,0.0012757733,0.00070187636,0.0010855448,0.00024544488,0.00004434976,0.00034037966],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9201855,0.06050126,0.008921801,0.0023505837,0.007702105,0.0003387118],"domain_scores_gemma":[0.69497186,0.2886581,0.010708122,0.002373401,0.0029424403,0.00034591963],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.05999932,0.0016428448,0.008299526,0.0059781536,0.00031408295,0.0031447068,0.0024942032,0.002591927,0.0041585932],"category_scores_gemma":[0.17110825,0.0008424613,0.008280536,0.0052881246,0.0014950773,0.0024566127,0.0017818765,0.0026712536,0.0005769001],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006370755,0.00004482574,0.00091325934,0.2577477,0.022712097,0.0000858859,0.00013675884,0.0037310992,0.00031223224,0.013742131,0.0060930774,0.6938439],"study_design_scores_gemma":[0.0025404007,0.001622633,0.010866434,0.4507018,0.11099717,0.0015183365,0.0003326643,0.008945067,0.002463824,0.18050162,0.22919776,0.0003122956],"about_ca_topic_score_codex":0.0009862441,"about_ca_topic_score_gemma":0.0011893847,"teacher_disagreement_score":0.94000065,"about_ca_system_score_codex":0.0026323812,"about_ca_system_score_gemma":0.0041712625,"threshold_uncertainty_score":0.3173105},"labels":[],"label_agreement":null},{"id":"W4386591827","doi":"10.1177/13524585231196786","title":"Do the current MS clinical course descriptors need to change and if so how? A survey of the MS community","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Queen's University","funders":"Multiple Sclerosis Society; European Committee for Treatment and Research in Multiple Sclerosis; National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Disease; Clinical trial; Medicine; Clinical Practice; Medical physics; Psychology; Data science; Medical education; Computer science; Pathology; Family medicine; Psychiatry","score_opus":0.5135206727010455,"score_gpt":0.4242158015613792,"score_spread":0.08930487113966629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386591827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926622,0.0006194273,0.0002645226,0.005037571,0.000033644905,0.000060636932,0.00013216655,0.000008155885,0.0011818383],"genre_scores_gemma":[0.9972959,0.0006777052,0.00029738338,0.0013914756,0.000018846054,0.00004603054,0.000083575316,0.000005056413,0.00018408512],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.99302554,0.0034760556,0.00086166215,0.00042087756,0.0011984165,0.0010174293],"domain_scores_gemma":[0.9786846,0.0068661445,0.005524889,0.00040716576,0.0043737097,0.0041434495],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.012904397,0.00023501522,0.00048802266,0.0014315057,0.0017521483,0.0023409564,0.00052673783,0.0017279644,0.0015878923],"category_scores_gemma":[0.03350656,0.00036719098,0.00047363958,0.0011562962,0.0015693338,0.0041108644,0.0024329976,0.0016858306,0.00027347752],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017908892,0.00024087558,0.7992658,0.00062316365,0.00008057049,0.00051365816,0.1463329,0.00013127089,0.0008227922,0.0005933312,0.0035811379,0.04763546],"study_design_scores_gemma":[0.000036782956,0.0007389569,0.48065227,0.00071255217,0.000047976486,0.0011753899,0.49953747,0.0007297547,0.00022719197,0.0005302353,0.015492711,0.00011868216],"about_ca_topic_score_codex":0.0099033825,"about_ca_topic_score_gemma":0.007215818,"teacher_disagreement_score":0.9870956,"about_ca_system_score_codex":0.0016788467,"about_ca_system_score_gemma":0.0026622494,"threshold_uncertainty_score":0.06824577},"labels":[],"label_agreement":null},{"id":"W4386593437","doi":"10.1177/13524585231199030","title":"Arterial stiffness in persons with multiple sclerosis and controls: Does aerobic fitness account for group differences?","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Arterial stiffness; Aerobic exercise; Pulse wave velocity; Medicine; Cardiology; Multiple sclerosis; Internal medicine; VO2 max; Physical therapy; Blood pressure; Heart rate","score_opus":0.09777390901970498,"score_gpt":0.29310113539648697,"score_spread":0.195327226376782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386593437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99907744,0.0004210904,0.000099002595,0.00004493259,0.000014127964,0.0000054789593,0.00006606294,0.000004220951,0.0002676031],"genre_scores_gemma":[0.9997445,0.00005233484,0.00003558869,0.000015482003,0.000017032671,0.000004146469,0.00007779098,0.0000013505464,0.000051880146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991937,0.00022571266,0.00009673882,0.0002608642,0.000108511296,0.000114432965],"domain_scores_gemma":[0.99845016,0.0006435903,0.0004342644,0.00018899138,0.00009041094,0.00019248306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011650487,0.0004347509,0.0007647743,0.0010601993,0.00041204505,0.00072828674,0.0003575053,0.0009091828,0.0013936555],"category_scores_gemma":[0.003982669,0.00025238228,0.00058998936,0.00078982755,0.00043296628,0.0006783268,0.0005020655,0.0004241166,0.00018946451],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014236874,0.00009824371,0.992015,0.00003619748,0.00046112697,0.00018201696,0.00036671714,0.000055824574,0.00076146383,0.000056791516,0.00007040384,0.0044725235],"study_design_scores_gemma":[0.000013305863,0.00021961387,0.99909794,0.0000043628347,0.00008417869,0.000114451796,0.00017139353,0.00014086554,0.000040542353,0.00006855,0.000041611074,0.000003183819],"about_ca_topic_score_codex":0.0024794328,"about_ca_topic_score_gemma":0.0020152137,"teacher_disagreement_score":0.0024794328,"about_ca_system_score_codex":0.00015673468,"about_ca_system_score_gemma":0.00012220663,"threshold_uncertainty_score":0.0061614513},"labels":[],"label_agreement":null},{"id":"W4386703670","doi":"10.1177/13524585231195861","title":"GM-CSF is a marker of compartmentalised intrathecal inflammation in multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Occupational Cancer Research Centre; St. Michael's Hospital","funders":"","keywords":"Multiple sclerosis; Cytokine; Cerebrospinal fluid; Medicine; Granulocyte macrophage colony-stimulating factor; Immunology; Inflammation; Intrathecal; Blood–brain barrier; Colony-stimulating factor; Granulocyte; Internal medicine; Central nervous system; Biology; Haematopoiesis","score_opus":0.1785297872248042,"score_gpt":0.3206793718710953,"score_spread":0.1421495846462911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386703670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893064,0.00619429,0.002489162,0.00008401243,0.000034584737,0.000060718594,0.00041244412,0.00008516551,0.0013332732],"genre_scores_gemma":[0.9947174,0.00070939463,0.00387308,0.00003787887,0.000027560805,0.000057087713,0.00019807743,0.0000081901935,0.00037136933],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997247,0.00006174921,0.00003084104,0.000049664985,0.000103955,0.000029140512],"domain_scores_gemma":[0.999426,0.00013457352,0.0002462709,0.000038983708,0.00009865808,0.00005557096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040986176,0.00033178466,0.00027914494,0.0011726153,0.00017451971,0.00034649268,0.00021102144,0.00037446973,0.0010925584],"category_scores_gemma":[0.0009270943,0.000122052326,0.000116744886,0.00065774017,0.00043118777,0.00020706313,0.0002900715,0.00045047037,0.0002676637],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015042282,0.00007796172,0.08199591,0.0005124792,0.00008334848,0.0005328397,0.0002924536,0.00015542319,0.8936123,0.000119613636,0.00030879994,0.020804597],"study_design_scores_gemma":[0.00005993249,0.0017987784,0.6507796,0.00020631494,0.00018952937,0.007348624,0.00040866528,0.0013282353,0.33239922,0.0006698267,0.0047835354,0.000027694708],"about_ca_topic_score_codex":0.00047848673,"about_ca_topic_score_gemma":0.00051316374,"teacher_disagreement_score":0.0011726153,"about_ca_system_score_codex":0.00024823318,"about_ca_system_score_gemma":0.0002239378,"threshold_uncertainty_score":0.0036549568},"labels":[],"label_agreement":null},{"id":"W4386758337","doi":"10.1177/13524585231198751","title":"Accuracy of serum neurofilament light to identify contrast-enhancing lesions in multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Multiple Sclerosis Society of Canada; U.S. Department of Defense","keywords":"Medicine; Youden's J statistic; Multiple sclerosis; Magnetic resonance imaging; Area under the curve; Asymptomatic; Biomarker; Nuclear medicine; Expanded Disability Status Scale; Internal medicine; Gastroenterology; Pathology; Receiver operating characteristic; Radiology; Immunology; Chemistry","score_opus":0.17753575343134723,"score_gpt":0.35913334267466857,"score_spread":0.18159758924332134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386758337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99369484,0.0036364621,0.0012160629,0.00010898498,0.00003737847,0.000013893955,0.00016370027,0.000075402335,0.0010532044],"genre_scores_gemma":[0.99902034,0.000169165,0.00059954927,0.000022555936,0.000010771929,0.000003777536,0.00010619717,0.0000045021357,0.000063242245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998197,0.0005754199,0.00025801532,0.00033978088,0.0005007953,0.000128967],"domain_scores_gemma":[0.98898405,0.005632438,0.0026357605,0.00055100734,0.0017379717,0.000458739],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005092041,0.00057312945,0.0005113015,0.0015238102,0.00025045098,0.001002233,0.00041445834,0.00082658604,0.00056052697],"category_scores_gemma":[0.016267408,0.00026148758,0.00045173374,0.0004353821,0.00042894404,0.00064731494,0.00039465987,0.0005463283,0.00041923567],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007387029,0.000033121018,0.98710585,0.00003479979,0.00012990263,0.000035713932,0.000050440274,0.00048669917,0.0012068641,0.00001692392,0.00015427572,0.010006691],"study_design_scores_gemma":[0.000040464744,0.0006342756,0.9823025,0.00006965606,0.0002572303,0.001441771,0.00008870503,0.010731994,0.003678861,0.00018260865,0.0005522896,0.000019604084],"about_ca_topic_score_codex":0.0009843451,"about_ca_topic_score_gemma":0.0013201601,"teacher_disagreement_score":0.005092041,"about_ca_system_score_codex":0.00037632437,"about_ca_system_score_gemma":0.00023037488,"threshold_uncertainty_score":0.026929617},"labels":[],"label_agreement":null},{"id":"W4386909919","doi":"10.1177/13524585231197926","title":"Intimate partner violence and multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Intimate Partner and Family Violence","field":"Social Sciences","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; St. Michael's Hospital; University of Toronto","funders":"","keywords":"Domestic violence; Medicine; Population; Resource (disambiguation); Multiple sclerosis; Family medicine; Poison control; Psychology; Psychiatry; Medical emergency; Suicide prevention; Nursing; Environmental health","score_opus":0.12239339110365859,"score_gpt":0.31528348877025125,"score_spread":0.19289009766659265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386909919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54014343,0.36453006,0.00052064325,0.03155911,0.00041192953,0.000052314106,0.0003832501,0.000015494505,0.062383812],"genre_scores_gemma":[0.9084432,0.08873771,0.00019520608,0.00095257914,0.000272518,0.000020799336,0.00007389957,0.0000020484322,0.0013021561],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989617,0.00058070995,0.00009096724,0.00006566411,0.00017094659,0.00013008442],"domain_scores_gemma":[0.99824333,0.0008242535,0.00060200127,0.000035788013,0.000094529154,0.00020014284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060987694,0.00012470306,0.0003084892,0.00092395634,0.0009228214,0.0011472671,0.0001801841,0.0006909249,0.0048740553],"category_scores_gemma":[0.0043007885,0.00010051444,0.0003164348,0.0013841492,0.00062610826,0.0007359367,0.0012734388,0.000897359,0.00020503896],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013638899,0.0003152429,0.67241347,0.0023342208,0.00036673527,0.0029742378,0.010764525,0.0003253801,0.00023332794,0.017771823,0.006921915,0.28544283],"study_design_scores_gemma":[0.000016003054,0.0002862245,0.8760698,0.009476384,0.00024000724,0.015009089,0.019462038,0.00034516805,0.00016764317,0.020103201,0.058781303,0.000043172986],"about_ca_topic_score_codex":0.004641302,"about_ca_topic_score_gemma":0.0059295567,"teacher_disagreement_score":0.0048740553,"about_ca_system_score_codex":0.0005382523,"about_ca_system_score_gemma":0.00096129754,"threshold_uncertainty_score":0.016305327},"labels":[],"label_agreement":null},{"id":"W4387210069","doi":"10.1177/13524585231201219","title":"Detecting isolated cognitive relapses in persons with MS","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"National Multiple Sclerosis Society","keywords":"Logistic regression; Multiple sclerosis; Confidence interval; Neuropsychology; Prospective cohort study; Cohort; Odds ratio; Psychology; Medicine; Cognitive decline; Demographics; Expanded Disability Status Scale; Demography; Cognition; Internal medicine; Disease; Psychiatry; Dementia","score_opus":0.11439181618834966,"score_gpt":0.31672161725117337,"score_spread":0.20232980106282372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387210069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99941134,0.00021554572,0.00004538692,0.00002510367,0.0000036799727,0.000011116573,0.000059720664,0.0000030139593,0.00022504278],"genre_scores_gemma":[0.9995938,0.00010086813,0.000104515624,0.000018655275,0.000008809474,0.000007303136,0.00009717468,9.2726043e-7,0.00006791596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994814,0.00017709968,0.00006695631,0.000094347655,0.00009771144,0.000082571816],"domain_scores_gemma":[0.9980009,0.000442736,0.0010461193,0.00008622771,0.00019181587,0.0002321776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012916046,0.00048756774,0.00041156885,0.0011392446,0.0004170366,0.000730558,0.0003834546,0.00055001443,0.0013450306],"category_scores_gemma":[0.0042532133,0.00023363097,0.00046092298,0.0005584214,0.00029951724,0.0005217897,0.00060639635,0.00069846,0.00027890498],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000115481234,0.00004945809,0.99769765,0.000011329185,0.000018140005,0.000054505166,0.000044898614,0.000013239894,0.000104929386,0.0000027328006,0.000028870583,0.0018586589],"study_design_scores_gemma":[0.000007669558,0.00029576087,0.99857163,0.000018564571,0.000033346416,0.0005545207,0.00019777523,0.00013092182,0.00011155157,0.0000136063745,0.00006153933,0.0000030634656],"about_ca_topic_score_codex":0.0021720456,"about_ca_topic_score_gemma":0.0031525013,"teacher_disagreement_score":0.0021720456,"about_ca_system_score_codex":0.00015908504,"about_ca_system_score_gemma":0.00028591402,"threshold_uncertainty_score":0.006830752},"labels":[],"label_agreement":null},{"id":"W4387599047","doi":"10.1177/13524585231202320","title":"Relapse recovery in relapsing–remitting multiple sclerosis: An analysis of the CombiRx dataset","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; University of Calgary","funders":"National Heart, Lung, and Blood Institute; Sanofi Genzyme; EMD Serono; Atara Biotherapeutics; BioDelivery Sciences International; Acorda Therapeutics; Sanofi; GW Pharmaceuticals; National Institutes of Health; Mylan; TG Therapeutics; Jazz Pharmaceuticals; AveXis; University of Texas Health Science Center at Houston; Pfizer; Biogen; Celgene; AbbVie; Cleveland Clinic Foundation; Bristol-Myers Squibb; Cleveland Clinic; Alexion Pharmaceuticals; Teva Pharmaceutical Industries; CSL Behring; MedDay Pharmaceuticals; Horizon Pharmaceuticals; Genentech; National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Relapsing remitting; Medicine; Proportional hazards model; Clinical trial; Internal medicine; Psychiatry","score_opus":0.15314911866077113,"score_gpt":0.3261595973250584,"score_spread":0.17301047866428726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387599047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87549746,0.0030088595,0.0005889923,0.00055552984,0.000048260456,0.00018547964,0.11897526,0.0002029676,0.00093717244],"genre_scores_gemma":[0.6843844,0.0008196048,0.0032098647,0.00033336403,0.000101284146,0.0006063057,0.3096292,0.000099696,0.00081624475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974733,0.0011533538,0.00030635681,0.0006283771,0.000305527,0.00013311753],"domain_scores_gemma":[0.9914554,0.0042669335,0.001921472,0.0015397657,0.00045485966,0.00036159347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005511022,0.00048231616,0.00169885,0.0010940097,0.0004817452,0.0012763689,0.0012230963,0.0011869898,0.0029232232],"category_scores_gemma":[0.015463263,0.00023933474,0.0014223089,0.0013154165,0.00029024994,0.00067114446,0.0010960172,0.00091516593,0.00082574325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023004832,0.0010147082,0.8500149,0.003379697,0.008838494,0.0014886637,0.00046645978,0.0063554035,0.0024058342,0.00071936974,0.062783904,0.039527755],"study_design_scores_gemma":[0.0028645075,0.0014668137,0.9473485,0.00036777265,0.0024455537,0.001995917,0.00034025562,0.020464197,0.0008919834,0.0006727646,0.021011714,0.00013000336],"about_ca_topic_score_codex":0.004794605,"about_ca_topic_score_gemma":0.0070240134,"teacher_disagreement_score":0.005511022,"about_ca_system_score_codex":0.00047098508,"about_ca_system_score_gemma":0.00068474375,"threshold_uncertainty_score":0.02914536},"labels":[],"label_agreement":null},{"id":"W4387661542","doi":"10.1177/13524585231199321","title":"Establishing the consistency of a voice recognition symbol digit modalities test analogue","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; London Health Sciences Centre; University of Toronto; Western University; Sunnybrook Health Science Centre","funders":"","keywords":"Multiple sclerosis; Audiology; Psychology; Reliability (semiconductor); Modalities; Replicate; Test (biology); Consistency (knowledge bases); Medicine; Computer science; Artificial intelligence; Mathematics; Psychiatry; Statistics","score_opus":0.18392184621282115,"score_gpt":0.30967384291786193,"score_spread":0.12575199670504078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387661542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99366623,0.0001458035,0.003252342,0.000027137017,0.00003462374,0.00013430383,0.00028140942,0.000028497692,0.002429776],"genre_scores_gemma":[0.997242,0.000027823147,0.0021753043,0.000019724543,0.000014832603,0.00007483898,0.00026980328,0.0000070282686,0.00016857956],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996786,0.0012013079,0.0005787894,0.00047294862,0.00084942323,0.00011155086],"domain_scores_gemma":[0.98483527,0.007567592,0.002294894,0.0011771184,0.0038206985,0.00030452738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004716518,0.0003190895,0.00041912997,0.0015396168,0.00022791635,0.0008142712,0.00064869184,0.0005444558,0.001901903],"category_scores_gemma":[0.025136571,0.00017013079,0.00042284172,0.00047463254,0.00063955283,0.0006685545,0.00079331326,0.00042270124,0.00044750565],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005658685,0.00018639198,0.9692169,0.000067096444,0.00019771565,0.00007873922,0.0006463148,0.0003236165,0.004682838,0.00022410956,0.00024274882,0.02356771],"study_design_scores_gemma":[0.000067041474,0.0010257009,0.991017,0.00003708662,0.00006927266,0.0005288148,0.00035501775,0.002695811,0.003332092,0.0002350512,0.00061859953,0.000018505125],"about_ca_topic_score_codex":0.0008324776,"about_ca_topic_score_gemma":0.0009041211,"teacher_disagreement_score":0.004716518,"about_ca_system_score_codex":0.00020231974,"about_ca_system_score_gemma":0.00031577118,"threshold_uncertainty_score":0.02494359},"labels":[],"label_agreement":null},{"id":"W4387948473","doi":"10.1177/13524585231204453","title":"The MoxFo initiative—Mechanisms of action: Biomarkers in multiple sclerosis exercise studies","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Gemeinnützige Hertie-Stiftung; Bundesministerium für Bildung und Forschung; Deutschen Multiple Sklerose Gesellschaft; Deutsche Forschungsgemeinschaft","keywords":"Multiple sclerosis; Medicine; Physical medicine and rehabilitation; Action (physics); Neuroscience; Physical therapy; Psychology; Immunology","score_opus":0.36178034326723996,"score_gpt":0.36979427815678834,"score_spread":0.00801393488954838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387948473","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034182865,0.5935202,0.032542456,0.2679287,0.015191413,0.008465109,0.013622173,0.0010847653,0.033462316],"genre_scores_gemma":[0.21860528,0.24909414,0.30238345,0.117472745,0.030111048,0.039452545,0.024777636,0.00063966203,0.017463468],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.94408536,0.038039412,0.0066228984,0.002272253,0.00704942,0.0019307159],"domain_scores_gemma":[0.8935359,0.042610396,0.029022034,0.005346002,0.02056059,0.008925112],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.19761005,0.0019514303,0.0033432327,0.007247052,0.0016471917,0.0065413904,0.0043409267,0.0056392793,0.004366605],"category_scores_gemma":[0.07719893,0.0005642935,0.002540049,0.0028769677,0.0024203714,0.0047451905,0.007756428,0.0033898444,0.0013639792],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010163976,0.0010260979,0.05804117,0.027099274,0.002264977,0.00024646035,0.0011803131,0.0006562881,0.0048812306,0.02000365,0.15015928,0.72427726],"study_design_scores_gemma":[0.004180035,0.0057349135,0.16820078,0.07315137,0.0048727877,0.0006315762,0.0009492436,0.0009380615,0.005011275,0.029202508,0.70676786,0.00035964168],"about_ca_topic_score_codex":0.0033629332,"about_ca_topic_score_gemma":0.0054550488,"teacher_disagreement_score":0.19761005,"about_ca_system_score_codex":0.0030420087,"about_ca_system_score_gemma":0.012508827,"threshold_uncertainty_score":0.9894897},"labels":[],"label_agreement":null},{"id":"W4387948873","doi":"10.1177/13524585231204459","title":"Safety of exercise training in multiple sclerosis: An updated systematic review and meta-analysis","year":2023,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Multiple Sclerosis Australia","keywords":"Medicine; Meta-analysis; Adverse effect; Relative risk; Physical therapy; Confidence interval; Population; Internal medicine; Multiple sclerosis; Randomized controlled trial; Psychiatry","score_opus":0.46289720579117344,"score_gpt":0.4002374185569418,"score_spread":0.06265978723423166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387948873","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021272728,0.99625254,0.00038935378,0.00024060326,0.00012794585,0.00019669105,0.0004901166,0.00001848918,0.00015691885],"genre_scores_gemma":[0.069981046,0.9245423,0.002109766,0.0010101986,0.00033100223,0.0008794251,0.0009283205,0.00002374312,0.00019427967],"study_design_codex":"systematic_review","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9861091,0.005481691,0.004823656,0.0011694753,0.0020482196,0.00036785015],"domain_scores_gemma":[0.96843016,0.01972615,0.0072873114,0.000859088,0.0033861976,0.00031120423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021349477,0.0025947664,0.017312186,0.009708503,0.00063663186,0.0031676018,0.0018881138,0.0022872875,0.0035569312],"category_scores_gemma":[0.04984589,0.0013670876,0.0353561,0.008291579,0.0007233553,0.0023707263,0.0017099273,0.0020162093,0.00028918622],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001752424,0.00003699196,0.0046032066,0.5552877,0.40721506,0.00013551449,0.00009334859,0.0004807381,0.00022719594,0.00012498356,0.0012129614,0.02882991],"study_design_scores_gemma":[0.0007515033,0.00023838728,0.0065782466,0.055968124,0.9329801,0.00020095444,0.00004076113,0.00016205673,0.0001279524,0.00023393189,0.0026832065,0.00003484533],"about_ca_topic_score_codex":0.005822924,"about_ca_topic_score_gemma":0.0115901,"teacher_disagreement_score":0.021349477,"about_ca_system_score_codex":0.0029297003,"about_ca_system_score_gemma":0.0056476383,"threshold_uncertainty_score":0.112908185},"labels":[],"label_agreement":null},{"id":"W4387949674","doi":"10.1177/13524585231204456","title":"The MoXFo initiative – study design: Considerations related to study design and methodology in exercise research for people with multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Multiple sclerosis; Research design; Physical medicine and rehabilitation; Physical therapy; Medicine; Psychology; Sociology; Psychiatry","score_opus":0.6401813634985462,"score_gpt":0.4601265371474156,"score_spread":0.18005482635113057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387949674","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015357281,0.036393877,0.43495518,0.093819745,0.018083896,0.38124585,0.0020099187,0.0008429907,0.017291186],"genre_scores_gemma":[0.025582278,0.0015229785,0.31685227,0.009965844,0.0014368948,0.6434314,0.00024872232,0.00013717308,0.0008223896],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.096356,0.8491006,0.03410928,0.003580652,0.014762416,0.002091011],"domain_scores_gemma":[0.23351349,0.62318385,0.04182599,0.05541069,0.039928243,0.0061377846],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.7987494,0.0021830383,0.006064393,0.005566442,0.005243966,0.010244791,0.0056637363,0.011909634,0.0053943167],"category_scores_gemma":[0.7386344,0.0024718035,0.004546131,0.0051114806,0.012238259,0.0069874227,0.009800165,0.007372906,0.0012876599],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028617723,0.0014341666,0.023360902,0.06686428,0.0049501564,0.000659127,0.03309668,0.0035380917,0.0027722297,0.20717832,0.100895785,0.52663255],"study_design_scores_gemma":[0.026400266,0.012229103,0.043518536,0.1272865,0.0046016565,0.0010167557,0.006513619,0.010480595,0.004570765,0.14743121,0.61508834,0.00086273276],"about_ca_topic_score_codex":0.0029557887,"about_ca_topic_score_gemma":0.0048917267,"teacher_disagreement_score":0.7987494,"about_ca_system_score_codex":0.007453003,"about_ca_system_score_gemma":0.036844525,"threshold_uncertainty_score":0.24817789},"labels":[],"label_agreement":null},{"id":"W4387949851","doi":"10.1177/13524585231204446","title":"The MoXFo initiative – adherence: Exercise adherence, compliance and sustainability among people with multiple sclerosis: An overview and roadmap for research","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Terminology; Context (archaeology); Compliance (psychology); Medicine; Psychological intervention; Sustainability; Categorization; MEDLINE; Psychology; Medical education; Applied psychology; Nursing; Political science; Social psychology","score_opus":0.3970842101185184,"score_gpt":0.42290155061528817,"score_spread":0.02581734049676976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387949851","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02509741,0.70053804,0.010210031,0.23863558,0.0036055462,0.0037636873,0.0010177026,0.00030034786,0.016831677],"genre_scores_gemma":[0.17933065,0.6299237,0.123625316,0.037458844,0.0049659275,0.016193945,0.0042134146,0.00015650227,0.0041317507],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9669495,0.021623941,0.0036355583,0.0012084165,0.0043885605,0.002193956],"domain_scores_gemma":[0.9483088,0.033888627,0.0038251532,0.0011117498,0.0077947737,0.005070923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08718456,0.0011047181,0.0029103889,0.00778757,0.0024255349,0.0055442383,0.0019405613,0.003684657,0.001998167],"category_scores_gemma":[0.0301878,0.0006052491,0.002565585,0.0047550374,0.0029671127,0.007310923,0.00931252,0.007009177,0.00041917711],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030137843,0.0006791513,0.017408486,0.028504279,0.00032757028,0.00015176213,0.010570615,0.00040330525,0.00038033983,0.017428052,0.0276871,0.896158],"study_design_scores_gemma":[0.00042247973,0.0044152774,0.13289301,0.26448017,0.0013230278,0.0010839095,0.02515044,0.0014968661,0.0009904666,0.029654605,0.53768504,0.0004047058],"about_ca_topic_score_codex":0.0103247315,"about_ca_topic_score_gemma":0.01893148,"teacher_disagreement_score":0.08718456,"about_ca_system_score_codex":0.0068971557,"about_ca_system_score_gemma":0.038081963,"threshold_uncertainty_score":0.46108156},"labels":[],"label_agreement":null},{"id":"W4387949950","doi":"10.1177/13524585231204451","title":"The MoxFo initiative – outcomes: Outcome measures in studies of exercise training in multiple sclerosis; scoping review of reviews and classification according to the ICF framework","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"International Classification of Functioning, Disability and Health; MEDLINE; Medicine; Physical therapy; Multiple sclerosis; Physical medicine and rehabilitation; Psychology; Rehabilitation","score_opus":0.6343627842457714,"score_gpt":0.4587632842730354,"score_spread":0.175599499972736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387949950","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020647014,0.9581443,0.0034532587,0.0027092404,0.00094442006,0.018214818,0.01119334,0.00018360795,0.00309228],"genre_scores_gemma":[0.02490366,0.8349324,0.032515917,0.002767617,0.00069774606,0.09204903,0.010796417,0.00013280913,0.0012044738],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9039885,0.032162108,0.045188233,0.004122601,0.012775675,0.0017628288],"domain_scores_gemma":[0.85141516,0.08340958,0.042143818,0.0045433054,0.01723965,0.0012484948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.085122034,0.0041022976,0.016181383,0.0899025,0.0028691741,0.008379875,0.0037664103,0.0048080296,0.0068008103],"category_scores_gemma":[0.21556792,0.0017930868,0.014566074,0.06730275,0.0030652916,0.006738808,0.007877575,0.002432294,0.00097579753],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038474816,0.000035125002,0.001822469,0.89773583,0.0049412563,0.0000724315,0.0006953053,0.00027588726,0.0002158114,0.0021195353,0.01050388,0.08119779],"study_design_scores_gemma":[0.00041472327,0.00017016412,0.00649832,0.93424463,0.016178321,0.00016163477,0.00043069775,0.0001679297,0.00020485757,0.0015246897,0.03994311,0.000060909664],"about_ca_topic_score_codex":0.020283898,"about_ca_topic_score_gemma":0.028300816,"teacher_disagreement_score":0.0899025,"about_ca_system_score_codex":0.0138760405,"about_ca_system_score_gemma":0.051448874,"threshold_uncertainty_score":0.45017374},"labels":[],"label_agreement":null},{"id":"W4387950254","doi":"10.1177/13524585231204460","title":"The MoXFo Initiative: Using consensus methodology to move forward towards internationally shared vocabulary in multiple sclerosis exercise research","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Department of Health and Social Care; National Institute for Health and Care Research","keywords":"Multiple sclerosis; Vocabulary; Physical medicine and rehabilitation; Consensus conference; MEDLINE; Psychology; Medicine; Physical therapy; Political science; Linguistics; Internal medicine","score_opus":0.5887619840314723,"score_gpt":0.4511037067195992,"score_spread":0.13765827731187308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387950254","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.036704898,0.018086514,0.6897412,0.07597992,0.005509962,0.12493377,0.003443902,0.0016047274,0.043995183],"genre_scores_gemma":[0.07971381,0.0028052034,0.7902283,0.0044402205,0.0003302607,0.11863572,0.0014052526,0.00034406406,0.0020971808],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.30197158,0.5857001,0.06340257,0.009381954,0.035542138,0.004001657],"domain_scores_gemma":[0.43500352,0.37218764,0.03413376,0.040861648,0.108994074,0.008819374],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.6568665,0.001940107,0.004056478,0.027423711,0.008211445,0.012996154,0.008082464,0.006655457,0.0064805956],"category_scores_gemma":[0.53856367,0.0022651744,0.004741672,0.013671585,0.013178026,0.013110748,0.034542236,0.0072276434,0.001406199],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006856045,0.00036444946,0.0059662242,0.051480576,0.0009984778,0.00066858757,0.23602596,0.0015178857,0.0034823352,0.15919344,0.051672112,0.48794436],"study_design_scores_gemma":[0.0020526564,0.0012532598,0.01887986,0.13335106,0.0012926592,0.0009048734,0.11641198,0.006368999,0.0034149643,0.32225102,0.39310354,0.0007150874],"about_ca_topic_score_codex":0.00874648,"about_ca_topic_score_gemma":0.009303906,"teacher_disagreement_score":0.3431335,"about_ca_system_score_codex":0.0227522,"about_ca_system_score_gemma":0.11328001,"threshold_uncertainty_score":0.42314476},"labels":[],"label_agreement":null},{"id":"W4388033279","doi":"10.1177/13524585231205708","title":"Diroximel fumarate in patients with relapsing–remitting multiple sclerosis: Final safety and efficacy results from the phase 3 EVOLVE-MS-1 study","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Ottawa Hospital; McGill University; NeuroRx Research (Canada); University of Ottawa; University of Toronto; Montreal Neurological Institute and Hospital","funders":"Academy of Military Medical Sciences; Chugai Pharmaceutical; EMD Serono; Eisai; Deutsche Forschungsgemeinschaft; Genentech; Horizon Therapeutics; TG Therapeutics; H. Lundbeck A/S; BeiGene; Federalno Ministarstvo Obrazovanja i Nauke; European Committee for Treatment and Research in Multiple Sclerosis; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; CSL Behring; Greenwich Biosciences; Alexion Pharmaceuticals; Bundesministerium für Bildung und Forschung; Teva Pharmaceutical Industries; Celgene; Pfizer; Biogen; CSL Behring Foundation for Research and Advancement of Patient Health; Sanofi","keywords":"Tolerability; Dimethyl fumarate; Medicine; Multiple sclerosis; Adverse effect; Relapsing remitting; Clinical endpoint; Confidence interval; Internal medicine; Gastroenterology; Clinical trial","score_opus":0.12902313581335922,"score_gpt":0.31164517626179405,"score_spread":0.18262204044843483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388033279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943381,0.0037582114,0.0002291056,0.000166617,0.000021895554,0.00030903798,0.00039275252,0.00003328633,0.00075108727],"genre_scores_gemma":[0.99570245,0.0013100335,0.0007105924,0.0004140064,0.00006161713,0.00024933886,0.0011017006,0.000009594903,0.000440759],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995327,0.00024002568,0.000045358243,0.000046973615,0.00008395839,0.000050890034],"domain_scores_gemma":[0.9990963,0.00020569052,0.00031525936,0.000055267483,0.00011724153,0.00021027416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026666336,0.0006375727,0.0012434811,0.00018598177,0.00024919095,0.00046479548,0.00034198604,0.0005576544,0.0008256194],"category_scores_gemma":[0.0013566783,0.00019202086,0.00070141663,0.00023197709,0.00023586264,0.00040129796,0.00022629667,0.0010469302,0.00026853173],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.50069827,0.023038,0.0794638,0.00179759,0.0038018834,0.0007018884,0.0008419348,0.0024623112,0.054049913,0.00019856315,0.0057567335,0.3271891],"study_design_scores_gemma":[0.2999221,0.40889314,0.26603672,0.00018074909,0.0023590813,0.0017259746,0.00017419137,0.003131321,0.009850478,0.00023357458,0.0074130804,0.00007953806],"about_ca_topic_score_codex":0.0004880383,"about_ca_topic_score_gemma":0.0013645387,"teacher_disagreement_score":0.0026666336,"about_ca_system_score_codex":0.00037597763,"about_ca_system_score_gemma":0.00047159923,"threshold_uncertainty_score":0.014102697},"labels":[],"label_agreement":null},{"id":"W4388224327","doi":"10.1177/13524585231210178","title":"The CogEx trial – Cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis: A randomised, blinded, sham-controlled trial","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada; Johns Hopkins University","keywords":"Multiple sclerosis; Medicine; Physical therapy; Rehabilitation; Physical medicine and rehabilitation; Aerobic exercise; Cognition; Cognitive impairment; Randomized controlled trial; Clinical trial; Cognitive rehabilitation therapy; Internal medicine; Psychiatry","score_opus":0.07469608602237887,"score_gpt":0.3252106235059547,"score_spread":0.2505145374835758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388224327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9520693,0.026915109,0.00076355744,0.0020825416,0.0026611432,0.006688455,0.0015064466,0.0002530357,0.0070604756],"genre_scores_gemma":[0.95842993,0.009749909,0.0021579862,0.0032976798,0.001851324,0.012674617,0.0013415986,0.00003194024,0.010464969],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990747,0.0005113537,0.00008523789,0.0001212494,0.000087518434,0.000119844124],"domain_scores_gemma":[0.99933076,0.0002619696,0.00013116487,0.000055050026,0.00006315274,0.00015796897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019554426,0.0020672146,0.0038585751,0.00071406236,0.0006400467,0.0013377061,0.001146883,0.0033645558,0.008181028],"category_scores_gemma":[0.003068874,0.0005445178,0.001991027,0.00043373424,0.0011922738,0.0013417457,0.00060856005,0.002444654,0.0008931375],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9824881,0.0023025316,0.00022513856,0.0018426377,0.0010181457,0.000046829766,0.000059946353,0.00014905151,0.0006139197,0.000249696,0.0009816136,0.010022408],"study_design_scores_gemma":[0.98553723,0.012043036,0.00077968306,0.00014204514,0.00045244952,0.00002031863,0.000021500124,0.00012312096,0.00008652956,0.00014907544,0.0006347835,0.000010091791],"about_ca_topic_score_codex":0.002781097,"about_ca_topic_score_gemma":0.0042371103,"teacher_disagreement_score":0.008181028,"about_ca_system_score_codex":0.0008919223,"about_ca_system_score_gemma":0.0011788893,"threshold_uncertainty_score":0.027368307},"labels":[],"label_agreement":null},{"id":"W4389685133","doi":"10.1177/13524585231214360","title":"A multicenter pilot study evaluating simplified central vein assessment for the diagnosis of multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Institute of Neurological Disorders and Stroke; Sanofi Genzyme; National Institutes of Health; MedDay Pharmaceuticals; Genentech; Multiple Sclerosis Society; Horizon Therapeutics; Kiniksa Pharmaceuticals; National Institute of Mental Health; NGM Biopharmaceuticals; Race to Erase MS; TG Therapeutics; Alexion Pharmaceuticals; Vertex Pharmaceuticals; Biogen; Celgene; Greenwich Biosciences; EMD Serono; University of Pennsylvania; Sanofi; Bristol-Myers Squibb; Patient-Centered Outcomes Research Institute; Atara Biotherapeutics","keywords":"Medicine; Multiple sclerosis; Fluid-attenuated inversion recovery; McDonald criteria; Magnetic resonance imaging; Receiver operating characteristic; Radiology; Nuclear medicine; Multicenter study; Internal medicine; Randomized controlled trial","score_opus":0.3770258864573576,"score_gpt":0.41873803383433367,"score_spread":0.041712147376976094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389685133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982784,0.00008114845,0.0006992332,0.00003673448,0.000020742535,0.00057608844,0.0000833753,0.000014941442,0.00020944423],"genre_scores_gemma":[0.9967193,0.000047034016,0.0023335412,0.00006636865,0.000046393,0.00046301977,0.00022447748,0.0000069862704,0.00009289283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99327314,0.004848026,0.00033388895,0.0007088363,0.0006239134,0.00021215562],"domain_scores_gemma":[0.9811321,0.006085109,0.0042888364,0.0020624702,0.0045130798,0.0019183112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014354196,0.0010010479,0.0006981861,0.0005153617,0.00057290716,0.0007775238,0.00050695526,0.00075840624,0.0009257972],"category_scores_gemma":[0.02194329,0.0004193638,0.00057860935,0.00033434678,0.0008184392,0.0008423056,0.0008073793,0.000797393,0.00040286448],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033884224,0.009745015,0.9123825,0.0002246097,0.0007199105,0.00050245965,0.0032368503,0.00068250945,0.010869739,0.00013072413,0.0008614573,0.02676002],"study_design_scores_gemma":[0.0045053945,0.11474352,0.8699226,0.000055515015,0.00037340558,0.0014434203,0.00077234785,0.004213799,0.0023862964,0.00012742392,0.0013925072,0.00006369249],"about_ca_topic_score_codex":0.0011228947,"about_ca_topic_score_gemma":0.0013626238,"teacher_disagreement_score":0.014354196,"about_ca_system_score_codex":0.0004235152,"about_ca_system_score_gemma":0.0007495204,"threshold_uncertainty_score":0.07591319},"labels":[],"label_agreement":null},{"id":"W4390195771","doi":"10.1177/13524585231219131","title":"Plasma glial fibrillary acidic protein levels correlate with paramagnetic rim lesions in people with radiologically isolated syndrome","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Multiple Sclerosis Society of Canada","keywords":"Medicine; Magnetic resonance imaging; Glial fibrillary acidic protein; Multiple sclerosis; Pathology; Spinal cord; White matter; Clinically isolated syndrome; Hyperintensity; Radiology; Immunohistochemistry; Immunology","score_opus":0.0797411277178661,"score_gpt":0.27689675066749325,"score_spread":0.19715562294962716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390195771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991567,0.0003354664,0.0000705211,0.000052424824,0.0000051982456,0.000005417985,0.000075766475,0.0000031663285,0.00029525027],"genre_scores_gemma":[0.99967456,0.000078989695,0.00008430885,0.000027108,0.0000101911255,0.0000048112483,0.000059429378,6.367055e-7,0.000059967795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996611,0.0001019741,0.000055532637,0.000074958014,0.00006949893,0.00003701325],"domain_scores_gemma":[0.99814034,0.0003672404,0.001059113,0.00007172747,0.0001891534,0.00017237042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006168787,0.0003124549,0.00032588944,0.00061495823,0.00032384502,0.00037380992,0.00020246312,0.00052458356,0.0023559704],"category_scores_gemma":[0.0029357586,0.00017793284,0.00029705875,0.00046232893,0.0003013027,0.00026971975,0.00032460046,0.00046002955,0.00026812268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002120561,0.000031857304,0.997347,0.000024776942,0.0000715021,0.00013602324,0.00008392865,0.000016613889,0.00070672284,0.000010958513,0.000051275205,0.001307312],"study_design_scores_gemma":[0.000009035251,0.00019217009,0.99856794,0.000012531494,0.000049306884,0.0007144321,0.000097861885,0.000059613274,0.00019399766,0.00003623166,0.000064511434,0.0000023471212],"about_ca_topic_score_codex":0.0007310379,"about_ca_topic_score_gemma":0.00094859104,"teacher_disagreement_score":0.0023559704,"about_ca_system_score_codex":0.00012658437,"about_ca_system_score_gemma":0.00015493287,"threshold_uncertainty_score":0.007881463},"labels":[],"label_agreement":null},{"id":"W4391685626","doi":"10.1177/13524585241229332","title":"Drop-out, adherence, and compliance in randomized controlled trials of exercise training in multiple sclerosis: Short report","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Randomized controlled trial; Medicine; Physical therapy; Compliance (psychology); Drop out; Patient compliance; Meta-analysis; Intervention (counseling); Multiple sclerosis; Internal medicine; Psychology; Family medicine; Nursing","score_opus":0.34958725539888164,"score_gpt":0.3860948823326166,"score_spread":0.03650762693373494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391685626","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11620491,0.7491236,0.07092006,0.0074461554,0.002276538,0.01738195,0.029646631,0.0010099306,0.0059902645],"genre_scores_gemma":[0.77598476,0.091021605,0.056403026,0.005904098,0.0021766422,0.05086021,0.015764529,0.00036832032,0.0015167943],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.5089949,0.21550189,0.22042227,0.010480267,0.04246168,0.002138987],"domain_scores_gemma":[0.17522869,0.62130964,0.1519243,0.022223335,0.02802814,0.0012860193],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.3388169,0.0022223261,0.007447911,0.008643385,0.0012155697,0.004118033,0.00174134,0.0035649356,0.0022517594],"category_scores_gemma":[0.60807365,0.0017887666,0.019184206,0.009837642,0.0020530352,0.0046957084,0.0035721874,0.0037072743,0.0003690935],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018355604,0.00039548668,0.2377236,0.25043848,0.25494117,0.0005367622,0.0027199879,0.0030266421,0.0013106047,0.0032047334,0.012427174,0.2149197],"study_design_scores_gemma":[0.013416724,0.010656775,0.4917474,0.094500944,0.30500072,0.003331698,0.0010315588,0.006296554,0.0070054075,0.009122038,0.057192687,0.00069754216],"about_ca_topic_score_codex":0.0017924102,"about_ca_topic_score_gemma":0.0024822708,"teacher_disagreement_score":0.6611831,"about_ca_system_score_codex":0.0025517957,"about_ca_system_score_gemma":0.004197374,"threshold_uncertainty_score":0.8153565},"labels":[],"label_agreement":null},{"id":"W4392290833","doi":"10.1177/13524585241228426","title":"Limited utility of adding 3T cervical spinal cord MRI to monitor disease activity in multiple sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Asymptomatic; Medicine; Multiple sclerosis; Spinal cord; Magnetic resonance imaging; Surgery; Concomitant; Radiology","score_opus":0.18783788841020563,"score_gpt":0.35571167098419587,"score_spread":0.16787378257399024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392290833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99742645,0.0014827327,0.00012915338,0.00008146968,0.000008153509,0.000011325404,0.000119520046,0.000007774377,0.00073340733],"genre_scores_gemma":[0.99924797,0.00038193446,0.00020043313,0.000021703063,0.000018928484,0.000003891316,0.000082394516,0.0000013321734,0.000041419542],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993969,0.00017578088,0.00008014618,0.00010781926,0.00019141854,0.00004784122],"domain_scores_gemma":[0.9956245,0.0013910398,0.0017014445,0.00028221446,0.00069278164,0.00030815526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013197497,0.00024900094,0.0003337369,0.0010238878,0.00020792353,0.0005706183,0.0004789435,0.00044374037,0.001005997],"category_scores_gemma":[0.008117473,0.000110130415,0.00023291522,0.0006921557,0.00037915786,0.000486779,0.00036001712,0.0003050856,0.00023442128],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029842058,0.000021369962,0.9861894,0.000034911514,0.000029308163,0.00018657486,0.00004590529,0.00007876538,0.00065526424,0.000005801398,0.000059225353,0.012395174],"study_design_scores_gemma":[0.0000095226815,0.00040143987,0.996249,0.00003403475,0.000053562562,0.0019504628,0.0000999778,0.0004930595,0.00047549861,0.000028032984,0.00020017836,0.0000051498696],"about_ca_topic_score_codex":0.0035898755,"about_ca_topic_score_gemma":0.0057512936,"teacher_disagreement_score":0.0035898755,"about_ca_system_score_codex":0.000376483,"about_ca_system_score_gemma":0.00035209907,"threshold_uncertainty_score":0.0071379542},"labels":[],"label_agreement":null},{"id":"W4392376725","doi":"10.1177/13524585241234783","title":"Efficacy and safety results after &gt;3.5 years of treatment with the Bruton’s tyrosine kinase inhibitor evobrutinib in relapsing multiple sclerosis: Long-term follow-up of a Phase II randomised clinical trial with a cerebrospinal fluid sub-study","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"","keywords":"Medicine; Internal medicine; Gastroenterology; Placebo; Expanded Disability Status Scale; Adverse effect; Population; Confidence interval; Tolerability; Multiple sclerosis; Immunology; Pathology","score_opus":0.09712180060595654,"score_gpt":0.34536530860207776,"score_spread":0.24824350799612122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392376725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99330753,0.0036299003,0.00023203505,0.0003361543,0.00013849819,0.0003204821,0.0009240035,0.000047320143,0.0010640358],"genre_scores_gemma":[0.9953258,0.00077718194,0.00017653516,0.00053520146,0.00017243816,0.0003510494,0.0014189904,0.000015607315,0.0012271862],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983897,0.0006764064,0.00011709874,0.00026355736,0.00013859323,0.00041470354],"domain_scores_gemma":[0.9971089,0.000529178,0.00085884647,0.000253291,0.00022837981,0.0010215174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004243416,0.0012337234,0.0030465745,0.00039000763,0.00056697376,0.0013583972,0.0008233692,0.0020350486,0.0025685704],"category_scores_gemma":[0.0024300516,0.00041345088,0.0032333634,0.0003857794,0.000997619,0.001389784,0.0005633031,0.003392368,0.00088207243],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94076294,0.013219994,0.006294009,0.00026048967,0.0015393088,0.000109569526,0.00013344933,0.0006971661,0.0043552564,0.000041719828,0.001191826,0.031394187],"study_design_scores_gemma":[0.38465413,0.54192317,0.0649648,0.00006443737,0.002425475,0.00020366204,0.00008298348,0.0008731485,0.0027502156,0.0001842663,0.0017970792,0.000076675555],"about_ca_topic_score_codex":0.0013465772,"about_ca_topic_score_gemma":0.0014109327,"teacher_disagreement_score":0.004243416,"about_ca_system_score_codex":0.00093740755,"about_ca_system_score_gemma":0.00091782137,"threshold_uncertainty_score":0.022441626},"labels":[],"label_agreement":null},{"id":"W4392813871","doi":"10.1177/13524585241238094","title":"Choroid plexus volume differentiates MS from its mimics","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Cerebrospinal fluid and hydrocephalus","field":"Neuroscience","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; Sanofi Genzyme; EMD Serono; National Institutes of Health; Idorsia Pharmaceuticals; Genentech; Multiple Sclerosis Society; Common Fund; Myelin Repair Foundation; Horizon Therapeutics; National Institute of Mental Health; NGM Biopharmaceuticals; Race to Erase MS; TG Therapeutics; Patient-Centered Outcomes Research Institute; Bristol-Myers Squibb; Eli Lilly and Company; Biogen; Sanofi; National Multiple Sclerosis Society","keywords":"Choroid plexus; Multiple sclerosis; Medicine; Neuroscience; Central nervous system; Internal medicine; Psychology","score_opus":0.08218949961202789,"score_gpt":0.25643241245643644,"score_spread":0.17424291284440857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392813871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967822,0.0011535949,0.0006757908,0.000028844257,0.000012092061,0.00002216845,0.0001448863,0.000019722971,0.0011605654],"genre_scores_gemma":[0.9991912,0.0001470622,0.00043113873,0.000009163336,0.0000116772435,0.000009156285,0.00009044405,0.0000030693445,0.000107050844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99925154,0.00022911537,0.000103498634,0.00022482169,0.00014420444,0.000046665882],"domain_scores_gemma":[0.997703,0.0009177434,0.0007953239,0.00017984839,0.0002590012,0.00014501532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013128452,0.0005409494,0.0004926261,0.0024381995,0.0003239299,0.0011473332,0.0002630424,0.00040637006,0.0009519632],"category_scores_gemma":[0.0058443416,0.00028289907,0.0003687464,0.0005992171,0.00050533225,0.00092120667,0.00068915,0.00029370614,0.00018525048],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001409484,0.00003219066,0.97315085,0.0001454418,0.00024525158,0.00045832616,0.0003125349,0.00034536474,0.0064127846,0.00024900094,0.00015849785,0.017080335],"study_design_scores_gemma":[0.0000324727,0.00049023173,0.9867871,0.00006774285,0.00027182812,0.0036916917,0.00050877174,0.0022443747,0.0040562456,0.0007432887,0.0010807632,0.000025518346],"about_ca_topic_score_codex":0.0015415738,"about_ca_topic_score_gemma":0.002021961,"teacher_disagreement_score":0.0024381995,"about_ca_system_score_codex":0.0002761447,"about_ca_system_score_gemma":0.00028307553,"threshold_uncertainty_score":0.0069431067},"labels":[],"label_agreement":null},{"id":"W4394820159","doi":"10.1177/13524585241242050","title":"Teriflunomide in pediatric patients with relapsing multiple sclerosis: Open-label extension of TERIKIDS","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"Sanofi","keywords":"Teriflunomide; Medicine; Tolerability; Placebo; Internal medicine; Multiple sclerosis; Adverse effect; Immunology; Pathology; Alternative medicine","score_opus":0.07754095278387704,"score_gpt":0.28221661118270736,"score_spread":0.2046756583988303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394820159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889426,0.006824939,0.00078582746,0.00028699244,0.0001219084,0.0015999463,0.0006582728,0.00007231912,0.00070717756],"genre_scores_gemma":[0.98448586,0.006268619,0.003857403,0.00036599085,0.00036018787,0.0029563836,0.00090058084,0.000018821484,0.0007862508],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99921477,0.00047747503,0.00007557717,0.000092798524,0.000070466565,0.000068899295],"domain_scores_gemma":[0.9983912,0.00045380756,0.00055054395,0.00020076687,0.00009952178,0.0003041358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002516932,0.0008361158,0.0022474173,0.0003658515,0.00018634778,0.00041626743,0.0005909526,0.00074791425,0.0028367362],"category_scores_gemma":[0.0018448593,0.0003492313,0.001557298,0.0004098885,0.00061345525,0.00067567924,0.0004594027,0.0019223948,0.00040586677],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8125244,0.016292242,0.0039312905,0.0019521011,0.001171554,0.00021464277,0.0002452088,0.0007239339,0.015228077,0.00020658183,0.0006773525,0.1468326],"study_design_scores_gemma":[0.7299859,0.25073528,0.013271215,0.00014267709,0.00080206135,0.00030423736,0.000050560826,0.0004960311,0.0020867952,0.00009847418,0.002005887,0.000020874986],"about_ca_topic_score_codex":0.00050662074,"about_ca_topic_score_gemma":0.00096057303,"teacher_disagreement_score":0.0028367362,"about_ca_system_score_codex":0.00040062252,"about_ca_system_score_gemma":0.0009212672,"threshold_uncertainty_score":0.013310909},"labels":[],"label_agreement":null},{"id":"W4399756276","doi":"10.1177/13524585241261200","title":"Monitoring cognitive functioning in multiple sclerosis will trigger anxiety in patients: Commentary","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; University of Calgary","funders":"","keywords":"Multiple sclerosis; Anxiety; Cognition; Psychology; Clinical psychology; Cognitive skill; Medicine; Psychiatry","score_opus":0.10376262789482071,"score_gpt":0.3019569323866519,"score_spread":0.19819430449183117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399756276","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00076182536,0.015574619,0.00009264152,0.91076547,0.070649184,0.000040147173,0.0006309373,0.000030572053,0.0014545851],"genre_scores_gemma":[0.006345927,0.0072450503,0.0002136556,0.89855975,0.08619377,0.00012276725,0.0001430026,0.000022816897,0.0011532074],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9893985,0.004935373,0.001890891,0.001137085,0.0020000818,0.00063800754],"domain_scores_gemma":[0.81718713,0.1506598,0.0074344086,0.001762531,0.017617898,0.0053381887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013115908,0.0010045986,0.0025303229,0.0010058575,0.0027697708,0.0028730745,0.00465791,0.034103896,0.00836378],"category_scores_gemma":[0.13713501,0.0007304052,0.0026684895,0.0017104221,0.002470501,0.0036374694,0.0018802636,0.032113362,0.0041374383],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003155438,0.000032284483,0.0010282046,0.001924678,0.00029153738,0.0002505912,0.00028325463,0.000055149525,0.00005529377,0.0010291788,0.9840267,0.010707555],"study_design_scores_gemma":[0.0027346793,0.00049044203,0.01030348,0.03736787,0.0032809533,0.0013789276,0.0025025867,0.00068456726,0.0006236492,0.013690118,0.9265867,0.0003559762],"about_ca_topic_score_codex":0.023550663,"about_ca_topic_score_gemma":0.03418104,"teacher_disagreement_score":0.034103896,"about_ca_system_score_codex":0.006297151,"about_ca_system_score_gemma":0.011680227,"threshold_uncertainty_score":0.06936443},"labels":[],"label_agreement":null},{"id":"W4399972848","doi":"10.1177/13524585241260145","title":"Brain and cervical spinal cord MRI correlates of sensorimotor impairment in patients with multiple sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministero della Salute; Multiple Sclerosis Society of Canada; Eli Lilly and Company; Bristol-Myers Squibb; Fondazione Italiana Sclerosi Multipla; Biogen; Celgene; Alexion Pharmaceuticals; Sanofi; Horizon Therapeutics; Novo Nordisk; Teva Pharmaceutical Industries","keywords":"Medicine; Multiple sclerosis; Expanded Disability Status Scale; Magnetic resonance imaging; Spinal cord; White matter; Brain size; Physical medicine and rehabilitation; Nuclear medicine; Radiology","score_opus":0.0541089373139094,"score_gpt":0.2898980175733567,"score_spread":0.2357890802594473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399972848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999584,0.00012894032,0.00001901313,0.000017148453,0.0000014660876,0.000004602468,0.000087673674,0.0000021135716,0.00015509906],"genre_scores_gemma":[0.9997154,0.00003500823,0.000030043413,0.000012709735,0.0000043237205,0.0000041428934,0.00014802632,6.4007025e-7,0.000049657607],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998,0.000033701937,0.000030730444,0.000064559375,0.00004197687,0.000029011047],"domain_scores_gemma":[0.99909055,0.00018353036,0.00042786266,0.0000404975,0.00011933428,0.00013824219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030137826,0.00035121603,0.00033399987,0.00079264556,0.00032707345,0.00032173056,0.00021304958,0.00053242134,0.0014619046],"category_scores_gemma":[0.0020364968,0.00016925736,0.00021510318,0.00037130207,0.00028095813,0.00020338042,0.00026088668,0.00030328322,0.0001987394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027203356,0.000025371617,0.99781203,0.00001026497,0.00005629476,0.00012798187,0.000035263653,0.00006147048,0.00057277933,0.0000039967626,0.000058857706,0.00096366403],"study_design_scores_gemma":[0.000005975481,0.00006118957,0.99943894,0.0000023468128,0.000014462409,0.00028753944,0.000023097866,0.00009951588,0.000037969705,0.000008168161,0.000019468242,0.0000013246334],"about_ca_topic_score_codex":0.0041116453,"about_ca_topic_score_gemma":0.0072879903,"teacher_disagreement_score":0.0041116453,"about_ca_system_score_codex":0.00026741117,"about_ca_system_score_gemma":0.00020863747,"threshold_uncertainty_score":0.008175433},"labels":[],"label_agreement":null},{"id":"W4401178900","doi":"10.1177/13524585241265961","title":"The first global landscape analysis of multiple sclerosis research funding","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Multiple Sclerosis Society of Canada","funders":"","keywords":"Multiple sclerosis; Portfolio; Government (linguistics); Business; Public relations; Political science; Medicine; Economic growth; Finance; Economics","score_opus":0.25233399842619536,"score_gpt":0.3873816783126662,"score_spread":0.13504767988647082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401178900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"incentives","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"incentives","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8221233,0.010608103,0.008780406,0.012741516,0.00010655005,0.00043129013,0.06873167,0.00051689823,0.07596029],"genre_scores_gemma":[0.97360784,0.0015913054,0.006069102,0.00034951055,0.000047984042,0.00024364147,0.01590885,0.000097899756,0.0020838657],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99662954,0.0013952595,0.00023445183,0.00038210972,0.00080154196,0.0005571261],"domain_scores_gemma":[0.98681366,0.0039308304,0.003906567,0.00066028896,0.0035712246,0.0011173618],"candidate_categories":["metaresearch","bibliometrics"],"consensus_categories":[],"category_scores_codex":[0.0036577345,0.00039914745,0.0006033406,0.009185848,0.000613635,0.0040593725,0.00057137694,0.00047598794,0.009617188],"category_scores_gemma":[0.020230135,0.00019673018,0.0009857212,0.021917874,0.0003678281,0.0019489273,0.0025267042,0.00041674095,0.0008720692],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041826864,0.0000990634,0.7388925,0.0015072591,0.0010811245,0.00044059596,0.0014007452,0.005541093,0.0008792918,0.035376776,0.0425022,0.1718611],"study_design_scores_gemma":[0.0000857103,0.00020892148,0.8604677,0.0009406418,0.00065772515,0.0007613014,0.003939864,0.013453471,0.00042822797,0.011566264,0.10743881,0.00005142758],"about_ca_topic_score_codex":0.021400267,"about_ca_topic_score_gemma":0.017697074,"teacher_disagreement_score":0.99634224,"about_ca_system_score_codex":0.00278982,"about_ca_system_score_gemma":0.004413779,"threshold_uncertainty_score":0.0425514},"labels":[],"label_agreement":null},{"id":"W4401226031","doi":"10.1177/13524585241267211","title":"Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; St. Michael's Hospital; Cegep de Saint Jerome; Centre intégré de santé et de services sociaux de Chaudière-Appalaches","funders":"National Health and Medical Research Council; F. Hoffmann-La Roche; Sanofi Genzyme; EMD Serono; Grifols; Monash University; Alexion Pharmaceuticals; Multiple Sclerosis Australia; Teva Pharmaceutical Industries; Atara Biotherapeutics; Medical Research Council; Biogen; Sanofi","keywords":"Medicine; Ocrelizumab; Cladribine; Multiple sclerosis; Natalizumab; Fingolimod; Alemtuzumab; Relapsing remitting; Expanded Disability Status Scale; Internal medicine; Gastroenterology; Oncology; Rituximab; Immunology; Transplantation","score_opus":0.09020544279069158,"score_gpt":0.3128205917848402,"score_spread":0.22261514899414858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401226031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957645,0.0034106865,0.00007104377,0.0000998364,0.000020780157,0.000023764385,0.00012175136,0.0000040123787,0.00048355464],"genre_scores_gemma":[0.9992291,0.0004417502,0.00007483821,0.000034688022,0.000016296663,0.000009812106,0.00010739193,0.0000010998995,0.0000850882],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99893016,0.0006645376,0.00008535212,0.00012124065,0.0001221679,0.00007651461],"domain_scores_gemma":[0.9968437,0.0013769185,0.001005119,0.00019475525,0.00010943027,0.00047009683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022717684,0.00024946267,0.00062716415,0.00024189864,0.00012659693,0.0004649382,0.00027115643,0.0002861619,0.0010110398],"category_scores_gemma":[0.0036832218,0.0001013028,0.0010021037,0.0001926025,0.00031315367,0.00029336807,0.00024084118,0.00049487985,0.00009457726],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6869127,0.0021192515,0.13700435,0.00113162,0.0069935303,0.00015422463,0.00031035437,0.0074787736,0.009255844,0.00032657234,0.0012071781,0.14710568],"study_design_scores_gemma":[0.064451285,0.23531155,0.6561915,0.0006282198,0.009756601,0.0010746015,0.00030367283,0.0147901215,0.011921801,0.0007384407,0.0047489647,0.00008319224],"about_ca_topic_score_codex":0.0008779433,"about_ca_topic_score_gemma":0.0017443525,"teacher_disagreement_score":0.0022717684,"about_ca_system_score_codex":0.0007901874,"about_ca_system_score_gemma":0.00039782547,"threshold_uncertainty_score":0.012014449},"labels":[],"label_agreement":null},{"id":"W4401622512","doi":"10.1177/13524585241264472","title":"Genetics of multiple sclerosis severity: The importance of statistical power in replication studies","year":2024,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Multiple sclerosis; Replication (statistics); Genetics; Medicine; MEDLINE; Statistical power; Biology; Psychiatry; Virology; Statistics; Mathematics","score_opus":0.09265093263910182,"score_gpt":0.30723913069638686,"score_spread":0.21458819805728505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401622512","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05922895,0.08713584,0.26520604,0.49223056,0.067151204,0.0066685188,0.0037001106,0.0018994296,0.016779365],"genre_scores_gemma":[0.6424009,0.007132752,0.16040191,0.14885905,0.025283247,0.010765035,0.0014845019,0.00097229733,0.0027002646],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.44096634,0.4474751,0.042072646,0.02508882,0.0421502,0.0022469342],"domain_scores_gemma":[0.10607194,0.80432034,0.014738518,0.05175043,0.020846622,0.0022721167],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.53026557,0.002289953,0.006951418,0.0037788923,0.0037681463,0.0075347433,0.007359699,0.011191315,0.0020254094],"category_scores_gemma":[0.7958297,0.0018767929,0.0028409152,0.0037253844,0.0146493865,0.009239431,0.004784695,0.015064914,0.0018029758],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016965333,0.00081081147,0.17889272,0.013405728,0.018130826,0.010794511,0.009093046,0.0043471796,0.006463789,0.0686355,0.23515165,0.43730894],"study_design_scores_gemma":[0.011191066,0.0057575335,0.1549552,0.012357765,0.0069436003,0.013583054,0.002831249,0.04475149,0.009793792,0.504553,0.23206116,0.0012210368],"about_ca_topic_score_codex":0.0036472587,"about_ca_topic_score_gemma":0.0028107907,"teacher_disagreement_score":0.46973443,"about_ca_system_score_codex":0.0029175472,"about_ca_system_score_gemma":0.0042060926,"threshold_uncertainty_score":0.5792662},"labels":[],"label_agreement":null},{"id":"W4402058562","doi":"10.1177/13524585241266483","title":"The refined Pathways to Cures Research Roadmap for multiple sclerosis cures","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; University of Calgary","funders":"National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Medicine; Clinical neurology; Neuroscience; Intensive care medicine; Psychology; Psychiatry","score_opus":0.36960673013697337,"score_gpt":0.40030614915448676,"score_spread":0.030699419017513385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402058562","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008278122,0.06381237,0.05491842,0.7392223,0.020608539,0.0056709736,0.016272359,0.0024935226,0.08872346],"genre_scores_gemma":[0.16288252,0.123643145,0.4438328,0.1452,0.007093885,0.018564278,0.054040615,0.0013957063,0.043347027],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.95362324,0.026913462,0.0041522435,0.002017362,0.008359833,0.0049338983],"domain_scores_gemma":[0.8652757,0.038491365,0.006080912,0.008338815,0.060353715,0.021459425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.078292094,0.00251941,0.001955854,0.0078900205,0.004565249,0.010768413,0.005723426,0.008299047,0.028208854],"category_scores_gemma":[0.11139692,0.0012855608,0.005383779,0.0064547565,0.0037484786,0.011066413,0.017830333,0.01340373,0.008490893],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005213611,0.0003858549,0.005503702,0.0097830035,0.00052386004,0.00030998723,0.001911767,0.0063439505,0.00066703645,0.14185183,0.50980943,0.3223883],"study_design_scores_gemma":[0.00036040347,0.0005515722,0.00511222,0.011181274,0.00052039744,0.00028497595,0.0015370807,0.0015201073,0.0005772263,0.06313512,0.91505283,0.00016667978],"about_ca_topic_score_codex":0.027827436,"about_ca_topic_score_gemma":0.0325013,"teacher_disagreement_score":0.078292094,"about_ca_system_score_codex":0.014824828,"about_ca_system_score_gemma":0.14948258,"threshold_uncertainty_score":0.41405314},"labels":[],"label_agreement":null},{"id":"W4402288515","doi":"10.1177/13524585241272939","title":"Investigation of health care use and a possible prodrome before the first attack in NMOSD and MOGAD","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Dalhousie University; University of British Columbia; University of Calgary; University of Ottawa; Institute for Clinical Evaluative Sciences; Ottawa Hospital; Health Sciences Centre; University of Waterloo; St. Michael's Hospital; Sunnybrook Health Science Centre; University of Toronto; Western University","funders":"","keywords":"Prodrome; Neuromyelitis optica; Multiple sclerosis; Medicine; Myelin oligodendrocyte glycoprotein; Spectrum disorder; Optic neuritis; Disease; Psychiatry; Immunology; Dermatology; Pathology","score_opus":0.1594880695345992,"score_gpt":0.3303628954360687,"score_spread":0.17087482590146952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402288515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99803835,0.00048010543,0.00005832207,0.00007188146,0.0000053663853,0.000019374495,0.00076665846,0.0000038868648,0.00055613194],"genre_scores_gemma":[0.99935704,0.000117709,0.00007427021,0.000016599242,0.000007001293,0.000008255599,0.00034941477,9.2479263e-7,0.00006880811],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993668,0.00013782593,0.00006795314,0.00010047765,0.00017286588,0.00015414914],"domain_scores_gemma":[0.99621457,0.0004970744,0.0023152374,0.00011480888,0.00042734158,0.00043100474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007905045,0.00022509096,0.00031098712,0.0013058442,0.000532879,0.00057845085,0.0005862435,0.0005426213,0.001637429],"category_scores_gemma":[0.0029859757,0.00023772026,0.0006343446,0.0016164336,0.00029919075,0.00035584377,0.000507129,0.0007298148,0.00012600762],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036981386,0.000009720646,0.9996152,0.0000070493566,0.000013768458,0.000033696182,0.000023042485,0.000008923995,0.000030535593,0.000004448132,0.000024164097,0.00019243585],"study_design_scores_gemma":[0.0000015141693,0.000031911684,0.99969375,0.000005135727,0.000008763979,0.00008716389,0.00005223187,0.00006682774,0.000013666256,0.0000036997994,0.00003430291,0.0000010155313],"about_ca_topic_score_codex":0.099399805,"about_ca_topic_score_gemma":0.10809589,"teacher_disagreement_score":0.099399805,"about_ca_system_score_codex":0.0013302052,"about_ca_system_score_gemma":0.0013299146,"threshold_uncertainty_score":0.19764245},"labels":[],"label_agreement":null},{"id":"W4402288582","doi":"10.1177/13524585241271988","title":"Diagnostic performance of central vein sign versus oligoclonal bands for multiple sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; Sanofi Genzyme; EMD Serono; National Institutes of Health; Idorsia Pharmaceuticals; Genentech; Multiple Sclerosis Society; Horizon Therapeutics; National Institute of Mental Health; Race to Erase MS; TG Therapeutics; Alexion Pharmaceuticals; Sanofi; Atara Biotherapeutics; Celgene; Biogen; MedDay Pharmaceuticals; GlaxoSmithKline; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Multiple sclerosis; Cerebrospinal fluid; Biomarker; Medicine; Sign (mathematics); Pathology; Central nervous system disease; Internal medicine; Immunology; Chemistry","score_opus":0.13378076064570546,"score_gpt":0.3104973616398545,"score_spread":0.17671660099414901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402288582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99535227,0.0024225828,0.000710214,0.00009742494,0.00003642116,0.00004104105,0.00024107986,0.000029619454,0.0010693202],"genre_scores_gemma":[0.9982041,0.0002065965,0.0012523375,0.00002533182,0.000034222932,0.000012563274,0.00018529665,0.0000032639418,0.00007628697],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99673635,0.0013076728,0.00032821306,0.00048394094,0.00096930115,0.00017449175],"domain_scores_gemma":[0.9798248,0.008609011,0.0068275533,0.0009184533,0.0027693287,0.0010509372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065336484,0.0006947215,0.0008144218,0.0021480485,0.00020756481,0.001164839,0.00068546034,0.0008087507,0.0017470737],"category_scores_gemma":[0.018304184,0.00022593081,0.000630476,0.00066181633,0.00067210814,0.00082550803,0.00073424185,0.00050900754,0.00042205685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030170467,0.00013405988,0.9709523,0.00023207607,0.0005091337,0.000116547366,0.000108613574,0.0007211496,0.0036494453,0.000051676267,0.0003227282,0.02018534],"study_design_scores_gemma":[0.000115627736,0.0024409203,0.98368317,0.00015426731,0.00039089605,0.0019081535,0.00014909383,0.0066192085,0.0035502908,0.0002805311,0.00066865375,0.000039239865],"about_ca_topic_score_codex":0.00092426135,"about_ca_topic_score_gemma":0.0018453959,"teacher_disagreement_score":0.0065336484,"about_ca_system_score_codex":0.0004545648,"about_ca_system_score_gemma":0.00028592302,"threshold_uncertainty_score":0.034553647},"labels":[],"label_agreement":null},{"id":"W4402379955","doi":"10.1177/13524585241274620","title":"Selecting Informative Patients for Phase 2 Progressive Trials in MS: Design Considerations for Phase 2 Clinical Trials in Progressive MS","year":2024,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Clinical trial; Multiple sclerosis; Medicine; Cohort; Selection (genetic algorithm); Dosing; Internal medicine; Computer science; Psychiatry; Machine learning","score_opus":0.7745573034653884,"score_gpt":0.6094124903853415,"score_spread":0.16514481308004691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402379955","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010996298,0.96853167,0.011363307,0.0071623474,0.0020286175,0.0070288675,0.00024954742,0.000084562416,0.002451343],"genre_scores_gemma":[0.016668411,0.87443954,0.07252064,0.013646943,0.0017746368,0.019149886,0.00039682628,0.00008053877,0.0013225954],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9304902,0.056131147,0.0074846204,0.001151151,0.0043321108,0.00041082365],"domain_scores_gemma":[0.8180738,0.16488002,0.0075054234,0.0027753876,0.0059637344,0.00080167357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.09391725,0.0013822693,0.0061677,0.0021299315,0.0005424168,0.004389095,0.0025765612,0.004220958,0.0033827513],"category_scores_gemma":[0.15350543,0.0006970901,0.0041277185,0.0022322033,0.0013373105,0.0033325998,0.0015967885,0.004811161,0.0010424649],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019506912,0.00020392703,0.0006624966,0.16138378,0.0021389334,0.00019843591,0.00047631498,0.0013407787,0.0012039678,0.01228367,0.01869679,0.7994601],"study_design_scores_gemma":[0.010295426,0.0028876965,0.004931605,0.40588948,0.014268136,0.0012664226,0.00068923377,0.0020573013,0.0017058977,0.03966025,0.51612645,0.00022213915],"about_ca_topic_score_codex":0.00076013803,"about_ca_topic_score_gemma":0.0019905174,"teacher_disagreement_score":0.09391725,"about_ca_system_score_codex":0.0016200731,"about_ca_system_score_gemma":0.007871696,"threshold_uncertainty_score":0.49668783},"labels":[],"label_agreement":null},{"id":"W4402385120","doi":"10.1177/13524585241272938","title":"Aging is associated with reduced inflammatory disease activity independent of disease duration in relapsing multiple sclerosis trial populations","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McGill University; NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"Sanofi Genzyme; EMD Serono; ZonMw; Multiple Sclerosis Society; International Progressive MS Alliance; Medical Research Council; Celgene; Biogen; Atara Biotherapeutics; National Institute for Health and Care Research; Teva Pharmaceutical Industries; MedDay Pharmaceuticals; Sanofi","keywords":"Multiple sclerosis; Medicine; Disease; Internal medicine; Immunology","score_opus":0.14280391978690815,"score_gpt":0.3265880378291837,"score_spread":0.18378411804227557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402385120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97148085,0.02336852,0.0013291894,0.00033202893,0.00014828717,0.00045432273,0.0013118198,0.000031627977,0.0015434425],"genre_scores_gemma":[0.9962159,0.0012263173,0.00080037076,0.00022538129,0.00010299545,0.0003955306,0.00079418917,0.000010257918,0.00022909802],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.990149,0.0072248075,0.0012413108,0.0007711033,0.0004354422,0.00017837336],"domain_scores_gemma":[0.9808848,0.008695715,0.0068234606,0.0019905542,0.00095509615,0.0006503833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020002875,0.00036569685,0.0016147392,0.00029162603,0.00036791645,0.0008253492,0.00035712108,0.0006153282,0.0018911527],"category_scores_gemma":[0.021739544,0.0001963958,0.0024102642,0.00054327236,0.00032107177,0.00066479255,0.0005309329,0.0006865881,0.00017501213],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.52334917,0.0009511935,0.3744461,0.004293656,0.041171297,0.00017085753,0.00035697222,0.0013526666,0.003031218,0.0004944568,0.0018058143,0.048576675],"study_design_scores_gemma":[0.058163896,0.05041154,0.82802814,0.0010307054,0.049267255,0.0005114375,0.00015802114,0.0022848952,0.0019608901,0.0019011889,0.006190826,0.00009125366],"about_ca_topic_score_codex":0.00028541806,"about_ca_topic_score_gemma":0.00053985976,"teacher_disagreement_score":0.020002875,"about_ca_system_score_codex":0.00018935723,"about_ca_system_score_gemma":0.0005127037,"threshold_uncertainty_score":0.10578656},"labels":[],"label_agreement":null},{"id":"W4402466338","doi":"10.1177/13524585241275491","title":"Is there a prodrome to NMOSD? An investigation of neurologic symptoms preceding the first NMOSD attack","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Health Sciences Centre; University of Ottawa; Sunnybrook Health Science Centre; University of Manitoba; University of Toronto","funders":"European Genomic Institute for Diabetes","keywords":"Prodrome; Neuromyelitis optica; Spectrum disorder; Aquaporin 4; Multiple sclerosis; Medicine; Serology; Pediatrics; Psychology; Psychiatry; Antibody; Immunology; Pathology","score_opus":0.1661710950545475,"score_gpt":0.3402583352286419,"score_spread":0.1740872401740944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402466338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948606,0.0012836916,0.00010350733,0.00028964033,0.00003233087,0.000063646476,0.00041091038,0.000007994693,0.002947552],"genre_scores_gemma":[0.99806005,0.0006977199,0.0002829569,0.00019480682,0.000036443937,0.0000134331995,0.0003948994,0.000002134594,0.00031771345],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99967444,0.000029778445,0.000039572267,0.00004916223,0.00010662668,0.00010037619],"domain_scores_gemma":[0.9988431,0.00013009638,0.00040542972,0.000031857475,0.00032166595,0.00026785414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047431843,0.00025221007,0.0003886618,0.0015346389,0.0010158389,0.00041393595,0.00042011403,0.0006577389,0.0018244853],"category_scores_gemma":[0.0018314142,0.00019609681,0.00031651565,0.00080733246,0.0004353219,0.0004228367,0.00036292538,0.000559596,0.00020789084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014679796,0.000037260936,0.98848724,0.00007154525,0.00001723435,0.0062672035,0.000374065,0.000028732147,0.0011990685,0.000025909228,0.00039167408,0.002953269],"study_design_scores_gemma":[0.000007675896,0.00012568341,0.9892657,0.000073445335,0.000016423633,0.009022858,0.000574309,0.000063608444,0.00016692176,0.000016731565,0.00066015974,0.0000064427727],"about_ca_topic_score_codex":0.101268545,"about_ca_topic_score_gemma":0.17146274,"teacher_disagreement_score":0.101268545,"about_ca_system_score_codex":0.0015362361,"about_ca_system_score_gemma":0.0022559124,"threshold_uncertainty_score":0.20135814},"labels":[],"label_agreement":null},{"id":"W4402939807","doi":"10.1177/13524585241275471","title":"Prognostic factors for worsening and improvement in multiple sclerosis using a multistate model","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"Novartis Pharma","keywords":"Expanded Disability Status Scale; Multiple sclerosis; Medicine; Hazard ratio; Confidence interval; Physical therapy; Physical medicine and rehabilitation; Internal medicine; Pediatrics; Psychiatry","score_opus":0.24372575761850196,"score_gpt":0.33956713603257005,"score_spread":0.09584137841406809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402939807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96815944,0.0016113583,0.024841385,0.002112431,0.00015215705,0.00020343608,0.001869918,0.00017332227,0.00087652233],"genre_scores_gemma":[0.99463516,0.00026800315,0.0031627424,0.00008376992,0.000054653272,0.00013148102,0.0010297202,0.000011865974,0.0006224406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966022,0.0022524763,0.00012733441,0.0005811158,0.00015278935,0.00028407367],"domain_scores_gemma":[0.98500663,0.011551695,0.0014829842,0.00063803437,0.00058830687,0.00073227077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012485765,0.0015381603,0.001600715,0.0017675556,0.0008447068,0.0023227106,0.0014690091,0.0015079309,0.00408654],"category_scores_gemma":[0.013697772,0.00067061186,0.0035262073,0.0011229647,0.0007419381,0.0008833728,0.001464866,0.0020314965,0.00042375934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032411711,0.0004962426,0.78664947,0.00013417506,0.0032075876,0.00038963548,0.0003115711,0.18754533,0.00030151667,0.0021794378,0.0025994335,0.0129443975],"study_design_scores_gemma":[0.0002952399,0.0006929731,0.09063545,0.00009233536,0.0011485334,0.00027055712,0.0001484309,0.90004903,0.00011175135,0.005669704,0.00082509086,0.000060883045],"about_ca_topic_score_codex":0.014452361,"about_ca_topic_score_gemma":0.0055416883,"teacher_disagreement_score":0.014452361,"about_ca_system_score_codex":0.0008391381,"about_ca_system_score_gemma":0.0016311932,"threshold_uncertainty_score":0.06603181},"labels":[],"label_agreement":null},{"id":"W4403552437","doi":"10.1177/13524585241287388","title":"Trajectories and management of vascular risk following the diagnosis of multiple sclerosis: A population-based matched cohort study between 1987 and 2018 in England","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Multiple sclerosis; Population; Diabetes mellitus; Internal medicine; Vascular disease; Incidence (geometry); Comorbidity; Cohort; Retrospective cohort study; Stroke (engine); Blood pressure; Cohort study; Physical therapy; Cardiology; Endocrinology; Immunology","score_opus":0.07406048083742164,"score_gpt":0.3035266560302018,"score_spread":0.22946617519278015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403552437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99814165,0.0002577826,0.000055753386,0.00008825511,0.00000609486,0.000016439588,0.0012552789,0.0000017306969,0.00017707968],"genre_scores_gemma":[0.99855095,0.00019163189,0.00005413609,0.000056941193,0.0000066940593,0.00002238867,0.0009114424,0.0000013967093,0.00020441951],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993857,0.00011202753,0.00010689415,0.000166168,0.00009748662,0.00013177101],"domain_scores_gemma":[0.99843115,0.00011848748,0.00078346964,0.00011015048,0.00026775207,0.0002888444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006845516,0.00018260238,0.0004754993,0.00058626814,0.00043324847,0.0006974366,0.00041792289,0.0004030116,0.0009848775],"category_scores_gemma":[0.0027888664,0.00037318768,0.00049312506,0.00092443,0.0002262149,0.00088462577,0.0009394071,0.00061723357,0.0002018446],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006910465,0.000020261818,0.99847144,0.000022157788,0.000040293053,0.00012079337,0.00040338383,0.000015613772,0.000068164154,0.000014540817,0.00015621987,0.000598037],"study_design_scores_gemma":[0.000005001709,0.00003353203,0.99931324,0.000015283833,0.000012803446,0.000088927634,0.00032795127,0.000040045645,0.00001096326,0.000008187269,0.00014191173,0.0000021862313],"about_ca_topic_score_codex":0.101335764,"about_ca_topic_score_gemma":0.11637066,"teacher_disagreement_score":0.101335764,"about_ca_system_score_codex":0.0010223609,"about_ca_system_score_gemma":0.00084982323,"threshold_uncertainty_score":0.20149183},"labels":[],"label_agreement":null},{"id":"W4404118886","doi":"10.1177/13524585241292797","title":"How to avoid missing a diagnosis of neuromyelitis optica spectrum disorder","year":2024,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Neuromyelitis optica; Spectrum disorder; Medicine; Multiple sclerosis; Medical diagnosis; Intensive care medicine; Differential diagnosis; Immunotherapy; Pediatrics; Aquaporin 4; Immunology; Pathology; Psychiatry","score_opus":0.17282751581581424,"score_gpt":0.36325745018129285,"score_spread":0.19042993436547861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404118886","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001760688,0.9958132,0.00025222183,0.0020934008,0.0006009993,0.000018270573,0.00004499032,0.000013016325,0.000987796],"genre_scores_gemma":[0.0011876421,0.9966993,0.0006769914,0.00079838344,0.00026654766,0.000021485,0.00006833841,0.0000023449618,0.00027902192],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991084,0.000298313,0.00023991532,0.0000864948,0.00022407611,0.000042946278],"domain_scores_gemma":[0.99804115,0.0011805592,0.00023552285,0.000037746922,0.00043873032,0.00006614911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016722749,0.0006725541,0.0013883726,0.00300556,0.00038143477,0.0012971429,0.0009101037,0.0015406192,0.0036089127],"category_scores_gemma":[0.0063190726,0.00027434924,0.0010839718,0.001432306,0.00043247087,0.0021081534,0.0005976235,0.0014454012,0.0017166947],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067713074,0.000052751642,0.00064171175,0.058720417,0.0003255799,0.0003755464,0.00014110557,0.00013820594,0.00047636032,0.0018512369,0.046740327,0.8904691],"study_design_scores_gemma":[0.00007344331,0.000106152154,0.0043775914,0.09070721,0.0010688386,0.0034879637,0.00062088453,0.0001357277,0.0005310279,0.0044569937,0.89438045,0.00005380217],"about_ca_topic_score_codex":0.003755662,"about_ca_topic_score_gemma":0.0049757827,"teacher_disagreement_score":0.003755662,"about_ca_system_score_codex":0.00062141445,"about_ca_system_score_gemma":0.0031952458,"threshold_uncertainty_score":0.01207304},"labels":[],"label_agreement":null},{"id":"W4404194774","doi":"10.1177/13524585241290102","title":"Development and initial validation of the Cognitive Change Scale (CCS)","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Multiple sclerosis; Scale (ratio); Cognition; Psychology; Neuroscience; Geography; Psychiatry; Cartography","score_opus":0.2180307942094561,"score_gpt":0.3519636776207886,"score_spread":0.13393288341133253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404194774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9693096,0.0007911149,0.011374576,0.0005461497,0.00011646776,0.010052451,0.0016292015,0.00010747301,0.0060730334],"genre_scores_gemma":[0.93089724,0.00055435154,0.050163493,0.00030557686,0.00008507692,0.013401448,0.002879466,0.000034386776,0.0016788522],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965958,0.0014383402,0.000536275,0.00016620614,0.0011573976,0.00010601928],"domain_scores_gemma":[0.99012274,0.0035989007,0.00093328085,0.00047845923,0.00436617,0.0005004529],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011832474,0.0005006247,0.00048980693,0.0012513723,0.00038858218,0.00048372272,0.0007891742,0.0007232943,0.0015294047],"category_scores_gemma":[0.021132953,0.0002717286,0.000581313,0.00061392545,0.00065907487,0.0006567702,0.0009530027,0.0010204483,0.0004527386],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001868796,0.0040406645,0.69670236,0.0005332962,0.00025446544,0.00026472384,0.0036816287,0.000839505,0.008742918,0.0011363529,0.003942405,0.27799287],"study_design_scores_gemma":[0.00046757728,0.0064442367,0.9821829,0.0001759685,0.000074762145,0.00034849936,0.0007611273,0.0021434529,0.0013869727,0.0004450413,0.005542306,0.000027026827],"about_ca_topic_score_codex":0.0021725046,"about_ca_topic_score_gemma":0.0036925564,"teacher_disagreement_score":0.011832474,"about_ca_system_score_codex":0.0006020321,"about_ca_system_score_gemma":0.0019959318,"threshold_uncertainty_score":0.06257689},"labels":[],"label_agreement":null},{"id":"W4404900898","doi":"10.1177/13524585241295554","title":"Safety, efficacy, and tolerability of alemtuzumab in pediatric patients with active relapsing-remitting multiple sclerosis: The LemKids study","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"Sanofi","keywords":"Alemtuzumab; Medicine; Multiple sclerosis; Tolerability; Relapsing remitting; Internal medicine; Mallinckrodt; Clinical endpoint; Adverse effect; Clinical trial; Immunology","score_opus":0.060693753650087875,"score_gpt":0.2880410208433752,"score_spread":0.2273472671932873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404900898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99270415,0.0046098945,0.00016554874,0.0001774381,0.000012071209,0.0001198652,0.0016128081,0.000013981244,0.0005841978],"genre_scores_gemma":[0.9951982,0.0018124188,0.000506786,0.00018326151,0.000049933482,0.00016729347,0.0019043983,0.0000065953727,0.00017122838],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99858594,0.0008690102,0.00011646893,0.00016415826,0.00019805836,0.00006637655],"domain_scores_gemma":[0.9970216,0.00063479214,0.001713947,0.00014825656,0.00021611807,0.0002651899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032850448,0.00056059856,0.00089764333,0.00025376026,0.00015703266,0.0006083278,0.0004347233,0.0003858158,0.0007777424],"category_scores_gemma":[0.0035696626,0.00017456713,0.0009962195,0.0003879122,0.00029729505,0.0004144779,0.00038708607,0.0006852758,0.00017086348],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09360325,0.0013043967,0.8329102,0.0012045746,0.0056579816,0.0006426802,0.00035205766,0.0013506397,0.0032476247,0.00021725114,0.003232441,0.056276962],"study_design_scores_gemma":[0.02511608,0.030586373,0.92541844,0.00034073094,0.0042745657,0.0021217961,0.00020893638,0.0017785389,0.0026110862,0.00015756163,0.007343464,0.000042441443],"about_ca_topic_score_codex":0.00055792846,"about_ca_topic_score_gemma":0.0010338613,"teacher_disagreement_score":0.0032850448,"about_ca_system_score_codex":0.0005423403,"about_ca_system_score_gemma":0.00073218683,"threshold_uncertainty_score":0.017373204},"labels":[],"label_agreement":null},{"id":"W4405127548","doi":"10.1177/13524585241303481","title":"Considerations for family planning in adolescent and young adults with multiple sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Reproductive Health and Technologies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Multiple sclerosis; Medicine; Clinical neurology; Psychology; Pediatrics; Neuroscience; Psychiatry","score_opus":0.14733193582433557,"score_gpt":0.306836361717758,"score_spread":0.15950442589342245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405127548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8589982,0.021535575,0.001324482,0.083725095,0.0009643911,0.00014263259,0.0004745564,0.000064454325,0.03277057],"genre_scores_gemma":[0.98341054,0.008269099,0.0013896636,0.004386445,0.00032897628,0.000045979825,0.00009638524,0.0000076089636,0.0020653473],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996749,0.00016393687,0.00003119684,0.000017644466,0.000057206627,0.000055116798],"domain_scores_gemma":[0.9988949,0.0004230506,0.00017555508,0.000013364424,0.00007386025,0.0004193569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069590827,0.00008496283,0.00015865164,0.00023926902,0.00096103345,0.0004156465,0.00014750376,0.0005328884,0.0047177733],"category_scores_gemma":[0.003108599,0.00006923754,0.00022019155,0.00014638912,0.0002459147,0.00041605817,0.0003976465,0.0008684832,0.00020075154],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011399557,0.00022373378,0.76771986,0.00034834538,0.000051675295,0.022854991,0.0080416445,0.00038750138,0.0007215475,0.001209915,0.030184267,0.16814253],"study_design_scores_gemma":[0.00007134233,0.0011784408,0.73392785,0.0039416044,0.00012827874,0.08511423,0.069107085,0.0008758748,0.00080441777,0.005280156,0.09948172,0.000089034555],"about_ca_topic_score_codex":0.005481039,"about_ca_topic_score_gemma":0.016554015,"teacher_disagreement_score":0.005481039,"about_ca_system_score_codex":0.00028591754,"about_ca_system_score_gemma":0.0013243625,"threshold_uncertainty_score":0.015782475},"labels":[],"label_agreement":null},{"id":"W4405263293","doi":"10.1177/13524585241301613","title":"Exercise as a Therapeutic Intervention in Multiple Sclerosis","year":2024,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; University of Ottawa","funders":"","keywords":"Multiple sclerosis; Intervention (counseling); Medicine; Exercise prescription; Physical therapy; Disease; Physical medicine and rehabilitation; Physical exercise; Exercise therapy; Psychology; Randomized controlled trial; Psychiatry; Pathology","score_opus":0.29444775047756466,"score_gpt":0.39641055776367806,"score_spread":0.1019628072861134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405263293","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000060895512,0.99942833,0.00002032986,0.00012183407,0.00008841481,0.000005475691,0.0000044280355,0.0000015025945,0.00026880333],"genre_scores_gemma":[0.00085216673,0.9987136,0.000077802135,0.00013431214,0.00007451268,0.000011662049,0.00000850699,6.9706203e-7,0.0001267721],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99919647,0.000327458,0.00014112012,0.00008699541,0.00020154966,0.000046415076],"domain_scores_gemma":[0.9990683,0.00071550003,0.00009771764,0.000014706196,0.00007978037,0.000024012415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001381916,0.0007302622,0.0017831704,0.0028090281,0.00031246504,0.0014392156,0.00066160125,0.0017635428,0.0051118326],"category_scores_gemma":[0.0021502422,0.0002817645,0.0014520821,0.0021188345,0.0004864682,0.0008872836,0.0008028957,0.0015350876,0.00079151726],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014189632,0.000100310855,0.00015646778,0.12923554,0.00053099875,0.00010000271,0.00013979863,0.00021534994,0.0005413556,0.0031257868,0.011796084,0.8539163],"study_design_scores_gemma":[0.00015641256,0.00043943652,0.004010157,0.16854814,0.0019396393,0.0013020745,0.0002404969,0.0002117483,0.00054535066,0.0033830716,0.81918424,0.000039273782],"about_ca_topic_score_codex":0.0018148022,"about_ca_topic_score_gemma":0.0032935431,"teacher_disagreement_score":0.0051118326,"about_ca_system_score_codex":0.00073967903,"about_ca_system_score_gemma":0.00161335,"threshold_uncertainty_score":0.017100811},"labels":[],"label_agreement":null},{"id":"W4405557779","doi":"10.1177/13524585241302170","title":"Long-term follow-up of patients with a first clinical demyelinating event (clinically isolated syndrome) who received cladribine tablets in CLASSIC-MS: Findings for the ORACLE-MS cohort","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Cladribine; Multiple sclerosis; Medicine; Clinically isolated syndrome; Relapsing remitting; Cohort; Pediatrics; Internal medicine; Immunology","score_opus":0.08249131676700497,"score_gpt":0.3470053581187855,"score_spread":0.2645140413517806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405557779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994506,0.00013346806,0.000036124897,0.000018350049,0.0000031904758,0.0000043017217,0.00023254323,0.0000010524986,0.000120287084],"genre_scores_gemma":[0.9993106,0.00007012873,0.000028774703,0.000016927506,0.000008433736,0.0000042228344,0.00048508093,0.0000010153725,0.00007469065],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99961746,0.00008002561,0.000038220645,0.00012760815,0.000070841714,0.00006581515],"domain_scores_gemma":[0.9983352,0.00027283657,0.00062247715,0.00019640026,0.00014485848,0.00042832765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010211748,0.0002424669,0.00044486692,0.00030753104,0.0003274263,0.0005883449,0.0002605951,0.00032893184,0.0013784479],"category_scores_gemma":[0.0023646634,0.00018029375,0.0005682487,0.00038522153,0.00017372526,0.0005442833,0.0005394164,0.00056371966,0.00019032856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013702646,0.000050208568,0.9956594,0.000008733008,0.00010439356,0.00011010374,0.000071003626,0.00005140923,0.00038777923,0.000010379994,0.00008764099,0.0020887055],"study_design_scores_gemma":[0.000049189177,0.0004386622,0.99836403,0.0000073688025,0.00009892256,0.00044851776,0.00013448593,0.00020899848,0.00008316525,0.000015266314,0.00014614286,0.0000052895452],"about_ca_topic_score_codex":0.0024960167,"about_ca_topic_score_gemma":0.002428643,"teacher_disagreement_score":0.0024960167,"about_ca_system_score_codex":0.00020019014,"about_ca_system_score_gemma":0.00023959455,"threshold_uncertainty_score":0.0054005384},"labels":[],"label_agreement":null},{"id":"W4405849416","doi":"10.1177/13524585241309257","title":"Trigeminal neuralgia within the disease course of MS: Diagnostic and therapeutic implications from a multicenter cohort","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Trigeminal Neuralgia and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Trigeminal neuralgia; Multiple sclerosis; Medicine; Multicenter study; Cohort; Disease; Cohort study; Surgery; Internal medicine; Psychiatry; Randomized controlled trial","score_opus":0.046482289508857834,"score_gpt":0.2907720276367278,"score_spread":0.24428973812787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405849416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994716,0.00013495804,0.000038824608,0.000034571356,0.0000047018452,0.000009526645,0.00011090426,0.0000010568568,0.00019390562],"genre_scores_gemma":[0.9994254,0.00013300372,0.000045603716,0.000033787856,0.000020953525,0.000013858816,0.00024888353,0.000002479262,0.00007598702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990735,0.00025062458,0.00008010557,0.00029186887,0.00014487936,0.00015895913],"domain_scores_gemma":[0.9988494,0.00019170744,0.00037180685,0.00012475699,0.00015999543,0.00030224773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011257184,0.0003491529,0.0004077039,0.0007300952,0.0010078201,0.0010117823,0.0004919206,0.00051686267,0.0013923037],"category_scores_gemma":[0.0036150014,0.000264015,0.00041444885,0.000765017,0.0004568778,0.0008033545,0.0009449854,0.00067310844,0.00023966079],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030177948,0.00007182377,0.997029,0.000006424125,0.000043861713,0.00031567007,0.00028519612,0.000016608892,0.00027039266,0.000017854954,0.00011486033,0.0015265914],"study_design_scores_gemma":[0.000024171946,0.00021168744,0.9972676,0.000007893417,0.000050322436,0.0013487997,0.00066648785,0.00012282566,0.00005078672,0.000027873848,0.00021391246,0.000007701079],"about_ca_topic_score_codex":0.0048661744,"about_ca_topic_score_gemma":0.0038462563,"teacher_disagreement_score":0.0048661744,"about_ca_system_score_codex":0.00042519643,"about_ca_system_score_gemma":0.0004522719,"threshold_uncertainty_score":0.009675741},"labels":[],"label_agreement":null},{"id":"W4405919577","doi":"10.1177/13524585241308134","title":"Recommendations for essential medicines for multiple sclerosis in low-resource settings","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Queen's University; Impact; University of British Columbia; Multiple Sclerosis Society of Canada","funders":"","keywords":"Fingolimod; Glatiramer acetate; Ocrelizumab; Multiple sclerosis; Medicine; Teriflunomide; Cladribine; Alemtuzumab; Context (archaeology); Interferon beta-1a; Physical therapy; Rituximab; Intensive care medicine; Internal medicine; Interferon beta; Immunology; Lymphoma","score_opus":0.1214893747593575,"score_gpt":0.34436699760239786,"score_spread":0.22287762284304036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405919577","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004976691,0.23922263,0.035235066,0.5643653,0.030676913,0.019992582,0.015817044,0.001581016,0.08813283],"genre_scores_gemma":[0.0382259,0.18555832,0.4299098,0.27871877,0.0053648036,0.027759824,0.010425484,0.00042428056,0.02361279],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9352974,0.031733274,0.018738996,0.0013539116,0.010853472,0.0020228245],"domain_scores_gemma":[0.8179786,0.09470945,0.021873461,0.004275729,0.056178514,0.004984151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.047218338,0.0021979127,0.0027507846,0.006583719,0.0016444613,0.0044027437,0.009321389,0.014740381,0.014325459],"category_scores_gemma":[0.1717831,0.0018640733,0.0089463685,0.0046594446,0.0020233383,0.005819121,0.005371121,0.01322266,0.0051787323],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054949994,0.0003853567,0.0018659369,0.06338084,0.0013346178,0.0005701564,0.0015625441,0.001307607,0.00094217935,0.013058278,0.6034338,0.31160918],"study_design_scores_gemma":[0.0012945569,0.00030160396,0.0047223694,0.15855993,0.0024109099,0.0003712101,0.00079449895,0.00067259243,0.0006028712,0.011672455,0.8183999,0.00019705131],"about_ca_topic_score_codex":0.015978701,"about_ca_topic_score_gemma":0.024507327,"teacher_disagreement_score":0.047218338,"about_ca_system_score_codex":0.0060206763,"about_ca_system_score_gemma":0.027615475,"threshold_uncertainty_score":0.24971741},"labels":[],"label_agreement":null},{"id":"W4406035973","doi":"10.1177/13524585241310104","title":"Post-acute sequela of COVID-19 infection in individuals with multiple sclerosis","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Long-Term Effects of COVID-19","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Multiple Sclerosis Society","keywords":"Sequela; Multiple sclerosis; Coronavirus disease 2019 (COVID-19); Medicine; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Betacoronavirus; Coronavirus Infections; Pandemic; Virology; Disease; Immunology; Internal medicine; Outbreak; Psychiatry; Infectious disease (medical specialty)","score_opus":0.04335266949194842,"score_gpt":0.3022120717825216,"score_spread":0.25885940229057314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406035973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99914086,0.00023665327,0.000023542992,0.000046049467,0.0000050406165,0.000009003798,0.00014544539,0.0000019330594,0.00039154515],"genre_scores_gemma":[0.9996476,0.00009839682,0.000029641307,0.000024398789,0.0000146899065,0.0000058270252,0.00010702215,6.4009225e-7,0.00007168967],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994862,0.00012322952,0.000075897355,0.0000849783,0.00011689745,0.00011275826],"domain_scores_gemma":[0.99701595,0.00033153832,0.0019399296,0.00008483363,0.00026973156,0.00035806667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072486134,0.00027754842,0.0002861761,0.0006967159,0.0006155886,0.0004983416,0.0002832853,0.0004126028,0.0015587475],"category_scores_gemma":[0.00284193,0.00014511136,0.00024076794,0.0007098304,0.0002749848,0.00049342343,0.00042794913,0.00062184106,0.0001956734],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005399661,0.000031824842,0.99880135,0.000013092776,0.000013830231,0.00013188588,0.000071487026,0.000011429845,0.00009024062,0.00000545388,0.000058077432,0.0007173306],"study_design_scores_gemma":[0.0000019231786,0.000105434374,0.9989843,0.0000086494,0.000008521437,0.000618585,0.00014646031,0.000029109324,0.000030993895,0.000009055351,0.00005545118,0.0000014094718],"about_ca_topic_score_codex":0.0025467786,"about_ca_topic_score_gemma":0.0039434563,"teacher_disagreement_score":0.0025467786,"about_ca_system_score_codex":0.00025370705,"about_ca_system_score_gemma":0.0003082499,"threshold_uncertainty_score":0.0052145123},"labels":[],"label_agreement":null},{"id":"W4406578583","doi":"10.1177/13524585241311441","title":"Upper cervical spinal cord atrophy in MS: Sex, menopause, and neurodegeneration","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute of Neurological Disorders and Stroke; Avid Radiopharmaceuticals; Genentech; National Institutes of Health; Horizon Therapeutics; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Mayo Clinic; Biogen; Alexion Pharmaceuticals; Pfizer; National Institute on Aging; Eli Lilly and Company","keywords":"Medicine; Menopause; Expanded Disability Status Scale; Multiple sclerosis; Atrophy; Internal medicine; Biomarker; Gynecology","score_opus":0.0684216378736437,"score_gpt":0.32395946598438247,"score_spread":0.2555378281107388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406578583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98008144,0.01850238,0.000064536216,0.0004012939,0.000025548325,0.000007991904,0.00020797848,0.000004902729,0.0007039704],"genre_scores_gemma":[0.99722207,0.0023281379,0.000065844615,0.000069167174,0.000069313304,0.0000052335913,0.0000989837,9.939812e-7,0.00014031079],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998877,0.000037424616,0.000012024715,0.000022116143,0.000023009146,0.000017740154],"domain_scores_gemma":[0.9994815,0.00014106349,0.00021589271,0.000021786078,0.000054186432,0.00008554872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043120378,0.00016825409,0.00028439888,0.0006645553,0.0002394468,0.00032046137,0.00019113,0.00033062615,0.001630888],"category_scores_gemma":[0.0013963113,0.00008346714,0.00022713626,0.0006870849,0.0002511341,0.00024212961,0.00024743355,0.00019044401,0.00010806008],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034357965,0.00003056212,0.9859386,0.00008233701,0.00012959249,0.00026593567,0.00016877434,0.000045672597,0.0005508786,0.000032545868,0.00026851165,0.0121429665],"study_design_scores_gemma":[0.0000038771627,0.000055483983,0.9992206,0.000018657474,0.000038217644,0.00028464,0.000052711785,0.000046803,0.000024663826,0.000045286775,0.0002071128,0.0000019183465],"about_ca_topic_score_codex":0.0028755108,"about_ca_topic_score_gemma":0.0057617784,"teacher_disagreement_score":0.0028755108,"about_ca_system_score_codex":0.0001934982,"about_ca_system_score_gemma":0.00021949981,"threshold_uncertainty_score":0.005717516},"labels":[],"label_agreement":null},{"id":"W4406687131","doi":"10.1177/13524585241303489","title":"DISCOntinuation of disease-modifying therapies in MS: The DISCOMS extension trial","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Pittsburgh; University of Rochester; Cleveland Clinic Foundation; York University; Cleveland Clinic; Vanderbilt University","keywords":"Medicine; Discontinuation; Clinical endpoint; Multiple sclerosis; Magnetic resonance imaging; Randomized controlled trial; Clinical trial; Disease; Internal medicine; Radiology; Psychiatry","score_opus":0.12146672046004658,"score_gpt":0.34939026547267726,"score_spread":0.22792354501263068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406687131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99351513,0.0038994385,0.00015634418,0.0004541164,0.00008236268,0.0002831335,0.00046605826,0.0000135745395,0.0011298667],"genre_scores_gemma":[0.9949563,0.0019385233,0.00047450815,0.0003405626,0.00026697142,0.000422815,0.0007464723,0.0000049948794,0.0008489118],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993285,0.00046181507,0.00004410275,0.000053980097,0.000061970466,0.00004971523],"domain_scores_gemma":[0.99823964,0.0005482714,0.0005863265,0.00015356671,0.00011902735,0.0003531955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023692448,0.0004118646,0.0009643009,0.00016822874,0.0001797815,0.00040172128,0.00025938195,0.0004575324,0.0025736596],"category_scores_gemma":[0.0029751402,0.00011675323,0.0007676928,0.00023877654,0.00033804888,0.00035338636,0.00032057322,0.0010443715,0.00020241333],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90693694,0.0030020834,0.019036833,0.0016048374,0.0016546438,0.00022247211,0.00018964117,0.00078779995,0.0030685312,0.0003959073,0.0025986603,0.060501758],"study_design_scores_gemma":[0.7580444,0.14103243,0.08528119,0.00062004034,0.0031102272,0.00043163772,0.00014593442,0.0014904033,0.0012679619,0.00070074614,0.0078441985,0.000030939],"about_ca_topic_score_codex":0.00027831263,"about_ca_topic_score_gemma":0.0006409734,"teacher_disagreement_score":0.0025736596,"about_ca_system_score_codex":0.00018383277,"about_ca_system_score_gemma":0.0005965542,"threshold_uncertainty_score":0.01252991},"labels":[],"label_agreement":null},{"id":"W4406827363","doi":"10.1177/13524585251313744","title":"Testing for myelin oligodendrocyte glycoprotein antibodies: Who, what, where, when, why, and how","year":2025,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Multiple sclerosis; Myelin oligodendrocyte glycoprotein; Medicine; Antibody; Immunology; Cerebrospinal fluid; Oligodendrocyte; Immunoglobulin G; Disease; Demyelinating disease; Myelin; Pathology; Central nervous system; Internal medicine; Experimental autoimmune encephalomyelitis","score_opus":0.19025294522413133,"score_gpt":0.3633327092842414,"score_spread":0.17307976406011005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406827363","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000044993398,0.9992586,0.000034263787,0.00032405474,0.000084803454,0.0000036725462,0.00001305481,0.000001718201,0.00023479202],"genre_scores_gemma":[0.00035867112,0.999213,0.00009136541,0.0001769792,0.00006161245,0.0000046476016,0.000017133832,5.1664057e-7,0.00007607578],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99916255,0.00024133068,0.00022213583,0.00010540806,0.00022293147,0.00004560638],"domain_scores_gemma":[0.9976278,0.0016082248,0.00030604706,0.000037157228,0.0003650764,0.000055752804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001743557,0.0008365354,0.0021399995,0.0035208997,0.00032914925,0.0014736848,0.0010350493,0.001507211,0.0031109124],"category_scores_gemma":[0.0048435247,0.00027800738,0.001019652,0.0032799386,0.0006280054,0.0020100046,0.0007228078,0.001387166,0.0011642417],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008093098,0.000039882667,0.00038285184,0.10079071,0.00031440094,0.0001570695,0.00017084337,0.00015733845,0.00058295985,0.0019683035,0.021276195,0.8740786],"study_design_scores_gemma":[0.000043372987,0.000142279,0.002651936,0.13205706,0.0014556758,0.0022175023,0.0004038426,0.00009105881,0.0004359674,0.00249648,0.85795206,0.00005276975],"about_ca_topic_score_codex":0.0029222157,"about_ca_topic_score_gemma":0.0042187455,"teacher_disagreement_score":0.0035208997,"about_ca_system_score_codex":0.00079982256,"about_ca_system_score_gemma":0.002859117,"threshold_uncertainty_score":0.010407031},"labels":[],"label_agreement":null},{"id":"W4407586252","doi":"10.1177/13524585251316519","title":"Presence of slowly expanding lesions in multiple sclerosis predicts progressive demyelination within lesions and normal-appearing tissue over time","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NeuroRx Research (Canada); McGill University; University of British Columbia","funders":"F. Hoffmann-La Roche","keywords":"Multiple sclerosis; Myelin; Medicine; Nuclear medicine; Magnetic resonance imaging; White matter; Hyperintensity; Pathology; Internal medicine; Radiology; Central nervous system; Immunology","score_opus":0.0875757200489801,"score_gpt":0.3272608859989193,"score_spread":0.2396851659499392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407586252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99946696,0.00014309029,0.000046840756,0.000011332449,0.0000020385173,0.000005208307,0.000038374194,0.000004034544,0.00028218704],"genre_scores_gemma":[0.9996469,0.000051488132,0.00011341079,0.0000051720885,0.0000039951633,0.000004067462,0.00006626848,0.0000015847545,0.00010702318],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981076,0.00003760878,0.000024929415,0.000048714326,0.000054713564,0.000023305414],"domain_scores_gemma":[0.9979334,0.00035310988,0.0011761672,0.00006793835,0.00021173242,0.00025760793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007115273,0.00033981292,0.00027338782,0.0008029447,0.00023483066,0.0004267689,0.00023632839,0.00041118276,0.0017243121],"category_scores_gemma":[0.0025088869,0.000120131095,0.00022229424,0.00036016453,0.00025232407,0.0004611902,0.00027855605,0.00028695638,0.00031153284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008527241,0.00010277491,0.98898685,0.000032598018,0.00005602561,0.0001623717,0.00013632028,0.000113405615,0.0055850577,0.000013956679,0.000060663573,0.003897168],"study_design_scores_gemma":[0.000006463263,0.00035855727,0.99812204,0.000008670266,0.000026680204,0.0006675954,0.00008047532,0.00017752429,0.00044662255,0.000027836975,0.00007404054,0.0000036249153],"about_ca_topic_score_codex":0.0010657837,"about_ca_topic_score_gemma":0.0015505104,"teacher_disagreement_score":0.0017243121,"about_ca_system_score_codex":0.00016447878,"about_ca_system_score_gemma":0.00013067656,"threshold_uncertainty_score":0.0057683587},"labels":[],"label_agreement":null},{"id":"W4407985964","doi":"10.1177/13524585251315344","title":"An interdisciplinary approach is necessary in the treatment of cognitive decline in multiple sclerosis: Yes","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; University of Saskatchewan","funders":"","keywords":"Multiple sclerosis; Cognition; Psychology; Medicine; Psychotherapist; Physical medicine and rehabilitation; Psychiatry","score_opus":0.1393346253237682,"score_gpt":0.374380703655447,"score_spread":0.23504607833167881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407985964","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.036758743,0.15478128,0.004637555,0.76170784,0.019663997,0.00022783068,0.0001676549,0.00017671396,0.021878311],"genre_scores_gemma":[0.3457853,0.19224761,0.03342788,0.34122875,0.0697425,0.001338179,0.00046360758,0.00010452101,0.015661666],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99571556,0.0016191028,0.0006580781,0.0004614691,0.0010220434,0.000523775],"domain_scores_gemma":[0.9836301,0.004490623,0.0018913398,0.00072668627,0.004203933,0.0050572557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006853969,0.00066355214,0.0021396026,0.0008013334,0.0035834392,0.0049221017,0.0017247414,0.010292268,0.0076565365],"category_scores_gemma":[0.011619684,0.0003291075,0.0016073365,0.0009317975,0.002237608,0.0060624075,0.0032910113,0.0084688505,0.0018515438],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021660882,0.0042018415,0.03276885,0.007983541,0.0011367043,0.0029307005,0.0020002802,0.00076361094,0.0029569445,0.0098418705,0.111423984,0.8218257],"study_design_scores_gemma":[0.0030878838,0.0066453405,0.284738,0.053488005,0.0023906738,0.015460845,0.03401628,0.0025186236,0.0023211588,0.1105397,0.48378035,0.0010132088],"about_ca_topic_score_codex":0.0024441273,"about_ca_topic_score_gemma":0.008044051,"teacher_disagreement_score":0.010292268,"about_ca_system_score_codex":0.0012641341,"about_ca_system_score_gemma":0.0073396293,"threshold_uncertainty_score":0.03624767},"labels":[],"label_agreement":null},{"id":"W4408546492","doi":"10.1177/13524585251326841","title":"Seizure history and cognitive dysfunction in people with multiple sclerosis","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Sunnybrook Foundation","keywords":"Hospital Anxiety and Depression Scale; Paced Auditory Serial Addition Test; California Verbal Learning Test; Population; Anxiety; Expanded Disability Status Scale; Verbal learning; Cognition; Wechsler Adult Intelligence Scale; Medicine; Psychology; Depression (economics); Trail Making Test; Verbal memory; Audiology; Psychiatry; Multiple sclerosis; Cognitive impairment","score_opus":0.06780697561429802,"score_gpt":0.27143376088265436,"score_spread":0.20362678526835634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408546492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99811906,0.00071569433,0.000019111045,0.0001221748,0.000010387879,0.000006353781,0.00029214396,0.0000041471444,0.00071092194],"genre_scores_gemma":[0.99938476,0.0002223455,0.000025193853,0.000043051834,0.000015746165,0.0000045753472,0.00018592743,7.505094e-7,0.00011768297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997143,0.000056352295,0.000044896442,0.000045559642,0.00009318831,0.0000456052],"domain_scores_gemma":[0.9985795,0.00019889217,0.0008636064,0.00004780095,0.00011404209,0.00019608653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039989967,0.00022903323,0.0003983188,0.0009656087,0.00045875984,0.0005179185,0.00021373344,0.00038830296,0.002087567],"category_scores_gemma":[0.0023828798,0.000170328,0.0003867753,0.0013915554,0.00027092334,0.00040109828,0.00042181308,0.0005513332,0.0002592188],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005955651,0.000022531578,0.998509,0.000012376383,0.000032332853,0.00008068015,0.00005628564,0.000017249502,0.00003989579,0.000004769801,0.000063929736,0.0011014383],"study_design_scores_gemma":[0.0000023098466,0.000043792053,0.9995989,0.000005349668,0.000010648788,0.00018985591,0.00006372229,0.000022371485,0.0000071391746,0.000011307526,0.000043327578,0.0000011399228],"about_ca_topic_score_codex":0.006145275,"about_ca_topic_score_gemma":0.008301815,"teacher_disagreement_score":0.006145275,"about_ca_system_score_codex":0.00027019822,"about_ca_system_score_gemma":0.00028207118,"threshold_uncertainty_score":0.012219012},"labels":[],"label_agreement":null},{"id":"W4409380838","doi":"10.1177/13524585251329800","title":"Emphasizing complementary in “Investigating the complementary value of OCT to MRI in cognitive impairment in relapsing-remitting multiple sclerosis”","year":2025,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Multiple sclerosis; Relapsing remitting; Cognitive impairment; Medicine; Neuroscience; Cognition; Psychology; Clinically isolated syndrome; Psychiatry","score_opus":0.15611338551928458,"score_gpt":0.34889562445534233,"score_spread":0.19278223893605775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409380838","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001924043,0.0016445013,0.00018934585,0.9695193,0.02481095,0.000028461569,0.00007821146,0.000017832856,0.0017873542],"genre_scores_gemma":[0.008684374,0.0012438409,0.00059452205,0.9227778,0.0641795,0.000057478705,0.000030266194,0.000012198723,0.0024200673],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965745,0.001066879,0.0007865307,0.0005130441,0.0007035652,0.00035543833],"domain_scores_gemma":[0.9813038,0.012049505,0.001091285,0.00051396264,0.0035732721,0.0014681204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051822364,0.000554607,0.0014770728,0.00091357465,0.0029579534,0.0029141132,0.0016369841,0.037414268,0.0019846568],"category_scores_gemma":[0.040220648,0.0006606697,0.0010904382,0.00096560456,0.0026529508,0.0028079813,0.0010648465,0.029452026,0.0014892026],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004387286,0.00019765507,0.010852099,0.00031762169,0.00010992184,0.017181048,0.0006038761,0.0001812851,0.0011829236,0.0041459017,0.93814254,0.026646437],"study_design_scores_gemma":[0.0013319111,0.0005095665,0.021230537,0.0019077325,0.0005407735,0.028436603,0.0020443096,0.003046973,0.0025588088,0.02303695,0.9150143,0.0003413914],"about_ca_topic_score_codex":0.006817808,"about_ca_topic_score_gemma":0.012365997,"teacher_disagreement_score":0.037414268,"about_ca_system_score_codex":0.002753479,"about_ca_system_score_gemma":0.003969871,"threshold_uncertainty_score":0.027406633},"labels":[],"label_agreement":null},{"id":"W4409509273","doi":"10.1177/13524585251325086","title":"Short- and long-term effects of early versus delayed treatment with ocrelizumab on cerebellar volume loss in patients with RMS and PPMS","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McGill University; NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"F. Hoffmann-La Roche","keywords":"Ocrelizumab; Medicine; Multiple sclerosis; Anesthesia; Cerebellum; Internal medicine; Immunology; Rituximab","score_opus":0.02938604986357733,"score_gpt":0.273589728841536,"score_spread":0.24420367897795867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409509273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970289,0.002373358,0.00008866023,0.000049040547,0.000030905012,0.000033190277,0.00009952967,0.000011811458,0.00028468794],"genre_scores_gemma":[0.99932253,0.0002210207,0.00009235895,0.000033524575,0.000029130346,0.0000348487,0.00011195914,0.0000019122513,0.00015278137],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9994518,0.00020973184,0.00005800889,0.00011080871,0.0000765821,0.00009304531],"domain_scores_gemma":[0.9981846,0.00062817155,0.0005039982,0.0001264289,0.00011220748,0.00044443976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013709317,0.00043000336,0.0014191355,0.00020957075,0.00014973599,0.0003727148,0.00026763638,0.00046951752,0.0011951602],"category_scores_gemma":[0.0023006839,0.0001272028,0.001012986,0.00016439099,0.00032843612,0.000465813,0.00025660585,0.0008869742,0.0001541163],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8159205,0.010623031,0.03241384,0.0005012689,0.0023482086,0.00016761167,0.00012965286,0.0016915204,0.012074022,0.00006175687,0.0004041748,0.123664536],"study_design_scores_gemma":[0.04691754,0.5670383,0.37170348,0.0001009639,0.0030735643,0.0003628046,0.00012808197,0.0029214332,0.0063877427,0.00019149149,0.0010997204,0.000074866744],"about_ca_topic_score_codex":0.00065951125,"about_ca_topic_score_gemma":0.0010003767,"teacher_disagreement_score":0.0014191355,"about_ca_system_score_codex":0.00044823758,"about_ca_system_score_gemma":0.0003589304,"threshold_uncertainty_score":0.007250309},"labels":[],"label_agreement":null},{"id":"W4409591550","doi":"10.1177/13524585251330109","title":"Risk factors for incident peripartum mental illness in multiple sclerosis","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Waterloo; University of Toronto; St. Michael's Hospital; University of Manitoba; Dalhousie University","funders":"Multiple Sclerosis Society of Canada","keywords":"Medicine; Anxiety; Incidence (geometry); Depression (economics); Mental illness; Poisson regression; Comorbidity; Population; Psychiatry; Mental health; Rate ratio","score_opus":0.11237532660868481,"score_gpt":0.3232877291034818,"score_spread":0.21091240249479698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409591550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99783534,0.00076589896,0.000060031023,0.00020117877,0.000006583627,0.00000923082,0.00040532748,0.0000054564516,0.00071093783],"genre_scores_gemma":[0.99934953,0.00029113292,0.00006057061,0.000019719571,0.000005812862,0.000005067081,0.00016704171,8.7299395e-7,0.00010022785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981064,0.000032755568,0.000016067404,0.000028140501,0.0000611359,0.00005125091],"domain_scores_gemma":[0.99937063,0.00005906934,0.00038248583,0.000017563558,0.00006268553,0.00010755558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021048932,0.000115958916,0.00013246419,0.00043166854,0.00044626242,0.00032871115,0.00023307206,0.0002046573,0.0017960687],"category_scores_gemma":[0.0014259361,0.0001256599,0.00017414686,0.00053839065,0.0001705204,0.00013051654,0.00029783265,0.00039756412,0.00010243163],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015284975,0.0000070852366,0.9987877,0.000006591828,0.000011862325,0.000067789704,0.00005791243,0.000011830399,0.00006337307,0.000008245436,0.000097277414,0.0008651059],"study_design_scores_gemma":[9.1381924e-7,0.000011552677,0.99954516,0.00001024704,0.0000058901796,0.00016984018,0.000089558394,0.00005418327,0.000013348291,0.0000069364305,0.00009140066,9.34697e-7],"about_ca_topic_score_codex":0.10210767,"about_ca_topic_score_gemma":0.1218064,"teacher_disagreement_score":0.10210767,"about_ca_system_score_codex":0.0009451966,"about_ca_system_score_gemma":0.0009228684,"threshold_uncertainty_score":0.20302671},"labels":[],"label_agreement":null},{"id":"W4409591881","doi":"10.1177/13524585251334488","title":"Addressing patient-reported cognitive impairment in multiple sclerosis clinical practice: A challenging endeavor","year":2025,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; University of Calgary; Université de Montréal; Hotchkiss Brain Institute; Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research; Sanofi Genzyme; EMD Serono; Biogen; Celgene; Sanofi; Multiple Sclerosis Society; International Progressive MS Alliance; Amgen","keywords":"Multiple sclerosis; Quality of life (healthcare); Cognition; Neuropsychology; Medicine; Confounding; Cognitive impairment; Clinical psychology; MEDLINE; Psychology; Psychiatry; Pathology","score_opus":0.4812248495583127,"score_gpt":0.4693702376745708,"score_spread":0.011854611883741872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409591881","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000108281296,0.99919003,0.000058551082,0.00030020997,0.000059102447,0.000010478636,0.000014784507,0.000003086042,0.00025555558],"genre_scores_gemma":[0.0010943416,0.99829096,0.00024245385,0.00019640823,0.0000666037,0.000017231285,0.000019069981,9.39131e-7,0.0000719905],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984034,0.00065439765,0.00038671077,0.00011404841,0.00038945506,0.000052127947],"domain_scores_gemma":[0.99512285,0.0037459855,0.00045774985,0.00006200462,0.0005431432,0.00006813864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027763098,0.0007822511,0.00265427,0.0027552682,0.0003712651,0.0018723567,0.0009043615,0.0013714163,0.0031102458],"category_scores_gemma":[0.0074692075,0.00028628553,0.0014336441,0.0026625076,0.0004316926,0.0014133974,0.00082576764,0.001310891,0.00064046803],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006351814,0.00005252833,0.0004415069,0.14817011,0.00056640967,0.000113541835,0.00021696898,0.00015436212,0.00028822498,0.00086857355,0.008245674,0.84081864],"study_design_scores_gemma":[0.00013379683,0.00047062273,0.006808993,0.34395683,0.0042489152,0.0025608493,0.0009900437,0.0002093207,0.00044831095,0.0030172637,0.6370852,0.00006985516],"about_ca_topic_score_codex":0.002376823,"about_ca_topic_score_gemma":0.0049998243,"teacher_disagreement_score":0.0031102458,"about_ca_system_score_codex":0.00076957274,"about_ca_system_score_gemma":0.003355636,"threshold_uncertainty_score":0.01468271},"labels":[],"label_agreement":null},{"id":"W4409959051","doi":"10.1177/13524585251335510","title":"Physical activity demonstrates protective associations with structural visual metrics in children with multiple sclerosis through time","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children","funders":"National Multiple Sclerosis Society","keywords":"Nerve fiber layer; Medicine; Retinal; Multiple sclerosis; Optic neuritis; Ophthalmology; Clinically isolated syndrome; Optical coherence tomography; Immunology","score_opus":0.058178383590443875,"score_gpt":0.31964573691921316,"score_spread":0.2614673533287693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409959051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991375,0.0003112578,0.00004486793,0.000053397103,0.0000039855036,0.0000025571694,0.00019393624,0.0000056612057,0.00024681742],"genre_scores_gemma":[0.9993781,0.00013555538,0.00007455785,0.0000118963535,0.0000058925993,0.000005008067,0.00021731772,0.000002635776,0.00016908297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996817,0.000059377573,0.000023506678,0.000094514806,0.000047382477,0.00009345235],"domain_scores_gemma":[0.9983442,0.0002130684,0.0009250725,0.00008684572,0.00015275077,0.0002781638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040535346,0.00033429198,0.00030620105,0.000731219,0.00029997475,0.0005443985,0.00030791067,0.00040791987,0.0021888774],"category_scores_gemma":[0.0019531893,0.0002170532,0.0005819544,0.0007663676,0.0002758153,0.00039065265,0.00053517136,0.00050156855,0.0002143751],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001120845,0.00003138415,0.9976108,0.000010514377,0.00003693149,0.00006192846,0.00009664305,0.000024671692,0.0002397557,0.000009387548,0.000053530457,0.0017123825],"study_design_scores_gemma":[0.0000012247289,0.000058754562,0.9996911,0.000004058393,0.000010743416,0.00007926728,0.00005383103,0.000029223664,0.000021422635,0.0000045418874,0.000044872842,9.1878366e-7],"about_ca_topic_score_codex":0.014092642,"about_ca_topic_score_gemma":0.0130067775,"teacher_disagreement_score":0.014092642,"about_ca_system_score_codex":0.00032324414,"about_ca_system_score_gemma":0.00043865276,"threshold_uncertainty_score":0.028021276},"labels":[],"label_agreement":null},{"id":"W4410210615","doi":"10.1177/13524585251335213","title":"Cognitive test performance and disease progression in primary and secondary progressive MS: An analysis of the SPRINT-MS study","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Sante Montreal","funders":"","keywords":"Multiple sclerosis; Cognition; Placebo; Effects of sleep deprivation on cognitive performance; Psychology; Physical medicine and rehabilitation; Audiology; Medicine; Stroop effect; Cognitive decline; Cognitive test; Physical therapy; Disease; Internal medicine; Psychiatry; Dementia; Pathology","score_opus":0.043397703104542544,"score_gpt":0.32798745565250553,"score_spread":0.284589752547963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410210615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99533135,0.0016782252,0.00021981615,0.00005490061,0.00002406566,0.00016604514,0.0020391548,0.0000126679915,0.00047365553],"genre_scores_gemma":[0.99592364,0.00027340127,0.00023903084,0.00004337974,0.000048319434,0.00019711144,0.002954225,0.0000071039094,0.0003137486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969151,0.001723235,0.00034879072,0.00038576993,0.0004936852,0.00013343262],"domain_scores_gemma":[0.9938099,0.0015265541,0.0019595437,0.0008157571,0.0009012092,0.000987148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068179625,0.0011152017,0.001988961,0.001178685,0.0004679601,0.0008283755,0.00066930905,0.00072033744,0.0015663778],"category_scores_gemma":[0.0071857073,0.00034314443,0.0026135512,0.0014808438,0.00033028808,0.0005137148,0.00088276283,0.0010399177,0.00028253061],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.101244025,0.0008990024,0.8707363,0.0005357721,0.015717901,0.0002180604,0.00019219848,0.00049682794,0.0009813688,0.00008171396,0.0010765038,0.007820261],"study_design_scores_gemma":[0.0050145,0.004250401,0.98546696,0.000035344252,0.0035591684,0.0001829026,0.00006635276,0.0005894126,0.0002260041,0.000096180156,0.0004892342,0.000023476729],"about_ca_topic_score_codex":0.002115775,"about_ca_topic_score_gemma":0.0024659517,"teacher_disagreement_score":0.0068179625,"about_ca_system_score_codex":0.00033252756,"about_ca_system_score_gemma":0.00056477886,"threshold_uncertainty_score":0.036057293},"labels":[],"label_agreement":null},{"id":"W4410622796","doi":"10.1177/13524585251338745","title":"Health care use preceding pediatric multiple sclerosis: A population-based study from Ontario, Canada","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; University of Waterloo; Nova Scotia Health Authority; Dalhousie University","funders":"Multiple Sclerosis Society of Canada; National Multiple Sclerosis Society","keywords":"Medicine; Prodrome; Pediatrics; Multiple sclerosis; Confidence interval; Population; Cohort; Retrospective cohort study; Demography; Cohort study; Health care; Environmental health; Psychiatry; Internal medicine","score_opus":0.09498750506452376,"score_gpt":0.30490590101886544,"score_spread":0.2099183959543417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410622796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98697156,0.0012005096,0.000109453526,0.00026564798,0.000011840623,0.000055124357,0.009452836,0.000011779487,0.0019212578],"genre_scores_gemma":[0.99602354,0.00089588086,0.00012583088,0.00007956288,0.000006022839,0.00002704459,0.002383954,0.0000045080033,0.0004535659],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990349,0.000055900382,0.00007341872,0.0001632433,0.0004113038,0.00026123776],"domain_scores_gemma":[0.99822825,0.00007875259,0.00058468373,0.00006004269,0.0007004111,0.00034795262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046235096,0.00032577605,0.00046421014,0.0011320506,0.0016423333,0.000921172,0.00091808685,0.00038514295,0.0013833487],"category_scores_gemma":[0.0013398227,0.00035724044,0.0005955742,0.004395741,0.00040459543,0.0003565606,0.00060133997,0.00047140123,0.00018431315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019256282,0.0000083073855,0.9983417,0.000022568962,0.000021820793,0.00005360678,0.0002640103,0.000027929318,0.00006234124,0.00001909865,0.00038007245,0.000779329],"study_design_scores_gemma":[0.0000027755086,0.000008580664,0.9992157,0.00001973422,0.000013118285,0.00003840251,0.00029317365,0.00006261428,0.000015596856,0.00000437904,0.00032334472,0.0000025307422],"about_ca_topic_score_codex":0.9891995,"about_ca_topic_score_gemma":0.9929027,"teacher_disagreement_score":0.017617688,"about_ca_system_score_codex":0.017617688,"about_ca_system_score_gemma":0.020445269,"threshold_uncertainty_score":0.12782586},"labels":[],"label_agreement":null},{"id":"W4411045440","doi":"10.1177/13524585251341174","title":"Gender-affirming interventions and prognosis in multiple sclerosis","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Multiple sclerosis; Medicine; Asymptomatic; Internal medicine; Psychiatry","score_opus":0.2677071482437232,"score_gpt":0.3586004048138374,"score_spread":0.09089325657011421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411045440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98797894,0.0072865835,0.00012466112,0.00123058,0.000075828946,0.000017187876,0.00017219977,0.000008585586,0.0031054069],"genre_scores_gemma":[0.9984487,0.0010901005,0.00010597044,0.00012614724,0.000030062805,0.0000066093025,0.000036598907,9.579841e-7,0.00015470704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996972,0.00014172589,0.00002638825,0.000028582122,0.0000515969,0.00005459587],"domain_scores_gemma":[0.99825174,0.0004249771,0.00079779315,0.000037411093,0.000121385114,0.00036667436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093216647,0.0001479472,0.00019098171,0.00037362197,0.00045879764,0.000465061,0.0001395799,0.00026127425,0.0024609996],"category_scores_gemma":[0.0046369927,0.00004301261,0.00018042342,0.00030585882,0.00023923641,0.00025891472,0.00034669373,0.00027713855,0.00019805084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014452739,0.00041659464,0.85986567,0.00021555832,0.000116509895,0.00036011287,0.0006999513,0.00015980423,0.00046319093,0.00028665626,0.0011454071,0.13482526],"study_design_scores_gemma":[0.00009892453,0.0016762736,0.9896125,0.00031896916,0.00013865574,0.0013950441,0.0010330866,0.00040607818,0.00032497657,0.0013509921,0.0036268125,0.00001766814],"about_ca_topic_score_codex":0.001612146,"about_ca_topic_score_gemma":0.002099616,"teacher_disagreement_score":0.0024609996,"about_ca_system_score_codex":0.0004096194,"about_ca_system_score_gemma":0.00057042605,"threshold_uncertainty_score":0.008232832},"labels":[],"label_agreement":null},{"id":"W4411976832","doi":"10.1177/13524585251347513","title":"Neural networks to estimate multiple sclerosis disability and predict progression using routinely collected healthcare data","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Expanded Disability Status Scale; Multiple sclerosis; Medicine; Population; Health care; Environmental health","score_opus":0.21337206683488424,"score_gpt":0.40645150820269793,"score_spread":0.1930794413678137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411976832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80062777,0.003839648,0.18258566,0.003327013,0.0002783126,0.00018250749,0.004038722,0.0007548096,0.004365573],"genre_scores_gemma":[0.9818787,0.00044678664,0.015220901,0.00020104037,0.000071052506,0.0000764539,0.0013496929,0.000012695011,0.0007426378],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99935836,0.0003206246,0.000048315018,0.00012872729,0.00007792887,0.00006601387],"domain_scores_gemma":[0.9968092,0.0022421444,0.00035230885,0.00010512629,0.00040988956,0.00008136067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025509233,0.0010263255,0.0005215473,0.0013081123,0.00021198032,0.000800841,0.00069308176,0.0006208796,0.0011357897],"category_scores_gemma":[0.008626037,0.0002504488,0.0006282751,0.0008806718,0.0002635467,0.0007030024,0.000671297,0.0013570491,0.0002521437],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025719474,0.0002943501,0.11049565,0.00012537731,0.00050078443,0.00013713926,0.00007324061,0.81126285,0.0003281712,0.001120311,0.0026893246,0.072715595],"study_design_scores_gemma":[0.000011628793,0.000041669813,0.0067726444,0.000038049504,0.000030987674,0.000018590503,0.000020911655,0.9910074,0.00014014401,0.0016478924,0.00026299688,0.000007033391],"about_ca_topic_score_codex":0.026883522,"about_ca_topic_score_gemma":0.019555692,"teacher_disagreement_score":0.026883522,"about_ca_system_score_codex":0.0010432006,"about_ca_system_score_gemma":0.0009891532,"threshold_uncertainty_score":0.05345404},"labels":[],"label_agreement":null},{"id":"W4412072012","doi":"10.1177/13524585251349125","title":"Four years on: Pregnancy and birth outcomes reported in the MSBase pregnancy, neonatal outcomes, and Women’s Health Registry (2020–2024)","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Cegep de Saint Jerome; Centre Hospitalier Universitaire de Sherbrooke; St. Michael's Hospital; Université de Montréal","funders":"Cliniques Universitaires Saint-Luc; UCB Pharma; Sanofi Genzyme; Trish Multiple Sclerosis Research Foundation; MedDay Pharmaceuticals; CinnaGen; Cilag; Ingham Institute for Applied Medical Research; Mitsubishi Tanabe Pharma Corporation; Sultan Qaboos University; Sanofi; Multiple Sclerosis International Federation; Razi University; Eisai; Monash University; H. Lundbeck A/S; Alexion Pharmaceuticals; University of New South Wales; Multiple Sclerosis Australia; Medical Research Council; Neuraxpharm; Teva Pharmaceutical Industries; Celgene; Biogen; Faculty of Medicine and Health, University of Sydney; Cairo University; Yeditepe Üniversitesi; European Commission; World Health Organization; Bristol-Myers Squibb; Eli Lilly and Company; National Health and Medical Research Council; AstraZeneca; American University of Beirut; Amgen","keywords":"Medicine; Pregnancy; Neuromyelitis optica; Gestation; Obstetrics; Multiple sclerosis; Pediatrics; Immunology","score_opus":0.0805820683593326,"score_gpt":0.33111136717330875,"score_spread":0.2505292988139761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412072012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8951428,0.0014204361,0.0004010894,0.0003817771,0.00005303231,0.00006281475,0.09740447,0.000078537836,0.0050549814],"genre_scores_gemma":[0.9257873,0.0013671975,0.000599848,0.00023021105,0.00004296258,0.00020217078,0.06971707,0.000022818538,0.0020303968],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99910694,0.00023281004,0.00018453764,0.00014223509,0.00016730516,0.00016615761],"domain_scores_gemma":[0.99694985,0.00051376823,0.0017207545,0.00018167657,0.00039663803,0.00023736211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017596706,0.00022860235,0.00028492976,0.0014163413,0.00028599688,0.00066482456,0.00040111627,0.00028663702,0.002274313],"category_scores_gemma":[0.0056059677,0.00014808847,0.00040064508,0.0021463525,0.00016867109,0.0005317531,0.00066436816,0.00052903173,0.00057825184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018639995,0.000012924353,0.9935248,0.00003091186,0.00004633282,0.00010552298,0.00007463742,0.00009925501,0.00006220235,0.000066582856,0.002318678,0.0034717869],"study_design_scores_gemma":[0.000010722318,0.000074759926,0.9961886,0.000051990486,0.00004131471,0.0004378086,0.0002528823,0.00018669968,0.00016307748,0.00004016525,0.0025444762,0.000007699088],"about_ca_topic_score_codex":0.017737987,"about_ca_topic_score_gemma":0.014080643,"teacher_disagreement_score":0.017737987,"about_ca_system_score_codex":0.00058557873,"about_ca_system_score_gemma":0.00074241206,"threshold_uncertainty_score":0.0352695},"labels":[],"label_agreement":null},{"id":"W4412111210","doi":"10.1177/13524585251353044","title":"High-risk populations should be screened for MS: Yes","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital","funders":"","keywords":"Multiple sclerosis; Medicine; Biology; Psychiatry","score_opus":0.24383516642815742,"score_gpt":0.3781122068347537,"score_spread":0.1342770404065963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412111210","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.058003,0.041546486,0.0041907826,0.7946371,0.025774717,0.0014026684,0.0020708703,0.0008130601,0.071561284],"genre_scores_gemma":[0.3830319,0.057847448,0.028173555,0.4278231,0.041742377,0.0042223088,0.0016487394,0.0001588927,0.055351734],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989343,0.00036421794,0.00016783393,0.000092404014,0.00030523541,0.00013606521],"domain_scores_gemma":[0.9955303,0.0011001182,0.00054200337,0.00022820727,0.0011551209,0.0014442938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019882368,0.00045332767,0.0010979892,0.0007493429,0.0017171877,0.0011289562,0.0007371458,0.0065426887,0.017727213],"category_scores_gemma":[0.014008329,0.00024990257,0.0006221546,0.00032027415,0.00072291255,0.0020344122,0.000837643,0.002993448,0.005418017],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011587004,0.0013437506,0.04721935,0.0034801962,0.0001817722,0.0017306688,0.00075452705,0.00011321835,0.0013307226,0.0018025936,0.5074393,0.43344525],"study_design_scores_gemma":[0.0024490724,0.004063021,0.27480304,0.0335771,0.00093587936,0.011219773,0.005963481,0.0008662051,0.0037583914,0.028177477,0.63379246,0.00039411857],"about_ca_topic_score_codex":0.0024867388,"about_ca_topic_score_gemma":0.0056843627,"teacher_disagreement_score":0.017727213,"about_ca_system_score_codex":0.00045743518,"about_ca_system_score_gemma":0.0018754372,"threshold_uncertainty_score":0.059303463},"labels":[],"label_agreement":null},{"id":"W4412592901","doi":"10.1177/13524585251355842","title":"Brain atrophy and associations with long-term disability and cognitive function in participants with relapsing multiple sclerosis treated with ozanimod: Results from phase 3 and open-label extension trials","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"Janssen Pharmaceuticals; EMD Serono; MedDay Pharmaceuticals; Innosuisse - Schweizerische Agentur für Innovationsförderung; Kiniksa Pharmaceuticals; Shionogi; Genentech; National Multiple Sclerosis Society; Horizon Therapeutics; Celltrion; Atara Biotherapeutics; National Institutes of Health; Mylan; TG Therapeutics; European Committee for Treatment and Research in Multiple Sclerosis; Sanofi; Multiple Sclerosis International Federation; University of Pennsylvania; Alexion Pharmaceuticals; Neuraxpharm; Teva Pharmaceutical Industries; Bayer HealthCare; European Commission; Celgene; Biogen; GlaxoSmithKline; AstraZeneca; Eli Lilly and Company; Samsung; Bristol-Myers Squibb","keywords":"Medicine; Atrophy; Multiple sclerosis; Physical therapy; Internal medicine; Psychiatry","score_opus":0.2598316333941632,"score_gpt":0.38964884958597784,"score_spread":0.12981721619181463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412592901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99525046,0.00343609,0.00013429212,0.0001032115,0.000019210853,0.00027283188,0.00046357716,0.000009853476,0.00031044925],"genre_scores_gemma":[0.9966428,0.0013635565,0.0006179735,0.000109890396,0.000040509123,0.0003862143,0.00061827555,0.0000047785315,0.00021604463],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99900705,0.000590091,0.00010341511,0.00010037723,0.00013392777,0.00006514041],"domain_scores_gemma":[0.9974667,0.00053593575,0.0013229673,0.00012307415,0.00029020468,0.00026104442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003733653,0.00055400527,0.00095422013,0.00023915271,0.00024362556,0.0005468227,0.00047414124,0.0006836392,0.0014499188],"category_scores_gemma":[0.002320281,0.00019784868,0.0011758634,0.00036268256,0.00044386048,0.0004479446,0.00035771038,0.0006786945,0.00013721836],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.70426637,0.006464853,0.15173936,0.0036160948,0.009156428,0.000117334675,0.00059810415,0.0005284113,0.017621305,0.000097865566,0.0011470617,0.1046469],"study_design_scores_gemma":[0.14319654,0.16335768,0.6757981,0.00043715892,0.008007995,0.00041905482,0.00038324535,0.0006945978,0.0041151373,0.00022631962,0.0032870278,0.00007705786],"about_ca_topic_score_codex":0.00070049544,"about_ca_topic_score_gemma":0.0020800866,"teacher_disagreement_score":0.003733653,"about_ca_system_score_codex":0.00030805718,"about_ca_system_score_gemma":0.0005211212,"threshold_uncertainty_score":0.019745648},"labels":[],"label_agreement":null},{"id":"W4412592969","doi":"10.1177/13524585251356967","title":"Embracing the complexity of rehabilitation in multiple sclerosis empowered by the resolution of the World Health Organization","year":2025,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Rehabilitation; Neurorehabilitation; Perspective (graphical); Health care; Discipline; Medicine; Psychology; Public relations; Political science; Physical therapy; Computer science; Sociology; Social science","score_opus":0.20835418318799806,"score_gpt":0.36747923057072385,"score_spread":0.1591250473827258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412592969","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000051679028,0.99393046,0.00005154318,0.005238269,0.00047193185,0.0000022623267,0.0000031102306,0.0000013921982,0.00024936008],"genre_scores_gemma":[0.0017657139,0.9929931,0.0002706008,0.0035462044,0.0011895183,0.000009423985,0.000008306722,0.0000016931342,0.00021545267],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939036,0.0032457237,0.0009248216,0.0003027428,0.0014362704,0.00018681563],"domain_scores_gemma":[0.9877374,0.0091906125,0.0011061078,0.00018304151,0.001534184,0.00024863606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008081978,0.0005039594,0.0017194017,0.0040729064,0.0006112314,0.0032964214,0.00074388366,0.002607826,0.0012037479],"category_scores_gemma":[0.013771938,0.00031857335,0.0013334099,0.0039405283,0.002101611,0.00440588,0.0017834769,0.00458404,0.00034382357],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011087037,0.000045947287,0.00042645034,0.09991573,0.000655039,0.00037172486,0.0012768073,0.00040197125,0.0007667535,0.034080226,0.07686399,0.78508455],"study_design_scores_gemma":[0.000027040067,0.00009442637,0.0017338516,0.07840584,0.00045921028,0.0012337615,0.00092025864,0.00013344373,0.00017973504,0.01360666,0.903159,0.000046784713],"about_ca_topic_score_codex":0.004684583,"about_ca_topic_score_gemma":0.008473112,"teacher_disagreement_score":0.008081978,"about_ca_system_score_codex":0.0018952452,"about_ca_system_score_gemma":0.008094009,"threshold_uncertainty_score":0.042742074},"labels":[],"label_agreement":null},{"id":"W4412741669","doi":"10.1177/13524585251359066","title":"Reduced brain volumes in children with radiologically isolated syndrome","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Multiple sclerosis; Clinically isolated syndrome; Brain size; Cerebrospinal fluid; Cohort; McDonald criteria; Nuclear medicine; Internal medicine; Magnetic resonance imaging; Radiology","score_opus":0.04181960331690517,"score_gpt":0.2860314713690402,"score_spread":0.24421186805213504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412741669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995585,0.00013461705,0.000031672742,0.000015558715,0.0000017732173,0.0000018983411,0.0001403125,0.000005053204,0.00011061517],"genre_scores_gemma":[0.9994019,0.000120052704,0.00008527077,0.000009986924,0.0000055152714,0.0000047400913,0.0003176307,0.0000024358792,0.000052413743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997781,0.000037094127,0.000021282764,0.000067785906,0.000056415094,0.00003929015],"domain_scores_gemma":[0.999003,0.00013692044,0.0006277483,0.000027441549,0.00006629241,0.00013860232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025769026,0.00045877253,0.00035726733,0.0010256598,0.00023364724,0.0004140441,0.0003092504,0.00037966965,0.0017140614],"category_scores_gemma":[0.0014368062,0.00020826024,0.000270383,0.0005932098,0.00040032383,0.00043186423,0.00038870165,0.00038265725,0.00018331308],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011878536,0.000017661374,0.9956469,0.000018182982,0.000026986685,0.00076245423,0.000121799574,0.000074807256,0.0010667407,0.000017749448,0.00012881504,0.0019991614],"study_design_scores_gemma":[0.000002667464,0.00008390996,0.9972771,0.0000055709797,0.0000102452705,0.0022279755,0.00007639667,0.000052275675,0.00016078915,0.000013760076,0.00008760876,0.0000016756044],"about_ca_topic_score_codex":0.0026113605,"about_ca_topic_score_gemma":0.0023842643,"teacher_disagreement_score":0.0026113605,"about_ca_system_score_codex":0.00026937333,"about_ca_system_score_gemma":0.00026714514,"threshold_uncertainty_score":0.005734086},"labels":[],"label_agreement":null},{"id":"W4413877854","doi":"10.1177/13524585251370884","title":"Neuroimmune interactions: How past lessons can inform the present and future of MS care","year":2025,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Multiple sclerosis; Neuroscience; Immune system; Compartmentalization (fire protection); Neuroimmunology; Central nervous system; Medicine; Neuroinflammation; Psychology; Biology; Immunology; Disease; Pathology","score_opus":0.14985841894266694,"score_gpt":0.37490312403803683,"score_spread":0.2250447050953699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413877854","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000045849505,0.99520844,0.00009338316,0.0030166828,0.00084579666,0.0000024102549,0.000010461515,0.000006469483,0.0007705798],"genre_scores_gemma":[0.0006792325,0.9964624,0.0002821338,0.0012623358,0.00083586265,0.0000053843737,0.000018687257,0.0000021462909,0.00045188246],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995548,0.00013588769,0.00006940597,0.000062220686,0.00013631304,0.000041370862],"domain_scores_gemma":[0.99827826,0.0010019426,0.00013049411,0.000049471157,0.00038707774,0.00015270864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016791367,0.0007133601,0.0013633475,0.0027159438,0.0006711758,0.0025530413,0.0010570267,0.00225693,0.0046762577],"category_scores_gemma":[0.0037978673,0.00024135702,0.00048017869,0.0022132862,0.0009893964,0.0047348696,0.0011092378,0.0034285155,0.0021564174],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000086771324,0.00004761079,0.0002581866,0.016352726,0.00009465078,0.0002328279,0.00027027886,0.0002719333,0.00059400196,0.015028436,0.083445065,0.88331753],"study_design_scores_gemma":[0.000009849524,0.00005376645,0.0006410785,0.013751007,0.00007394622,0.0006827409,0.00038253507,0.00007640063,0.000104433755,0.010028113,0.9741746,0.000021559386],"about_ca_topic_score_codex":0.0023093764,"about_ca_topic_score_gemma":0.005359014,"teacher_disagreement_score":0.0046762577,"about_ca_system_score_codex":0.0016435151,"about_ca_system_score_gemma":0.0033818702,"threshold_uncertainty_score":0.015643597},"labels":[],"label_agreement":null},{"id":"W4414162836","doi":"10.1177/13524585251367343","title":"ECTRIMS 2024 Lecture: Unraveling the spectrum of the antibody-mediated demyelinating diseases: Emerging insights","year":2025,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Neuromyelitis optica; Myelin oligodendrocyte glycoprotein; Multiple sclerosis; Oligodendrocyte; Disease; Myelin; Spectrum disorder; Remyelination","score_opus":0.07237566541092212,"score_gpt":0.3536003491990235,"score_spread":0.2812246837881014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414162836","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015386585,0.90881264,0.0003686828,0.012982654,0.068600245,0.000024979785,0.000109675355,0.000074332675,0.008872859],"genre_scores_gemma":[0.0018224311,0.8890835,0.00070671586,0.012949282,0.05826774,0.00003684837,0.0003066498,0.000050943603,0.036775813],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99934286,0.00012490866,0.0000673235,0.00008159385,0.00032296486,0.000060406604],"domain_scores_gemma":[0.9988176,0.0003058743,0.000105969055,0.000030302328,0.0004919137,0.00024837657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012654817,0.001123762,0.0012481373,0.0022245562,0.00035220367,0.0017438876,0.00097163254,0.0020088637,0.02358372],"category_scores_gemma":[0.0031181774,0.00023306941,0.00076107593,0.0016338597,0.00046296045,0.002418194,0.0012497408,0.003840183,0.016921148],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012060086,0.000030589898,0.00009123603,0.004420455,0.000052152907,0.00011571291,0.000039920382,0.00009402082,0.0007848134,0.0018486938,0.6388983,0.35350356],"study_design_scores_gemma":[0.000015868134,0.000040166313,0.00024453478,0.0015181799,0.00002637708,0.00035382208,0.000020353878,0.000028780183,0.000116768686,0.00062025734,0.99700755,0.0000074104396],"about_ca_topic_score_codex":0.00095685164,"about_ca_topic_score_gemma":0.0015924013,"teacher_disagreement_score":0.02358372,"about_ca_system_score_codex":0.0009320515,"about_ca_system_score_gemma":0.0017296448,"threshold_uncertainty_score":0.07889539},"labels":[],"label_agreement":null},{"id":"W4414354255","doi":"10.1177/13524585251375365","title":"Choroid plexus enlargement correlates with demyelinating lesions and thalamic atrophy in radiologically isolated syndrome","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Multiple Sclerosis Society of Canada; St. Michael's Hospital Foundation","keywords":"Atrophy; Multiple sclerosis; Choroid plexus; Clinically isolated syndrome; Central nervous system disease; Magnetic resonance imaging; Stage (stratigraphy)","score_opus":0.04338374246080682,"score_gpt":0.27994395611770884,"score_spread":0.23656021365690202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414354255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995427,0.00013603568,0.00005723906,0.000015873944,0.0000018711384,0.0000033734173,0.000039909486,0.0000039707875,0.00019901892],"genre_scores_gemma":[0.99976987,0.00004941682,0.00006814989,0.0000062681247,0.0000060087173,0.0000024429235,0.00006525354,0.0000013412132,0.000031331663],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996573,0.00007257618,0.000054221502,0.000106675085,0.00007337527,0.000035866844],"domain_scores_gemma":[0.9980564,0.00039874646,0.0011067833,0.000082637824,0.0001321781,0.00022333054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037499773,0.0004695936,0.00030416233,0.0013259748,0.00031657147,0.00046519225,0.0003011192,0.00036743327,0.0029821468],"category_scores_gemma":[0.002509128,0.0002712963,0.00032928045,0.00059057167,0.00054264616,0.00039371237,0.00054161245,0.00043043087,0.0002130811],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000199896,0.00002044007,0.9957218,0.000018157698,0.00006375365,0.00060436927,0.00008053355,0.00003645939,0.0020278732,0.000016603037,0.000032540636,0.0011776945],"study_design_scores_gemma":[0.000005671533,0.000073616575,0.9973232,0.0000066998455,0.000026279256,0.0021473872,0.00008476861,0.00009138214,0.00018248083,0.000027602557,0.000028919701,0.0000020089667],"about_ca_topic_score_codex":0.0018809054,"about_ca_topic_score_gemma":0.001780215,"teacher_disagreement_score":0.0029821468,"about_ca_system_score_codex":0.00021631457,"about_ca_system_score_gemma":0.00021696734,"threshold_uncertainty_score":0.009976268},"labels":[],"label_agreement":null},{"id":"W4414374458","doi":"10.1177/13524585251368248","title":"Disease course after pregnancy in women with progressive multiple sclerosis symptoms","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Multiple sclerosis; Pregnancy; Disease; Central nervous system disease; Progressive disease; Young adult","score_opus":0.041287198089445504,"score_gpt":0.29023559846381847,"score_spread":0.24894840037437296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414374458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985424,0.0008157333,0.000048459664,0.00008038056,0.000006328296,0.0000063885764,0.00023225484,0.0000015299719,0.00026654164],"genre_scores_gemma":[0.9993882,0.00031050565,0.000034684217,0.000026531905,0.00000495217,0.0000073597507,0.00014797533,7.575057e-7,0.00007895096],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995664,0.00015820388,0.000039624934,0.00009910103,0.000055323977,0.00008134976],"domain_scores_gemma":[0.99856734,0.00035933728,0.0007928052,0.00008240242,0.0000536078,0.00014457013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083336496,0.00015492519,0.0002315773,0.00034694982,0.00031360687,0.00042228203,0.00025357647,0.0003448412,0.0009716807],"category_scores_gemma":[0.0044650217,0.00017460476,0.00034194623,0.00063091895,0.0002549814,0.00038830185,0.000343474,0.0005077258,0.00013194142],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024099233,0.000015399366,0.9977465,0.000011169556,0.000029454619,0.00020369985,0.0001019282,0.000019663172,0.00008411968,0.000019991956,0.000049029248,0.0014780081],"study_design_scores_gemma":[0.000010296783,0.00019337104,0.9983181,0.00002375026,0.00003089031,0.000904902,0.0001751648,0.000080086844,0.000040244624,0.000052411702,0.00016741111,0.0000034056857],"about_ca_topic_score_codex":0.0038767422,"about_ca_topic_score_gemma":0.0034845155,"teacher_disagreement_score":0.0038767422,"about_ca_system_score_codex":0.0002962637,"about_ca_system_score_gemma":0.0003727761,"threshold_uncertainty_score":0.0077083707},"labels":[],"label_agreement":null},{"id":"W4414514566","doi":"10.1177/13524585251366096","title":"The language and memory test: A brief multidomain digital cognitive measure for multiple sclerosis","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Multiple sclerosis; Discriminative model; Cognition; Measure (data warehouse); Construct (python library)","score_opus":0.06782779993484835,"score_gpt":0.30073823298014485,"score_spread":0.23291043304529652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414514566","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9693747,0.0020004823,0.0036041355,0.00082146854,0.000122007754,0.0025349422,0.007366234,0.00028864294,0.013887524],"genre_scores_gemma":[0.96340674,0.0010024041,0.015837438,0.0008924056,0.00008305353,0.0037024124,0.006116801,0.000026571084,0.008932068],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999468,0.000121152516,0.00011236461,0.000072796574,0.00018802212,0.000037691847],"domain_scores_gemma":[0.9988613,0.00019847737,0.00055023906,0.00005216812,0.00018144948,0.00015632172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008592121,0.00060031353,0.000518123,0.0010276777,0.0003448721,0.0004351796,0.00052618084,0.0005137118,0.0038819255],"category_scores_gemma":[0.0026689388,0.00013189098,0.0004981789,0.00046121178,0.00021449776,0.00067239674,0.00057154935,0.00069927785,0.0010481756],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037426732,0.004474752,0.67788005,0.00093690405,0.00072405284,0.0011865386,0.0011756028,0.0017860428,0.012638368,0.0006883183,0.029103423,0.26566327],"study_design_scores_gemma":[0.0004802038,0.0039013517,0.9801846,0.00013910134,0.00011812089,0.0029281562,0.00018922365,0.0014074405,0.0021061643,0.00070202537,0.00779207,0.00005148802],"about_ca_topic_score_codex":0.0014928941,"about_ca_topic_score_gemma":0.0033046016,"teacher_disagreement_score":0.0038819255,"about_ca_system_score_codex":0.00027716445,"about_ca_system_score_gemma":0.0005288566,"threshold_uncertainty_score":0.012986362},"labels":[],"label_agreement":null},{"id":"W4415207932","doi":"10.1177/13524585251383381","title":"Affective reserve in multiple sclerosis","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Sunnybrook Foundation","keywords":"","score_opus":0.14609817543853573,"score_gpt":0.32923547837194334,"score_spread":0.1831373029334076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415207932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930375,0.0027284424,0.00002596191,0.00020567166,0.000015045731,0.000007811745,0.00007785182,0.0000026680161,0.0038990353],"genre_scores_gemma":[0.9993618,0.00029294318,0.000014726786,0.000038000573,0.000021979979,0.0000034488842,0.000026728074,5.188408e-7,0.0002399194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979204,0.00009175988,0.000025379424,0.000020012472,0.000035110326,0.000035691704],"domain_scores_gemma":[0.9987551,0.000537058,0.00037797834,0.00005281219,0.000089400855,0.00018762174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059019827,0.0001801233,0.0003128493,0.0010092586,0.0007055286,0.0007063386,0.00021897179,0.0003073162,0.0028723683],"category_scores_gemma":[0.0035631524,0.000126266,0.00014786566,0.0005599745,0.0002392987,0.000417545,0.0005316761,0.0004928574,0.00026184384],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026081721,0.0006510952,0.9535774,0.00021148854,0.00030302856,0.0015020308,0.0014618832,0.0002152209,0.0032077015,0.00060202734,0.00050863315,0.03515143],"study_design_scores_gemma":[0.000018804578,0.00010603194,0.998154,0.000026003456,0.00004798026,0.00049099326,0.0003466931,0.00010965701,0.000100139645,0.0002910357,0.00030358287,0.0000050322],"about_ca_topic_score_codex":0.0042354832,"about_ca_topic_score_gemma":0.0045886487,"teacher_disagreement_score":0.0042354832,"about_ca_system_score_codex":0.00036333903,"about_ca_system_score_gemma":0.00021370307,"threshold_uncertainty_score":0.009609044},"labels":[],"label_agreement":null},{"id":"W4415566526","doi":"10.1177/13524585251382801","title":"Psychiatric morbidity during the multiple sclerosis prodrome is associated with future disability","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; University of Manitoba; University of British Columbia; Health Sciences Centre; Manitoba Health","funders":"Multiple Sclerosis Society of Canada; National Multiple Sclerosis Society","keywords":"Prodrome; Multiple sclerosis; Psychosis; Schizophrenia (object-oriented programming); Clinical neurology; MEDLINE; Epidemiology; Neuropsychiatry","score_opus":0.06499577442412431,"score_gpt":0.2907922619629978,"score_spread":0.2257964875388735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415566526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983583,0.0006272987,0.000051744915,0.00014158656,0.0000053354875,0.0000065466456,0.00027242428,0.000004781623,0.00053187547],"genre_scores_gemma":[0.9994721,0.00021320723,0.000035657802,0.000010967941,0.000008853491,0.0000018552829,0.00016550608,8.0418647e-7,0.000091124886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996086,0.0000726545,0.00004068426,0.00007233922,0.00009634708,0.00010939587],"domain_scores_gemma":[0.99664426,0.00027617184,0.0022308296,0.00008367921,0.00023323363,0.0005317947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043216776,0.00025016718,0.00026286463,0.00073414005,0.00051774207,0.0007223079,0.00032546252,0.0003116169,0.0020457688],"category_scores_gemma":[0.0025606614,0.00020803459,0.00046975946,0.00083227054,0.00036002192,0.0002656137,0.0006098136,0.0008054437,0.00018696679],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000075982396,0.0000134746,0.9986681,0.000009539825,0.00003134262,0.000078126024,0.000027523829,0.00003944205,0.00007976438,0.0000122371885,0.00004144595,0.0009230731],"study_design_scores_gemma":[8.114377e-7,0.00001872636,0.9997576,0.000004596134,0.000007240216,0.00010076601,0.000023577617,0.000043492735,0.0000094118595,0.0000093699455,0.000023437324,8.1758435e-7],"about_ca_topic_score_codex":0.02968251,"about_ca_topic_score_gemma":0.05341177,"teacher_disagreement_score":0.02968251,"about_ca_system_score_codex":0.0008943902,"about_ca_system_score_gemma":0.0008396936,"threshold_uncertainty_score":0.059019506},"labels":[],"label_agreement":null},{"id":"W4415654614","doi":"10.1177/13524585251389797","title":"Clinical validation of a novel in vitro diagnostic neurofilament light chain assay for the prognostication of disease activity in people with relapsing multiple sclerosis","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Janssen Pharmaceuticals; EMD Serono; MedDay Pharmaceuticals; Siemens Healthineers; Schweizerische Multiple Sklerose Gesellschaft; Eisai; Bundesministerium für Bildung und Forschung; Atara Biotherapeutics; National Institutes of Health; Mylan; TG Therapeutics; Novartis Pharmaceuticals Corporation; Multiple Sclerosis Society; European Committee for Treatment and Research in Multiple Sclerosis; Grifols; F. Hoffmann-La Roche; Alexion Pharmaceuticals; Bayer HealthCare; Novartis Pharma; European Commission; Eli Lilly and Company; U.S. Department of Defense; Multiple Sclerosis International Federation; Gemeinnützige Hertie-Stiftung; Sanofi; Neuraxpharm; Teva Pharmaceutical Industries; Novartis; Celgene; Biogen; Deutsche Forschungsgemeinschaft; Genentech; National Multiple Sclerosis Society; GlaxoSmithKline; AstraZeneca; Samsung; Bristol-Myers Squibb","keywords":"Multiple sclerosis; Disease; Central nervous system disease; Degenerative disease; Amyotrophic lateral sclerosis; Clinical neurology","score_opus":0.11141296411895409,"score_gpt":0.34318341111949263,"score_spread":0.23177044700053856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415654614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9796696,0.0024289624,0.010565411,0.000294049,0.000102074686,0.0006517935,0.0013636696,0.00028769573,0.0046367664],"genre_scores_gemma":[0.99453825,0.00012251169,0.0041462434,0.000105273204,0.00004464027,0.00014333153,0.0005030225,0.00001068488,0.00038599956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970233,0.001133124,0.0002152153,0.0004382373,0.0010350463,0.0001549554],"domain_scores_gemma":[0.99482614,0.0017318787,0.0014777619,0.0005071021,0.0010705327,0.000386523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059940396,0.0007659606,0.0005635389,0.0009459863,0.0003509143,0.001016626,0.0005841447,0.0009567965,0.0014299565],"category_scores_gemma":[0.009521091,0.00023311339,0.00032266497,0.0004193334,0.00069690845,0.00038342774,0.0004618761,0.0007571497,0.0008465755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073290244,0.0013397353,0.88075346,0.0002589169,0.0002234587,0.00029238212,0.0005108205,0.0010843285,0.0671294,0.0003196374,0.0011787778,0.03958],"study_design_scores_gemma":[0.000713973,0.018370396,0.8463376,0.00019204432,0.00044667354,0.0031862787,0.00031808077,0.011043117,0.11378347,0.0006020908,0.0049315277,0.00007459861],"about_ca_topic_score_codex":0.00050150877,"about_ca_topic_score_gemma":0.00071924296,"teacher_disagreement_score":0.0059940396,"about_ca_system_score_codex":0.00056100613,"about_ca_system_score_gemma":0.0004575804,"threshold_uncertainty_score":0.031699896},"labels":[],"label_agreement":null},{"id":"W4415914732","doi":"10.1177/13524585251382796","title":"Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Final analysis of the DAYBREAK open-label extension trial","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"","keywords":"Tolerability; Clinical trial; Disease; Multiple sclerosis; MEDLINE","score_opus":0.18999274652216197,"score_gpt":0.36565114723946923,"score_spread":0.17565840071730726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415914732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99044776,0.0027313067,0.00034979402,0.00037406007,0.000118236996,0.0013480335,0.003320857,0.000037595226,0.0012722809],"genre_scores_gemma":[0.99012774,0.0011384159,0.0008260342,0.0003806387,0.00015967729,0.0017175017,0.0042660343,0.000020126061,0.0013638282],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99770397,0.0014888153,0.00013009309,0.00023279173,0.00022179252,0.00022247061],"domain_scores_gemma":[0.99475056,0.0014650561,0.0015540256,0.00053160544,0.00063214835,0.0010665338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007091478,0.0009052925,0.0020150603,0.00019810446,0.00050366746,0.0011532377,0.00087807217,0.0014353455,0.0056962087],"category_scores_gemma":[0.0056204787,0.00036213355,0.002036296,0.00031791348,0.0006517361,0.0012006052,0.0007650991,0.0025086019,0.0007554895],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97242695,0.0019723538,0.005253166,0.0007611749,0.001819904,0.000062735926,0.000101398065,0.0002670752,0.0017437463,0.00007490599,0.0014513775,0.014065301],"study_design_scores_gemma":[0.79411376,0.123798855,0.07253668,0.00017829615,0.002782207,0.00026202263,0.00014095445,0.0009883356,0.0010696066,0.000344142,0.003728791,0.00005630953],"about_ca_topic_score_codex":0.0003708701,"about_ca_topic_score_gemma":0.001021077,"teacher_disagreement_score":0.007091478,"about_ca_system_score_codex":0.0005457245,"about_ca_system_score_gemma":0.00080407906,"threshold_uncertainty_score":0.03750378},"labels":[],"label_agreement":null},{"id":"W4417520740","doi":"10.1177/13524585251398682","title":"Managing reactivation of multiple sclerosis during treatment with natalizumab","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Université de Montréal","funders":"National Health and Medical Research Council; Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada; Trish Multiple Sclerosis Research Foundation; EMD Serono; Sanofi; Multiple Sclerosis International Federation; Eisai; National Research Foundation; Multiple Sclerosis Australia; Università di Catania; Biogen; Celgene; Alnylam Pharmaceuticals; International Progressive MS Alliance; Universität Basel; Sanofi Genzyme; F. Hoffmann-La Roche; Monash University; Alexion Pharmaceuticals; Medical Research Council; Teva Pharmaceutical Industries; Bayer HealthCare; European Commission; Atara Biotherapeutics; Bristol-Myers Squibb","keywords":"Natalizumab; Multiple sclerosis; Dimethyl fumarate; Progressive multifocal leukoencephalopathy; Fingolimod; Clinical trial; Central nervous system disease","score_opus":0.08393791848612009,"score_gpt":0.29502295285249486,"score_spread":0.21108503436637477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417520740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883371,0.009182662,0.0009711146,0.00035285924,0.000019545503,0.00008070333,0.0001635901,0.000023216884,0.00086916646],"genre_scores_gemma":[0.9981206,0.0012749857,0.0003500359,0.00007150299,0.000024577468,0.000023766885,0.00009240282,0.0000035022404,0.000038601454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956418,0.0028822338,0.00037905073,0.0002609824,0.00053976284,0.000296047],"domain_scores_gemma":[0.9864602,0.00664147,0.0055999365,0.00067214266,0.0003157021,0.00031055606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0087590935,0.00033809076,0.0009777229,0.00065133773,0.00027415392,0.0009635781,0.00048755514,0.00039025626,0.0006299066],"category_scores_gemma":[0.020520441,0.00015792716,0.00136942,0.0005625,0.00028789358,0.0005596184,0.00054064504,0.00063334237,0.00009595544],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004482163,0.00032209308,0.87522984,0.0007395763,0.003209226,0.00040547742,0.00034111473,0.00441,0.0012883184,0.00026467608,0.0005604301,0.108747125],"study_design_scores_gemma":[0.0006613616,0.0051695765,0.9704728,0.0006508561,0.0031452824,0.002671634,0.0003817875,0.010625527,0.0026091186,0.0012140166,0.0023521145,0.000045862915],"about_ca_topic_score_codex":0.0016168222,"about_ca_topic_score_gemma":0.0018250932,"teacher_disagreement_score":0.0087590935,"about_ca_system_score_codex":0.0007285717,"about_ca_system_score_gemma":0.0008351018,"threshold_uncertainty_score":0.04632306},"labels":[],"label_agreement":null},{"id":"W7117359334","doi":"10.1177/13524585251398381","title":"Toward a global research agenda for preventing multiple sclerosis","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Multiple Sclerosis Society of Canada; Nova Scotia Health Authority","funders":"Multiple Sclerosis Australia; Multiple Sclerosis Society of Canada","keywords":"Multiple sclerosis; Developing country; MEDLINE; Clinical neurology; Global health","score_opus":0.40094354077023764,"score_gpt":0.42432199224995537,"score_spread":0.023378451479717732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117359334","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016066887,0.013686392,0.007334218,0.957835,0.008821678,0.00024099104,0.0001323698,0.00019124469,0.010151453],"genre_scores_gemma":[0.08627526,0.054378875,0.09660933,0.73077583,0.013030772,0.0025001217,0.0010720809,0.00032013675,0.015037505],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9696082,0.01978088,0.0014791942,0.0015288745,0.0039287126,0.003674215],"domain_scores_gemma":[0.93990535,0.021802502,0.0027159022,0.0029848227,0.012508429,0.020083107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08329141,0.0026182402,0.0021858332,0.0036668498,0.0060286345,0.016176404,0.004210529,0.025131496,0.02156736],"category_scores_gemma":[0.04281723,0.0010880346,0.0033142224,0.0022391086,0.008391056,0.020439478,0.026151052,0.03432041,0.005046518],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047636358,0.0015854643,0.0060555763,0.006383298,0.00037145222,0.0008524466,0.012476598,0.0023593844,0.0035918877,0.20175806,0.48905683,0.2750326],"study_design_scores_gemma":[0.00032965283,0.00055172725,0.004070512,0.008512518,0.0002640013,0.0003949207,0.018366156,0.0008462839,0.0012779249,0.16143692,0.80382067,0.00012868017],"about_ca_topic_score_codex":0.003005283,"about_ca_topic_score_gemma":0.0033526246,"teacher_disagreement_score":0.08329141,"about_ca_system_score_codex":0.007851951,"about_ca_system_score_gemma":0.06994517,"threshold_uncertainty_score":0.44049233},"labels":[],"label_agreement":null},{"id":"W7117366757","doi":"10.1177/13524585251396439","title":"Periventricular gradients in axonal and myelin microstructure are present in people with multiple sclerosis having low and high disability","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Western University; McGill University; Montreal Neurological Institute and Hospital","funders":"Canadian Institutes of Health Research; Canada First Research Excellence Fund","keywords":"Multiple sclerosis; Myelin; Central nervous system disease; Clinical neurology; Lesion; Degenerative disease","score_opus":0.031639146619924584,"score_gpt":0.2610034982684369,"score_spread":0.2293643516485123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117366757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988663,0.00029558587,0.00006690369,0.000044640583,0.0000025767151,0.000006273465,0.000112124035,0.0000075039234,0.0005981497],"genre_scores_gemma":[0.99958223,0.00008371717,0.00010455139,0.000013083259,0.000006462621,0.0000037446575,0.00007887235,0.0000015719348,0.00012587526],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997719,0.00003190712,0.00003393885,0.000067157285,0.00006197437,0.00003304975],"domain_scores_gemma":[0.99920005,0.000093427276,0.00049213396,0.000035540084,0.00006476384,0.000114025825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031514413,0.00032617757,0.000382468,0.0012479572,0.00048662102,0.00054365204,0.00022365402,0.00046948614,0.0022160427],"category_scores_gemma":[0.0013634344,0.00017028692,0.000158103,0.0008555211,0.0004561896,0.00048176452,0.00060644554,0.00030396404,0.00029001178],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033996737,0.000047888934,0.9899294,0.000059153666,0.000053799547,0.0003599255,0.00044980092,0.000037033977,0.0028110882,0.000045060482,0.000089641944,0.0057771006],"study_design_scores_gemma":[0.0000023735113,0.000073999836,0.99865556,0.0000063696675,0.000013053491,0.00081301096,0.00017027081,0.00003181692,0.000111689216,0.000058889604,0.00006067135,0.0000022600498],"about_ca_topic_score_codex":0.0022322936,"about_ca_topic_score_gemma":0.0031769702,"teacher_disagreement_score":0.0022322936,"about_ca_system_score_codex":0.00017933891,"about_ca_system_score_gemma":0.00015461439,"threshold_uncertainty_score":0.0074133873},"labels":[],"label_agreement":null},{"id":"W7117368559","doi":"10.1177/13524585251396433","title":"Safety and efficacy of opicinumab in participants with relapsing multiple sclerosis (AFFINITY Part 1): A randomized, controlled, phase 2 trial","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"Biogen","keywords":"Multiple sclerosis; Clinical trial; Phase (matter); Phases of clinical research; Central nervous system disease; Fingolimod","score_opus":0.10943033343178012,"score_gpt":0.3429658681211005,"score_spread":0.23353553468932042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117368559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9713765,0.009641848,0.0006639627,0.0012307337,0.00055170996,0.011717225,0.0022668252,0.00013354157,0.0024177115],"genre_scores_gemma":[0.96933293,0.0048847347,0.0022230174,0.0020867984,0.0007605061,0.015178707,0.0015105271,0.000029401981,0.003993376],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99894947,0.00061058754,0.00007884153,0.00017529914,0.00007803334,0.00010778579],"domain_scores_gemma":[0.9985232,0.00042442163,0.00048041862,0.00009645776,0.0001331315,0.0003424215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026469536,0.0016609376,0.0024112873,0.00036994126,0.0006353132,0.000996999,0.00081513287,0.0025634752,0.009637579],"category_scores_gemma":[0.002899184,0.0006197291,0.001734095,0.00036338842,0.0008559537,0.0011057315,0.00042548732,0.0020111755,0.001097447],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9819724,0.0045726374,0.00064725947,0.0009833362,0.0007770522,0.00003129799,0.000047573823,0.00006172595,0.0017295185,0.00005057296,0.0005312107,0.008595374],"study_design_scores_gemma":[0.96062887,0.036572553,0.0016249407,0.000049046525,0.0004365145,0.000023433187,0.000013002529,0.00007400862,0.00015446197,0.000058078338,0.0003577975,0.0000072078556],"about_ca_topic_score_codex":0.0006392825,"about_ca_topic_score_gemma":0.0017953577,"teacher_disagreement_score":0.009637579,"about_ca_system_score_codex":0.0006610536,"about_ca_system_score_gemma":0.0012222317,"threshold_uncertainty_score":0.032240868},"labels":[],"label_agreement":null},{"id":"W795514964","doi":"10.1177/1352458515593822","title":"PML in DMF-treated patients with normal lymphocytes: Worried well or well to be worried?","year":2015,"lang":"en","type":"letter","venue":"Multiple Sclerosis Journal","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Multiple sclerosis; Medicine; Psychology; Psychiatry","score_opus":0.056740762744539784,"score_gpt":0.24693289939564025,"score_spread":0.19019213665110046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W795514964","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5276229,0.01813882,0.0006973942,0.40054184,0.005370158,0.00009460697,0.00039855612,0.000126271,0.04700947],"genre_scores_gemma":[0.93390816,0.0039534876,0.00034306938,0.052182335,0.006338452,0.0000172132,0.00010182579,0.00001571713,0.0031397936],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.99939096,0.0001677946,0.00010660538,0.000065292406,0.000087237604,0.00018210754],"domain_scores_gemma":[0.99869365,0.0005430444,0.00023373062,0.000044172695,0.00013416518,0.00035126475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004896081,0.00044017745,0.00089500233,0.00064048235,0.0017411942,0.0014665457,0.00055235706,0.006023719,0.0028757341],"category_scores_gemma":[0.0067693186,0.00027692303,0.0007205839,0.000787416,0.00074682955,0.0013784565,0.00048025238,0.0039073112,0.00076156424],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008471164,0.00025303214,0.17187764,0.00019799183,0.00008790025,0.76332814,0.0016181468,0.0001590366,0.0012216212,0.0013820693,0.030141218,0.02888609],"study_design_scores_gemma":[0.00033436198,0.0007385526,0.104189344,0.00055456936,0.00024403332,0.8574689,0.0058353906,0.0011610246,0.0006511248,0.0042988914,0.024430756,0.00009305197],"about_ca_topic_score_codex":0.004152383,"about_ca_topic_score_gemma":0.0039675976,"teacher_disagreement_score":0.006023719,"about_ca_system_score_codex":0.0015276492,"about_ca_system_score_gemma":0.000787911,"threshold_uncertainty_score":0.0110839605},"labels":[],"label_agreement":null}]}